Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AASDH "ACSF4, LYS2, NRPS998" ENSG00000157426 "Aminoadipate-semialdehyde dehydrogenase" Q4L235 4 56338287-56387508 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036472, HPA036473" Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "HPA036472: AB_2675142, HPA036473: AB_10673656" "unprognostic (1.95e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (5.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (8.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-3)" "unprognostic (1.59e-1)" "unprognostic (1.73e-1)" "unprognostic (4.52e-2)" "unprognostic (1.85e-3)" 4.3 4.9 3.9 4.7 4.6 4.5 8.4 6.1 4.2 5.8 4.0 4.5 4.5 6.4 8.1 4.6 7.0 4.4 3.7 3.6 4.2 6.7 6.5 4.5 6.4 4.5 4.5 8.4 3.8 7.2 4.2 5.0 4.6 6.4 5.8 11.8 5.6 5.4 4.2 7.1 4.2 5.7 4.1 5.9 4.7 5.0 4.3 6.2 7.1 4.2 6.7 4.3 4.3 5.3 5.0 3.3 8.6 6.6 12.8 14.7 5.3 6.2 7.5 6.3 5.4 3.8 10.2 10.9 5.7 6.8 4.8 3.1 6.3 6.3 7.0 4.4 6.3 5.1 6.3 4.9 11.4 9.4 3.7 8.5 10.2 6.7 10.0 9.1 9.8 6.9 11.9 5.4 7.2 4.9 11.1 7.8 4.8 9.1 4.8 8.2 4.2 5.1 9.0 4.2 5.7 5.5 7.1 11.2 7.2 8.1 8.9 6.0 6.7 4.2 5.6 4.4 4.5 4.3 3.6 7.1 6.6 8.4 4.6 0.0 2.0 1.6 2.8 2.5 3.7 2.4 2.8 2.4 2.2 3.0 4.0 3.0 0.4 2.8 1.6 1.9 2.9 1.3 3.9 4.6 6.1 4.2 3.6 4.2 4.5 4.5 4.6 4.1 4.3 5.3 14.1 6.4 16.2 59.4 17.3 10.1 13.9 26.0 13.6 38.7 21.7 21.2 10.1 14.3 17.3 18.4 27.1 40.7 22.8 9.4 25.4 9.9 26.0 22.0 28.6 13.9 12.1 24.0 26.9 7.6 19.4 17.9 14.8 21.0 20.3 26.4 19.6 21.9 15.4 35.3 36.7 14.7 22.4 17.6 8.7 5.2 16.8 12.6 10.6 19.7 21.5 31.3 20.6 36.2 39.1 6.0 13.4 18.0 9.9 14.2 8.0 29.2 11.2 56.4 6.6 22.5 11.9 43.3 35.0 13.6 15.6 23.9 16.5 23.8 15.9 8.1 ABRACL "C6orf115, Costars, HSPC280, PRO2013" ENSG00000146386 "ABRA C-terminal like" Q9P1F3 6 139028745-139043302 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 440.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 501.5;NB-4: 530.8;U-937: 515.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030217 Enhanced Approved Nucleoplasm,Cytosol NA NA 9200000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA030217: AB_10602335" "unprognostic (1.10e-2)" "unprognostic (1.63e-1)" "unprognostic (9.30e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.72e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.21e-1)" "unprognostic (8.17e-2)" "unprognostic (2.16e-1)" "unprognostic (3.07e-3)" "unprognostic (5.90e-3)" "unprognostic (3.63e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.65e-6)" 20.1 9.6 16.8 73.7 16.2 87.7 44.9 13.5 20.8 20.7 14.7 95.0 74.1 22.0 136.0 42.0 12.4 36.0 13.3 18.6 15.7 50.0 60.7 31.2 123.1 14.7 14.6 4.1 16.1 49.1 14.4 29.1 16.2 16.3 86.5 5.4 40.8 12.2 3.0 38.8 74.4 23.5 14.9 73.9 34.4 32.3 16.4 139.6 42.4 7.5 87.9 79.6 17.1 16.0 76.8 40.7 100.7 94.8 39.7 62.2 110.6 59.7 42.9 44.5 91.2 91.2 87.4 0.4 105.8 59.8 189.5 112.9 90.4 130.0 51.9 204.4 167.4 297.8 20.7 31.6 57.6 501.5 130.5 55.9 108.2 59.9 49.1 79.4 237.5 204.9 38.4 100.4 129.5 162.7 314.2 530.8 120.9 119.1 78.5 199.8 62.3 23.8 121.7 225.0 225.4 24.8 40.5 112.3 194.5 141.9 45.1 369.8 175.7 28.2 24.0 58.9 107.7 54.1 169.2 20.9 35.7 515.5 84.2 232.3 178.0 114.2 161.1 334.3 252.2 93.8 259.3 208.2 193.9 96.9 250.9 235.9 48.8 152.1 514.5 215.9 260.2 347.8 16.8 16.2 13.5 20.8 18.6 15.7 14.7 14.6 16.2 14.9 16.4 16.0 54.2 19.2 22.2 2.0 87.1 139.6 71.4 195.2 108.1 0.3 86.6 67.8 3.8 27.1 126.2 44.1 0.0 77.1 151.3 304.5 60.7 145.3 4.8 85.8 20.1 55.0 43.1 75.7 12.8 145.0 207.7 23.5 55.5 129.0 79.4 59.9 53.6 254.3 353.1 0.0 9.1 116.8 162.8 286.1 133.9 13.7 4.7 187.6 87.2 5.6 167.9 49.8 189.5 1.0 1.0 167.4 250.6 12.8 121.0 47.9 247.5 440.3 74.1 1.3 32.9 7.2 37.3 3.6 7.7 116.6 90.1 48.6 198.5 17.7 123.6 133.8 AC069544.1 ENSG00000284024 "Zinc finger and SCAN domain containing 29" 10 14838302-14846999 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.8;Breast myoepithelial cells: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.2;Granulosa cells: 2.3;Proximal tubular cells: 1.3;Theca cells: 4.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" 4.3 4.1 2.8 6.2 2.7 8.9 6.8 6.8 4.5 5.5 1.7 5.9 5.4 5.9 3.4 6.7 3.7 6.1 3.6 3.8 3.3 3.0 3.8 3.1 8.4 2.5 2.2 7.3 5.9 5.3 3.6 7.9 2.5 5.3 6.3 10.1 3.8 4.3 2.4 7.6 5.2 4.4 2.2 5.8 6.5 6.8 2.8 9.7 5.3 4.3 7.2 6.3 2.9 3.8 13.9 9.7 15.3 14.9 9.1 7.8 15.1 12.6 5.6 15.7 20.3 16.5 10.0 21.5 6.1 7.9 8.4 14.5 24.1 12.5 20.2 11.9 14.3 22.0 20.1 10.8 11.1 8.9 13.3 5.8 10.2 25.0 11.1 7.4 9.9 13.2 25.1 16.8 18.7 12.8 18.2 8.0 13.5 8.0 6.1 15.8 13.2 14.3 8.8 6.4 12.1 14.6 11.8 13.9 12.6 9.7 9.9 10.2 8.1 16.0 16.9 18.2 12.8 9.9 12.9 19.9 8.3 13.5 7.5 2.9 1.6 1.9 1.8 2.0 2.0 2.1 1.7 1.7 1.6 2.2 2.0 2.5 1.6 3.5 2.9 2.2 1.8 1.7 2.8 2.7 6.8 4.5 3.8 3.3 2.5 2.2 2.5 2.2 2.8 3.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 1.2 1.8 0.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 AC092329.3 ENSG00000283201 "Zinc finger protein 724" 19 23222755-23274221 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Club cells: 1.8;Distal tubular cells: 3.9;Proximal tubular cells: 3.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 12.3" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" 0.9 0.8 1.1 1.1 1.1 1.9 1.4 2.8 1.2 0.8 0.9 1.3 0.7 1.3 3.7 0.7 1.4 0.5 0.7 1.5 0.9 1.9 1.9 1.2 1.5 0.8 0.4 2.1 0.8 1.9 0.0 0.6 0.9 1.9 1.6 1.1 0.6 1.0 0.2 1.0 0.7 1.0 0.0 1.1 1.1 1.2 1.2 2.7 2.1 0.2 1.5 1.3 0.0 0.9 2.5 0.7 9.7 5.6 1.4 0.7 6.0 2.6 1.9 4.1 5.5 4.1 1.3 0.2 1.9 1.2 3.0 1.6 7.0 1.8 4.2 1.8 4.5 2.2 0.7 0.9 0.5 0.0 2.3 0.9 0.5 3.9 0.8 1.0 0.1 6.1 2.4 0.0 2.0 1.4 7.0 1.7 6.3 0.0 2.6 8.4 4.8 1.7 1.5 12.3 3.9 3.2 0.0 0.0 0.6 4.2 3.5 0.2 0.1 0.3 0.7 4.4 3.3 0.0 1.9 7.5 0.0 0.6 0.7 0.8 0.4 0.4 0.9 0.2 0.9 0.4 0.6 0.8 0.5 0.9 0.7 0.6 0.3 0.9 0.3 1.4 1.2 0.4 1.1 1.1 2.8 1.2 1.5 0.9 0.8 0.4 0.9 0.0 1.2 0.9 0.4 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 3.9 0.3 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.8 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 ACAP2 "CENTB2, CNT-B2, KIAA0041" ENSG00000114331 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 2" Q15057 3 195274745-195443044 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 215.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034807, HPA034808" Supported Approved Endosomes NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" Endosomes "HPA034807: AB_10669896, HPA034808: AB_10673103" "unprognostic (9.13e-2)" "unprognostic (1.75e-3)" "unprognostic (7.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.90e-2)" "unprognostic (5.64e-2)" "unprognostic (3.08e-3)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.49e-2)" "unprognostic (2.36e-2)" "unprognostic (1.01e-2)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (3.77e-2)" "unprognostic (8.54e-2)" 15.9 10.2 10.7 22.2 10.3 39.6 13.5 21.4 14.5 14.3 1.8 17.0 14.0 14.4 10.9 21.7 12.2 14.2 8.3 14.1 6.4 10.3 11.8 15.7 26.9 2.5 4.2 19.0 9.0 13.2 8.5 15.5 6.1 10.7 17.3 29.4 9.5 10.4 5.3 15.5 15.3 14.5 3.3 23.6 14.0 15.1 5.0 21.0 21.7 9.7 27.9 13.5 11.5 7.7 34.6 13.5 21.5 21.1 34.3 41.9 31.6 28.0 37.2 20.5 21.4 18.5 19.8 38.7 65.7 25.8 20.0 21.6 16.5 14.0 29.4 43.4 9.7 38.5 14.2 7.6 33.5 52.5 26.7 32.3 24.0 20.4 46.1 17.6 22.7 21.4 19.1 37.0 30.3 20.3 33.7 19.1 13.0 19.8 18.1 39.7 24.8 27.8 14.1 32.2 23.8 11.5 30.7 27.4 32.9 18.2 51.7 30.6 40.3 25.9 14.7 34.6 32.7 21.8 50.2 84.0 19.1 56.2 27.5 62.8 55.2 55.3 27.5 49.0 21.2 39.3 26.1 21.3 32.9 45.6 22.0 22.4 215.8 17.6 59.0 34.4 26.2 25.4 10.7 10.3 21.4 14.5 14.1 6.4 2.5 4.2 6.1 3.3 5.0 7.7 110.7 44.8 40.9 103.8 103.1 44.5 28.8 45.1 88.2 58.7 43.1 50.3 17.9 22.8 43.4 31.3 77.2 20.2 101.9 75.8 19.6 24.1 11.1 49.7 60.4 74.1 51.6 50.1 141.2 24.3 22.2 62.2 44.4 49.7 39.9 33.5 57.5 32.5 65.4 121.1 143.1 44.4 22.4 115.7 67.5 9.7 46.6 110.8 35.6 143.4 122.3 29.1 68.0 132.7 130.1 31.7 70.7 37.6 67.6 41.5 39.3 28.6 45.1 92.6 59.2 43.8 61.4 39.6 26.7 143.7 51.7 29.0 85.1 43.0 37.6 38.6 ADAR "ADAR1, G1P1, IFI4" ENSG00000160710 "Adenosine deaminase RNA specific" P55265 1 154581695-154628013 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing" "DNA-binding, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003890, HPA051519, CAB056157" Enhanced Enhanced Nucleoplasm,Nucleoli No No "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520" "unprognostic (3.46e-1)" "unprognostic (8.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.83e-2)" "unprognostic (2.38e-1)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (2.90e-1)" "unprognostic (4.13e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.30e-5)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (9.00e-2)" "unprognostic (3.94e-2)" 41.9 44.7 30.4 57.2 29.9 47.1 41.1 18.0 35.1 49.4 16.3 42.9 46.4 50.2 26.3 37.9 50.3 45.6 36.1 31.5 40.0 51.7 56.1 54.6 66.1 32.1 33.8 54.9 40.6 62.8 53.9 46.5 34.8 42.8 44.4 47.9 59.4 43.0 18.8 39.9 52.8 56.6 39.2 73.5 40.3 34.4 37.8 85.2 47.1 27.6 65.0 50.5 40.0 25.5 93.2 103.1 84.4 104.8 87.4 88.5 97.8 59.5 132.7 209.8 183.4 87.8 85.3 162.6 97.7 98.7 112.4 85.4 111.9 115.5 109.8 159.1 52.3 84.9 66.2 48.4 96.7 122.8 83.8 86.2 84.7 100.4 104.1 81.2 104.5 112.4 82.4 111.6 72.0 107.8 165.0 43.3 139.7 125.5 74.6 140.1 74.2 131.2 67.6 106.1 84.8 100.2 104.4 167.9 126.2 128.1 113.4 148.2 94.3 67.5 68.5 58.8 71.5 132.9 179.0 177.6 70.2 78.4 81.0 7.8 8.1 15.0 10.8 9.9 10.2 9.0 10.6 11.2 7.8 5.8 9.8 10.0 29.1 8.6 9.4 6.3 9.1 7.4 30.4 29.9 18.0 35.1 31.5 40.0 32.1 33.8 34.8 39.2 37.8 25.5 73.3 83.3 51.2 37.5 80.5 33.3 39.4 39.9 32.5 94.5 43.6 36.6 22.1 45.8 44.0 47.8 95.9 41.2 103.0 73.3 9.8 49.2 4.2 48.9 61.0 86.7 63.1 45.2 44.8 66.9 57.8 49.1 56.6 52.4 62.1 88.6 84.9 93.8 53.5 168.2 53.2 53.9 34.6 104.1 43.9 13.1 73.7 78.0 19.6 32.8 110.2 37.9 126.7 38.2 39.7 69.6 62.7 59.0 87.5 61.1 86.7 42.5 50.0 80.2 52.6 40.1 45.2 11.4 35.0 37.9 40.3 31.5 85.6 66.5 56.2 53.8 AFF3 "LAF4, MLLT2-like" ENSG00000144218 "AF4/FMR2 family member 3" P51826 2 99545419-100192428 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 154.9;Excitatory neurons: 491.3;Inhibitory neurons: 300.7;Oligodendrocyte precursor cells: 211.6" "Group enriched" "Detected in many" 5 "breast cancer: 11.4;prostate cancer: 7.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9" "Group enriched" "Detected in many" 17 "B-cells: 44.2;dendritic cells: 23.9" "Cell line enhanced" "Detected in many" "Daudi: 51.1;U-698: 56.5" "Low region specificity" "Detected in all" "HPA044512, HPA053379" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Cytosol "HPA044512: AB_10795984, HPA053379: AB_2682133" "unprognostic (1.05e-2)" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.88e-3)" "unprognostic (1.02e-1)" "unprognostic (4.98e-5)" "unprognostic (1.11e-3)" "unprognostic (3.04e-2)" "unprognostic (8.75e-2)" "unprognostic (3.07e-1)" "unprognostic (1.95e-3)" "unprognostic (7.57e-2)" "prognostic unfavorable (5.64e-4)" "unprognostic (6.40e-3)" "unprognostic (6.79e-2)" "unprognostic (3.69e-2)" "unprognostic (7.87e-3)" 3.3 1.6 3.1 6.2 3.9 11.2 11.6 17.4 13.2 3.5 0.0 5.1 1.1 7.7 0.8 3.5 4.5 2.2 4.3 9.7 5.0 1.4 1.7 6.5 14.2 2.2 0.0 6.3 0.4 0.1 4.4 6.2 1.8 16.2 2.2 4.2 1.9 2.5 0.7 0.9 6.0 5.9 0.0 7.3 4.6 5.4 0.0 7.7 1.2 0.7 12.2 6.7 2.2 9.8 0.2 0.0 18.0 6.4 0.0 0.6 0.0 2.8 0.7 5.6 1.9 0.0 0.0 51.1 0.1 3.8 12.4 0.2 0.5 0.0 4.0 14.3 6.3 0.0 0.0 0.0 0.4 0.2 12.4 0.8 0.0 12.8 0.2 13.8 0.0 2.2 0.3 0.1 0.0 0.1 4.3 0.3 1.8 0.0 3.2 7.5 0.0 0.3 0.0 0.0 17.4 6.5 0.0 0.3 11.0 1.5 17.9 16.5 6.7 19.1 3.4 0.5 2.9 0.8 0.1 56.5 15.9 1.5 2.0 0.6 0.5 0.1 0.0 0.5 0.3 31.0 0.2 0.0 5.1 44.2 1.9 0.0 0.0 1.0 0.4 23.9 0.0 0.8 3.1 3.9 17.4 13.2 9.7 5.0 2.2 0.0 1.8 0.0 0.0 9.8 1.2 6.4 40.9 41.8 154.9 1.8 0.4 0.0 1.8 21.8 78.9 37.7 11.1 0.0 3.7 0.0 12.5 0.4 32.8 0.1 0.0 0.0 33.9 0.9 19.8 6.0 22.9 3.4 491.3 0.0 0.2 13.5 1.1 1.1 0.0 31.6 0.7 1.2 1.8 47.1 300.7 0.5 0.0 9.2 18.2 38.5 10.8 16.5 14.2 66.5 5.2 6.8 0.0 211.6 46.7 0.0 0.1 21.1 0.8 14.3 0.1 1.9 0.0 1.7 0.0 1.1 8.5 10.5 9.8 0.0 1.3 0.1 6.1 5.7 0.6 0.3 AGPS "ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY" ENSG00000018510 "Alkylglycerone phosphate synthase" O00116 2 177392746-177567024 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 262.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030209, HPA030210, HPA030211" Supported Supported Peroxisomes "Intracellular and membrane" NA NA 69000 "Cluster 26: Non-specific - Mitochondria" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Peroxisomes "HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195" "unprognostic (7.10e-2)" "unprognostic (1.20e-2)" "unprognostic (1.76e-3)" "unprognostic (3.79e-2)" "unprognostic (8.34e-2)" "unprognostic (3.78e-2)" "prognostic unfavorable (8.62e-6)" "unprognostic (1.23e-2)" "unprognostic (7.23e-2)" "unprognostic (5.41e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (7.74e-2)" "prognostic favorable (9.45e-4)" "unprognostic (7.18e-2)" "unprognostic (3.46e-1)" "unprognostic (4.94e-3)" "unprognostic (1.92e-2)" 14.3 9.2 4.4 15.6 6.9 19.6 13.9 7.1 6.9 14.3 4.6 20.1 11.1 14.6 6.5 12.7 9.8 11.3 10.4 4.7 6.6 18.1 19.3 13.7 11.9 8.9 7.0 7.8 11.4 18.5 3.4 13.2 8.2 7.0 21.9 6.4 8.3 8.8 11.7 4.5 13.1 21.1 7.8 8.7 9.9 16.3 6.3 16.1 12.6 12.6 12.8 14.6 5.2 11.9 43.1 36.3 23.3 19.0 32.2 33.2 33.3 29.6 21.9 34.5 34.8 70.6 34.0 58.5 59.5 45.0 46.3 47.5 64.4 45.1 47.8 51.4 16.7 77.6 56.5 75.8 31.9 82.3 63.5 28.6 28.7 58.6 44.6 33.3 75.3 42.1 44.9 26.3 45.7 0.1 59.9 22.4 33.3 42.7 30.9 47.0 65.1 32.7 60.0 65.0 22.0 31.3 66.2 5.8 43.0 58.1 0.4 35.4 70.0 29.4 61.9 26.8 64.2 28.7 59.0 23.6 29.4 43.1 11.8 2.6 3.3 5.8 1.9 4.0 2.9 1.7 3.0 2.4 3.6 1.1 2.7 1.6 1.5 2.8 3.6 0.1 4.3 2.2 4.4 6.9 7.1 6.9 4.7 6.6 8.9 7.0 8.2 7.8 6.3 11.9 20.2 16.0 13.1 29.4 10.7 10.8 6.5 15.5 12.0 11.5 19.2 6.7 20.0 20.0 13.0 14.7 2.1 14.1 15.5 25.6 13.7 20.9 262.2 25.2 17.2 14.0 19.8 20.8 53.0 23.2 20.6 23.0 18.8 25.4 64.1 16.6 11.7 31.0 31.8 15.2 61.7 30.4 16.2 30.0 31.8 41.4 14.6 28.7 14.2 56.2 36.0 12.0 21.6 45.8 83.8 23.9 17.4 13.9 14.1 3.8 15.3 46.5 21.6 7.6 6.6 16.8 16.4 41.7 22.2 16.2 9.8 7.0 19.0 22.7 26.0 6.1 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 11.4 13.3 10.5 12.3 12.4 10.6 12.3 11.4 13.6 11.5 15.1 11.4 9.5 12.4 8.8 10.6 10.4 10.7 7.4 11.3 11.6 13.1 8.1 11.0 16.0 9.9 10.7 13.5 8.4 15.1 7.5 12.2 10.6 10.9 11.6 15.3 9.8 11.7 7.2 9.5 10.1 13.3 10.4 14.9 11.1 14.2 13.8 14.1 15.1 9.4 12.5 11.3 10.2 14.7 18.1 21.3 13.9 9.7 18.0 22.5 25.7 20.6 21.9 22.4 26.7 23.2 10.6 15.4 13.6 16.4 19.4 18.8 18.1 17.2 30.4 12.8 15.4 13.2 20.2 11.4 17.0 9.7 20.7 19.1 21.1 20.5 25.1 25.0 18.3 18.5 8.6 7.5 23.6 13.1 18.1 14.3 9.1 25.1 7.2 11.8 45.5 8.1 18.7 11.3 4.7 14.1 23.6 11.0 19.7 84.8 26.7 10.7 16.1 17.2 14.2 14.8 19.3 9.3 10.7 18.8 22.8 11.5 17.0 4.9 9.7 12.6 8.6 14.4 8.0 8.4 8.4 9.4 8.5 9.2 10.0 8.9 33.8 7.6 13.9 6.3 7.1 4.3 10.5 12.4 11.4 13.6 11.3 11.6 9.9 10.7 10.6 10.4 13.8 14.7 13.4 3.2 12.3 71.2 24.4 7.0 9.7 8.9 10.2 24.6 11.1 9.0 8.4 21.5 11.9 5.5 16.7 14.9 16.8 15.8 1.9 9.9 12.8 11.0 14.8 12.6 7.2 15.2 55.1 7.2 11.1 11.7 14.8 10.8 10.1 18.0 16.8 13.6 16.5 33.7 54.6 9.9 12.2 35.1 10.5 13.9 15.2 21.4 5.4 61.8 32.3 11.7 25.7 51.8 78.5 7.9 15.2 13.9 11.2 15.6 14.6 5.7 15.3 23.2 19.7 10.5 11.2 23.1 23.6 11.0 7.7 14.0 19.0 15.6 11.8 12.1 ALG10 "ALG10A, DIE2, FLJ14751" ENSG00000139133 "ALG10 alpha-1,2-glucosyltransferase" Q5BKT4 12 34022468-34029694 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043329, HPA063387" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 12: Non-specific - Cell cycle regulation" "Endoplasmic reticulum" "HPA043329: AB_2678432, HPA063387: AB_2685000" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (3.16e-3)" "unprognostic (2.80e-2)" "unprognostic (9.23e-2)" "unprognostic (3.49e-2)" "unprognostic (5.88e-4)" "unprognostic (2.13e-1)" "unprognostic (1.73e-2)" "unprognostic (8.01e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "unprognostic (9.29e-2)" "unprognostic (8.99e-2)" "unprognostic (1.53e-1)" "unprognostic (2.43e-1)" "unprognostic (6.45e-2)" 2.3 2.6 1.3 2.7 1.5 4.1 2.8 1.7 1.1 1.9 0.9 2.3 1.6 2.2 2.7 2.1 3.4 1.8 1.0 0.8 1.5 1.9 2.9 1.8 3.7 1.9 1.2 2.3 1.5 2.3 0.6 2.3 1.6 2.6 1.9 3.3 1.5 1.9 0.9 1.9 1.8 2.1 1.6 2.9 2.0 2.6 1.3 3.6 2.8 1.3 2.9 1.3 0.9 2.2 5.3 5.8 4.0 7.0 4.6 4.3 14.0 5.1 4.7 5.4 9.8 8.8 12.6 10.3 7.3 2.6 8.2 7.8 7.9 6.8 7.9 13.0 7.2 9.2 6.7 3.9 1.8 11.4 8.1 4.0 3.6 11.3 9.3 2.6 3.7 8.1 13.9 13.6 5.5 6.8 8.4 6.3 15.1 3.2 7.7 6.5 14.8 8.3 3.2 7.8 3.8 3.0 9.4 3.8 5.6 11.7 8.6 3.2 7.5 7.4 10.7 11.3 6.5 7.4 14.7 17.3 5.0 4.8 6.2 0.0 1.0 1.7 0.6 0.4 0.9 0.8 0.9 0.4 0.6 0.8 1.1 1.3 0.1 0.8 0.5 0.7 1.2 0.5 1.3 1.5 1.7 1.1 0.8 1.5 1.9 1.2 1.6 1.6 1.3 2.2 3.0 6.4 0.5 1.3 5.1 1.5 3.0 4.3 2.8 4.6 2.0 1.7 0.8 2.8 5.1 5.5 4.2 6.8 3.5 1.4 1.9 2.4 1.0 3.1 2.8 2.3 1.2 7.0 1.5 3.8 5.5 2.7 3.1 2.2 1.3 3.6 0.7 2.9 3.3 1.7 1.8 1.7 2.0 2.8 1.9 0.3 1.5 2.2 0.0 1.9 3.3 3.4 1.0 2.5 1.8 3.3 0.6 1.2 4.0 0.8 1.2 1.3 3.9 4.2 0.0 2.5 2.0 12.4 5.8 4.3 2.7 3.1 3.2 2.6 1.9 1.8 ALG10B KCR1 ENSG00000175548 "ALG10 alpha-1,2-glucosyltransferase B" Q5I7T1 12 38316762-38329721 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043329, HPA063387" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA043329: AB_2678432, HPA063387: AB_2685000" "unprognostic (4.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-1)" "unprognostic (1.25e-1)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (4.43e-2)" "unprognostic (8.58e-2)" "unprognostic (7.40e-2)" "unprognostic (8.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.30e-3)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (2.28e-1)" 2.9 3.5 2.1 3.0 2.3 4.3 5.2 3.1 2.5 2.8 1.8 2.1 2.4 3.7 3.7 1.8 3.4 2.6 2.2 1.8 2.0 3.3 3.7 2.5 4.6 2.5 2.3 5.0 2.9 3.7 1.1 5.0 2.6 3.4 2.6 9.1 2.8 2.2 1.5 4.3 2.6 2.5 2.6 4.6 3.7 2.6 2.2 4.0 4.2 2.4 3.7 1.5 1.4 3.1 5.1 4.6 6.1 6.2 3.0 5.5 6.3 4.0 2.0 5.3 4.6 1.7 15.2 8.0 7.2 2.3 4.1 5.3 5.7 4.4 7.6 5.2 6.8 8.4 8.4 3.5 3.5 11.3 6.1 3.1 5.7 7.5 5.5 4.7 4.2 10.4 9.6 4.6 4.8 3.9 7.5 8.9 7.8 0.5 4.6 2.5 13.2 6.3 4.4 6.4 1.8 6.3 7.1 2.3 5.0 6.6 10.6 4.6 3.3 5.5 6.6 4.9 5.2 3.6 10.1 12.5 4.7 7.7 7.3 0.3 0.4 0.6 0.3 0.5 0.5 0.4 0.3 0.4 0.3 1.3 0.5 0.7 0.1 0.4 0.4 0.7 1.2 0.3 2.1 2.3 3.1 2.5 1.8 2.0 2.5 2.3 2.6 2.6 2.2 3.1 7.1 6.4 13.9 9.1 2.6 2.0 3.4 3.3 4.0 14.9 5.0 3.8 3.9 0.0 7.0 3.7 33.3 16.1 2.1 0.9 7.9 4.3 0.3 6.5 6.2 5.7 0.0 2.5 4.8 5.8 9.6 4.8 2.0 4.6 1.3 9.5 6.8 7.1 4.8 10.1 5.7 1.9 4.1 1.6 2.0 1.8 4.1 3.1 1.8 10.3 2.5 8.0 1.0 9.0 9.1 4.5 2.0 5.7 1.6 2.0 2.6 2.6 5.2 14.5 6.6 6.5 3.2 10.7 4.7 3.1 1.8 8.1 3.0 4.6 2.3 2.3 ALG13 "CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W" ENSG00000101901 "ALG13 UDP-N-acetylglucosaminyltransferase subunit" Q9NP73 X 111665811-111760649 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002853, HPA005498" Approved Approved Vesicles,Cytosol NA NA 11000000 "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Vesicles Cytosol "HPA002853: AB_1078131, HPA005498: " "unprognostic (4.13e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-2)" "unprognostic (1.51e-1)" "unprognostic (6.97e-2)" "unprognostic (6.14e-2)" "unprognostic (2.74e-1)" "unprognostic (6.55e-3)" "unprognostic (2.26e-2)" "unprognostic (3.39e-3)" "unprognostic (1.73e-2)" "unprognostic (4.62e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.45e-2)" 15.1 17.9 10.5 18.8 11.7 16.6 18.3 11.5 19.0 17.2 12.3 18.2 13.7 16.1 20.5 14.7 15.4 16.4 13.2 10.2 13.8 21.0 23.8 13.8 23.4 12.6 12.1 15.8 14.7 23.4 17.9 14.1 13.3 17.7 19.4 11.8 15.6 13.4 9.2 19.4 17.3 17.5 11.4 18.5 15.5 17.4 11.8 17.3 18.2 9.9 20.1 21.3 14.7 16.6 22.3 24.4 21.8 13.8 13.8 19.6 12.3 17.7 18.3 22.4 27.5 24.9 23.1 19.5 33.0 24.7 46.5 12.6 26.1 12.5 23.5 14.4 17.6 10.7 26.1 28.4 20.3 19.5 40.5 23.6 22.8 18.0 38.6 23.3 24.8 21.8 23.9 53.5 22.5 55.8 16.4 17.6 19.9 66.3 33.6 12.8 13.9 26.7 36.6 34.0 13.1 19.1 25.2 15.2 16.3 21.7 13.6 18.5 16.7 19.2 9.7 24.9 34.4 25.8 47.1 31.5 20.5 25.5 15.2 39.5 15.8 16.6 9.5 16.3 9.3 10.6 10.6 9.2 18.5 12.1 13.0 10.8 3.0 4.6 12.9 9.5 14.6 9.6 10.5 11.7 11.5 19.0 10.2 13.8 12.6 12.1 13.3 11.4 11.8 16.6 50.9 16.0 30.8 33.6 127.9 35.2 65.8 53.5 33.6 15.1 33.9 31.6 18.7 22.8 36.0 18.4 10.4 27.3 73.9 39.2 45.0 37.4 21.1 48.2 31.1 37.4 26.5 27.1 64.7 52.1 39.1 34.6 37.2 47.9 109.8 15.7 28.2 28.4 42.5 11.8 57.4 49.0 46.8 39.2 52.3 9.4 21.5 56.1 28.4 83.4 41.8 16.0 29.9 41.7 77.5 58.0 55.6 16.1 60.4 46.9 38.5 55.5 35.3 16.5 26.3 38.7 46.2 32.6 22.4 26.5 35.4 48.7 71.1 28.8 32.8 64.6 AMMECR1 ENSG00000101935 "AMMECR nuclear protein 1" Q9Y4X0 X 110194186-110440318 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 83.1;Excitatory neurons: 92.8;Inhibitory neurons: 108.7;Rod photoreceptor cells: 87.3;Syncytiotrophoblasts: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000590, HPA051762" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Mitochondria "HPA000590: AB_2666037, HPA051762: AB_2681596" "unprognostic (7.77e-2)" "unprognostic (1.93e-1)" "unprognostic (2.06e-1)" "unprognostic (5.17e-2)" "unprognostic (1.25e-1)" "unprognostic (6.87e-2)" "unprognostic (1.66e-3)" "unprognostic (6.55e-2)" "unprognostic (5.98e-2)" "prognostic favorable (6.62e-5)" "unprognostic (3.61e-2)" "unprognostic (3.96e-2)" "unprognostic (2.43e-3)" "unprognostic (3.33e-1)" "unprognostic (1.02e-1)" "prognostic favorable (8.44e-4)" "unprognostic (7.82e-2)" 3.6 2.9 1.7 3.7 1.7 13.4 3.4 1.8 2.0 2.9 8.5 3.7 3.1 2.3 2.1 7.9 3.3 2.3 1.1 1.5 1.7 3.4 3.3 2.8 4.2 1.3 1.3 5.5 2.0 2.2 2.0 7.0 1.2 2.2 3.9 14.5 2.8 1.9 1.3 7.4 3.3 2.9 1.0 3.7 3.7 1.6 1.7 4.5 2.4 1.7 5.7 4.8 4.5 1.5 20.3 9.8 7.1 3.4 7.9 11.8 7.8 13.8 12.3 11.1 16.2 15.9 14.4 12.0 6.4 18.4 9.0 9.5 22.7 15.7 11.3 8.4 10.1 16.7 21.7 3.3 19.9 13.5 6.7 6.6 27.3 12.7 22.6 6.0 8.9 5.9 47.1 34.8 8.5 17.2 6.5 4.8 32.6 17.4 19.1 13.7 7.6 21.2 18.8 16.8 11.3 5.3 23.2 22.7 19.9 8.5 5.6 13.3 4.1 7.6 4.6 22.8 12.6 7.1 8.6 18.9 11.6 27.5 25.9 0.6 0.9 0.8 1.6 0.6 2.1 1.6 3.2 2.6 1.5 2.2 2.1 1.9 0.4 0.6 2.7 0.6 2.3 1.0 1.7 1.7 1.8 2.0 1.5 1.7 1.3 1.3 1.2 1.0 1.7 1.5 4.4 0.0 9.8 17.9 11.5 9.6 3.9 10.5 5.7 35.3 7.5 4.4 4.2 8.6 8.9 3.7 52.1 27.2 9.5 8.9 23.5 9.2 0.5 10.5 7.7 9.6 15.0 83.1 92.8 12.0 9.9 12.8 13.7 13.4 2.5 14.4 19.6 8.4 7.1 1.7 108.7 11.2 12.2 7.6 3.1 2.1 12.8 7.3 3.6 21.5 9.4 7.1 14.4 35.7 19.2 11.5 3.7 17.3 8.0 9.1 10.3 10.2 10.4 87.3 13.1 6.7 8.4 2.2 6.9 17.4 26.7 86.5 13.0 34.7 10.5 15.7 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493979-94499578 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 7.8 6.8 8.3 12.7 8.9 25.2 13.1 11.1 11.4 9.7 8.2 10.8 11.4 10.4 18.3 9.5 8.5 8.4 5.3 8.3 8.4 7.8 8.6 7.5 20.8 8.2 7.7 12.6 13.4 9.3 8.9 12.1 8.0 10.9 13.6 11.8 10.7 10.8 5.8 10.2 16.2 8.8 7.8 15.6 12.7 5.4 9.3 17.1 14.2 7.3 20.8 7.9 8.5 9.5 8.9 4.4 11.0 9.4 10.2 12.0 13.5 13.3 12.0 14.9 17.1 20.7 18.4 23.4 20.9 8.5 12.5 20.5 14.0 9.8 12.2 17.9 12.1 18.9 16.8 7.8 11.1 17.8 15.8 9.1 23.1 10.7 14.9 10.4 11.3 20.9 18.4 14.4 9.4 6.1 19.8 32.8 6.3 17.5 9.8 14.9 11.3 12.0 12.9 9.2 10.5 10.9 10.2 9.8 8.7 18.4 18.0 12.9 7.5 13.0 9.3 13.8 7.2 7.6 20.0 24.6 4.4 21.8 7.4 77.8 23.1 23.9 21.9 19.5 23.7 34.1 23.4 19.4 18.4 28.8 28.4 25.9 42.7 27.2 15.8 30.5 31.4 17.8 8.3 8.9 11.1 11.4 8.3 8.4 8.2 7.7 8.0 7.8 9.3 9.5 20.5 12.8 9.3 11.1 43.2 5.6 10.0 15.1 14.2 16.3 14.0 11.3 9.1 24.3 15.4 25.8 14.6 31.1 36.1 27.8 21.5 20.3 10.1 11.9 18.1 15.4 13.3 40.0 11.1 23.0 13.8 16.5 27.0 15.1 21.5 18.7 16.4 18.8 14.3 11.8 9.5 23.6 8.2 28.5 8.4 3.7 35.8 18.5 10.6 8.4 28.1 21.8 57.7 5.5 12.7 22.8 35.2 23.7 28.0 11.3 45.3 19.3 8.1 14.4 26.3 11.3 18.4 21.0 19.9 11.6 6.8 28.0 36.5 9.8 22.0 5.8 AP002495.1 ENSG00000254469 "XRCC1 N-terminal domain containing 1-like" Q6ZNB5 11 71865504-71928665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051121, HPA051124" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes NA "Cluster 20: T-cells - T-cell receptor" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoli "Mitotic chromosome" "HPA051121: AB_2681349, HPA051124: " "unprognostic (1.66e-1)" "unprognostic (1.19e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "unprognostic (2.39e-1)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (9.79e-4)" "unprognostic (5.91e-3)" "unprognostic (5.04e-3)" "unprognostic (7.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (3.60e-1)" "unprognostic (3.12e-3)" 1.9 2.1 1.9 2.2 2.8 4.7 3.2 4.3 2.6 2.8 2.8 2.2 2.6 3.7 5.3 2.6 2.4 2.1 2.1 1.7 2.2 2.9 2.2 1.8 4.2 2.5 1.5 4.6 3.1 2.9 2.5 2.0 2.4 3.1 3.5 7.3 2.2 2.8 1.6 4.2 2.6 2.4 0.6 2.9 2.4 3.3 2.8 3.2 3.2 1.5 3.4 2.3 2.2 5.0 2.6 6.2 4.7 4.5 1.8 1.6 3.1 2.9 2.3 3.1 3.0 6.5 6.4 5.8 2.6 2.0 3.9 8.4 4.9 3.3 3.2 8.4 4.5 9.4 7.7 4.2 1.1 4.2 3.1 2.2 1.6 5.2 3.6 2.6 4.9 8.0 6.3 7.6 3.0 4.9 4.8 3.5 4.9 9.6 4.5 3.6 16.3 4.0 3.5 3.1 6.9 6.6 4.6 4.1 9.2 3.3 5.1 2.3 4.6 2.5 4.1 4.9 1.9 5.5 8.4 7.0 4.0 4.6 3.7 2.7 1.9 1.7 2.9 3.0 1.7 2.5 5.1 3.8 2.2 3.3 4.8 4.1 2.0 1.2 1.9 4.8 4.9 1.9 1.9 2.8 4.3 2.6 1.7 2.2 2.5 1.5 2.4 0.6 2.8 5.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 AP1G1 "ADTG, CLAPG1" ENSG00000166747 "Adaptor related protein complex 1 subunit gamma 1" O43747 16 71729000-71809201 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 268.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009049, HPA041224" Approved Enhanced Vesicles,Cytosol NA NA 62000 "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles Cytosol "CAB009049: AB_2058329, HPA041224: AB_2677370" "unprognostic (4.84e-2)" "unprognostic (5.07e-2)" "unprognostic (2.65e-2)" "unprognostic (2.91e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (8.90e-2)" "unprognostic (9.16e-2)" "unprognostic (2.72e-1)" "unprognostic (2.22e-2)" "unprognostic (4.30e-2)" "prognostic favorable (2.96e-8)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.75e-1)" 19.0 25.7 15.4 23.4 16.4 76.7 24.8 19.6 20.8 20.3 26.9 23.6 22.6 17.8 25.5 26.7 18.0 18.9 13.6 16.8 14.9 36.4 33.2 21.4 24.6 14.4 14.5 15.3 24.2 40.4 16.8 17.5 15.8 22.5 25.7 52.8 22.6 16.3 28.2 26.6 23.6 16.1 13.5 22.4 29.3 30.7 15.6 24.9 24.0 36.5 30.4 20.6 18.4 24.3 43.9 62.4 46.3 48.1 48.2 45.4 41.0 44.6 42.1 56.8 54.5 64.3 47.1 55.0 41.9 60.4 41.5 55.4 62.7 49.3 74.4 21.6 33.8 36.2 31.7 46.5 28.9 44.7 114.1 39.1 33.4 76.0 46.9 36.1 50.2 35.8 47.8 23.0 56.1 80.0 39.2 35.3 43.7 34.6 26.8 62.9 37.3 59.3 53.7 49.3 42.5 25.5 55.7 34.8 24.5 46.6 61.0 33.7 60.2 49.4 37.9 27.3 32.9 35.1 50.2 109.2 40.3 34.4 43.3 5.7 6.9 10.0 6.7 7.6 6.8 5.4 5.9 7.5 7.5 5.7 4.6 5.8 14.9 6.7 6.4 5.2 6.6 4.2 15.4 16.4 19.6 20.8 16.8 14.9 14.4 14.5 15.8 13.5 15.6 24.3 32.6 32.1 31.1 42.4 34.2 28.8 27.4 17.3 22.8 26.8 47.6 25.4 13.4 35.8 25.2 36.8 73.0 14.4 40.6 39.3 19.6 21.1 268.8 55.8 37.9 26.0 23.4 9.9 54.2 21.8 13.3 24.0 46.4 84.8 21.0 26.2 21.4 58.5 16.7 30.3 59.0 25.7 12.2 30.4 27.2 130.7 17.7 32.4 23.2 36.5 25.1 16.4 24.7 53.8 79.2 30.5 24.2 19.9 30.6 36.9 30.5 46.4 31.7 66.6 19.7 33.0 26.4 35.8 37.1 32.4 38.6 24.5 33.4 23.0 26.4 47.8 AP3M1 ENSG00000185009 "Adaptor related protein complex 3 subunit mu 1" Q9Y2T2 10 74120255-74150842 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 266.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045591, HPA048380" Uncertain NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" "HPA045591: AB_2679377, HPA048380: AB_2680379" "unprognostic (1.83e-3)" "unprognostic (1.26e-1)" "unprognostic (6.69e-2)" "unprognostic (7.52e-2)" "unprognostic (3.40e-2)" "unprognostic (1.61e-1)" "unprognostic (4.92e-3)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (6.99e-2)" "unprognostic (9.64e-2)" "unprognostic (1.55e-1)" "unprognostic (1.68e-1)" "unprognostic (3.84e-1)" "unprognostic (3.43e-2)" 24.6 23.3 9.8 22.6 11.2 16.3 22.5 13.2 13.6 21.3 11.9 21.8 20.7 23.2 16.5 25.6 20.0 18.0 21.5 9.9 13.6 19.7 27.1 19.2 25.6 12.8 15.1 20.0 24.1 36.0 9.0 32.4 13.6 26.1 27.5 17.6 19.0 22.7 14.3 17.3 19.1 29.0 12.3 21.8 20.4 17.6 11.2 30.5 24.5 20.6 32.8 25.7 14.5 14.5 51.8 52.3 64.8 74.3 41.9 56.3 44.1 50.9 65.1 61.1 67.8 60.1 45.9 52.2 34.0 49.2 35.2 55.0 76.7 48.3 74.6 51.8 55.4 43.6 39.4 35.8 34.9 72.9 43.5 40.0 27.5 52.7 43.6 66.9 81.8 43.5 84.9 63.2 55.2 28.2 70.0 34.0 28.2 56.6 266.0 61.9 52.4 41.7 46.1 40.4 30.5 47.5 40.2 102.5 57.3 52.5 97.6 41.3 60.5 31.0 44.5 40.1 60.4 33.3 62.2 75.0 51.1 80.7 31.3 38.1 22.5 16.9 20.5 24.4 23.6 19.9 18.1 21.5 24.5 18.6 18.9 20.1 13.8 23.5 29.3 15.6 19.3 23.2 9.8 11.2 13.2 13.6 9.9 13.6 12.8 15.1 13.6 12.3 11.2 14.5 11.5 28.9 12.1 8.8 19.7 11.0 13.3 10.6 18.8 8.2 17.8 12.2 8.6 11.5 17.3 11.0 33.3 38.3 27.8 15.4 7.9 14.1 2.0 16.8 15.1 15.9 12.0 12.4 16.7 15.7 16.8 15.3 18.3 23.6 12.7 20.9 14.3 19.5 21.1 21.9 15.2 17.6 8.2 19.8 8.2 2.0 17.4 17.4 10.6 8.4 23.1 17.3 17.5 18.6 13.7 15.8 10.2 13.9 18.6 13.6 12.3 10.6 5.8 14.5 19.7 12.7 19.4 19.9 14.7 23.6 13.5 34.2 19.2 20.1 15.4 12.9 API5 "AAC-11, AAC11, API5L1" ENSG00000166181 "Apoptosis inhibitor 5" Q9BZZ5 11 43311963-43344529 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026598 Approved Enhanced "Nuclear speckles" NA NA 31000 "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" "HPA026598: AB_1844927" "unprognostic (4.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.58e-3)" "unprognostic (6.08e-2)" "unprognostic (5.88e-2)" "unprognostic (3.46e-2)" "unprognostic (1.24e-2)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (1.45e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.06e-4)" "unprognostic (5.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (3.05e-2)" 37.6 33.1 29.2 43.4 31.1 35.3 45.7 38.5 37.4 39.3 25.9 44.3 42.8 42.1 34.5 44.6 36.6 32.4 28.2 32.0 30.6 49.1 57.7 34.8 53.5 29.2 28.5 35.1 45.9 46.6 19.0 29.9 30.8 40.4 46.6 44.1 39.0 39.5 37.1 40.0 45.5 46.6 32.8 40.3 41.1 26.8 29.9 62.1 51.4 35.9 57.2 44.2 27.6 38.6 90.2 93.0 119.4 75.2 82.7 82.4 82.9 83.8 89.4 116.3 110.2 69.4 38.8 106.4 67.2 90.2 86.9 107.7 143.2 99.7 160.6 122.4 134.9 96.5 53.0 60.8 74.8 165.6 88.9 64.2 104.6 59.0 102.9 72.4 98.9 65.8 160.3 93.9 82.1 57.0 141.2 71.1 214.6 111.1 86.0 145.2 126.3 85.3 89.5 103.8 95.5 64.2 100.7 88.7 81.4 88.4 109.1 76.6 86.5 102.0 78.3 139.8 144.5 77.5 122.7 172.1 88.8 95.0 62.3 61.3 47.3 51.5 66.5 64.5 75.1 61.7 64.8 69.3 62.1 60.4 66.3 68.7 9.9 116.3 67.3 40.0 61.4 88.4 29.2 31.1 38.5 37.4 32.0 30.6 29.2 28.5 30.8 32.8 29.9 38.6 26.4 16.0 27.3 30.0 35.9 43.8 16.6 21.6 47.3 23.8 27.8 17.8 14.4 31.5 28.0 20.2 10.4 30.4 31.8 20.1 31.3 21.3 13.6 23.5 25.8 26.2 24.0 48.0 40.2 19.7 30.4 28.3 35.2 28.2 32.3 25.9 22.1 48.0 26.3 28.6 33.5 27.5 12.2 33.6 28.8 6.5 18.6 30.0 32.0 27.2 41.7 21.1 17.5 25.1 45.4 24.9 19.8 20.3 44.2 24.0 29.4 37.3 20.8 19.0 6.6 28.9 31.1 28.4 26.6 43.1 51.9 38.9 33.8 26.6 31.4 19.2 APOBEC3C "APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI" ENSG00000244509 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3C" Q9NRW3 22 39014257-39020352 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB033048, HPA071523" Approved Approved "Intermediate filaments" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Intermediate filaments" "CAB033048: AB_2057401, HPA071523: AB_2686409" "unprognostic (1.79e-3)" "prognostic favorable (1.08e-5)" "unprognostic (4.32e-3)" "unprognostic (3.20e-3)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (5.18e-2)" "unprognostic (2.55e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-3)" "unprognostic (7.40e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (8.91e-10)" "unprognostic (5.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-1)" "unprognostic (3.52e-3)" 12.3 36.2 3.1 31.1 3.2 31.4 12.3 3.1 4.0 23.1 3.5 20.2 14.0 22.6 51.7 22.7 56.0 18.4 24.0 3.0 3.5 6.0 7.0 20.6 57.8 5.0 3.6 38.2 5.1 10.5 3.8 11.6 5.1 25.9 33.1 3.4 22.1 36.1 2.7 19.8 17.4 30.8 4.5 36.5 18.1 29.4 3.9 25.2 15.2 11.3 67.8 27.6 17.3 6.5 39.4 38.1 6.3 73.9 40.2 82.6 32.4 28.3 54.9 41.0 54.5 36.8 43.7 115.5 18.6 56.1 26.2 39.4 6.5 120.2 39.5 44.3 32.0 111.8 1.6 30.6 43.5 73.4 107.1 90.5 68.1 54.0 13.3 20.4 23.0 0.9 69.9 142.3 83.0 0.4 29.6 39.8 9.8 0.5 82.8 51.1 16.9 96.6 27.2 51.4 1.9 4.9 40.9 0.2 21.7 15.9 0.2 26.8 11.9 21.8 37.1 11.9 12.4 38.6 42.7 9.5 66.9 47.1 58.8 86.6 104.4 277.0 309.1 220.6 212.6 241.6 164.7 276.9 106.9 249.1 54.0 196.9 14.1 196.9 247.8 86.9 168.9 173.6 3.1 3.2 3.1 4.0 3.0 3.5 5.0 3.6 5.1 4.5 3.9 6.5 3.3 3.2 16.2 0.0 68.8 25.2 45.4 44.1 24.5 0.2 16.4 8.9 23.0 28.6 18.4 7.3 0.0 4.3 60.2 56.6 0.0 31.6 3.2 11.0 16.4 9.6 26.4 57.2 0.0 1.3 1.4 26.5 5.6 15.6 57.0 78.6 30.0 1.2 61.9 0.0 0.0 17.8 28.5 49.0 37.3 9.3 57.8 34.2 44.4 0.0 65.1 24.4 117.4 0.5 0.0 11.5 16.6 38.0 55.4 18.9 3.2 1.3 13.6 0.8 26.3 11.9 20.1 1.5 1.5 9.7 16.3 1.9 67.7 53.5 18.8 41.9 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39055972 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.9" HPA073637 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favorable (8.28e-4)" 2.2 6.3 2.2 9.2 2.1 3.3 2.5 2.2 2.7 4.0 3.4 3.5 3.7 4.1 6.3 2.4 8.3 3.5 5.5 2.0 2.2 3.4 2.9 3.4 15.7 3.1 2.6 8.8 3.0 5.2 3.4 2.2 2.8 4.8 2.8 1.1 4.9 5.2 0.6 1.6 3.8 4.5 2.3 11.9 4.8 8.2 2.5 5.3 3.0 1.3 14.5 4.5 3.2 2.9 4.9 4.2 1.8 6.2 4.9 7.1 2.2 4.2 6.9 8.8 14.0 3.9 9.1 12.9 4.1 8.9 7.7 6.5 1.7 6.0 3.8 11.7 5.3 16.5 0.5 2.5 8.6 3.6 7.0 9.5 3.0 5.0 1.5 5.1 8.5 3.5 1.3 19.9 4.8 3.9 4.0 2.7 0.8 0.5 0.7 6.1 0.7 2.5 8.1 6.6 0.9 1.5 4.7 1.2 2.5 3.5 4.7 1.9 2.3 2.0 5.0 0.4 2.0 3.4 1.7 0.5 5.6 1.9 3.1 3.2 4.7 9.4 8.5 9.1 9.8 27.7 5.6 9.0 6.0 34.2 3.4 5.6 3.1 14.6 14.5 4.6 8.4 7.4 2.2 2.1 2.2 2.7 2.0 2.2 3.1 2.6 2.8 2.3 2.5 2.9 1.6 0.0 0.5 0.0 9.8 0.9 4.9 6.3 2.2 0.0 2.1 2.2 5.9 8.6 4.2 0.0 0.0 2.0 7.6 0.8 1.9 7.4 2.4 4.8 3.8 2.6 1.2 2.1 0.1 3.9 1.4 2.9 2.6 3.6 2.5 11.0 3.6 1.6 5.9 0.0 0.0 2.2 4.1 2.2 1.4 5.2 5.0 2.8 5.4 2.8 5.3 2.2 8.2 0.5 0.0 4.8 3.6 6.4 9.6 4.5 0.5 5.3 4.6 0.2 0.0 1.0 2.6 0.3 0.4 1.6 0.9 1.6 5.4 7.8 1.5 5.9 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343781 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavorable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 11.4 10.3 5.6 14.6 5.3 27.5 13.6 8.2 6.8 14.2 10.1 19.2 16.9 10.5 11.0 15.2 11.8 12.5 9.6 4.6 5.5 22.8 15.2 13.8 15.4 6.2 6.5 10.3 17.5 28.0 5.4 14.4 6.7 13.0 17.2 36.5 14.8 12.1 12.8 13.7 17.5 10.8 5.2 13.8 19.6 28.3 6.4 22.2 22.4 14.0 17.2 19.7 7.9 7.3 31.8 20.4 19.3 7.3 21.9 29.8 22.5 21.4 24.3 21.7 22.0 12.6 30.0 23.9 8.9 27.6 26.2 22.2 23.5 30.4 26.6 28.3 16.0 40.2 12.0 13.5 18.6 20.9 37.3 18.4 21.6 19.2 31.8 22.3 31.5 24.6 24.5 25.3 25.5 7.2 48.1 9.7 42.5 34.5 18.5 22.4 13.9 4.8 35.8 58.2 7.6 14.9 14.1 33.9 19.5 29.5 58.5 18.3 38.6 14.4 19.3 19.5 16.4 20.4 22.6 17.5 23.6 20.8 14.2 6.1 1.6 4.3 2.8 2.3 3.6 1.2 1.8 2.3 1.6 1.3 3.0 2.6 5.1 2.5 0.9 2.2 3.9 0.9 5.6 5.3 8.2 6.8 4.6 5.5 6.2 6.5 6.7 5.2 6.4 7.3 38.5 44.8 23.1 73.1 32.7 23.7 34.0 23.8 19.9 36.8 32.7 18.9 33.1 18.6 31.9 38.6 139.7 20.0 47.0 43.2 11.7 29.7 25.4 42.5 34.7 28.5 29.4 16.2 119.0 25.6 15.4 22.9 57.6 53.0 15.2 40.0 23.2 19.6 15.8 43.7 146.3 27.9 14.2 31.3 20.4 36.0 40.0 35.2 17.8 105.9 47.1 22.9 46.4 151.8 126.6 40.1 25.7 30.1 29.8 38.2 30.8 24.7 33.9 100.8 6.6 23.6 26.5 69.4 50.7 26.0 29.5 24.9 42.4 32.1 28.0 60.4 ARHGEF3 "DKFZP434F2429, GEF3, STA3, XPLN" ENSG00000163947 "Rho guanine nucleotide exchange factor 3" Q9NR81 3 56727418-57079329 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 157.8;NK-cells: 137.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 88.8;RPMI-8226: 92.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034715, HPA064945" Uncertain Approved Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA034715: AB_10600780, HPA064945: AB_2685389" "unprognostic (1.84e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "prognostic favorable (2.17e-4)" "unprognostic (8.25e-2)" "prognostic favorable (2.61e-4)" "unprognostic (9.42e-2)" "unprognostic (3.83e-2)" "unprognostic (9.67e-2)" "unprognostic (7.44e-2)" "unprognostic (6.90e-2)" "unprognostic (4.99e-2)" "prognostic favorable (1.96e-7)" "unprognostic (8.24e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-2)" 16.8 43.2 11.2 20.6 14.8 9.8 13.8 14.4 17.4 16.0 30.9 14.3 6.4 38.0 12.5 19.0 23.2 22.3 12.7 25.9 10.8 25.3 5.2 24.8 29.3 11.2 9.1 20.6 29.1 52.3 21.6 21.3 10.7 14.8 13.5 8.2 21.5 15.3 8.0 12.6 9.6 34.5 7.6 21.5 15.8 14.3 11.6 36.1 14.2 8.5 28.7 17.2 11.6 12.8 24.2 8.4 1.2 7.7 2.7 2.2 16.5 2.6 2.2 2.6 3.4 4.1 22.3 12.6 2.5 4.7 25.3 12.1 7.2 30.8 3.0 18.4 3.5 10.3 5.2 88.8 6.6 0.0 10.9 9.7 19.9 2.3 3.5 23.6 25.5 13.3 2.9 27.2 5.9 3.7 34.8 1.3 2.3 19.5 12.9 0.2 9.2 92.2 19.8 13.2 1.4 3.8 15.3 11.2 6.9 8.5 2.9 10.6 11.8 1.3 6.0 5.4 4.0 35.0 14.2 45.1 21.7 12.2 10.9 20.6 23.0 3.7 96.1 25.5 72.5 26.0 73.6 85.0 13.9 16.9 59.3 73.5 8.3 39.7 32.2 5.9 67.4 76.0 11.2 14.8 14.4 17.4 25.9 10.8 11.2 9.1 10.7 7.6 11.6 12.8 22.7 16.0 22.4 30.0 24.2 11.1 8.6 16.3 32.5 9.5 7.6 9.9 9.8 2.8 12.6 23.9 4.2 11.4 57.5 4.8 11.7 11.0 22.6 10.1 7.0 40.3 9.6 14.1 157.8 10.2 7.9 13.5 36.2 16.5 13.9 4.8 22.9 0.1 7.6 0.0 70.8 1.3 2.0 38.1 8.2 14.1 17.7 18.7 10.6 63.7 19.9 9.0 137.0 68.3 80.0 7.5 1.4 24.0 22.1 11.2 0.2 7.3 9.5 1.2 0.0 8.0 4.4 3.3 2.6 37.9 14.9 11.9 64.3 3.2 3.2 13.4 ARID3B "BDP, DRIL2" ENSG00000179361 "AT-rich interaction domain 3B" Q8IVW6 15 74541206-74598131 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0" "Cancer enhanced" "Detected in all" "testis cancer: 10.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 28.8" HPA050320 Enhanced Supported Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA050320: AB_2681085" "unprognostic (2.97e-1)" "unprognostic (5.91e-2)" "unprognostic (6.41e-2)" "unprognostic (8.15e-2)" "unprognostic (8.42e-2)" "unprognostic (1.13e-1)" "unprognostic (3.33e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (4.71e-2)" "unprognostic (3.52e-2)" "unprognostic (9.45e-3)" "unprognostic (2.20e-1)" 2.8 2.4 3.1 6.1 2.4 24.6 2.6 5.2 3.4 3.3 6.6 4.9 4.4 2.3 1.9 6.2 2.5 2.4 2.3 3.3 4.4 3.6 4.0 7.3 7.2 2.9 3.4 1.5 5.7 1.7 6.2 15.7 2.9 4.6 4.0 18.7 3.8 1.7 3.4 3.2 7.0 1.6 2.3 9.5 7.1 22.1 3.7 6.0 3.8 2.2 6.3 3.2 3.9 2.8 7.6 3.1 40.7 8.9 1.5 0.8 43.8 1.8 2.0 2.5 2.7 49.9 3.6 0.7 2.0 1.9 14.3 9.0 49.8 6.8 2.2 47.7 11.6 29.5 6.0 13.7 1.0 4.7 18.5 1.0 3.0 4.2 4.3 2.0 4.3 11.7 26.1 16.8 0.7 1.8 12.9 15.7 87.8 3.2 2.7 5.7 1.6 12.1 2.4 7.9 10.4 18.4 2.2 4.5 8.8 95.4 5.8 8.5 2.7 3.4 4.3 2.7 5.6 53.0 36.1 5.3 1.8 7.3 1.3 2.6 1.9 7.0 5.0 1.5 3.0 3.1 2.9 3.8 1.4 1.4 2.2 2.9 13.0 4.0 2.0 1.9 4.4 3.4 3.1 2.4 5.2 3.4 3.3 4.4 2.9 3.4 2.9 2.3 3.7 2.8 3.5 3.2 5.6 10.7 11.8 5.2 5.2 3.5 3.4 23.9 4.4 2.3 1.2 4.3 1.9 0.0 43.8 36.0 10.2 10.2 0.0 2.5 45.4 20.5 4.4 4.8 5.4 9.7 7.3 3.5 20.6 2.3 8.6 45.6 2.5 4.2 4.2 2.5 8.3 11.8 7.8 6.0 0.0 8.7 9.1 65.8 2.8 9.5 3.6 5.6 6.4 5.9 18.6 5.5 7.8 7.6 8.4 3.0 19.2 7.8 7.0 1.7 3.8 50.8 0.0 1.5 1.8 17.2 19.4 10.4 3.3 64.0 12.8 5.5 4.0 8.0 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 486.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027205, HPA027333" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Mitochondria, Cytosol" Nucleoplasm "HPA027205: , HPA027333: AB_1845013" "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 11.3 10.9 9.6 14.1 11.2 33.0 13.5 12.8 13.0 15.0 7.8 10.2 8.1 15.9 14.4 9.8 10.9 13.2 7.4 8.4 9.5 10.6 11.9 12.0 21.0 10.4 10.5 17.2 11.4 13.6 10.9 12.7 10.8 14.3 9.1 14.6 11.5 10.8 9.0 9.0 10.3 10.2 9.9 18.4 13.2 17.1 9.6 21.4 16.9 9.8 17.0 12.9 10.6 13.0 15.8 10.5 18.0 16.5 15.3 15.5 17.5 17.6 15.1 11.3 10.9 12.2 16.9 18.1 19.9 12.0 8.7 13.4 16.4 7.4 17.8 23.5 17.3 14.7 14.7 10.9 11.9 15.8 21.0 10.8 10.4 13.5 12.7 16.1 18.2 11.4 19.3 25.4 11.9 7.5 21.9 15.3 18.9 12.1 8.2 9.4 13.4 15.3 14.1 13.2 15.9 22.4 22.1 20.3 18.3 6.2 19.1 27.4 21.6 14.4 11.5 18.2 17.7 25.1 22.1 18.2 9.8 11.9 19.4 61.7 13.7 41.1 29.9 15.0 27.5 32.2 31.6 26.0 13.8 34.0 31.2 26.7 72.5 33.8 25.6 23.6 28.3 12.6 9.6 11.2 12.8 13.0 8.4 9.5 10.4 10.5 10.8 9.9 9.6 13.0 156.8 102.5 106.8 107.7 150.1 124.3 83.8 61.2 103.0 125.5 86.2 78.5 77.4 47.1 91.7 31.3 120.9 64.0 218.9 47.9 19.6 76.4 334.7 119.3 127.9 128.9 90.1 45.2 157.0 47.9 70.2 101.6 59.1 169.2 110.1 78.0 67.8 27.6 44.4 112.7 158.4 53.2 65.1 61.2 127.6 486.5 101.2 97.3 83.6 107.7 122.8 67.7 204.9 144.8 304.2 68.6 57.3 77.5 104.1 108.7 48.3 20.6 82.3 150.7 46.0 130.2 121.4 236.7 161.9 66.5 106.4 156.7 209.8 84.8 44.7 149.6 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602589-100651701 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 4.6 3.6 4.2 4.5 4.7 12.8 5.1 4.9 4.6 5.2 5.6 6.8 4.6 5.3 6.5 4.6 5.7 3.8 3.9 4.2 4.1 6.7 6.8 4.9 6.3 4.5 4.3 5.7 3.5 6.7 3.1 4.3 4.2 4.7 6.3 4.9 4.5 4.3 3.1 4.4 4.4 6.0 4.2 5.9 4.3 6.8 4.9 7.0 6.2 4.7 6.3 5.1 3.5 5.0 6.7 14.5 6.6 7.9 8.6 9.2 7.5 7.2 13.0 11.8 12.3 8.8 13.2 10.9 6.4 9.2 11.6 14.5 9.2 9.4 12.2 7.6 9.8 14.4 9.0 8.8 13.0 8.6 12.3 8.9 10.3 9.6 15.8 11.4 11.0 11.7 8.6 8.9 6.8 7.2 6.7 8.7 6.3 14.9 6.9 9.0 14.1 9.2 11.8 14.8 6.5 9.2 11.1 10.8 15.0 12.5 7.6 10.7 8.4 10.3 9.5 7.3 10.2 10.6 23.5 10.4 8.0 7.8 8.3 1.2 5.8 10.2 5.2 4.7 4.2 4.3 4.5 6.4 5.1 4.2 6.2 4.4 5.2 4.3 3.1 3.3 5.7 4.8 4.2 4.7 4.9 4.6 4.2 4.1 4.5 4.3 4.2 4.2 4.9 5.0 4.6 0.0 5.4 14.7 6.6 6.5 2.3 3.5 13.1 4.9 6.2 4.1 3.4 12.8 6.4 3.7 6.2 3.8 9.9 12.9 1.9 5.7 4.0 8.1 8.3 6.7 8.4 3.0 20.6 4.9 3.0 4.0 7.1 8.1 10.8 7.3 4.2 8.0 6.0 13.5 15.0 6.2 4.1 7.8 4.3 2.1 5.0 5.2 3.6 20.6 7.8 3.1 6.2 16.6 17.4 6.5 9.7 5.3 4.9 5.5 5.4 7.1 10.3 5.0 0.0 4.3 4.3 9.9 8.2 10.8 4.5 5.9 8.2 6.7 5.8 5.6 ASCC3 "ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH" ENSG00000112249 "Activating signal cointegrator 1 complex subunit 3" Q8N3C0 6 100508194-100881372 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 166.0;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031608, HPA031609, HPA031610" Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Golgi apparatus" "HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526" "unprognostic (6.79e-2)" "unprognostic (1.46e-2)" "unprognostic (2.96e-3)" "unprognostic (1.12e-1)" "unprognostic (9.70e-3)" "unprognostic (4.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.14e-2)" "unprognostic (4.02e-1)" "unprognostic (3.34e-1)" "unprognostic (5.08e-3)" "unprognostic (1.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-1)" "unprognostic (1.55e-2)" 6.0 6.6 4.1 10.0 5.3 11.2 9.2 6.6 4.2 10.2 7.7 9.3 8.2 7.9 8.5 8.4 5.8 7.5 6.5 3.9 5.2 5.0 12.5 7.1 10.1 4.7 4.3 5.9 6.4 10.7 6.2 12.9 5.1 9.2 11.3 5.7 6.3 8.1 6.0 7.2 8.5 8.5 4.7 8.3 8.6 8.6 4.6 12.7 7.2 5.4 11.0 14.8 7.4 6.0 16.8 21.1 30.1 18.6 32.9 41.7 48.0 71.5 45.5 24.1 27.6 43.3 13.0 52.1 14.4 48.3 19.0 37.6 26.2 63.5 38.7 35.2 23.2 38.7 36.0 27.8 30.1 41.0 28.5 38.1 31.7 35.4 44.2 22.6 45.1 20.5 47.1 23.0 67.3 16.5 21.1 12.7 15.9 31.8 16.4 24.7 23.3 18.7 23.7 46.6 20.2 15.3 30.1 26.7 12.5 53.3 14.7 23.2 64.2 26.9 20.6 23.3 30.4 9.9 11.3 46.4 19.4 30.6 29.0 6.2 2.7 1.8 4.3 4.3 5.2 4.2 3.8 4.0 2.9 5.7 4.3 4.2 0.2 4.4 3.8 6.4 3.1 1.4 4.1 5.3 6.6 4.2 3.9 5.2 4.7 4.3 5.1 4.7 4.6 6.0 32.7 32.1 24.9 58.1 45.4 25.5 41.3 33.3 19.4 27.0 24.1 24.0 32.0 20.0 37.7 3.7 22.9 24.4 49.0 17.3 11.7 23.1 11.3 30.1 77.3 25.2 13.8 20.8 166.0 25.1 66.3 32.2 46.9 35.0 22.1 29.9 10.4 30.3 17.7 28.6 166.2 22.8 22.4 17.2 12.5 3.7 23.0 27.5 5.4 103.0 26.2 14.6 29.9 150.8 132.3 28.6 14.4 17.3 66.4 66.9 17.5 10.6 32.0 31.1 6.6 39.6 30.0 50.2 30.3 38.2 27.4 38.0 43.7 42.6 23.5 65.4 ASTE1 HT001 ENSG00000034533 "Asteroid homolog 1" Q2TB18 3 131013875-131027649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037010, HPA037011" Supported Approved "Endoplasmic reticulum" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Endoplasmic reticulum" "HPA037010: AB_10673629, HPA037011: AB_10696929" "unprognostic (7.42e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.56e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (2.27e-3)" "unprognostic (2.80e-2)" "unprognostic (1.89e-2)" "unprognostic (2.22e-1)" "unprognostic (1.38e-2)" "unprognostic (2.58e-2)" "unprognostic (1.65e-1)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.64e-2)" 3.4 3.2 2.9 4.9 3.3 6.7 5.5 6.1 4.8 6.0 3.4 5.4 5.8 3.8 5.9 3.7 4.5 3.9 2.9 3.2 2.5 3.7 6.1 4.1 7.0 2.5 2.8 5.7 3.3 5.0 3.3 3.9 3.0 3.8 5.8 4.7 3.1 4.2 2.3 4.1 7.1 3.4 2.9 4.4 4.7 6.1 3.3 7.2 7.0 2.8 6.8 3.9 2.9 4.6 9.7 7.1 4.5 4.7 7.7 8.4 1.9 5.4 4.6 6.4 7.0 11.4 4.2 10.8 8.2 5.5 5.5 10.5 9.1 4.4 9.6 5.8 5.3 6.4 3.6 5.4 7.9 9.9 3.6 5.3 6.1 5.2 4.9 5.7 5.4 8.7 5.9 5.3 6.7 6.6 9.0 5.2 4.1 11.6 6.8 9.4 6.4 9.4 5.2 5.9 7.7 7.2 10.5 2.4 7.6 4.3 6.3 6.9 3.8 7.2 4.8 12.1 4.3 6.6 6.5 14.0 5.6 8.5 3.6 51.2 13.0 28.4 20.4 15.3 21.3 15.5 22.0 17.7 14.5 16.5 28.3 21.2 9.4 29.4 20.9 10.7 28.2 11.8 2.9 3.3 6.1 4.8 3.2 2.5 2.5 2.8 3.0 2.9 3.3 4.6 6.5 12.8 5.8 7.5 14.6 3.2 3.7 4.8 2.2 9.2 5.1 7.4 1.8 4.3 6.3 3.7 14.6 6.0 17.5 11.1 5.9 4.9 42.1 4.5 5.8 6.9 6.7 6.1 8.3 6.0 4.8 5.1 8.6 4.6 8.8 7.0 10.0 5.6 4.8 3.3 6.3 7.0 4.1 5.7 2.0 12.6 7.2 7.2 1.8 5.6 3.9 5.8 18.6 7.5 10.5 3.6 7.8 4.9 8.7 2.9 15.6 3.5 2.1 13.9 0.0 3.6 6.1 4.4 4.9 3.6 1.4 4.0 15.7 6.1 7.1 2.8 ATF7IP "FLJ10688, p621" ENSG00000171681 "Activating transcription factor 7 interacting protein" Q6VMQ6 12 14365632-14502935 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016578, HPA023505" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" "HPA016578: AB_1845147, HPA023505: AB_1845148" "unprognostic (2.06e-2)" "unprognostic (3.12e-2)" "unprognostic (1.25e-1)" "unprognostic (6.25e-3)" "unprognostic (1.20e-3)" "unprognostic (2.48e-2)" "unprognostic (5.84e-2)" "unprognostic (8.56e-3)" "unprognostic (7.36e-2)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (1.86e-1)" "unprognostic (7.90e-3)" "unprognostic (2.88e-1)" "unprognostic (7.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.78e-2)" 12.4 10.4 12.1 16.8 18.8 30.9 14.7 32.8 11.7 12.8 21.7 11.2 8.3 15.6 13.7 14.3 13.4 11.8 16.3 9.9 14.1 11.0 14.4 13.3 28.2 16.9 15.5 17.9 11.5 17.2 8.5 14.2 15.8 13.4 13.0 17.1 20.6 12.0 16.4 16.7 11.9 16.4 11.2 20.8 14.2 33.8 18.8 32.5 21.7 21.2 28.1 12.6 11.4 21.3 23.2 13.8 54.3 31.7 27.9 35.2 11.4 24.4 13.7 18.8 28.6 31.4 23.9 38.5 16.2 16.6 34.3 23.0 34.3 22.4 42.3 27.5 20.1 25.8 23.3 6.5 16.6 17.7 15.1 19.0 18.3 23.2 23.9 29.3 41.5 13.6 15.6 19.7 29.9 21.7 25.5 15.4 35.1 11.9 12.7 52.3 60.3 21.0 16.2 44.6 17.4 14.2 27.7 16.0 15.4 44.0 16.2 20.5 19.2 26.3 16.7 14.9 20.3 13.2 13.9 53.1 16.7 16.5 29.0 29.2 11.6 19.4 16.2 8.3 16.8 23.1 13.6 16.0 9.8 30.9 10.9 15.5 17.8 11.4 14.2 12.9 18.7 11.0 12.1 18.8 32.8 11.7 9.9 14.1 16.9 15.5 15.8 11.2 18.8 21.3 46.6 67.3 42.5 67.9 121.2 6.6 12.8 9.7 75.1 50.2 31.6 24.6 73.0 20.0 26.6 35.0 68.8 17.2 112.1 13.2 7.9 16.6 79.6 31.1 34.7 40.3 28.1 55.1 62.6 12.2 10.9 32.0 41.8 31.9 25.9 34.8 30.0 31.3 20.5 63.9 73.9 19.6 10.2 48.4 11.2 19.6 29.2 46.3 5.4 107.7 47.9 23.5 64.9 136.7 147.9 14.5 13.5 29.3 85.9 13.6 12.0 16.4 24.3 39.8 13.1 40.0 33.3 42.4 25.0 62.7 6.7 15.5 98.5 35.1 18.3 12.1 B3GNT10 ENSG00000214654 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10 (putative)" A8MXE2 9 120792403-120799918 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Distal tubular cells: 1.9;Endometrial ciliated cells: 1.5;Endometrial stromal cells: 1.3;Proximal tubular cells: 1.3;Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" "unprognostic (4.59e-3)" "unprognostic (2.71e-2)" "unprognostic (3.04e-2)" "unprognostic (5.71e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (7.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.42e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.57e-2)" "unprognostic (1.08e-7)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" 1.2 1.2 0.7 1.8 1.3 4.8 2.1 0.9 0.7 1.3 1.4 1.8 1.5 0.8 2.0 1.2 1.9 1.2 1.1 0.7 0.8 2.7 1.2 1.1 2.7 1.2 0.8 1.7 1.4 2.2 0.8 1.2 1.1 1.9 2.2 2.4 1.3 1.5 1.0 1.2 1.5 0.9 1.0 1.9 2.3 2.4 1.2 2.1 2.8 0.4 2.9 1.2 0.5 2.7 3.0 3.7 4.0 2.6 3.4 2.6 4.9 2.8 2.9 4.7 2.8 1.2 4.5 5.7 2.4 1.4 5.5 7.8 7.1 5.7 5.4 7.0 2.2 3.3 2.7 1.9 5.7 3.9 1.4 2.8 2.9 3.5 8.2 1.0 0.9 6.5 10.2 7.7 2.9 4.3 2.9 0.9 5.8 6.4 3.6 3.0 7.6 8.8 2.6 2.9 5.7 4.4 5.2 2.5 5.5 2.5 10.1 0.8 1.4 2.3 2.0 5.0 2.8 9.1 14.8 5.4 4.9 2.2 4.8 0.3 0.5 1.2 0.9 0.5 1.0 0.8 0.9 1.1 0.6 0.8 1.3 0.7 0.4 1.1 1.0 0.4 1.2 0.7 0.7 1.3 0.9 0.7 0.7 0.8 1.2 0.8 1.1 1.0 1.2 2.7 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 3.7 0.0 0.0 0.6 0.0 1.9 0.5 0.0 1.5 1.3 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 BAZ2A "KIAA0314, TIP5, WALp3" ENSG00000076108 "Bromodomain adjacent to zinc finger domain 2A" Q9UIF9 12 56595596-56636816 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005782, HPA063806" Enhanced "Nuclear speckles" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA005782: AB_10601089, HPA063806: AB_2685128" "unprognostic (1.70e-1)" "unprognostic (1.75e-2)" "unprognostic (5.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (3.72e-2)" "unprognostic (3.10e-1)" "unprognostic (6.45e-2)" "unprognostic (9.64e-2)" "unprognostic (3.00e-2)" "unprognostic (3.77e-2)" "unprognostic (1.73e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-2)" "unprognostic (3.43e-1)" 29.1 23.9 10.3 30.8 13.3 65.9 27.2 22.9 18.7 29.3 19.1 27.0 25.5 25.4 22.9 30.9 24.9 20.9 21.1 10.3 20.0 19.8 21.7 35.9 33.4 17.2 13.0 36.3 30.8 33.4 27.7 35.4 14.6 23.3 26.6 48.8 25.7 21.0 28.2 29.9 31.1 23.1 5.5 35.3 26.2 47.4 19.0 50.6 27.3 32.0 30.6 24.8 30.6 19.8 50.3 45.6 61.9 52.5 35.3 35.4 66.5 32.6 44.2 46.9 34.1 56.2 59.3 69.2 49.2 38.6 44.3 41.5 70.6 46.3 40.6 48.1 37.1 80.8 35.5 28.8 38.5 47.1 60.2 31.0 43.8 40.2 55.7 50.8 46.3 28.4 87.7 94.1 26.3 30.7 40.2 30.9 54.9 32.7 34.6 33.9 45.0 48.3 32.6 48.8 41.0 33.8 54.8 57.0 30.0 66.0 65.6 41.7 65.2 24.3 49.1 30.0 23.0 46.0 48.4 65.1 22.5 33.4 34.6 12.1 7.6 5.6 4.8 6.2 4.2 6.8 3.8 3.7 3.0 6.0 3.1 2.7 28.6 17.2 15.5 11.7 3.6 3.0 10.3 13.3 22.9 18.7 10.3 20.0 17.2 13.0 14.6 5.5 19.0 19.8 47.6 67.3 61.3 29.4 74.7 50.9 43.2 35.3 60.3 70.5 43.3 26.7 26.4 30.0 36.9 25.8 137.6 48.0 62.8 71.6 7.9 32.0 66.8 29.4 33.7 50.1 44.8 53.4 29.3 28.7 37.2 35.6 34.1 41.7 43.6 34.8 53.9 32.5 24.3 32.0 27.4 39.6 26.4 62.1 65.6 73.7 60.6 38.5 39.2 40.3 80.1 24.4 116.4 25.6 33.2 34.8 39.4 57.6 78.0 65.1 44.7 12.6 34.4 67.3 85.5 44.9 44.0 134.1 131.2 59.5 61.8 95.6 58.0 41.6 34.8 67.6 BCL2L11 "BIM, BimEL, BimL, BimS, BOD" ENSG00000153094 "BCL2 like 11" O43521 2 111119378-111168445 "Predicted intracellular proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 118.3;Plasma cells: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 91.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026332, CAB079899" Approved Supported Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Mitochondria "CAB026332: AB_566386, CAB079899: AB_10981505" "unprognostic (1.43e-1)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-3)" "unprognostic (8.15e-3)" "unprognostic (7.86e-2)" 8.1 7.4 4.2 16.4 5.0 38.8 12.5 3.7 3.7 7.2 4.6 11.0 7.2 6.5 4.9 9.8 7.0 8.8 5.7 3.0 3.9 10.7 14.3 8.5 24.2 4.3 4.0 10.3 10.3 18.8 9.4 6.0 4.5 7.8 11.9 12.1 10.1 7.1 12.3 5.8 11.7 4.8 3.9 16.3 7.0 8.1 4.4 18.9 16.6 7.3 23.0 8.9 8.2 6.7 8.0 2.4 10.8 10.4 9.1 4.7 29.1 1.2 2.3 3.3 3.3 6.6 24.9 32.0 6.5 1.2 18.9 9.5 10.0 3.9 2.0 24.9 18.2 39.7 8.1 10.5 3.9 14.6 8.8 4.8 10.5 3.7 3.8 7.0 4.6 14.2 20.8 46.6 0.7 5.2 15.3 14.7 13.2 6.3 7.5 19.5 10.3 40.7 4.5 13.0 9.3 24.0 11.0 14.5 8.3 7.1 5.0 31.2 1.9 1.7 11.4 3.7 4.3 91.2 19.5 45.3 2.7 10.1 1.5 5.2 3.7 1.8 1.7 2.6 1.8 3.3 2.3 1.9 1.9 1.9 1.5 1.5 5.2 1.7 5.7 0.4 5.9 1.5 4.2 5.0 3.7 3.7 3.0 3.9 4.3 4.0 4.5 3.9 4.4 6.7 33.9 3.2 9.9 2.9 61.3 17.5 18.2 7.0 34.7 7.4 19.5 29.2 19.3 12.8 10.3 9.2 10.4 4.6 43.9 37.6 13.7 9.7 118.3 36.6 10.8 18.0 21.5 26.5 2.2 6.5 7.8 11.6 8.6 54.7 11.4 5.9 14.6 11.3 10.9 0.0 4.8 15.2 12.2 26.8 52.6 39.2 5.9 34.8 23.2 6.5 41.0 12.1 5.2 3.0 5.3 8.8 16.4 3.8 137.9 15.9 16.6 6.4 15.2 21.1 0.0 11.8 11.9 7.3 17.7 66.1 10.9 5.7 41.0 2.5 12.3 16.0 BCL7A BCL7 ENSG00000110987 "BAF chromatin remodeling complex subunit BCL7A" Q4VC05 12 122019422-122062044 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 77.9;Horizontal cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 1.0;naive B-cell: 2.1;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 14 "B-cells: 2.1;dendritic cells: 2.8" "Cell line enhanced" "Detected in many" "Daudi: 71.9;MOLT-4: 71.4;U-698: 95.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019762 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Vesicles" "HPA019762: AB_10962489" "unprognostic (3.27e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (5.18e-1)" "unprognostic (5.13e-2)" "unprognostic (1.06e-2)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.86e-2)" "unprognostic (8.56e-2)" "unprognostic (6.16e-3)" "unprognostic (1.51e-2)" 3.1 2.8 9.2 5.2 10.8 9.8 5.7 8.9 11.2 5.1 0.0 4.0 2.5 4.5 6.7 2.8 8.4 2.4 7.6 9.6 3.2 9.1 4.9 3.9 16.2 3.5 4.7 3.7 9.1 9.1 5.2 1.9 3.3 5.1 2.9 4.1 7.0 5.9 11.5 8.2 3.0 3.3 2.9 5.8 3.8 2.2 4.5 24.7 9.0 8.9 15.4 4.8 4.8 9.1 6.0 6.2 29.9 17.9 2.2 1.1 6.0 3.2 3.1 5.3 4.9 3.2 2.4 71.9 9.2 2.7 2.7 8.8 22.7 16.4 5.3 0.0 25.0 3.5 0.4 5.5 6.5 13.8 8.1 4.7 21.3 3.9 26.7 8.1 7.7 42.3 18.3 0.0 4.3 10.7 71.4 1.3 10.7 9.7 11.0 33.2 8.5 1.2 13.4 14.3 26.5 28.9 3.4 0.8 13.1 7.7 17.4 13.6 6.9 0.7 5.1 10.0 6.1 9.4 5.4 95.8 2.1 9.3 6.7 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.3 2.1 0.1 0.1 0.1 0.0 0.0 2.8 0.0 0.1 9.2 10.8 8.9 11.2 9.6 3.2 3.5 4.7 3.3 2.9 4.5 9.1 4.6 22.4 9.2 8.5 51.6 35.9 77.9 26.5 22.8 41.8 32.7 33.5 28.6 42.9 19.0 38.6 18.8 1.5 38.1 5.9 58.7 33.5 6.9 39.3 10.9 5.6 21.5 18.7 15.9 10.9 0.9 11.9 7.1 26.8 10.8 16.6 5.3 18.6 4.2 107.7 19.9 8.6 16.2 2.2 14.3 18.7 14.0 9.8 12.4 1.9 6.2 5.5 1.0 13.6 16.2 10.0 6.9 7.9 6.8 29.9 1.6 31.3 20.7 14.0 6.6 34.7 16.6 0.7 7.7 5.3 30.1 0.5 3.2 42.9 11.7 32.3 BCLAF3 CXorf23 ENSG00000173681 "BCLAF1 and THRAP3 family member 3" A2AJT9 X 19912860-19970298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 17.0;Granulosa cells: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027215 Approved Approved Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA027215: AB_1847358" "unprognostic (2.46e-1)" "unprognostic (1.96e-1)" "unprognostic (3.15e-1)" "unprognostic (2.24e-1)" "unprognostic (2.27e-2)" "unprognostic (2.48e-2)" "unprognostic (3.72e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.82e-2)" "unprognostic (1.10e-1)" "unprognostic (1.43e-1)" "unprognostic (4.83e-2)" "unprognostic (2.03e-2)" "unprognostic (2.21e-1)" "unprognostic (9.38e-2)" "unprognostic (2.30e-2)" "prognostic favorable (5.56e-4)" 4.6 3.0 3.5 3.8 4.0 3.6 5.2 10.2 3.8 4.7 2.0 5.2 3.4 5.5 8.3 3.5 4.0 4.2 3.4 4.0 3.1 4.3 2.7 4.5 4.3 3.4 3.4 5.0 3.4 5.7 3.4 3.3 3.6 5.0 5.9 6.4 3.4 5.1 4.5 6.0 4.4 4.0 2.6 4.1 3.9 2.6 5.0 5.3 4.7 5.2 4.2 4.2 4.1 5.0 4.8 3.8 5.1 8.7 4.5 6.3 2.8 4.4 3.7 2.8 3.9 3.4 5.0 4.9 2.6 5.2 4.9 3.5 4.6 3.3 5.3 3.2 3.7 3.1 4.3 3.4 6.3 4.4 5.3 5.7 5.0 3.1 4.2 6.5 3.2 3.9 2.3 11.5 3.2 3.6 3.1 2.9 4.5 4.5 4.8 1.3 5.1 6.7 7.3 4.7 3.1 4.8 5.6 4.6 4.5 9.5 5.5 3.9 6.0 4.7 2.3 11.4 3.3 3.6 3.0 4.0 4.0 2.4 4.1 1.8 0.3 0.6 0.4 0.4 0.5 0.4 0.3 0.4 0.2 0.8 0.3 0.4 1.5 0.4 0.4 0.7 0.2 0.1 3.5 4.0 10.2 3.8 4.0 3.1 3.4 3.4 3.6 2.6 5.0 5.0 10.8 16.0 17.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 8.8 8.1 0.0 0.0 7.4 9.2 0.0 4.5 8.9 0.0 1.9 6.1 0.0 8.2 9.4 3.4 0.0 0.0 0.0 3.6 3.5 5.0 0.0 10.9 6.3 12.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 6.1 0.0 0.0 3.6 0.0 0.0 6.2 4.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 4.5 3.9 7.4 0.0 0.0 BICRAL "GLTSCR1L, KIAA0240" ENSG00000112624 "BRD4 interacting chromatin remodeling complex associated protein like" Q6AI39 6 42746958-42868560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029390, HPA029391" Approved Supported Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA029390: AB_10599730, HPA029391: AB_10599949" "unprognostic (2.30e-1)" "unprognostic (1.76e-1)" "unprognostic (2.15e-2)" "unprognostic (3.46e-2)" "unprognostic (9.25e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.74e-1)" "unprognostic (6.17e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-2)" "unprognostic (1.55e-1)" "unprognostic (7.24e-2)" "unprognostic (1.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.60e-1)" "unprognostic (1.29e-1)" "unprognostic (6.54e-2)" 8.5 5.7 4.5 8.3 4.4 7.7 9.5 15.9 6.9 9.4 1.1 7.6 6.1 11.3 7.7 6.5 10.2 7.2 7.0 4.2 5.0 6.1 5.7 7.8 12.2 4.8 4.0 16.2 7.0 10.4 5.8 5.2 5.1 9.2 9.5 14.3 8.3 8.1 8.0 8.7 6.7 9.6 2.9 9.8 7.5 5.0 4.0 11.6 11.3 9.4 12.2 7.7 7.3 7.4 6.2 4.9 4.3 6.9 8.7 10.0 3.7 5.4 5.6 4.7 3.6 2.2 4.4 14.4 4.8 9.1 7.2 4.8 4.2 5.6 7.7 10.8 2.7 10.1 4.9 6.3 4.6 8.6 8.8 6.2 10.6 4.6 8.4 8.9 4.9 8.4 9.8 12.5 5.6 7.4 1.4 4.9 4.8 24.3 3.0 8.9 2.5 14.3 4.8 4.0 14.6 7.8 6.1 8.7 6.1 4.1 7.6 10.0 5.7 6.5 6.4 4.3 5.4 11.3 7.0 21.6 3.9 10.8 4.7 2.3 0.5 2.8 2.2 0.4 1.9 1.2 1.3 2.1 0.4 1.3 1.2 1.6 3.7 1.6 0.8 0.7 1.6 0.6 4.5 4.4 15.9 6.9 4.2 5.0 4.8 4.0 5.1 2.9 4.0 7.4 10.3 9.6 9.4 0.0 4.2 0.0 0.0 0.0 0.0 0.0 10.2 9.1 0.0 0.0 4.3 3.7 0.0 2.3 11.6 0.0 0.0 3.8 0.0 6.2 9.6 3.1 0.0 0.0 0.0 3.8 2.1 3.9 0.0 9.8 1.3 8.4 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 3.5 0.0 0.0 4.3 2.9 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.4 5.0 5.2 0.0 0.0 BIRC2 "API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48" ENSG00000110330 "Baculoviral IAP repeat containing 2" Q13490 11 102347211-102378670 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005513, CAB020661" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 2: Hepatocytes - Metabolism" "Nucleoli fibrillar center, Cytosol" Nucleoplasm "CAB020661: , HPA005513: AB_1846746" "unprognostic (1.36e-1)" "unprognostic (3.29e-1)" "unprognostic (9.52e-3)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (7.02e-2)" "unprognostic (2.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.05e-2)" "unprognostic (3.02e-2)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (5.00e-2)" "unprognostic (1.64e-2)" 23.2 27.6 18.4 25.8 19.6 36.4 28.2 20.0 23.4 27.5 22.5 27.2 23.6 25.7 30.2 18.1 19.7 24.8 23.6 17.9 19.9 28.8 44.3 22.6 34.5 19.7 19.4 21.8 33.7 20.4 18.8 29.4 19.8 21.4 26.0 22.2 21.1 16.1 29.7 18.2 25.2 21.6 20.1 26.7 23.5 24.6 18.8 50.6 22.2 32.9 27.1 30.4 20.4 24.9 34.0 24.7 37.3 29.3 46.1 63.3 23.9 128.3 48.8 71.9 43.4 30.9 81.7 37.1 123.5 59.2 40.3 36.7 24.5 33.8 85.7 50.0 12.6 37.2 17.6 37.8 46.9 22.9 23.0 40.8 64.4 41.2 52.3 66.2 50.1 22.2 34.4 0.2 131.0 10.9 24.3 20.1 18.1 40.1 23.7 11.9 48.4 24.9 55.4 38.5 15.5 20.3 44.7 26.9 40.7 56.7 42.5 27.3 82.7 150.7 34.4 46.2 84.2 14.9 21.9 25.0 32.6 28.2 112.5 97.2 43.3 104.4 22.9 42.2 18.9 15.7 21.5 21.3 33.8 15.1 27.4 27.7 67.6 34.3 46.7 20.4 33.2 27.5 18.4 19.6 20.0 23.4 17.9 19.9 19.7 19.4 19.8 20.1 18.8 24.9 61.8 41.7 41.1 17.0 52.6 67.2 109.2 53.6 39.9 24.4 52.3 52.8 58.6 67.2 49.5 64.4 29.2 38.4 77.9 85.7 43.0 49.8 20.8 63.2 54.0 51.0 48.5 80.0 22.4 73.7 27.8 55.9 28.5 85.7 62.7 43.7 59.3 182.1 41.5 20.2 21.7 54.3 46.8 84.3 71.5 11.2 36.4 71.1 51.6 26.2 81.2 34.3 55.6 21.6 33.1 54.5 71.1 29.0 49.2 75.0 82.1 110.1 56.6 31.0 26.3 45.7 48.9 44.7 42.4 28.4 62.8 35.2 57.1 36.4 44.2 82.5 BIRC6 BRUCE ENSG00000115760 "Baculoviral IAP repeat containing 6" Q9NR09 2 32357028-32618899 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 9.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 9.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074409, HPA074738" Approved Supported "Golgi apparatus,Vesicles,Mitotic spindle" Yes No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus, Vesicles" "Mitotic spindle" "HPA074409: , HPA074738: AB_2686710" "unprognostic (3.38e-2)" "unprognostic (8.13e-3)" "unprognostic (8.88e-2)" "unprognostic (7.06e-3)" "unprognostic (6.69e-3)" "unprognostic (9.01e-2)" "unprognostic (4.51e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (4.49e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-2)" "unprognostic (1.30e-1)" "unprognostic (4.61e-1)" "unprognostic (7.32e-2)" "unprognostic (3.37e-1)" 4.6 4.7 3.1 6.7 9.7 11.3 8.9 13.9 5.7 7.7 6.3 7.6 5.0 6.8 5.2 5.3 6.2 5.8 4.9 4.6 3.7 7.6 8.9 5.4 9.6 6.4 5.5 12.0 14.7 10.9 2.9 6.9 7.3 6.2 7.5 15.5 5.5 5.9 6.1 6.7 5.4 6.1 4.4 8.5 7.1 6.8 5.6 14.7 11.4 8.8 9.7 7.2 3.1 16.3 21.7 17.8 16.1 7.9 14.9 19.1 11.3 10.8 14.1 11.0 11.3 14.2 5.7 23.6 7.3 19.7 13.2 10.1 22.9 15.1 13.9 18.8 10.5 31.2 11.3 10.7 7.9 32.4 11.9 12.4 6.9 18.0 16.2 10.1 17.7 5.4 25.6 10.0 11.9 9.3 15.5 7.5 11.7 9.2 10.5 14.6 26.6 8.2 9.2 23.4 11.7 18.4 18.6 10.8 8.2 12.5 6.4 11.5 28.7 13.0 13.3 9.1 15.3 13.9 20.0 30.6 10.1 15.1 8.7 9.7 0.9 0.6 1.3 0.7 1.8 0.8 1.0 1.2 0.7 1.8 1.1 1.4 1.5 1.6 1.5 1.6 1.0 0.5 3.1 9.7 13.9 5.7 4.6 3.7 6.4 5.5 7.3 4.4 5.6 16.3 53.9 32.1 30.5 239.3 74.8 46.0 28.6 34.7 41.5 60.8 40.0 23.4 45.8 38.6 42.7 36.8 191.8 35.0 93.4 70.1 1.9 26.9 45.9 39.3 58.0 49.8 32.5 34.3 272.0 31.2 22.0 39.7 68.3 63.1 29.9 52.1 45.7 47.5 29.8 69.0 291.3 43.3 26.4 54.7 60.0 17.6 45.4 59.1 23.2 202.4 67.2 34.9 64.9 231.8 361.3 34.3 30.3 59.0 70.9 46.4 48.5 22.6 30.6 88.2 39.5 56.0 49.1 53.7 46.2 49.7 54.8 38.0 72.4 52.8 45.3 44.0 BLOC1S5 "dJ303A1.3, MU, MUTED" ENSG00000188428 "Biogenesis of lysosomal organelles complex 1 subunit 5" Q8TDH9 6 8013567-8064396 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025613, HPA077525" Uncertain Supported Vesicles NA NA "Cluster 10: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "CAB025613: , HPA077525: AB_2686843" "unprognostic (1.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (8.12e-4)" "unprognostic (4.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.47e-2)" "unprognostic (2.87e-2)" "unprognostic (1.00e-1)" "unprognostic (1.62e-3)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.16e-2)" "unprognostic (7.60e-3)" 6.8 7.0 3.6 6.3 4.2 3.9 10.5 3.9 4.7 8.1 3.0 6.4 4.2 7.0 6.9 6.6 6.4 6.1 6.0 3.3 4.7 15.7 11.4 5.9 9.9 4.4 4.2 9.9 4.7 9.6 3.1 6.8 4.5 6.5 5.8 5.2 4.7 9.2 6.5 6.4 5.0 6.6 4.0 7.4 6.0 3.7 3.9 15.6 10.1 8.6 10.6 6.2 5.3 4.6 6.1 7.0 14.7 18.9 15.7 18.8 9.6 6.7 9.4 9.5 9.4 13.6 5.8 21.8 43.9 8.6 10.8 5.4 10.8 5.4 13.6 20.6 11.5 13.1 4.8 25.8 13.4 23.2 14.8 8.4 13.4 9.6 14.4 14.5 17.3 17.3 27.7 3.9 13.6 6.7 26.6 15.1 7.9 14.3 9.4 21.5 17.0 33.8 17.6 5.4 13.5 7.2 6.8 10.3 21.3 26.4 12.9 11.8 7.2 15.1 10.7 8.9 5.9 16.5 37.3 19.7 6.2 17.9 15.9 16.2 9.4 18.3 11.8 12.3 15.7 18.9 15.3 15.2 16.6 17.7 15.2 15.9 2.3 19.6 6.7 7.2 15.2 11.8 3.6 4.2 3.9 4.7 3.3 4.7 4.4 4.2 4.5 4.0 3.9 4.6 18.1 12.8 6.9 0.0 14.6 6.0 8.3 6.8 8.6 7.0 7.1 9.9 7.3 0.0 7.9 25.8 2.1 12.5 15.6 5.9 35.2 9.9 7.5 11.5 12.4 10.7 1.8 7.2 0.0 8.7 9.2 10.6 7.7 19.5 16.5 14.5 0.0 0.0 7.8 6.7 0.0 6.9 2.0 0.0 6.1 7.8 9.6 11.0 3.6 0.0 10.7 13.2 12.3 0.0 0.0 10.1 3.9 12.4 7.3 8.4 6.7 41.8 7.7 8.4 0.0 12.4 9.3 5.8 14.4 8.9 7.5 8.2 12.7 22.5 6.6 7.5 BLOC1S6 "HPS9, PA, PLDN" ENSG00000104164 "Biogenesis of lysosomal organelles complex 1 subunit 6" Q9UL45 15 45587214-45615945 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 230.8;Alveolar cells type 2: 292.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039928 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 11: Alveolar cells - Smell perception" "HPA039928: AB_10673538" "unprognostic (6.90e-2)" "unprognostic (3.38e-1)" "unprognostic (7.73e-2)" "unprognostic (2.32e-2)" "unprognostic (9.92e-3)" "unprognostic (1.51e-1)" "unprognostic (8.52e-3)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (4.34e-2)" "unprognostic (4.72e-2)" "unprognostic (1.14e-1)" "unprognostic (6.44e-2)" "unprognostic (8.96e-2)" "unprognostic (2.78e-1)" "unprognostic (5.13e-2)" "unprognostic (2.50e-2)" 30.0 31.2 15.3 31.1 17.1 58.2 25.5 15.6 19.1 25.8 13.9 21.2 20.2 30.7 18.4 21.0 18.1 26.5 25.1 17.0 22.7 24.2 26.8 20.4 41.9 14.8 18.6 37.8 20.4 16.8 19.0 26.3 17.7 36.4 21.5 24.6 20.7 20.4 23.6 18.2 21.3 24.3 13.8 27.9 20.1 17.0 19.2 25.2 44.4 23.2 35.4 28.5 15.6 16.8 31.5 15.9 38.9 46.2 70.1 57.0 22.2 59.0 58.4 28.5 30.4 37.6 15.9 78.1 36.2 47.5 42.6 27.6 41.7 43.2 36.6 52.8 22.0 79.8 34.9 26.2 44.1 82.2 112.9 44.6 36.7 30.7 55.9 43.8 42.4 54.7 62.4 78.7 50.7 11.8 40.0 38.6 22.5 31.4 22.4 55.8 60.3 43.9 36.6 47.9 29.3 49.4 32.7 21.2 33.9 36.8 33.8 83.2 49.0 68.6 35.6 68.6 55.7 81.2 134.8 102.4 69.5 57.1 62.5 19.3 12.5 10.5 7.5 12.6 10.5 12.9 7.3 7.7 16.8 12.8 9.0 10.2 6.0 7.0 11.1 8.1 6.7 8.9 15.3 17.1 15.6 19.1 17.0 22.7 14.8 18.6 17.7 13.8 19.2 16.8 42.0 230.8 292.6 13.7 59.6 34.5 38.7 21.5 39.3 59.8 33.5 30.4 38.4 21.5 126.0 18.4 37.5 26.0 58.9 15.9 37.2 29.9 37.2 36.2 81.8 54.8 62.1 57.4 31.8 33.0 25.6 75.9 22.4 58.7 197.7 38.0 35.0 36.6 37.6 50.5 27.3 30.4 12.2 67.9 123.0 28.4 28.0 97.6 26.6 17.8 80.4 54.0 40.2 22.6 31.0 40.1 25.9 37.2 67.7 71.8 21.2 60.4 141.5 46.7 19.7 52.1 39.2 51.8 37.8 36.9 32.8 22.0 56.1 34.5 24.7 34.4 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26383054-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 913.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (7.59e-3)" 130.6 53.4 42.7 37.2 60.4 192.6 77.9 55.6 62.0 63.9 38.9 39.6 22.2 52.8 66.3 48.3 50.5 54.7 63.2 50.0 49.6 79.4 45.4 62.9 39.4 60.7 54.0 119.7 20.1 55.1 25.4 104.5 58.4 44.4 28.2 146.5 44.1 64.4 38.9 71.5 28.4 51.3 46.6 40.7 28.9 68.6 48.8 39.9 41.9 31.7 52.1 48.9 49.5 80.8 90.6 33.8 79.1 53.9 214.5 134.0 66.8 89.0 259.9 81.9 179.6 15.3 42.7 27.7 82.5 169.0 113.4 44.8 39.6 114.5 270.0 17.8 21.8 114.9 32.0 26.9 119.3 10.3 191.1 162.5 89.2 92.9 55.3 269.2 106.2 66.9 52.6 65.0 173.7 39.1 72.7 38.5 26.2 56.7 36.6 38.4 99.9 55.6 85.3 58.3 83.9 74.4 43.2 8.8 70.0 85.9 43.7 21.7 140.4 152.2 64.6 96.2 20.5 93.2 46.0 36.8 232.6 20.6 35.1 334.9 298.3 182.9 39.5 154.8 34.9 68.4 58.4 43.3 166.9 78.0 89.3 65.5 369.0 47.6 104.1 38.0 86.1 239.3 42.7 60.4 55.6 62.0 50.0 49.6 60.7 54.0 58.4 46.6 48.8 80.8 118.3 86.6 157.4 28.7 72.2 98.8 56.0 231.7 82.6 142.5 90.6 85.3 34.0 50.1 126.4 103.0 33.3 33.2 55.6 32.7 49.0 115.4 194.1 173.5 140.8 101.2 120.6 913.9 50.6 39.1 166.5 179.9 38.7 341.2 120.9 96.5 167.0 32.2 132.1 82.4 39.4 46.8 118.0 221.3 300.4 206.7 320.3 233.6 106.7 30.0 165.0 406.4 32.0 29.1 75.8 154.1 39.8 347.5 64.6 83.6 44.0 306.4 107.6 64.0 144.7 59.1 183.9 154.4 110.7 65.4 126.6 162.5 67.0 117.6 27.6 79.3 BOD1L1 "BOD1L, FAM44A, FLJ33215, KIAA1327" ENSG00000038219 "Biorientation of chromosomes in cell division 1 like 1" Q8NFC6 4 13568738-13627725 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036943, HPA037362, HPA041290" Approved Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (7.73e-2)" "unprognostic (2.29e-2)" "unprognostic (5.94e-2)" "unprognostic (6.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-2)" "unprognostic (3.19e-1)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.48e-6)" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (6.60e-2)" 15.9 10.6 11.8 17.6 12.8 41.6 16.2 17.5 15.0 14.3 10.1 16.1 10.8 16.6 16.8 12.8 14.8 12.4 11.9 11.2 14.4 13.5 11.1 12.9 21.8 13.5 12.3 23.0 13.7 22.6 9.1 16.6 13.1 12.3 12.5 22.0 14.5 12.7 11.3 17.7 18.8 11.8 10.6 21.9 14.2 16.7 12.9 25.3 13.7 14.1 20.8 12.7 14.0 15.7 17.6 23.2 22.7 16.3 27.0 28.4 17.4 20.0 21.0 16.3 18.1 17.6 18.7 23.6 8.9 22.0 30.2 11.7 18.7 19.9 31.2 16.3 10.7 33.2 31.0 21.6 16.6 50.5 26.4 22.9 22.1 33.7 25.9 22.3 17.0 16.4 23.8 27.4 20.6 10.5 26.2 33.4 29.2 11.3 19.9 19.8 33.6 9.6 30.6 17.5 13.5 24.6 22.0 7.7 18.2 24.3 9.1 19.3 38.9 25.1 13.2 15.6 26.7 32.3 20.3 29.0 24.6 23.4 20.3 2.5 1.1 2.3 1.1 1.1 0.9 1.3 0.7 0.8 0.7 1.5 1.0 0.8 9.2 0.6 0.7 1.9 0.7 0.4 11.8 12.8 17.5 15.0 11.2 14.4 13.5 12.3 13.1 10.6 12.9 15.7 113.2 83.3 95.8 72.1 93.7 26.3 22.6 17.4 33.0 170.8 39.6 67.8 88.5 51.5 49.7 36.8 89.6 16.5 105.8 31.0 3.9 30.2 20.8 135.4 108.7 68.7 34.7 57.4 56.1 25.3 18.6 60.0 29.6 193.7 63.3 110.1 41.0 32.7 21.5 161.5 62.8 29.1 6.1 41.5 29.0 17.6 50.4 70.9 24.9 56.2 64.1 87.6 57.7 57.8 96.5 33.2 23.8 57.9 68.4 24.8 22.4 7.6 40.0 198.3 46.0 103.4 78.8 83.1 32.1 29.7 28.8 18.6 73.5 106.7 24.3 27.4 BPTF "FAC1, FALZ, NURF301" ENSG00000171634 "Bromodomain PHD finger transcription factor" Q12830 17 67825503-67984378 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029069, HPA048289" Approved Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA029069: AB_10602597, HPA048289: AB_2680342" "unprognostic (1.22e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-2)" "unprognostic (3.74e-2)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (1.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (9.24e-2)" "prognostic favorable (8.46e-4)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" 25.5 23.7 24.1 25.4 29.5 32.0 25.5 88.1 26.3 30.3 10.9 27.9 15.7 27.9 28.7 26.6 29.6 19.1 20.7 21.0 38.2 27.9 20.7 22.6 43.7 26.4 21.9 38.1 22.9 27.4 34.6 22.2 24.3 25.2 22.2 44.0 25.2 16.7 25.9 37.5 28.5 19.6 17.6 31.4 23.6 32.1 22.6 52.9 27.4 22.3 39.2 24.4 27.7 34.3 42.2 52.8 76.3 38.7 41.6 39.0 42.2 32.0 29.4 37.1 31.8 49.6 29.0 167.7 22.4 35.4 28.5 32.2 74.4 34.5 60.0 24.2 72.5 64.9 50.4 68.8 19.8 97.3 49.9 28.6 37.3 36.9 27.6 34.0 70.2 52.9 75.1 46.1 32.3 64.0 99.1 47.3 58.9 37.9 47.8 70.3 91.0 33.6 32.5 50.6 56.5 65.6 42.8 117.4 46.4 91.4 49.1 53.7 49.6 56.2 43.7 20.7 39.7 39.3 42.0 97.9 26.9 45.1 22.0 20.3 4.2 8.5 7.2 2.4 5.7 6.2 5.9 5.7 3.0 11.8 6.1 6.3 9.2 10.7 5.7 10.9 4.5 1.6 24.1 29.5 88.1 26.3 21.0 38.2 26.4 21.9 24.3 17.6 22.6 34.3 118.7 115.4 148.2 192.3 130.9 75.2 55.3 37.8 87.0 216.8 76.2 78.5 136.0 61.5 92.0 58.8 143.9 39.4 170.3 64.1 7.9 63.8 26.6 147.7 174.5 108.1 126.1 114.6 124.4 63.1 30.8 94.8 88.2 165.9 121.4 124.9 71.0 46.4 42.2 198.5 136.4 68.9 48.8 56.3 54.4 25.7 108.7 84.7 64.0 109.6 88.0 129.3 146.2 231.8 262.7 65.4 64.5 111.3 129.2 62.1 37.7 17.4 80.8 202.6 65.7 167.3 92.3 144.9 101.3 82.6 75.6 38.7 128.8 126.6 85.8 60.7 BRAF BRAF1 ENSG00000157764 "B-Raf proto-oncogene, serine/threonine kinase" P15056 7 140719327-140924929 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 252.3;Inhibitory neurons: 242.4;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 202.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001328, CAB004552, HPA071048" Approved Approved Vesicles,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Cytosol "CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336" "unprognostic (2.98e-3)" "unprognostic (5.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.66e-3)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.07e-2)" "unprognostic (4.23e-2)" "unprognostic (4.07e-2)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (1.91e-2)" "unprognostic (3.79e-3)" "unprognostic (2.08e-1)" "unprognostic (1.76e-1)" "unprognostic (8.01e-2)" "unprognostic (5.46e-2)" 8.8 5.8 6.3 5.6 7.7 15.9 8.8 12.5 8.7 8.2 5.4 8.6 4.7 8.3 8.3 7.5 8.0 5.8 7.6 8.3 6.7 7.6 6.6 9.9 6.9 4.0 3.6 9.8 8.3 11.5 9.0 7.2 4.6 8.2 5.4 17.0 7.2 5.9 8.6 10.4 6.9 6.0 3.1 6.7 7.8 13.7 5.2 8.7 10.2 8.4 6.4 9.9 8.5 6.7 6.3 5.2 7.7 9.4 9.1 11.8 12.3 6.8 7.5 5.4 7.6 5.7 6.7 10.8 5.0 7.3 8.4 3.4 6.8 5.5 10.0 9.8 5.4 7.1 5.1 5.2 7.6 11.7 6.8 7.9 6.1 6.0 12.0 8.2 6.6 7.7 11.3 19.1 9.8 3.3 15.6 12.0 6.9 6.2 3.1 10.1 6.5 8.9 5.3 11.9 8.9 7.3 7.9 4.9 7.3 7.5 4.5 7.8 9.7 5.9 4.3 12.9 5.5 21.6 12.9 16.7 9.7 11.3 6.6 1.9 1.0 4.1 1.5 0.9 1.0 1.3 1.5 1.2 0.8 1.1 2.6 1.3 2.0 3.5 1.3 1.0 1.5 0.6 6.3 7.7 12.5 8.7 8.3 6.7 4.0 3.6 4.6 3.1 5.2 6.7 43.4 22.4 45.7 151.1 58.4 21.5 24.6 6.0 23.3 29.7 31.2 21.2 19.8 10.0 18.7 25.8 35.5 15.7 73.5 8.8 7.9 14.3 68.6 50.6 37.4 23.4 19.2 14.9 252.3 9.8 12.9 22.0 21.9 69.2 24.7 45.5 9.3 9.6 9.4 25.2 242.4 9.8 8.2 13.6 37.1 36.5 16.4 30.1 16.0 126.5 14.6 11.3 15.5 206.1 202.6 15.4 8.1 10.1 48.7 23.8 8.0 13.4 20.0 33.0 6.6 24.1 24.7 43.8 26.0 14.5 24.0 75.5 41.4 30.9 8.7 33.4 BRWD3 "FLJ38568, MRX93" ENSG00000165288 "Bromodomain and WD repeat domain containing 3" Q6RI45 X 80669503-80809877 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 69.4" "Cancer enhanced" "Detected in all" "testis cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012802 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA012802: AB_2066662" "unprognostic (1.13e-2)" "unprognostic (2.14e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-3)" "unprognostic (7.04e-3)" "unprognostic (2.00e-1)" "unprognostic (1.50e-1)" "unprognostic (7.18e-2)" "unprognostic (7.44e-2)" "unprognostic (2.75e-1)" "unprognostic (7.18e-2)" "unprognostic (1.62e-2)" "unprognostic (1.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.01e-1)" "unprognostic (3.35e-1)" 3.2 2.2 1.5 4.0 2.2 5.1 3.1 6.0 1.8 3.0 1.2 3.0 3.6 3.0 2.5 4.4 3.2 2.4 1.9 1.6 2.4 2.2 3.1 3.4 4.3 1.6 2.3 4.5 3.1 2.0 3.1 3.6 1.7 2.3 3.2 5.8 3.3 1.9 1.4 6.1 4.1 1.9 1.6 3.9 3.1 3.9 2.4 5.2 3.5 1.7 3.9 2.8 3.5 2.0 4.4 4.6 7.1 4.6 2.8 3.4 5.0 2.5 2.1 3.1 4.2 2.2 5.9 4.7 5.7 2.3 3.8 7.7 10.7 4.2 4.2 4.0 4.5 9.6 7.8 3.3 2.1 5.5 6.2 2.3 2.9 3.5 4.9 4.6 4.8 4.1 7.1 11.5 3.7 0.8 3.3 5.6 10.6 4.8 1.9 2.8 12.2 2.9 3.8 3.7 1.6 4.0 6.1 3.3 2.7 12.9 1.5 5.5 4.4 3.7 4.5 3.4 2.7 5.1 5.7 5.4 3.0 11.0 2.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 1.5 2.2 6.0 1.8 1.6 2.4 1.6 2.3 1.7 1.6 2.4 2.0 16.1 12.8 13.4 48.3 14.5 17.5 8.0 8.6 13.6 27.7 9.7 6.2 8.2 15.7 15.4 5.5 16.7 5.7 13.1 13.8 0.0 6.5 2.8 11.5 15.6 13.3 7.2 12.0 47.0 6.0 7.7 10.5 21.9 16.6 11.4 22.4 8.2 5.6 5.5 62.2 54.2 10.8 2.0 13.2 17.7 3.7 9.9 19.7 1.8 45.9 17.5 8.1 6.2 69.4 53.5 8.8 22.4 10.1 13.5 13.0 17.1 4.0 12.7 20.8 6.6 14.3 11.9 6.7 9.6 16.8 20.9 7.7 15.1 12.7 12.1 19.2 BTAF1 "MOT1, TAF-172, TAF(II)170, TAF172, TAFII170" ENSG00000095564 "B-TFIID TATA-box binding protein associated factor 1" O14981 10 91923770-92030325 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070682 Supported Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Vesicles "HPA070682: AB_2686294" "unprognostic (2.41e-1)" "unprognostic (1.29e-1)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-1)" "prognostic favorable (5.07e-4)" "unprognostic (2.72e-1)" "unprognostic (9.28e-2)" "unprognostic (1.16e-1)" "unprognostic (7.34e-2)" "unprognostic (9.70e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.45e-2)" "unprognostic (1.10e-1)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" 20.4 13.2 5.2 20.1 7.3 32.1 19.2 8.5 8.6 18.4 5.9 20.4 16.2 20.7 21.1 17.2 23.4 15.2 14.4 6.1 5.5 11.8 15.4 19.1 32.0 6.1 5.3 25.4 18.1 14.7 13.3 13.7 6.0 16.8 15.9 34.3 19.2 12.7 14.8 50.4 22.0 14.0 5.9 22.0 18.4 17.9 5.8 21.7 17.3 9.2 25.5 20.1 19.9 10.4 28.9 13.8 31.7 38.7 16.5 25.8 15.8 16.5 19.6 16.0 23.7 19.1 17.2 30.8 10.3 16.3 9.9 30.4 21.5 14.6 23.8 21.2 23.2 21.9 35.7 20.0 16.8 33.3 22.0 18.4 18.5 24.3 35.1 34.3 15.6 25.9 18.2 34.5 16.6 12.6 25.8 21.0 14.4 8.3 10.8 20.6 19.7 14.5 14.9 17.5 12.2 14.3 15.8 8.0 20.3 20.8 16.2 21.9 16.9 14.3 11.4 19.5 23.7 39.7 19.6 24.9 22.4 30.1 3.8 4.4 2.7 1.5 2.5 1.9 2.2 2.5 1.9 1.8 2.1 3.1 2.3 1.8 1.9 2.2 3.6 4.9 1.6 1.4 5.2 7.3 8.5 8.6 6.1 5.5 6.1 5.3 6.0 5.9 5.8 10.4 18.3 19.2 31.5 58.4 29.5 21.7 12.1 7.3 21.6 26.7 16.2 11.9 13.6 7.2 14.6 20.2 45.9 6.6 34.8 7.9 1.9 6.8 12.9 33.3 28.0 15.6 16.2 13.9 78.5 6.6 9.8 17.3 35.2 46.6 24.1 22.4 8.9 8.7 7.1 18.5 66.4 7.1 6.1 9.7 19.8 5.1 11.8 27.1 5.4 67.5 16.4 13.9 14.4 68.3 91.5 6.7 6.3 11.7 52.1 15.7 9.6 3.3 24.9 35.5 6.6 25.7 22.8 24.7 12.2 20.4 29.8 14.6 24.7 11.4 9.3 16.4 BUD13 "Cwc26, fSAP71, MGC13125" ENSG00000137656 "BUD13 homolog" Q9BRD0 11 116748170-116772987 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038340, HPA038341" Enhanced Enhanced Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA038340: AB_2675967, HPA038341: AB_10671528" "unprognostic (1.89e-1)" "unprognostic (1.73e-1)" "unprognostic (1.01e-2)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.07e-5)" "unprognostic (1.77e-1)" "unprognostic (8.39e-2)" "unprognostic (1.46e-1)" "unprognostic (4.23e-2)" "unprognostic (9.10e-2)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.63e-1)" 10.8 7.5 7.4 12.2 8.9 12.7 13.5 10.5 9.3 11.8 8.5 11.9 11.0 15.4 10.5 11.4 13.7 8.1 8.0 7.3 8.8 9.1 9.7 12.2 16.4 8.6 8.1 16.0 11.3 10.5 8.0 11.0 8.8 10.2 13.4 10.6 10.1 10.6 12.3 11.2 12.8 12.8 7.7 12.7 11.3 21.6 8.5 25.5 12.0 14.0 18.8 11.0 11.2 10.4 22.4 12.0 33.3 20.1 10.4 12.5 16.6 21.6 23.9 24.3 23.5 28.6 33.0 47.1 26.8 17.9 25.4 30.7 27.2 16.8 26.6 27.8 11.1 55.1 8.8 21.8 12.7 46.9 31.6 11.3 19.2 20.6 20.8 15.6 24.0 46.1 36.0 22.8 20.2 17.7 57.5 41.0 20.0 31.6 19.0 42.9 28.6 36.3 17.0 25.5 19.7 26.2 25.3 18.3 10.0 21.0 25.1 30.6 13.7 27.7 17.5 14.3 29.0 9.3 12.4 39.1 9.0 42.6 25.3 15.8 7.6 20.2 10.0 7.8 10.8 10.4 8.6 7.9 8.2 7.4 9.5 8.1 9.1 7.5 8.7 7.2 8.1 5.7 7.4 8.9 10.5 9.3 7.3 8.8 8.6 8.1 8.8 7.7 8.5 10.4 11.7 9.6 5.6 6.2 14.3 7.6 10.8 7.1 11.4 6.8 6.6 6.0 4.9 2.8 6.5 9.2 12.5 9.2 9.5 11.7 7.9 8.5 13.5 10.4 8.7 8.5 9.6 17.7 7.2 8.1 10.5 7.8 7.1 9.3 11.4 9.6 7.1 8.0 8.2 3.3 6.8 6.9 2.0 12.0 6.7 5.3 9.0 7.8 7.2 3.7 9.4 7.3 26.8 9.0 11.2 6.4 8.5 10.9 16.6 6.4 15.4 5.8 10.9 7.3 6.6 8.5 7.7 51.2 21.8 11.0 4.8 9.9 13.1 7.9 11.3 7.0 C14orf119 FLJ20671 ENSG00000179933 "Chromosome 14 open reading frame 119" Q9NWQ9 14 23095505-23100456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003638 Uncertain Supported Mitochondria,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria Cytosol "HPA003638: AB_2243669" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (2.91e-1)" "unprognostic (2.33e-2)" "unprognostic (5.26e-3)" "prognostic unfavorable (5.42e-5)" "unprognostic (1.23e-1)" "unprognostic (3.36e-2)" "unprognostic (1.65e-2)" "unprognostic (4.08e-3)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-2)" "unprognostic (3.61e-2)" "prognostic favorable (3.30e-5)" "unprognostic (1.63e-1)" 41.5 49.2 26.7 34.3 28.6 15.5 46.9 30.3 32.0 41.1 34.7 42.8 33.6 40.1 42.3 45.6 33.2 27.5 36.6 26.8 29.7 49.4 37.2 38.1 34.2 30.3 29.6 33.6 31.6 35.3 38.4 33.7 30.6 30.6 51.3 25.5 36.2 38.5 32.9 30.9 41.2 48.8 29.7 47.1 41.0 25.2 31.5 40.4 33.9 31.1 50.8 47.5 33.9 32.2 53.9 52.5 77.4 47.2 166.8 144.3 62.1 88.5 129.9 114.1 134.6 41.9 81.3 40.9 44.8 144.2 138.0 89.9 74.6 117.4 157.6 65.2 36.5 61.6 41.4 180.8 130.7 93.2 91.9 177.0 104.1 96.3 70.5 104.0 126.6 72.7 41.9 44.4 127.2 77.8 44.3 72.1 48.7 124.5 79.2 38.6 57.5 47.0 130.8 85.9 37.1 33.8 73.7 68.6 81.0 85.5 46.4 53.2 103.0 54.0 47.0 81.6 40.6 41.5 52.6 50.5 49.4 58.3 49.2 317.0 160.8 302.7 122.6 106.0 140.9 143.9 138.9 137.3 150.7 121.0 144.0 142.6 94.5 131.0 74.4 102.2 188.7 203.2 26.7 28.6 30.3 32.0 26.8 29.7 30.3 29.6 30.6 29.7 31.5 32.2 50.9 48.1 47.7 4.2 41.9 26.5 89.0 144.5 23.9 28.6 41.9 50.5 23.7 34.3 75.9 31.3 8.4 89.0 53.5 44.1 129.1 95.9 22.6 39.0 45.2 56.2 28.3 65.4 3.8 84.3 105.5 42.9 30.5 33.2 54.4 39.6 46.4 29.6 107.8 20.2 4.4 57.4 81.4 38.9 32.1 15.1 64.0 53.1 48.0 5.6 93.2 36.1 58.7 2.0 11.5 97.0 42.4 48.5 31.4 59.8 61.5 100.3 48.3 21.5 32.9 18.6 47.1 52.7 25.6 33.5 34.0 143.1 46.5 81.3 51.7 83.2 C1orf112 FLJ10706 ENSG00000000460 "Chromosome 1 open reading frame 112" Q9NSG2 1 169662007-169854080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.5" "Cell type enhanced" "Detected in many" "Microglial cells: 30.0;Spermatocytes: 37.1;Spermatogonia: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023778, HPA024451" Uncertain Approved Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Mitochondria "HPA023778: AB_1848665, HPA024451: AB_1848667" "unprognostic (4.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (9.56e-5)" "unprognostic (1.33e-1)" "unprognostic (9.40e-2)" "unprognostic (2.50e-3)" "unprognostic (2.09e-1)" "unprognostic (9.11e-3)" "unprognostic (8.79e-2)" "unprognostic (3.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.65e-8)" "unprognostic (1.76e-1)" "unprognostic (2.81e-2)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" 1.8 1.2 0.6 3.3 0.9 9.0 2.9 1.7 0.8 2.3 0.5 2.6 1.2 2.9 1.0 2.0 1.5 1.4 1.0 0.5 0.4 1.1 2.6 1.7 6.3 1.0 0.6 2.2 1.5 13.5 1.0 3.4 0.8 1.8 4.1 5.4 1.5 2.0 0.9 2.4 1.8 2.7 0.7 2.8 1.9 10.3 0.9 11.6 1.7 1.5 7.9 3.1 1.7 1.5 32.7 17.5 21.9 11.3 3.5 4.8 32.2 21.1 10.7 30.0 30.6 19.1 27.7 29.0 9.3 7.0 10.7 26.0 27.6 14.7 34.3 16.9 16.5 27.1 23.0 14.1 1.2 35.8 11.3 1.5 1.9 22.5 5.3 3.5 12.8 16.8 44.9 48.0 24.8 7.9 31.5 10.3 28.8 22.9 12.1 23.3 24.7 19.5 4.0 16.1 16.2 16.9 13.4 22.1 6.9 20.6 21.0 18.3 9.5 24.1 19.1 17.8 28.9 12.9 20.9 30.6 9.0 26.4 24.1 2.2 0.8 1.0 0.6 1.9 0.4 1.4 0.6 0.6 1.2 1.4 0.3 0.5 0.1 2.1 2.3 0.4 0.7 0.6 0.6 0.9 1.7 0.8 0.5 0.4 1.0 0.6 0.8 0.7 0.9 1.5 1.2 0.0 3.3 4.2 4.0 1.8 2.7 2.6 1.2 4.1 1.7 1.8 0.5 0.0 1.5 0.0 6.2 9.1 1.6 1.9 0.0 2.7 8.7 0.9 2.1 2.2 0.0 3.4 9.9 3.4 9.1 2.5 2.6 1.2 4.5 9.8 2.9 3.8 6.2 1.7 9.6 1.2 6.1 3.5 2.1 4.1 2.1 3.0 3.6 30.0 1.3 2.4 0.0 13.0 13.2 3.0 0.3 3.8 5.5 1.0 0.8 0.7 2.0 6.6 6.6 1.4 2.6 37.1 20.3 2.8 1.0 3.8 3.3 2.2 2.6 2.4 C2CD5 "CDP138, KIAA0528" ENSG00000111731 "C2 calcium dependent domain containing 5" Q86YS7 12 22448583-22544546 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 244.6;Inhibitory neurons: 253.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 103.0" "Cancer enriched" "Detected in all" 5 "testis cancer: 39.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046194 Approved Supported "Centriolar satellite,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Centriolar satellite" "HPA046194: AB_10965327" "unprognostic (2.59e-1)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.17e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-3)" "unprognostic (1.17e-2)" "unprognostic (8.47e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-3)" 13.3 15.9 14.4 17.1 17.5 20.2 19.6 32.1 22.6 17.8 3.6 27.3 26.4 22.4 17.2 13.5 22.1 22.5 11.7 16.0 9.2 22.3 12.0 16.7 22.7 10.1 7.4 24.0 16.7 28.0 20.8 14.1 11.7 14.5 28.5 56.2 15.5 13.8 10.1 17.6 22.3 18.3 4.4 19.2 27.8 20.0 7.7 26.9 22.3 16.3 21.8 13.0 13.8 18.8 18.6 18.0 39.2 21.4 25.3 33.4 24.9 20.1 21.4 36.6 43.3 19.9 24.0 20.9 8.7 18.9 20.4 16.2 25.2 16.4 50.7 34.2 26.3 25.9 19.8 17.9 23.3 35.4 29.9 19.3 11.7 23.6 41.1 34.6 26.9 28.5 17.2 13.2 23.9 19.8 33.5 53.9 78.3 36.0 13.5 28.9 43.3 28.5 21.7 14.9 18.1 15.7 18.1 17.5 19.3 57.5 23.2 23.4 23.4 21.9 17.5 19.9 21.5 10.6 8.8 33.4 13.5 26.4 16.4 23.2 6.7 3.3 5.6 14.9 7.6 7.6 8.4 5.6 6.8 5.1 7.3 5.9 6.9 14.2 17.1 3.9 9.1 4.9 14.4 17.5 32.1 22.6 16.0 9.2 10.1 7.4 11.7 4.4 7.7 18.8 12.4 9.6 19.6 41.1 14.8 6.9 4.3 4.1 10.2 30.4 8.0 6.6 16.2 14.3 16.3 5.5 52.1 3.9 13.6 16.9 5.9 3.5 72.2 14.3 13.2 11.2 16.2 17.1 244.6 4.6 2.6 11.5 30.1 11.7 17.7 18.8 16.8 6.7 8.3 18.5 253.4 20.4 6.1 33.8 6.7 17.6 8.7 17.3 7.2 84.3 9.1 6.4 10.3 149.3 103.0 3.4 11.4 7.9 12.0 3.9 13.6 6.4 17.4 42.9 6.6 12.0 11.7 14.1 7.8 13.3 5.5 2.6 11.5 9.4 16.5 4.6 C2orf49 "asw, MGC5509" ENSG00000135974 "Chromosome 2 open reading frame 49" Q9BVC5 2 105337532-105349211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043846, HPA060814" Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Mitochondria "HPA043846: AB_2678698, HPA060814: AB_2684372" "unprognostic (4.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.06e-1)" "unprognostic (6.16e-3)" "unprognostic (2.57e-3)" "unprognostic (8.75e-3)" "unprognostic (1.89e-3)" "unprognostic (6.51e-2)" "unprognostic (5.01e-2)" "unprognostic (2.07e-1)" "unprognostic (2.56e-1)" "unprognostic (5.94e-2)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.04e-2)" 11.3 9.3 9.6 10.6 11.9 19.3 11.1 12.0 12.9 12.5 6.2 9.1 9.4 14.6 7.8 11.8 12.4 9.5 15.3 8.9 10.7 8.7 10.1 8.6 12.6 11.2 11.5 19.9 11.0 10.5 5.5 12.0 11.3 11.3 9.9 24.9 9.1 11.0 19.9 9.5 10.1 12.2 10.2 11.1 13.8 13.0 10.6 16.0 12.6 21.0 13.3 11.3 10.5 13.8 20.0 13.9 17.2 17.5 19.4 23.6 30.7 19.6 20.6 17.0 23.3 30.7 19.5 23.3 23.9 17.1 45.6 18.7 23.9 16.7 22.2 30.6 18.1 25.3 11.6 23.8 23.6 21.3 20.1 17.1 28.7 24.0 21.6 24.3 15.8 18.1 35.9 18.7 24.3 15.4 25.9 24.5 22.6 13.5 16.8 17.1 25.4 27.1 19.2 18.9 20.3 16.2 17.3 15.5 23.8 19.2 15.2 23.8 25.4 17.9 25.1 13.0 16.1 23.6 20.5 24.6 18.1 21.3 17.6 15.4 13.2 12.0 9.0 8.3 8.9 14.5 10.1 9.0 9.2 17.6 11.0 9.3 17.8 9.2 11.9 19.1 12.7 6.7 9.6 11.9 12.0 12.9 8.9 10.7 11.2 11.5 11.3 10.2 10.6 13.8 27.0 16.0 14.3 7.5 26.3 29.1 13.4 21.8 15.4 37.1 24.8 22.9 30.9 18.6 22.0 25.8 29.2 21.2 31.6 16.5 25.4 22.9 40.6 43.1 34.7 19.3 11.3 21.2 10.8 18.2 26.5 22.8 12.8 33.9 16.5 18.1 19.6 22.4 16.1 23.5 11.2 22.5 12.2 18.5 13.5 35.8 27.7 15.5 7.2 10.3 21.1 39.6 28.8 7.1 15.8 21.0 17.5 29.0 19.0 16.2 21.8 22.3 36.1 44.3 19.7 17.3 19.8 45.8 28.1 13.7 24.7 36.8 22.4 16.6 14.8 15.8 C4orf46 "LOC201725, RCDG1" ENSG00000205208 "Chromosome 4 open reading frame 46" Q504U0 4 158666675-158672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047287, HPA052670" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "HPA047287: AB_2680011, HPA052670: " "unprognostic (2.71e-1)" "unprognostic (2.38e-1)" "unprognostic (1.41e-2)" "unprognostic (2.57e-1)" "unprognostic (2.26e-1)" "unprognostic (6.10e-2)" "unprognostic (6.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.71e-2)" "unprognostic (4.20e-2)" "unprognostic (1.35e-1)" "unprognostic (5.29e-2)" "unprognostic (4.56e-2)" "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (5.69e-2)" "unprognostic (9.06e-3)" 2.5 2.4 1.9 4.1 2.4 14.5 2.9 2.4 2.8 2.7 1.3 3.3 3.0 5.0 2.1 2.9 2.4 2.8 3.7 1.9 1.9 1.9 1.5 2.6 6.0 2.3 2.2 4.2 2.4 1.7 1.1 4.5 2.3 2.4 4.2 9.4 1.7 2.2 2.1 2.9 2.8 4.0 2.1 3.2 2.6 12.8 2.0 10.2 4.3 6.0 5.4 2.6 2.0 2.9 16.6 9.9 23.7 35.0 10.3 10.6 11.8 27.5 18.9 31.5 27.4 8.9 14.6 29.3 4.3 14.0 11.6 9.0 20.6 14.2 40.3 40.5 10.7 44.5 10.4 11.9 3.5 33.9 23.7 6.2 5.0 25.6 11.2 10.4 22.7 29.3 19.7 72.1 43.2 8.9 65.8 29.7 16.3 10.6 13.0 47.0 13.5 13.0 9.6 8.1 12.8 38.5 12.1 10.9 10.1 11.9 9.3 26.9 12.0 48.0 22.1 27.0 23.2 16.5 22.3 37.0 12.1 29.8 18.9 2.4 1.9 1.7 1.9 1.6 1.4 1.7 1.5 1.9 2.1 1.4 2.1 2.3 0.6 3.4 2.2 1.8 1.8 1.3 1.9 2.4 2.4 2.8 1.9 1.9 2.3 2.2 2.3 2.1 2.0 2.9 10.3 3.2 1.8 1.3 7.8 24.1 5.1 5.8 14.2 7.5 6.5 5.2 7.6 1.5 3.2 1.8 4.2 9.8 8.2 2.9 7.9 3.6 0.8 7.6 10.8 6.9 7.7 11.2 1.2 3.0 11.8 14.5 4.6 15.0 7.0 8.7 5.0 2.0 9.7 10.1 1.8 5.1 6.1 10.3 25.8 1.8 4.7 7.6 19.6 0.0 18.9 6.5 5.2 1.0 6.2 3.8 3.1 6.0 18.1 6.6 3.2 2.8 3.3 28.2 6.6 7.7 10.6 49.1 15.2 30.1 15.6 3.3 9.6 2.5 5.8 7.2 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269358-67319953 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 5900000 "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 18.4 23.1 19.6 19.9 21.4 22.6 25.9 25.3 21.8 21.4 15.9 19.8 19.5 21.2 27.8 22.5 19.2 18.3 12.6 20.9 21.7 24.3 27.4 16.8 27.5 18.8 19.0 25.0 18.7 28.3 19.3 23.2 21.2 22.4 20.6 37.5 16.5 20.0 9.9 29.3 18.5 21.6 19.5 19.1 18.2 27.8 19.5 38.8 26.0 11.4 30.8 23.3 19.3 19.5 62.1 62.6 93.1 66.6 69.7 54.3 62.4 60.2 51.6 62.0 54.2 58.4 34.5 132.9 51.0 60.6 38.9 57.8 101.1 68.3 70.6 50.8 60.5 75.1 46.5 55.7 45.7 89.5 40.9 51.5 51.0 56.8 51.9 75.8 58.7 63.9 60.4 72.3 67.7 61.0 81.6 60.3 98.8 47.4 43.1 78.4 79.8 56.3 57.3 103.9 95.2 47.3 74.9 68.0 49.9 77.8 73.2 40.7 50.3 49.0 31.5 34.1 46.1 23.5 31.1 111.5 58.3 52.2 51.4 9.3 6.4 7.4 14.0 7.4 17.0 10.9 16.8 15.3 10.0 14.7 17.7 14.9 2.7 19.0 14.0 8.6 19.3 5.7 19.6 21.4 25.3 21.8 20.9 21.7 18.8 19.0 21.2 19.5 19.5 19.5 37.6 60.9 36.3 38.5 61.2 58.1 50.2 51.6 57.5 92.4 51.4 40.6 17.0 42.9 42.0 44.1 116.7 37.4 61.5 47.3 13.7 30.7 3.9 45.2 53.9 44.6 45.4 34.9 48.8 28.6 42.7 47.7 41.3 51.1 7.6 71.0 40.4 49.8 31.3 87.5 61.7 50.4 34.6 42.4 52.4 11.0 69.0 35.9 33.8 32.8 54.6 53.8 48.4 49.8 63.5 35.2 28.6 60.9 55.1 56.6 59.8 32.3 55.3 115.3 26.3 52.1 50.7 82.5 47.7 47.1 63.9 44.6 59.3 66.4 46.5 64.2 CBLB "Cbl-b, RNF56" ENSG00000114423 "Cbl proto-oncogene B" Q13191 3 105655461-105869552 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018327, HPA019880" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" Cytosol Nucleoplasm "HPA018327: AB_1846097, HPA019880: AB_1846099" "unprognostic (2.65e-1)" "unprognostic (9.42e-2)" "unprognostic (1.72e-2)" "unprognostic (2.38e-1)" "unprognostic (5.89e-3)" "unprognostic (2.80e-2)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.29e-2)" "unprognostic (1.50e-2)" "unprognostic (1.43e-2)" "unprognostic (8.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.20e-2)" "unprognostic (3.09e-2)" 17.3 5.8 5.6 6.7 4.6 11.9 11.0 17.4 5.9 6.8 5.8 6.3 6.2 6.3 4.3 3.5 8.8 8.4 12.2 5.2 7.3 4.3 4.4 9.9 14.5 4.4 5.3 10.0 3.6 2.3 3.8 6.5 5.7 4.7 5.1 9.2 6.7 2.3 7.8 6.8 8.2 3.0 2.0 8.5 8.3 6.4 6.5 4.3 9.1 5.1 6.9 10.0 6.5 4.0 2.4 3.2 10.7 5.4 11.8 12.1 6.8 7.6 4.0 2.3 3.7 4.1 2.6 5.2 5.4 4.2 3.6 3.9 1.5 1.4 2.8 3.8 4.0 2.8 16.1 2.7 17.7 2.0 2.0 11.9 4.3 6.2 16.7 8.5 7.9 5.2 3.0 15.5 5.0 2.8 2.9 1.3 3.6 2.9 4.4 6.1 3.1 0.9 5.9 10.2 8.2 8.9 9.5 1.1 11.9 7.3 2.4 4.3 4.8 32.0 2.6 4.5 2.0 8.8 0.7 8.3 8.6 1.7 2.1 0.7 1.4 2.8 8.9 0.9 7.9 2.1 4.6 5.1 1.3 4.8 3.9 7.0 1.0 10.2 2.0 3.1 5.7 1.7 5.6 4.6 17.4 5.9 5.2 7.3 4.4 5.3 5.7 2.0 6.5 4.0 26.0 16.0 6.1 57.8 43.1 10.8 6.9 35.6 25.6 42.6 12.0 9.7 43.7 2.8 13.7 12.9 27.1 10.1 113.7 12.8 5.9 8.4 34.1 20.9 47.0 34.0 12.6 10.8 48.9 7.8 83.2 55.2 43.8 26.4 8.8 21.3 33.2 8.1 13.9 3.3 112.5 18.8 6.1 13.5 17.1 14.4 7.5 14.6 16.0 74.9 9.0 7.5 59.8 123.1 100.3 15.5 8.6 10.9 53.1 8.9 17.6 3.9 20.2 28.9 6.6 23.6 28.9 11.1 13.3 10.3 7.0 45.4 111.5 5.5 9.9 7.0 CBX3 HP1Hs-gamma ENSG00000122565 "Chromobox 3" Q13185 7 26201162-26213607 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001973, HPA004902" Supported Supported "Nucleoplasm,Nuclear bodies" NA Yes 180000 "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "CAB001973: , HPA004902: AB_1850635" "prognostic unfavorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (4.84e-2)" "unprognostic (1.12e-2)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "prognostic unfavorable (2.20e-8)" "unprognostic (2.13e-2)" "unprognostic (3.95e-2)" "unprognostic (3.71e-3)" "prognostic unfavorable (4.00e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.56e-7)" "unprognostic (7.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.17e-1)" "unprognostic (5.78e-2)" 76.2 93.0 55.5 99.2 57.8 168.8 98.5 58.8 74.1 65.0 56.6 75.3 105.8 76.7 79.7 63.9 62.9 58.5 64.2 54.2 63.2 87.6 84.9 62.1 145.7 60.2 61.0 79.5 56.3 51.5 40.5 88.8 60.7 56.6 87.2 122.7 61.3 59.8 87.2 54.7 99.0 65.9 60.2 82.0 61.7 99.6 58.2 190.4 55.3 68.6 140.4 84.1 55.7 63.6 365.4 156.3 330.0 332.2 115.0 205.8 257.8 275.9 209.1 205.2 207.2 185.8 296.8 544.1 218.7 183.9 440.6 283.0 275.7 231.2 332.1 151.8 209.1 312.8 201.0 208.5 126.1 508.3 294.7 153.9 197.5 163.2 231.2 253.9 281.7 343.2 506.1 263.9 351.7 207.5 489.4 625.9 424.4 311.3 225.1 313.6 303.9 452.3 303.8 201.4 401.1 448.2 230.5 482.6 274.9 345.3 412.4 455.1 212.0 186.0 340.5 222.1 376.8 394.6 596.5 929.3 163.2 422.3 864.3 135.7 85.9 137.7 77.3 116.3 96.9 86.8 114.4 96.1 89.1 77.7 118.4 119.6 92.6 99.2 123.2 72.4 148.3 87.2 55.5 57.8 58.8 74.1 54.2 63.2 60.2 61.0 60.7 60.2 58.2 63.6 139.1 109.0 98.4 16.3 158.5 143.6 93.3 128.0 105.3 101.8 223.8 181.0 124.1 133.0 119.7 64.4 77.2 176.3 138.7 111.2 140.8 167.6 162.2 132.4 215.4 142.6 110.2 306.6 27.4 141.4 362.1 123.6 81.1 129.0 222.0 166.2 145.3 289.2 143.1 50.5 26.8 156.6 107.8 254.9 200.0 41.9 136.4 157.6 104.9 15.0 183.3 155.9 166.9 23.1 35.8 166.3 103.8 98.2 129.1 135.1 112.6 187.4 107.3 132.1 78.9 60.0 110.1 274.5 388.6 112.5 107.8 270.8 155.2 133.1 205.9 110.9 CCAR1 "CARP-1, CARP1, FLJ10590" ENSG00000060339 "Cell division cycle and apoptosis regulator 1" Q8IX12 10 68721012-68792377 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007856, HPA048513" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Golgi apparatus" "HPA007856: AB_1078415, HPA048513: AB_2680424" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.86e-1)" "unprognostic (5.15e-3)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "prognostic favorable (4.05e-5)" "unprognostic (2.89e-2)" "unprognostic (3.21e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.67e-1)" "unprognostic (2.36e-1)" "unprognostic (2.24e-1)" "unprognostic (1.41e-2)" 17.4 21.4 14.4 20.2 16.0 23.4 17.2 21.1 25.4 15.9 15.2 17.9 16.8 16.7 16.1 20.1 14.5 16.5 15.6 13.6 17.0 18.4 19.1 15.9 30.3 16.9 14.9 19.9 20.4 15.9 14.5 21.7 16.4 17.3 22.2 20.9 18.5 13.5 20.6 23.9 19.4 16.0 13.2 21.5 17.8 14.3 16.8 29.8 18.2 17.9 28.7 21.7 17.0 19.2 64.0 64.8 73.9 49.7 31.4 30.3 57.7 56.0 47.4 59.3 40.0 87.2 50.8 74.7 29.9 39.1 29.8 49.3 78.4 44.3 64.8 51.5 48.2 60.1 46.1 54.5 35.7 96.2 67.5 30.5 54.2 50.1 61.7 36.7 48.5 37.5 83.5 46.8 58.8 46.5 64.2 60.7 74.1 49.7 58.4 74.2 44.1 44.7 52.5 48.6 42.7 36.9 55.1 89.1 57.1 57.6 60.6 58.9 48.1 36.8 46.3 40.1 61.4 32.2 45.5 78.5 30.8 63.8 35.6 6.1 14.6 14.3 16.3 13.0 14.6 14.2 11.3 15.8 21.0 17.3 13.5 14.3 3.3 10.6 15.5 13.1 18.4 11.3 14.4 16.0 21.1 25.4 13.6 17.0 16.9 14.9 16.4 13.2 16.8 19.2 50.5 35.3 85.5 61.4 69.2 37.0 49.6 54.7 66.0 51.0 36.1 40.0 65.5 41.5 49.0 46.0 58.4 73.1 62.9 44.1 23.5 68.0 28.8 55.2 68.5 54.0 46.1 61.2 49.7 78.1 83.8 49.2 45.3 62.2 67.2 76.8 39.3 40.4 49.2 55.5 51.2 55.1 30.5 47.4 36.3 14.5 53.7 49.8 21.4 41.2 65.4 36.5 66.9 47.7 66.1 77.7 34.2 50.4 61.0 45.3 36.0 18.3 49.1 68.7 65.7 53.2 62.3 128.7 77.2 50.4 37.4 109.5 61.3 83.2 67.2 49.4 CCDC134 FLJ22349 ENSG00000100147 "Coiled-coil domain containing 134" Q9H6E4 22 41800679-41832164 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003936 Approved "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA003936: AB_1078419" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-2)" "prognostic favorable (4.09e-4)" "unprognostic (1.73e-1)" "unprognostic (3.85e-2)" "prognostic unfavorable (7.42e-7)" "unprognostic (4.35e-1)" "unprognostic (1.69e-1)" "unprognostic (3.08e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "prognostic favorable (1.36e-5)" "unprognostic (6.24e-3)" "unprognostic (2.52e-2)" "unprognostic (5.47e-1)" "unprognostic (6.63e-2)" 1.4 10.2 2.2 3.7 2.5 12.6 2.7 9.0 2.4 2.0 2.3 2.6 3.3 1.8 10.5 2.7 3.6 1.3 2.1 2.0 1.9 2.8 2.7 2.4 4.0 3.3 2.7 2.1 3.7 5.0 1.6 2.7 2.8 2.5 2.8 5.8 4.3 2.6 2.8 4.6 3.6 1.8 1.8 2.9 4.2 6.1 3.8 3.7 2.5 2.3 4.6 1.6 1.4 3.5 8.6 6.4 7.3 11.0 4.4 1.3 5.9 7.1 3.8 9.4 11.2 9.7 5.4 8.6 12.1 5.0 7.2 9.5 7.7 5.6 7.0 7.5 11.2 7.5 19.4 7.1 2.3 10.8 8.7 2.2 2.5 11.6 2.5 4.3 4.4 7.5 4.5 16.1 6.1 5.8 7.0 7.3 4.9 11.5 5.4 12.6 11.6 11.0 7.7 7.1 3.6 3.2 13.8 10.3 5.3 4.1 12.6 5.5 3.6 7.5 11.6 4.5 12.0 18.3 11.9 6.8 7.2 6.6 12.2 1.1 3.3 6.9 4.1 5.1 2.9 3.8 2.6 3.5 1.5 2.5 4.7 3.3 1.9 3.6 5.2 1.6 5.2 2.2 2.2 2.5 9.0 2.4 2.0 1.9 3.3 2.7 2.8 1.8 3.8 3.5 1.0 3.2 2.0 6.8 2.5 0.3 1.5 2.4 0.6 1.1 2.1 1.5 0.8 2.8 1.5 3.7 2.1 4.0 3.0 3.3 0.0 5.0 0.8 3.5 1.3 1.7 0.0 2.5 6.0 1.9 18.2 1.7 3.6 2.5 0.0 2.1 0.4 1.6 4.3 0.0 6.4 2.0 0.0 1.0 0.7 0.9 0.6 1.7 1.8 10.3 4.1 0.7 2.1 9.0 5.8 2.6 1.9 0.4 7.9 1.8 3.5 1.4 2.6 2.3 0.0 1.7 2.1 3.7 1.3 1.8 0.0 2.9 2.1 3.3 3.1 1.6 CCDC14 "DKFZp434L1050, FLJ12892" ENSG00000175455 "Coiled-coil domain containing 14" Q49A88 3 123897305-123961408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035278, HPA035279" Uncertain Enhanced "Centriolar satellite" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite" "HPA035278: AB_2674548, HPA035279: AB_10601253" "unprognostic (7.41e-3)" "unprognostic (5.18e-2)" "unprognostic (1.86e-1)" "unprognostic (1.41e-1)" "unprognostic (9.45e-2)" "prognostic favorable (5.27e-4)" "prognostic unfavorable (4.82e-4)" "unprognostic (6.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.76e-1)" "prognostic unfavorable (4.76e-4)" "prognostic unfavorable (3.50e-8)" "unprognostic (2.14e-2)" "unprognostic (2.86e-1)" "unprognostic (9.37e-2)" "prognostic favorable (2.72e-5)" 11.8 9.6 5.3 12.8 8.5 36.6 21.4 6.4 7.5 17.1 4.6 22.5 12.8 22.1 35.5 10.0 14.5 13.6 8.6 5.1 8.7 14.4 15.3 13.7 16.6 8.8 7.5 17.4 16.8 5.6 13.7 10.6 9.0 16.3 34.8 43.2 14.9 7.9 6.2 23.8 15.4 14.2 7.7 12.4 13.9 23.7 10.1 20.5 13.2 2.9 15.0 12.0 12.4 10.0 42.6 22.5 72.1 28.0 10.6 16.1 34.0 79.9 26.2 41.6 45.2 17.5 28.5 12.4 19.9 19.1 30.1 44.5 27.1 14.8 55.9 10.5 20.0 49.9 50.7 17.7 9.0 31.2 29.9 15.1 9.7 20.7 21.9 49.0 19.7 48.9 25.8 21.0 28.1 18.3 26.4 17.3 22.2 19.0 28.0 47.2 29.0 15.2 23.3 34.1 25.4 28.3 45.2 13.0 33.4 46.5 27.5 31.2 22.9 91.1 45.8 28.5 26.5 20.0 15.8 32.8 32.2 25.6 31.5 1.1 0.6 1.3 1.4 0.9 1.0 0.8 1.2 1.2 0.3 0.7 1.3 1.1 0.1 2.5 0.2 1.8 2.6 0.7 5.3 8.5 6.4 7.5 5.1 8.7 8.8 7.5 9.0 7.7 10.1 10.0 22.1 22.4 71.5 72.8 21.3 21.9 36.4 31.2 25.6 35.9 48.9 37.7 14.6 38.6 29.4 36.8 60.5 27.5 27.6 67.9 0.0 26.1 38.6 33.7 44.0 23.8 89.7 72.1 83.8 13.8 22.9 32.3 26.0 29.9 25.9 67.9 28.5 22.3 20.9 28.6 67.7 85.6 67.1 19.7 29.9 17.3 32.6 21.0 24.9 41.2 20.1 18.6 49.4 91.0 77.1 22.8 63.7 31.2 25.3 20.4 41.6 12.6 18.9 75.5 19.7 39.2 29.4 144.0 49.6 18.2 16.1 11.6 30.3 33.5 77.7 22.9 CCDC186 "C10orf118, CCCP-1, FLJ10188, FLJ35301, golgin104" ENSG00000165813 "Coiled-coil domain containing 186" Q7Z3E2 10 114120862-114174232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 49.3" "Group enriched" "Detected in all" 4 "dendritic cells: 49.3;granulocytes: 26.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014569, HPA018019" Approved Approved "Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA014569: AB_2066352, HPA018019: AB_1845513" "unprognostic (1.66e-2)" "unprognostic (1.76e-2)" "unprognostic (9.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.85e-3)" "unprognostic (2.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.06e-1)" "unprognostic (3.20e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "prognostic favorable (7.65e-8)" "unprognostic (8.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" 7.4 7.3 2.8 9.0 3.3 32.8 12.5 8.6 5.4 8.5 9.2 12.4 15.4 7.5 9.6 12.5 8.2 6.8 9.4 2.8 5.9 14.9 7.2 10.8 9.1 3.4 2.9 8.0 21.1 13.1 7.1 9.4 3.7 15.1 11.9 14.1 15.6 9.2 7.1 12.6 16.1 6.2 2.5 11.0 16.7 16.6 4.8 12.0 14.7 9.2 10.2 7.7 6.8 4.3 17.9 6.1 6.0 6.9 6.8 7.9 7.8 11.0 13.2 5.1 8.1 11.2 18.3 4.2 7.0 9.1 6.3 14.1 7.1 9.8 9.8 21.9 7.3 3.3 7.0 6.6 6.3 9.6 14.6 5.9 11.1 6.0 16.9 12.6 7.7 11.1 6.1 13.5 6.0 6.5 8.8 5.3 3.5 10.6 3.9 8.4 20.7 6.6 9.0 10.9 4.2 4.4 9.7 13.4 6.6 9.7 8.6 4.1 11.2 3.9 7.8 3.9 9.3 7.6 13.3 8.4 4.1 0.1 3.0 26.5 3.3 11.7 8.6 3.8 8.5 7.9 6.6 7.8 4.0 8.6 6.4 6.4 19.9 5.8 3.7 49.3 8.7 2.6 2.8 3.3 8.6 5.4 2.8 5.9 3.4 2.9 3.7 2.5 4.8 4.3 63.2 141.1 85.7 23.8 46.7 0.0 79.5 0.0 63.2 63.8 73.5 49.0 57.4 38.6 57.6 77.3 62.6 94.9 174.6 107.1 66.5 78.2 221.9 98.4 40.6 41.3 64.6 33.1 53.0 70.7 40.7 43.7 48.9 108.9 24.7 28.1 21.0 20.9 21.4 107.7 49.9 78.9 0.0 25.0 0.0 143.6 50.1 37.1 0.0 33.7 40.0 31.7 70.0 25.6 27.7 74.9 89.9 44.4 77.8 94.8 91.4 84.0 64.1 74.0 26.3 61.7 28.3 83.7 69.2 56.1 0.0 113.6 62.1 32.5 53.7 120.3 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.5;Hofbauer cells: 72.0;Syncytiotrophoblasts: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 16.0 20.5 16.2 17.0 14.8 20.2 15.5 13.9 18.1 16.0 16.9 17.3 17.0 14.6 17.3 9.3 18.2 17.8 18.1 18.3 17.1 22.8 13.0 14.2 28.7 16.1 17.6 25.0 17.9 20.0 13.6 21.3 18.6 13.9 19.8 15.1 13.0 14.9 15.5 10.3 14.9 15.4 15.6 21.5 18.0 8.3 18.2 19.4 20.9 11.1 25.8 19.2 12.1 16.2 15.4 10.8 14.1 22.8 28.8 29.9 8.4 12.0 17.8 20.9 21.8 16.4 20.9 5.6 32.9 18.0 30.2 28.3 13.8 13.8 14.8 35.0 16.2 62.6 18.1 20.6 19.6 24.0 31.5 25.4 14.1 16.3 11.0 19.8 26.7 22.0 35.0 36.9 16.1 13.3 11.2 20.4 5.6 35.3 13.6 19.1 18.5 19.1 39.6 36.3 15.8 15.5 17.9 18.5 9.3 16.6 19.6 43.4 29.8 19.5 17.0 34.1 17.5 21.1 21.1 18.4 20.7 37.2 27.8 58.2 32.4 33.9 32.6 34.2 25.9 147.1 35.6 35.3 43.0 167.2 35.8 30.7 34.0 29.1 35.7 57.6 50.6 42.1 16.2 14.8 13.9 18.1 18.3 17.1 16.1 17.6 18.6 15.6 18.2 16.2 32.1 12.8 13.4 0.0 24.6 0.0 0.0 0.0 0.0 0.0 18.6 20.8 0.0 0.0 9.9 20.2 0.0 80.5 19.6 0.0 29.4 27.0 0.0 22.7 13.7 10.2 0.0 0.0 0.0 29.2 32.5 11.3 0.0 14.4 6.3 15.5 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 10.3 0.0 0.0 0.0 0.0 38.3 0.0 0.0 7.8 0.0 0.0 30.0 12.4 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 81.4 10.1 35.0 0.0 0.0 CCDC66 DKFZp686C0433 ENSG00000180376 "Coiled-coil domain containing 66" A2RUB6 3 56557161-56621837 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 202.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044185, HPA051937" Approved Supported "Cell Junctions,Midbody ring,Centriolar satellite,Cytosol" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Centriolar satellite" "Cell Junctions, Midbody ring, Cytosol" "HPA044185: AB_10965852, HPA051937: " "unprognostic (2.28e-2)" "unprognostic (7.74e-2)" "unprognostic (7.37e-2)" "unprognostic (2.90e-1)" "unprognostic (5.28e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.68e-3)" "unprognostic (2.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.05e-3)" "unprognostic (5.48e-3)" "unprognostic (6.85e-3)" "unprognostic (1.81e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-1)" "unprognostic (6.81e-3)" 2.7 3.1 3.8 3.6 3.7 3.0 5.2 3.7 4.3 4.8 4.2 4.0 3.0 4.1 5.3 2.5 5.7 3.4 2.9 3.7 4.2 4.1 2.0 3.6 4.9 3.8 3.7 6.0 3.3 5.4 4.5 3.3 3.9 4.0 4.1 7.8 3.3 3.6 4.5 2.5 2.8 4.9 3.8 4.3 3.2 3.7 3.7 5.1 4.9 2.6 4.9 3.7 3.1 3.8 5.6 2.0 5.8 3.7 8.9 5.2 4.6 6.8 6.4 9.1 7.8 4.3 4.3 15.6 1.6 3.8 5.8 2.8 3.4 6.5 10.1 5.6 4.0 9.5 9.0 4.6 6.2 12.8 3.3 4.9 8.8 7.7 5.1 8.0 6.0 7.7 9.3 2.4 7.2 4.7 10.0 7.5 9.7 4.8 7.5 3.4 5.2 8.6 5.3 1.9 2.2 4.2 8.7 5.5 5.2 4.9 1.9 5.2 3.1 6.6 5.2 6.3 9.9 4.7 5.3 8.0 4.9 14.3 5.5 10.0 1.5 3.5 4.1 2.0 5.4 2.7 7.0 5.0 1.1 1.6 8.0 5.8 0.3 5.1 2.4 1.0 14.8 2.6 3.8 3.7 3.7 4.3 3.7 4.2 3.8 3.7 3.9 3.8 3.7 3.8 39.7 22.4 22.6 42.7 41.3 28.2 20.1 30.5 15.9 68.5 18.5 21.0 30.5 30.0 29.0 22.0 108.4 23.0 51.5 7.7 29.4 23.7 202.5 58.1 33.5 28.8 21.0 40.8 93.2 10.5 14.6 29.9 18.8 13.9 34.2 38.3 37.9 8.5 18.4 52.2 95.8 11.4 22.4 35.8 27.9 109.6 54.0 20.7 26.6 51.5 56.1 36.8 105.0 70.9 96.7 14.1 9.8 47.8 28.1 25.5 11.5 20.3 51.5 111.5 32.9 38.6 30.9 55.8 46.8 12.1 29.5 16.4 51.7 33.6 14.5 11.4 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047155-77076309 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533" "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 176.7 98.4 182.1 109.8 191.0 222.9 183.6 253.4 218.2 234.8 131.4 182.7 100.0 211.0 249.1 177.9 196.5 150.7 195.7 148.1 171.8 183.8 133.7 144.8 185.2 184.0 185.9 341.6 155.2 145.2 71.1 138.0 188.6 198.9 129.8 213.2 183.0 208.9 225.8 136.4 120.8 195.6 167.5 149.1 149.0 131.7 186.1 229.2 273.5 177.8 238.8 186.6 170.5 220.7 163.3 96.0 305.0 268.6 447.6 406.7 117.0 122.5 298.4 189.9 181.5 119.3 240.6 300.1 183.2 309.4 118.9 83.4 211.7 428.9 300.2 214.0 83.7 180.3 102.1 114.0 438.1 312.0 346.4 320.4 502.6 175.1 426.2 542.6 270.1 154.3 157.2 315.9 273.4 187.7 406.3 292.5 135.2 113.9 59.0 250.7 290.0 126.5 283.5 182.7 387.3 211.8 162.9 247.2 209.2 212.6 141.2 131.6 184.6 231.0 137.0 249.0 170.4 173.7 86.1 310.9 195.4 210.6 153.3 160.7 113.2 236.7 95.6 108.0 131.2 148.2 157.0 142.0 119.5 153.7 165.2 143.8 145.8 109.3 134.0 135.3 149.7 100.0 182.1 191.0 253.4 218.2 148.1 171.8 184.0 185.9 188.6 167.5 186.1 220.7 368.4 173.1 231.3 59.7 606.6 422.9 633.0 489.3 578.8 629.5 550.2 523.5 460.5 323.1 238.7 196.8 68.8 273.7 441.5 258.8 794.3 400.9 71.0 250.5 321.3 405.5 412.3 510.9 125.8 334.3 427.4 510.9 220.2 231.2 278.4 300.9 382.7 121.5 337.0 181.7 150.3 346.6 329.6 685.1 676.5 147.5 604.0 490.4 402.0 77.8 613.0 403.2 390.3 52.3 69.1 515.1 317.6 989.2 500.8 854.8 468.4 596.6 161.4 228.7 552.2 373.3 510.8 200.4 745.5 466.1 394.8 379.5 497.3 326.5 345.9 747.1 CDC23 "ANAPC8, APC8, CUT23" ENSG00000094880 "Cell division cycle 23" Q9UJX2 5 138187650-138213343 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039593 Approved "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA039593: AB_10795146" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (5.26e-3)" "unprognostic (3.46e-2)" "unprognostic (8.46e-2)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.37e-1)" "unprognostic (2.85e-1)" "unprognostic (3.12e-1)" "unprognostic (3.64e-1)" "unprognostic (1.64e-1)" "unprognostic (9.68e-3)" "unprognostic (9.30e-2)" "unprognostic (1.02e-1)" "unprognostic (3.12e-2)" "unprognostic (3.46e-1)" 12.4 11.8 12.3 13.6 12.7 14.1 17.4 14.5 15.7 12.7 10.0 14.0 11.4 15.1 17.2 14.5 12.4 10.6 15.3 12.5 11.7 19.8 18.3 13.3 17.9 11.6 11.6 14.8 9.5 18.4 10.0 26.2 11.8 15.5 15.6 14.0 11.8 13.6 10.1 16.5 10.9 16.9 12.0 14.4 12.8 15.1 11.8 20.3 16.1 12.2 19.4 14.6 11.7 13.1 42.7 35.8 51.2 62.7 22.2 24.8 59.8 34.8 26.8 70.0 72.3 83.9 46.7 52.0 52.3 32.6 71.9 41.6 67.5 54.0 64.4 40.3 61.9 41.5 30.6 37.7 30.8 33.1 39.4 26.0 36.4 43.9 37.0 29.1 47.3 55.1 43.7 39.1 34.9 28.6 65.6 40.3 32.6 52.6 28.6 58.3 60.8 36.0 38.8 26.9 40.7 36.8 51.8 33.1 61.1 97.3 49.3 41.2 32.6 42.0 27.6 37.1 56.7 43.6 46.7 67.7 28.9 57.2 37.2 41.4 15.1 21.6 18.3 16.5 22.2 16.8 17.9 19.3 14.4 16.2 23.4 20.7 2.9 27.0 12.3 10.4 18.1 16.0 12.3 12.7 14.5 15.7 12.5 11.7 11.6 11.6 11.8 12.0 11.8 13.1 11.7 19.2 9.5 9.8 9.7 8.0 13.9 18.8 11.4 10.5 11.8 10.5 19.0 5.7 23.3 9.2 25.0 31.9 10.3 8.2 39.2 12.5 0.8 9.1 15.1 13.2 6.1 19.8 14.0 7.2 20.4 11.9 8.6 12.3 9.5 13.5 11.0 20.0 15.7 16.8 12.8 9.0 26.4 13.0 4.7 1.1 8.7 8.8 12.4 5.6 12.6 16.4 9.2 10.6 13.5 9.7 4.6 6.4 11.4 11.3 5.6 26.4 10.4 13.1 6.6 9.7 13.2 14.5 25.3 15.9 10.1 40.8 11.2 13.1 9.8 13.8 CDK13 "CDC2L, CDC2L5, CHED, KIAA1791" ENSG00000065883 "Cyclin dependent kinase 13" Q14004 7 39950121-40099580 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059241 Uncertain Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Golgi apparatus, Cytosol" "HPA059241: AB_2683956" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (2.72e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (4.18e-3)" "unprognostic (3.42e-2)" "unprognostic (8.09e-2)" "unprognostic (1.13e-2)" "unprognostic (3.77e-2)" "unprognostic (8.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.21e-1)" "unprognostic (3.33e-2)" "unprognostic (3.53e-1)" "unprognostic (3.53e-2)" 11.4 10.2 8.8 14.6 10.8 28.1 11.1 19.3 9.9 12.8 6.7 11.9 10.5 13.6 14.2 14.7 15.0 12.7 10.4 8.1 10.7 12.7 15.9 12.1 21.7 10.5 8.5 20.1 12.8 17.2 8.0 13.6 8.6 11.2 13.6 19.7 12.9 11.8 11.2 12.0 12.0 12.0 7.2 16.6 12.3 19.0 10.1 19.6 20.6 14.0 20.2 13.4 10.0 14.9 28.4 16.6 28.2 27.0 24.9 24.1 19.3 22.1 23.8 19.8 24.6 17.8 19.1 51.0 12.6 23.4 34.8 33.6 23.4 19.4 29.0 25.3 17.3 22.8 20.0 16.0 23.7 34.8 23.5 14.3 25.5 22.6 30.0 22.6 23.6 23.1 39.0 34.3 20.7 14.7 28.0 24.9 40.8 20.0 19.1 30.5 18.5 20.5 18.5 28.1 20.0 28.8 27.6 59.8 19.9 36.7 24.6 43.0 28.3 27.0 26.0 17.6 30.5 28.3 26.0 41.2 19.8 30.9 35.4 7.8 2.2 4.0 4.1 1.9 2.8 6.4 3.8 3.0 1.3 10.5 3.8 3.9 5.9 4.3 3.1 3.3 3.9 1.3 8.8 10.8 19.3 9.9 8.1 10.7 10.5 8.5 8.6 7.2 10.1 14.9 47.6 44.8 72.0 131.6 49.7 21.4 18.5 15.9 29.0 47.8 36.7 27.7 30.9 25.8 37.1 31.3 70.9 13.7 91.0 23.1 7.9 20.4 13.9 54.3 51.4 30.9 18.7 5.9 179.0 15.4 9.1 31.7 30.1 72.6 17.1 95.5 19.2 23.7 13.2 37.0 166.2 17.6 14.2 23.8 17.4 9.2 26.1 31.6 14.2 145.2 27.9 22.4 53.5 171.9 199.6 28.6 12.9 17.7 50.1 21.8 15.2 12.7 32.8 69.4 6.6 38.5 32.0 36.1 33.4 34.7 26.1 12.2 49.7 56.8 20.1 25.0 CDKN2C "INK4C, p18" ENSG00000123080 "Cyclin dependent kinase inhibitor 2C" P42773 1 50960745-50974634 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 98.4;lymphoid tissue: 96.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 73.5;Sertoli cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 273.1;U-937: 284.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005303, CAB018398, HPA019057, HPA019764" Approved Approved Nucleoplasm,Cytosol NA Yes "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytosol" "CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866" "unprognostic (4.07e-2)" "unprognostic (1.47e-3)" "unprognostic (2.89e-1)" "unprognostic (4.86e-2)" "unprognostic (6.70e-2)" "unprognostic (4.76e-3)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.70e-10)" "unprognostic (2.55e-2)" "unprognostic (2.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.24e-1)" 98.4 23.2 21.6 9.1 23.6 36.0 30.6 22.6 31.4 17.5 20.3 19.3 13.4 20.4 11.8 11.1 15.2 15.5 24.2 21.6 23.0 10.4 7.2 9.9 22.5 23.0 22.4 47.6 17.4 19.9 7.8 7.3 24.0 9.9 12.6 7.8 8.8 24.9 20.5 18.9 14.2 22.2 21.2 11.1 7.4 5.2 22.2 96.2 9.7 8.6 23.4 13.1 16.3 30.3 67.6 32.9 5.9 99.6 108.0 16.4 1.5 61.8 76.2 121.8 107.8 1.8 25.7 140.3 58.5 63.5 41.6 8.2 71.4 9.8 63.4 78.4 90.7 102.5 254.6 21.5 5.5 74.0 42.8 5.6 1.9 32.8 14.6 45.6 32.7 115.0 45.0 0.0 76.2 22.0 91.1 40.4 0.1 31.6 71.3 108.6 86.8 0.4 42.9 34.1 49.6 114.3 88.1 67.5 23.6 0.6 31.3 273.1 21.6 130.8 44.1 76.3 0.9 128.1 131.9 113.2 0.0 284.5 118.3 22.4 3.7 17.9 7.3 2.2 8.4 4.9 10.8 9.7 9.3 4.3 6.0 5.8 0.4 10.5 0.9 11.5 22.0 5.6 21.6 23.6 22.6 31.4 21.6 23.0 23.0 22.4 24.0 21.2 22.2 30.3 9.5 0.0 3.9 2.0 5.6 10.1 2.6 8.1 23.9 8.2 3.8 29.5 14.3 5.7 6.1 3.7 16.7 4.9 11.3 2.8 17.6 6.3 4.9 1.1 18.2 8.1 8.4 73.5 0.6 3.4 12.1 31.0 3.1 1.2 16.5 12.6 20.3 8.8 28.3 5.0 0.6 10.2 14.2 20.5 16.0 7.1 39.4 11.0 7.2 1.9 17.1 26.9 17.5 2.0 3.3 3.1 10.2 47.8 14.0 1.8 24.6 40.8 3.2 9.9 85.5 38.9 26.7 32.0 15.0 22.0 11.2 1.9 18.2 28.6 9.1 1.2 CEP135 "CEP4, FLJ13621, KIAA0635" ENSG00000174799 "Centrosomal protein 135" Q66GS9 4 55948871-56033361 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 92.3;monocytes: 64.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (2.75e-1)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.06e-2)" "unprognostic (3.63e-1)" "unprognostic (3.42e-2)" "unprognostic (4.65e-3)" "unprognostic (4.78e-3)" "unprognostic (1.83e-3)" "unprognostic (9.89e-3)" "unprognostic (9.50e-2)" "unprognostic (2.27e-1)" "unprognostic (6.02e-9)" "unprognostic (7.55e-2)" "unprognostic (5.54e-2)" "unprognostic (1.95e-1)" "prognostic favorable (6.11e-5)" 2.6 1.6 1.0 7.2 1.3 10.1 2.8 2.1 1.6 3.5 1.9 2.4 3.1 7.6 2.1 2.0 3.3 3.1 1.4 1.2 1.3 4.0 1.3 3.2 10.2 1.7 1.5 5.0 1.7 2.0 1.2 5.9 1.7 2.3 3.2 3.7 1.5 1.6 0.8 3.9 3.3 5.0 1.0 5.7 2.2 6.4 2.0 9.5 2.6 1.3 7.6 2.9 2.2 1.9 8.9 4.8 13.0 12.3 2.6 5.0 5.5 8.6 6.1 7.7 9.0 5.2 9.0 23.7 6.4 3.8 6.0 4.0 13.8 5.2 14.6 6.5 8.4 8.3 7.6 4.9 2.9 15.2 12.6 3.9 4.1 9.9 7.0 3.4 6.5 11.9 15.4 11.0 8.1 5.2 21.3 9.5 8.3 4.4 4.9 15.4 6.1 4.8 5.6 6.4 9.3 9.6 7.7 5.2 6.4 7.8 6.9 9.7 6.5 10.4 17.0 12.5 15.1 5.9 4.4 15.7 5.2 11.8 13.1 9.9 2.1 2.9 3.0 2.8 2.8 3.0 3.9 2.9 1.5 5.6 5.0 3.1 4.3 4.7 3.2 5.6 2.7 1.4 1.0 1.3 2.1 1.6 1.2 1.3 1.7 1.5 1.7 1.0 2.0 1.9 16.3 6.4 12.4 7.8 30.2 9.1 8.2 6.3 7.4 12.6 5.6 6.6 8.5 2.8 9.4 7.3 10.4 20.0 27.3 5.2 3.9 9.4 92.3 23.1 14.6 18.2 5.4 28.2 10.0 5.4 16.3 11.5 3.1 13.0 14.5 38.2 12.5 1.7 10.4 26.9 10.4 5.5 6.1 12.9 11.3 19.4 5.9 19.2 5.4 19.7 64.5 4.3 32.0 8.0 13.9 15.6 6.7 8.2 16.7 5.2 3.0 10.0 17.4 24.5 6.6 16.2 11.2 57.3 38.7 6.8 6.7 9.6 20.0 34.6 5.7 6.3 CEP192 "FLJ10352, KIAA1569, PPP1R62" ENSG00000101639 "Centrosomal protein 192" Q8TEP8 18 12991362-13125052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 67.6;Excitatory neurons: 94.4;Inhibitory neurons: 91.3;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039392, HPA040503" Uncertain Supported Centrosome,Cytosol Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Centrosome, Cytosol" "HPA039392: AB_10697549, HPA040503: AB_10670919" "unprognostic (6.94e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-3)" "unprognostic (6.87e-3)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (9.00e-2)" "unprognostic (6.61e-2)" "unprognostic (1.28e-1)" "unprognostic (7.89e-2)" "unprognostic (2.39e-1)" "unprognostic (4.54e-2)" "unprognostic (1.66e-3)" 2.9 2.2 5.0 4.6 7.6 10.8 4.9 9.8 5.2 4.7 0.0 4.5 4.0 6.4 3.9 3.7 4.9 5.7 3.6 4.1 2.4 2.8 2.9 4.4 6.9 4.1 4.7 9.9 4.6 4.7 2.5 4.6 3.6 4.0 5.4 6.8 4.1 3.5 1.8 3.5 4.7 4.6 3.4 5.2 4.7 9.3 5.0 11.6 5.5 3.9 5.6 4.1 2.5 9.7 13.5 7.2 19.1 10.1 8.1 12.6 6.1 9.2 12.1 14.3 15.1 9.9 5.8 15.2 6.1 9.4 10.4 6.4 16.7 8.8 16.8 6.0 6.0 13.8 11.3 5.2 4.3 22.2 10.2 8.8 3.2 12.0 10.9 8.2 11.9 10.7 19.3 9.9 11.3 6.8 19.2 9.6 6.1 24.9 4.4 16.3 14.9 7.9 4.9 13.6 13.9 7.8 14.7 7.2 4.4 9.0 5.8 11.3 12.1 11.2 26.2 12.9 12.8 6.6 10.1 17.0 7.2 9.9 11.0 0.4 0.6 0.5 0.9 0.4 0.7 0.5 0.6 0.6 0.3 1.3 0.6 1.0 0.6 0.2 1.7 0.5 0.5 0.3 5.0 7.6 9.8 5.2 4.1 2.4 4.1 4.7 3.6 3.4 5.0 9.7 13.3 9.6 12.8 67.6 11.4 1.9 3.9 4.3 5.2 13.1 6.4 5.8 28.7 4.3 9.3 7.3 22.9 5.3 13.7 7.6 0.0 4.7 23.3 11.0 11.8 8.5 0.0 18.7 94.4 3.6 3.3 10.5 15.8 12.1 2.5 40.9 8.2 6.5 4.6 11.8 91.3 8.7 4.1 10.1 3.9 14.2 10.2 10.1 1.8 62.8 15.3 6.5 14.4 76.9 90.6 4.8 5.7 13.9 15.0 5.5 4.5 1.2 8.0 17.8 26.3 11.3 8.1 33.5 24.0 8.5 3.1 1.9 12.3 60.6 8.0 7.6 CEP295 KIAA1731 ENSG00000166004 "Centrosomal protein 295" Q9C0D2 11 93661682-93730358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038595, HPA038596, HPA038597" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106" "unprognostic (1.35e-2)" "unprognostic (3.08e-1)" "unprognostic (7.66e-2)" "unprognostic (5.56e-2)" "unprognostic (5.73e-2)" "unprognostic (4.08e-3)" "unprognostic (6.03e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (3.73e-2)" "unprognostic (4.99e-4)" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (2.18e-2)" 6.6 5.8 7.5 6.3 8.1 16.0 8.3 14.4 10.5 7.6 5.0 8.7 6.2 7.0 7.4 5.8 6.8 5.2 5.3 7.3 6.9 6.2 5.0 6.0 11.1 6.3 5.9 8.3 6.6 4.7 8.4 6.3 6.6 8.3 6.8 14.7 5.5 5.2 5.3 8.9 7.5 5.5 4.9 9.4 6.2 12.0 7.6 10.3 8.7 5.8 7.4 7.7 6.6 10.2 10.5 9.4 23.9 20.4 10.8 10.4 11.6 13.2 9.7 12.2 14.2 17.3 19.2 3.1 19.1 8.3 16.9 18.7 11.8 9.5 12.4 15.0 9.4 19.0 28.2 8.6 6.5 17.1 17.4 7.7 5.6 11.6 10.0 11.5 10.4 16.9 21.6 19.4 15.8 8.8 8.9 28.1 7.5 19.6 9.7 17.7 22.6 12.6 10.1 17.9 13.9 12.9 20.9 13.8 3.7 14.8 22.8 9.4 9.6 11.3 14.8 20.9 10.1 6.9 16.7 20.2 6.7 19.7 15.9 3.3 1.7 3.6 1.5 0.9 1.2 3.2 1.3 1.0 0.8 3.5 1.6 1.4 5.2 1.6 1.3 1.7 1.1 0.4 7.5 8.1 14.4 10.5 7.3 6.9 6.3 5.9 6.6 4.9 7.6 10.2 10.9 9.6 14.3 24.2 14.0 0.0 3.3 0.0 5.2 30.5 7.0 8.9 9.4 5.7 5.6 5.5 27.1 12.8 8.6 2.5 3.9 7.8 78.7 12.4 15.0 9.6 3.6 25.7 41.2 7.8 10.3 8.8 11.2 10.2 16.4 48.8 6.8 4.2 8.0 18.5 40.8 5.5 0.0 7.9 0.0 21.4 12.8 7.7 0.0 15.0 10.3 10.3 10.3 23.6 33.5 5.3 4.1 14.3 12.2 5.6 5.8 4.0 5.1 38.1 6.6 9.4 8.7 48.8 18.6 7.5 0.0 6.6 9.8 15.8 5.8 2.8 CEP44 KIAA1712 ENSG00000164118 "Centrosomal protein 44" Q9C0F1 4 174283730-174333380 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 73.9;SH-SY5Y: 142.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041515, HPA041835" Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "HPA041515: AB_10795638, HPA041835: AB_10794637" "unprognostic (2.43e-1)" "unprognostic (1.30e-1)" "unprognostic (1.26e-1)" "unprognostic (4.03e-2)" "unprognostic (8.69e-2)" "unprognostic (6.96e-2)" "unprognostic (1.07e-2)" "unprognostic (6.62e-2)" "unprognostic (1.90e-2)" "unprognostic (1.11e-2)" "unprognostic (7.97e-2)" "unprognostic (2.72e-3)" "unprognostic (5.54e-2)" "unprognostic (2.44e-1)" "unprognostic (2.80e-1)" "unprognostic (1.21e-2)" "unprognostic (1.90e-2)" 6.1 8.7 5.7 7.8 8.2 11.1 9.7 11.5 7.6 7.9 7.4 9.2 7.6 10.5 9.2 8.7 7.6 8.1 8.7 7.8 6.0 5.9 7.8 7.1 10.2 7.5 6.5 10.8 6.3 9.2 8.1 11.5 8.5 8.4 8.6 12.6 7.6 6.1 5.8 13.0 8.6 7.6 6.6 8.8 8.7 13.4 6.6 11.0 9.0 6.2 8.5 7.3 7.3 13.2 12.5 11.4 19.2 9.6 12.1 17.3 10.7 18.7 7.1 12.1 12.5 6.9 27.1 19.0 18.1 4.8 11.5 10.1 20.4 9.3 15.5 30.9 32.2 23.2 33.1 8.0 8.3 17.7 16.6 9.2 14.4 9.9 10.6 12.0 10.6 14.7 30.9 73.9 14.6 4.9 20.7 13.7 10.0 9.4 9.8 15.4 18.2 15.6 10.8 5.0 34.5 142.6 16.1 12.8 14.2 17.6 13.8 12.7 11.5 9.6 10.5 23.1 11.8 18.7 14.0 24.0 18.6 15.7 19.6 5.9 3.1 2.3 3.9 3.7 3.9 5.6 4.1 3.4 3.2 5.6 5.2 4.5 2.3 2.8 4.6 3.0 8.7 2.7 5.7 8.2 11.5 7.6 7.8 6.0 7.5 6.5 8.5 6.6 6.6 13.2 12.6 9.6 16.4 24.5 14.4 9.9 9.0 10.1 14.8 22.8 10.7 8.0 17.1 8.6 11.9 1.8 33.3 6.6 14.2 8.0 5.9 7.8 6.6 25.4 15.8 9.1 7.7 27.4 24.0 8.0 10.3 14.2 10.2 20.0 12.0 19.4 6.1 7.8 6.6 15.2 25.5 7.8 8.2 9.5 6.0 7.9 16.4 12.3 8.8 10.3 7.9 11.1 8.2 39.2 58.4 9.5 4.9 10.1 13.7 7.2 9.2 4.9 31.5 30.3 13.1 21.1 14.6 44.8 15.0 8.8 11.1 6.7 13.0 9.3 8.1 10.1 CEP57 "KIAA0092, Translokin, TSP57" ENSG00000166037 "Centrosomal protein 57" Q86XR8 11 95789965-95832693 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 462.9;Late spermatids: 372.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA018315 Approved Approved Microtubules,Cytosol "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" Microtubules Cytosol "HPA018315: AB_1846537" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (1.45e-2)" "unprognostic (2.66e-1)" "prognostic favorable (7.24e-4)" "unprognostic (1.69e-1)" "unprognostic (2.25e-2)" "unprognostic (8.10e-2)" "unprognostic (9.04e-3)" "unprognostic (7.93e-2)" "unprognostic (2.38e-3)" "unprognostic (7.81e-2)" "unprognostic (1.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.35e-1)" "unprognostic (6.69e-3)" "unprognostic (3.25e-1)" 16.6 14.0 10.6 19.2 11.4 29.0 21.6 15.0 13.3 19.0 12.6 17.7 32.4 21.8 19.8 15.0 17.7 27.3 15.6 10.4 11.2 15.7 44.6 16.9 30.1 12.2 11.2 31.2 22.8 12.2 14.9 16.1 10.8 16.2 18.6 25.9 14.1 17.3 12.8 17.8 21.9 15.5 10.9 20.5 17.8 27.9 11.7 34.2 22.7 14.3 30.6 14.0 15.1 12.4 26.7 13.1 42.0 32.7 19.4 38.6 34.4 29.8 48.6 41.4 46.1 47.5 55.1 47.1 39.6 22.4 24.2 43.8 34.7 29.5 43.8 38.1 21.8 66.4 36.9 38.4 33.9 67.0 37.2 25.9 42.5 43.2 80.4 39.3 33.4 49.6 43.8 25.3 33.8 13.1 74.7 89.1 23.3 30.2 29.2 43.8 53.2 40.7 34.8 27.8 21.5 28.9 36.1 34.4 38.3 29.7 35.1 44.0 17.2 35.2 28.3 52.0 28.2 16.9 38.1 51.7 14.6 74.4 31.0 19.0 11.8 24.3 19.5 14.4 25.9 23.6 25.7 22.7 15.6 21.7 24.8 23.5 11.6 26.0 13.2 21.1 33.7 17.5 10.6 11.4 15.0 13.3 10.4 11.2 12.2 11.2 10.8 10.9 11.7 12.4 43.7 54.5 51.1 35.9 58.5 36.3 30.6 35.7 51.2 72.3 30.6 42.7 41.3 85.8 41.7 29.5 35.5 44.1 42.8 16.2 54.8 34.2 462.9 52.2 33.0 38.2 28.8 88.1 68.0 25.7 50.8 41.1 18.3 33.0 27.3 58.4 30.7 71.5 33.1 57.2 78.3 34.0 16.2 35.0 37.3 372.7 33.8 33.2 17.8 27.2 37.6 29.6 44.3 57.8 60.9 26.2 23.9 35.7 57.8 28.8 45.2 40.2 52.6 59.0 65.7 34.4 37.8 75.8 46.1 42.0 32.0 38.4 59.1 53.0 47.2 27.6 CEP76 "C18orf9, FLJ12542, HsT1705" ENSG00000101624 "Centrosomal protein 76" Q8TAP6 18 12661833-12702777 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 209.7;Late spermatids: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 60.5" "Region enriched" "Detected in all" 9 "cerebellum: 55.0" "Region enriched" "Detected in all" 5 "cerebellum: 16.3" HPA039395 Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" "HPA039395: AB_10673357" "unprognostic (3.39e-1)" "unprognostic (2.99e-2)" "unprognostic (2.26e-1)" "unprognostic (9.31e-3)" "unprognostic (1.65e-1)" "unprognostic (1.37e-1)" "unprognostic (2.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.00e-4)" "unprognostic (7.88e-3)" "unprognostic (2.45e-1)" "unprognostic (8.70e-2)" "unprognostic (1.67e-2)" "unprognostic (4.39e-2)" "unprognostic (2.37e-1)" "unprognostic (5.70e-2)" "unprognostic (8.21e-2)" 3.0 3.4 2.5 2.6 2.5 6.2 3.8 7.7 3.3 3.4 2.6 2.9 2.7 3.3 5.1 5.3 2.7 2.6 2.7 2.3 2.5 3.1 4.8 2.7 3.8 2.3 2.4 3.2 2.3 2.5 2.2 3.4 2.5 2.8 3.9 4.5 2.9 2.8 3.2 4.0 3.1 3.3 2.3 2.5 2.8 8.2 2.6 7.9 3.7 3.5 4.7 3.2 2.8 2.6 7.3 7.2 12.1 5.9 7.1 3.8 11.7 8.4 9.4 16.1 12.5 16.6 8.5 9.7 7.3 5.5 9.4 5.6 12.1 5.3 13.7 6.1 9.8 8.5 8.0 14.1 5.3 20.0 9.5 3.0 5.3 9.5 6.2 4.5 8.5 13.5 14.5 14.3 10.4 5.5 17.5 13.9 8.7 60.5 4.7 12.2 10.5 10.4 8.4 7.1 9.2 8.0 10.5 6.7 6.9 7.9 4.8 11.0 8.0 10.8 21.9 10.6 10.0 8.0 14.8 11.5 5.4 9.7 7.2 0.4 2.3 2.1 2.6 4.4 3.5 1.8 2.9 3.2 2.1 2.3 2.9 3.4 0.7 3.7 1.7 1.2 3.5 2.2 2.5 2.5 7.7 3.3 2.3 2.5 2.3 2.4 2.5 2.3 2.6 2.6 4.3 6.4 5.9 7.5 7.2 9.7 3.9 3.0 5.2 6.3 4.1 4.6 1.8 1.5 5.4 0.0 12.5 5.9 6.7 3.7 1.9 3.0 209.7 5.5 5.8 5.2 6.0 13.9 16.9 2.5 7.5 4.0 2.0 4.6 5.7 14.0 4.2 4.8 4.1 3.3 16.7 5.5 4.1 3.5 4.1 57.8 3.7 3.4 7.2 3.7 2.5 2.9 6.2 7.5 7.9 3.8 0.6 4.5 10.3 5.1 7.8 2.5 3.5 8.0 6.6 7.1 3.7 27.7 22.1 12.4 8.2 6.2 6.4 11.5 4.8 5.7 CEP78 "C9orf81, FLJ12643" ENSG00000148019 "Centrosomal protein 78" Q5JTW2 9 78236062-78279690 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Cone-rod dystrophy, Deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 110.5;dendritic cells: 106.8;NK-cells: 249.3;Spermatocytes: 82.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 39.1" "Group enriched" "Detected in many" 5 "NK-cells: 39.1;T-cells: 18.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048846 Approved NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" "HPA048846: AB_2680537" "unprognostic (4.62e-1)" "unprognostic (6.33e-3)" "unprognostic (2.87e-2)" "unprognostic (1.36e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-2)" "unprognostic (5.13e-4)" "unprognostic (6.75e-2)" "unprognostic (8.48e-3)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (7.03e-2)" "unprognostic (1.25e-2)" "unprognostic (2.27e-3)" "unprognostic (4.93e-1)" "unprognostic (1.18e-3)" "unprognostic (3.34e-1)" 2.2 2.9 4.3 4.6 5.0 12.3 4.3 5.9 4.4 4.1 3.8 3.5 2.8 5.6 3.2 3.5 3.4 2.4 1.6 4.2 4.7 3.6 3.5 3.4 6.2 4.6 4.5 4.3 2.5 4.3 2.7 3.9 4.6 3.1 3.9 9.2 3.3 3.4 1.6 3.5 2.9 4.7 5.1 5.0 3.0 15.1 4.3 11.5 3.7 1.7 7.7 3.2 3.0 6.2 31.7 14.5 33.3 20.5 5.4 9.4 22.3 25.6 10.1 15.1 19.1 2.7 8.4 28.9 12.7 9.2 21.4 36.9 49.6 13.7 22.5 24.3 16.6 15.4 17.1 11.4 4.9 26.0 14.6 5.2 2.9 17.1 11.1 7.5 23.4 29.4 12.2 22.4 19.8 20.3 32.6 12.8 35.2 32.7 14.0 32.2 38.4 8.4 9.0 14.0 30.4 21.1 33.7 10.6 8.4 22.7 12.6 6.9 12.5 13.3 22.6 27.5 24.7 13.1 17.8 18.4 11.8 17.6 23.0 0.7 0.8 0.7 18.3 3.4 8.9 5.0 7.9 16.0 2.3 3.4 3.9 12.8 0.5 39.1 5.5 4.2 13.1 8.3 4.3 5.0 5.9 4.4 4.2 4.7 4.6 4.5 4.6 5.1 4.3 6.2 10.3 25.6 9.2 26.1 13.7 5.1 8.1 6.9 8.0 27.1 7.6 10.5 8.9 4.3 7.2 1.8 110.5 14.0 106.8 3.9 5.9 8.4 14.1 18.7 16.9 9.0 7.7 25.7 28.6 6.7 19.5 10.3 10.2 10.4 5.1 20.6 7.1 9.0 9.6 3.3 20.5 8.0 4.1 6.1 6.1 9.9 14.9 10.0 1.8 9.4 9.7 14.7 249.3 27.2 24.6 4.7 4.1 15.1 43.7 3.7 1.0 5.1 22.1 49.4 0.0 14.8 11.3 82.1 34.2 10.0 4.8 4.0 34.0 12.3 13.2 4.0 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506865-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052426, HPA052428, HPA061371" Approved Uncertain "Centriolar satellite,Cytosol" NA No "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "Centriolar satellite" "HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495" "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favorable (5.78e-4)" "prognostic unfavorable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 8.4 6.4 8.1 11.7 10.2 42.5 17.5 20.5 10.8 12.8 15.4 11.7 13.5 23.4 15.9 9.4 16.6 13.0 8.5 8.5 8.6 10.4 11.3 11.3 20.1 10.4 10.7 25.6 14.4 10.4 6.3 9.5 10.7 14.6 14.6 40.4 9.6 11.7 9.5 23.1 11.8 12.5 8.9 14.0 13.9 19.0 8.3 18.9 21.3 6.9 16.4 9.7 7.9 16.2 18.5 10.7 26.3 22.8 8.6 15.4 23.7 9.6 10.9 12.8 16.9 14.4 11.3 28.7 6.1 13.3 13.2 25.3 21.2 15.9 24.9 7.3 15.6 27.2 28.2 30.8 21.1 28.9 15.3 18.9 19.8 14.2 30.7 18.5 10.9 29.1 31.5 21.5 12.5 21.4 40.3 23.4 14.8 20.9 14.2 31.6 46.1 21.0 16.5 28.4 14.9 28.0 11.8 22.0 30.2 39.1 20.2 25.0 12.7 27.6 23.9 11.5 13.1 23.6 18.5 31.4 11.6 21.5 19.0 0.6 2.7 2.1 2.9 2.9 7.1 3.5 3.6 4.3 3.0 3.7 5.9 4.0 0.9 2.0 2.8 2.9 3.2 1.8 8.1 10.2 20.5 10.8 8.5 8.6 10.4 10.7 10.7 8.9 8.3 16.2 14.9 41.7 26.3 44.7 29.4 16.2 25.6 14.3 40.5 29.9 17.9 20.2 17.6 14.3 29.4 3.7 45.9 9.4 25.1 18.1 7.9 18.6 58.0 45.9 28.9 13.8 7.7 26.5 47.5 11.8 10.8 23.5 18.8 44.8 29.7 31.9 13.2 8.9 8.5 18.5 56.2 13.8 8.2 10.3 12.8 18.5 20.8 16.6 12.4 23.4 15.2 21.3 15.5 42.7 46.7 14.1 10.4 21.4 21.1 15.4 20.2 6.8 53.1 84.8 13.1 41.3 21.6 38.8 27.5 28.4 20.3 6.6 23.7 23.8 19.7 21.9 CGGBP1 "CGGBP, p20-CGGBP" ENSG00000163320 "CGG triplet repeat binding protein 1" Q9UFW8 3 88051944-88149885 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 528.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035568, HPA037017" Supported Enhanced Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA035568: AB_10670022, HPA037017: AB_2675433" "unprognostic (2.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.43e-2)" "unprognostic (4.89e-2)" "unprognostic (1.30e-2)" "unprognostic (2.96e-2)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" "unprognostic (8.30e-2)" "unprognostic (3.63e-1)" "unprognostic (1.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (3.35e-2)" "unprognostic (3.00e-1)" "prognostic favorable (7.79e-4)" 40.2 31.0 22.2 45.8 25.5 75.7 36.9 26.5 29.8 39.9 27.1 32.8 35.6 45.3 32.7 35.6 33.5 37.3 35.9 23.5 27.3 40.2 41.3 39.5 65.2 23.0 22.9 56.2 37.9 44.4 23.2 42.0 23.3 35.5 39.6 48.8 35.2 35.3 37.6 28.1 37.6 44.3 24.4 52.7 33.7 32.5 23.6 85.3 47.0 47.4 61.9 35.7 27.7 34.9 37.4 64.1 109.3 77.4 92.8 78.1 34.5 81.9 71.4 82.0 97.9 46.7 56.4 81.9 52.7 74.7 63.0 30.2 91.4 63.2 103.2 126.0 46.5 132.3 66.0 47.4 79.7 86.3 93.8 74.4 53.8 95.0 118.7 99.2 85.1 99.0 58.2 87.5 89.5 62.9 136.5 59.5 58.1 62.5 59.0 83.6 106.9 58.0 56.0 66.3 22.0 66.6 66.9 35.6 179.1 79.6 57.5 95.6 81.5 98.8 72.5 528.4 81.8 64.0 83.2 90.5 73.1 81.5 84.9 107.9 42.7 81.2 44.2 45.7 43.8 45.0 39.6 46.4 40.6 47.6 46.6 39.6 77.0 47.4 51.6 34.0 48.9 44.7 22.2 25.5 26.5 29.8 23.5 27.3 23.0 22.9 23.3 24.4 23.6 34.9 65.1 51.3 48.0 32.3 75.1 53.2 65.7 45.6 60.9 35.8 59.8 45.3 45.9 42.9 47.8 40.5 16.7 55.0 66.0 49.0 66.5 39.0 21.0 37.8 64.5 63.0 41.9 107.5 40.6 42.0 63.6 57.5 50.4 46.8 46.9 61.1 74.6 55.1 41.2 67.3 35.6 38.3 38.7 56.2 72.8 36.3 69.6 58.7 40.9 42.2 52.4 70.6 53.5 62.8 91.1 52.8 43.9 50.0 63.7 63.0 41.1 65.1 25.3 32.9 65.7 63.3 79.0 94.1 47.9 52.5 50.0 83.9 80.5 31.8 36.0 72.7 CHAMP1 "C13orf8, CAMP, CHAMP, ZNF828" ENSG00000198824 "Chromosome alignment maintaining phosphoprotein 1" Q96JM3 13 114314482-114337626 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006623, HPA008900" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Midbody ring" Yes No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA006623: AB_1845548, HPA008900: AB_1845547" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (1.67e-1)" "unprognostic (3.89e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.13e-2)" "unprognostic (4.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.67e-1)" "unprognostic (4.62e-2)" "unprognostic (2.40e-1)" 9.9 7.1 3.4 9.8 3.3 14.2 9.5 6.6 5.2 8.1 3.8 8.7 10.0 8.5 8.0 6.4 9.8 7.6 6.2 3.0 4.3 8.9 15.2 8.9 15.7 2.7 3.4 12.1 15.4 9.3 3.6 9.9 3.4 10.0 9.9 9.1 8.4 9.3 7.9 9.2 8.0 10.1 2.3 9.6 7.7 6.9 2.7 16.5 10.7 9.7 17.3 7.5 4.4 3.1 36.9 15.8 56.6 24.2 20.1 30.9 24.3 38.2 32.0 35.6 39.4 23.5 22.0 75.2 15.1 30.0 22.3 23.0 41.8 30.6 52.7 29.8 50.0 49.7 21.8 20.7 22.5 73.3 28.3 30.4 18.8 27.8 27.3 12.6 17.4 25.8 32.1 20.3 46.1 14.6 48.6 21.4 43.1 45.2 20.2 48.1 26.9 26.0 27.0 22.2 27.5 32.8 22.2 49.2 36.7 39.1 28.2 61.3 19.3 19.5 30.8 20.7 23.6 25.7 27.9 80.4 38.6 42.7 38.1 7.5 3.3 4.4 3.7 4.0 4.6 5.4 3.3 3.7 3.9 5.8 2.6 3.0 0.8 3.5 6.6 12.5 2.4 2.1 3.4 3.3 6.6 5.2 3.0 4.3 2.7 3.4 3.4 2.3 2.7 3.1 11.2 9.6 9.6 3.6 13.9 3.3 6.6 7.6 10.8 12.5 11.3 10.8 5.7 11.5 4.1 12.9 4.2 14.2 18.1 9.3 13.7 11.7 1.0 8.5 14.8 10.9 10.8 24.4 6.1 11.4 18.1 11.5 10.2 8.3 10.1 13.1 13.9 21.6 21.7 15.2 7.8 12.5 6.1 20.7 7.8 1.6 11.8 13.0 12.4 7.5 18.4 8.8 17.5 4.0 8.0 10.9 7.8 11.3 17.6 13.2 12.5 17.0 7.6 10.9 6.6 11.7 10.5 10.6 20.7 13.1 3.8 7.9 11.4 12.4 11.4 3.5 CHCHD7 "COX23, MGC2217" ENSG00000170791 "Coiled-coil-helix-coiled-coil-helix domain containing 7" Q9BUK0 8 56211686-56218809 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050783 Approved Approved "Cell Junctions,Aggresome" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" "Cell Junctions" Aggresome "HPA050783: AB_2681236" "unprognostic (1.64e-2)" "unprognostic (3.23e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (4.46e-2)" "unprognostic (2.43e-1)" "unprognostic (5.04e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "prognostic favorable (9.47e-5)" "unprognostic (1.94e-1)" "unprognostic (5.07e-1)" "unprognostic (1.77e-2)" "unprognostic (2.50e-1)" 24.9 20.2 25.8 30.0 27.1 29.2 25.8 30.8 32.5 22.9 25.2 30.7 33.2 18.6 46.0 22.8 24.5 17.1 41.6 26.6 26.6 42.2 26.2 28.0 39.4 27.0 26.3 49.1 26.9 36.0 38.1 19.3 27.3 26.4 30.2 32.6 35.3 21.0 37.5 21.3 36.0 18.5 28.6 46.3 27.7 11.7 26.7 36.5 28.0 39.7 38.1 28.1 24.2 28.7 59.3 18.9 39.4 13.1 100.9 71.3 42.4 41.0 37.0 30.7 23.0 46.2 68.9 54.7 34.8 23.6 43.6 32.3 40.7 61.3 38.6 24.5 77.4 83.6 45.5 66.2 51.8 72.1 52.0 86.2 54.2 22.2 98.0 43.8 32.8 100.0 41.8 34.9 74.1 29.0 72.2 106.5 35.1 93.5 25.6 82.0 12.0 46.3 57.3 63.3 10.2 7.0 21.8 32.2 31.2 47.8 34.1 40.5 49.0 16.5 35.4 53.7 39.5 37.1 40.3 93.5 46.0 105.3 28.9 55.2 37.8 53.3 42.4 38.2 40.2 60.4 46.9 43.5 44.1 52.5 55.0 49.6 15.2 49.7 35.0 62.6 60.1 33.9 25.8 27.1 30.8 32.5 26.6 26.6 27.0 26.3 27.3 28.6 26.7 28.7 31.7 19.2 77.9 2.6 72.5 20.8 44.1 49.0 16.5 31.4 37.1 27.1 93.7 35.8 48.0 49.7 14.6 44.0 66.0 75.4 125.2 41.4 27.5 25.2 15.9 29.8 39.6 32.6 9.1 75.4 80.8 26.3 92.8 32.2 53.8 13.8 42.8 78.4 162.3 13.5 8.0 66.3 34.6 67.8 45.3 13.4 37.0 58.0 53.4 14.0 68.5 50.8 60.8 1.5 6.5 65.4 63.9 30.9 59.3 45.3 115.0 82.3 41.5 37.9 13.1 23.9 39.0 51.4 39.4 34.7 23.9 42.1 61.7 21.7 73.5 48.8 CHML REP-2 ENSG00000203668 "CHM like Rab escort protein" P26374 1 241628851-241640369 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029627, HPA029628, HPA062967" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 9: U-2 OS - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (3.57e-1)" "unprognostic (8.00e-2)" "unprognostic (2.46e-1)" "unprognostic (5.66e-2)" "prognostic unfavorable (9.23e-5)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (8.01e-3)" "unprognostic (3.02e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.03e-3)" "unprognostic (1.09e-1)" 2.7 1.8 0.7 3.5 1.5 7.5 3.6 0.0 3.6 3.1 0.0 3.0 2.2 4.2 2.7 3.3 2.8 3.2 3.0 1.5 0.2 2.9 2.4 3.8 3.7 0.1 1.0 7.4 2.0 4.1 1.5 11.4 0.0 1.9 3.4 3.3 2.3 1.5 2.6 3.2 2.8 3.2 0.0 3.9 3.1 6.1 1.7 6.4 4.4 3.4 3.0 2.1 2.3 1.5 31.3 9.5 14.6 11.7 4.3 12.8 28.4 12.1 6.0 10.3 7.0 17.5 5.6 8.6 18.1 8.1 8.4 6.3 20.6 13.1 19.0 16.5 19.2 11.3 39.4 12.3 8.7 27.2 14.0 10.7 5.8 13.6 14.0 7.2 8.2 22.7 31.0 10.2 12.3 12.2 18.1 18.1 19.4 11.8 30.6 27.3 18.0 28.8 10.4 19.2 18.6 30.6 15.2 11.5 13.3 14.2 13.5 17.4 16.7 20.9 40.8 10.6 23.3 11.9 31.2 9.0 20.3 16.0 33.0 1.1 0.2 0.1 0.1 0.3 0.1 0.3 0.0 0.0 0.2 0.3 0.3 0.2 0.0 0.1 0.2 0.7 0.0 0.0 0.7 1.5 0.0 3.6 1.5 0.2 0.1 1.0 0.0 0.0 1.7 1.5 14.0 48.1 7.0 0.0 17.2 8.5 6.1 3.8 3.4 3.6 9.9 11.7 19.6 4.3 7.9 0.0 0.0 23.5 26.4 6.2 5.9 14.8 12.3 14.4 15.1 8.1 6.7 10.3 0.0 21.3 26.7 6.5 6.6 34.8 3.8 21.3 4.2 2.1 7.1 5.0 0.0 4.2 6.1 17.6 31.0 30.9 10.5 34.7 17.8 0.0 18.6 3.1 4.1 0.0 0.0 22.5 4.3 18.0 5.8 3.9 4.3 2.2 2.0 4.7 13.1 11.4 20.7 9.0 12.6 7.6 7.2 20.1 5.8 9.9 5.0 4.3 CHUK "IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16" ENSG00000213341 "Component of inhibitor of nuclear factor kappa B kinase complex" O15111 10 100188300-100229596 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001402, CAB004240, CAB018564" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (3.74e-2)" "unprognostic (3.01e-1)" "unprognostic (3.02e-2)" "unprognostic (5.93e-2)" "unprognostic (4.02e-2)" "unprognostic (2.09e-1)" "unprognostic (8.58e-2)" "unprognostic (8.39e-2)" "unprognostic (6.73e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.27e-4)" "unprognostic (2.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-3)" "unprognostic (2.22e-1)" 13.5 10.3 6.6 11.7 7.6 19.6 10.8 7.1 8.3 8.4 8.3 11.9 12.8 8.8 9.1 9.7 7.5 9.0 6.8 6.4 9.2 21.0 17.0 10.2 12.7 7.3 7.5 5.6 11.5 14.0 6.5 10.5 7.6 9.6 13.3 8.0 8.8 9.0 14.2 6.9 10.8 11.8 7.7 9.9 11.2 8.3 8.7 14.3 11.1 11.7 12.6 13.6 6.4 8.7 27.7 22.9 23.0 34.4 21.6 19.3 17.6 34.3 33.5 31.3 38.0 25.9 15.9 37.2 19.7 23.5 21.8 26.7 38.7 18.2 34.9 39.8 33.5 24.7 18.0 28.7 18.4 46.2 34.8 15.5 19.1 36.2 35.0 21.8 22.7 30.1 28.5 29.9 34.6 16.7 36.9 28.4 15.0 21.8 16.5 23.7 25.5 17.0 19.9 17.6 13.7 20.3 18.6 14.2 30.9 18.0 28.5 27.8 23.9 19.6 21.9 21.5 39.7 34.9 33.7 35.7 21.3 36.9 15.8 1.0 1.2 2.1 0.9 1.9 1.5 1.6 1.1 1.6 1.4 1.0 1.3 1.5 2.8 1.8 1.3 0.8 1.2 0.5 6.6 7.6 7.1 8.3 6.4 9.2 7.3 7.5 7.6 7.7 8.7 8.7 11.4 12.8 11.5 17.9 10.8 19.8 7.1 5.1 8.0 6.3 7.3 4.8 9.2 7.2 5.9 5.5 2.1 6.5 14.1 12.2 11.7 7.1 7.6 8.9 8.6 8.4 6.0 12.0 22.7 11.8 7.8 6.5 7.7 12.7 8.2 6.2 7.1 14.4 10.6 13.5 21.3 8.0 8.2 16.9 12.7 8.0 6.2 11.7 7.2 19.7 15.6 4.5 9.2 20.6 27.7 10.4 6.0 6.0 18.5 9.6 9.5 20.0 6.4 5.0 19.7 7.8 12.0 16.4 12.9 13.2 19.0 13.8 11.1 10.1 6.6 10.6 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769978 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in some" 6 "basal ganglia: 7.8" "Low region specificity" "Detected in many" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 0.5 0.2 0.7 3.2 0.6 11.3 0.5 0.6 1.4 0.2 0.4 1.4 1.0 0.4 0.7 0.9 0.2 0.3 0.1 1.3 0.3 0.2 0.5 0.4 4.9 0.4 0.4 0.1 0.1 0.2 0.0 1.5 0.6 0.2 2.0 6.8 0.2 0.1 0.6 1.2 1.0 0.9 0.2 1.3 0.9 5.7 0.6 7.9 0.2 0.0 5.2 0.6 0.4 0.9 22.0 17.5 37.8 19.9 2.6 4.8 14.1 43.6 12.0 31.0 41.3 27.9 19.6 45.7 13.9 11.8 22.7 21.4 37.1 14.9 48.1 31.6 16.8 64.5 38.1 12.6 0.1 54.0 36.8 1.0 0.6 53.8 3.7 3.7 16.9 27.1 44.2 30.8 30.3 14.1 56.9 13.1 36.0 14.9 12.2 36.0 57.0 13.8 6.4 35.3 14.0 16.2 37.7 11.6 7.4 25.6 10.0 21.1 12.5 44.6 33.8 27.6 49.3 11.1 29.1 47.1 14.1 37.4 37.0 1.1 0.3 0.3 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.2 1.0 0.5 0.2 0.2 0.3 0.3 0.7 0.6 0.6 1.4 1.3 0.3 0.4 0.4 0.6 0.2 0.6 0.9 2.6 0.0 0.5 0.3 6.5 5.6 5.7 4.4 1.2 9.4 2.9 3.8 1.4 2.8 2.7 0.0 12.5 19.7 4.6 12.8 0.0 1.6 7.9 1.0 3.6 3.6 1.2 55.6 1.6 0.6 41.1 5.2 4.6 3.3 1.3 12.0 2.2 0.4 16.9 1.7 1.5 9.4 2.0 3.0 8.2 6.1 2.5 5.8 3.6 0.0 9.1 9.4 4.1 0.0 0.6 1.4 9.5 0.4 32.5 1.8 0.4 0.2 0.0 101.0 6.6 5.3 8.7 281.1 263.3 5.8 2.0 10.4 7.2 1.2 12.0 3.9 CMTR2 "AFT, FLJ11171, FTSJD1, MTr2" ENSG00000180917 "Cap methyltransferase 2" Q8IYT2 16 71281389-71289715 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 95.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041700, HPA048265" Uncertain Approved "Nuclear speckles,Cell Junctions" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Cell Junctions" "Nuclear speckles" "HPA041700: AB_2677623, HPA048265: AB_2680334" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (2.94e-3)" "unprognostic (1.43e-1)" "unprognostic (6.30e-2)" "unprognostic (3.82e-2)" "unprognostic (1.93e-3)" "unprognostic (2.86e-2)" "unprognostic (7.93e-2)" "unprognostic (3.41e-1)" "unprognostic (1.85e-2)" "unprognostic (7.39e-2)" "prognostic favorable (4.97e-5)" "unprognostic (9.55e-2)" "unprognostic (5.99e-2)" "unprognostic (1.54e-1)" "unprognostic (5.34e-2)" 6.7 8.8 4.0 10.3 4.6 7.2 15.9 4.6 4.2 7.6 8.0 10.1 14.9 8.5 12.2 14.3 9.0 9.4 7.0 3.2 4.7 12.5 14.3 11.4 14.4 5.1 4.4 11.2 8.1 10.7 7.8 10.6 4.8 10.8 10.4 7.3 13.3 8.0 5.7 10.3 14.2 9.0 5.2 13.6 10.0 13.8 4.9 10.7 14.1 5.7 17.9 9.7 7.6 6.6 17.8 11.6 23.2 19.5 18.9 15.3 10.6 14.9 18.2 17.4 18.4 10.6 26.5 10.0 18.4 13.7 18.9 19.4 11.1 14.2 24.9 10.5 7.9 22.3 13.1 8.3 20.3 16.8 37.7 12.7 24.7 15.4 17.9 12.8 18.5 22.2 11.6 6.6 31.1 15.9 18.8 23.1 11.0 14.2 6.7 28.5 10.2 24.5 16.3 19.5 12.0 12.8 15.1 12.2 15.4 10.3 18.0 10.4 18.7 21.1 15.1 15.5 11.4 13.3 17.6 21.3 14.7 14.6 16.8 22.6 9.6 9.2 10.8 10.3 13.2 13.1 10.6 11.7 13.7 12.0 11.4 11.1 0.7 16.6 6.9 3.9 9.8 11.4 4.0 4.6 4.6 4.2 3.2 4.7 5.1 4.4 4.8 5.2 4.9 6.6 11.4 3.2 11.8 13.7 28.1 14.1 14.5 10.7 15.9 20.3 23.9 13.7 8.6 20.0 9.4 16.5 31.3 24.2 30.2 25.8 7.9 12.2 95.6 12.6 15.1 14.6 18.6 17.0 9.9 9.7 12.7 11.5 15.8 11.5 8.2 26.1 18.9 32.7 16.1 15.2 10.3 20.5 18.3 18.0 11.4 30.9 16.8 13.6 1.8 21.5 17.8 12.1 51.5 17.6 21.5 12.9 15.2 12.4 17.9 13.5 46.3 17.7 6.5 25.5 6.6 11.1 10.1 26.1 13.8 22.0 24.3 26.4 20.0 21.8 17.9 18.2 CNOT2 "CDC36, NOT2, NOT2H" ENSG00000111596 "CCR4-NOT transcription complex subunit 2" Q9NZN8 12 70243002-70354993 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067711 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA067711: AB_2685893" "unprognostic (5.00e-2)" "unprognostic (2.12e-1)" "unprognostic (6.95e-2)" "unprognostic (3.60e-2)" "unprognostic (3.48e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.36e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.32e-1)" "unprognostic (9.70e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.28e-1)" "unprognostic (5.58e-2)" "unprognostic (5.97e-2)" "unprognostic (6.23e-2)" 29.8 25.6 24.2 31.2 33.3 78.5 35.0 65.9 28.1 29.2 24.9 31.6 30.2 34.3 34.5 24.4 29.0 27.3 24.0 25.2 28.8 28.7 34.9 29.5 40.4 33.7 32.1 35.1 24.1 32.5 23.4 32.1 30.0 27.8 34.5 46.2 26.0 27.0 33.4 50.3 30.9 30.5 28.6 35.8 25.7 26.2 32.3 50.1 30.7 33.8 42.7 32.8 27.9 43.5 46.2 44.5 70.7 45.3 38.5 42.8 60.1 49.2 59.5 53.8 46.1 55.8 42.1 100.2 45.1 57.4 33.8 43.9 50.2 49.1 59.7 47.1 50.2 66.4 38.8 55.7 40.7 84.3 54.6 50.1 52.4 50.5 59.1 78.7 59.0 61.5 61.9 55.4 47.2 52.4 95.7 61.0 61.0 46.1 46.4 75.1 59.9 61.1 50.7 93.2 50.6 55.7 59.1 46.4 45.6 60.5 59.1 68.4 44.7 50.2 33.6 45.8 40.7 50.3 59.5 77.3 52.5 42.3 41.9 92.8 49.2 57.6 50.1 69.4 56.6 54.0 54.7 58.9 60.3 51.5 62.6 67.6 30.3 62.6 58.5 44.4 55.8 56.3 24.2 33.3 65.9 28.1 25.2 28.8 33.7 32.1 30.0 28.6 32.3 43.5 71.1 41.7 43.2 76.7 79.8 51.1 37.7 45.4 47.3 64.4 40.9 38.0 30.1 58.6 45.6 36.8 56.3 45.3 144.3 50.2 33.2 49.5 44.5 47.8 55.8 55.4 58.0 49.2 110.9 44.7 47.4 57.4 41.3 62.2 76.5 60.1 46.4 34.6 40.3 52.2 115.8 39.0 44.7 55.1 46.7 12.6 45.7 62.7 32.0 86.2 46.3 54.3 56.7 123.6 204.0 45.8 44.4 46.6 77.9 45.4 45.2 30.3 44.7 54.8 39.5 72.3 64.5 53.8 44.7 46.7 64.1 35.4 94.2 50.4 39.2 48.9 CPSF6 "CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7" ENSG00000111605 "Cleavage and polyadenylation specific factor 6" Q16630 12 69239569-69274358 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039973 Supported Enhanced "Nucleoplasm,Nuclear speckles" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear speckles" "HPA039973: AB_10795242" "unprognostic (1.50e-1)" "unprognostic (3.33e-2)" "unprognostic (4.37e-3)" "unprognostic (5.47e-2)" "unprognostic (4.24e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.91e-6)" "unprognostic (6.82e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.20e-1)" "unprognostic (7.63e-2)" "unprognostic (2.05e-1)" "unprognostic (7.41e-2)" 23.8 26.3 14.4 35.8 13.9 71.9 23.8 30.5 16.8 27.5 1.8 24.0 26.2 28.4 38.6 27.8 25.3 18.3 21.5 14.5 18.0 20.8 20.6 22.5 46.9 6.1 5.6 40.5 23.9 28.3 26.5 25.0 8.4 23.1 24.8 43.5 26.0 20.2 27.9 24.6 25.4 23.7 8.2 27.1 26.6 22.3 12.6 43.6 26.6 17.0 40.8 25.6 25.2 12.3 97.5 80.3 115.7 81.7 43.8 49.7 87.1 62.7 74.1 87.3 82.0 83.8 64.8 153.6 62.6 63.9 48.5 89.2 114.5 73.7 92.3 101.4 78.1 124.3 85.7 97.1 65.4 170.1 87.1 60.0 57.2 70.4 28.7 58.2 68.3 90.6 130.1 159.6 73.3 112.9 159.9 110.3 112.3 80.4 67.8 159.9 91.6 108.2 68.9 113.4 97.0 85.4 83.7 77.7 88.9 68.8 93.2 118.5 79.1 65.4 80.0 62.6 104.5 101.9 88.5 190.9 53.1 97.5 85.9 44.3 26.0 29.9 27.9 32.6 29.5 32.8 30.8 29.1 39.0 28.9 23.4 28.2 7.7 30.2 28.7 27.8 47.2 19.7 14.4 13.9 30.5 16.8 14.5 18.0 6.1 5.6 8.4 8.2 12.6 12.3 29.1 12.8 24.9 53.2 49.9 76.0 46.7 55.7 43.3 56.5 30.0 24.5 31.7 30.0 39.9 18.4 37.5 64.6 51.1 22.5 37.2 59.6 18.7 35.6 40.2 35.0 52.5 47.1 97.6 56.8 85.7 36.6 33.6 37.9 34.9 54.0 23.6 23.0 39.5 89.2 115.4 32.6 75.3 29.3 39.7 19.8 56.8 37.1 24.9 53.4 53.5 37.8 45.3 137.2 126.0 61.1 23.3 53.0 56.3 37.4 25.4 26.6 28.0 45.8 39.5 37.4 56.0 68.1 69.4 43.9 59.1 51.2 38.5 54.1 36.2 51.5 CREB1 ENSG00000118260 "CAMP responsive element binding protein 1" P16220 2 207529737-207605988 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Early spermatids: 417.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003803, HPA019150" Supported Enhanced Nucleoplasm NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "CAB003803: AB_562092, HPA019150: AB_1847220" "unprognostic (1.20e-1)" "unprognostic (3.15e-1)" "unprognostic (3.30e-2)" "unprognostic (2.69e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (8.41e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (9.58e-2)" "unprognostic (1.74e-2)" "unprognostic (4.82e-3)" "unprognostic (5.53e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (8.45e-2)" 13.0 8.7 10.6 15.3 11.4 22.4 14.7 17.5 11.1 15.8 11.9 11.4 10.0 15.7 10.8 15.0 13.1 14.0 11.5 10.3 10.7 12.4 11.6 13.6 22.1 10.6 9.9 17.2 8.7 15.6 6.9 18.0 10.4 13.0 14.0 17.8 8.9 12.6 6.7 11.5 10.6 16.3 9.7 17.1 12.1 32.4 9.9 28.7 18.1 14.6 25.0 16.8 9.6 15.0 24.9 20.9 38.6 15.6 22.9 22.4 21.8 15.9 23.5 26.6 26.5 21.6 22.9 15.4 19.8 21.1 29.8 19.5 34.8 20.4 37.7 25.1 13.2 29.2 18.9 23.0 18.7 27.7 20.0 16.0 16.3 21.1 31.1 25.4 34.9 28.9 20.5 22.5 30.4 16.8 41.0 16.1 27.8 24.2 13.1 31.4 22.1 20.2 25.1 24.6 27.1 23.4 21.6 16.2 18.1 35.5 16.5 30.1 18.5 21.8 22.6 22.1 20.5 19.6 27.5 36.4 25.2 25.3 22.0 33.6 28.2 28.2 27.0 29.2 23.7 36.7 25.3 26.2 34.1 34.8 30.0 20.7 56.1 45.6 34.9 18.6 38.6 26.7 10.6 11.4 17.5 11.1 10.3 10.7 10.6 9.9 10.4 9.7 9.9 15.0 46.7 19.2 18.2 47.0 52.3 70.9 47.1 33.3 34.1 38.9 25.3 18.5 26.3 17.2 29.0 12.9 33.3 29.1 35.5 25.3 23.5 23.6 417.8 19.6 39.2 47.2 32.4 54.7 56.1 20.3 24.9 35.8 18.8 21.0 43.7 41.5 35.7 15.8 29.4 40.4 51.1 28.2 30.5 48.8 75.9 47.2 26.1 35.8 44.4 68.4 60.9 42.1 33.0 66.9 70.7 26.4 27.5 29.3 29.1 56.5 22.8 19.7 18.9 40.2 39.5 37.4 40.7 44.5 29.4 33.5 57.8 18.6 42.6 19.6 25.7 62.6 CREBBP "CBP, KAT3A, RSTS, RTS" ENSG00000005339 "CREB binding protein" Q92793 16 3725054-3880713 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004212, HPA055861" Supported Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Nuclear bodies" "CAB004212: AB_626817, HPA055861: AB_2682948" "unprognostic (1.17e-1)" "unprognostic (8.51e-2)" "unprognostic (1.60e-1)" "unprognostic (1.63e-1)" "unprognostic (1.49e-1)" "unprognostic (5.09e-2)" "unprognostic (9.59e-3)" "unprognostic (6.98e-2)" "unprognostic (8.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "prognostic favorable (6.24e-5)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (3.97e-2)" "unprognostic (8.23e-2)" 17.4 10.6 5.8 17.1 5.2 52.9 16.8 25.4 11.5 20.9 3.7 18.8 12.5 26.5 12.4 16.5 22.4 16.6 14.4 5.9 3.1 12.0 14.3 15.9 17.6 8.9 6.8 37.3 29.7 18.5 11.3 16.9 2.9 16.1 14.1 13.8 17.2 16.2 29.6 21.0 16.4 19.6 0.4 21.0 16.3 33.2 7.9 29.1 23.3 28.9 20.7 16.6 16.5 6.4 12.3 31.0 39.3 17.4 23.5 23.1 20.4 17.4 28.9 29.2 28.2 28.2 22.4 33.7 20.1 33.3 18.7 23.2 45.7 14.2 32.9 57.5 18.5 26.6 29.2 17.9 26.0 26.9 36.5 20.7 14.2 32.5 38.9 18.0 22.3 17.0 30.9 44.8 16.0 42.0 17.9 13.0 32.3 11.7 12.7 83.4 31.1 26.1 11.2 16.2 32.6 21.5 29.5 28.7 16.8 25.3 25.6 25.9 34.7 35.5 35.2 18.4 16.0 20.8 24.3 63.7 7.2 15.8 25.6 1.9 1.1 0.9 1.7 1.5 0.8 3.7 0.8 1.3 0.7 2.1 0.8 1.1 6.7 1.4 2.9 1.5 0.8 0.9 5.8 5.2 25.4 11.5 5.9 3.1 8.9 6.8 2.9 0.4 7.9 6.4 48.1 44.8 51.6 91.1 38.3 56.2 31.0 16.0 27.3 34.2 34.4 25.7 41.2 40.0 28.0 11.0 25.0 17.4 50.1 31.2 5.9 20.9 43.0 37.2 56.4 35.7 15.0 33.4 88.7 20.3 11.3 39.5 32.1 63.5 30.4 53.1 32.5 29.5 20.9 28.6 89.8 25.3 18.3 44.0 42.8 80.2 56.5 49.0 17.8 87.1 52.5 34.5 43.3 111.6 101.2 27.5 19.5 51.1 35.6 39.8 25.2 10.9 28.2 17.6 46.0 75.8 44.9 35.1 42.2 34.6 58.8 30.8 44.2 36.2 24.6 44.2 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85657990-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HeLa: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA021526: AB_2670738, HPA063652: AB_2685075" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 17.1 12.4 9.8 12.9 11.1 9.7 16.8 18.3 15.4 15.9 11.3 12.8 14.1 21.3 12.2 10.1 15.1 10.3 8.2 10.1 9.9 8.8 10.8 15.4 18.7 10.6 10.0 21.7 14.8 11.8 8.7 13.2 11.1 12.9 13.7 27.9 16.4 10.2 9.9 17.2 16.4 10.3 10.5 17.2 12.7 6.1 10.3 13.6 16.3 6.8 15.3 12.1 14.9 13.5 5.6 12.4 18.4 7.6 8.4 8.8 13.7 9.8 6.0 8.4 11.0 15.6 22.5 16.4 9.1 5.8 22.1 19.6 12.7 6.2 14.1 9.3 11.9 14.9 53.1 7.2 5.7 14.1 8.0 7.8 12.2 8.5 11.8 11.5 5.3 10.8 11.7 18.6 10.1 7.9 12.0 27.5 6.8 16.3 8.7 19.2 15.7 10.1 9.2 10.7 14.5 12.4 12.6 19.3 4.2 11.6 20.8 20.8 6.3 17.4 10.7 24.3 11.0 6.4 7.6 16.8 4.1 10.4 10.9 0.3 0.1 0.1 0.4 0.1 0.7 0.2 0.3 0.3 0.2 0.2 0.4 0.4 0.2 0.4 0.3 0.2 0.6 0.1 9.8 11.1 18.3 15.4 10.1 9.9 10.6 10.0 11.1 10.5 10.3 13.5 30.3 19.2 21.5 58.1 41.9 41.3 21.6 12.4 31.3 97.5 35.1 20.6 13.9 17.2 17.9 22.0 91.8 16.9 53.1 30.0 9.8 13.2 34.5 27.6 31.1 25.1 39.4 30.1 57.6 8.6 14.9 34.7 46.9 34.0 22.2 64.3 23.2 29.5 9.9 90.9 60.7 23.8 10.2 19.2 27.3 16.6 30.7 15.6 33.8 25.3 24.8 47.9 46.4 56.8 114.5 9.2 22.8 33.4 39.1 29.5 29.8 8.0 22.5 113.5 13.1 34.6 30.9 27.4 11.4 27.7 41.3 14.4 43.0 51.9 25.7 26.5 CRNKL1 "CLF, Clf1, CRN, SYF3" ENSG00000101343 "Crooked neck pre-mRNA splicing factor 1" Q9BZJ0 20 20034368-20056046 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "unprognostic (5.43e-2)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (4.56e-1)" "unprognostic (2.06e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.06e-6)" "unprognostic (1.18e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-1)" "unprognostic (6.09e-2)" "unprognostic (1.43e-3)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" "unprognostic (2.78e-2)" 8.5 8.3 7.3 9.7 9.2 23.7 16.2 12.1 8.1 11.2 6.8 10.2 10.2 13.0 10.3 10.1 9.8 8.1 9.7 7.0 7.9 11.9 11.2 7.8 12.2 7.6 7.7 14.7 6.7 14.9 5.8 11.5 8.2 14.0 11.3 9.8 8.2 10.6 16.6 9.0 9.9 11.2 8.2 10.5 10.1 11.3 7.6 13.9 12.9 15.3 12.2 9.7 7.1 12.1 21.2 26.0 20.1 24.2 18.7 19.5 26.9 18.9 18.2 23.9 22.9 17.5 19.6 20.7 14.0 20.0 31.4 29.1 24.1 25.3 29.0 10.5 12.2 20.5 8.0 37.1 15.2 24.6 46.5 15.8 14.5 25.9 15.7 16.9 18.8 23.1 22.0 24.9 22.9 32.5 28.2 18.8 18.4 34.3 26.2 23.8 49.8 28.4 14.2 14.7 30.0 22.0 25.8 42.2 27.2 19.2 35.6 18.5 17.0 18.8 15.1 18.3 21.0 33.7 35.4 22.2 9.4 13.6 16.7 37.2 13.8 32.0 13.8 15.3 16.6 14.8 15.9 15.2 10.8 14.4 14.8 13.2 37.7 22.4 23.7 9.8 17.5 11.7 7.3 9.2 12.1 8.1 7.0 7.9 7.6 7.7 8.2 8.2 7.6 12.1 20.1 22.4 15.1 6.2 23.3 9.3 8.9 11.7 12.5 11.9 19.6 12.7 19.2 18.6 20.5 14.7 12.5 19.8 32.3 17.0 9.8 22.8 11.7 39.7 37.9 16.9 20.4 24.4 8.1 18.5 17.1 18.3 23.0 40.5 35.5 26.5 15.0 19.6 19.4 16.8 7.7 30.2 12.2 18.4 7.6 5.7 20.2 18.3 3.6 5.6 23.3 17.2 19.6 8.0 10.0 19.7 12.7 18.8 30.3 8.3 17.7 18.3 24.8 16.3 26.3 21.7 20.8 62.5 36.9 18.0 8.9 20.1 25.4 22.0 14.9 13.0 CTDSPL2 "FLJ10523, HSPC129" ENSG00000137770 "CTD small phosphatase like 2" Q05D32 15 44427622-44529038 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.5;Late spermatids: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040763, HPA062198" Approved Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA040763: AB_10960989, HPA062198: AB_2684708" "unprognostic (6.64e-2)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (2.06e-1)" "unprognostic (7.39e-3)" "unprognostic (5.20e-2)" "unprognostic (7.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.37e-2)" "unprognostic (2.54e-2)" "unprognostic (3.68e-3)" "unprognostic (5.35e-2)" "unprognostic (8.36e-3)" "unprognostic (7.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.16e-1)" 9.1 7.4 2.9 12.9 3.6 20.5 14.1 12.8 5.3 14.0 3.4 10.8 10.0 17.5 7.0 12.5 11.1 11.9 9.5 3.4 4.4 10.7 10.3 10.4 19.4 3.4 2.7 19.1 11.5 11.1 4.0 15.8 3.1 10.2 11.3 15.1 9.1 10.2 5.4 8.1 12.7 13.9 3.0 13.3 9.8 21.0 2.9 25.3 15.0 9.4 19.0 12.2 6.2 6.0 28.6 14.2 57.7 29.4 9.1 19.9 31.9 29.1 25.4 37.3 46.8 29.3 26.4 30.1 27.7 20.3 20.6 39.2 33.4 19.6 42.6 30.9 16.1 37.4 34.8 17.6 12.3 65.7 33.5 15.7 14.0 25.6 33.4 15.8 28.4 37.9 44.2 34.0 26.7 12.1 78.2 23.1 31.2 30.4 20.3 86.7 80.5 28.0 19.4 38.9 26.7 38.5 36.0 28.5 16.2 21.2 38.7 57.7 24.9 46.0 49.5 44.3 49.4 19.3 79.2 93.9 22.2 50.4 36.0 7.4 10.8 9.2 10.3 11.3 9.4 10.6 9.8 9.3 13.8 10.5 10.4 11.8 7.7 15.7 8.9 8.8 14.9 9.4 2.9 3.6 12.8 5.3 3.4 4.4 3.4 2.7 3.1 3.0 2.9 6.0 34.4 19.2 35.7 26.4 25.4 24.6 14.7 14.5 27.9 23.7 24.5 21.0 23.1 11.5 31.3 12.9 10.4 18.9 40.9 16.9 17.6 12.5 165.5 18.3 35.4 27.2 9.0 16.2 41.8 14.6 18.4 30.2 11.7 29.6 36.0 26.7 20.3 13.6 14.0 30.3 41.2 13.9 20.3 22.2 20.9 166.9 20.2 22.1 16.0 49.6 23.8 19.2 39.1 50.3 65.7 17.7 10.4 13.2 24.0 18.0 17.2 14.5 19.5 31.1 26.3 30.4 34.2 23.7 31.4 19.6 21.9 14.6 31.4 21.9 15.3 16.8 CTR9 "KIAA0155, p150TSP, SH2BP1, TSBP" ENSG00000198730 "CTR9 homolog, Paf1/RNA polymerase II complex component" Q6PD62 11 10751246-10801625 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 186.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061027, HPA068122" Supported Enhanced Nucleoplasm No No "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "HPA061027: AB_2684418, HPA068122: AB_2685959" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.89e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.58e-1)" "unprognostic (6.27e-2)" "unprognostic (2.42e-1)" "unprognostic (5.26e-2)" "unprognostic (2.80e-1)" "unprognostic (2.63e-1)" "unprognostic (7.27e-2)" "prognostic favorable (3.65e-6)" "unprognostic (6.88e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" 15.4 20.6 10.0 21.0 10.2 23.7 18.8 9.9 11.3 19.9 13.4 16.9 16.2 22.2 48.0 17.5 16.8 15.3 17.2 10.4 10.8 22.5 25.2 17.2 26.3 10.0 12.0 22.0 13.3 30.0 12.5 20.3 10.5 17.6 18.1 29.2 18.3 16.1 17.9 19.2 16.8 16.4 9.7 22.5 17.2 27.0 10.4 30.3 23.2 15.1 26.0 21.8 11.8 11.0 40.5 30.9 43.5 41.4 93.1 37.0 21.2 43.9 29.2 34.8 36.5 51.1 83.9 36.7 23.6 36.6 42.3 40.9 54.0 36.2 56.7 56.7 64.6 186.6 31.0 29.2 29.7 74.1 98.8 34.6 28.8 22.5 30.1 32.1 40.6 34.5 77.0 43.2 42.6 18.3 47.5 28.9 36.0 48.7 38.2 43.6 52.9 25.1 29.9 54.8 19.9 47.4 39.6 38.9 31.3 41.5 34.6 32.3 40.2 29.2 30.0 51.7 24.0 23.6 59.8 39.5 31.2 49.5 30.5 54.4 15.4 31.3 20.0 17.7 26.3 16.7 21.4 19.7 18.1 17.0 20.1 19.6 11.3 26.7 18.3 9.0 19.4 15.8 10.0 10.2 9.9 11.3 10.4 10.8 10.0 12.0 10.5 9.7 10.4 11.0 51.5 57.7 48.8 14.7 49.0 87.2 46.2 29.7 64.3 34.0 30.2 31.6 49.2 31.5 41.7 25.8 56.3 37.9 42.7 30.7 19.6 26.9 28.5 34.0 38.0 37.7 26.9 25.5 16.5 24.5 24.8 36.4 15.8 52.4 85.9 33.2 28.5 38.6 29.1 63.9 21.4 45.1 32.6 32.3 23.6 13.1 33.5 36.1 12.4 15.0 31.8 31.1 29.9 20.6 18.6 26.9 17.5 31.2 37.2 26.1 22.8 18.3 33.7 45.9 26.3 47.8 33.1 100.3 71.3 51.1 81.1 45.7 48.0 56.4 25.3 31.5 CWC22 "EIF4GL, fSAPb, KIAA1604, NCM" ENSG00000163510 "CWC22 spliceosome associated protein homolog" Q9HCG8 2 179944876-180007297 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036748 Approved Supported "Nuclear speckles,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 50: Fibroblasts - ECM organization" "Nuclear speckles" Cytosol "HPA036748: AB_10669913" "unprognostic (1.90e-1)" "unprognostic (7.10e-2)" "unprognostic (7.30e-2)" "unprognostic (6.14e-2)" "unprognostic (4.96e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (3.15e-1)" "unprognostic (1.31e-2)" "unprognostic (3.30e-2)" "unprognostic (3.84e-2)" "unprognostic (4.80e-2)" "prognostic unfavorable (7.76e-5)" "unprognostic (1.74e-1)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-3)" 12.7 10.2 7.1 13.1 7.8 16.0 15.0 13.5 10.1 14.1 7.1 11.9 10.1 16.9 10.4 12.5 12.0 12.1 10.1 7.6 7.2 13.4 16.8 11.5 18.5 6.4 6.9 19.3 9.2 13.5 8.2 14.5 7.0 12.5 11.8 12.4 10.2 10.9 13.6 11.0 10.4 13.9 7.1 14.7 11.0 9.0 7.0 21.8 16.0 14.5 18.2 14.1 12.1 8.9 19.1 11.2 31.6 21.1 22.7 26.7 24.1 24.5 28.7 29.4 28.7 25.9 23.1 36.7 21.6 17.9 25.6 20.5 30.4 23.1 44.2 33.0 26.2 49.1 15.1 35.4 22.0 69.6 26.2 17.5 27.1 37.4 49.8 19.3 22.3 25.2 54.6 21.9 19.7 18.9 36.5 34.7 48.8 22.5 18.3 32.8 38.9 27.7 20.2 23.5 21.6 28.8 20.3 15.9 28.5 33.8 11.8 42.2 19.0 25.1 21.2 16.8 25.7 19.2 21.5 44.3 22.6 27.2 26.1 49.7 13.3 31.4 16.1 16.7 16.3 17.4 17.3 19.5 13.9 14.5 21.1 16.7 22.0 16.0 13.3 8.6 16.5 11.5 7.1 7.8 13.5 10.1 7.6 7.2 6.4 6.9 7.0 7.1 7.0 8.9 38.0 19.2 33.8 20.5 38.0 19.1 29.2 16.9 22.2 19.5 12.9 19.8 26.6 22.8 27.0 11.0 25.0 18.3 36.5 11.8 9.8 23.4 1.6 24.2 31.9 27.2 15.6 14.9 35.8 19.1 17.5 32.5 19.9 25.1 27.3 24.7 16.8 12.8 13.7 13.5 28.4 16.4 14.2 20.6 12.1 2.4 23.3 24.2 3.6 15.0 31.6 17.3 30.9 35.2 35.1 18.7 17.6 18.4 20.8 16.8 15.7 20.3 34.4 19.1 46.0 40.3 25.1 22.8 21.3 14.1 18.6 24.8 32.5 18.6 15.6 19.5 CWC27 "NY-CO-10, SDCCAG-10, SDCCAG10" ENSG00000153015 "CWC27 spliceosome associated cyclophilin" Q6UX04 5 64768930-65018750 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Dwarfism, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 255.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020344, HPA024149, HPA065809" Approved Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561" "unprognostic (1.71e-1)" "unprognostic (6.47e-3)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (8.91e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (5.27e-6)" "unprognostic (1.58e-2)" "unprognostic (3.43e-2)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.46e-1)" "unprognostic (2.05e-1)" "unprognostic (2.74e-1)" "unprognostic (7.45e-3)" 13.4 13.0 13.6 13.0 14.6 20.5 13.4 16.7 18.4 12.6 10.7 14.3 9.8 15.5 12.3 11.8 11.8 11.2 18.9 13.1 15.5 14.1 10.2 10.7 15.4 14.5 13.7 18.2 9.0 16.9 8.8 14.6 14.4 13.9 15.0 14.0 10.5 12.3 22.2 11.5 10.1 14.3 13.5 12.8 11.1 17.2 14.1 21.7 13.9 26.4 16.0 13.2 11.5 15.4 32.7 21.4 37.5 69.9 31.4 38.2 41.8 33.5 27.7 36.7 38.2 36.0 40.3 48.0 57.0 35.0 41.2 20.2 39.8 60.5 66.2 40.4 32.4 36.2 35.6 30.3 48.0 38.3 23.5 25.6 45.7 46.3 58.3 32.3 39.4 53.9 35.8 30.8 36.8 32.6 53.5 34.7 30.4 16.9 25.6 49.0 50.4 50.3 35.0 28.0 44.4 19.6 40.8 16.4 39.7 35.5 35.9 55.5 32.9 21.4 37.8 34.6 54.2 23.9 33.1 46.5 40.1 65.9 38.8 13.2 13.1 9.6 13.6 13.2 16.8 17.5 15.3 17.4 16.9 13.2 16.2 16.9 2.7 20.4 10.2 13.8 18.0 10.4 13.6 14.6 16.7 18.4 13.1 15.5 14.5 13.7 14.4 13.5 14.1 15.4 24.2 9.6 26.2 64.3 26.0 16.4 27.7 37.5 13.6 31.4 17.4 20.3 63.6 18.6 23.2 14.7 14.6 44.0 16.8 11.6 21.5 44.1 255.6 21.0 27.2 27.2 29.9 37.8 114.1 33.1 54.5 25.1 13.7 20.2 19.6 40.7 16.4 11.4 33.0 20.2 110.3 17.0 40.7 17.1 15.2 57.9 38.5 22.3 14.2 61.8 33.6 34.2 36.0 103.0 103.2 40.4 16.0 36.1 21.0 22.1 13.3 24.4 28.6 51.3 32.9 31.3 33.6 74.2 28.3 20.6 20.0 30.8 26.2 30.7 28.6 23.8 CXorf38 MGC39350 ENSG00000185753 "Chromosome X open reading frame 38" Q8TB03 X 40626921-40647561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050120 Approved Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "HPA050120: AB_2681024" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "unprognostic (2.91e-1)" "unprognostic (6.98e-2)" "unprognostic (1.37e-1)" "unprognostic (3.15e-1)" "unprognostic (1.48e-3)" "unprognostic (7.59e-2)" "unprognostic (1.46e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (1.23e-1)" "unprognostic (1.71e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.73e-2)" "prognostic favorable (1.44e-8)" 9.0 8.2 5.1 11.5 5.9 10.5 8.2 5.8 5.3 8.0 4.5 7.6 8.3 7.3 4.6 6.1 10.0 6.4 4.8 4.9 5.3 8.1 8.0 10.2 16.1 6.2 5.6 9.5 6.0 9.5 4.8 6.8 6.3 6.3 7.7 5.7 6.5 6.1 5.0 7.9 9.7 5.8 5.8 14.4 6.6 2.1 5.9 13.2 11.1 4.1 13.4 7.2 7.0 7.0 11.3 5.9 6.2 4.9 6.5 10.8 3.3 7.5 10.5 9.1 9.1 7.7 15.8 18.5 6.4 11.2 15.2 7.4 7.6 12.5 8.3 25.7 11.4 12.5 7.1 4.6 10.8 22.0 18.6 9.6 9.0 12.7 12.5 8.7 10.4 15.8 5.3 13.7 17.0 10.5 15.4 16.7 5.6 8.2 12.8 12.7 13.2 14.4 10.7 17.0 7.0 9.6 15.1 7.5 8.9 11.6 11.4 10.1 13.0 11.9 6.8 8.7 6.5 14.7 5.5 7.9 15.4 11.4 8.0 9.3 16.0 22.1 9.2 15.8 9.7 6.9 8.7 7.4 14.2 9.6 7.6 7.8 19.7 7.3 25.1 5.9 10.9 10.3 5.1 5.9 5.8 5.3 4.9 5.3 6.2 5.6 6.3 5.8 5.9 7.0 19.8 9.6 9.1 10.1 26.9 3.6 11.3 6.3 10.8 12.6 10.5 8.0 6.4 18.6 7.6 16.5 18.8 9.2 48.3 15.1 7.9 27.7 1.0 25.2 15.0 14.0 7.3 6.3 11.9 30.1 9.7 8.9 9.7 21.6 17.1 16.5 10.4 10.8 36.6 15.2 13.1 12.7 8.2 30.7 9.8 1.3 9.6 29.5 3.6 8.4 61.9 10.2 41.2 12.1 17.8 40.5 17.2 5.3 16.4 14.7 15.8 14.4 7.8 7.6 6.6 13.5 9.2 6.5 7.4 9.7 5.4 8.2 31.2 20.6 13.3 28.3 DCAF16 "C4orf30, FLJ20280" ENSG00000163257 "DDB1 and CUL4 associated factor 16" Q9NXF7 4 17800655-17810758 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042487 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Cytosol" "HPA042487: AB_10795505" "unprognostic (2.23e-3)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (8.02e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.40e-4)" "prognostic favorable (5.78e-4)" "unprognostic (5.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" "unprognostic (3.19e-2)" "unprognostic (1.78e-1)" "unprognostic (8.72e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-3)" "prognostic favorable (7.67e-4)" 9.6 8.2 4.5 8.0 7.0 18.1 13.0 6.4 6.7 12.8 2.9 10.4 7.9 13.8 10.2 7.9 11.9 6.6 8.4 4.2 7.4 9.2 4.8 9.1 11.9 6.1 5.8 19.4 11.3 12.3 13.3 9.8 5.7 10.6 9.5 13.3 10.9 7.9 8.2 15.0 10.2 8.9 4.5 8.9 8.8 10.9 7.8 12.0 10.1 4.4 11.4 10.0 10.2 9.4 21.7 4.6 24.3 25.5 6.8 11.9 13.2 13.9 16.3 16.2 19.1 13.1 17.2 24.2 10.8 12.9 13.1 10.7 14.4 14.7 23.9 8.3 13.2 34.2 16.0 21.5 16.3 30.4 13.4 15.5 11.8 20.6 20.3 10.8 11.3 23.6 37.4 39.3 9.4 8.2 33.4 29.0 20.0 6.3 13.1 35.0 27.8 15.7 7.1 16.9 36.0 28.9 14.8 3.9 16.9 12.2 14.3 8.1 14.5 18.7 14.7 20.8 17.8 17.3 7.4 29.4 15.4 20.6 12.8 7.8 1.4 2.1 2.5 1.6 3.3 2.0 2.7 2.8 0.9 2.9 3.4 3.2 1.0 2.1 1.1 1.8 2.1 1.3 4.5 7.0 6.4 6.7 4.2 7.4 6.1 5.8 5.7 4.5 7.8 9.4 11.6 19.2 24.8 13.1 17.6 25.4 24.3 9.4 25.6 12.2 16.3 16.9 21.9 12.8 14.4 9.2 6.2 17.6 27.0 8.6 13.7 9.9 19.6 12.9 18.4 13.0 17.5 21.7 20.2 7.7 10.0 15.9 14.3 13.3 17.1 24.8 11.4 6.4 7.7 15.2 20.2 12.5 14.2 11.9 11.3 11.5 21.1 9.4 10.6 15.0 10.2 27.5 7.2 29.1 36.7 11.8 7.6 22.2 27.6 14.6 9.2 5.1 17.1 14.6 13.1 21.7 16.2 28.8 17.3 19.5 21.2 12.3 20.3 19.0 13.9 19.2 DCAF7 "HAN11, SWAN-1, WDR68" ENSG00000136485 "DDB1 and CUL4 associated factor 7" P61962 17 63550477-63594279 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022948, HPA022962" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA022948: AB_1858820, HPA022962: AB_1858821" "unprognostic (7.75e-2)" "unprognostic (3.31e-1)" "unprognostic (1.37e-3)" "unprognostic (3.78e-2)" "unprognostic (1.03e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.86e-1)" "unprognostic (2.28e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.40e-2)" "unprognostic (1.97e-1)" "unprognostic (9.95e-2)" "unprognostic (4.18e-2)" 12.4 13.6 23.3 22.6 23.1 9.0 15.5 20.1 21.0 19.8 17.8 23.9 25.9 16.7 18.8 17.5 19.3 16.7 18.1 22.2 23.0 26.5 14.3 21.6 29.1 22.7 22.7 16.5 18.4 37.4 12.4 26.7 22.8 21.9 25.7 29.9 18.1 23.3 13.3 14.0 25.0 18.9 24.9 25.4 20.8 14.8 23.6 37.2 22.1 15.3 32.4 22.3 12.8 23.2 33.2 46.4 79.6 51.0 26.9 22.2 20.9 32.6 28.7 35.3 29.7 34.2 35.2 61.2 25.7 32.7 36.9 34.7 67.0 45.8 45.0 23.7 42.7 79.9 29.3 40.3 27.7 89.7 44.4 18.6 29.7 20.6 46.8 42.5 55.8 50.9 85.7 27.8 45.3 40.9 97.7 43.0 25.9 57.5 61.7 77.1 94.5 34.9 51.4 49.7 76.4 141.0 29.4 56.2 38.9 70.0 41.5 72.1 59.3 58.0 26.4 29.6 54.4 28.9 39.6 32.2 33.0 57.1 35.2 10.9 11.3 12.6 11.2 13.1 9.0 8.1 7.7 8.7 10.6 8.3 6.9 7.5 4.7 8.9 16.2 7.8 5.9 8.6 23.3 23.1 20.1 21.0 22.2 23.0 22.7 22.7 22.8 24.9 23.6 23.2 28.5 44.8 45.9 30.3 57.4 31.4 30.5 49.8 46.7 55.4 29.3 25.1 30.8 38.6 38.1 68.0 77.2 51.7 49.0 47.2 23.5 50.1 95.5 30.5 38.0 43.1 72.0 62.6 42.3 45.2 47.7 33.8 31.1 30.1 60.2 67.1 48.9 40.2 55.4 65.6 41.1 49.0 52.9 64.3 45.2 27.6 35.1 61.9 26.6 43.1 72.9 53.1 69.0 36.2 40.5 55.0 41.2 38.0 45.0 45.3 67.7 52.0 43.7 54.0 59.2 23.2 35.8 96.5 35.0 51.6 34.8 21.6 53.1 49.8 57.2 47.6 DCLRE1B "APOLLO, FLJ12810, FLJ13998, SNM1B" ENSG00000118655 "DNA cross-link repair 1B" Q9H816 1 113905213-113914086 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.6;Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064934 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Nuclear bodies" "HPA064934: AB_2685387" "unprognostic (1.21e-1)" "unprognostic (3.38e-2)" "unprognostic (4.47e-3)" "unprognostic (4.92e-3)" "unprognostic (1.89e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.31e-2)" "unprognostic (9.67e-3)" "unprognostic (2.73e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.03e-7)" "unprognostic (1.24e-2)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (5.08e-2)" 3.5 1.2 2.5 3.7 2.7 6.0 2.9 4.5 2.8 2.5 2.1 2.8 1.7 2.4 1.6 3.0 2.7 2.2 1.3 2.4 2.7 1.6 1.7 3.2 4.1 2.5 2.7 3.0 0.9 1.1 0.7 3.5 2.5 1.7 3.0 1.2 1.2 1.9 0.8 2.6 1.9 3.3 2.5 4.0 1.6 2.4 2.8 4.8 2.0 1.0 3.9 2.2 1.6 3.3 14.1 5.5 9.9 10.5 7.9 5.4 5.7 11.1 7.4 14.2 15.3 6.0 3.9 14.3 6.8 7.8 6.4 6.4 13.7 11.2 19.6 12.0 10.1 12.4 7.8 5.9 1.5 14.1 12.1 6.2 4.4 18.5 10.6 3.9 7.9 16.5 17.5 11.8 16.7 57.8 21.7 11.5 7.7 5.5 12.6 17.2 30.4 6.5 5.6 6.1 8.7 8.0 12.0 9.2 7.7 7.8 6.1 14.9 4.8 18.6 19.6 31.3 15.8 5.2 5.6 16.0 15.7 13.8 32.9 1.9 4.5 1.3 2.3 3.7 2.5 0.9 2.6 2.2 2.6 1.4 1.7 2.2 0.2 5.8 2.1 1.0 1.8 2.5 2.5 2.7 4.5 2.8 2.4 2.7 2.5 2.7 2.5 2.5 2.8 3.3 3.0 3.2 2.0 0.3 2.8 3.6 1.2 1.7 8.0 3.0 2.6 2.0 1.2 1.5 0.8 0.0 2.1 4.6 4.0 1.0 1.9 4.4 1.3 4.1 2.3 3.4 3.0 23.6 0.8 2.7 9.8 3.4 0.5 2.4 1.3 5.6 2.2 1.6 9.7 1.7 0.9 3.1 2.0 8.5 12.8 0.6 1.8 10.5 0.0 1.0 13.5 0.9 2.1 0.0 1.1 3.7 0.5 2.2 5.0 1.5 0.3 1.7 3.1 1.4 26.3 2.1 5.5 7.9 11.4 6.2 2.7 1.4 4.4 3.0 4.2 1.0 DCP1A "HSA275986, SMAD4IP1, SMIF" ENSG00000272886 "Decapping mRNA 1A" Q9NPI6 3 53283429-53347586 "Plasma proteins, Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013202 Approved Supported "Cytoplasmic bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "Cytoplasmic bodies" "HPA013202: AB_1857287" "unprognostic (2.10e-1)" "unprognostic (7.61e-2)" "prognostic favorable (9.01e-4)" "unprognostic (9.79e-3)" "unprognostic (7.68e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (3.24e-2)" "unprognostic (1.86e-1)" "unprognostic (8.37e-2)" "unprognostic (7.33e-3)" "unprognostic (9.14e-2)" "unprognostic (3.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.95e-1)" 9.3 8.2 4.3 8.7 4.9 29.9 8.9 11.3 6.8 8.5 5.5 8.5 6.1 11.7 5.8 7.9 9.1 8.2 8.0 4.6 4.9 6.0 6.4 7.7 10.3 4.6 4.6 14.9 6.3 10.3 6.3 10.2 4.8 7.9 8.4 8.6 6.1 6.9 9.5 7.4 7.3 10.4 4.1 9.2 6.8 8.2 5.2 14.2 8.7 9.5 9.8 9.0 7.0 6.3 8.3 8.3 19.4 15.8 13.1 13.5 26.3 9.5 12.5 20.5 19.0 24.7 14.5 18.9 3.7 12.0 12.3 6.8 25.3 9.7 17.8 16.9 11.3 18.5 11.8 12.9 11.4 23.0 24.6 10.7 9.4 18.5 15.0 12.6 15.1 13.2 16.4 20.2 10.1 5.0 30.6 11.2 13.1 8.6 12.1 14.0 12.9 13.2 8.6 18.2 10.1 16.7 16.3 10.7 14.3 14.4 7.0 17.8 16.3 9.8 14.1 10.3 14.5 12.9 11.9 21.9 12.0 12.8 17.8 46.9 25.0 43.0 41.0 25.5 50.4 38.9 41.4 47.8 27.1 48.7 49.6 46.8 26.0 54.3 52.3 31.4 30.9 38.5 4.3 4.9 11.3 6.8 4.6 4.9 4.6 4.6 4.8 4.1 5.2 6.3 28.6 28.9 30.7 26.4 43.6 57.5 48.5 32.4 48.9 27.5 32.7 25.5 26.4 15.7 24.7 7.3 47.9 41.1 34.5 25.5 3.9 29.2 10.8 21.5 33.4 33.5 51.8 20.2 43.4 35.1 52.3 33.6 18.3 34.0 36.8 34.8 24.7 13.2 19.9 28.6 40.5 27.6 24.4 27.6 48.9 26.3 24.8 29.2 10.6 20.6 35.2 18.3 30.9 40.7 44.2 45.0 19.6 25.9 31.8 48.4 22.3 13.5 14.2 30.3 13.1 39.2 32.5 12.8 19.1 27.4 41.2 64.0 39.1 27.7 27.9 62.1 DDX18 "Has1, MrDb" ENSG00000088205 "DEAD-box helicase 18" Q9NVP1 2 117814691-117832377 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 376.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035400, HPA041056" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 17000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA035400: AB_10672091, HPA041056: AB_2677277" "unprognostic (1.44e-1)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.64e-4)" "unprognostic (2.06e-1)" "unprognostic (1.77e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (8.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (1.42e-2)" "unprognostic (4.94e-2)" "unprognostic (8.51e-2)" "unprognostic (1.45e-1)" "unprognostic (1.53e-1)" "unprognostic (7.28e-2)" "unprognostic (5.65e-2)" 25.3 21.4 14.9 30.2 15.9 21.8 32.7 16.1 18.0 23.4 15.1 28.3 22.4 30.0 22.9 24.8 23.6 22.2 21.2 14.1 15.9 27.0 35.2 24.8 41.1 15.7 15.2 25.5 21.1 21.4 10.8 26.2 16.1 23.2 31.0 19.4 19.3 23.0 18.6 22.9 23.4 26.3 16.6 32.3 22.8 20.6 15.1 34.5 30.2 18.3 41.7 33.2 17.3 19.0 94.0 41.9 61.3 55.5 35.5 31.9 101.0 54.7 43.0 73.7 64.6 104.2 60.6 137.8 85.9 45.6 68.0 71.1 120.3 70.7 108.0 70.6 83.9 132.0 36.9 105.1 49.5 178.4 66.0 33.4 63.9 93.7 94.3 37.6 44.9 70.3 146.5 58.4 57.1 58.6 98.2 92.6 154.4 79.1 62.3 84.4 95.8 121.3 48.8 55.2 58.8 99.3 62.7 69.2 73.4 62.1 43.9 96.7 34.9 65.6 96.5 46.8 99.5 66.3 87.9 376.0 48.2 82.9 30.1 11.7 23.0 16.3 24.9 28.9 32.0 37.4 29.8 28.9 20.7 30.3 35.6 31.7 5.8 29.7 33.1 33.7 25.7 32.1 14.9 15.9 16.1 18.0 14.1 15.9 15.7 15.2 16.1 16.6 15.1 19.0 144.4 96.1 62.5 24.8 153.9 192.7 114.4 149.4 100.2 150.5 82.8 94.5 50.4 101.5 103.8 121.4 83.4 110.3 140.6 69.0 117.4 125.4 17.1 92.2 125.1 109.1 56.9 76.4 24.3 115.2 120.9 98.2 63.2 102.8 110.3 71.8 107.1 195.6 87.9 82.4 28.0 108.0 109.9 104.8 100.8 17.7 106.6 100.6 92.5 20.6 117.1 70.3 135.9 26.7 39.1 130.0 68.8 103.8 103.3 118.1 53.3 186.5 90.6 132.9 65.7 158.7 110.1 138.6 129.9 81.4 160.5 88.8 143.2 67.4 114.6 65.3 DDX46 "FLJ25329, KIAA0801, Prp5, PRPF5" ENSG00000145833 "DEAD-box helicase 46" Q7L014 5 134758771-134855133 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036554, HPA057501" Supported Supported "Nucleoli fibrillar center,Nuclear speckles" NA NA 13000 "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Nucleoli fibrillar center" "HPA036554: AB_10673621, HPA057501: AB_2683449" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "prognostic favorable (9.01e-6)" "unprognostic (7.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.71e-2)" "unprognostic (2.04e-3)" "unprognostic (1.07e-1)" "unprognostic (1.60e-2)" "unprognostic (5.05e-2)" "unprognostic (9.21e-2)" "unprognostic (6.02e-2)" "unprognostic (9.70e-3)" "unprognostic (4.36e-2)" "unprognostic (4.35e-2)" "unprognostic (1.64e-2)" "unprognostic (4.50e-2)" 16.5 14.6 7.6 23.9 8.8 23.1 17.7 16.1 10.8 16.3 11.4 17.3 17.0 19.8 12.3 17.5 15.0 13.4 13.4 6.8 11.2 18.8 17.7 15.8 25.6 10.0 8.4 18.5 20.8 18.4 11.1 15.7 9.2 15.5 20.7 18.0 16.8 12.1 35.2 19.4 18.7 17.6 5.4 20.6 20.0 16.3 10.0 32.1 18.7 22.9 26.6 18.2 15.6 10.3 87.1 78.0 54.4 71.1 20.8 23.2 75.0 56.8 43.7 58.8 65.6 119.2 61.7 108.9 47.7 38.3 62.3 52.5 80.9 54.2 68.7 73.8 73.3 131.0 84.7 48.5 18.0 120.5 67.8 21.0 28.9 62.1 34.8 24.9 47.3 85.9 113.6 45.3 44.1 41.5 104.2 46.9 75.2 50.1 34.8 89.7 142.0 54.8 32.0 73.9 64.2 61.3 79.4 37.2 42.7 63.0 58.3 68.0 59.0 61.8 43.2 47.9 114.0 35.6 103.2 140.2 42.8 112.0 40.0 55.6 31.9 48.2 30.7 29.2 28.0 38.1 30.4 31.3 25.3 43.4 30.9 31.5 55.9 32.3 27.5 38.5 29.7 17.8 7.6 8.8 16.1 10.8 6.8 11.2 10.0 8.4 9.2 5.4 10.0 10.3 102.4 76.9 131.5 35.9 123.6 113.8 121.5 102.7 68.9 131.5 80.6 79.4 69.3 64.3 94.9 103.0 83.4 133.7 142.3 91.3 56.7 100.5 53.4 111.4 155.8 104.7 92.2 90.6 38.7 107.9 160.4 85.1 69.3 115.9 101.2 122.3 76.8 113.1 94.4 121.1 41.2 112.4 63.1 119.3 113.2 26.7 111.9 103.4 56.9 21.5 178.5 79.9 194.7 28.1 57.6 130.7 62.6 113.2 134.7 139.5 79.2 84.1 74.5 176.0 98.6 114.9 115.2 246.3 275.7 81.0 137.0 157.2 131.8 114.5 112.7 144.1 DDX5 "G17P1, HLR1, p68" ENSG00000108654 "DEAD-box helicase 5" P17844 17 64498254-64508199 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005868, HPA020043, HPA071154" Supported Supported Nucleoplasm,Nucleoli No No 310000 "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: " "unprognostic (6.64e-2)" "unprognostic (6.98e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.94e-2)" "unprognostic (5.08e-2)" "unprognostic (9.85e-2)" "unprognostic (5.80e-2)" "unprognostic (1.61e-2)" "unprognostic (3.17e-2)" "unprognostic (4.71e-2)" "unprognostic (3.03e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-1)" "unprognostic (2.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (9.28e-3)" 202.9 124.0 75.2 75.7 80.0 219.5 163.4 93.4 91.3 190.4 122.8 176.8 36.1 181.7 61.9 136.9 181.2 186.4 109.8 83.6 83.8 113.6 157.5 185.9 124.7 85.5 79.7 134.2 83.3 177.7 118.9 119.4 79.0 122.8 157.7 211.7 112.0 144.8 165.7 130.6 116.3 274.6 65.4 127.5 137.1 88.7 83.2 272.5 172.8 107.5 157.5 228.2 128.9 100.2 204.7 85.5 353.1 144.4 316.2 316.7 134.1 221.4 349.8 306.9 300.3 98.2 105.3 299.7 102.0 364.8 238.1 87.1 361.6 291.5 428.2 107.7 76.0 211.2 84.5 81.6 216.6 383.9 186.3 301.4 306.8 270.2 264.1 241.5 362.2 303.6 174.3 247.3 284.0 108.7 520.4 44.8 159.5 294.5 32.0 310.1 286.7 239.1 201.8 145.6 151.0 305.7 181.5 167.6 284.0 326.5 138.5 132.1 158.2 123.0 146.3 170.0 207.3 112.2 283.9 622.0 166.6 140.5 184.2 232.6 160.6 170.0 117.2 143.3 149.8 111.5 105.4 125.4 148.5 106.3 107.6 109.4 86.6 112.2 197.1 85.5 135.9 319.9 75.2 80.0 93.4 91.3 83.6 83.8 85.5 79.7 79.0 65.4 83.2 100.2 990.8 535.2 690.9 200.8 909.4 879.5 1536.4 837.0 618.1 403.5 433.3 393.7 249.6 346.0 855.7 369.6 335.7 439.9 1284.6 521.5 334.6 476.2 603.0 1021.9 987.2 767.7 664.1 309.7 187.9 419.2 371.3 733.5 452.1 1288.8 874.3 647.9 528.7 254.3 445.8 420.6 165.7 475.9 801.5 577.8 629.4 136.9 415.4 833.2 432.2 280.1 800.2 587.1 777.5 291.6 325.7 464.2 598.6 437.8 661.5 537.7 552.6 287.5 737.9 550.4 493.0 1437.7 961.5 407.6 399.1 466.4 746.0 887.3 1043.4 745.0 424.7 1056.4 DDX6 "HLR2, RCK, Rck/p54" ENSG00000110367 "DEAD-box helicase 6" P26196 11 118747763-118791164 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004668, HPA024201, HPA026644" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA 19000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 24: Non-specific - Transcription regulation" "Cytoplasmic bodies" Cytosol "CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582" "unprognostic (1.26e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-1)" "unprognostic (3.40e-2)" "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (3.43e-1)" "unprognostic (1.48e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (7.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.91e-3)" "unprognostic (1.88e-1)" "unprognostic (9.58e-2)" "unprognostic (4.55e-2)" 31.5 28.4 29.1 34.9 36.0 69.0 34.9 50.7 31.9 33.2 12.7 30.0 23.7 30.5 30.5 33.1 29.1 23.6 37.2 31.5 35.4 30.6 34.2 27.3 49.0 28.4 29.3 48.8 30.7 28.3 17.3 31.6 25.2 32.9 27.9 48.7 32.4 29.2 43.2 27.2 26.2 30.6 29.9 45.4 29.9 28.8 37.1 54.9 37.5 41.9 60.9 30.0 21.9 36.6 33.9 50.4 73.6 71.7 64.0 64.8 47.2 45.6 62.0 43.0 40.4 72.1 50.9 77.6 47.1 78.8 44.3 53.2 88.8 69.1 69.0 62.7 17.4 154.5 30.8 57.1 42.0 110.9 55.8 67.1 49.5 63.5 100.8 54.8 69.1 53.2 72.5 110.4 59.2 96.8 81.0 52.1 53.3 50.1 33.6 89.3 59.2 60.1 50.1 92.7 48.7 63.9 84.7 67.2 28.5 56.2 79.2 44.2 81.2 67.2 38.4 39.8 47.6 34.1 47.8 91.7 26.8 52.2 59.2 13.8 4.8 13.2 10.2 6.2 12.3 12.1 10.0 10.8 5.1 12.0 12.2 11.0 19.0 8.3 12.4 7.1 9.9 6.8 29.1 36.0 50.7 31.9 31.5 35.4 28.4 29.3 25.2 29.9 37.1 36.6 84.6 60.9 57.9 37.9 140.1 30.2 75.2 31.3 69.4 82.2 49.8 43.2 116.9 42.9 41.4 44.1 50.1 38.4 184.0 58.6 31.3 32.2 4.2 77.3 81.5 64.6 85.7 88.2 57.3 35.5 36.5 55.6 42.3 91.7 52.5 54.2 61.8 41.5 38.3 62.2 60.9 59.8 42.7 66.9 44.3 10.5 54.0 70.1 33.8 68.4 75.9 90.0 119.4 50.3 80.9 51.2 57.0 45.1 106.0 49.8 57.2 41.3 35.9 91.3 39.5 92.6 69.7 71.1 76.8 73.4 30.5 76.5 130.2 48.8 53.1 78.2 DENND6A "AFI1A, FAM116A, FLJ34969" ENSG00000174839 "DENN domain containing 6A" Q8IWF6 3 57625454-57693077 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 66.9;Inhibitory neurons: 65.4;Oligodendrocytes: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 18.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 18.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062618, HPA069725, HPA071711" Approved Supported Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435" "unprognostic (6.20e-2)" "unprognostic (3.86e-2)" "prognostic favorable (9.21e-4)" "unprognostic (1.76e-1)" "unprognostic (7.75e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (6.36e-4)" "unprognostic (7.16e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-3)" "unprognostic (5.97e-3)" "unprognostic (1.12e-1)" "prognostic favorable (7.77e-6)" "unprognostic (3.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.61e-3)" "unprognostic (2.94e-1)" 11.6 7.3 3.4 8.8 4.6 12.6 12.9 12.9 7.1 11.8 3.8 10.7 7.1 12.7 9.9 11.4 10.3 8.3 8.0 3.0 5.5 8.9 7.7 10.5 12.6 4.2 4.8 20.9 5.3 11.4 6.6 11.8 5.3 9.9 9.2 10.0 8.4 11.7 7.1 8.6 9.2 11.3 4.7 12.9 9.7 8.0 4.7 11.8 14.0 9.8 10.5 10.7 10.5 8.4 16.8 13.5 18.0 11.0 9.4 10.6 10.2 8.6 11.0 10.5 8.2 8.7 18.4 19.9 3.6 8.9 9.2 8.8 14.4 18.2 8.9 5.1 12.9 15.7 15.1 6.7 9.0 12.1 8.9 11.3 13.0 7.2 18.7 10.6 15.2 21.1 10.8 21.1 7.6 7.3 26.2 14.9 10.2 10.6 9.3 10.9 10.7 14.8 12.8 28.1 6.1 22.0 17.1 13.9 12.5 7.7 9.1 14.7 16.7 12.7 6.8 13.6 22.8 15.7 22.2 20.7 14.8 19.9 18.9 18.7 1.0 1.4 2.4 1.1 2.9 0.8 2.3 2.4 1.3 1.2 3.4 2.6 1.5 1.9 1.4 1.0 1.3 1.0 3.4 4.6 12.9 7.1 3.0 5.5 4.2 4.8 5.3 4.7 4.7 8.4 28.8 19.2 8.2 31.3 14.5 12.9 11.8 10.6 12.0 16.2 9.9 9.1 20.8 11.5 10.0 5.5 8.4 6.4 21.4 5.7 3.9 8.1 22.2 10.1 25.6 16.0 3.0 16.2 66.9 10.9 4.4 15.7 10.2 17.1 2.5 24.1 20.7 11.1 11.1 10.1 65.4 5.5 12.2 34.3 9.9 11.3 11.8 16.8 3.6 47.8 16.8 10.2 20.6 42.3 74.3 18.9 3.5 14.3 9.5 8.4 6.5 8.9 8.0 14.5 6.6 19.2 18.3 13.3 5.0 14.1 10.7 2.3 19.6 16.7 6.1 13.0 DHX15 "DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p" ENSG00000109606 "DEAH-box helicase 15" O43143 4 24517441-24584554 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047047 Approved Enhanced "Nuclear speckles" NA NA 130000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "HPA047047: AB_2679916" "unprognostic (4.46e-3)" "unprognostic (2.47e-2)" "prognostic favorable (5.74e-4)" "unprognostic (3.35e-1)" "unprognostic (5.30e-2)" "unprognostic (5.74e-2)" "unprognostic (2.06e-3)" "unprognostic (5.53e-3)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (8.68e-3)" "unprognostic (7.77e-3)" "unprognostic (2.51e-3)" "unprognostic (2.19e-1)" "unprognostic (1.59e-1)" "unprognostic (5.41e-3)" 40.3 35.7 17.0 51.2 23.2 78.5 50.7 30.5 22.6 41.3 29.4 48.8 36.8 44.5 30.2 43.9 38.5 35.6 33.3 18.4 20.9 45.7 44.7 37.1 60.2 20.9 20.3 43.8 47.7 52.1 21.6 55.0 22.0 39.5 57.9 40.1 37.7 35.9 43.0 42.1 37.9 48.0 20.8 40.0 44.7 33.5 20.2 79.8 40.0 42.2 70.9 65.6 34.7 29.0 135.0 129.1 209.4 104.6 100.6 97.4 124.7 153.0 133.9 157.8 155.5 132.0 158.5 245.4 91.8 126.2 183.7 109.8 272.1 184.1 243.7 90.6 129.0 213.3 134.7 107.3 59.2 222.3 140.9 82.2 108.4 154.3 103.1 100.8 133.9 113.4 203.4 96.2 181.3 101.3 293.7 148.2 228.4 133.4 115.8 190.4 245.3 114.6 187.1 190.2 179.0 111.9 118.7 112.8 109.1 149.0 123.8 113.7 123.5 132.8 87.5 101.6 181.4 72.1 130.2 289.3 89.1 177.9 161.8 57.5 29.6 28.5 28.8 30.8 39.7 28.7 32.0 33.7 39.0 29.9 33.2 32.2 13.9 37.1 38.5 25.8 38.6 28.5 17.0 23.2 30.5 22.6 18.4 20.9 20.9 20.3 22.0 20.8 20.2 29.0 51.2 76.9 57.4 40.1 53.4 98.7 68.3 58.0 56.3 30.2 50.1 36.7 28.1 35.8 70.6 27.6 22.9 72.7 44.9 79.8 37.2 59.3 32.6 61.7 53.2 53.6 60.5 58.9 51.4 41.8 69.7 55.5 79.5 97.3 57.0 47.4 42.8 48.4 44.7 26.9 50.8 69.3 36.7 46.9 53.2 16.5 39.4 50.2 48.0 49.6 48.0 24.4 34.0 61.3 99.1 57.1 41.2 40.3 51.0 73.1 33.2 34.8 55.6 32.1 26.3 59.6 69.4 72.9 46.3 60.4 100.0 88.2 49.3 34.0 71.2 89.4 DHX9 "DDX9, LKP, RHA" ENSG00000135829 "DExH-box helicase 9" Q08211 1 182839347-182887982 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport" "Activator, DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011819, HPA028050, HPA055684" Supported Supported Nucleoplasm,Nucleoli NA NA 360000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885" "unprognostic (8.14e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.58e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.88e-2)" "unprognostic (5.53e-2)" "unprognostic (7.51e-2)" "unprognostic (1.43e-1)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-1)" 38.7 30.5 13.6 47.4 15.8 131.4 53.2 19.0 19.7 43.7 17.0 40.2 32.6 49.4 33.0 32.2 45.9 31.1 28.5 13.1 16.0 49.9 36.9 38.6 56.9 15.2 13.6 52.8 30.5 68.2 21.1 44.6 16.3 39.6 47.1 66.5 32.5 44.3 30.3 31.1 36.3 50.8 16.6 40.9 34.5 50.4 14.6 88.7 48.0 37.7 70.2 54.0 30.0 25.5 165.7 158.8 223.0 122.3 113.7 87.8 219.2 143.5 130.3 203.6 137.0 175.8 124.2 264.3 133.7 129.6 121.7 138.8 342.6 155.2 225.7 108.3 169.5 176.4 121.0 119.6 62.5 258.3 115.0 78.6 75.8 200.4 53.4 91.6 161.7 132.9 281.8 91.9 165.1 142.3 263.6 61.1 282.8 173.9 96.8 236.0 208.0 151.0 127.0 187.8 160.0 183.2 203.2 125.0 83.2 186.4 148.4 140.9 127.6 125.3 138.8 128.9 195.9 93.6 167.2 305.0 79.0 137.0 174.5 7.7 21.3 16.1 23.4 22.5 26.2 20.5 19.8 21.1 29.9 16.6 21.6 23.7 8.0 20.0 19.7 14.2 20.1 21.2 13.6 15.8 19.0 19.7 13.1 16.0 15.2 13.6 16.3 16.6 14.6 25.5 43.6 41.7 74.1 59.1 54.5 53.7 61.2 42.7 38.7 59.6 43.3 38.9 43.9 30.0 60.8 51.5 52.1 50.9 70.2 38.6 19.6 49.0 26.8 79.2 67.4 50.7 53.8 74.5 49.4 50.8 47.5 48.0 37.8 109.8 44.9 67.7 36.0 28.0 40.8 28.6 55.5 40.9 30.5 35.4 35.1 45.8 60.3 44.7 30.2 55.3 55.9 42.7 42.2 55.3 70.3 52.3 28.0 47.0 52.4 48.3 35.4 38.0 67.7 77.1 39.5 73.9 54.1 69.9 68.2 51.7 47.2 49.5 59.2 60.9 54.4 55.4 DIPK2A "C3orf58, DIA1, HASF, MGC33365" ENSG00000181744 "Divergent protein kinase domain 2A" Q8NDZ4 3 143971823-144048719 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.5;Cardiomyocytes: 19.6;dendritic cells: 11.3;Fibroblasts: 22.6;Hofbauer cells: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 147.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048992 Approved "Secreted in other tissues" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" "HPA048992: AB_2680591" "unprognostic (5.96e-2)" "unprognostic (8.54e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-1)" "unprognostic (2.43e-1)" "unprognostic (2.85e-2)" "unprognostic (3.74e-2)" "unprognostic (2.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (3.44e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (2.92e-7)" "unprognostic (4.82e-3)" "unprognostic (2.87e-1)" "unprognostic (1.70e-1)" "unprognostic (1.50e-2)" 9.8 7.4 10.3 10.5 14.5 32.4 15.7 24.5 17.9 13.6 3.8 8.2 6.8 14.2 6.0 14.1 12.7 14.2 7.0 9.1 10.9 6.8 18.9 12.9 11.3 12.6 11.0 20.2 4.5 15.0 3.4 38.1 11.9 11.5 8.8 5.8 9.0 12.6 4.6 24.4 5.9 15.1 9.7 10.7 8.4 8.0 10.6 16.6 12.7 7.2 11.0 11.5 9.7 23.9 24.9 9.9 24.8 147.9 22.6 20.4 13.5 17.7 17.2 16.6 17.6 6.7 9.8 15.5 13.6 6.8 11.9 13.9 37.2 14.3 25.9 7.3 13.5 23.0 9.4 10.1 9.8 21.3 10.3 17.0 7.5 10.2 15.4 16.7 26.1 7.0 4.1 43.9 21.2 6.7 7.7 10.4 15.7 10.3 6.2 11.3 12.8 17.2 10.3 29.1 16.5 0.0 12.7 5.8 5.8 6.7 15.5 11.5 12.5 14.6 7.0 22.9 20.6 17.4 6.5 22.1 23.6 10.0 19.3 24.9 11.9 20.1 3.5 7.8 5.8 8.2 4.2 3.7 14.9 7.1 3.6 3.6 3.3 9.5 10.6 9.3 3.9 6.0 10.3 14.5 24.5 17.9 9.1 10.9 12.6 11.0 11.9 9.7 10.6 23.9 23.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 1.6 11.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 3.4 2.6 0.0 0.0 0.0 DIS3 "dis3p, EXOSC11, KIAA1008, RRP44" ENSG00000083520 "DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease" Q9Y2L1 13 72752169-72782096 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 169.2;Late spermatids: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039281, HPA058762" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Cytosol "HPA039281: AB_10795583, HPA058762: AB_2683810" "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" "unprognostic (8.97e-2)" "unprognostic (8.14e-2)" "unprognostic (1.51e-2)" "unprognostic (1.49e-1)" "unprognostic (2.84e-1)" "unprognostic (6.38e-2)" "unprognostic (8.68e-2)" "unprognostic (1.32e-3)" "unprognostic (3.35e-3)" "unprognostic (1.02e-1)" "unprognostic (2.37e-2)" "unprognostic (3.69e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-1)" 13.8 9.9 5.3 12.4 5.7 20.4 15.8 9.1 6.7 11.3 7.1 10.0 8.5 11.2 11.5 12.4 9.9 10.4 11.6 5.2 5.9 12.8 16.6 11.4 17.6 5.2 5.6 13.4 8.9 11.9 8.9 12.0 5.3 12.3 10.9 12.1 9.4 10.5 10.2 11.1 9.9 11.0 5.5 12.2 9.9 21.3 6.3 14.1 15.0 10.4 17.3 14.1 10.8 6.9 29.5 13.4 25.9 21.9 26.9 31.9 17.0 25.5 31.0 25.6 31.1 20.7 23.8 35.6 21.6 26.3 16.2 23.8 35.7 29.4 40.9 29.3 26.3 41.8 27.8 18.7 33.4 71.4 23.2 33.4 20.1 29.0 37.9 25.5 27.8 26.6 28.3 14.4 31.4 10.3 30.5 34.8 24.3 44.7 15.7 24.2 19.7 16.2 25.4 23.2 23.3 30.8 20.9 17.3 25.4 26.8 16.7 32.1 26.1 15.4 12.5 17.5 27.4 27.6 33.2 28.0 42.9 33.2 22.7 8.4 3.6 5.2 4.0 6.3 5.6 4.2 5.0 4.5 4.3 3.7 4.9 4.5 2.1 6.9 5.2 2.7 6.7 3.2 5.3 5.7 9.1 6.7 5.2 5.9 5.2 5.6 5.3 5.5 6.3 6.9 51.6 35.3 37.2 12.4 35.3 25.5 36.5 24.5 18.2 38.8 27.6 26.4 27.6 21.5 40.2 9.2 29.2 23.8 45.0 19.0 23.5 21.7 169.2 26.2 37.6 41.2 30.5 18.7 21.5 20.1 23.5 33.3 19.9 45.6 33.6 26.3 26.7 23.7 14.4 32.0 24.0 17.2 18.3 19.2 13.8 135.5 28.9 21.4 12.4 24.4 38.2 23.6 25.7 17.6 24.2 25.4 8.1 28.2 30.2 27.4 16.3 17.2 35.4 41.6 6.6 58.3 27.0 28.9 37.7 31.4 31.3 22.6 33.7 29.1 21.2 53.9 DMXL1 ENSG00000172869 "Dmx like 1" Q9Y485 5 119037772-119249138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.3;Inhibitory neurons: 147.3;Oligodendrocytes: 224.0" "Cancer enhanced" "Detected in all" "prostate cancer: 14.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036431, HPA036432" Approved Approved Nucleoli,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli Cytosol "HPA036431: AB_10669791, HPA036432: AB_2675120" "unprognostic (2.47e-1)" "unprognostic (4.84e-2)" "unprognostic (7.87e-3)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-1)" "unprognostic (6.77e-2)" "unprognostic (1.40e-1)" "unprognostic (4.88e-2)" "unprognostic (5.93e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.16e-5)" "unprognostic (4.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-2)" "unprognostic (5.18e-2)" 7.0 4.8 3.1 7.3 7.0 25.9 9.2 7.8 5.1 7.4 11.9 6.8 6.2 8.7 5.7 8.2 6.6 7.5 6.1 3.5 5.3 13.8 7.1 6.6 10.1 7.4 4.5 10.4 12.0 11.8 2.6 7.2 8.0 27.2 7.1 9.0 8.0 5.8 4.1 8.4 6.1 8.2 6.3 8.2 7.9 5.8 5.6 10.3 13.4 7.3 9.7 6.2 4.5 15.2 10.4 8.0 8.8 9.0 9.3 12.2 9.4 8.4 8.4 8.3 9.6 9.6 6.2 20.2 8.5 10.8 12.9 6.1 9.9 10.0 10.7 15.6 9.9 14.2 14.0 3.4 7.8 9.4 11.8 9.8 5.5 9.6 7.9 8.5 11.0 12.4 12.1 13.3 6.7 6.5 12.6 5.3 4.8 3.6 4.7 9.8 16.3 7.9 6.4 11.9 8.2 8.3 14.5 5.2 12.6 9.4 8.6 10.7 10.7 9.8 8.2 9.9 9.0 12.4 9.4 17.6 12.2 9.1 8.0 4.1 4.9 3.6 2.4 4.4 3.0 8.8 1.9 2.0 3.4 9.1 3.0 1.8 3.8 1.3 8.9 8.3 2.6 2.7 3.1 7.0 7.8 5.1 3.5 5.3 7.4 4.5 8.0 6.3 5.6 15.2 23.7 28.9 20.1 93.4 56.5 13.6 16.5 17.7 22.8 36.8 22.8 15.4 25.7 7.2 17.6 16.5 25.0 12.6 27.5 16.2 17.6 12.0 10.2 19.8 21.1 16.7 6.0 19.1 122.3 20.1 10.3 20.4 27.5 25.0 14.0 15.6 11.0 15.6 16.6 21.9 147.3 12.2 10.2 21.9 19.9 12.1 15.2 31.0 33.8 68.4 29.1 16.9 25.7 111.6 224.0 14.1 11.6 15.4 27.2 36.0 15.8 32.5 13.9 22.6 13.1 28.6 24.7 28.0 23.2 35.0 18.8 16.3 24.3 17.8 11.3 15.0 DNAJC14 "DNAJ, DRIP78, FLJ32792, HDJ3, LIP6" ENSG00000135392 "DnaJ heat shock protein family (Hsp40) member C14" Q6Y2X3 12 55820960-55830824 "Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017653 Approved NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 10: Non-specific - Unknown function" "HPA017653: AB_1847799" "unprognostic (2.54e-2)" "unprognostic (1.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.90e-1)" "unprognostic (6.04e-2)" "unprognostic (3.14e-2)" "unprognostic (6.91e-3)" "unprognostic (6.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.63e-1)" "unprognostic (4.34e-2)" "unprognostic (3.89e-3)" "unprognostic (4.73e-2)" "unprognostic (7.98e-2)" "unprognostic (9.17e-2)" "unprognostic (8.92e-2)" 14.0 13.2 14.2 15.4 14.8 16.3 15.6 13.4 14.2 16.0 14.2 14.2 13.8 15.4 16.9 11.3 17.4 12.6 12.2 14.0 13.3 16.4 16.9 15.2 16.9 14.5 14.6 12.8 13.5 24.6 11.5 16.2 13.8 14.8 15.0 12.3 15.5 13.4 11.2 13.2 15.0 16.1 13.8 17.6 14.6 18.6 14.6 23.6 17.7 11.3 19.0 14.2 10.4 16.2 25.0 29.7 31.9 32.3 31.3 29.5 36.1 27.6 35.8 35.2 25.5 24.2 41.5 31.5 51.9 31.4 24.3 26.9 28.7 34.4 32.1 50.8 20.6 43.6 28.0 20.4 32.4 26.5 35.9 26.5 28.3 35.4 32.8 52.4 38.7 45.7 34.0 36.4 40.6 29.5 48.8 26.3 25.1 24.8 24.8 39.6 28.5 27.6 32.4 21.3 43.1 40.2 22.2 30.5 21.0 30.6 64.1 40.1 33.6 33.2 30.6 31.2 22.6 43.7 40.7 27.7 33.7 24.1 42.1 14.8 9.5 16.1 12.9 8.4 10.2 10.3 9.6 11.6 9.1 7.4 8.4 10.5 7.8 11.3 11.5 11.6 8.4 11.1 14.2 14.8 13.4 14.2 14.0 13.3 14.5 14.6 13.8 13.8 14.6 16.2 9.2 6.4 7.7 1.6 6.8 4.0 4.0 8.1 5.7 7.1 7.5 4.2 0.8 7.2 9.0 11.0 10.4 10.0 6.7 9.6 3.9 9.8 4.5 7.1 7.7 8.1 7.2 10.8 3.9 7.7 14.1 6.4 7.7 6.8 1.3 9.7 5.3 7.4 9.8 1.7 3.8 5.2 0.0 12.5 10.7 4.7 9.6 9.2 7.2 3.7 8.6 7.9 13.4 1.5 5.5 9.3 7.7 9.1 8.5 5.6 8.0 7.5 6.9 5.2 6.6 7.4 11.5 6.8 10.0 5.1 4.1 13.0 6.3 7.7 7.2 3.5 DNAJC17 FLJ10634 ENSG00000104129 "DnaJ heat shock protein family (Hsp40) member C17" Q9NVM6 15 40765161-40807478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040914, HPA041187" Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA040914: AB_10794072, HPA041187: AB_10794192" "unprognostic (9.79e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.65e-1)" "unprognostic (2.84e-1)" "unprognostic (1.94e-1)" "unprognostic (5.98e-2)" "unprognostic (5.37e-2)" "unprognostic (2.72e-1)" "unprognostic (4.78e-1)" "unprognostic (2.64e-2)" "unprognostic (6.58e-2)" 13.2 11.1 6.9 9.9 6.7 6.3 13.4 9.3 9.3 12.5 4.6 13.8 8.2 14.6 9.6 12.5 14.2 10.1 8.8 6.5 6.4 12.0 14.8 11.1 13.6 6.5 6.5 17.1 9.8 16.8 8.9 13.9 6.6 9.7 11.4 5.4 9.2 11.2 8.0 12.2 10.8 12.7 5.8 12.2 10.6 4.5 6.7 16.2 11.8 11.2 16.8 10.9 10.7 7.3 10.8 9.6 23.8 23.1 10.5 26.2 10.1 19.9 19.5 32.7 26.7 7.7 15.1 16.6 21.5 23.9 15.0 22.2 24.4 32.6 28.9 30.8 15.3 28.1 19.2 7.6 29.8 14.7 24.0 26.2 20.6 25.8 46.2 18.2 30.5 28.0 20.0 8.6 25.3 13.6 21.5 19.7 8.6 25.3 14.1 15.7 19.8 8.6 33.2 19.5 15.0 9.6 14.4 13.4 10.2 16.8 17.0 29.1 30.0 18.5 16.0 21.0 17.1 9.6 31.0 36.5 11.9 37.1 15.9 30.0 21.5 28.9 24.5 28.6 17.6 19.8 21.2 23.7 24.3 19.4 22.4 21.8 7.9 13.3 17.0 19.8 39.2 14.1 6.9 6.7 9.3 9.3 6.5 6.4 6.5 6.5 6.6 5.8 6.7 7.3 26.6 12.8 16.4 9.4 16.5 5.6 19.2 40.6 8.6 15.0 24.3 14.7 5.8 22.8 33.2 25.8 12.5 25.1 15.5 17.5 19.6 18.9 3.2 13.4 15.8 16.2 7.8 9.4 13.0 17.5 15.8 14.7 12.8 16.9 22.1 13.6 19.6 14.4 22.5 13.5 15.0 16.1 20.3 10.3 10.6 2.0 15.2 13.1 7.2 12.2 13.0 8.5 36.0 11.6 16.1 16.9 24.6 16.1 9.9 12.8 30.6 27.2 20.2 10.4 0.0 14.5 22.6 5.6 4.7 16.3 5.3 17.2 16.7 16.6 16.9 20.6 DNMT1 "CXXC9, DNMT, MCMT" ENSG00000130816 "DNA methyltransferase 1" P26358 19 10133342-10231286 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Deafness, Disease variant, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002694, CAB005876" Enhanced Supported Nucleoplasm NA Yes "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "CAB005876: AB_731983, HPA002694: AB_1847810" "unprognostic (3.51e-1)" "unprognostic (1.20e-2)" "unprognostic (1.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.62e-1)" "unprognostic (7.59e-3)" "prognostic unfavorable (1.46e-4)" "unprognostic (2.90e-1)" "unprognostic (4.23e-3)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.28e-3)" "unprognostic (7.81e-3)" "unprognostic (1.73e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" 7.1 3.9 0.9 16.9 2.9 23.1 7.0 11.7 3.1 9.1 0.0 6.9 6.6 7.3 3.1 7.7 6.5 6.2 4.8 2.1 6.6 3.0 3.9 7.8 26.2 3.8 4.5 5.6 3.6 4.3 4.5 26.0 5.7 4.5 6.8 7.5 5.6 4.6 5.3 7.9 7.9 8.8 0.3 8.1 6.3 12.4 3.3 20.6 6.3 5.0 24.9 7.3 6.4 10.6 77.0 40.6 49.5 45.8 24.6 24.0 138.8 52.4 43.9 77.5 74.9 50.6 40.8 138.3 33.8 30.0 38.6 46.6 68.4 44.2 68.4 57.5 100.9 181.5 39.5 27.1 9.6 91.5 73.4 11.5 9.3 68.5 24.1 18.4 39.9 37.6 75.0 82.8 63.3 37.6 109.2 50.4 87.5 38.3 76.6 117.1 67.9 77.2 21.5 49.3 64.5 41.5 58.2 26.2 16.5 33.6 28.9 42.2 31.8 111.3 42.2 73.0 84.4 49.6 69.5 166.8 35.0 68.5 87.1 20.3 21.2 5.9 29.8 22.0 25.1 14.2 22.8 20.4 19.3 20.0 25.5 20.5 4.6 42.6 13.8 31.9 21.9 12.6 0.9 2.9 11.7 3.1 2.1 6.6 3.8 4.5 5.7 0.3 3.3 10.6 36.4 6.4 26.5 12.7 38.0 29.6 20.7 26.8 21.1 86.7 32.6 29.6 14.6 7.2 28.2 22.0 56.3 388.1 54.4 29.0 13.7 26.0 46.1 48.1 42.0 38.9 15.7 109.6 17.6 14.3 73.2 33.6 33.6 60.3 37.2 43.6 25.0 14.8 76.8 65.6 22.6 25.5 38.7 31.4 47.8 50.8 28.0 57.9 14.2 15.0 52.5 32.2 123.6 14.6 20.1 21.1 11.3 28.6 73.4 16.3 4.5 9.3 42.8 50.2 13.1 22.6 32.8 229.6 145.3 41.6 22.4 323.7 70.4 38.7 43.1 16.6 DNMT3A ENSG00000119772 "DNA methyltransferase 3 alpha" Q9Y6K1 2 25227855-25342590 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009469, HPA026588" Approved Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "CAB009469: AB_2093990, HPA026588: AB_1847812" "unprognostic (2.38e-1)" "unprognostic (2.94e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (8.38e-2)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.18e-4)" "unprognostic (2.35e-2)" "prognostic unfavorable (2.49e-4)" "unprognostic (1.43e-1)" "unprognostic (1.87e-1)" "unprognostic (1.14e-1)" "unprognostic (2.70e-2)" 5.6 9.0 8.9 9.8 12.6 8.7 6.2 9.3 10.7 9.1 2.4 11.3 6.7 9.3 8.7 6.0 7.5 6.3 5.9 8.8 7.9 11.3 5.3 7.3 11.1 9.0 7.6 13.0 8.3 4.2 11.5 15.7 8.6 7.2 6.6 15.4 6.2 5.9 21.0 4.9 8.9 7.1 5.2 13.4 8.5 5.2 9.4 20.6 6.9 10.2 9.0 7.3 6.2 11.3 1.6 8.1 34.6 8.3 3.8 2.7 45.2 1.9 2.2 4.7 3.8 21.1 13.2 0.0 4.7 4.7 3.5 2.2 3.8 5.2 2.8 5.7 4.3 14.7 12.8 25.4 8.8 2.9 7.6 8.2 2.6 6.0 2.2 9.1 19.5 34.0 18.0 2.9 3.5 20.6 33.7 36.5 59.6 14.3 4.2 59.5 32.5 3.8 2.9 3.4 18.6 71.5 2.7 19.6 6.2 29.5 2.1 16.2 6.8 5.4 4.7 1.0 2.5 5.6 5.1 19.6 2.2 8.4 5.5 2.8 1.0 2.1 2.7 1.7 4.0 1.3 1.7 2.4 1.3 1.6 4.6 3.9 2.5 5.5 2.7 2.3 1.9 1.2 8.9 12.6 9.3 10.7 8.8 7.9 9.0 7.6 8.6 5.2 9.4 11.3 18.5 6.4 13.1 28.1 11.0 5.2 10.2 6.6 5.7 73.3 12.1 9.8 15.8 5.7 9.9 20.2 127.2 40.6 15.3 6.3 5.9 16.9 1.6 13.3 19.1 20.5 13.1 15.8 49.4 9.8 10.7 16.4 9.7 10.7 37.4 37.3 11.0 6.4 23.2 95.9 43.2 11.4 2.0 14.2 3.9 1.9 19.3 13.7 7.2 38.4 7.4 20.6 13.4 36.7 63.4 9.3 9.4 15.4 9.8 12.4 6.2 6.6 7.3 143.5 19.7 15.1 14.3 2.8 14.6 8.1 2.6 32.2 19.6 26.1 12.1 10.2 DROSHA "Etohi2, HSA242976, RN3, RNASE3L, RNASEN" ENSG00000113360 "Drosha ribonuclease III" Q9NRR4 5 31400494-31532196 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, RNA-mediated gene silencing" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031150 Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Cytosol "HPA031150: AB_2673761" "unprognostic (8.37e-3)" "unprognostic (1.81e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.40e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.11e-1)" "unprognostic (4.08e-2)" "unprognostic (9.08e-2)" "unprognostic (1.86e-1)" "unprognostic (5.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (6.94e-2)" "unprognostic (2.32e-2)" 12.3 11.3 2.6 15.9 3.8 11.6 11.5 9.4 8.0 13.3 4.2 13.8 13.6 15.9 20.4 11.4 14.5 11.7 13.0 2.0 8.1 12.3 9.7 10.9 16.0 1.1 2.9 20.5 14.4 15.2 4.5 13.8 2.3 13.6 15.6 27.2 12.5 13.2 22.2 13.5 12.2 13.8 0.2 12.5 13.2 11.1 5.2 24.5 15.5 19.6 17.1 12.2 3.9 4.9 38.7 47.3 51.8 70.8 27.0 32.8 74.2 50.0 24.4 45.6 33.9 50.6 49.0 43.3 55.9 36.9 52.7 33.0 63.5 37.8 50.4 40.9 44.6 52.9 157.8 37.0 24.3 59.2 151.6 25.8 26.0 50.7 24.2 34.6 39.5 45.3 68.9 19.7 40.5 38.5 58.3 44.8 49.1 31.2 37.9 52.2 98.9 31.1 25.7 43.2 26.9 35.6 127.1 51.4 30.0 46.0 47.4 34.1 33.9 43.7 50.3 39.0 48.0 35.8 63.5 47.1 30.3 65.9 42.9 0.9 1.2 1.5 2.2 1.3 2.4 1.8 2.4 2.7 2.5 2.0 2.7 2.0 0.3 2.5 2.5 3.0 2.5 1.6 2.6 3.8 9.4 8.0 2.0 8.1 1.1 2.9 2.3 0.2 5.2 4.9 6.2 12.8 14.3 45.4 7.1 3.6 5.0 7.0 10.8 19.4 7.1 6.0 23.4 5.7 12.8 5.5 0.0 8.5 11.4 12.9 3.9 7.8 3.5 12.3 11.6 9.0 11.4 8.0 43.4 8.1 7.6 12.7 8.6 13.6 9.5 20.4 10.0 7.2 7.8 6.7 45.8 8.5 14.2 6.3 3.0 8.2 10.8 6.0 1.8 34.7 8.4 10.2 9.2 74.9 43.9 9.3 10.2 13.2 8.8 6.1 7.3 5.1 16.8 18.8 6.6 10.4 11.6 7.1 10.9 8.8 3.4 4.9 8.3 13.9 11.7 5.9 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 component of MIS12 kinetochore complex" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 5.9 9.9 4.2 7.5 4.2 14.3 8.6 3.9 4.5 5.0 5.2 9.2 6.8 4.4 9.3 7.9 4.1 4.4 5.1 4.3 4.4 4.8 9.1 6.3 12.8 4.0 3.9 4.3 4.3 5.5 3.5 8.8 4.1 6.5 10.8 10.7 5.9 6.3 4.0 8.0 7.8 6.3 3.9 9.6 7.3 23.3 4.1 16.4 5.1 4.8 14.3 4.4 4.7 4.7 36.7 29.1 35.7 29.5 14.0 18.0 24.7 42.9 35.1 63.9 70.2 52.5 44.4 39.3 27.4 23.0 69.1 45.8 33.3 32.7 60.3 18.2 22.7 78.3 26.2 36.1 3.0 46.2 34.0 7.0 9.4 43.7 13.8 10.4 31.5 42.4 30.9 33.7 41.7 25.3 59.2 34.5 16.8 63.3 55.1 46.1 109.4 28.4 16.2 20.5 37.8 16.9 52.9 53.7 25.8 26.3 55.9 30.5 16.4 60.1 35.0 56.9 46.1 27.3 39.1 46.4 49.8 40.8 42.6 53.4 6.4 14.5 7.4 11.0 8.4 14.6 8.1 10.3 7.1 18.4 10.1 9.0 11.9 11.1 10.1 46.9 12.2 6.7 4.2 4.2 3.9 4.5 4.3 4.4 4.0 3.9 4.1 3.9 4.1 4.7 6.5 6.4 4.4 1.6 10.3 5.0 11.4 7.6 3.4 8.0 8.7 7.6 5.4 2.8 8.6 5.5 29.2 49.8 9.8 9.2 7.9 6.8 10.6 5.5 5.9 8.1 2.4 22.1 6.3 6.4 30.4 8.4 20.9 9.4 3.8 21.8 7.9 6.2 14.7 6.7 4.4 13.6 4.1 6.3 4.6 8.0 8.7 6.7 1.8 5.6 7.4 6.0 7.2 3.0 3.6 5.1 5.4 7.5 22.9 7.1 7.7 3.6 8.2 17.5 0.0 5.3 8.2 115.5 75.1 12.3 7.2 47.5 7.7 6.9 13.6 11.0 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515938-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.96e-4)" "unprognostic (3.24e-2)" 37.3 35.8 26.3 24.6 27.0 89.2 51.0 29.7 35.5 33.3 27.1 50.8 35.7 35.0 44.7 29.0 39.4 28.1 29.0 27.1 28.6 42.4 50.2 29.5 37.2 25.9 26.5 49.7 26.7 54.7 21.6 35.2 26.3 33.7 51.7 37.1 36.4 31.2 37.0 46.9 45.6 29.2 28.1 31.3 29.3 23.5 27.1 49.1 45.5 29.3 37.1 31.1 30.0 30.0 37.7 45.1 41.3 24.4 47.8 48.7 64.1 33.8 51.6 41.5 43.1 21.6 48.6 39.1 46.6 41.5 24.7 34.5 30.8 45.1 48.3 49.1 27.1 28.7 31.6 91.7 65.1 51.5 30.4 56.3 56.7 23.8 60.9 54.6 41.7 54.1 28.9 42.0 39.1 88.0 71.4 41.5 24.3 69.4 50.0 44.8 49.5 39.5 50.2 50.3 33.1 36.5 47.8 45.6 76.4 39.4 79.7 32.3 45.2 21.4 18.1 28.1 22.0 52.8 63.1 41.5 20.1 28.0 27.6 139.9 61.9 134.3 65.3 57.8 79.1 107.7 81.9 75.0 54.9 101.0 82.7 75.8 140.2 100.6 80.9 47.8 124.4 80.0 26.3 27.0 29.7 35.5 27.1 28.6 25.9 26.5 26.3 28.1 27.1 30.0 59.8 22.4 53.3 17.0 78.6 46.4 67.2 145.0 74.6 75.6 60.0 70.1 35.4 60.1 78.8 82.8 31.3 125.3 76.3 91.8 174.1 86.6 20.9 82.0 59.6 57.8 66.0 66.7 20.5 84.5 76.5 67.6 26.5 54.8 73.5 98.7 57.5 109.0 58.8 25.2 21.3 112.8 87.5 50.6 33.9 14.9 89.5 47.5 90.7 16.9 71.3 122.0 87.6 17.6 23.1 59.8 102.5 94.4 46.8 61.4 131.5 164.8 102.0 75.7 72.3 69.9 78.7 103.3 38.3 63.8 66.5 189.4 74.2 101.2 98.0 58.2 ECD "GCR2, hSGT1" ENSG00000122882 "Ecdysoneless cell cycle regulator" O95905 10 73130155-73169055 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006465 Approved Supported Nucleoplasm,Cytosol Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA006465: AB_2667595" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (2.19e-1)" "unprognostic (2.75e-2)" "unprognostic (4.71e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.22e-1)" "unprognostic (3.55e-2)" "unprognostic (6.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (7.05e-2)" "unprognostic (3.84e-2)" 13.8 17.2 8.0 14.6 11.2 31.9 17.9 12.7 10.7 14.8 10.2 13.1 12.1 16.0 16.2 15.2 11.9 15.9 12.8 8.5 7.7 17.4 18.9 12.6 17.7 7.4 7.1 13.9 16.7 22.8 11.3 17.8 7.5 16.5 13.9 17.0 14.4 14.3 13.8 15.3 11.7 14.7 7.2 14.4 13.1 19.2 7.6 21.0 19.0 14.3 18.4 20.0 12.5 12.5 41.0 28.8 32.0 48.1 28.8 28.2 26.3 31.1 48.5 49.9 57.8 52.0 41.4 31.8 29.9 30.5 36.7 33.0 34.6 36.9 50.3 26.1 33.5 39.9 21.2 38.0 43.7 48.3 25.3 31.5 30.9 41.6 51.7 37.9 53.3 29.3 42.1 21.4 47.6 34.8 44.5 28.6 33.0 37.7 81.8 32.1 35.6 17.6 40.4 29.5 13.9 26.5 28.4 62.5 40.3 32.6 36.1 23.0 33.3 21.1 42.8 23.3 36.2 25.2 18.1 54.5 40.1 40.4 18.5 21.0 23.3 26.3 24.7 24.9 26.4 24.3 23.0 24.4 20.3 21.2 29.9 21.5 27.5 32.5 34.7 13.8 24.8 20.3 8.0 11.2 12.7 10.7 8.5 7.7 7.4 7.1 7.5 7.2 7.6 12.5 21.2 28.9 12.1 13.1 22.7 11.0 27.9 16.6 24.5 13.9 11.9 10.3 12.5 8.6 23.0 7.3 25.0 22.7 22.7 9.0 7.9 15.8 39.4 15.3 15.5 17.4 10.8 21.8 17.3 12.2 15.7 15.7 23.4 24.8 19.6 12.2 15.0 8.8 16.6 20.2 16.3 11.8 8.2 12.4 10.1 11.5 15.8 16.0 14.2 9.4 10.8 10.3 14.4 11.6 18.6 14.7 5.7 13.2 16.7 13.1 9.8 12.2 10.5 13.1 6.6 17.8 18.2 32.9 16.0 19.2 10.9 33.2 22.1 11.6 9.2 24.7 EFL1 "EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1" ENSG00000140598 "Elongation factor like GTPase 1" Q7Z2Z2 15 82130233-82262734 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Elongation factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 9.2;Glandular and luminal cells: 9.5;Granulosa cells: 16.0;Pancreatic endocrine cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039654, HPA047110, HPA052345" Uncertain Approved Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794" "unprognostic (2.53e-1)" "unprognostic (2.04e-1)" "unprognostic (9.92e-3)" "unprognostic (8.99e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" "unprognostic (2.64e-3)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (4.75e-3)" "unprognostic (3.56e-2)" "unprognostic (3.14e-1)" "prognostic favorable (1.50e-6)" "unprognostic (8.58e-2)" "unprognostic (2.96e-1)" "unprognostic (2.60e-1)" "unprognostic (7.05e-2)" 6.2 7.4 5.0 8.2 5.3 8.8 9.9 4.9 5.4 7.3 6.7 13.3 11.6 7.1 7.5 8.3 7.7 7.0 7.3 4.6 5.4 8.6 9.3 6.9 9.6 5.0 5.1 4.9 6.2 14.7 4.6 6.9 5.7 7.2 16.5 7.2 6.7 6.8 11.6 9.0 12.8 8.8 4.8 7.0 8.3 11.2 5.3 16.6 7.8 12.4 10.8 8.1 7.2 6.0 9.8 24.5 18.0 14.9 11.7 16.1 11.6 28.0 33.1 19.9 26.1 12.2 16.7 24.0 11.4 21.4 25.2 24.9 47.5 18.5 31.8 21.8 23.1 26.8 20.2 9.3 18.3 17.0 18.3 7.9 28.9 20.5 46.0 23.7 27.0 30.8 20.5 10.8 23.6 14.1 22.5 13.9 16.0 17.5 12.6 23.8 26.4 13.3 14.1 29.7 15.8 16.8 17.7 20.5 21.6 30.7 15.6 15.1 22.9 28.1 18.5 71.6 28.6 13.4 54.9 20.1 25.1 32.2 10.5 23.1 5.7 14.6 8.6 8.2 6.9 9.4 8.0 7.5 7.0 9.9 6.9 6.0 1.0 6.5 9.9 3.3 7.9 4.8 5.0 5.3 4.9 5.4 4.6 5.4 5.0 5.1 5.7 4.8 5.3 6.0 4.1 3.2 5.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.7 3.9 0.0 0.0 4.3 0.0 0.0 7.1 5.5 0.0 3.9 6.8 0.0 9.2 5.1 1.4 0.0 0.0 0.0 6.0 4.0 2.5 0.0 9.5 5.1 16.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.4 0.0 0.0 5.5 7.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 6.8 2.9 4.9 0.0 0.0 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772605-43777315 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 57.7;skin 1: 25.0" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 10.5;naive B-cell: 15.9" "Lineage enriched" "Detected in many" 7 "B-cells: 15.9" "Cell line enhanced" "Detected in many" "Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9" "Region enriched" "Detected in single" 11 "olfactory bulb: 1.9" "Not detected" "Not detected" "HPA028938, HPA073494" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA028938: AB_10795352, HPA073494: " "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.5 0.9 1.0 9.7 1.0 0.2 5.2 1.0 1.1 1.6 4.7 8.0 14.1 0.6 1.1 4.5 3.9 0.7 0.5 1.0 1.1 1.4 0.7 1.5 49.7 1.0 1.1 1.7 0.4 1.6 0.5 3.7 1.1 2.0 12.3 0.1 2.2 1.0 0.4 25.0 12.9 1.0 1.0 1.0 1.8 16.2 1.4 1.5 0.7 1.9 57.7 0.7 0.8 1.1 2.1 0.2 0.6 1.1 4.9 1.2 0.4 0.2 1.3 2.8 3.1 0.0 1.3 73.8 0.1 1.2 0.1 13.7 1.3 0.7 1.4 1.6 7.3 0.4 2.6 4.6 1.0 0.1 0.0 1.4 12.3 0.7 0.2 0.2 1.1 0.4 0.2 0.0 0.7 4.0 1.5 1.4 0.1 28.5 2.4 0.8 0.0 0.0 1.8 0.0 9.5 0.0 1.7 21.5 0.0 0.3 39.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 149.9 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 10.5 0.6 0.1 0.0 15.9 1.1 0.2 0.0 0.1 0.0 2.2 0.6 0.6 1.0 1.0 1.0 1.1 1.0 1.1 1.0 1.1 1.1 1.0 1.4 1.1 0.1 0.0 0.0 0.0 2.2 0.4 0.1 0.2 5.2 0.0 0.7 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.3 1.2 0.0 0.1 1.8 0.4 0.1 0.2 0.0 0.4 0.1 0.7 0.0 0.5 4.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.5 0.0 0.0 0.5 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 6.5 0.1 3.1 0.0 0.0 0.2 0.4 0.2 0.2 21.0 1.0 0.3 0.1 0.1 2.3 0.2 ELOVL5 "dJ483K16.1, HELO1, SCA38" ENSG00000012660 "ELOVL fatty acid elongase 5" Q9NYP7 6 53267398-53349179 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017042, HPA047752, HPA054197" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 35: Glandular cells - Unknown function" "Endoplasmic reticulum" "CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413" "unprognostic (7.33e-2)" "unprognostic (5.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.16e-1)" "unprognostic (5.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.19e-1)" "unprognostic (4.38e-2)" "unprognostic (1.43e-2)" "unprognostic (3.23e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (1.58e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (6.80e-4)" "unprognostic (2.76e-2)" 242.4 134.7 51.3 74.9 67.0 114.6 199.2 74.6 79.2 48.9 49.4 40.0 28.3 39.8 49.7 28.4 46.0 51.3 37.8 50.8 65.3 38.9 108.9 68.4 106.7 80.7 69.0 32.3 15.4 24.3 28.5 40.2 74.5 128.0 18.3 36.5 24.8 103.0 9.9 32.9 47.5 52.4 67.7 56.1 22.8 82.5 65.8 107.3 45.1 19.5 102.4 67.1 27.0 98.9 137.2 98.1 168.0 309.0 436.0 250.8 71.3 155.8 174.2 123.2 171.5 87.4 154.5 154.4 110.3 163.3 193.1 78.9 168.0 142.6 183.7 131.2 117.5 153.1 85.0 122.9 239.0 122.2 107.2 233.6 109.8 123.6 153.9 124.5 139.1 301.4 194.2 87.3 90.3 14.9 364.4 107.9 91.2 5.2 73.6 139.9 115.3 54.3 232.7 80.6 155.7 107.1 129.3 66.9 135.2 108.7 152.3 112.9 133.0 134.7 118.5 242.2 208.8 72.8 72.1 116.2 70.2 173.6 97.8 47.6 49.2 183.7 34.9 34.9 56.5 88.4 58.1 42.7 77.9 101.5 27.8 26.3 261.5 36.7 45.0 20.4 110.0 50.6 51.3 67.0 74.6 79.2 50.8 65.3 80.7 69.0 74.5 67.7 65.8 98.9 48.6 80.1 50.7 75.4 118.3 52.4 108.2 36.8 44.3 11.6 177.3 70.9 23.3 21.5 40.2 12.9 2.1 25.3 55.5 2.1 15.6 34.9 94.2 37.4 53.2 54.4 25.0 77.0 25.8 36.1 58.2 54.8 3.1 66.4 99.0 28.4 39.3 88.7 35.5 8.4 29.8 1.6 16.2 57.3 114.6 181.0 20.8 55.5 48.0 39.4 53.5 83.2 39.1 49.3 111.2 27.8 1.4 32.0 45.2 169.2 21.9 48.4 58.5 6.0 65.7 27.3 77.5 27.0 18.9 35.7 60.9 31.2 97.2 60.0 4.4 73.4 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.4;epididymis: 6.3;testis: 5.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "basophil: 18.6" "Lineage enriched" "Detected in single" 33 "granulocytes: 18.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 0.5 0.3 0.2 1.7 0.3 4.4 0.6 0.1 0.4 0.5 0.0 0.9 0.8 0.4 6.3 1.1 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.4 2.3 0.3 0.2 0.5 0.2 0.1 0.1 1.4 0.3 0.2 1.3 0.4 0.5 0.1 0.2 1.1 0.7 0.6 0.1 0.9 0.5 5.7 0.3 3.3 0.2 0.0 2.6 0.4 0.5 0.4 13.9 20.0 26.2 13.7 1.2 2.6 18.8 14.2 5.4 19.3 17.7 31.7 11.0 11.0 18.3 5.7 12.0 10.7 24.5 11.3 27.3 21.7 19.3 26.3 23.3 14.8 0.1 10.9 8.4 0.5 0.8 22.3 9.2 2.6 4.5 31.2 16.3 25.6 11.6 15.2 25.0 13.9 15.1 14.2 13.6 25.5 50.7 15.4 4.3 5.6 10.1 20.2 8.7 4.8 8.1 20.9 16.8 12.3 3.1 24.8 14.9 16.6 19.7 16.0 17.4 10.5 7.8 12.2 15.6 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.3 0.1 0.4 0.1 0.1 0.3 0.2 0.3 0.1 0.3 0.4 0.1 0.0 1.1 0.3 0.8 0.1 0.3 0.5 0.6 1.5 0.5 0.3 0.4 0.0 0.7 0.0 0.0 4.6 0.5 0.6 0.0 0.3 0.5 0.8 0.7 0.4 0.0 3.8 0.1 0.0 4.8 0.8 2.0 0.5 0.0 4.5 0.0 0.3 2.2 0.0 0.1 0.9 0.0 0.0 1.4 0.6 0.6 0.8 0.0 0.0 1.0 0.5 1.0 0.0 0.3 0.1 0.0 0.0 2.5 0.1 0.1 0.0 0.9 0.3 0.0 0.6 1.0 13.2 9.1 1.5 0.1 1.1 0.5 0.6 1.3 0.2 EMSY C11orf30 ENSG00000158636 "EMSY transcriptional repressor, BRCA2 interacting" Q7Z589 11 76444923-76553025 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012234, HPA050777" Supported Supported Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB012234: AB_449325, HPA050777: AB_2681232" "unprognostic (1.69e-2)" "unprognostic (8.15e-2)" "unprognostic (1.51e-3)" "unprognostic (3.66e-2)" "unprognostic (2.60e-2)" "unprognostic (1.54e-2)" "unprognostic (3.32e-2)" "unprognostic (3.87e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "unprognostic (8.47e-2)" "unprognostic (5.37e-2)" "unprognostic (2.99e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (6.64e-2)" "unprognostic (8.74e-2)" 6.8 5.8 4.6 7.7 7.5 13.1 8.7 15.3 8.6 8.1 6.9 7.6 5.2 10.0 7.6 6.1 8.6 6.4 9.0 4.9 8.0 7.3 5.6 9.0 8.9 6.0 5.9 11.4 8.8 9.8 5.7 12.2 6.7 7.7 8.7 17.8 7.1 7.7 9.3 5.7 6.6 10.1 4.3 7.9 6.6 8.7 6.3 13.3 8.2 12.6 8.4 7.3 7.4 12.3 8.6 11.9 26.8 16.5 9.9 9.8 11.8 13.5 13.3 17.3 18.9 20.3 11.5 11.7 12.7 14.7 14.3 16.8 21.9 13.0 26.6 18.7 8.2 18.2 18.5 8.8 6.3 20.0 15.8 8.9 8.5 19.8 16.3 11.0 15.8 19.6 12.9 20.0 14.1 22.8 26.9 12.0 11.7 26.9 15.6 17.1 49.2 16.4 12.0 10.0 16.7 7.3 19.0 12.8 4.1 16.5 25.9 12.2 11.9 16.2 21.8 42.0 9.6 11.1 12.8 33.1 5.4 12.0 12.1 11.9 3.5 7.5 4.5 3.3 4.3 4.3 4.3 5.5 2.6 4.9 3.9 3.7 7.3 3.6 2.7 4.2 4.7 3.0 4.6 7.5 15.3 8.6 4.9 8.0 6.0 5.9 6.7 4.3 6.3 12.3 14.0 16.0 7.8 0.0 15.1 0.0 7.5 0.0 17.1 19.7 12.1 10.2 0.0 2.8 6.2 12.9 35.5 15.6 14.0 4.8 13.7 6.2 1.8 13.7 14.0 10.7 7.3 13.5 0.0 4.3 7.7 9.2 10.2 10.1 2.5 17.2 12.8 7.3 8.6 15.2 0.0 12.0 0.0 7.9 0.0 2.0 11.5 9.0 0.0 0.0 7.3 8.9 14.4 0.0 0.0 5.9 4.4 12.4 20.1 14.1 8.4 10.1 6.6 22.8 13.1 11.5 10.6 25.8 12.3 15.0 0.0 21.1 13.3 12.3 8.1 11.7 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 80.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 42.2" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 136.3;K-562: 136.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebellum: 105.6" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 1100000 "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 11.0 10.2 1.8 21.9 18.3 63.3 14.1 42.2 6.0 14.5 4.9 23.6 17.7 10.2 5.3 16.6 6.3 15.0 9.7 1.2 4.7 12.7 21.7 15.1 37.4 8.2 5.6 16.3 18.8 15.5 4.7 7.2 8.5 15.0 23.1 80.0 19.1 9.1 15.9 15.3 23.3 9.9 3.5 22.9 27.0 10.4 4.7 69.0 15.2 13.8 37.0 15.5 1.9 3.0 27.0 6.9 62.3 29.4 5.2 0.8 19.5 6.9 10.1 8.4 10.5 16.8 31.2 49.1 17.2 9.2 13.5 11.9 78.7 6.6 8.6 86.4 23.8 136.3 19.7 28.6 10.1 45.8 88.2 1.7 18.4 8.2 13.8 19.9 14.1 73.5 136.5 36.2 0.1 8.8 72.3 30.4 62.0 44.1 10.0 110.9 28.2 68.3 7.7 33.3 78.0 60.5 19.7 19.2 43.3 21.7 14.7 18.2 1.2 0.3 13.3 12.9 13.4 52.5 72.4 85.2 12.1 47.8 6.8 33.3 3.2 21.4 12.9 1.1 15.4 17.2 18.3 14.1 4.4 13.6 22.1 12.7 44.2 10.9 1.5 4.4 28.9 15.3 1.8 18.3 42.2 6.0 1.2 4.7 8.2 5.6 8.5 3.5 4.7 3.0 25.3 19.2 71.7 20.2 58.2 10.5 8.6 7.8 15.4 151.6 20.0 12.2 21.5 20.0 16.8 16.5 137.6 2.4 75.3 26.5 17.6 17.1 16.4 11.3 4.1 15.1 41.6 187.1 76.3 18.7 4.2 7.9 29.6 29.1 24.1 24.9 17.5 30.0 7.1 21.9 61.7 29.0 16.2 23.7 9.0 22.7 2.1 32.4 0.0 78.7 29.3 15.7 85.5 7.5 4.8 28.6 20.3 2.2 46.7 12.2 32.8 13.4 15.2 171.4 13.1 2.8 8.5 39.3 55.7 14.9 16.8 4.1 71.6 4.2 33.0 12.6 EPC2 DKFZP566F2124 ENSG00000135999 "Enhancer of polycomb homolog 2" Q52LR7 2 148644440-148787569 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 125.7;Oligodendrocytes: 99.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036759 Uncertain Approved "Nuclear speckles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 44: Endometrium - Transcription" "Nuclear speckles" "HPA036759: AB_10672365" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "unprognostic (2.83e-3)" "unprognostic (2.59e-2)" "unprognostic (1.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.47e-2)" "unprognostic (3.86e-2)" "unprognostic (2.29e-1)" "unprognostic (6.21e-2)" "unprognostic (5.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.54e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" 16.4 14.0 9.6 13.5 10.9 50.3 17.2 22.0 13.4 18.2 7.8 12.4 9.7 25.5 14.1 12.2 15.3 15.3 15.5 9.9 11.3 12.9 12.7 14.6 18.0 9.6 9.9 31.9 9.8 12.1 9.9 18.5 9.9 16.2 13.9 14.0 11.5 15.5 15.9 11.7 10.5 19.1 9.7 15.9 12.0 14.2 11.5 23.1 19.3 18.5 15.9 15.6 14.0 14.5 9.2 7.0 23.8 14.8 15.7 19.5 17.9 15.9 21.4 25.3 21.2 14.1 12.0 19.8 7.8 18.7 10.9 12.1 20.7 12.7 31.1 17.6 15.4 38.9 11.0 19.8 16.0 29.7 22.7 20.5 22.1 25.8 25.3 15.6 15.9 15.9 20.9 33.4 16.0 14.7 20.2 19.8 24.3 8.7 13.6 20.7 22.1 18.2 12.7 25.6 32.5 23.6 19.6 12.0 29.8 16.6 7.7 25.8 19.2 20.2 17.7 14.0 13.6 20.3 17.0 25.0 16.0 17.4 21.9 0.1 0.9 1.2 0.9 0.7 1.3 0.8 1.4 0.8 0.9 0.8 1.5 1.1 4.5 0.3 2.0 1.0 1.4 0.5 9.6 10.9 22.0 13.4 9.9 11.3 9.6 9.9 9.9 9.7 11.5 14.5 24.2 25.6 13.6 60.1 21.1 14.0 26.4 4.8 4.0 19.6 15.4 17.1 22.0 8.6 15.1 9.2 6.2 11.3 27.5 8.4 3.9 9.1 28.5 23.5 25.9 17.0 18.0 15.8 79.2 8.8 11.7 20.7 8.6 27.3 6.3 15.6 7.9 5.0 8.6 8.4 75.3 9.2 2.0 16.1 10.2 5.5 23.9 17.7 12.4 70.3 11.3 14.1 20.6 125.7 99.3 9.3 9.1 23.0 10.7 20.3 6.3 6.7 9.8 15.7 13.1 44.4 25.4 19.3 18.6 7.8 15.6 20.1 25.2 16.3 8.1 23.6 ERCC6L2 "C9orf102, FLJ37706, HEBO, RAD26L" ENSG00000182150 "ERCC excision repair 6 like 2" Q5T890 9 95871264-96121154 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 105.8;Excitatory neurons: 90.1;Inhibitory neurons: 88.5;Oligodendrocyte precursor cells: 130.7;Oligodendrocytes: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021259, HPA021260, HPA021271, HPA022422" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Cytosol" "HPA021259: AB_1859542, HPA021260: AB_1859544, HPA021271: AB_1859543, HPA022422: " "unprognostic (6.70e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-1)" "unprognostic (1.28e-1)" "unprognostic (8.30e-2)" "unprognostic (3.62e-2)" "unprognostic (4.64e-2)" "unprognostic (3.92e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.32e-1)" "prognostic favorable (8.70e-5)" "unprognostic (3.63e-1)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (7.39e-2)" 3.2 3.8 3.3 2.6 4.6 5.1 4.1 5.8 4.2 4.4 3.6 4.0 2.6 4.7 3.5 3.2 3.2 3.4 2.9 4.3 3.8 3.8 3.6 3.2 4.4 3.3 3.4 5.0 2.9 5.5 2.1 3.8 4.1 4.3 3.5 5.4 2.8 4.1 3.7 3.0 2.7 4.2 3.0 4.7 4.2 4.5 3.4 6.8 5.5 3.8 3.9 3.4 2.7 6.9 5.4 8.5 8.3 9.0 5.2 4.3 3.7 5.9 7.8 8.1 5.9 8.9 4.4 6.6 2.6 9.5 10.5 8.0 12.0 5.0 8.6 3.9 3.8 8.2 7.5 5.4 4.8 9.4 6.0 5.2 2.9 8.2 6.0 3.4 6.0 7.9 8.2 3.7 4.5 6.4 8.2 4.9 6.0 6.1 5.1 6.3 14.5 2.7 5.3 5.7 7.7 6.0 5.8 4.3 4.1 4.9 5.6 4.0 7.6 8.1 6.7 9.3 6.8 3.0 4.0 3.6 6.5 5.8 7.0 1.2 1.9 2.0 3.7 1.7 4.8 2.6 4.2 3.9 2.0 4.3 5.1 5.1 1.5 2.7 3.0 5.4 3.2 1.1 3.3 4.6 5.8 4.2 4.3 3.8 3.3 3.4 4.1 3.0 3.4 6.9 20.2 16.0 16.2 105.8 13.8 5.0 12.6 7.2 12.5 0.0 6.6 6.2 18.8 8.6 13.5 0.0 0.0 6.3 18.3 7.5 0.0 8.8 7.8 9.0 32.4 12.9 4.9 12.4 90.1 8.2 3.5 19.3 11.7 11.3 15.2 24.9 8.6 6.6 6.3 0.0 88.5 8.4 6.1 11.1 3.8 3.8 26.8 10.8 3.6 62.8 13.7 0.0 12.3 130.7 117.9 8.3 4.5 27.8 13.5 9.7 7.2 4.0 15.5 0.0 19.7 26.1 19.9 17.0 11.1 12.2 4.4 4.8 15.7 45.9 6.4 9.5 ERI1 "3'HEXO, THEX1" ENSG00000104626 "Exoribonuclease 1" Q8IV48 8 9002147-9116746 "Predicted intracellular proteins" "RNA-mediated gene silencing, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033838, HPA055548, HPA056074" Uncertain Approved Vesicles,Microtubules NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules Vesicles "CAB033838: AB_2098575, HPA055548: AB_2682845, HPA056074: AB_2683029" "unprognostic (2.49e-1)" "unprognostic (1.13e-1)" "prognostic favorable (8.05e-5)" "unprognostic (1.96e-2)" "unprognostic (2.79e-2)" "unprognostic (2.61e-3)" "unprognostic (1.08e-3)" "unprognostic (2.90e-1)" "unprognostic (5.50e-2)" "unprognostic (1.49e-1)" "unprognostic (1.25e-3)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.27e-2)" "unprognostic (3.57e-1)" "unprognostic (8.75e-2)" "unprognostic (2.36e-2)" 5.3 3.1 3.1 6.5 3.8 13.0 4.8 3.7 4.1 4.3 3.5 3.8 4.7 4.7 2.5 4.3 3.9 3.9 2.8 3.0 3.5 4.2 4.4 5.1 7.4 4.5 3.9 4.2 3.0 4.2 2.5 6.7 3.7 3.2 4.6 11.3 3.8 3.2 2.4 3.2 3.8 5.1 3.8 5.0 3.6 9.1 3.8 6.9 2.9 2.7 7.4 6.2 3.5 4.1 32.3 19.9 17.2 13.1 13.4 21.7 23.5 27.4 14.4 19.6 24.1 14.8 14.4 36.7 7.0 15.7 32.7 11.2 15.1 18.5 27.3 15.1 10.8 20.3 15.8 11.5 13.7 15.6 28.6 12.9 6.1 16.3 14.4 10.9 26.8 21.6 23.3 22.6 22.8 10.5 47.2 19.3 20.0 24.2 12.1 20.1 25.1 13.7 25.2 45.6 2.4 18.8 16.4 12.5 13.8 12.1 9.3 13.9 23.2 20.7 21.4 39.5 21.6 4.9 18.1 31.9 15.3 22.2 16.5 6.4 4.6 3.4 4.2 5.1 4.3 5.3 4.9 4.4 3.9 3.9 3.8 3.6 3.3 6.0 3.5 2.9 9.8 3.5 3.1 3.8 3.7 4.1 3.0 3.5 4.5 3.9 3.7 3.8 3.8 4.1 9.2 3.2 8.1 17.6 9.7 18.2 9.6 6.7 3.4 17.4 8.6 5.0 5.7 2.8 10.1 3.7 14.6 25.3 11.3 7.4 3.9 9.0 46.9 14.8 14.4 8.6 3.6 18.7 11.4 12.0 27.6 9.1 8.6 23.3 8.2 7.7 11.4 4.8 13.5 5.0 9.7 5.2 8.2 9.7 15.9 16.7 6.5 12.9 10.6 9.4 11.9 8.0 6.2 9.5 16.7 11.2 5.6 9.1 11.2 6.3 4.3 8.2 9.1 21.6 13.1 7.8 7.5 43.6 45.6 6.1 10.1 20.8 11.7 5.9 6.8 3.8 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099869 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favorable (5.27e-4)" "unprognostic (1.33e-1)" 31.8 21.4 18.3 25.9 18.4 39.4 30.8 23.1 22.2 32.5 14.7 27.6 20.7 28.7 23.9 27.3 26.4 19.2 20.3 17.7 15.9 21.8 20.0 24.3 31.1 17.2 15.2 35.8 24.0 25.2 26.1 26.1 16.6 25.3 27.6 35.4 25.4 21.0 33.3 37.0 26.1 27.5 13.7 27.4 26.1 23.4 17.9 32.7 23.3 22.6 34.2 24.6 28.4 19.1 66.4 41.5 84.9 33.0 44.3 48.7 48.5 63.8 46.8 109.8 99.1 61.6 94.1 66.3 40.3 61.0 48.8 64.2 95.0 71.2 100.1 74.9 95.0 96.5 80.5 63.2 43.4 79.5 73.7 38.4 60.2 108.1 63.1 40.9 69.4 58.0 103.2 59.3 61.4 37.4 78.5 73.1 56.5 50.3 49.1 79.8 72.2 58.1 64.8 33.3 54.5 53.3 68.8 58.9 77.0 59.4 51.5 72.1 63.6 58.2 60.4 53.0 76.2 35.7 60.0 130.0 59.4 116.2 71.5 57.7 32.0 26.6 36.2 41.5 43.0 36.4 37.7 36.7 37.9 36.5 31.9 35.4 6.2 49.3 51.2 19.3 39.4 43.3 18.3 18.4 23.1 22.2 17.7 15.9 17.2 15.2 16.6 13.7 17.9 19.1 18.4 28.9 18.3 17.0 26.1 13.3 14.3 19.8 26.2 14.9 11.0 23.6 6.4 12.8 29.2 5.5 47.9 26.5 18.8 16.4 9.8 25.0 16.4 14.3 21.0 20.1 9.0 28.0 20.3 31.9 34.3 17.2 31.1 19.2 20.2 26.2 13.9 11.1 24.7 21.9 24.3 16.5 22.4 15.1 14.1 7.1 29.5 18.7 12.4 9.4 24.0 6.1 28.8 30.2 15.2 30.2 9.4 23.0 26.8 8.5 12.7 8.8 27.3 34.8 13.1 18.4 17.6 21.9 20.8 28.7 13.4 22.7 21.2 19.7 20.1 10.0 FADD "GIG3, MORT1" ENSG00000168040 "Fas associated via death domain" Q13158 11 70203296-70207390 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 75.0;Ductal cells: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 331.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001464, CAB010209" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Cytosol" "CAB010209: AB_2100622, HPA001464: AB_1848348" "unprognostic (2.08e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (6.91e-2)" "unprognostic (9.51e-2)" "unprognostic (3.89e-1)" "prognostic unfavorable (8.22e-5)" "unprognostic (7.25e-3)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" "unprognostic (2.45e-3)" "unprognostic (2.78e-3)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "prognostic favorable (3.45e-4)" "unprognostic (7.29e-2)" 9.8 13.8 10.6 14.0 10.5 8.8 13.6 10.9 10.1 13.1 10.6 14.8 14.1 12.6 17.6 14.3 13.2 12.1 8.4 9.9 10.8 14.2 16.0 10.6 16.9 12.6 10.8 12.5 8.2 9.1 6.4 15.3 11.6 9.2 12.8 4.0 11.3 13.4 10.9 12.5 13.9 10.3 11.2 13.2 14.8 5.7 11.4 20.3 11.3 9.0 16.9 11.4 9.2 11.3 331.2 54.7 26.6 24.3 31.6 25.4 23.8 55.3 43.6 47.5 31.6 47.1 52.3 48.7 51.9 37.1 44.8 47.7 26.3 49.3 36.8 45.7 28.8 22.3 30.6 24.3 28.5 28.0 28.4 25.4 34.5 51.4 64.7 38.1 45.3 26.7 37.0 24.4 42.1 48.5 34.4 49.5 42.1 75.1 89.1 26.3 64.3 47.0 46.8 24.1 23.5 22.3 41.0 38.0 117.1 30.3 41.3 30.7 51.0 36.6 35.7 56.7 53.9 33.8 27.8 28.6 53.2 28.0 52.6 37.1 36.2 28.2 41.7 38.4 47.5 38.7 44.1 48.9 37.1 33.9 44.6 40.7 88.6 37.7 45.3 33.7 45.7 36.1 10.6 10.5 10.9 10.1 9.9 10.8 12.6 10.8 11.6 11.2 11.4 11.3 7.8 0.0 5.3 0.7 12.1 11.9 14.8 18.1 6.2 6.8 14.0 15.7 0.1 14.3 7.7 18.4 0.0 75.0 9.3 22.9 21.5 55.9 0.7 7.3 11.7 15.6 2.4 19.8 1.4 34.7 37.3 10.0 12.8 10.6 1.3 13.8 14.6 8.5 31.2 3.3 1.6 14.3 0.0 11.0 8.8 2.4 13.4 10.8 32.0 2.8 20.9 10.0 18.6 0.5 1.4 49.0 15.3 16.6 9.6 11.8 24.5 33.7 5.4 4.1 0.0 5.2 14.5 10.4 14.2 14.4 10.5 30.8 13.3 18.9 17.4 14.4 FAF2 "ETEA, KIAA0887, UBXD8, UBXN3B" ENSG00000113194 "Fas associated factor family member 2" Q96CS3 5 176447628-176510074 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065968, HPA071246, HPA073828" Approved Enhanced "Endoplasmic reticulum,Lipid droplets" NA NA 12000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Lipid droplets" "Endoplasmic reticulum" "HPA065968: AB_2685589, HPA071246: AB_2732176, HPA073828: AB_2686636" "unprognostic (6.25e-3)" "unprognostic (9.61e-2)" "unprognostic (3.52e-3)" "unprognostic (1.02e-3)" "unprognostic (4.74e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (1.38e-4)" "unprognostic (6.02e-2)" "unprognostic (2.68e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (2.74e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.56e-3)" "unprognostic (1.48e-1)" 15.5 19.7 13.5 15.0 14.1 21.7 17.5 15.0 17.0 16.9 18.1 16.8 15.0 18.6 17.5 16.7 17.3 14.6 11.4 14.0 14.9 14.7 21.0 15.4 16.3 13.5 14.4 20.0 16.2 24.9 14.7 16.7 14.6 18.2 19.2 22.6 16.4 14.7 11.6 19.4 14.7 18.8 13.3 14.9 14.5 21.0 14.7 23.1 19.5 12.8 18.7 18.0 13.1 13.5 36.9 41.1 39.9 44.4 55.4 43.9 54.6 47.2 53.8 52.7 56.6 53.9 64.9 32.1 52.0 50.2 95.6 55.5 57.8 119.6 72.3 128.7 31.8 21.1 40.7 26.4 56.3 46.2 26.4 58.1 51.6 64.5 53.2 34.0 44.3 35.8 30.7 42.6 50.8 61.2 40.6 24.2 32.4 39.8 34.4 39.5 34.7 35.9 44.7 48.0 35.3 37.7 57.5 49.4 52.9 34.1 58.1 36.2 49.9 71.9 38.8 40.1 63.8 36.2 41.6 41.2 45.4 32.5 64.2 9.0 6.8 4.7 6.8 5.6 8.3 4.9 5.6 7.3 8.0 4.8 7.1 6.4 5.6 9.2 12.1 5.3 9.8 5.7 13.5 14.1 15.0 17.0 14.0 14.9 13.5 14.4 14.6 13.3 14.7 13.5 26.4 28.9 54.5 26.8 19.6 5.4 34.4 49.7 16.5 46.3 18.6 18.7 13.4 15.7 44.9 18.4 45.9 34.8 19.2 17.6 11.7 34.0 12.1 24.6 41.0 29.0 19.9 17.5 29.0 37.2 40.8 32.6 23.4 27.6 32.2 32.6 28.2 24.3 22.5 15.2 34.2 15.1 34.6 16.1 8.0 5.6 30.4 17.9 12.4 14.0 23.3 39.6 26.8 31.7 36.1 59.1 12.0 31.2 22.0 32.3 17.3 9.3 41.3 29.9 26.3 36.3 36.6 59.8 51.3 16.6 8.5 57.9 18.4 43.2 17.1 29.0 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" "DNA-binding, Hydrolase, Protease" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favorable (4.39e-4)" 14.8 18.9 7.0 23.1 7.0 20.3 16.0 6.7 9.6 20.8 12.9 17.1 22.5 13.8 17.3 12.8 16.5 18.7 11.6 6.6 7.6 23.7 17.9 25.2 36.1 9.0 7.7 14.6 15.0 16.9 14.3 19.5 8.1 33.2 19.3 9.1 19.0 10.7 5.5 18.8 27.6 10.9 7.8 42.5 22.5 7.1 8.2 42.3 26.6 4.1 30.1 14.8 17.4 8.4 66.0 16.2 7.9 7.5 16.9 21.4 5.1 91.6 50.8 38.5 56.3 24.9 59.0 94.3 37.1 29.7 51.2 21.9 26.9 40.4 47.4 86.0 1.2 36.3 22.7 7.6 17.8 58.7 45.7 14.5 9.6 36.2 11.1 22.0 37.7 57.2 4.8 76.7 42.2 18.0 85.6 36.9 3.5 19.5 17.5 59.9 28.7 22.8 25.4 57.6 0.2 2.3 48.6 38.5 17.5 4.1 80.1 24.7 37.0 61.9 55.5 42.5 42.7 39.0 43.4 15.3 34.3 39.5 75.9 6.0 5.0 4.8 4.2 3.4 5.3 2.6 2.7 3.2 4.6 2.6 2.4 2.5 5.4 5.0 1.9 1.2 3.1 2.2 7.0 7.0 6.7 9.6 6.6 7.6 9.0 7.7 8.1 7.8 8.2 8.4 38.9 64.1 43.7 14.4 27.4 8.5 10.7 21.3 26.2 1.7 24.2 24.3 5.5 14.3 24.7 16.5 0.0 11.1 40.5 20.8 9.8 13.8 0.2 31.5 26.0 25.9 6.0 42.5 0.2 7.7 1.4 22.7 30.5 20.7 27.8 83.9 30.0 8.1 28.2 0.0 0.2 24.8 22.4 31.3 19.5 1.8 13.1 39.2 7.2 21.5 40.2 25.2 47.4 12.1 3.9 7.5 17.6 6.8 29.7 14.2 19.4 10.3 36.9 7.3 0.0 17.0 14.3 0.4 2.1 24.3 8.8 4.4 41.3 48.8 18.6 14.0 FAM117B "ALS2CR13, FLJ38771" ENSG00000138439 "Family with sequence similarity 117 member B" Q6P1L5 2 202634969-202769757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 45.8;Inhibitory neurons: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003229, HPA028746" Uncertain Approved Nucleoplasm,Centrosome Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm Centrosome "HPA003229: AB_2246696, HPA028746: AB_2672760" "unprognostic (1.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (4.59e-2)" "unprognostic (1.07e-2)" "unprognostic (4.07e-3)" "unprognostic (1.55e-2)" "unprognostic (4.84e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (8.40e-3)" "unprognostic (5.75e-1)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (3.18e-1)" "unprognostic (8.59e-2)" "unprognostic (1.37e-3)" 3.1 7.5 5.1 4.5 5.4 2.9 3.3 7.0 7.1 2.7 0.7 4.9 4.3 2.9 2.9 5.4 3.8 3.0 1.8 5.0 6.3 4.9 1.9 2.9 7.2 3.1 3.8 5.1 4.6 7.3 3.5 6.9 3.6 5.1 4.7 2.6 3.3 3.0 1.5 5.0 3.7 2.0 3.3 5.4 4.1 5.8 6.4 9.6 2.8 1.8 7.4 3.8 3.2 4.1 2.0 2.4 10.5 7.2 3.5 1.9 10.2 0.6 0.9 0.6 1.1 3.1 4.2 8.2 6.5 1.2 1.6 1.9 9.0 4.6 1.7 0.2 7.2 6.9 4.3 11.6 2.8 5.9 3.0 2.6 6.3 1.3 1.9 4.7 2.8 10.8 10.1 1.6 0.6 3.9 16.1 12.1 10.7 5.8 4.5 12.5 2.1 9.8 5.5 5.2 17.7 15.4 8.0 5.3 3.9 8.7 2.2 8.1 1.7 1.2 2.4 1.9 1.1 5.9 3.6 10.8 2.4 4.5 1.3 0.4 3.9 1.5 1.3 8.2 3.4 8.1 3.0 2.7 4.5 7.7 8.2 5.7 2.2 4.4 9.1 1.5 1.2 3.1 5.1 5.4 7.0 7.1 5.0 6.3 3.1 3.8 3.6 3.3 6.4 4.1 9.7 3.2 7.5 13.1 21.5 17.2 2.9 3.0 12.0 4.9 8.1 4.3 4.9 12.8 2.6 18.4 4.2 8.4 8.8 11.7 0.0 10.2 2.2 8.6 6.5 4.9 25.8 3.0 45.8 6.4 6.3 6.1 7.1 10.1 5.7 15.3 8.2 2.2 2.8 6.7 49.7 11.8 2.0 27.4 13.9 1.4 13.1 17.1 3.6 23.4 17.1 1.7 3.1 29.1 29.4 5.8 9.7 23.7 5.2 6.7 4.9 5.9 3.0 2.7 6.6 2.0 4.1 5.0 16.3 29.2 19.9 2.7 10.1 11.1 13.8 6.0 FAM122C RP3-473B4.1 ENSG00000156500 "Family with sequence similarity 122C" Q6P4D5 X 134796395-134854835 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 12.5" "Cell type enhanced" "Detected in many" "Early spermatids: 57.8;Granulosa cells: 39.0;Theca cells: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059961 Approved Uncertain Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA059961: AB_2684181" "unprognostic (1.32e-2)" "unprognostic (3.50e-2)" "unprognostic (7.63e-2)" "unprognostic (3.38e-3)" "unprognostic (1.08e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-1)" "unprognostic (3.76e-3)" "unprognostic (3.50e-2)" "unprognostic (7.20e-3)" "unprognostic (2.28e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-2)" "unprognostic (5.93e-2)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (4.16e-3)" 2.3 1.8 2.1 2.6 1.9 5.8 1.2 2.7 3.5 1.7 4.0 1.8 0.9 3.8 1.8 1.8 2.5 1.8 1.5 2.0 2.0 1.5 1.8 2.1 4.3 2.1 1.7 12.5 0.7 1.5 1.5 1.6 1.8 1.8 1.6 5.7 4.0 1.6 1.6 1.7 1.4 3.1 1.7 3.9 2.8 6.1 1.7 4.3 1.6 1.4 2.2 2.0 1.1 3.3 1.1 1.3 4.1 4.2 1.0 1.6 2.4 3.6 3.1 3.2 4.3 3.0 4.2 1.4 5.3 1.5 6.8 1.6 3.4 1.3 2.3 3.7 1.4 2.5 15.3 1.3 1.2 3.8 2.1 1.6 0.6 3.1 1.9 2.0 2.7 11.0 10.8 8.1 2.3 6.5 3.9 3.1 2.2 1.1 3.1 6.7 2.8 3.2 1.0 0.9 1.6 2.8 2.2 0.6 3.4 2.9 1.0 1.0 0.8 1.9 1.2 2.9 2.3 3.0 3.0 6.1 2.6 4.2 2.1 1.8 1.2 3.5 1.1 1.4 1.2 2.3 1.3 1.7 0.9 1.6 1.6 1.4 2.1 2.2 3.0 3.3 1.2 0.9 2.1 1.9 2.7 3.5 2.0 2.0 2.1 1.7 1.8 1.7 1.7 3.3 2.9 6.4 4.5 14.7 4.8 1.3 2.1 1.8 0.0 4.1 1.9 1.9 2.1 0.0 2.9 1.8 14.6 1.7 2.9 1.7 1.9 1.3 57.8 4.4 3.9 6.5 1.2 6.9 6.7 1.8 2.7 4.3 6.6 6.9 12.7 39.0 7.5 0.9 2.2 3.3 7.0 3.0 0.0 4.1 3.0 9.6 4.1 3.4 3.6 12.2 3.8 3.8 3.1 11.1 12.1 1.9 1.7 2.2 5.9 1.5 4.5 1.7 8.8 14.1 0.0 3.2 3.9 10.4 2.6 1.5 1.1 1.9 11.7 35.5 1.8 2.8 FAM126B "HYCC2, MGC39518" ENSG00000155744 "Family with sequence similarity 126 member B" Q8IXS8 2 200973718-201071671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 164.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in all" 4 "neutrophil: 25.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 25.7" "Cell line enhanced" "Detected in all" "U-266/84: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036166, HPA036167, HPA067307" Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Cell Junctions" Nucleoplasm "HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821" "unprognostic (7.47e-3)" "unprognostic (5.54e-2)" "unprognostic (2.52e-1)" "unprognostic (9.08e-2)" "unprognostic (8.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.11e-2)" "unprognostic (2.61e-3)" "unprognostic (1.34e-1)" "unprognostic (1.48e-2)" "unprognostic (1.79e-2)" "unprognostic (1.90e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" 7.8 4.5 4.7 6.3 5.2 17.4 4.8 15.9 8.1 4.0 2.3 7.2 6.8 3.9 4.0 8.2 3.2 4.3 3.4 6.5 3.1 7.8 7.4 5.4 5.9 3.3 3.2 3.8 4.9 4.9 3.8 5.0 3.3 3.7 6.4 10.4 4.3 2.7 3.0 7.1 6.6 3.9 0.6 6.8 7.5 4.5 5.2 5.9 6.9 3.6 6.1 3.8 4.4 6.1 5.4 2.8 3.9 4.2 4.0 5.3 8.2 5.0 3.0 4.0 3.7 7.2 6.2 4.9 4.8 5.1 3.7 6.5 8.1 3.1 6.0 7.1 4.9 14.3 7.6 6.7 3.3 17.6 11.9 2.3 3.9 5.5 3.3 3.1 3.9 5.2 13.4 17.6 4.1 3.3 10.5 11.4 2.8 3.5 4.7 6.1 5.9 4.6 3.7 5.9 7.7 3.8 5.3 6.0 4.7 5.1 4.2 7.7 7.9 7.5 5.3 3.7 4.6 13.1 58.8 10.5 4.3 6.7 5.4 2.6 1.8 6.3 3.8 2.4 4.0 2.6 3.2 3.0 1.6 2.7 3.1 3.7 25.7 3.1 2.7 1.1 2.4 1.9 4.7 5.2 15.9 8.1 6.5 3.1 3.3 3.2 3.3 0.6 5.2 6.1 21.5 28.9 23.9 45.1 29.3 52.6 10.7 17.0 23.3 52.9 16.3 9.4 17.2 27.1 20.4 20.2 164.7 16.6 38.3 59.1 17.6 10.6 9.1 12.7 16.4 22.7 37.1 23.1 113.4 10.5 10.1 15.9 24.5 16.2 24.7 19.9 35.3 21.0 12.0 26.9 98.3 23.4 22.4 33.9 51.6 6.6 31.7 21.1 30.2 45.0 41.5 20.3 73.2 57.8 64.6 21.3 31.1 25.6 34.0 13.2 47.3 16.4 23.1 42.7 19.7 14.8 15.9 32.8 22.9 31.6 74.2 17.4 35.6 15.3 22.0 19.6 FAM13B "ARHGAP49, C5orf5, FAM13B1, KHCHP, N61" ENSG00000031003 "Family with sequence similarity 13 member B" Q9NYF5 5 137937960-138051961 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 140.6;Inhibitory neurons: 140.0;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 227.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036525, HPA041819, HPA071936" Uncertain Approved Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA036525: AB_10696655, HPA041819: AB_2677690, HPA071936: AB_2686474" "unprognostic (8.09e-2)" "unprognostic (1.27e-1)" "unprognostic (2.34e-3)" "unprognostic (9.61e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "unprognostic (1.44e-2)" "unprognostic (2.02e-3)" "unprognostic (6.51e-2)" "unprognostic (6.31e-2)" "unprognostic (1.69e-2)" "unprognostic (3.60e-1)" "prognostic favorable (3.55e-5)" "unprognostic (9.56e-2)" "unprognostic (4.46e-1)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" 13.4 22.6 14.4 15.7 18.5 24.0 15.9 18.7 15.7 15.4 7.9 14.1 9.8 22.4 14.0 14.0 14.7 14.8 20.6 13.8 22.0 13.7 8.6 13.7 21.4 14.8 14.3 24.6 9.5 15.6 8.7 16.2 15.9 24.4 12.2 12.6 11.3 35.7 4.4 11.1 10.9 32.4 8.9 17.8 11.6 34.0 21.3 17.7 15.1 7.6 23.4 17.1 11.6 18.7 18.1 9.0 26.2 21.6 34.3 10.7 20.6 39.1 31.7 29.3 33.8 24.1 16.0 40.7 12.8 34.3 37.4 13.8 16.3 12.6 38.0 30.9 17.6 18.3 21.7 7.6 11.6 30.0 24.3 13.7 6.9 22.4 13.0 15.4 10.2 14.6 10.7 20.2 27.4 13.3 30.5 16.4 10.4 14.0 10.7 21.7 26.1 8.1 17.7 31.6 29.6 26.0 30.5 9.3 38.8 37.6 25.4 30.2 13.5 31.3 13.5 23.2 29.9 16.2 42.2 38.2 17.6 24.3 27.3 10.7 2.2 8.6 4.6 3.3 3.9 5.3 3.3 4.2 1.7 5.6 3.4 4.5 7.1 6.0 5.9 2.9 3.5 1.7 14.4 18.5 18.7 15.7 13.8 22.0 14.8 14.3 15.9 8.9 21.3 18.7 21.2 22.4 19.8 63.6 56.7 15.4 15.7 10.0 64.9 19.4 23.2 20.7 43.3 14.3 15.2 5.5 20.9 12.4 44.9 8.7 3.9 6.8 40.8 28.1 25.2 17.8 10.3 18.5 140.6 3.5 4.0 21.7 16.8 36.0 30.4 29.2 18.9 5.4 13.9 11.8 140.0 9.9 6.1 24.6 28.9 30.5 16.1 31.2 12.4 73.1 17.6 5.9 28.8 130.2 227.6 6.4 7.0 25.6 37.5 12.5 7.6 5.6 12.9 15.2 26.3 29.8 24.8 29.9 21.7 39.6 13.8 5.2 46.9 49.6 8.4 12.8 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles NA NA 20000 "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 12.7 11.4 9.5 12.8 10.2 9.8 12.9 16.4 12.6 9.7 7.2 15.4 9.6 13.3 9.0 9.0 8.1 7.0 12.4 10.8 10.9 13.1 7.8 8.1 13.8 9.4 9.7 11.2 6.1 19.3 6.4 12.0 10.0 12.1 11.6 19.8 6.3 10.0 13.8 8.8 10.0 9.5 10.1 11.2 9.5 8.5 9.6 28.6 11.7 16.3 13.3 11.9 7.0 12.6 30.7 16.2 77.7 40.0 14.1 25.7 37.9 38.6 28.2 37.4 37.5 35.8 14.4 21.1 41.4 32.2 37.9 31.8 47.4 39.5 52.2 21.8 25.7 62.6 33.9 27.8 20.4 59.8 34.6 23.9 24.1 33.3 38.5 27.4 38.9 45.7 45.6 25.7 36.0 13.8 50.7 31.8 42.0 34.8 22.3 53.3 42.0 17.7 32.8 39.9 47.8 48.9 42.5 27.0 19.8 34.6 33.0 36.6 32.7 42.1 51.5 28.2 44.0 47.6 46.1 78.3 23.1 38.9 44.8 2.3 0.5 1.4 2.8 0.4 2.4 1.6 2.8 2.3 0.6 1.9 3.4 2.6 0.4 2.2 0.6 1.4 1.9 0.4 9.5 10.2 16.4 12.6 10.8 10.9 9.4 9.7 10.0 10.1 9.6 12.6 17.9 16.0 21.4 16.3 16.8 14.7 12.7 14.1 14.2 36.8 15.2 11.6 48.9 12.8 18.1 16.5 16.7 30.6 16.4 11.0 7.9 16.4 3.4 19.1 21.5 16.9 12.6 16.6 22.5 19.8 22.4 16.6 16.8 17.0 13.3 18.4 16.8 13.1 12.6 20.2 20.5 22.6 12.2 15.8 12.2 2.5 12.5 10.9 5.4 18.7 21.4 18.5 21.6 12.1 23.8 14.3 9.8 17.0 18.2 12.4 11.1 12.7 18.8 27.9 6.6 21.5 16.2 27.2 17.1 19.7 14.8 21.5 15.3 14.7 19.3 14.1 FANCF FAF ENSG00000183161 "FA complementation group F" Q9NPI8 11 22622533-22625823 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Distal tubular cells: 45.0;Early spermatids: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008899 Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA008899: " "unprognostic (1.16e-2)" "unprognostic (4.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.37e-2)" "unprognostic (4.55e-2)" "unprognostic (8.84e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (4.29e-2)" "unprognostic (1.11e-1)" "unprognostic (2.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (3.73e-2)" "unprognostic (1.81e-1)" "unprognostic (9.14e-2)" "unprognostic (7.64e-3)" 2.1 3.8 3.8 5.6 3.8 2.8 5.2 4.1 3.9 4.9 6.1 5.6 7.9 3.9 8.5 2.8 8.9 3.2 3.6 3.5 4.2 5.0 4.2 3.4 8.2 4.2 4.3 6.1 8.1 4.9 3.7 3.0 3.9 4.6 5.9 5.1 6.1 4.8 1.2 5.1 7.6 2.5 4.1 6.3 7.1 4.9 4.6 9.3 5.6 1.1 7.7 3.5 2.1 4.5 2.3 6.7 8.6 9.5 4.5 5.4 3.5 4.3 5.3 5.0 5.5 4.3 3.5 11.3 1.2 4.5 8.9 9.6 7.2 7.5 2.5 18.5 3.3 4.3 2.7 7.0 5.2 8.0 4.6 5.2 14.1 1.7 7.7 8.5 8.1 15.9 10.9 13.8 3.2 7.0 20.4 7.5 9.8 19.2 8.4 17.0 4.1 12.8 9.7 8.7 32.0 15.1 2.4 7.7 7.8 9.2 15.5 7.1 5.7 5.0 5.1 9.3 6.4 8.0 11.0 3.4 8.1 3.2 11.8 12.3 7.6 16.8 15.3 8.1 18.0 16.1 14.3 14.9 9.2 20.9 19.3 16.2 1.1 15.0 8.7 13.5 10.7 10.6 3.8 3.8 4.1 3.9 3.5 4.2 4.2 4.3 3.9 4.1 4.6 4.5 4.7 3.2 2.2 2.3 13.9 3.3 6.2 8.8 6.8 15.2 7.1 6.0 5.7 18.6 6.3 3.7 10.4 11.6 15.3 10.2 45.0 18.8 168.1 14.1 6.8 6.3 3.5 8.0 2.6 18.7 7.5 5.4 10.7 6.8 2.5 9.6 6.4 10.7 6.9 16.8 3.3 16.5 10.2 6.9 2.6 25.5 9.6 6.7 5.4 5.6 11.3 13.1 22.6 0.5 6.2 10.7 10.3 9.8 7.1 5.6 13.2 22.5 24.4 18.0 6.6 3.2 5.3 23.1 16.7 10.1 2.3 2.3 11.2 11.1 15.8 2.4 FBLN7 "FLJ37440, TM14" ENSG00000144152 "Fibulin 7" Q53RD9 2 112138385-112188218 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 14.4;Fibroblasts: 16.6;Inhibitory neurons: 30.7;Melanocytes: 17.8;Skeletal myocytes: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 26 "memory CD4 T-cell: 34.4;naive CD4 T-cell: 29.5;T-reg: 36.5" "Lineage enriched" "Detected in many" 35 "T-cells: 36.5" "Cell line enhanced" "Detected in many" "AF22: 24.5;BJ hTERT+: 17.7;hTERT-RPE1: 12.8;SCLC-21H: 15.8;SH-SY5Y: 12.6;U-2197: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034992 Approved "Plasma membrane,Cell Junctions" "Secreted to extracellular matrix" NA NA 310000 "Cluster 20: T-cells - T-cell receptor" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Cell Junctions" "HPA034992: AB_10601469" "unprognostic (1.72e-1)" "unprognostic (1.47e-1)" "unprognostic (5.88e-2)" "unprognostic (4.88e-3)" "unprognostic (1.24e-1)" "unprognostic (1.70e-3)" "unprognostic (4.34e-2)" "unprognostic (4.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (7.91e-2)" "unprognostic (2.02e-2)" "unprognostic (2.35e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-2)" "unprognostic (1.21e-2)" "unprognostic (9.33e-2)" 6.5 4.0 0.8 4.3 0.6 0.7 7.8 4.0 6.4 10.3 0.4 1.8 1.1 4.8 2.8 1.9 7.1 3.4 2.5 2.1 3.8 1.5 5.2 2.7 9.8 9.2 4.4 1.4 2.4 6.9 12.2 3.2 9.7 3.3 1.3 2.5 2.5 3.1 1.4 5.5 2.9 2.2 2.2 5.6 3.0 0.5 4.1 8.6 10.7 2.5 6.0 2.5 7.5 1.1 0.0 0.1 24.5 0.0 2.6 1.9 0.1 5.5 17.7 5.9 9.2 0.0 0.2 0.0 0.1 8.3 1.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.9 1.1 1.2 0.0 0.0 1.9 0.1 9.9 0.0 12.8 1.4 0.3 0.0 0.0 2.1 0.0 0.7 0.1 0.6 0.0 0.5 0.0 0.0 6.6 0.3 0.0 15.8 12.6 0.1 0.1 0.7 0.1 0.7 0.2 5.2 0.8 0.7 25.4 0.8 0.0 0.0 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.4 0.0 1.3 0.0 34.4 0.4 0.0 0.0 29.5 1.0 0.0 0.0 0.0 1.0 36.5 6.2 0.8 0.6 4.0 6.4 2.1 3.8 9.2 4.4 9.7 2.2 4.1 1.1 1.4 3.2 0.5 0.3 0.7 4.5 1.0 0.3 0.0 3.8 1.0 2.4 1.1 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.0 0.3 1.7 1.2 5.9 2.6 0.0 0.0 14.4 0.2 10.1 16.6 0.0 1.2 1.3 0.7 0.4 2.2 0.5 3.3 30.7 0.0 0.0 0.0 4.0 3.6 0.3 0.4 17.8 1.9 0.0 2.3 0.0 6.6 0.9 0.6 0.0 5.3 0.1 0.4 0.1 0.5 0.3 7.6 6.6 19.3 7.8 0.1 0.4 0.1 3.8 1.5 7.7 0.2 0.0 0.3 FBXL3 "FBL3, FBL3A, FBXL3A" ENSG00000005812 "F-box and leucine rich repeat protein 3" Q9UKT7 13 76992598-77027195 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053283, HPA065626" Enhanced "Nuclear bodies" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 6: Erythroid cells - Oxygen transport" "Nuclear bodies" "HPA053283: AB_2682100, HPA065626: AB_2685523" "unprognostic (3.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.55e-2)" "unprognostic (7.24e-2)" "unprognostic (9.92e-2)" "unprognostic (1.01e-1)" "unprognostic (2.75e-1)" "unprognostic (2.23e-1)" "unprognostic (5.12e-2)" "unprognostic (8.70e-2)" "unprognostic (2.81e-1)" "unprognostic (4.24e-2)" "unprognostic (1.10e-3)" "unprognostic (8.52e-2)" "unprognostic (1.43e-1)" "unprognostic (1.97e-1)" "unprognostic (2.78e-1)" 45.7 25.0 17.9 24.0 20.4 69.1 42.6 23.5 26.1 31.7 12.4 27.4 24.0 31.4 23.1 27.9 27.4 24.2 25.1 17.1 17.5 37.8 31.4 29.8 32.7 17.6 17.4 44.6 20.8 29.7 9.7 32.5 18.3 29.9 25.1 21.1 22.9 26.2 30.0 30.5 25.0 27.8 18.5 31.3 22.2 30.0 17.0 36.2 48.0 37.9 31.4 25.4 23.1 28.1 43.4 11.1 21.4 14.8 50.7 50.1 17.0 48.6 39.6 28.3 36.0 16.0 30.1 27.9 31.6 43.1 17.1 31.9 21.4 26.1 40.4 55.7 56.8 36.2 32.9 14.3 33.6 46.7 26.9 42.5 34.2 22.6 31.0 33.1 37.7 15.3 14.0 20.8 34.0 15.8 33.7 25.0 8.2 37.0 20.1 27.3 24.3 17.0 30.2 22.7 25.2 20.5 31.0 30.0 28.4 14.5 16.6 51.1 46.7 27.1 17.8 18.6 23.9 26.5 32.9 25.6 46.9 33.1 30.0 8.0 1.9 4.6 2.1 2.9 2.9 2.6 3.8 2.2 1.9 2.8 4.5 3.1 5.2 2.1 3.1 2.0 5.1 1.4 17.9 20.4 23.5 26.1 17.1 17.5 17.6 17.4 18.3 18.5 17.0 28.1 35.9 44.8 22.2 31.6 48.9 67.3 38.0 17.0 50.1 25.1 36.5 21.6 21.6 12.8 15.4 22.0 10.4 33.0 42.4 54.8 41.1 17.9 41.2 26.8 29.0 38.3 23.9 50.7 30.4 18.8 41.7 42.8 17.3 34.7 28.5 20.4 32.2 28.5 23.3 37.0 29.8 23.9 22.4 36.1 41.5 24.6 74.6 33.3 42.7 37.5 36.5 45.4 20.6 33.7 58.1 19.1 25.7 74.9 33.6 40.2 38.3 29.2 19.9 24.3 59.2 46.1 52.7 52.5 58.9 40.9 56.1 28.5 44.9 22.7 23.1 38.5 FCF1 "Bka, C14orf111, CGI-35, UTP24" ENSG00000119616 "FCF1 rRNA-processing protein" Q9Y324 14 74713144-74738620 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 104.7;Smooth muscle cells: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046681 Approved Approved Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA046681: AB_10960541" "unprognostic (1.39e-2)" "unprognostic (1.54e-1)" "unprognostic (5.74e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (5.54e-6)" "unprognostic (3.17e-1)" "unprognostic (3.43e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (7.79e-2)" "prognostic favorable (2.26e-4)" "unprognostic (3.30e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (1.47e-1)" 32.5 23.1 9.9 25.4 12.7 27.0 34.9 12.7 13.0 30.5 11.5 28.6 18.9 29.2 20.9 24.9 38.4 22.0 26.8 9.4 12.1 30.1 32.8 27.9 34.4 12.5 12.7 39.9 16.5 26.6 12.9 32.1 12.8 28.2 29.3 13.2 19.9 30.6 25.3 17.3 20.5 30.2 11.3 23.5 23.0 18.4 11.4 33.2 43.3 22.4 41.3 29.2 19.0 17.4 109.3 78.7 55.8 63.5 86.8 76.3 73.5 93.6 71.7 91.4 81.2 88.1 87.3 97.2 59.6 82.1 44.2 78.5 94.1 88.5 160.7 90.6 40.8 67.4 46.4 57.9 62.6 83.1 59.5 60.3 76.6 97.3 101.4 72.4 86.6 82.7 82.2 56.9 83.3 77.5 97.0 29.6 75.0 63.2 90.5 72.9 109.5 46.3 46.4 88.1 39.1 56.9 120.1 62.8 55.0 61.4 80.7 57.0 79.9 72.7 77.6 69.5 108.3 49.9 140.7 147.7 69.2 77.5 82.5 13.5 17.0 20.5 19.1 15.3 21.0 24.3 18.4 16.6 13.9 21.2 19.5 20.5 14.7 15.3 18.8 31.3 19.6 9.2 9.9 12.7 12.7 13.0 9.4 12.1 12.5 12.7 12.8 11.3 11.4 17.4 11.9 6.4 18.3 7.5 18.8 3.1 7.6 10.5 11.4 7.5 12.2 7.5 24.0 34.3 14.9 12.9 6.2 11.8 26.6 16.3 15.6 17.4 23.8 28.0 18.5 13.7 10.2 36.2 11.6 19.0 14.7 13.3 6.1 13.5 26.0 9.3 28.5 104.7 12.8 11.8 11.7 15.9 8.2 33.6 4.3 11.9 15.5 12.6 0.0 7.5 16.4 13.5 24.7 11.6 17.5 17.4 10.3 17.0 12.0 6.1 13.1 18.4 45.4 7.2 13.1 12.5 67.7 12.4 12.3 11.1 4.8 8.8 14.3 8.2 15.6 6.7 FDXACB1 "hCG_2033039, LOC91893" ENSG00000255561 "Ferredoxin-fold anticodon binding domain containing 1" Q9BRP7 11 111874056-111881243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.1;Late spermatids: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039012, HPA061375" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA039012: AB_10670916, HPA061375: " "unprognostic (2.91e-2)" "unprognostic (3.32e-3)" "unprognostic (1.32e-2)" "unprognostic (6.81e-7)" "unprognostic (1.32e-1)" "unprognostic (9.64e-2)" "unprognostic (2.05e-1)" "unprognostic (7.11e-3)" "unprognostic (3.95e-2)" "unprognostic (7.42e-2)" "unprognostic (3.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (6.57e-2)" "unprognostic (4.42e-1)" "unprognostic (4.61e-2)" "unprognostic (1.79e-2)" 1.1 1.9 0.9 1.9 1.0 2.0 2.1 0.8 1.2 1.7 0.7 1.4 1.6 1.4 2.4 1.1 1.5 1.0 0.9 1.0 1.2 1.5 1.6 1.7 3.1 1.0 1.0 1.5 1.5 1.6 0.9 1.2 0.9 1.2 1.7 0.7 0.8 0.9 0.7 2.7 1.5 1.1 1.0 2.4 1.0 3.1 1.2 1.7 1.3 0.8 3.2 1.6 0.8 1.1 1.4 1.9 2.1 5.3 2.0 1.8 1.2 1.1 1.2 1.2 1.2 2.4 3.1 5.5 2.7 1.0 1.5 4.3 2.6 2.5 2.7 6.9 1.1 6.1 1.1 1.8 1.2 6.4 5.3 1.5 1.5 1.7 2.2 1.0 2.2 6.5 4.4 6.4 2.3 1.8 6.0 6.2 1.4 6.0 2.7 3.6 1.6 6.5 2.8 2.5 1.0 1.6 1.5 3.2 1.4 1.2 4.5 3.9 1.7 2.5 2.7 3.0 2.6 3.6 5.5 14.1 1.6 9.1 3.7 0.3 2.3 1.5 5.0 3.7 6.5 4.6 4.4 4.4 3.8 3.8 6.5 7.5 0.7 4.8 3.0 3.6 2.5 3.7 0.9 1.0 0.8 1.2 1.0 1.2 1.0 1.0 0.9 1.0 1.2 1.1 2.2 6.4 0.6 0.7 3.1 0.8 1.3 4.2 1.2 3.0 1.6 1.4 1.6 0.0 3.0 0.0 0.0 3.4 1.3 1.2 5.9 2.5 37.1 1.5 1.2 1.8 2.4 0.8 1.0 3.3 1.9 1.3 1.1 0.9 1.3 2.2 2.2 1.8 4.0 1.7 1.3 1.4 4.1 1.3 1.2 14.2 3.1 2.0 0.0 1.9 2.2 3.2 4.1 1.0 1.2 2.1 0.5 0.4 1.6 1.9 0.9 2.3 1.6 2.5 6.6 1.1 1.2 7.5 9.1 1.0 1.3 2.2 2.6 3.8 1.6 0.8 FIG4 "ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3" ENSG00000112367 "FIG4 phosphoinositide 5-phosphatase" Q92562 6 109690609-109878098 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.5;Oligodendrocyte precursor cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017823, HPA068859" Approved Supported "Vesicles,Lipid droplets" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Lipid droplets" "CAB017823: , HPA068859: AB_2686049" "prognostic unfavorable (5.91e-4)" "unprognostic (4.12e-2)" "prognostic favorable (8.42e-4)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.73e-4)" "unprognostic (7.06e-2)" "unprognostic (2.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.44e-3)" "unprognostic (4.22e-2)" "prognostic favorable (8.19e-4)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (5.45e-2)" "unprognostic (2.00e-2)" 9.3 10.2 5.5 7.1 7.2 5.6 8.1 5.9 7.7 8.2 12.9 10.1 5.0 8.5 7.8 9.4 7.2 7.6 7.7 6.0 8.8 9.5 6.1 13.4 10.1 6.4 7.3 8.2 7.5 17.4 11.9 8.8 8.9 7.7 9.5 10.8 10.7 7.8 10.6 7.6 9.1 10.3 5.6 13.8 8.7 8.2 6.1 12.3 9.3 8.3 10.1 9.2 8.4 7.0 8.3 8.4 11.7 14.9 11.8 17.2 7.8 9.9 14.1 8.3 23.2 4.6 7.2 23.2 5.8 18.9 14.9 5.2 12.6 8.5 20.7 13.3 16.5 10.9 5.9 5.5 11.4 9.5 10.0 8.8 9.9 12.8 10.6 22.8 18.3 13.9 6.8 8.8 12.7 6.8 12.0 8.4 5.9 12.0 4.7 7.9 6.1 7.3 13.3 18.4 12.8 11.7 7.1 10.7 21.1 15.6 6.0 23.1 11.2 4.2 3.8 5.4 9.5 3.4 2.6 7.9 27.3 8.5 4.6 15.4 24.9 14.2 8.8 24.5 7.7 18.9 6.3 8.5 19.2 21.2 7.5 7.5 7.4 10.0 15.2 8.1 9.4 11.7 5.5 7.2 5.9 7.7 6.0 8.8 6.4 7.3 8.9 5.6 6.1 7.0 4.9 16.0 9.0 24.5 15.7 4.6 7.1 7.3 5.2 8.8 5.4 3.3 6.7 2.8 6.9 9.2 2.1 13.4 9.5 7.0 5.9 9.8 18.0 7.5 5.3 5.2 10.2 3.0 49.5 11.4 7.0 6.0 8.2 7.9 8.8 8.6 7.1 4.1 23.3 1.7 32.4 8.6 8.2 19.2 6.8 17.7 3.4 17.3 8.8 29.0 16.4 8.5 11.3 46.8 37.4 7.6 6.3 6.8 6.5 4.0 6.3 8.2 9.1 7.6 0.0 5.1 6.6 5.5 12.1 8.3 4.4 12.3 9.3 5.6 6.4 8.9 FIGNL1 ENSG00000132436 "Fidgetin like 1" Q6PIW4 7 50444128-50542535 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA055542 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "HPA055542: AB_2682841" "unprognostic (4.62e-2)" "unprognostic (8.76e-2)" "unprognostic (3.99e-3)" "unprognostic (1.18e-2)" "unprognostic (1.18e-1)" "unprognostic (8.73e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.15e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.62e-2)" "unprognostic (3.11e-1)" "unprognostic (4.79e-2)" "prognostic unfavorable (9.54e-7)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" 4.5 4.1 4.0 8.4 4.9 8.7 8.8 6.2 5.3 5.4 1.6 6.2 6.8 8.5 4.7 9.0 4.8 4.5 3.9 4.3 4.2 3.5 4.7 3.3 10.3 4.4 3.9 11.3 2.7 3.8 2.5 5.2 4.9 5.9 6.4 9.7 3.8 4.4 6.5 8.6 6.3 9.9 3.9 7.7 4.2 7.2 4.4 10.2 3.7 8.0 13.3 3.6 4.9 5.7 12.9 25.8 33.0 36.1 7.4 13.3 21.1 43.8 22.3 46.0 50.9 40.6 28.5 49.1 22.9 13.1 38.3 43.6 35.3 21.9 73.0 42.0 26.5 21.8 53.7 14.2 4.5 52.5 33.4 6.1 10.7 30.4 15.6 7.3 48.8 22.1 51.5 30.0 35.3 19.1 32.1 38.8 30.2 48.6 30.4 29.8 28.5 17.9 14.3 32.7 37.6 29.2 16.3 35.5 16.6 15.4 34.8 17.4 19.0 0.1 19.2 55.9 36.4 50.5 56.5 38.1 14.7 47.2 73.4 0.0 1.1 0.8 1.7 2.0 3.0 3.4 2.0 3.4 1.2 4.0 3.0 2.9 0.6 3.8 6.1 1.2 4.1 1.5 4.0 4.9 6.2 5.3 4.3 4.2 4.4 3.9 4.9 3.9 4.4 5.7 3.4 0.0 0.5 3.9 7.8 4.1 1.9 3.2 8.6 10.8 4.3 3.9 17.2 2.8 2.3 1.8 6.2 7.0 6.0 1.7 3.9 3.0 1.1 3.3 5.6 4.4 0.0 17.9 11.0 1.2 9.8 5.7 2.6 6.0 2.5 21.3 3.9 2.1 4.6 10.1 7.6 1.3 4.1 2.9 4.2 1.4 11.5 2.9 3.6 4.7 4.4 6.0 7.2 6.6 11.1 2.3 2.8 9.4 8.6 0.7 1.5 2.2 0.8 14.9 0.0 6.0 4.3 27.6 20.4 7.7 3.0 1.4 5.5 9.9 4.0 1.2 FMR1 "FMRP, FRAXA, MGC87458, POF, POF1" ENSG00000102081 "FMRP translational regulator 1" Q06787 X 147911919-147951125 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Disease variant, Mental retardation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012444, HPA050118, HPA056084" Approved Enhanced Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 44: Endometrium - Transcription" Cytosol "CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033" "unprognostic (4.11e-1)" "unprognostic (1.25e-3)" "unprognostic (1.89e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (6.45e-3)" "unprognostic (2.59e-2)" "unprognostic (1.26e-2)" "unprognostic (2.29e-2)" "unprognostic (3.30e-2)" "unprognostic (3.15e-3)" "unprognostic (6.56e-2)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (5.98e-2)" 18.1 16.5 22.3 20.6 24.1 43.5 18.3 29.6 29.2 18.8 16.1 19.1 17.5 27.3 41.0 17.0 22.8 15.9 20.1 21.7 21.0 34.0 39.6 20.1 22.7 21.9 21.1 27.7 13.3 29.6 13.5 31.2 21.3 16.5 18.9 27.6 14.1 21.4 9.5 23.2 19.7 21.1 22.7 27.7 17.8 19.6 22.9 24.6 30.6 11.6 21.7 16.7 14.7 23.4 44.9 39.6 41.2 27.2 24.4 19.4 31.9 23.8 24.9 37.6 66.4 43.5 42.1 89.5 93.5 29.8 43.3 74.4 65.8 30.2 42.0 34.9 45.2 25.3 71.3 41.4 24.0 28.3 15.1 21.2 16.2 31.6 28.8 22.6 31.8 24.4 15.9 57.7 32.7 59.0 32.0 20.3 18.2 30.9 21.8 34.7 116.8 37.6 43.2 119.3 35.1 23.3 26.8 24.4 35.7 55.4 21.8 24.9 30.4 30.5 25.5 37.7 60.0 61.1 65.5 94.5 27.4 46.9 16.3 2.0 1.3 3.4 2.7 1.6 3.5 2.6 1.8 3.1 1.7 2.4 2.3 2.7 3.5 2.5 1.6 1.3 2.4 1.3 22.3 24.1 29.6 29.2 21.7 21.0 21.9 21.1 21.3 22.7 22.9 23.4 35.3 57.7 26.6 26.8 22.1 31.4 16.0 12.6 21.1 37.5 20.7 17.4 43.2 14.3 23.9 22.0 12.5 37.2 37.1 27.2 19.6 14.7 1.0 36.4 42.5 27.2 14.9 10.7 33.3 9.8 43.5 27.2 17.9 49.3 19.7 36.8 17.5 37.5 15.4 70.7 32.2 13.8 18.3 25.4 15.7 3.0 30.1 23.7 35.6 29.0 16.8 40.0 11.3 28.6 33.9 13.5 18.1 29.7 20.3 22.7 20.7 42.6 23.4 30.0 6.6 37.2 33.3 14.9 20.9 28.1 32.4 40.8 24.1 39.4 16.9 34.7 FUBP1 "FBP, FUBP" ENSG00000162613 "Far upstream element binding protein 1" Q96AE4 1 77944055-77979110 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006149 Supported Enhanced Nucleoplasm NA NA 300000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA006149: AB_1849172" "unprognostic (4.17e-2)" "unprognostic (2.83e-2)" "unprognostic (3.35e-3)" "unprognostic (3.89e-2)" "unprognostic (3.77e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.83e-9)" "unprognostic (2.32e-2)" "unprognostic (2.16e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-3)" "unprognostic (9.80e-3)" "unprognostic (9.02e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (6.24e-2)" "unprognostic (9.46e-2)" 29.6 37.8 13.4 35.5 15.3 79.6 30.9 24.0 17.9 28.1 18.5 24.3 24.9 36.4 36.8 24.8 28.5 16.8 29.7 13.8 15.9 39.3 17.1 31.6 42.8 15.6 13.4 46.9 33.7 23.0 41.7 23.0 15.7 24.1 27.5 57.2 30.5 13.3 33.8 27.5 27.5 19.0 15.1 35.2 26.1 17.0 15.3 35.7 36.9 15.2 38.6 25.3 27.4 24.3 49.4 36.5 106.9 40.0 11.9 19.0 77.6 53.5 23.4 35.8 29.2 34.7 49.1 91.3 22.1 31.9 49.1 51.4 54.8 45.4 48.1 91.6 38.5 58.8 87.4 56.9 25.8 104.9 22.8 25.2 35.5 39.7 36.4 39.6 29.2 59.1 65.8 45.1 31.0 39.0 74.0 60.4 75.7 38.0 26.2 94.6 78.7 30.9 35.2 49.0 54.2 61.1 41.5 42.8 44.2 44.7 52.9 38.7 50.7 50.7 66.0 14.7 62.5 44.8 39.4 106.1 21.1 45.3 44.5 6.5 10.5 12.3 20.5 17.0 23.3 19.0 19.6 20.8 9.3 14.7 19.4 23.6 5.3 29.4 19.1 15.4 24.5 15.3 13.4 15.3 24.0 17.9 13.8 15.9 15.6 13.4 15.7 15.1 15.3 24.3 38.6 73.7 57.5 48.0 70.7 84.8 107.0 49.5 39.3 44.7 48.7 31.2 76.4 24.3 71.0 33.1 41.7 46.8 68.2 27.1 43.0 59.5 33.3 54.8 50.7 52.0 55.1 43.1 48.8 72.1 66.2 49.0 28.5 60.5 77.8 59.4 30.4 23.4 33.4 18.5 53.6 35.9 36.7 32.1 37.0 19.8 48.1 41.8 39.2 61.8 61.5 32.5 52.5 56.3 88.3 69.2 33.5 30.1 68.9 54.2 23.6 28.9 73.2 40.5 32.9 70.3 65.7 33.2 41.3 40.9 63.1 35.7 72.1 38.0 37.8 72.7 FUCA1 ENSG00000179163 "Alpha-L-fucosidase 1" P04066 1 23845077-23868290 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 181.7;Distal enterocytes: 226.6;Paneth cells: 221.0;Proximal enterocytes: 210.9;Syncytiotrophoblasts: 200.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 165.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046542, HPA056371" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 60000000 "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" Vesicles "HPA046542: AB_2679691, HPA056371: AB_2683108" "unprognostic (6.94e-3)" "unprognostic (6.53e-2)" "unprognostic (2.68e-3)" "prognostic favorable (2.45e-4)" "unprognostic (5.64e-3)" "unprognostic (2.59e-3)" "unprognostic (1.56e-2)" "unprognostic (1.79e-3)" "unprognostic (4.99e-1)" "unprognostic (2.18e-2)" "unprognostic (2.05e-1)" "unprognostic (4.23e-2)" "prognostic favorable (5.70e-13)" "unprognostic (3.75e-2)" "unprognostic (4.35e-2)" "unprognostic (1.54e-2)" "unprognostic (2.13e-3)" 34.2 34.4 8.3 49.8 8.2 7.7 26.3 8.3 11.2 54.5 23.8 124.2 90.3 20.7 113.0 17.0 51.1 46.6 20.6 8.3 10.5 78.2 104.8 55.1 168.2 9.5 8.8 23.8 23.9 56.9 17.6 72.6 9.6 50.2 140.7 5.7 40.8 60.4 15.8 14.9 81.3 26.7 9.3 71.8 63.9 27.7 10.8 26.8 70.6 17.7 94.1 74.9 13.2 12.8 15.9 10.6 2.2 31.9 4.2 0.3 11.0 16.6 34.4 17.1 31.6 14.5 165.1 23.9 40.9 21.3 18.8 9.4 15.3 35.4 22.4 16.9 25.6 19.7 9.2 32.7 14.2 2.0 62.7 15.3 19.7 6.2 8.1 55.2 6.9 13.3 9.3 0.5 20.6 17.5 5.0 17.7 5.4 48.1 16.9 26.9 0.2 26.2 63.5 40.5 10.9 10.6 47.9 18.5 26.2 17.9 13.6 7.8 1.8 5.8 9.0 38.9 5.6 28.5 31.0 8.5 14.5 58.9 9.5 54.8 100.4 51.9 27.2 99.9 23.1 23.8 19.5 22.9 44.0 14.1 18.9 22.0 12.8 44.6 91.1 25.4 21.4 64.8 8.3 8.2 8.3 11.2 8.3 10.5 9.5 8.8 9.6 9.3 10.8 12.8 12.9 25.6 28.6 4.2 10.5 3.6 27.4 99.3 6.8 4.4 22.2 10.4 5.6 40.0 77.8 84.6 0.0 181.7 13.9 226.6 15.6 64.1 61.0 31.5 2.8 11.6 10.8 20.6 5.8 50.3 24.2 16.7 33.1 13.3 8.2 11.1 25.7 42.7 156.4 0.0 6.3 44.4 44.7 121.0 13.5 24.4 23.3 85.4 8.8 2.8 29.6 13.0 10.3 4.0 4.7 34.9 221.0 19.5 8.7 23.6 210.9 40.2 53.7 5.0 6.6 16.7 13.2 109.0 24.8 8.5 2.8 200.6 11.2 34.6 79.5 40.3 FUS "ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS" ENSG00000089280 "FUS RNA binding protein" P35637 16 31180138-31191605 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008784, CAB033036, CAB058691" Supported Supported Nucleoplasm NA NA 480000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181" "unprognostic (3.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.86e-2)" "unprognostic (8.68e-2)" "unprognostic (1.44e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.22e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-3)" "unprognostic (1.12e-3)" "unprognostic (1.87e-1)" "unprognostic (5.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 88.6 47.6 43.6 102.9 48.6 98.9 65.1 50.6 59.2 85.3 27.2 72.5 59.5 102.0 40.9 58.5 99.2 38.8 70.4 46.9 48.6 83.6 54.3 64.8 97.9 44.3 43.0 134.2 57.3 85.0 47.2 58.3 46.9 59.1 62.8 59.4 60.0 70.4 98.6 53.8 62.6 98.1 45.7 69.3 59.4 69.1 44.8 174.1 58.6 86.0 113.2 87.5 63.2 52.1 386.6 337.2 492.6 292.9 128.3 101.7 429.3 504.1 253.1 319.6 238.3 440.7 254.9 579.6 359.3 310.7 349.4 173.0 563.6 421.0 284.3 341.5 304.7 486.6 224.6 445.3 222.7 529.7 348.5 222.4 99.8 437.5 258.9 120.1 295.7 419.6 537.6 204.7 357.0 483.0 446.2 475.5 649.0 307.7 402.0 677.0 535.9 350.1 344.0 265.6 279.1 478.9 344.5 255.7 267.8 314.9 291.8 597.5 276.3 371.5 365.5 242.1 520.5 181.4 350.4 779.0 204.4 364.2 460.9 12.3 38.2 52.8 53.6 67.3 49.9 29.1 36.5 45.9 41.7 35.2 40.3 43.9 35.0 37.3 59.3 50.3 31.0 27.4 43.6 48.6 50.6 59.2 46.9 48.6 44.3 43.0 46.9 45.7 44.8 52.1 414.6 102.5 121.2 58.1 470.7 144.8 345.7 201.0 507.6 272.6 209.8 223.8 102.1 112.9 156.3 104.8 131.3 299.3 488.8 266.8 68.4 183.6 130.8 201.0 366.1 278.4 212.1 188.2 75.4 154.8 398.5 309.0 222.8 309.7 229.7 445.0 174.2 59.1 208.5 201.9 85.9 229.5 132.2 148.4 270.7 51.2 307.3 282.7 165.4 94.6 185.4 230.8 341.9 117.6 122.2 175.7 219.4 215.5 266.6 245.4 205.4 69.7 115.4 266.3 164.3 584.4 344.2 221.0 237.1 443.6 154.3 295.1 518.2 327.9 232.6 281.2 GABPA "E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A" ENSG00000154727 "GA binding protein transcription factor subunit alpha" Q06546 21 25734570-25772460 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003258, CAB004411, HPA028791" Supported Enhanced Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598" "unprognostic (5.50e-2)" "unprognostic (2.40e-1)" "unprognostic (3.74e-2)" "unprognostic (2.68e-1)" "unprognostic (3.98e-2)" "unprognostic (1.17e-2)" "unprognostic (3.01e-1)" "unprognostic (2.73e-1)" "unprognostic (2.56e-2)" "unprognostic (1.76e-1)" "unprognostic (4.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (3.97e-5)" "unprognostic (1.62e-1)" "unprognostic (1.77e-1)" "unprognostic (5.70e-2)" "unprognostic (2.73e-3)" 17.0 13.8 6.8 14.1 9.4 16.0 14.9 7.9 10.2 14.6 7.2 12.5 12.9 18.3 15.1 11.3 12.4 13.4 12.9 6.2 7.1 13.8 19.3 13.3 20.4 7.5 7.6 18.1 10.2 15.3 6.7 24.5 8.1 12.4 13.8 11.5 10.4 10.3 10.6 10.3 13.4 15.3 7.6 18.7 11.8 15.0 7.6 22.1 21.2 16.5 19.5 12.9 10.0 10.3 22.2 9.2 25.8 18.2 25.4 33.9 20.0 17.5 18.7 13.7 13.5 11.4 18.2 45.7 13.4 19.7 13.9 9.7 28.5 17.2 22.7 27.6 26.8 32.9 11.9 10.7 17.1 35.3 21.2 25.1 16.3 18.5 17.2 22.9 25.6 24.9 30.8 27.5 23.2 11.0 37.9 15.1 35.9 23.6 12.5 31.1 37.5 28.7 15.9 14.3 16.0 21.1 30.9 19.5 22.0 15.5 17.2 26.8 26.5 16.9 15.5 18.7 14.8 22.2 20.3 40.3 17.2 26.5 21.1 8.8 4.7 7.4 4.3 5.5 5.8 5.6 5.1 5.3 4.7 5.4 5.9 5.2 5.5 6.7 4.3 2.6 5.8 4.4 6.8 9.4 7.9 10.2 6.2 7.1 7.5 7.6 8.1 7.6 7.6 10.3 43.2 9.6 12.0 14.0 20.7 11.6 12.2 7.0 15.4 7.6 13.0 10.8 9.1 14.3 11.8 22.0 0.0 18.1 18.4 19.0 3.9 7.6 13.2 12.0 22.6 26.3 9.0 11.6 21.0 8.1 12.4 23.7 12.2 14.8 6.3 21.1 27.8 18.7 12.7 13.5 19.6 11.1 6.1 19.0 10.1 3.6 17.7 16.7 7.2 22.5 16.0 23.2 10.3 21.1 43.4 7.9 10.2 22.2 15.3 11.9 11.4 10.4 9.3 10.2 19.7 26.1 18.4 34.0 19.5 12.6 12.6 25.2 19.2 14.2 11.3 14.4 GDAP2 "dJ776P7.1, FLJ20142, MACROD3" ENSG00000196505 "Ganglioside induced differentiation associated protein 2" Q9NXN4 1 117863485-117929621 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046185 Approved Approved "Endoplasmic reticulum" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" "Endoplasmic reticulum" "HPA046185: AB_10960897" "unprognostic (4.12e-2)" "unprognostic (1.40e-1)" "unprognostic (2.64e-1)" "unprognostic (1.82e-2)" "unprognostic (4.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "unprognostic (4.26e-3)" "unprognostic (2.26e-3)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (3.28e-2)" "unprognostic (8.68e-2)" "unprognostic (1.68e-1)" 3.0 2.4 2.3 3.2 2.1 8.0 3.2 3.6 2.7 3.4 3.4 3.8 4.0 2.8 4.0 3.1 2.4 3.2 2.5 2.0 2.3 4.8 5.1 3.4 3.6 2.1 2.6 2.4 4.5 4.9 2.3 4.1 2.4 3.4 4.4 2.9 3.0 3.3 1.8 2.9 4.7 3.0 2.4 4.2 4.4 4.8 2.7 4.1 4.6 2.1 4.4 4.5 3.1 2.9 9.2 5.1 6.1 5.1 6.5 3.1 9.0 5.2 6.8 10.3 9.9 5.4 6.2 3.6 6.2 7.1 7.8 5.3 8.1 6.8 12.6 7.2 4.7 5.4 6.7 5.9 7.7 6.8 6.6 2.5 8.5 12.9 9.9 4.7 6.9 8.1 5.7 7.6 8.6 9.6 6.0 5.5 10.6 6.9 8.8 3.2 16.7 5.3 5.8 9.1 4.6 5.1 6.3 10.7 8.2 18.3 3.7 6.8 4.3 7.3 8.5 8.5 7.1 7.9 6.1 5.1 9.4 4.8 9.1 11.4 6.7 12.6 2.4 7.2 3.8 2.3 2.7 2.9 6.5 2.2 2.4 2.3 6.5 4.1 7.6 1.5 3.6 3.2 2.3 2.1 3.6 2.7 2.0 2.3 2.1 2.6 2.4 2.4 2.7 2.9 9.2 9.6 8.6 27.7 13.5 13.5 6.5 8.1 8.6 13.1 8.1 5.5 7.8 8.6 10.8 3.7 18.8 12.4 11.6 13.4 7.9 10.6 21.2 12.8 9.0 7.6 4.2 13.9 36.7 6.2 11.4 7.7 18.3 11.5 0.0 10.4 6.4 9.0 13.8 15.2 39.1 14.0 14.2 17.2 15.8 5.7 5.9 20.0 10.6 34.7 16.2 9.2 8.2 31.7 35.8 10.7 7.5 7.2 21.0 9.8 17.8 10.2 10.5 13.7 0.0 8.6 10.2 28.4 14.5 14.3 13.8 21.1 13.8 6.7 8.3 9.6 GDI2 RABGDIB ENSG00000057608 "GDP dissociation inhibitor 2" P50395 10 5765223-5842132 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049290, HPA057668" Supported Approved Cytosol NA NA 53000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 3: Monocytes - Immune response regulation" Cytosol "HPA049290: AB_2680700, HPA057668: AB_2683498" "unprognostic (1.08e-2)" "unprognostic (8.33e-3)" "unprognostic (5.25e-2)" "unprognostic (1.13e-1)" "prognostic favorable (9.26e-4)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.56e-7)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-2)" "unprognostic (6.97e-2)" "unprognostic (3.10e-1)" "unprognostic (4.09e-2)" "unprognostic (1.71e-2)" "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" 125.1 111.5 62.4 151.6 70.0 126.6 138.1 76.0 90.3 120.6 66.8 152.9 175.4 96.3 115.3 131.1 96.8 112.6 86.8 59.3 70.7 146.0 241.1 98.3 217.5 85.8 72.7 116.9 165.1 91.3 59.6 135.5 82.6 88.8 160.7 69.1 97.7 92.2 107.0 107.6 160.2 124.1 80.9 138.7 108.6 74.3 65.1 149.1 114.1 99.7 239.2 145.5 81.7 95.4 343.4 245.8 341.1 241.2 298.2 347.5 191.4 325.0 170.8 287.3 312.0 351.8 287.3 553.2 198.2 340.5 88.1 320.8 368.3 289.3 288.0 212.2 174.7 380.0 152.0 428.4 276.9 252.1 230.7 292.6 235.8 249.6 148.9 324.0 400.6 340.1 398.5 203.4 331.6 291.1 390.9 208.0 242.5 355.1 159.3 466.7 181.9 389.8 330.7 250.1 138.0 210.0 257.5 468.5 358.3 289.9 382.3 299.0 342.0 142.3 243.4 420.3 282.2 180.0 314.8 526.5 212.0 275.5 130.0 154.9 280.8 169.0 109.9 347.8 136.4 210.7 136.9 121.6 329.1 204.2 124.8 119.3 138.4 177.5 445.1 146.1 181.5 416.8 62.4 70.0 76.0 90.3 59.3 70.7 85.8 72.7 82.6 80.9 65.1 95.4 101.5 25.6 83.8 31.0 208.1 161.7 131.3 144.8 145.7 37.1 124.5 81.8 76.6 107.2 109.0 57.0 18.8 252.1 148.5 156.6 133.1 185.7 29.5 69.1 138.0 125.4 118.4 177.1 27.7 212.2 312.0 151.5 109.6 84.3 132.5 121.7 121.3 145.9 284.5 92.5 32.1 184.7 91.6 354.2 302.8 40.4 152.2 255.7 149.4 36.5 485.8 75.0 97.9 34.7 49.2 158.1 141.9 141.8 151.3 129.2 271.0 194.1 63.0 36.8 111.7 96.1 125.8 126.2 119.3 177.6 165.1 247.4 120.1 136.9 213.5 131.9 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548615-109600195 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 350.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome NA NA 1400000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 41: Macrophages - Immune response" Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: AB_2677870" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavorable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 12.7 8.2 5.8 14.2 6.1 27.7 11.9 7.3 7.5 10.9 8.6 11.8 10.4 12.1 8.0 21.8 8.0 11.3 4.2 6.0 6.5 11.2 15.3 9.7 14.1 6.7 5.9 8.8 9.3 8.9 1.8 14.8 6.8 10.3 11.8 17.8 7.7 9.0 3.8 18.4 10.6 13.6 6.3 11.4 9.0 8.7 6.2 14.2 8.0 5.5 15.9 15.5 4.0 7.3 48.3 16.4 31.0 17.3 28.4 35.0 25.7 35.3 28.6 36.0 35.5 24.4 16.1 25.3 22.4 37.6 21.6 24.5 30.0 35.3 49.4 29.2 18.0 22.1 26.3 21.9 25.1 34.9 18.8 25.2 30.4 41.3 27.8 24.2 42.8 19.1 29.8 24.2 35.5 32.9 27.3 28.4 31.3 23.0 19.1 19.2 73.6 16.6 37.4 35.4 19.5 34.9 24.7 27.6 39.4 22.8 21.1 30.5 36.7 29.4 40.7 44.9 39.2 25.6 30.2 29.2 47.6 34.4 47.1 32.4 29.7 57.8 21.1 44.3 22.4 20.1 20.4 20.6 31.9 17.1 16.8 19.4 53.8 19.9 44.6 14.2 23.8 36.3 5.8 6.1 7.3 7.5 6.0 6.5 6.7 5.9 6.8 6.3 6.2 7.3 104.0 44.8 31.5 17.0 76.6 151.2 104.3 92.2 63.2 29.9 67.7 45.3 14.3 37.1 61.0 58.8 350.3 80.3 98.8 63.9 64.6 97.9 14.7 65.5 71.5 82.6 84.3 43.8 37.5 101.7 153.7 69.2 55.5 110.9 46.3 50.1 56.7 57.2 107.9 25.2 36.4 72.3 59.0 115.0 106.9 9.4 48.7 127.4 74.7 31.9 102.4 47.9 45.3 35.7 31.3 101.6 58.9 47.4 66.3 72.5 48.9 53.5 51.7 26.2 52.6 59.0 77.6 68.6 54.7 82.1 188.4 106.9 94.3 51.7 63.5 143.0 GON4L "FLJ20203, GON-4, GON4, YARP" ENSG00000116580 "Gon-4 like" Q3T8J9 1 155749659-155859400 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 160.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006986, HPA057305, HPA074504" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear bodies" "HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696" "unprognostic (3.16e-2)" "unprognostic (9.26e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (9.85e-3)" "unprognostic (5.21e-2)" "unprognostic (1.83e-2)" "unprognostic (1.15e-1)" "unprognostic (7.49e-2)" "unprognostic (7.50e-2)" "unprognostic (1.69e-1)" "unprognostic (1.94e-1)" "unprognostic (5.12e-3)" "unprognostic (3.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.26e-2)" "unprognostic (5.83e-2)" 11.3 7.6 4.7 10.7 4.9 9.5 11.4 7.6 5.9 10.1 6.3 10.9 7.4 10.7 10.4 8.3 9.7 7.4 8.4 4.4 4.5 8.9 7.9 10.5 12.3 4.4 6.1 10.1 10.1 10.8 9.5 10.0 4.3 9.9 9.2 14.0 9.5 9.1 12.4 11.4 11.2 10.5 3.5 12.6 9.4 9.0 5.2 14.3 11.3 8.1 12.1 10.0 9.4 5.9 13.7 11.1 21.2 13.0 13.0 16.2 13.2 12.0 14.7 15.4 14.9 13.2 12.2 15.7 13.0 15.8 7.7 15.3 15.9 14.1 17.6 14.7 11.1 15.3 14.0 7.3 12.2 18.6 14.0 14.4 12.2 17.0 15.9 15.7 18.5 17.0 20.3 5.8 13.2 13.5 16.2 11.1 23.4 16.7 12.6 14.8 13.2 17.7 11.2 16.1 11.8 19.8 14.3 14.4 11.6 21.0 16.2 22.2 20.5 12.4 10.1 12.7 15.4 23.9 16.9 25.6 10.8 11.0 14.0 3.5 2.6 2.4 3.6 2.0 2.4 2.1 2.4 2.5 2.7 4.0 2.4 2.2 5.7 4.5 1.8 2.9 2.5 1.8 4.7 4.9 7.6 5.9 4.4 4.5 4.4 6.1 4.3 3.5 5.2 5.9 52.3 16.0 36.1 52.5 41.8 12.1 20.6 18.6 17.6 67.2 25.0 26.2 22.1 17.2 27.7 20.2 131.3 27.1 41.6 25.5 9.8 23.5 18.8 29.5 40.0 42.2 32.4 36.4 45.0 18.1 23.8 28.8 37.8 37.5 38.1 40.8 29.3 13.8 19.7 77.4 40.3 23.5 16.2 23.8 19.1 11.7 35.1 27.0 16.0 28.1 40.2 39.2 80.3 26.2 27.6 24.0 20.6 27.4 38.5 26.9 23.2 14.0 19.8 160.7 39.5 38.8 30.6 54.7 40.5 18.3 17.5 45.0 47.9 50.1 22.6 24.0 GPATCH1 "ECGP, FLJ10206, FLJ38686, GPATC1" ENSG00000076650 "G-patch domain containing 1" Q9BRR8 19 33080899-33130542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043430, HPA043604, HPA074327" Approved Approved "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Golgi apparatus, Cell Junctions" "HPA043430: AB_10960493, HPA043604: AB_10960499, HPA074327: " "unprognostic (2.38e-2)" "unprognostic (1.71e-2)" "unprognostic (9.95e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.41e-1)" "unprognostic (1.28e-2)" "unprognostic (4.60e-3)" "unprognostic (3.54e-2)" "unprognostic (5.17e-2)" "unprognostic (3.56e-2)" "unprognostic (6.53e-2)" "unprognostic (5.37e-3)" "unprognostic (8.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.25e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-3)" 3.5 3.1 3.0 3.5 3.2 3.7 4.4 5.1 4.0 4.0 2.0 4.8 5.4 4.5 4.4 4.3 3.9 2.8 3.8 3.1 2.9 4.4 3.4 3.4 4.9 2.8 3.0 7.2 3.8 6.3 2.6 4.2 3.0 4.2 4.5 3.9 4.6 3.4 4.2 5.6 4.6 4.4 2.7 4.3 4.9 4.4 3.3 5.9 4.7 3.2 5.0 3.6 3.6 3.4 8.8 18.2 8.4 9.1 5.5 6.2 7.1 7.8 5.4 11.6 9.7 12.9 7.9 12.3 9.7 6.2 5.5 7.7 10.6 6.4 10.1 21.4 6.6 11.7 6.8 9.8 7.2 20.3 7.6 5.3 7.4 7.9 7.2 5.6 6.6 9.6 12.5 7.7 5.8 11.2 11.8 7.1 5.9 11.5 7.5 11.9 10.6 5.5 5.4 5.4 9.3 6.2 12.3 7.6 4.6 7.2 6.4 14.5 7.5 10.2 7.6 5.6 11.3 6.4 11.1 10.6 6.3 10.3 9.5 23.1 6.4 7.4 6.0 6.6 4.1 6.2 5.6 7.7 6.0 7.0 9.6 6.0 4.7 3.5 3.7 5.3 9.2 5.0 3.0 3.2 5.1 4.0 3.1 2.9 2.8 3.0 3.0 2.7 3.3 3.4 6.5 9.6 7.9 5.9 9.1 6.1 5.0 6.0 10.8 9.7 5.2 4.6 11.8 1.5 9.8 7.3 14.6 10.5 10.7 12.0 15.6 6.8 3.2 5.2 9.4 6.4 4.2 4.2 7.2 4.5 5.2 7.5 10.2 6.8 16.5 10.1 7.9 4.6 4.1 3.3 7.0 7.7 8.2 6.0 5.2 2.1 10.2 5.8 8.8 2.8 5.8 7.1 16.5 5.5 7.0 9.0 8.7 8.2 5.5 3.3 6.8 6.6 10.3 11.9 0.0 8.0 7.3 19.5 14.8 6.5 3.7 5.5 9.1 7.0 6.5 3.4 GTF2H3 "BTF2, P34, TFIIH" ENSG00000111358 "General transcription factor IIH subunit 3" Q13889 12 123633739-123662604 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004844, HPA053562" Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA004844: AB_2667265, HPA053562: AB_2682191" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.02e-2)" "unprognostic (6.13e-3)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.72e-8)" "unprognostic (1.02e-1)" "unprognostic (1.22e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.10e-1)" "unprognostic (5.68e-3)" "unprognostic (4.71e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (2.80e-2)" 10.4 9.0 6.1 12.9 6.0 11.2 15.6 5.8 6.9 11.7 5.0 14.0 10.5 12.9 8.9 15.4 15.0 9.7 10.7 5.8 5.2 11.2 14.1 9.7 16.6 5.9 6.3 11.2 5.6 11.7 5.9 12.9 6.4 13.0 16.2 10.1 7.3 11.3 13.8 12.8 10.6 14.2 5.8 10.4 11.7 12.2 6.2 16.0 13.4 11.1 16.1 11.4 8.2 7.1 42.0 21.7 27.6 35.5 33.3 37.1 38.9 31.2 38.2 47.1 31.6 23.2 21.1 48.4 37.4 43.0 18.8 27.8 46.2 56.4 56.2 41.4 32.5 39.7 19.3 33.3 46.8 80.9 25.3 39.7 42.2 38.2 85.9 35.3 34.2 59.4 60.4 15.7 42.9 27.4 40.5 27.2 35.6 29.6 39.9 41.3 42.1 27.4 24.1 40.1 24.8 21.8 41.1 19.8 32.1 30.1 55.4 48.1 22.9 29.3 22.3 45.9 50.7 28.8 42.3 47.6 33.7 40.5 34.3 11.4 4.6 6.0 7.6 6.9 7.6 5.9 6.1 8.1 7.0 5.7 8.7 8.0 0.6 10.7 7.0 5.9 6.7 4.1 6.1 6.0 5.8 6.9 5.8 5.2 5.9 6.3 6.4 5.8 6.2 7.1 20.8 22.4 24.3 23.5 19.2 11.7 12.3 20.9 27.9 16.2 12.6 15.2 7.4 12.8 22.3 12.9 10.4 26.3 13.8 8.4 3.9 12.9 8.6 18.3 24.7 11.1 6.7 21.6 26.6 11.0 23.4 17.1 16.8 16.7 24.1 19.9 12.1 16.9 17.2 16.8 27.8 12.3 6.1 12.3 7.9 4.3 11.8 15.3 1.8 10.3 16.1 21.9 7.2 15.6 23.1 10.8 10.8 11.3 17.1 10.5 6.1 15.8 20.7 13.7 13.1 18.8 15.2 32.6 27.1 25.7 13.2 23.7 14.5 36.2 15.7 10.4 GTF3C2 "KIAA0011, TFIIIC110" ENSG00000115207 "General transcription factor IIIC subunit 2" Q8WUA4 2 27325849-27357034 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA008274, HPA035836" Uncertain Supported Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA008274: , HPA035836: AB_10601813" "unprognostic (1.76e-1)" "unprognostic (9.64e-2)" "unprognostic (9.89e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (1.33e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (1.21e-8)" "unprognostic (1.57e-1)" "unprognostic (1.77e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-2)" "unprognostic (7.39e-2)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.94e-1)" "unprognostic (7.97e-2)" "unprognostic (3.00e-1)" 18.7 25.6 19.5 23.2 20.8 23.5 21.1 26.2 27.6 19.0 23.5 25.3 22.4 19.8 23.7 34.5 24.4 15.3 23.2 19.9 20.8 23.3 21.1 19.7 26.6 21.2 18.7 20.7 30.7 33.1 20.0 19.6 20.0 20.1 27.7 25.2 25.2 18.5 28.7 32.2 24.2 23.3 17.2 26.8 24.3 26.0 22.0 30.4 29.4 18.5 33.5 23.2 21.4 28.1 86.2 75.7 62.5 60.6 36.2 35.2 91.2 30.8 41.8 39.8 33.7 56.3 53.7 75.1 54.1 43.0 40.8 50.6 93.2 59.2 38.0 59.5 81.0 63.3 48.5 76.0 33.0 69.7 60.6 44.4 52.3 45.4 58.4 38.0 51.8 50.4 90.1 54.9 38.8 70.4 64.9 50.7 118.2 69.0 47.6 79.1 69.2 83.9 56.8 63.9 58.0 101.5 33.1 78.6 57.7 52.8 42.2 39.3 39.6 48.2 52.4 36.9 58.1 60.2 71.9 169.4 48.1 55.4 53.8 29.6 18.2 14.5 14.3 15.0 15.1 13.3 12.6 15.2 15.6 11.4 12.4 12.2 8.4 13.3 19.2 9.8 8.5 19.7 19.5 20.8 26.2 27.6 19.9 20.8 21.2 18.7 20.0 17.2 22.0 28.1 7.9 19.2 22.1 11.8 17.5 9.8 9.8 11.9 18.2 11.3 13.9 11.6 11.7 14.3 14.9 5.5 22.9 19.3 12.9 22.2 9.8 16.6 54.9 13.6 10.9 10.3 3.5 24.8 17.3 22.8 23.6 10.0 17.3 14.6 18.3 16.2 10.0 11.1 16.1 10.1 16.2 17.6 12.2 18.4 7.6 61.9 9.3 12.1 5.4 16.9 18.3 8.9 12.3 14.1 18.9 21.5 9.0 7.9 18.6 13.0 16.0 11.8 14.8 18.0 6.6 9.7 11.8 9.1 16.4 19.4 12.6 20.0 13.7 11.8 15.1 14.4 HAUS1 "CCDC5, FLJ40084, HEI-C, HsT1461" ENSG00000152240 "HAUS augmin like complex subunit 1" Q96CS2 18 46104378-46128333 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 111.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040601, HPA040652" Supported Supported Centrosome,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Centrosome "HPA040601: AB_10794743, HPA040652: AB_10793966" "unprognostic (1.74e-2)" "unprognostic (1.89e-2)" "unprognostic (8.13e-3)" "unprognostic (1.92e-1)" "unprognostic (2.29e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.39e-1)" "unprognostic (4.76e-3)" "prognostic favorable (1.55e-4)" "unprognostic (3.75e-1)" "prognostic unfavorable (6.76e-4)" "unprognostic (5.97e-3)" "unprognostic (5.40e-2)" "unprognostic (9.79e-3)" "unprognostic (3.66e-2)" "unprognostic (7.96e-2)" 14.3 11.0 7.2 18.4 7.2 37.8 18.9 7.3 10.2 13.7 9.0 18.5 14.3 17.0 38.7 14.5 13.4 16.9 11.8 7.0 7.8 13.0 13.7 12.2 35.6 7.5 7.6 26.4 11.4 14.3 10.7 17.8 7.8 10.4 22.1 9.5 10.5 12.9 7.2 10.1 14.3 16.8 8.0 14.6 13.0 16.2 7.3 41.4 13.3 13.2 39.5 16.2 11.9 8.1 72.8 43.6 157.3 86.9 38.8 59.4 42.5 68.4 65.7 105.5 104.4 43.2 39.5 136.4 40.5 48.3 49.8 74.6 94.0 56.4 115.1 77.7 64.2 99.2 40.7 82.0 32.5 184.2 59.7 28.6 21.6 64.6 33.3 45.6 115.1 91.5 72.4 39.8 94.2 41.9 150.0 87.7 101.1 33.0 24.9 144.6 112.4 98.4 85.4 49.9 74.3 77.2 64.3 22.3 52.9 60.7 33.3 89.0 67.9 62.8 42.1 27.9 73.4 43.5 73.2 130.6 39.9 157.0 74.0 11.1 46.5 36.7 40.3 45.4 45.0 79.4 53.0 48.9 58.3 64.8 38.1 45.0 4.9 55.9 35.8 62.5 99.9 55.4 7.2 7.2 7.3 10.2 7.0 7.8 7.5 7.6 7.8 8.0 7.3 8.1 20.6 12.8 12.2 3.3 26.5 17.5 15.8 47.8 16.5 6.1 16.4 18.7 10.1 15.7 33.0 14.7 4.2 58.7 22.0 11.1 17.6 38.2 7.5 15.9 18.3 29.4 12.1 53.9 4.2 42.3 111.7 25.1 7.1 14.5 29.8 31.3 23.2 6.9 50.9 11.8 4.8 24.1 28.5 33.6 24.7 12.4 22.7 25.8 21.4 4.7 45.8 21.5 37.0 8.0 5.2 31.8 12.4 25.9 21.9 8.1 14.3 24.7 29.3 8.7 19.7 15.9 20.2 50.8 55.8 15.3 15.5 23.7 23.9 20.7 26.8 12.9 HAUS6 "dgt6, FAM29A, FLJ20060, KIAA1574" ENSG00000147874 "HAUS augmin like complex subunit 6" Q7Z4H7 9 19053141-19102904 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 124.9;Spermatocytes: 68.9;Spermatogonia: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 215.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020960, HPA020965" Approved Approved "Nuclear speckles,Centriolar satellite,Cytosol" No No "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 29: Early spermatids - Spermatogenesis" "Centriolar satellite, Cytosol" "Nuclear speckles" "HPA020960: AB_1848393, HPA020965: AB_1848394" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (6.04e-3)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.21e-1)" "unprognostic (2.15e-1)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.52e-1)" "unprognostic (1.68e-1)" "unprognostic (3.13e-2)" "unprognostic (2.03e-1)" 5.3 6.5 5.2 7.9 7.3 17.0 9.2 8.9 7.4 5.4 4.2 5.8 4.0 7.1 6.2 5.2 4.7 5.1 5.2 5.1 6.2 4.1 6.9 4.7 11.4 6.4 6.2 8.2 3.9 6.1 3.0 6.9 6.6 5.6 6.2 9.1 4.5 5.6 4.4 8.1 5.2 7.2 6.1 6.9 4.3 24.0 6.1 15.1 5.3 7.2 10.7 6.2 4.2 9.3 34.7 23.7 46.4 36.3 17.4 20.9 25.1 36.5 25.5 32.7 49.9 12.2 15.4 40.5 13.1 21.1 25.0 14.2 43.3 21.3 50.4 36.8 20.9 215.8 42.1 27.8 11.6 29.0 46.7 13.0 21.5 30.9 66.9 16.9 24.0 40.4 29.8 25.7 37.8 11.3 56.6 49.1 49.9 19.4 23.2 43.3 31.8 16.4 18.0 19.8 27.1 37.3 16.4 15.0 23.6 29.5 11.6 36.1 24.1 29.3 17.7 25.5 42.2 10.2 24.0 39.7 27.3 24.0 13.0 9.8 1.5 1.6 2.8 1.5 3.9 2.3 2.8 3.6 1.5 2.3 3.3 2.9 2.3 5.0 1.4 1.8 3.7 1.7 5.2 7.3 8.9 7.4 5.1 6.2 6.4 6.2 6.6 6.1 6.1 9.3 15.9 19.2 12.5 7.8 14.3 9.7 12.6 8.7 9.1 11.8 9.4 9.3 8.4 5.7 7.2 9.2 10.4 10.5 21.9 5.6 0.0 9.8 124.9 11.8 14.4 11.6 2.4 34.1 10.3 6.1 15.3 9.5 5.6 15.3 11.4 23.8 3.9 6.8 8.2 11.8 10.2 4.6 2.0 5.8 7.7 28.2 11.8 14.5 8.8 10.3 8.2 13.5 12.3 7.1 16.8 9.0 3.4 8.2 17.3 14.6 4.5 3.2 3.6 9.7 6.6 16.2 10.1 68.9 56.0 9.1 8.1 4.9 18.2 11.0 9.4 9.4 HEATR1 "BAP28, FLJ10359, UTP10" ENSG00000119285 "HEAT repeat containing 1" Q9H583 1 236549005-236604516 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046917, HPA062200" Approved Enhanced "Nucleoli fibrillar center,Mitochondria" NA NA 470000 "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoli fibrillar center" Mitochondria "HPA046917: AB_2679863, HPA062200: AB_2684709" "unprognostic (2.61e-1)" "unprognostic (1.44e-3)" "unprognostic (6.26e-2)" "unprognostic (1.34e-3)" "unprognostic (7.18e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (5.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.80e-1)" "unprognostic (4.67e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (8.08e-2)" "unprognostic (3.38e-1)" "unprognostic (3.27e-2)" "unprognostic (4.00e-2)" 8.5 5.6 3.3 11.1 4.1 12.7 9.8 4.6 4.0 6.8 3.3 6.2 5.6 8.7 6.5 7.3 7.0 5.5 4.4 3.5 3.7 5.4 5.5 5.2 12.9 3.7 3.3 9.4 8.7 7.9 3.4 7.7 3.8 6.2 7.5 4.8 6.2 6.4 6.6 10.4 6.2 8.0 3.7 8.5 6.2 14.4 4.2 10.1 7.9 5.7 13.5 10.8 6.7 6.5 35.2 41.4 21.2 32.3 29.1 32.5 47.4 27.7 17.8 31.2 27.7 41.8 29.0 57.3 30.4 25.8 19.3 41.5 48.7 29.7 42.0 29.0 56.0 40.7 28.3 36.1 26.1 73.5 25.2 26.7 26.2 47.2 40.5 14.9 36.3 25.9 93.8 18.8 31.5 18.8 35.1 20.1 84.9 44.8 16.9 38.6 30.6 53.8 19.9 34.9 19.9 44.1 33.5 23.7 28.3 14.1 28.2 27.2 34.7 31.2 29.5 40.6 69.4 35.4 47.2 65.5 27.8 40.2 47.4 1.6 3.3 1.0 6.0 4.2 5.6 9.1 5.9 6.6 4.0 6.5 8.1 7.8 0.4 5.7 4.2 5.2 5.3 2.3 3.3 4.1 4.6 4.0 3.5 3.7 3.7 3.3 3.8 3.7 4.2 6.5 13.3 3.2 12.8 19.6 21.8 19.8 16.3 8.3 26.2 12.4 9.8 7.6 4.2 7.2 11.7 5.5 18.8 8.1 15.0 3.6 3.9 8.9 10.5 8.4 26.3 12.4 4.2 12.6 35.1 8.5 10.8 15.2 8.6 11.3 32.9 23.4 10.4 9.7 7.5 6.7 30.4 6.2 4.1 11.3 7.5 2.7 14.0 11.7 1.8 26.2 9.6 3.0 9.2 36.2 34.1 12.0 4.3 10.1 19.0 15.7 3.3 5.6 11.5 9.6 0.0 19.4 11.8 29.3 30.1 19.3 16.9 4.9 18.1 15.6 11.1 12.0 HEATR5B "DKFZp686P15184, KIAA1414" ENSG00000008869 "HEAT repeat containing 5B" Q9P2D3 2 36968383-37084372 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 62.3;Inhibitory neurons: 58.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042025, HPA055639" Approved Approved "Nuclear speckles,Vesicles,Cytosol" NA NA 6800 "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nuclear speckles, Vesicles, Cytosol" "HPA042025: AB_10959880, HPA055639: AB_2682870" "unprognostic (3.11e-2)" "unprognostic (1.65e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-2)" "unprognostic (3.70e-2)" "unprognostic (7.75e-2)" "unprognostic (5.95e-2)" "unprognostic (3.33e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-2)" "unprognostic (1.66e-1)" "unprognostic (8.07e-2)" "unprognostic (5.80e-3)" "unprognostic (8.69e-2)" "unprognostic (4.18e-1)" "unprognostic (2.72e-1)" "unprognostic (3.95e-1)" 9.7 8.8 7.1 15.0 7.1 24.3 14.5 11.7 9.8 9.9 4.9 9.9 10.8 9.5 16.9 11.7 8.1 10.7 9.7 7.4 6.4 9.3 9.3 10.8 31.9 5.8 5.2 9.8 18.2 13.4 6.3 10.2 6.4 11.4 13.5 24.3 14.3 7.7 4.9 18.2 11.5 8.3 3.9 19.0 12.3 9.6 7.0 24.7 11.8 9.4 31.2 10.1 8.5 8.1 16.2 8.1 11.7 17.8 11.9 11.7 14.9 10.1 7.4 9.0 9.1 9.6 10.9 34.6 7.1 8.6 11.9 13.4 11.6 8.2 11.7 17.0 12.6 22.6 11.3 13.1 7.4 24.5 28.5 10.8 11.2 13.0 12.3 9.9 15.5 18.3 21.6 29.8 10.9 9.6 21.5 17.4 7.7 16.7 5.6 20.5 11.9 26.3 10.5 13.8 14.3 12.6 10.6 16.7 7.8 11.7 12.0 7.9 17.2 13.5 7.7 9.9 7.9 18.5 16.2 39.0 11.0 14.3 9.0 18.3 5.0 12.3 7.7 2.8 7.1 9.7 8.5 8.7 9.0 14.0 8.7 7.6 5.2 7.5 4.4 11.2 9.7 5.9 7.1 7.1 11.7 9.8 7.4 6.4 5.8 5.2 6.4 3.9 7.0 8.1 12.9 22.4 10.3 35.9 20.8 9.8 4.2 4.7 6.8 13.0 11.9 8.3 20.8 8.6 7.1 5.5 10.4 7.0 24.4 11.3 1.9 4.6 6.3 14.8 10.0 9.5 5.4 18.7 62.3 6.2 6.2 9.4 25.5 11.1 7.0 9.8 11.7 7.8 6.3 16.8 58.9 8.9 6.1 17.0 15.7 2.6 9.0 13.2 7.2 56.2 9.2 6.5 16.5 57.3 69.7 8.8 6.3 6.4 17.6 5.5 12.7 5.4 12.8 16.2 19.7 6.5 10.6 3.6 11.2 11.7 11.6 5.6 14.5 7.7 8.7 4.9 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070444-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoli, Nucleoli rim" "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 6.3 6.6 3.8 8.5 4.9 12.5 6.6 12.0 5.7 7.6 8.4 5.8 4.8 7.4 6.1 4.7 6.1 7.1 6.1 3.6 6.9 6.9 10.9 6.8 9.8 4.1 5.2 12.3 7.8 12.0 6.1 11.2 4.0 6.1 6.6 14.3 6.2 6.2 9.1 4.4 5.9 7.5 3.3 9.1 6.5 10.8 5.5 15.4 8.7 14.0 8.9 6.6 5.0 3.3 10.3 10.0 12.3 12.3 14.8 8.4 18.7 9.0 8.8 11.8 12.4 14.7 7.9 21.2 7.2 12.0 7.4 10.5 23.3 11.3 18.4 8.2 7.3 27.2 10.7 12.5 7.1 22.3 15.6 9.8 10.5 11.4 14.1 8.8 18.1 15.6 19.1 12.9 9.8 13.0 29.0 7.6 7.4 9.2 9.7 19.3 21.6 9.2 9.1 14.3 12.0 11.0 14.3 11.5 15.2 16.9 13.7 13.7 16.1 14.5 16.6 8.0 8.1 10.7 13.4 15.5 7.2 13.7 15.5 2.3 3.3 2.8 5.1 2.8 6.3 1.7 3.1 3.2 2.8 2.8 1.9 2.6 2.3 2.6 1.9 2.2 3.0 2.3 3.8 4.9 12.0 5.7 3.6 6.9 4.1 5.2 4.0 3.3 5.5 3.3 42.9 19.2 37.1 89.1 44.3 32.1 24.6 30.2 29.6 50.8 32.8 23.6 31.1 24.3 30.2 27.6 93.8 32.9 95.8 29.4 7.9 19.1 5.2 49.4 55.8 32.3 38.3 48.8 93.1 14.2 42.8 30.9 38.7 118.5 33.7 51.9 61.8 52.1 31.9 67.3 112.1 30.2 16.2 79.4 28.8 10.5 38.8 55.4 14.2 107.7 62.0 24.0 104.0 134.2 72.6 19.2 23.1 42.9 67.1 29.3 27.7 14.6 26.1 54.9 13.1 45.9 34.0 36.0 26.0 33.6 20.2 18.3 71.0 32.6 26.3 45.8 HERC1 "p532, p619" ENSG00000103657 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 1" Q15751 15 63608618-63833948 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transport, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 458.8;Inhibitory neurons: 338.0;Oligodendrocytes: 201.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049749 Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA049749: AB_2680866" "unprognostic (9.72e-2)" "unprognostic (7.51e-2)" "unprognostic (3.43e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-1)" "prognostic favorable (4.87e-5)" "unprognostic (1.53e-1)" "unprognostic (2.15e-2)" "unprognostic (3.02e-2)" "unprognostic (2.89e-3)" "prognostic favorable (3.66e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.36e-6)" "unprognostic (2.87e-1)" "unprognostic (3.36e-2)" "unprognostic (9.04e-3)" "unprognostic (3.94e-1)" 10.5 7.4 8.6 10.3 10.1 27.4 12.7 14.1 20.3 13.0 5.2 11.8 5.3 10.8 6.5 8.1 7.6 9.6 15.2 9.3 0.0 9.1 9.1 10.6 13.7 1.7 0.3 18.5 8.4 22.7 8.8 10.3 1.8 8.6 9.2 18.3 8.8 10.3 30.4 12.1 9.9 12.4 0.0 15.2 10.2 11.5 0.0 25.6 14.0 29.3 12.8 9.2 7.9 22.7 13.5 17.1 19.1 6.6 33.3 21.1 6.4 10.3 13.4 10.7 12.3 10.9 5.3 19.8 9.3 19.8 9.7 14.5 31.2 9.0 14.6 15.4 9.6 42.5 26.4 7.8 5.3 31.6 25.1 15.3 8.5 15.1 14.5 9.3 22.7 13.3 44.0 8.6 9.4 21.7 11.3 6.5 9.3 10.4 8.7 12.2 20.6 11.6 4.4 32.9 17.0 8.4 18.2 12.5 10.5 23.0 6.1 12.7 23.6 13.6 12.6 11.9 13.6 9.4 17.4 13.3 7.8 23.3 4.9 24.4 3.8 8.7 4.9 3.4 3.7 5.9 5.5 4.6 3.4 9.5 5.5 5.4 13.5 2.9 6.7 7.5 7.8 1.8 8.6 10.1 14.1 20.3 9.3 0.0 1.7 0.3 1.8 0.0 0.0 22.7 66.0 6.4 39.5 113.0 44.2 14.9 10.6 16.1 17.1 65.3 19.7 17.1 64.8 17.2 19.9 22.0 66.7 8.8 66.1 11.4 1.9 11.0 28.7 13.5 24.0 44.5 10.2 47.5 458.8 14.1 15.1 28.5 34.7 17.8 50.6 36.5 47.2 21.0 16.2 85.8 338.0 13.1 10.2 43.2 27.4 14.3 27.7 39.2 19.6 137.7 36.0 29.9 35.0 160.4 201.5 11.7 14.7 39.9 44.9 12.7 12.5 15.7 16.6 55.0 6.6 34.4 36.0 43.5 31.3 17.1 15.3 8.9 61.1 31.9 14.4 12.1 HMCES "C3orf37, DC12, SRAPD1" ENSG00000183624 "5-hydroxymethylcytosine binding, ES cell specific" Q96FZ2 3 129278828-129306186 "Predicted intracellular proteins" "DNA damage" "DNA-binding, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 124.9;Spermatocytes: 127.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044968 Enhanced Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA044968: AB_2679160" "unprognostic (9.18e-3)" "unprognostic (1.11e-3)" "unprognostic (4.16e-2)" "unprognostic (2.80e-2)" "unprognostic (2.93e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.29e-1)" "unprognostic (3.00e-1)" "unprognostic (4.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-2)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.25e-2)" "unprognostic (9.08e-3)" 35.8 22.0 27.6 37.3 32.5 37.8 32.9 26.6 32.4 25.8 22.4 36.1 29.4 24.0 23.0 41.7 27.0 21.1 40.3 29.8 30.1 27.4 53.7 27.1 99.7 27.3 27.6 28.3 15.3 68.9 22.2 20.9 27.6 24.6 30.9 27.7 26.8 26.2 57.7 35.5 28.8 23.2 26.4 29.8 26.4 39.9 32.5 57.1 22.4 48.5 131.0 28.5 28.8 27.1 149.4 66.2 74.4 85.9 90.6 37.8 66.8 51.2 41.5 73.1 56.6 105.0 67.9 286.0 53.9 46.9 57.2 106.3 94.8 110.8 83.7 58.0 51.2 59.7 52.7 76.0 38.8 52.1 41.9 36.7 56.6 61.1 60.2 35.6 45.5 63.5 61.2 244.2 40.9 197.3 74.8 45.1 48.4 108.5 42.8 66.6 63.8 50.5 77.0 88.8 74.0 45.6 114.4 70.8 70.6 45.6 121.0 52.1 36.8 36.3 63.7 87.3 66.5 135.8 87.2 289.3 43.4 41.9 41.1 35.5 25.5 65.0 30.4 27.4 31.6 37.5 36.7 36.3 26.3 62.1 36.1 40.0 52.5 27.2 40.9 28.1 48.0 31.2 27.6 32.5 26.6 32.4 29.8 30.1 27.3 27.6 27.6 26.4 32.5 27.1 26.1 32.1 25.6 11.4 23.5 58.2 71.2 72.4 54.7 21.5 18.8 16.1 35.6 30.0 30.4 22.0 10.4 49.2 32.0 30.8 37.2 39.6 8.6 16.0 10.2 27.8 21.0 28.2 13.6 47.0 37.6 23.3 17.9 15.7 22.2 11.0 20.7 26.1 19.7 26.9 14.7 17.3 32.6 8.1 39.4 8.6 24.5 15.7 58.7 10.3 16.4 38.6 25.7 7.1 10.6 33.8 16.9 31.2 124.9 37.3 19.9 21.1 25.2 12.5 13.1 21.0 27.1 127.8 83.6 30.7 43.9 35.0 47.3 23.9 30.7 61.0 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990771 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 136.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 419.1;Extravillous trophoblasts: 820.7;Syncytiotrophoblasts: 1400.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 11.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 738.7;U-698: 675.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062583, HPA073663" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Nucleoli "HPA062583: AB_2684800, HPA073663: " "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favorable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favorable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 8.9 13.7 10.5 19.7 10.5 85.6 15.6 10.4 20.3 34.0 6.5 43.9 27.1 16.4 44.8 26.1 16.9 9.7 11.3 14.5 13.9 19.6 101.4 15.9 25.2 13.0 11.2 5.9 17.2 85.4 4.2 136.6 11.3 13.9 32.4 3.1 23.8 15.9 53.5 19.2 28.1 13.8 10.2 21.2 16.1 40.1 13.4 65.2 14.3 8.9 35.8 18.7 10.5 9.5 263.5 115.5 351.9 184.2 14.5 42.9 437.4 112.9 73.6 127.9 66.1 91.6 106.0 183.0 354.8 87.5 72.3 123.3 324.4 738.7 143.3 125.6 94.7 159.4 110.2 145.6 21.5 243.9 78.0 33.9 171.6 52.5 131.5 32.7 168.3 110.5 84.5 105.4 154.2 201.9 269.3 186.2 209.2 171.0 138.1 325.4 286.3 103.6 95.2 125.3 252.7 164.4 167.4 177.7 56.0 199.3 157.8 158.5 128.0 53.0 123.9 169.9 253.1 94.9 128.7 675.7 63.1 121.3 109.9 0.0 4.3 11.3 0.4 3.0 0.1 2.7 2.0 2.9 6.1 0.5 0.0 0.2 0.7 0.8 5.0 3.1 5.8 2.5 10.5 10.5 10.4 20.3 14.5 13.9 13.0 11.2 11.3 10.2 13.4 9.5 10.4 38.5 31.2 0.7 15.1 23.7 18.9 158.6 12.5 0.5 24.2 16.0 16.0 8.6 123.5 31.3 2.1 419.1 4.5 32.1 37.2 82.4 232.3 61.9 18.9 19.6 65.7 136.1 1.3 86.5 820.7 17.6 22.4 55.9 8.2 44.2 13.6 84.4 101.0 0.0 3.7 37.0 219.7 20.8 43.7 75.9 3.7 22.1 21.4 2.8 23.6 4.1 1.0 1.5 0.5 91.5 35.7 3.4 47.1 27.5 31.8 66.5 113.3 1.8 0.0 39.8 29.0 22.7 50.2 41.1 20.3 1400.2 10.1 10.4 60.7 18.5 HMGN1 "FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425" ENSG00000205581 "High mobility group nucleosome binding domain 1" P05114 21 39342315-39349647 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012260, HPA048694" Supported Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "CAB012260: AB_304786, HPA048694: AB_2680496" "unprognostic (4.49e-2)" "unprognostic (5.52e-2)" "unprognostic (4.85e-2)" "unprognostic (6.28e-2)" "unprognostic (2.20e-1)" "unprognostic (5.21e-3)" "unprognostic (8.50e-3)" "unprognostic (1.32e-1)" "unprognostic (2.46e-3)" "unprognostic (5.68e-2)" "unprognostic (3.02e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (8.74e-7)" "unprognostic (3.20e-1)" "unprognostic (3.72e-2)" "unprognostic (3.84e-2)" "unprognostic (8.98e-3)" 56.1 73.7 54.1 120.5 52.3 202.4 121.4 52.0 63.7 115.8 54.6 126.0 121.3 78.8 187.6 124.8 100.2 72.9 39.1 53.3 58.7 114.4 100.8 72.5 219.1 57.1 57.5 72.9 92.2 132.1 73.8 111.6 55.7 93.2 136.2 245.5 97.1 75.2 16.2 82.5 133.6 65.3 57.2 100.9 113.2 64.8 56.4 238.7 117.2 26.3 294.9 114.2 73.8 58.5 517.7 135.9 450.3 316.3 74.5 131.1 299.7 266.6 191.8 261.0 233.0 262.6 420.6 1161.6 246.8 223.7 309.8 106.5 317.4 377.9 336.1 459.5 317.7 883.6 225.7 355.8 187.0 768.2 291.3 167.4 349.9 260.2 350.6 222.4 363.6 513.6 680.2 191.6 436.7 686.7 780.2 691.0 798.0 682.3 237.8 853.2 224.7 466.0 469.5 308.3 386.3 362.2 582.8 364.1 356.0 183.1 479.5 807.5 239.6 127.2 128.7 94.0 279.7 235.6 394.8 690.7 179.4 882.9 341.4 103.7 76.4 282.5 138.0 68.9 153.5 228.9 175.2 143.7 216.5 205.8 195.2 172.2 53.8 174.5 67.7 294.9 221.5 231.4 54.1 52.3 52.0 63.7 53.3 58.7 57.1 57.5 55.7 57.2 56.4 58.5 169.9 93.0 139.7 55.2 420.4 278.5 532.0 674.9 233.9 265.1 650.7 412.6 56.1 307.4 349.0 285.1 331.5 599.2 405.1 306.8 737.6 479.9 642.8 304.4 287.3 223.3 345.2 275.6 34.9 350.5 970.7 196.6 221.7 309.2 219.9 277.8 135.7 176.2 533.9 240.6 55.1 442.1 514.7 176.1 389.6 180.6 175.8 279.6 243.7 45.0 415.1 427.8 358.4 96.5 68.8 381.0 307.4 200.1 335.9 684.7 327.8 625.4 226.8 1301.8 32.9 122.0 179.5 81.9 149.1 399.7 313.7 602.1 326.1 289.2 537.1 699.9 HMGN4 "HMG17L3, NHC" ENSG00000182952 "High mobility group nucleosomal binding domain 4" O00479 6 26538366-26546933 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 39.3;Basal squamous epithelial cells: 38.7;Plasma cells: 51.5;Squamous epithelial cells: 34.8;T-cells: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077364 Uncertain Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA077364: AB_2686835" "unprognostic (1.91e-1)" "unprognostic (2.48e-2)" "unprognostic (5.88e-2)" "unprognostic (8.81e-2)" "unprognostic (4.10e-2)" "unprognostic (6.02e-2)" "unprognostic (4.00e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (3.22e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (9.01e-2)" "unprognostic (6.07e-3)" 39.6 34.5 21.3 49.2 21.5 33.0 54.3 21.5 26.5 45.4 30.4 52.7 40.7 56.6 50.2 35.2 46.0 38.4 38.1 21.4 24.3 48.6 19.9 46.0 68.7 22.4 22.9 50.1 26.3 58.4 22.3 41.2 22.5 47.0 55.8 18.6 33.2 56.7 38.6 31.4 48.9 66.9 22.8 52.4 32.8 31.3 23.0 70.6 57.0 32.6 71.6 55.3 35.8 24.2 81.3 29.7 60.2 79.3 78.6 118.0 37.4 67.0 116.1 99.2 138.0 30.6 50.5 94.4 104.0 95.1 101.0 37.4 100.2 85.0 109.3 118.9 94.1 96.7 42.3 58.9 86.9 85.2 98.9 87.6 114.0 80.0 132.7 93.0 95.5 121.2 92.8 152.8 91.5 40.7 151.0 114.9 36.2 68.0 51.9 53.8 66.6 168.8 77.9 54.6 95.0 85.4 55.4 45.0 138.6 71.0 50.1 45.6 71.2 68.5 52.1 63.5 61.7 100.4 276.9 79.3 33.1 190.1 91.1 182.8 42.1 81.9 81.8 41.5 80.5 71.7 85.2 85.8 57.2 61.2 71.0 70.2 62.5 75.7 53.9 47.9 93.6 92.5 21.3 21.5 21.5 26.5 21.4 24.3 22.4 22.9 22.5 22.8 23.0 24.2 4.2 3.2 5.8 6.8 39.3 7.5 4.0 3.1 38.7 0.5 5.6 3.0 2.1 7.2 7.5 1.8 0.0 3.5 13.9 2.9 5.9 2.2 0.4 3.9 10.0 4.8 0.0 16.8 16.1 1.4 10.1 11.8 13.3 5.7 8.8 1.8 3.3 0.7 4.0 0.0 13.9 2.3 2.0 5.1 11.1 0.4 1.5 16.3 8.8 6.5 7.5 2.6 8.2 17.1 13.5 2.6 1.9 2.6 51.5 3.7 4.3 7.8 1.1 0.8 0.0 4.4 8.3 0.6 1.2 34.8 5.1 8.1 32.5 2.5 1.9 2.1 HNRNPC HNRPC ENSG00000092199 "Heterogeneous nuclear ribonucleoprotein C" P07910 14 21209136-21269494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005223, HPA051075, CAB075755, CAB075756" Supported Enhanced Nucleoplasm NA NA 1200000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335" "unprognostic (1.92e-3)" "unprognostic (1.02e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.42e-2)" "unprognostic (5.21e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (8.66e-3)" "unprognostic (5.96e-3)" "prognostic favorable (1.19e-4)" "unprognostic (3.31e-3)" "unprognostic (5.30e-3)" "prognostic unfavorable (7.29e-5)" "unprognostic (7.36e-2)" "unprognostic (3.73e-3)" "unprognostic (2.28e-3)" "unprognostic (5.42e-2)" 286.9 309.2 274.1 319.5 290.1 540.3 328.5 283.9 332.6 307.8 248.8 266.7 232.3 318.9 311.9 318.3 328.5 246.4 269.5 275.3 289.2 372.9 334.4 251.8 497.7 287.2 275.4 427.3 237.7 257.8 237.7 342.0 299.0 249.6 290.9 407.3 225.9 247.9 288.2 260.1 255.2 265.9 295.2 306.5 232.3 193.7 276.6 557.8 259.2 244.0 496.0 374.6 278.6 327.1 1076.2 832.7 1277.7 748.5 754.8 704.7 910.2 673.2 764.3 1034.3 900.6 799.4 787.6 1935.6 414.1 772.1 656.8 775.6 1611.4 1035.4 1389.0 1236.1 918.1 992.8 614.2 1241.4 920.6 1495.2 762.6 731.8 854.2 756.5 1781.1 897.8 1078.4 957.7 1483.6 787.1 829.5 1020.0 1713.7 1435.2 1351.4 990.3 770.1 1375.0 1073.9 925.3 1159.7 956.9 699.0 665.5 838.5 760.9 786.4 1057.3 725.2 1332.6 783.1 388.9 698.2 473.8 972.8 708.8 1144.4 1873.6 370.6 1215.3 794.1 480.2 515.1 516.9 419.0 450.9 544.5 531.4 494.0 451.2 716.3 467.0 552.1 478.2 810.8 471.0 439.4 460.5 575.7 1220.5 274.1 290.1 283.9 332.6 275.3 289.2 287.2 275.4 299.0 295.2 276.6 327.1 172.7 153.8 233.9 69.5 307.2 536.2 583.9 512.2 331.8 169.8 259.9 191.5 137.9 173.0 393.2 275.8 198.1 612.6 309.4 134.0 283.7 315.0 169.0 365.1 352.2 257.5 224.0 389.9 74.3 216.6 746.8 287.1 197.2 555.6 415.9 281.3 174.2 233.9 388.5 116.1 79.2 276.0 260.4 293.8 500.1 76.5 270.0 325.7 208.1 99.3 341.9 157.9 227.6 97.5 112.2 210.7 151.1 230.9 293.6 531.5 135.0 370.8 381.9 296.1 151.2 285.1 282.6 391.5 249.0 315.5 539.9 874.9 339.1 311.8 318.0 590.3 HNRNPD "AUF1, HNRPD" ENSG00000138668 "Heterogeneous nuclear ribonucleoprotein D" Q14103 4 82352498-82374503 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004911 Supported Enhanced Nucleoplasm NA NA 1100000 "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA004911: AB_1078250" "unprognostic (9.60e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (1.77e-1)" "unprognostic (1.03e-3)" "unprognostic (1.75e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-2)" "unprognostic (5.93e-2)" "unprognostic (1.08e-1)" "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" 147.4 114.7 61.9 207.3 61.6 377.7 155.5 83.7 89.1 167.3 68.4 153.6 169.8 176.6 137.1 155.5 152.0 98.7 122.7 60.7 81.0 144.2 140.6 129.0 290.2 61.0 61.7 180.6 146.7 134.1 117.0 167.8 59.2 138.6 164.4 188.1 147.1 125.4 169.7 151.8 177.2 140.1 54.1 184.6 164.6 97.7 61.6 335.1 122.8 103.4 310.7 159.8 145.7 69.2 661.7 257.5 1073.5 344.2 138.9 179.1 508.9 506.2 384.6 566.7 484.9 461.1 565.7 1332.6 357.1 343.3 301.9 318.2 863.8 376.6 883.9 250.1 450.8 957.4 345.2 630.7 282.1 1283.9 475.2 221.0 164.7 459.6 459.5 290.2 521.2 637.3 1076.0 446.6 487.7 254.3 1569.2 887.2 897.8 487.2 236.1 1149.2 1089.0 556.7 478.0 394.8 540.9 583.3 496.5 426.0 262.2 497.0 319.7 504.9 443.7 435.3 595.3 339.7 661.7 472.5 403.1 1516.3 334.6 651.6 508.9 26.1 11.3 12.4 13.3 12.5 15.1 20.3 16.2 17.0 13.5 13.9 17.5 14.6 13.6 14.1 14.1 23.6 19.7 7.2 61.9 61.6 83.7 89.1 60.7 81.0 61.0 61.7 59.2 54.1 61.6 69.2 152.4 102.5 143.5 63.6 128.0 261.3 227.8 139.0 111.0 128.4 124.6 121.9 202.6 125.8 149.0 112.2 62.6 299.7 163.4 71.6 70.5 204.3 35.3 136.2 218.9 162.3 146.6 182.6 65.3 210.6 355.2 134.7 98.4 204.5 92.3 191.5 114.9 114.4 156.6 107.7 72.9 158.9 85.5 125.6 172.7 21.8 124.8 134.5 90.7 63.7 169.3 187.8 130.7 84.9 105.8 157.4 56.7 102.3 151.0 208.3 91.3 80.9 115.7 118.8 111.7 185.5 154.5 106.7 133.7 147.0 229.7 272.0 133.6 149.1 169.3 228.8 HNRNPK "CSBP, HNRPK, TUNP" ENSG00000165119 "Heterogeneous nuclear ribonucleoprotein K" P61978 9 83968083-83980616 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004435, HPA007644, CAB016225, HPA044105" Supported Enhanced Nucleoplasm NA NA 7100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812" "unprognostic (4.84e-2)" "unprognostic (4.69e-1)" "unprognostic (1.15e-2)" "unprognostic (8.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.83e-3)" "prognostic unfavorable (6.68e-5)" "unprognostic (3.46e-3)" "unprognostic (8.11e-2)" "unprognostic (1.47e-1)" "unprognostic (8.85e-3)" "unprognostic (2.81e-2)" "unprognostic (2.76e-3)" "unprognostic (2.23e-3)" "unprognostic (6.50e-2)" "unprognostic (4.59e-1)" "unprognostic (2.82e-1)" 283.6 308.1 186.1 326.2 197.1 637.3 265.3 202.4 236.6 264.5 227.4 270.2 287.0 297.0 227.3 276.8 269.7 243.8 275.8 188.8 220.3 279.2 346.8 240.4 401.9 203.1 187.8 317.5 247.4 350.8 198.2 325.8 203.0 251.3 277.5 342.2 242.2 251.4 315.3 256.1 282.9 287.6 205.7 298.3 250.1 183.4 194.4 548.5 297.2 312.9 423.7 351.2 230.7 241.0 926.1 624.2 1048.4 625.7 492.2 540.7 840.0 634.1 785.0 778.2 726.4 527.0 641.2 1087.2 425.8 671.1 673.8 689.5 1061.5 772.9 941.8 753.7 624.2 765.1 511.9 754.6 648.7 958.6 726.5 554.6 577.4 665.6 876.1 583.7 806.1 605.5 792.8 541.4 776.4 809.0 1198.4 652.1 934.7 929.3 599.3 1030.2 835.0 727.6 760.3 747.6 677.1 802.6 669.6 703.8 645.5 721.8 698.6 801.6 665.8 537.9 631.7 552.7 844.2 564.7 795.5 784.6 514.3 762.6 779.5 582.0 438.9 559.2 302.2 419.8 378.9 347.8 346.6 348.7 457.5 324.4 354.8 327.2 546.1 477.9 429.1 270.8 457.4 1012.5 186.1 197.1 202.4 236.6 188.8 220.3 203.1 187.8 203.0 205.7 194.4 241.0 354.7 205.1 270.0 58.4 398.4 506.0 540.7 421.5 313.0 180.9 281.6 203.3 195.0 230.2 322.4 263.0 89.6 585.3 379.9 288.1 395.2 448.2 43.4 326.2 329.0 331.7 387.0 447.9 45.9 368.3 738.5 323.4 233.9 384.2 336.8 300.0 260.9 356.6 388.4 156.5 51.2 379.2 307.2 352.9 412.9 45.4 334.6 333.4 327.3 58.1 448.9 362.5 338.8 71.9 116.2 397.0 282.7 321.2 281.0 353.3 260.0 416.7 308.1 182.6 276.1 340.9 479.7 345.9 241.7 309.5 448.7 728.5 368.6 334.9 406.9 453.2 HNRNPR "hnRNP-R, HNRPR" ENSG00000125944 "Heterogeneous nuclear ribonucleoprotein R" O43390 1 23303771-23344336 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011687, HPA026092" Supported Enhanced Nucleoplasm NA NA 470000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB011687: AB_2295532, HPA026092: AB_1850885" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.92e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.29e-2)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-3)" "unprognostic (3.28e-2)" "unprognostic (7.65e-2)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.14e-2)" "unprognostic (4.12e-1)" 51.1 47.9 18.4 48.7 21.6 56.6 49.0 26.0 22.9 55.0 22.3 44.7 33.6 66.1 25.8 54.9 52.6 29.0 40.4 18.1 22.2 43.8 27.2 47.6 58.0 20.2 19.6 61.6 34.0 42.3 33.9 50.0 21.6 35.0 43.2 40.2 46.7 31.8 55.9 51.2 46.7 44.7 20.1 41.9 38.9 31.0 19.2 71.9 43.5 27.7 60.0 48.3 50.1 26.8 161.7 103.9 200.9 123.5 70.0 73.6 103.6 102.7 118.0 178.3 123.0 73.2 113.4 202.3 52.1 141.4 88.9 89.5 211.0 143.9 208.5 142.3 161.4 192.5 131.0 121.9 68.4 224.2 125.1 74.8 86.7 141.5 113.4 73.3 112.9 153.0 185.4 139.9 119.2 98.3 268.3 71.6 111.6 105.3 103.4 196.9 186.5 144.1 96.5 88.7 137.3 132.6 141.8 116.0 88.7 109.5 98.6 102.6 121.0 102.6 133.4 123.8 129.5 81.3 149.0 276.8 71.9 200.7 117.7 21.7 35.9 44.9 49.0 47.2 51.7 41.4 45.0 47.7 45.8 41.6 48.0 45.5 12.8 53.9 48.1 30.0 58.4 46.6 18.4 21.6 26.0 22.9 18.1 22.2 20.2 19.6 21.6 20.1 19.2 26.8 112.0 118.6 109.1 29.0 132.7 127.6 207.1 139.0 95.6 127.8 89.1 78.0 72.3 84.4 138.0 88.3 43.8 253.0 125.8 60.2 92.0 126.6 22.9 110.5 183.8 129.3 116.4 150.4 28.6 126.5 274.4 135.3 92.2 146.2 172.0 171.4 61.8 73.1 106.6 126.2 32.6 107.8 138.4 77.7 92.4 17.2 120.9 98.8 83.6 36.5 147.7 159.9 112.3 63.3 60.6 125.2 64.1 116.6 144.3 208.5 59.6 76.9 114.5 111.1 85.5 159.1 170.2 170.4 148.3 136.4 129.9 206.7 136.5 157.3 116.8 182.4 HOOK3 HK3 ENSG00000168172 "Hook microtubule tethering protein 3" Q86VS8 8 42896946-43030535 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024756 Approved Supported "Golgi apparatus,Centriolar satellite,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "Centriolar satellite" "Golgi apparatus, Cytosol" "HPA024756: AB_1850913" "unprognostic (1.84e-2)" "unprognostic (1.61e-1)" "unprognostic (2.73e-1)" "unprognostic (8.61e-3)" "unprognostic (6.05e-2)" "unprognostic (1.77e-3)" "unprognostic (2.36e-1)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.13e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.63e-1)" "unprognostic (3.78e-1)" "unprognostic (2.55e-1)" "unprognostic (7.12e-2)" 9.8 6.2 3.1 7.4 8.7 11.1 8.9 11.9 8.9 8.2 1.5 7.5 7.5 8.3 8.2 10.6 7.0 14.4 4.6 4.0 11.1 6.6 7.3 8.0 6.6 7.6 4.9 6.1 7.6 7.2 4.1 8.6 7.3 12.4 7.7 8.8 9.6 7.1 10.6 8.1 8.9 6.7 4.4 6.6 9.5 11.4 4.9 6.4 21.7 8.2 7.4 9.3 6.0 15.5 11.2 10.9 26.2 14.2 19.0 16.7 10.1 14.0 11.6 11.5 10.7 14.5 12.8 13.9 13.9 18.8 10.9 6.4 22.1 9.5 18.5 9.5 6.4 26.3 9.2 10.2 10.6 2.8 14.9 13.7 6.6 15.4 13.2 15.9 16.7 9.7 14.7 15.9 14.0 2.7 21.7 5.2 9.5 8.8 3.3 12.6 27.3 3.5 8.6 16.5 6.7 10.6 15.9 6.7 7.4 11.4 12.2 9.4 30.2 17.1 13.2 20.9 9.0 15.6 18.6 18.1 14.5 9.9 25.8 9.4 2.0 2.0 1.2 2.0 0.4 0.9 1.1 0.9 2.4 0.9 0.6 0.8 2.2 1.2 1.9 1.4 0.8 1.1 3.1 8.7 11.9 8.9 4.0 11.1 7.6 4.9 7.3 4.4 4.9 15.5 75.3 93.0 60.6 90.1 43.2 68.3 36.2 28.7 43.3 40.1 29.4 22.4 48.2 44.3 43.6 25.8 33.3 43.6 40.6 26.1 27.4 47.1 120.3 60.0 84.0 65.2 65.4 34.5 102.1 32.8 25.9 65.8 33.1 93.8 53.8 37.9 60.3 36.4 38.0 75.7 107.6 26.9 20.3 79.4 96.4 36.3 44.7 82.8 55.2 78.7 118.6 36.3 37.0 119.1 157.8 59.7 27.6 53.8 43.6 43.5 37.3 21.4 35.2 32.2 65.7 63.4 74.6 28.0 21.5 39.8 74.7 113.7 40.9 42.6 16.2 71.1 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3 biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129638-149173732 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 115.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: AB_2681943" "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 7.6 9.2 4.2 11.4 4.7 5.6 7.9 4.8 4.2 7.5 8.3 7.5 11.0 9.9 4.9 5.6 8.6 9.0 5.0 3.7 6.0 12.0 8.0 9.7 17.6 6.7 5.6 14.0 6.7 5.7 3.7 10.6 6.8 9.3 9.1 9.6 6.6 8.5 2.8 4.7 10.8 10.3 5.6 16.0 9.2 6.9 5.2 16.8 8.8 3.9 16.4 8.4 5.2 8.5 49.1 26.5 15.7 16.3 21.4 27.4 11.7 19.7 38.4 25.3 32.4 9.1 31.8 12.4 23.8 23.7 115.3 16.5 17.4 13.4 32.4 30.6 13.9 5.8 11.8 9.9 19.1 15.7 9.1 18.0 13.5 24.4 10.0 51.6 26.2 20.2 6.5 29.4 32.5 30.3 11.3 22.1 37.7 26.3 21.1 13.4 10.3 33.7 13.9 24.1 4.7 12.4 16.8 17.7 35.9 33.4 19.2 20.5 13.2 25.2 4.5 26.0 29.0 24.0 10.0 30.6 37.7 30.1 6.3 20.7 12.5 12.1 12.0 15.2 14.5 15.4 10.9 12.9 19.5 12.2 8.4 10.9 5.7 9.8 10.3 11.0 10.7 10.9 4.2 4.7 4.8 4.2 3.7 6.0 6.7 5.6 6.8 5.6 5.2 8.5 9.9 12.8 19.5 17.6 28.6 3.7 3.9 11.5 6.8 6.7 9.1 7.4 2.5 5.7 22.9 7.3 2.1 21.0 24.3 8.0 5.9 10.7 3.0 10.6 11.6 9.9 9.0 7.4 13.3 18.1 14.6 10.8 16.8 10.4 15.2 18.0 17.5 6.9 19.8 3.3 16.5 8.8 14.2 29.3 23.8 4.8 11.5 33.1 14.2 38.4 14.4 25.1 19.6 19.1 27.3 12.9 4.9 30.1 15.4 6.8 13.6 22.8 20.7 5.2 0.0 7.4 8.4 4.4 8.4 8.7 5.3 14.1 18.9 5.4 7.5 5.1 HSPB11 "C1orf41, FAP232, HSPCO34, IFT25, PP25" ENSG00000081870 "Heat shock protein family B (small) member 11" Q9Y547 1 53916574-53945699 "Human disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Stress response, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 412.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030140 Uncertain Approved Nucleoplasm,Cytosol NA NA 38000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Cytosol "HPA030140: AB_10600713" "unprognostic (5.73e-2)" "unprognostic (6.37e-3)" "unprognostic (8.81e-2)" "unprognostic (2.99e-3)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (9.58e-7)" "unprognostic (5.12e-1)" "unprognostic (6.70e-3)" "unprognostic (8.31e-3)" "unprognostic (2.22e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.84e-2)" "unprognostic (2.74e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-2)" 25.9 36.4 36.2 34.1 37.1 61.2 46.5 35.5 49.9 33.9 46.4 31.9 25.0 42.6 70.5 30.1 79.6 26.8 26.6 38.4 36.9 35.3 55.1 29.7 62.5 35.5 35.5 41.8 26.4 30.8 23.1 41.6 35.6 34.9 34.5 29.8 24.0 36.6 11.4 37.3 26.0 36.8 36.3 34.8 36.8 30.7 35.3 55.8 96.8 19.6 62.3 39.5 19.2 38.6 115.4 50.3 141.8 31.2 51.1 67.7 59.4 95.8 91.4 142.5 163.8 122.2 60.5 134.7 77.1 69.6 251.8 88.9 62.2 99.5 168.7 114.6 91.6 166.6 108.1 163.7 58.2 83.7 108.0 70.0 76.7 135.5 37.0 88.4 77.4 82.5 102.3 30.6 184.4 24.9 184.8 132.4 59.5 96.1 111.5 125.5 184.3 72.5 118.3 128.7 74.2 59.8 140.7 64.8 95.4 142.7 396.4 118.5 52.7 92.4 115.1 104.9 107.8 54.6 97.3 141.7 148.5 78.1 81.5 171.2 47.4 130.6 87.0 65.9 78.8 95.6 85.6 104.7 56.8 76.9 67.1 84.9 33.5 109.4 71.8 121.8 122.0 58.3 36.2 37.1 35.5 49.9 38.4 36.9 35.5 35.5 35.6 36.3 35.3 38.6 37.8 32.1 31.4 14.7 54.3 106.4 79.6 244.6 68.9 22.4 67.5 73.2 42.7 42.9 134.6 51.5 8.4 181.9 72.0 42.4 117.4 60.4 55.7 249.2 60.0 40.7 77.3 48.6 18.2 65.7 101.3 59.0 27.5 60.3 61.5 59.3 31.8 64.9 115.0 13.5 16.9 42.2 217.7 46.5 74.8 15.7 61.5 57.2 78.2 11.2 80.5 87.8 70.0 13.0 22.9 79.6 52.0 63.6 80.8 70.5 54.7 119.2 412.1 19.8 39.5 32.6 93.0 130.0 97.9 66.4 82.8 116.8 73.7 120.3 39.7 118.0 ICE1 KIAA0947 ENSG00000164151 "Interactor of little elongation complex ELL subunit 1" Q9Y2F5 5 5420664-5490220 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054452, HPA061934" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA054452: AB_2682492, HPA061934: AB_2684641" "unprognostic (1.45e-2)" "unprognostic (9.73e-2)" "unprognostic (6.92e-2)" "unprognostic (2.39e-3)" "unprognostic (4.42e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.16e-1)" "unprognostic (4.29e-1)" "unprognostic (1.78e-1)" "unprognostic (3.51e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (4.59e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-2)" "unprognostic (2.33e-1)" 8.7 6.9 8.1 9.1 8.8 13.7 10.2 11.3 8.4 8.7 4.4 9.0 7.2 11.6 9.0 7.6 8.2 7.1 8.1 10.2 7.0 10.0 7.1 8.1 11.5 6.2 5.7 13.9 9.2 14.1 7.5 12.7 6.4 7.8 7.8 12.8 7.5 8.8 16.5 8.7 7.5 10.3 4.5 10.0 7.7 7.5 7.1 14.5 10.2 15.5 11.3 9.5 6.6 8.1 17.9 22.1 24.8 23.9 23.6 23.1 32.0 15.1 18.0 17.8 19.5 17.1 12.9 24.1 20.6 21.8 35.1 16.5 34.4 17.7 29.8 33.4 17.5 19.5 68.9 12.5 14.3 44.5 15.4 18.5 18.6 21.3 32.8 17.7 22.3 18.0 28.1 19.5 18.8 15.6 32.6 15.9 21.0 11.4 18.6 37.7 22.6 16.3 15.0 19.9 16.0 16.6 52.5 16.9 20.2 23.8 14.7 13.9 25.4 23.0 29.4 29.9 23.9 21.1 26.9 39.6 19.3 32.9 19.9 0.4 0.5 1.1 0.9 0.7 1.1 0.9 0.8 0.9 0.5 0.8 0.7 0.9 0.1 1.1 0.4 1.1 1.1 0.3 8.1 8.8 11.3 8.4 10.2 7.0 6.2 5.7 6.4 4.5 7.1 8.1 29.8 22.4 29.5 42.1 30.3 0.0 17.7 0.0 26.2 40.2 20.1 26.3 33.0 14.3 14.2 16.5 31.3 35.6 35.1 10.8 25.4 22.6 5.8 19.5 37.4 27.5 9.0 23.5 68.2 22.7 22.4 25.0 19.9 25.7 11.4 28.6 15.4 13.8 15.7 45.4 57.3 11.6 0.0 13.8 0.0 5.2 22.4 19.9 0.0 36.5 26.1 24.6 17.5 39.7 62.1 23.0 6.4 22.2 37.5 24.1 11.1 14.8 6.6 34.7 6.6 50.5 27.8 51.6 47.0 25.9 0.0 10.9 33.9 36.4 11.4 16.9 IFNLR1 "CRF2/12, IFNLR, IL-28R1, IL28RA" ENSG00000185436 "Interferon lambda receptor 1" Q8IU57 1 24154168-24187959 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 17.4;Proximal enterocytes: 18.2;Urothelial cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory B-cell: 4.9;naive B-cell: 5.9;plasmacytoid DC: 11.3" "Group enriched" "Detected in many" 5 "B-cells: 5.9;dendritic cells: 11.3" "Cell line enhanced" "Detected in many" "U-266/70: 51.4;U-266/84: 19.4;U-698: 40.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017319 Uncertain Approved Cytosol "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA017319: AB_1851708" "prognostic favorable (5.12e-4)" "unprognostic (7.16e-2)" "unprognostic (8.61e-3)" "unprognostic (8.48e-2)" "unprognostic (8.09e-2)" "unprognostic (1.22e-2)" "unprognostic (7.28e-3)" "unprognostic (2.33e-1)" "unprognostic (5.10e-2)" "unprognostic (1.93e-1)" "unprognostic (5.51e-2)" "unprognostic (4.50e-1)" "unprognostic (3.66e-3)" "unprognostic (5.15e-2)" "unprognostic (1.69e-1)" "unprognostic (2.69e-1)" "unprognostic (1.10e-1)" 0.4 2.2 1.1 2.8 1.2 0.6 2.6 6.2 1.1 1.7 2.2 3.8 5.8 0.9 1.9 3.6 1.8 2.1 3.1 0.8 2.6 3.0 8.4 2.9 7.8 2.5 2.2 1.3 5.0 5.2 5.9 0.3 2.5 3.4 4.0 1.8 4.5 2.1 3.6 7.3 9.2 0.4 1.9 2.8 2.9 1.0 2.7 1.4 4.4 1.3 9.7 2.1 2.3 2.7 6.7 1.3 0.0 0.0 0.0 0.0 1.6 0.0 0.6 1.2 1.0 11.3 1.9 14.3 15.1 0.0 5.4 5.0 6.6 11.6 0.9 3.0 3.5 0.0 2.3 3.4 0.0 0.0 0.0 0.0 3.8 0.3 3.5 2.5 0.0 2.9 0.3 0.0 0.0 1.6 0.2 0.4 14.0 0.5 4.1 0.1 0.0 1.2 2.6 2.8 2.0 1.3 3.5 2.0 1.4 2.4 2.7 0.1 0.0 0.0 2.7 0.0 0.1 51.4 19.4 40.8 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.3 4.9 0.3 1.4 0.0 5.9 0.5 1.4 0.0 0.0 0.0 11.3 0.3 0.5 1.1 1.2 6.2 1.1 0.8 2.6 2.5 2.2 2.5 1.9 2.7 2.7 0.5 0.0 4.8 2.3 5.9 11.1 10.0 4.1 12.5 3.4 1.4 3.2 3.5 2.8 2.3 1.8 0.0 0.6 5.3 17.4 3.9 2.9 2.2 3.4 0.2 0.5 0.0 0.0 2.2 2.3 1.0 0.8 3.1 2.7 0.0 1.5 0.0 8.4 2.3 0.0 2.8 4.1 0.0 0.8 1.9 4.3 0.3 3.0 0.0 2.8 5.5 2.9 0.0 0.5 0.1 2.4 6.1 0.0 12.5 4.3 18.2 2.3 5.1 2.3 0.0 0.0 0.6 0.0 0.7 8.3 12.6 0.3 2.2 0.1 3.3 17.2 INIP "C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C" ENSG00000148153 "INTS3 and NABP interacting protein" Q9NRY2 9 112683926-112718149 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020382 Approved Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA020382: AB_1845840" "prognostic unfavorable (7.08e-4)" "unprognostic (1.67e-1)" "unprognostic (9.64e-2)" "unprognostic (2.35e-1)" "unprognostic (8.05e-2)" "unprognostic (8.56e-2)" "unprognostic (1.01e-2)" "unprognostic (6.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (4.47e-3)" "prognostic favorable (2.00e-8)" "prognostic favorable (2.53e-4)" "unprognostic (2.28e-1)" "unprognostic (3.50e-2)" "unprognostic (1.26e-1)" 7.4 8.7 8.0 8.4 10.9 10.4 11.4 9.7 11.9 8.0 5.4 10.1 10.3 7.2 8.6 9.8 8.4 8.6 7.5 8.1 9.6 10.8 11.0 8.4 14.5 9.2 8.8 8.2 5.0 10.7 6.5 6.1 9.6 6.9 11.5 10.3 8.1 6.5 6.5 9.2 10.9 7.6 8.4 9.7 7.4 5.4 9.6 14.5 10.6 10.0 14.1 9.3 6.2 15.5 16.5 15.6 21.4 31.0 18.2 19.2 21.9 22.7 12.4 19.4 19.3 19.7 13.2 43.8 13.9 15.7 14.6 22.9 21.0 10.9 25.8 53.0 12.3 18.2 17.6 18.0 11.8 37.1 13.3 10.4 14.7 20.6 16.6 9.5 18.2 22.1 31.7 27.5 21.4 27.8 33.3 19.0 11.1 29.8 28.8 36.5 45.1 18.9 22.2 21.9 27.9 20.9 28.7 18.1 15.7 14.2 27.1 23.1 15.4 16.1 24.7 30.9 22.4 13.7 62.4 37.3 20.4 21.3 27.7 30.4 24.8 32.5 15.7 29.3 20.7 15.5 20.1 23.4 27.1 20.0 21.8 18.9 19.8 18.4 27.0 9.7 20.8 20.3 8.0 10.9 9.7 11.9 8.1 9.6 9.2 8.8 9.6 8.4 9.6 15.5 15.6 22.4 15.6 9.1 19.1 36.7 18.1 31.4 13.1 17.1 19.2 16.5 15.5 15.7 22.4 14.7 16.7 21.4 20.6 19.4 56.7 23.4 3.9 21.0 18.8 18.1 22.3 19.4 18.3 16.1 32.0 14.9 12.8 18.7 26.6 11.2 15.7 17.7 26.1 43.7 15.4 17.1 32.6 24.5 33.5 3.2 14.0 26.2 19.6 3.7 42.3 24.7 34.0 16.6 25.2 24.2 12.3 12.0 11.8 17.9 21.7 31.7 13.0 16.9 0.0 17.3 13.1 17.4 15.8 19.4 41.8 14.8 23.0 12.4 19.8 25.2 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" No No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 12.5 15.8 13.2 14.2 15.8 18.0 22.3 14.7 16.6 20.9 18.2 21.8 14.1 18.1 27.4 16.1 24.2 19.6 13.4 13.5 14.8 21.3 21.1 15.6 22.7 14.5 14.9 18.4 17.7 22.9 16.3 19.2 14.6 19.1 23.6 13.1 16.2 19.8 9.9 18.0 17.2 18.8 14.8 18.9 18.1 18.9 15.8 25.4 23.2 13.6 24.3 23.6 13.6 17.7 26.4 46.7 46.1 36.8 25.2 31.4 29.5 28.4 36.5 46.4 42.5 42.2 61.2 42.9 38.9 35.6 38.5 52.0 99.4 47.6 40.5 37.8 60.2 37.5 32.2 46.4 50.0 38.7 46.2 30.6 46.9 35.1 53.7 34.1 50.8 64.8 52.2 24.3 33.4 41.7 44.3 41.2 33.8 66.2 25.6 37.5 38.8 49.0 36.7 48.6 33.1 26.3 34.2 34.5 49.5 39.2 32.3 44.0 25.2 31.8 33.2 28.8 45.6 23.9 48.4 58.1 32.1 70.0 38.1 25.7 11.0 6.2 19.8 12.7 22.3 19.3 20.3 22.6 19.8 14.8 21.1 19.2 1.2 23.8 9.5 17.9 30.8 16.6 13.2 15.8 14.7 16.6 13.5 14.8 14.5 14.9 14.6 14.8 15.8 17.7 12.2 22.4 10.9 0.0 3.8 0.0 0.0 0.0 0.0 0.0 13.0 11.0 0.0 0.0 5.6 12.9 0.0 40.5 7.7 0.0 21.5 18.2 0.0 12.8 11.8 6.8 0.0 0.0 0.0 15.4 30.5 6.7 0.0 12.6 7.6 22.5 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 9.3 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.5 0.0 0.0 15.1 10.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 49.8 4.8 24.0 0.0 0.0 INTS2 "INT2, KIAA1287" ENSG00000108506 "Integrator complex subunit 2" Q9H0H0 17 61865367-61928016 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049524 Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" "HPA049524: AB_2680804" "unprognostic (4.57e-3)" "unprognostic (2.11e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.72e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.52e-1)" "unprognostic (7.79e-2)" "unprognostic (5.91e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (7.03e-2)" "unprognostic (1.81e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.42e-1)" 3.2 3.0 0.3 3.6 1.0 2.5 3.0 2.5 1.4 3.2 0.2 2.8 2.7 3.3 1.0 3.6 2.8 1.5 3.1 0.3 0.4 2.1 2.7 2.6 5.4 0.8 0.5 3.1 2.2 4.0 3.1 2.5 0.5 2.4 3.3 4.3 2.9 0.8 3.1 3.6 3.1 1.9 0.0 3.4 2.8 4.6 1.1 4.9 2.7 1.7 5.4 2.8 3.3 1.9 8.9 15.4 14.8 8.2 4.5 5.2 6.8 6.2 3.6 9.1 6.9 9.1 4.9 17.7 5.0 3.2 11.4 12.7 14.3 4.1 15.2 8.2 10.5 20.7 6.1 15.8 2.8 26.0 14.3 4.0 6.0 6.9 14.2 5.0 6.6 11.5 19.0 10.6 6.4 17.2 31.0 10.5 5.5 12.7 10.4 23.3 39.6 13.9 3.5 7.9 11.3 12.6 7.7 4.2 5.9 10.3 18.1 8.7 6.6 19.8 12.9 6.8 8.9 8.4 16.2 24.3 6.0 9.6 6.2 2.1 0.3 0.2 0.9 0.6 1.4 1.5 1.0 1.3 0.8 0.4 1.1 1.4 0.4 0.4 0.9 0.7 1.2 0.4 0.3 1.0 2.5 1.4 0.3 0.4 0.8 0.5 0.5 0.0 1.1 1.9 7.3 6.4 3.1 17.3 8.3 4.6 3.3 4.7 6.8 12.9 5.9 4.6 9.1 8.6 6.1 1.8 14.6 5.5 6.7 3.3 0.0 3.3 4.5 8.4 8.4 5.8 2.4 9.4 19.8 2.6 3.9 5.9 5.1 9.3 5.1 11.1 6.1 6.4 5.3 15.2 26.4 5.7 6.1 7.9 2.2 9.6 4.4 6.0 0.0 9.4 7.4 6.0 3.1 24.1 37.3 4.7 1.7 3.4 5.4 4.9 3.1 1.7 8.4 10.9 0.0 8.0 7.3 12.4 10.9 9.1 5.4 2.2 8.7 7.1 5.8 3.8 IPCEF1 "KIAA0403, PIP3-E" ENSG00000074706 "Interaction protein for cytohesin exchange factors 1" Q8WWN9 6 154154496-154356792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "bone marrow: 17.7;brain: 13.6;lymphoid tissue: 13.5;thyroid gland: 39.1" "Cell type enhanced" "Detected in many" "dendritic cells: 46.1;Excitatory neurons: 120.0;Microglial cells: 252.9;T-cells: 65.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 71.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HMC-1: 19.8;THP-1: 10.5;U-937: 11.0" "Low region specificity" "Detected in all" "HPA028708, HPA028710" Supported Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: AB_2732442" "unprognostic (1.23e-2)" "unprognostic (8.93e-3)" "unprognostic (4.18e-2)" "unprognostic (5.63e-3)" "unprognostic (2.05e-1)" "unprognostic (6.55e-3)" "unprognostic (1.30e-3)" "unprognostic (2.57e-2)" "unprognostic (3.87e-1)" "unprognostic (5.84e-2)" "unprognostic (3.27e-2)" "unprognostic (4.87e-2)" "unprognostic (5.01e-2)" "unprognostic (8.64e-2)" "unprognostic (5.45e-2)" "unprognostic (1.42e-2)" "unprognostic (1.51e-4)" 0.7 0.2 8.4 7.9 5.4 17.7 1.5 4.1 13.6 2.7 0.0 1.3 0.7 1.1 1.4 1.4 2.1 2.9 0.6 5.4 3.2 2.8 2.0 1.5 13.5 0.0 7.4 0.6 0.7 0.1 0.6 1.6 0.0 0.8 1.2 0.2 1.2 0.4 0.2 0.5 2.3 0.9 0.0 6.8 2.4 0.9 12.2 10.6 39.1 0.2 12.8 2.1 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 19.8 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 3.1 1.2 0.8 0.0 0.5 0.1 0.1 0.3 0.7 2.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.0 0.0 3.2 14.5 71.6 13.0 6.5 27.6 0.0 16.3 12.5 16.2 0.1 27.9 16.8 42.7 14.3 8.5 0.4 22.6 12.6 8.4 5.4 4.1 13.6 5.4 3.2 0.0 7.4 0.0 0.0 12.2 5.4 1.1 0.0 1.7 7.8 3.5 0.6 0.5 0.4 12.0 0.6 1.8 1.0 1.1 1.5 1.7 1.8 0.0 1.7 46.1 0.0 7.9 2.1 1.3 2.0 1.2 2.3 0.0 3.2 120.0 0.0 0.1 1.0 3.1 2.5 0.0 0.1 3.3 1.1 2.8 3.3 9.8 0.5 2.0 23.4 15.2 0.3 0.3 15.2 0.0 252.9 17.9 0.2 27.8 9.0 14.6 0.0 0.1 0.4 20.7 0.6 0.1 2.0 1.3 0.2 0.0 3.4 0.4 0.2 1.1 4.0 0.6 2.7 65.5 2.0 0.3 1.3 IQCB1 "KIAA0036, NPHP5, SLSN5" ENSG00000173226 "IQ motif containing B1" Q15051 3 121769761-121835079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 155.3;Spermatogonia: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 131.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042028 Approved Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA042028: AB_2677806" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (3.08e-5)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "unprognostic (6.78e-3)" "unprognostic (1.50e-3)" "unprognostic (2.59e-3)" "unprognostic (2.75e-1)" "unprognostic (1.67e-1)" "unprognostic (4.75e-3)" 11.6 11.2 9.6 14.7 10.0 20.4 23.1 11.0 10.5 15.7 10.8 13.0 12.0 15.5 19.7 12.5 16.6 12.1 9.7 10.1 10.1 12.2 8.9 12.3 24.3 9.7 9.5 17.9 18.3 13.9 15.3 11.5 9.5 15.9 16.2 18.9 15.6 15.5 11.4 15.5 14.1 11.8 9.7 18.3 12.3 28.9 10.4 22.1 10.5 5.7 25.7 14.2 13.7 11.0 38.3 10.1 48.9 55.5 7.5 11.6 57.2 17.4 10.8 19.7 23.8 33.6 18.1 76.8 23.9 10.1 30.2 28.7 30.5 14.5 29.3 15.1 23.8 51.2 22.2 28.7 20.0 64.1 14.8 7.4 27.2 13.7 30.3 10.2 15.2 32.4 31.0 27.9 22.3 19.3 41.7 44.5 40.1 22.6 18.1 40.4 23.4 24.9 11.4 16.9 26.0 20.9 17.3 12.2 31.3 16.0 10.8 49.4 12.9 18.5 22.4 9.1 23.4 66.4 44.9 131.2 17.9 29.0 17.1 3.2 6.6 11.7 7.2 12.3 10.5 22.8 9.8 9.0 9.6 21.6 11.5 7.2 2.8 12.2 14.1 8.7 11.7 6.4 9.6 10.0 11.0 10.5 10.1 10.1 9.7 9.5 9.5 9.7 10.4 11.0 15.8 6.4 15.0 48.3 28.4 18.9 19.2 20.0 19.9 15.2 19.6 17.3 8.4 11.5 26.5 11.0 27.1 26.6 21.9 7.7 3.9 11.1 3.7 31.1 12.7 11.2 7.2 21.5 60.1 12.9 8.2 15.4 11.7 12.6 8.8 21.9 6.8 6.2 10.5 13.5 66.8 8.6 20.3 9.8 14.1 7.4 15.5 11.3 14.2 51.5 15.8 12.8 17.5 49.3 59.5 13.9 8.2 13.5 45.2 15.7 7.9 7.5 69.2 27.7 13.1 17.8 15.9 155.3 96.5 16.2 20.6 14.1 19.9 8.4 11.9 16.3 IRAK1BP1 "AIP70, SIMPL" ENSG00000146243 "Interleukin 1 receptor associated kinase 1 binding protein 1" Q5VVH5 6 78867551-78946440 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 65.4;Excitatory neurons: 73.1;Inhibitory neurons: 57.2;Late spermatids: 52.0;Oligodendrocyte precursor cells: 56.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 5.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035742, HPA035743" Uncertain Approved Vesicles NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA035742: AB_10670119, HPA035743: AB_2674764" "unprognostic (2.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (5.82e-2)" "unprognostic (2.12e-1)" "unprognostic (2.38e-3)" "unprognostic (3.93e-2)" "unprognostic (6.55e-2)" "unprognostic (2.34e-2)" "unprognostic (1.32e-2)" "unprognostic (9.88e-2)" "unprognostic (2.81e-2)" "unprognostic (4.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.39e-2)" "unprognostic (2.58e-1)" 1.5 1.8 0.4 1.0 1.0 5.3 2.4 5.3 2.8 1.8 1.7 1.7 1.1 2.8 4.4 1.2 3.2 1.4 1.7 1.0 0.5 2.9 0.9 2.2 1.8 0.3 0.1 3.1 3.2 3.6 3.4 1.1 0.6 1.8 1.4 5.6 2.6 2.4 1.2 2.3 1.4 2.1 0.0 2.0 3.5 3.9 0.5 3.0 3.3 1.1 1.0 1.5 1.5 1.4 1.1 2.0 3.7 3.5 1.6 3.5 2.1 0.8 2.1 0.8 1.4 1.8 0.9 1.6 0.9 1.9 2.0 2.3 7.1 3.4 1.4 3.7 2.8 1.3 2.4 0.9 2.1 7.6 1.3 2.9 3.3 1.5 1.8 2.7 2.7 4.9 4.0 2.1 1.3 0.6 2.2 3.8 1.8 0.5 2.0 0.4 2.2 1.2 3.6 1.9 5.1 6.0 1.1 1.2 0.9 2.4 2.8 5.1 1.9 1.8 1.3 0.6 2.4 2.5 3.3 2.2 0.6 0.3 2.3 0.9 0.0 0.0 0.3 0.0 0.2 0.3 0.3 0.1 0.1 0.2 0.4 0.4 0.4 0.2 0.1 0.4 0.4 0.1 0.4 1.0 5.3 2.8 1.0 0.5 0.3 0.1 0.6 0.0 0.5 1.4 6.1 19.2 7.8 39.2 3.3 2.5 5.3 3.9 10.8 10.3 5.2 8.5 13.6 8.6 9.3 3.7 33.3 3.6 3.5 1.0 9.8 5.5 65.4 20.5 11.5 5.5 6.6 7.8 73.1 6.0 0.8 5.8 5.1 3.6 0.0 11.6 5.0 2.4 1.6 5.0 57.2 2.7 0.0 1.3 0.9 52.0 10.5 1.6 0.0 22.5 0.8 12.9 2.1 56.3 33.6 3.3 1.0 8.2 3.1 1.2 0.6 11.8 21.5 17.9 13.1 8.2 8.1 42.3 15.2 6.3 2.6 0.8 2.5 11.1 3.2 2.8 IREB2 IRP2 ENSG00000136381 "Iron responsive element binding protein 2" P48200 15 78437431-78501453 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032885, HPA040371, HPA068982" Uncertain Approved "Cell Junctions,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Cell Junctions" Cytosol "CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064" "unprognostic (1.00e-2)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (3.44e-2)" "unprognostic (3.39e-2)" "unprognostic (2.29e-1)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (7.30e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (6.51e-2)" "unprognostic (3.85e-3)" "unprognostic (4.09e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (9.40e-2)" 17.1 25.2 7.5 18.2 7.7 27.7 18.8 16.3 9.3 15.2 8.4 17.4 17.9 17.9 11.8 15.2 14.6 14.9 12.5 7.4 10.5 18.3 23.1 14.9 22.8 7.0 7.2 22.0 11.4 17.8 8.2 21.8 7.1 16.5 20.3 19.4 10.6 15.4 18.8 14.4 18.4 16.1 7.0 24.8 16.4 15.1 9.5 29.7 28.7 23.5 20.9 13.4 11.7 8.8 19.9 34.9 52.8 33.2 45.5 29.7 35.5 33.3 26.0 29.7 26.9 34.6 33.8 73.1 22.1 28.0 20.3 37.8 124.7 33.2 26.1 23.4 43.0 63.6 35.0 24.4 23.8 69.4 65.7 31.5 22.4 22.9 27.7 30.2 35.4 42.6 67.9 25.4 25.5 29.7 42.8 35.2 69.1 24.1 12.4 49.6 53.0 20.8 32.4 54.2 31.7 47.3 45.1 31.4 35.7 59.2 29.5 59.7 28.9 30.3 20.8 16.8 29.2 31.5 74.8 41.7 21.8 63.1 22.2 3.8 2.5 2.0 2.4 3.3 3.1 2.7 2.6 2.4 3.5 2.6 2.5 3.5 2.8 3.0 2.6 4.0 2.3 1.4 7.5 7.7 16.3 9.3 7.4 10.5 7.0 7.2 7.1 7.0 9.5 8.8 24.3 22.4 40.7 33.0 37.5 14.1 16.6 19.3 14.8 55.6 23.1 18.4 24.9 25.8 26.1 23.9 66.7 35.0 56.2 45.3 0.0 19.9 18.1 19.3 38.2 26.6 31.9 42.3 52.3 19.6 23.7 27.7 32.1 21.2 17.7 66.2 38.9 41.8 26.1 79.1 55.6 31.0 18.3 61.3 18.4 10.8 32.9 37.7 14.2 28.1 52.9 22.4 54.6 50.3 49.0 26.3 49.8 30.5 28.5 33.7 49.1 19.6 25.7 51.1 6.6 29.5 23.2 33.9 29.6 24.5 18.6 30.6 33.9 56.3 36.0 29.6 IST1 "CHMP8, KIAA0174" ENSG00000182149 "IST1 factor associated with ESCRT-III" P53990 16 71845996-71931199 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041802, HPA054532" Approved Supported Vesicles NA NA 270000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA041802: AB_10794491, HPA054532: AB_2682517" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-3)" "unprognostic (2.04e-2)" "unprognostic (3.13e-3)" "unprognostic (2.11e-2)" "unprognostic (4.49e-2)" "unprognostic (3.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "prognostic favorable (4.55e-4)" "unprognostic (1.64e-2)" "unprognostic (7.88e-3)" "unprognostic (8.43e-3)" "prognostic favorable (8.88e-4)" 47.7 44.1 43.2 38.8 49.7 81.0 50.5 46.2 50.6 49.0 43.9 68.3 52.4 55.9 42.4 50.5 61.4 46.8 50.4 42.9 45.3 68.7 37.9 50.0 64.3 47.2 47.6 60.0 46.9 90.4 57.2 60.1 47.1 45.7 62.9 32.4 52.0 45.8 64.1 52.5 52.0 60.8 45.5 50.6 52.5 47.4 46.1 62.2 59.4 80.8 81.6 53.0 44.3 53.8 57.0 81.9 113.3 73.2 110.7 77.9 95.7 70.0 87.1 95.2 98.9 90.1 77.1 80.5 84.2 81.2 67.7 83.8 112.0 74.2 120.4 53.7 54.1 68.1 46.8 146.9 83.8 66.9 91.9 92.7 100.8 85.5 81.6 94.8 120.6 74.8 94.5 28.7 99.5 94.9 87.4 55.6 129.7 92.7 50.6 135.7 62.0 99.1 78.5 81.8 85.0 63.3 77.2 40.3 63.9 138.2 73.7 82.2 60.7 71.8 70.9 44.5 55.9 75.0 145.5 226.7 60.7 59.2 88.6 234.9 195.1 243.5 158.7 185.4 172.6 179.1 150.6 166.9 180.1 178.5 159.6 150.1 300.0 193.7 185.1 124.9 244.9 293.9 43.2 49.7 46.2 50.6 42.9 45.3 47.2 47.6 47.1 45.5 46.1 53.8 59.7 48.1 51.8 39.8 57.1 70.1 41.2 49.8 39.9 29.2 69.1 50.0 43.9 60.1 48.1 46.0 25.0 56.7 68.4 130.6 35.2 47.1 18.4 50.0 52.8 55.4 75.4 30.7 35.5 41.7 44.3 48.1 42.3 70.1 61.4 55.1 61.1 40.8 53.4 21.9 41.6 76.3 46.8 81.1 73.8 22.5 41.0 57.2 42.7 38.4 75.9 22.2 51.5 34.2 59.7 58.1 88.4 47.8 45.2 51.5 82.2 52.4 56.2 30.3 59.2 45.3 44.4 52.4 57.3 34.4 70.0 65.7 51.8 31.3 57.6 66.4 ISY1-RAB43 ENSG00000261796 "ISY1-RAB43 readthrough" 3 129087575-129161036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.5;granulocytes: 1.3;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA006312, HPA016995" Approved Enhanced "Nuclear speckles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 11: Alveolar cells - Smell perception" "Nuclear speckles" "HPA006312: AB_1079734, HPA016995: AB_1852387" "unprognostic (1.09e-1)" "unprognostic (5.42e-2)" "unprognostic (1.52e-1)" "unprognostic (9.05e-3)" "unprognostic (2.81e-1)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (2.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.89e-1)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (1.87e-1)" 7.6 7.2 2.4 10.1 2.8 7.1 7.5 2.4 5.7 7.3 2.5 7.6 3.9 8.1 4.4 5.2 6.9 4.2 5.7 2.3 2.9 7.8 9.6 9.4 8.1 2.5 2.6 9.4 7.2 8.8 5.6 6.5 3.2 7.6 7.4 2.7 6.6 8.3 3.9 5.5 6.7 7.7 2.1 9.2 6.8 5.1 2.7 16.7 7.6 3.7 9.0 7.6 4.6 3.5 26.1 5.7 12.9 11.9 15.8 9.3 5.6 12.2 28.5 19.4 23.6 3.0 13.1 0.9 17.7 22.0 22.2 9.8 5.1 20.4 11.9 9.9 1.0 2.4 2.5 10.2 27.1 10.8 12.9 21.5 10.7 12.1 7.7 19.2 25.4 23.7 4.2 9.9 16.9 10.8 16.3 7.7 9.1 27.7 6.7 13.7 5.6 9.1 20.8 9.9 0.9 5.8 5.8 13.1 18.9 10.7 6.5 10.3 21.0 9.4 7.9 13.5 5.6 14.3 7.0 4.4 10.7 1.1 13.3 0.1 0.5 0.1 0.6 0.2 0.6 0.0 0.6 0.8 0.2 0.1 0.8 0.7 0.6 0.6 0.4 0.2 0.4 0.6 2.4 2.8 2.4 5.7 2.3 2.9 2.5 2.6 3.2 2.1 2.7 3.5 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ITGB3BP "CENPR, HSU37139, NRIF3, TAP20" ENSG00000142856 "Integrin subunit beta 3 binding protein" Q13352 1 63440770-63593721 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028463 Approved Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA028463: AB_10601435" "unprognostic (4.98e-2)" "unprognostic (5.88e-3)" "unprognostic (6.28e-3)" "unprognostic (3.96e-2)" "unprognostic (4.58e-1)" "prognostic favorable (4.32e-4)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.68e-2)" "unprognostic (7.89e-3)" "unprognostic (2.15e-2)" "unprognostic (1.35e-1)" "unprognostic (4.97e-3)" "prognostic unfavorable (8.45e-6)" "unprognostic (1.34e-2)" "unprognostic (5.24e-2)" "unprognostic (7.34e-3)" "unprognostic (6.14e-2)" 6.8 11.5 2.3 7.9 2.3 11.9 15.0 2.5 4.6 7.8 3.7 10.7 8.0 8.8 15.9 9.0 9.3 10.8 4.4 2.2 2.5 12.6 6.4 7.2 18.0 2.5 2.4 14.1 10.1 18.2 5.3 10.1 2.5 8.7 10.1 2.8 7.8 6.2 2.5 9.1 6.0 5.6 2.4 8.9 8.0 20.6 2.3 20.2 13.5 4.4 16.4 10.1 8.3 2.6 63.6 32.9 35.9 28.6 8.6 25.2 32.3 30.3 18.7 51.6 63.4 18.2 29.0 57.4 22.6 7.3 26.2 44.3 28.2 30.8 63.7 43.4 74.2 43.9 41.3 35.1 9.2 60.4 27.6 6.5 22.4 29.9 23.5 24.3 26.6 34.5 51.5 74.6 7.3 27.8 66.4 57.0 45.5 24.1 38.2 42.5 61.4 84.7 34.8 19.4 46.1 28.8 34.7 20.0 50.4 53.0 19.9 20.0 16.1 17.9 26.1 36.6 46.2 37.1 64.1 54.4 30.0 75.4 27.7 14.2 4.0 1.4 6.5 3.2 11.3 15.9 10.2 10.6 5.1 15.4 11.3 10.2 1.1 15.6 3.9 8.8 12.2 6.7 2.3 2.3 2.5 4.6 2.2 2.5 2.5 2.4 2.5 2.4 2.3 2.6 22.0 9.6 13.9 24.2 40.9 33.9 56.3 49.8 34.7 10.7 35.9 43.7 11.5 28.6 38.2 25.8 10.4 45.9 19.3 10.1 29.4 42.2 100.8 45.2 22.1 21.6 17.4 40.0 23.6 34.3 56.3 28.6 20.4 21.1 23.5 40.7 23.9 9.7 30.0 6.7 23.6 18.1 42.7 21.0 26.1 121.4 21.5 18.9 21.4 15.0 23.7 21.2 30.9 18.6 31.0 24.8 4.1 25.9 30.7 13.7 6.0 39.1 54.3 15.8 32.9 18.2 21.9 200.5 54.4 30.8 32.7 19.2 26.6 13.6 31.9 35.8 JMJD1C "DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8" ENSG00000171988 "Jumonji domain containing 1C" Q15652 10 63167221-63521850 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 590.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 49.7" "Immune cell enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056175, HPA066195" Approved Supported Nucleoplasm,Cytosol No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA056175: AB_2683057, HPA066195: AB_2685634" "unprognostic (7.72e-2)" "unprognostic (5.57e-2)" "unprognostic (9.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.87e-2)" "unprognostic (6.91e-2)" "unprognostic (3.85e-1)" "unprognostic (2.54e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-2)" "unprognostic (2.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.13e-1)" 16.3 12.5 3.7 18.9 5.4 40.2 22.3 49.7 6.6 19.9 6.4 11.3 16.9 24.0 11.3 12.8 12.5 24.6 12.1 4.0 4.5 15.6 22.3 16.0 22.1 5.0 5.0 24.7 13.1 21.9 6.8 14.4 6.2 14.1 12.3 41.4 13.1 11.5 11.0 11.1 18.9 15.6 3.1 20.9 14.5 15.7 4.8 20.4 20.8 13.8 21.3 16.0 9.4 7.7 23.2 11.5 26.5 20.4 13.8 25.2 9.3 15.8 32.5 13.9 19.0 19.8 24.2 31.3 9.4 14.9 12.6 18.6 7.6 15.2 24.7 8.5 9.6 11.9 11.9 14.4 16.8 25.8 4.3 25.3 15.3 24.7 71.3 31.5 25.4 22.0 21.4 23.0 33.1 6.2 19.8 13.8 28.3 5.2 40.0 34.0 57.5 15.0 14.1 16.5 14.4 23.5 23.8 14.7 22.8 19.3 14.6 46.0 30.6 12.9 18.1 11.3 20.0 20.4 17.4 29.1 15.7 15.1 11.7 0.6 2.7 3.2 1.8 1.8 2.7 4.4 1.9 1.9 2.3 4.2 2.7 2.3 14.1 1.7 1.6 4.0 1.8 1.1 3.7 5.4 49.7 6.6 4.0 4.5 5.0 5.0 6.2 3.1 4.8 7.7 256.1 112.2 93.3 214.5 184.4 151.9 369.2 46.6 93.9 88.7 106.7 92.7 69.4 55.8 96.9 55.2 152.2 34.7 117.4 80.7 13.7 63.3 38.3 155.8 179.7 176.7 86.0 75.3 590.1 47.0 27.7 141.1 119.8 210.1 93.1 79.1 118.2 37.2 57.9 117.8 416.5 66.8 38.7 89.8 185.0 42.3 103.8 206.8 76.5 355.1 96.6 61.2 58.7 419.2 378.8 76.7 88.4 89.5 124.8 161.0 90.6 32.4 104.1 170.9 72.3 214.4 112.6 158.6 146.5 56.4 134.0 33.2 145.6 76.0 52.3 286.7 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051994 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Supported "Nucleoli,Nuclear speckles,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414" "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 14.4 7.1 8.6 15.4 12.7 38.2 12.3 20.1 10.5 13.7 9.7 10.2 9.6 15.6 8.6 13.4 12.0 11.2 9.1 9.1 12.8 9.1 10.0 16.7 16.8 12.7 12.4 21.5 11.7 18.0 6.7 14.9 12.9 11.0 10.6 18.1 9.6 9.7 13.1 16.6 12.1 13.5 8.2 15.7 11.3 11.4 10.1 27.0 14.2 16.0 17.2 12.0 10.7 16.7 19.6 23.2 34.8 21.8 17.8 20.3 9.8 15.4 20.6 17.9 14.2 16.3 11.5 33.4 13.4 19.0 19.5 17.3 27.3 18.6 23.2 16.1 14.4 60.4 14.2 10.3 14.8 27.3 23.6 17.1 19.1 20.4 24.8 14.5 18.8 29.7 36.6 24.2 16.0 10.4 59.9 9.4 12.8 20.4 8.1 37.7 39.1 9.9 11.0 27.1 17.6 16.7 15.8 12.4 13.8 15.8 26.3 12.9 25.5 21.6 15.3 21.1 15.5 16.8 22.1 33.8 12.6 14.1 17.3 2.5 0.8 1.8 1.6 0.9 1.6 1.4 1.6 2.1 0.6 1.6 1.9 1.8 5.1 1.9 0.9 1.1 1.9 1.2 8.6 12.7 20.1 10.5 9.1 12.8 12.7 12.4 12.9 8.2 10.1 16.7 87.5 35.3 34.9 64.0 54.0 50.3 24.2 15.5 18.2 54.8 31.7 25.5 23.7 18.6 25.3 12.9 54.2 14.4 61.5 23.2 3.9 14.2 2.6 30.3 47.5 56.7 24.7 31.2 62.8 11.8 17.0 32.4 21.4 44.8 35.4 31.9 43.5 25.3 17.0 58.9 76.6 24.9 10.2 44.2 34.5 4.8 28.3 43.7 23.2 120.9 30.3 27.9 61.8 93.5 129.2 15.7 20.2 23.0 38.7 30.7 22.9 10.6 22.8 44.9 19.7 49.3 34.6 37.8 37.0 23.0 61.2 21.1 61.4 19.7 19.3 27.2 KDM3A "JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA" ENSG00000115548 "Lysine demethylase 3A" Q9Y4C1 2 86440647-86492716 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055543, HPA065162" Enhanced Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA055543: AB_2682842, HPA065162: AB_2685424" "unprognostic (1.97e-2)" "unprognostic (3.03e-3)" "unprognostic (1.32e-2)" "unprognostic (4.04e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.15e-6)" "unprognostic (2.01e-1)" "unprognostic (3.35e-3)" "unprognostic (9.50e-3)" "unprognostic (4.44e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (2.17e-1)" "unprognostic (2.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.66e-2)" 21.2 12.9 17.9 13.1 19.0 70.3 19.9 17.5 18.9 18.0 18.6 25.0 18.9 20.7 18.2 20.8 18.4 15.9 21.7 15.3 18.1 15.4 12.9 16.7 17.9 18.1 17.4 21.5 16.1 14.6 12.8 22.1 17.8 16.6 15.9 54.7 19.8 19.7 21.5 38.6 20.1 15.0 16.6 18.4 14.9 50.9 18.7 27.4 20.0 21.4 19.6 20.8 20.2 20.1 34.7 13.5 31.5 8.3 15.9 16.1 29.4 16.5 16.2 15.1 18.5 17.3 14.3 20.1 30.4 13.8 31.1 21.5 23.7 16.6 29.2 27.1 19.7 32.4 12.6 24.8 11.9 26.1 19.9 17.8 24.5 13.6 24.9 51.9 19.0 18.5 21.1 31.9 16.1 8.9 36.2 36.4 28.3 20.6 20.4 24.5 42.6 44.0 13.6 19.2 24.4 25.9 21.7 15.5 30.2 27.5 9.0 16.8 21.2 30.6 12.6 31.8 19.1 33.3 33.9 29.6 38.8 26.6 38.2 16.9 3.0 5.8 6.7 3.3 7.1 4.2 7.5 6.6 4.6 3.6 7.9 7.0 13.4 5.0 2.2 4.2 8.3 3.9 17.9 19.0 17.5 18.9 15.3 18.1 18.1 17.4 17.8 16.6 18.7 20.1 26.0 35.3 17.0 56.8 19.7 30.5 23.2 19.5 43.3 24.0 18.9 14.6 30.3 7.2 24.8 5.5 52.1 5.2 29.2 24.2 0.0 12.1 82.0 36.6 15.6 23.4 15.6 21.0 28.7 9.8 8.5 19.1 23.0 35.5 38.6 11.9 15.4 7.6 10.4 55.5 27.4 13.7 26.4 10.9 18.2 29.7 17.4 17.5 21.4 28.1 8.6 36.0 21.6 26.2 23.5 11.3 8.0 17.3 21.4 16.0 23.0 5.6 44.1 34.4 6.6 21.3 20.4 38.7 14.1 35.5 40.1 11.6 27.4 15.2 10.7 13.6 KDM4C "GASC1, JMJD2C, KIAA0780, TDRD14C" ENSG00000107077 "Lysine demethylase 4C" Q9H3R0 9 6720863-7175648 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 206.9;Inhibitory neurons: 235.9;Microglial cells: 148.0;Oligodendrocyte precursor cells: 189.0;Oligodendrocytes: 347.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069357 Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA069357: AB_2686128" "unprognostic (1.56e-2)" "unprognostic (1.91e-2)" "unprognostic (4.38e-2)" "unprognostic (1.38e-1)" "unprognostic (3.52e-1)" "unprognostic (4.36e-2)" "unprognostic (2.50e-2)" "unprognostic (6.89e-3)" "unprognostic (2.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.65e-2)" "unprognostic (2.03e-2)" "unprognostic (1.92e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" "unprognostic (2.23e-2)" "unprognostic (1.64e-3)" 10.0 9.6 9.8 12.8 12.0 30.1 11.3 30.6 11.5 10.2 13.5 13.7 13.1 10.4 11.8 10.1 10.3 9.7 7.8 9.9 11.1 8.7 11.1 10.6 19.1 13.8 11.7 11.5 16.1 17.8 11.8 8.9 13.3 9.9 16.1 28.9 11.6 8.8 8.3 15.2 14.4 10.8 9.7 13.9 15.1 9.8 11.9 23.6 13.4 6.0 18.8 10.3 10.7 16.4 17.2 9.8 4.0 6.0 13.4 14.3 11.8 7.6 9.6 8.5 8.1 11.3 9.1 20.1 4.6 10.3 8.7 5.1 8.6 12.8 11.1 60.6 7.4 27.9 13.8 15.1 12.4 10.8 18.5 12.5 8.4 6.7 14.0 21.1 10.4 16.4 4.7 13.4 9.3 8.3 18.0 40.4 7.0 18.0 3.8 10.8 3.4 12.9 12.3 9.2 14.0 8.3 7.1 12.7 6.8 10.7 6.6 17.5 11.0 8.4 4.0 9.9 7.5 10.2 8.1 21.3 8.2 10.0 3.3 7.5 7.1 13.5 9.6 7.7 11.2 12.1 10.4 11.2 9.6 13.8 11.3 8.8 1.6 11.2 13.1 3.7 10.0 8.0 9.8 12.0 30.6 11.5 9.9 11.1 13.8 11.7 13.3 9.7 11.9 16.4 11.3 6.4 14.4 110.4 40.6 19.9 7.9 10.5 18.8 22.6 11.2 8.0 9.2 11.5 9.2 7.3 45.9 5.2 22.7 10.3 3.9 7.0 84.8 10.0 12.2 9.4 9.7 42.1 206.9 6.2 5.3 6.9 34.7 16.8 8.8 6.0 6.8 13.0 6.7 11.8 235.9 14.7 6.1 10.0 19.4 83.3 9.6 16.5 7.2 148.0 15.0 3.3 19.6 189.0 347.2 7.6 9.5 9.4 27.1 6.2 14.1 4.0 10.8 28.3 13.1 7.3 7.6 6.6 5.4 14.4 23.9 5.9 28.2 6.2 8.1 8.0 KHDRBS1 "FLJ34027, p62, Sam68" ENSG00000121774 "KH RNA binding domain containing, signal transduction associated 1" Q07666 1 32013868-32060850 "Predicted intracellular proteins" "Cell cycle, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005355, HPA051280, HPA056813" Supported Enhanced Nucleoplasm NA NA 110000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240" "unprognostic (1.31e-1)" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.55e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (5.01e-2)" "unprognostic (2.51e-3)" "unprognostic (4.03e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.26e-1)" "unprognostic (7.03e-2)" 59.8 47.4 36.3 67.0 38.8 93.3 61.7 44.7 37.4 59.5 34.8 62.9 62.3 82.6 47.2 57.3 70.3 48.6 56.8 36.6 39.7 54.0 50.6 52.1 94.1 40.7 38.7 110.6 50.9 61.7 38.3 63.7 38.1 55.1 57.3 58.5 45.2 55.8 45.9 57.3 59.2 65.6 44.1 64.0 52.3 42.2 37.2 112.2 63.8 40.6 96.7 62.2 47.6 46.7 204.6 121.0 272.6 201.6 92.5 115.4 159.5 120.7 152.1 221.5 185.5 136.2 178.1 302.9 131.5 153.5 128.4 139.2 221.9 165.1 225.6 181.7 188.8 191.1 111.8 188.0 121.5 256.2 123.8 127.6 92.7 168.9 132.8 145.6 212.6 183.1 251.0 136.5 172.6 132.6 379.2 218.7 277.0 127.3 144.3 300.1 230.2 257.7 156.0 203.7 185.7 241.7 175.7 148.8 157.2 192.9 177.3 183.7 160.5 143.9 154.5 155.3 205.9 140.3 163.5 296.0 149.2 202.3 112.1 5.8 5.7 5.9 7.8 8.9 11.7 9.9 9.2 8.2 7.8 8.0 9.8 9.5 5.0 8.0 7.5 8.9 9.3 3.0 36.3 38.8 44.7 37.4 36.6 39.7 40.7 38.7 38.1 44.1 37.2 46.7 130.6 38.5 77.4 40.8 181.9 147.6 200.3 58.8 183.2 94.8 111.1 109.9 104.4 97.2 89.8 69.9 50.1 192.7 131.9 87.9 84.1 96.2 24.7 122.5 154.4 125.7 117.8 131.6 46.0 103.1 234.5 132.4 103.5 127.0 128.1 224.5 99.6 64.6 120.8 63.9 48.1 101.1 28.5 141.9 148.4 21.7 111.2 139.2 108.5 36.5 142.6 142.6 105.0 43.7 59.6 107.1 76.2 124.1 141.8 136.4 74.5 123.8 93.3 89.3 92.1 140.4 157.9 198.2 122.7 173.8 130.6 173.5 161.7 138.7 152.0 167.1 KIAA1586 ENSG00000168116 KIAA1586 Q9HCI6 6 57046532-57055239 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 87.0;Erythroid cells: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036370 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA036370: AB_10672219" "unprognostic (7.17e-2)" "unprognostic (3.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.29e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (4.96e-3)" "unprognostic (2.62e-2)" "unprognostic (1.55e-1)" "unprognostic (1.36e-3)" "unprognostic (5.64e-2)" "unprognostic (8.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.07e-1)" 4.1 4.8 2.0 3.6 2.4 8.6 5.4 9.4 3.7 4.6 0.0 2.9 2.1 6.1 3.7 3.3 2.8 4.6 3.5 2.3 3.0 3.6 4.9 2.7 4.6 2.9 2.4 7.6 2.8 5.2 3.7 9.4 2.8 5.2 2.6 4.0 2.7 3.6 1.6 2.5 2.4 4.4 1.4 4.5 2.1 8.0 2.8 5.9 5.7 3.4 3.9 4.8 2.6 2.6 8.6 3.5 21.9 25.1 8.5 13.7 12.0 14.1 11.6 12.0 14.4 5.9 2.7 3.4 11.4 10.4 10.6 4.2 16.7 8.3 16.4 10.7 12.7 35.9 8.0 13.3 11.1 29.0 12.7 10.1 5.9 10.6 11.7 8.5 11.5 9.1 49.9 2.7 14.4 6.8 14.0 17.5 14.2 3.0 5.0 12.8 16.0 8.4 8.0 17.6 18.5 16.8 9.3 3.0 10.6 15.1 7.2 26.0 9.4 18.6 7.7 17.9 10.2 10.9 15.4 16.8 11.5 21.0 7.7 0.2 2.5 2.0 2.3 2.0 2.7 3.7 3.4 3.0 3.9 3.1 4.2 3.6 0.1 5.3 2.0 4.0 4.4 1.9 2.0 2.4 9.4 3.7 2.3 3.0 2.9 2.4 2.8 1.4 2.8 2.6 15.4 9.6 6.3 10.4 8.8 10.5 4.5 13.0 13.1 15.4 7.4 11.7 23.1 1.5 7.8 7.3 2.1 43.3 11.7 1.0 11.7 7.0 87.0 4.6 29.6 12.5 5.4 74.9 32.4 5.4 33.2 21.4 3.1 3.2 13.3 30.5 8.2 4.0 12.5 10.1 32.7 2.4 6.1 6.6 7.1 21.9 12.8 8.9 3.6 12.2 9.7 9.6 15.5 23.6 24.4 2.8 0.9 14.7 13.0 2.3 0.7 14.6 8.4 8.2 19.7 19.5 17.6 23.4 17.9 8.7 4.4 10.7 10.6 29.5 3.2 1.6 KIN "KIN17, Rts2" ENSG00000151657 "Kin17 DNA and RNA binding protein" O60870 10 7750962-7787993 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016339, HPA038700" Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB016339: AB_627860, HPA038700: AB_2676159" "unprognostic (4.33e-3)" "unprognostic (1.24e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-2)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "unprognostic (3.17e-3)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (3.98e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-1)" "prognostic favorable (3.23e-5)" 2.1 2.4 1.9 2.6 1.9 3.1 2.6 4.4 2.5 2.8 1.8 2.2 2.4 3.3 2.8 2.0 2.4 2.1 2.1 1.8 1.8 2.3 3.3 2.2 3.4 1.7 1.8 3.0 2.7 2.0 2.6 3.0 1.9 2.5 2.2 3.4 2.5 2.1 2.8 3.4 2.4 2.1 1.4 2.8 2.5 2.1 2.0 2.4 2.9 2.2 2.7 2.1 2.4 2.6 4.3 2.7 4.1 2.5 3.3 3.9 3.3 3.8 1.7 4.5 4.8 5.2 4.2 3.3 1.9 2.3 1.4 4.0 3.5 2.3 5.1 3.8 4.0 5.2 2.7 5.1 4.6 1.9 4.1 3.3 2.5 3.4 2.2 3.7 3.4 4.1 5.3 3.1 3.5 3.9 3.8 2.9 3.9 4.5 1.6 4.8 2.9 3.1 3.8 2.3 1.7 3.8 3.0 2.9 6.2 3.8 5.5 3.8 2.5 2.9 3.2 5.1 3.1 4.0 4.7 4.1 3.6 2.9 2.0 15.9 3.9 7.1 3.7 4.3 3.7 5.9 3.3 3.1 3.0 5.4 3.6 3.8 8.8 4.9 4.1 5.8 3.0 1.5 1.9 1.9 4.4 2.5 1.8 1.8 1.7 1.8 1.9 1.4 2.0 2.6 31.5 35.3 27.2 12.1 20.7 17.3 14.6 31.3 13.6 54.8 17.2 20.1 13.0 20.0 24.8 18.4 39.6 36.7 32.0 20.4 13.7 32.9 5.7 21.7 28.4 25.6 23.3 30.3 17.4 21.5 23.8 24.0 14.3 27.9 16.4 22.9 21.0 11.9 32.1 63.9 14.8 20.3 18.3 16.9 22.8 6.2 27.7 21.8 16.0 11.2 30.7 28.7 38.1 13.0 19.4 21.2 23.6 30.9 18.1 18.9 18.2 16.9 26.0 54.7 13.1 27.8 29.7 29.1 19.0 12.1 14.3 38.4 25.7 30.1 14.7 17.3 KLHL18 "FLJ13703, KIAA0795" ENSG00000114648 "Kelch like family member 18" O94889 3 47282917-47346816 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035027, HPA035028" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Nuclear bodies" "HPA035027: AB_10602340, HPA035028: AB_10669899" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.22e-1)" "unprognostic (9.01e-2)" "unprognostic (3.05e-1)" "unprognostic (9.60e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-3)" "unprognostic (3.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.07e-1)" "unprognostic (4.67e-1)" 5.9 6.2 6.5 6.2 6.9 15.9 4.6 5.9 7.7 5.7 3.9 5.8 4.4 5.3 5.1 8.7 4.6 5.4 6.2 6.8 6.3 6.1 3.7 6.2 6.9 4.9 6.0 3.9 5.5 7.2 6.0 5.5 5.1 5.1 4.6 20.2 4.4 6.2 6.7 13.8 5.6 6.6 5.5 8.8 4.9 6.3 6.7 5.1 7.0 5.6 7.5 6.7 6.7 6.3 11.6 14.6 11.1 16.5 12.0 8.6 7.9 15.6 8.1 15.5 12.6 15.6 7.0 22.6 8.6 13.1 14.2 7.0 33.7 16.5 15.9 18.0 11.3 33.3 20.9 14.3 12.3 17.9 14.7 10.0 12.5 22.4 20.8 8.7 17.5 12.1 41.0 9.2 12.6 9.6 13.7 10.3 20.4 9.4 29.2 9.4 7.3 13.2 14.6 21.6 7.6 10.1 10.9 13.2 7.9 11.3 7.8 9.7 18.4 14.3 14.8 16.6 19.9 10.3 21.9 19.5 9.2 20.5 15.4 6.1 12.1 3.7 2.0 10.7 2.9 3.8 1.6 3.9 7.8 2.4 1.3 2.0 4.9 1.3 18.6 2.0 1.7 5.7 6.5 6.9 5.9 7.7 6.8 6.3 4.9 6.0 5.1 5.5 6.7 6.3 19.6 12.8 13.7 13.1 24.4 11.3 10.6 8.1 12.0 65.2 17.4 13.0 62.1 4.3 7.5 3.7 20.9 10.6 26.1 15.2 21.5 15.5 3.0 15.5 24.8 16.1 9.5 21.7 24.2 14.8 11.9 9.3 12.2 27.5 36.1 11.0 14.3 19.7 29.6 13.5 23.0 11.1 4.1 28.8 14.9 3.5 5.9 26.7 0.0 18.7 22.4 13.9 8.2 15.1 17.4 17.7 10.6 8.2 12.0 9.3 9.8 28.2 6.3 54.2 6.6 19.5 13.5 13.9 14.8 14.8 21.0 14.1 20.8 15.4 10.3 13.0 KMT2A "ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1" ENSG00000118058 "Lysine methyltransferase 2A" Q03164 11 118436490-118526832 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017794, CAB024270, HPA044910" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "CAB017794: , CAB024270: , HPA044910: AB_2679141" "unprognostic (6.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.83e-1)" "unprognostic (4.56e-1)" "unprognostic (4.96e-2)" "unprognostic (1.72e-3)" "unprognostic (4.52e-3)" "unprognostic (6.07e-2)" "unprognostic (1.61e-1)" "unprognostic (8.46e-2)" "unprognostic (3.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.91e-3)" "unprognostic (7.90e-2)" "unprognostic (3.73e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" 9.9 6.7 8.0 8.5 8.6 19.5 9.9 21.2 9.3 10.3 1.6 10.8 5.4 10.7 8.2 6.8 10.3 6.4 6.5 7.4 9.6 6.7 6.0 10.5 12.4 6.3 6.3 21.2 11.1 9.8 10.2 5.6 6.6 9.2 6.4 23.9 9.4 8.4 7.4 10.4 9.8 7.6 3.2 9.7 8.2 5.3 7.0 14.1 9.9 8.4 11.3 10.7 9.3 11.9 17.9 8.6 20.1 14.5 11.1 16.1 6.2 8.7 11.8 9.0 9.6 17.3 11.4 23.1 15.9 10.8 14.6 16.0 22.9 7.2 17.9 26.0 10.0 45.7 8.9 9.3 6.1 28.5 7.8 7.2 7.4 20.3 24.0 8.9 12.8 13.3 32.8 18.8 9.2 12.7 18.2 12.7 13.6 6.6 13.7 13.8 21.9 6.9 9.8 13.8 18.0 11.8 22.0 6.7 3.9 9.8 11.9 9.1 20.4 14.1 12.7 9.4 14.7 5.1 4.4 15.6 4.7 17.6 8.3 2.1 0.6 1.9 1.6 0.6 1.6 2.5 1.8 1.5 0.3 1.8 1.8 1.2 0.5 2.0 0.7 1.4 1.7 0.4 8.0 8.6 21.2 9.3 7.4 9.6 6.3 6.3 6.6 3.2 7.0 11.9 87.1 70.5 65.8 93.4 83.4 86.9 67.6 29.4 64.9 158.1 76.8 73.9 44.5 40.0 32.2 38.6 152.2 13.9 81.0 26.2 3.9 33.0 10.1 62.1 101.4 74.4 66.4 67.3 146.0 25.6 10.2 65.6 44.4 85.2 29.0 57.5 60.0 27.3 16.8 195.2 170.1 29.6 20.3 37.0 63.7 5.8 66.8 44.8 42.7 62.8 49.9 98.9 78.2 106.6 131.9 28.2 20.1 78.6 83.3 88.3 22.7 10.5 52.7 152.4 65.7 113.4 84.6 25.5 30.7 46.3 80.6 6.0 102.8 55.8 30.6 64.8 KMT2E "HDCMC04P, MLL5" ENSG00000005483 "Lysine methyltransferase 2E (inactive)" Q8IZD2 7 105014190-105115019 "Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042866, HPA056125" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear bodies" "HPA042866: , HPA056125: AB_2683044" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (6.49e-2)" "unprognostic (4.34e-1)" "unprognostic (1.94e-1)" "unprognostic (4.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.98e-3)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (3.53e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.80e-5)" "unprognostic (1.68e-1)" "unprognostic (1.53e-1)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" 23.0 16.4 17.6 28.8 23.6 69.9 22.5 53.6 26.1 28.9 11.6 29.0 22.7 33.4 22.1 22.7 24.8 24.5 21.1 16.9 25.9 18.7 16.4 27.9 31.4 19.0 19.2 43.8 22.8 23.1 11.5 26.8 17.7 24.9 28.5 40.5 25.5 23.0 15.0 30.3 22.3 26.8 14.4 33.4 26.7 18.6 17.1 35.6 27.4 22.9 33.0 27.9 14.3 34.4 35.7 24.8 49.3 43.5 29.3 34.5 12.3 24.3 38.2 21.0 25.5 19.0 30.1 28.8 24.7 30.0 27.7 26.2 27.1 25.7 35.0 45.8 17.4 27.0 31.6 19.2 28.1 39.7 34.8 24.2 23.3 28.6 30.6 38.6 40.2 32.3 39.9 76.9 28.7 26.5 62.1 35.0 17.9 19.1 19.1 53.4 30.3 33.5 23.0 34.5 28.8 36.1 35.7 32.3 20.2 32.8 13.6 23.5 47.2 50.0 33.1 57.5 26.4 61.6 50.8 63.5 34.3 29.5 36.3 246.8 73.2 173.1 118.3 56.2 114.6 153.9 109.7 103.0 53.8 152.0 106.0 100.0 290.3 89.9 94.4 103.2 101.5 71.7 17.6 23.6 53.6 26.1 16.9 25.9 19.0 19.2 17.7 14.4 17.1 34.4 169.3 141.1 158.4 108.4 283.5 146.6 115.5 119.2 118.4 236.4 93.4 81.5 102.9 85.8 124.6 115.8 252.3 40.5 278.0 138.0 35.2 82.2 27.0 77.8 89.3 205.6 100.0 90.5 160.2 68.1 50.4 128.8 91.7 112.4 247.9 78.2 119.2 33.6 60.4 185.1 148.9 96.4 89.5 91.8 348.4 27.3 141.1 152.2 140.5 148.9 147.5 104.1 255.4 189.0 236.2 80.7 102.9 131.7 223.1 149.7 82.6 32.4 78.3 297.5 124.9 136.7 168.3 100.0 76.4 86.1 134.7 65.3 278.3 58.2 115.4 159.9 KMT5B "CGI-85, SUV420H1" ENSG00000110066 "Lysine methyltransferase 5B" Q4FZB7 11 68154863-68213828 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 128.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063648 Supported Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA063648: AB_2685073" "unprognostic (5.82e-2)" "unprognostic (4.25e-2)" "unprognostic (2.54e-1)" "unprognostic (5.36e-3)" "unprognostic (3.52e-1)" "unprognostic (2.94e-1)" "unprognostic (1.83e-2)" "unprognostic (1.08e-1)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "unprognostic (5.54e-2)" "unprognostic (1.21e-1)" "unprognostic (3.79e-3)" "unprognostic (2.62e-1)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "prognostic favorable (9.30e-4)" 18.6 16.5 16.3 15.7 17.5 28.5 27.5 26.2 17.6 20.2 17.3 22.3 22.8 26.2 19.0 17.2 18.2 15.0 15.9 15.8 17.2 19.7 22.4 18.1 19.2 16.1 16.3 22.4 22.8 20.6 15.6 22.3 15.6 22.0 21.6 33.4 23.4 16.3 16.9 21.7 21.8 20.7 14.8 17.2 20.7 20.7 16.1 27.0 31.0 16.7 20.4 16.5 17.6 21.3 25.3 18.8 37.6 24.5 8.6 21.4 40.8 17.7 12.3 21.7 12.8 59.7 39.6 20.5 30.2 24.4 21.4 13.0 26.2 20.6 31.6 23.2 15.1 19.4 21.9 24.7 31.0 27.7 25.6 21.3 41.6 26.2 27.3 20.0 21.8 20.3 29.3 23.4 18.7 52.2 19.6 28.9 40.4 50.4 13.9 31.9 29.4 55.4 16.2 24.2 32.7 39.1 27.5 27.4 128.7 20.3 35.1 17.9 23.1 29.2 38.9 22.5 18.4 29.5 13.8 43.0 18.4 17.3 31.8 10.0 3.7 16.5 4.4 5.2 3.1 3.2 4.6 5.4 3.5 3.8 5.3 4.8 10.9 9.6 5.3 5.4 4.1 2.8 16.3 17.5 26.2 17.6 15.8 17.2 16.1 16.3 15.6 14.8 16.1 21.3 39.8 60.9 61.3 0.0 32.9 0.0 42.3 0.0 50.7 50.0 45.8 34.7 0.0 25.8 25.4 25.8 12.5 27.4 37.6 32.6 21.5 27.9 22.0 42.6 46.3 31.7 25.5 31.4 0.0 32.7 29.6 26.3 37.2 44.3 22.7 40.7 30.0 37.7 17.9 63.9 0.0 26.6 0.0 32.4 0.0 21.0 28.0 27.7 0.0 0.0 38.2 29.6 43.3 0.0 0.0 37.1 25.7 31.6 34.8 43.7 36.4 22.7 32.1 39.6 32.9 44.8 28.6 45.8 58.9 38.0 0.0 51.7 30.7 31.8 25.1 53.6 KRCC1 FLJ22333 ENSG00000172086 "Lysine rich coiled-coil 1" Q9NPI7 2 88027205-88064252 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045618, HPA052666" Approved Approved Nucleoli,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Nucleoli "HPA045618: AB_10960406, HPA052666: AB_2681907" "unprognostic (7.37e-3)" "unprognostic (1.30e-1)" "unprognostic (2.09e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (2.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "unprognostic (4.83e-2)" "unprognostic (2.22e-1)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-3)" 28.2 21.0 20.1 28.7 22.8 10.1 38.4 21.7 28.0 33.0 20.7 45.9 32.0 23.9 41.7 32.2 27.1 22.2 31.7 19.9 21.6 31.9 43.6 21.9 38.0 23.2 22.0 24.6 28.6 34.1 15.7 21.9 23.7 25.2 43.8 14.5 24.8 26.0 29.1 25.8 35.7 22.9 21.8 30.7 27.2 15.2 21.7 31.5 33.2 34.6 32.4 24.4 24.9 24.9 29.4 17.8 27.4 20.1 64.1 75.3 20.2 45.5 50.3 23.7 23.1 1.6 38.5 41.4 16.0 28.9 36.1 14.8 6.3 9.4 26.7 43.7 8.7 8.0 4.4 2.8 46.7 12.2 5.5 38.0 46.3 15.9 33.7 61.9 27.1 32.9 11.5 20.2 51.7 25.0 14.1 16.9 20.9 42.3 11.8 28.3 5.0 4.5 36.0 15.8 21.1 21.3 17.3 23.7 54.8 20.1 16.7 49.2 38.2 28.0 2.1 46.5 14.5 45.3 33.6 32.5 30.1 32.0 67.5 59.4 21.6 77.7 18.8 23.8 21.7 36.6 23.0 23.2 25.7 32.5 25.8 21.0 35.8 31.6 21.5 22.5 34.3 16.8 20.1 22.8 21.7 28.0 19.9 21.6 23.2 22.0 23.7 21.8 21.7 24.9 24.2 35.3 41.7 29.4 61.8 33.0 32.6 49.9 53.5 11.9 50.9 50.9 41.3 40.0 49.0 35.0 2.1 46.1 24.8 109.1 60.7 50.5 16.7 34.4 37.8 31.6 41.6 28.2 14.5 70.9 16.3 42.5 17.3 30.9 43.1 28.4 37.9 59.5 48.6 10.1 13.9 56.8 26.4 40.3 39.8 5.3 47.8 38.8 28.4 44.0 53.6 35.9 58.7 34.7 53.5 51.4 79.6 43.2 29.6 62.6 60.4 76.0 62.6 5.4 19.7 40.3 29.7 41.0 20.7 45.4 42.6 41.9 37.2 32.2 72.4 26.4 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL histone methyl-lysine binding protein 3" Q96JM7 6 130013699-130141449 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 63.5;HUVEC TERT2: 62.5;TIME: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA No "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044382: AB_2678920, HPA053035: AB_2682021" "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 4.5 11.0 3.3 9.9 3.3 7.7 4.7 1.7 3.6 9.5 9.6 4.6 2.8 11.2 11.7 2.3 5.5 5.3 2.4 4.1 3.8 4.8 5.8 4.0 11.1 2.5 3.1 10.1 2.3 5.6 5.5 5.7 2.4 7.0 5.0 2.1 4.9 6.2 2.5 2.7 5.1 8.3 2.5 12.6 3.3 7.6 4.5 7.7 6.0 2.1 8.9 5.7 5.3 2.6 1.7 6.5 15.2 2.4 10.4 13.4 3.1 7.8 15.9 3.0 5.5 8.0 8.1 2.7 11.0 9.9 9.3 6.5 8.7 13.6 4.6 6.1 8.8 18.3 3.2 2.0 5.2 10.8 63.5 8.8 9.6 3.6 10.2 15.1 62.5 8.3 13.3 7.1 7.7 0.7 23.2 1.9 7.0 1.7 3.3 8.7 4.2 0.0 9.8 2.5 0.5 2.0 2.9 0.7 6.1 18.2 16.4 9.3 43.0 5.1 6.9 0.9 5.3 1.4 0.1 4.7 2.5 4.5 5.2 8.2 4.9 4.8 3.7 5.5 3.2 10.7 3.5 4.7 1.9 13.4 3.2 4.1 4.9 2.1 22.7 14.8 5.9 1.0 3.3 3.3 1.7 3.6 4.1 3.8 2.5 3.1 2.4 2.5 4.5 2.6 9.1 3.2 6.5 6.5 20.5 5.1 5.1 2.4 10.2 4.2 5.3 2.8 3.9 1.5 3.8 9.2 2.1 13.4 20.7 2.8 1.9 5.6 24.2 6.1 12.8 9.4 3.6 5.0 20.8 5.4 7.1 7.3 4.6 16.1 40.4 24.7 8.9 6.3 4.0 0.0 10.5 9.3 6.1 8.2 4.0 3.1 9.6 9.5 1.8 11.2 12.9 5.3 13.4 15.6 8.5 10.9 5.2 6.0 5.2 4.7 0.5 5.9 4.1 0.7 6.6 11.2 8.6 5.8 7.6 4.0 4.4 6.2 15.6 9.5 5.0 5.5 LATS1 WARTS ENSG00000131023 "Large tumor suppressor kinase 1" O95835 6 149658153-149718105 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031804 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" "HPA031804: AB_10601688" "unprognostic (4.02e-3)" "unprognostic (3.80e-3)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (2.09e-1)" "unprognostic (6.15e-3)" "unprognostic (1.29e-2)" "unprognostic (9.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (5.62e-2)" "unprognostic (1.92e-1)" "unprognostic (8.43e-2)" "unprognostic (2.63e-1)" "unprognostic (2.65e-1)" 8.1 8.0 4.8 8.6 4.9 15.4 9.2 11.0 7.0 10.1 5.5 7.3 7.2 12.1 7.4 8.2 9.7 7.7 5.6 5.2 4.6 7.7 7.8 9.1 9.8 4.7 4.3 15.6 6.8 11.7 5.2 8.8 5.0 11.0 8.5 11.0 8.7 7.7 6.4 9.1 7.7 10.7 4.3 10.2 7.7 6.2 5.1 11.7 8.9 8.1 8.4 9.0 7.2 7.6 8.7 6.8 13.7 19.8 12.9 16.6 10.7 11.3 11.4 11.8 11.7 11.1 7.3 14.0 11.1 15.7 9.4 11.8 18.3 12.0 18.5 12.9 14.7 28.1 8.2 9.9 11.9 26.5 19.8 11.3 19.1 13.5 22.7 12.2 14.8 12.1 35.3 13.9 11.9 10.4 13.8 11.0 8.5 8.0 6.5 13.6 16.4 6.5 11.0 12.2 9.3 14.7 16.1 11.5 8.4 9.3 12.0 22.9 18.7 9.5 14.8 11.4 18.2 11.6 13.5 15.8 8.7 14.8 14.3 8.2 3.0 4.8 5.9 5.3 5.3 3.8 4.5 5.0 3.3 4.7 3.8 5.1 2.0 3.0 8.9 2.8 4.8 2.4 4.8 4.9 11.0 7.0 5.2 4.6 4.7 4.3 5.0 4.3 5.1 7.6 21.1 12.8 21.3 33.0 21.9 16.3 11.2 9.7 27.9 20.3 15.2 10.2 9.6 12.8 12.5 7.3 18.8 8.5 18.7 15.3 1.9 7.5 23.0 14.1 23.4 16.2 16.8 17.7 51.4 6.6 11.4 19.7 20.9 17.1 14.0 19.8 21.0 13.3 11.0 13.5 48.0 12.6 6.1 14.7 11.6 6.9 13.7 16.6 14.2 32.8 15.0 10.7 10.3 54.8 64.0 9.9 11.5 25.9 21.9 15.4 13.6 6.6 12.8 22.0 19.7 28.8 15.1 8.8 9.6 18.8 18.0 13.1 23.3 13.8 11.7 11.8 LCP1 "CP64, L-PLASTIN, LC64P, PLS2" ENSG00000136167 "Lymphocyte cytosolic protein 1" P13796 13 46125920-46211871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 709.0;epididymis: 402.7;lymphoid tissue: 605.1" "Cell type enhanced" "Detected in many" "dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019493, CAB020673" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 1800000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane, Cytosol" "Actin filaments" "CAB020673: , HPA019493: AB_1855457" "unprognostic (2.79e-2)" "unprognostic (8.20e-3)" "unprognostic (1.19e-2)" "unprognostic (3.95e-3)" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (2.70e-1)" "unprognostic (4.99e-2)" "unprognostic (6.70e-3)" "unprognostic (2.54e-1)" "unprognostic (5.47e-2)" "unprognostic (3.63e-1)" "unprognostic (3.32e-3)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (7.50e-2)" "unprognostic (2.92e-1)" 85.9 31.1 11.3 396.9 13.1 709.0 43.9 13.9 30.9 28.5 16.8 54.7 42.4 27.4 402.7 29.5 21.5 76.4 14.5 11.3 14.2 13.1 89.0 173.8 563.5 19.7 18.9 10.0 12.2 12.6 4.3 67.2 21.3 184.5 71.2 4.9 44.4 24.3 7.1 40.6 62.3 60.4 18.6 375.2 53.2 33.2 24.8 499.8 23.6 17.8 605.1 133.0 7.7 29.9 36.1 0.2 1.9 0.0 0.0 0.0 409.8 0.1 1.2 3.9 2.9 237.4 1.4 875.8 179.5 0.0 249.1 1.7 0.1 0.6 3.9 799.3 202.9 187.6 0.4 1.1 0.9 850.7 861.7 2.3 0.1 1.4 1.2 0.3 0.0 792.7 100.4 569.7 0.0 2.8 624.8 789.2 1.0 0.4 8.2 451.6 1.6 638.2 0.0 233.8 2.8 7.5 1.9 91.8 6.4 25.0 6.4 840.5 3.1 22.0 13.6 1.5 25.5 135.3 292.5 1105.7 17.0 530.9 3.6 1007.3 1559.5 810.8 915.7 1806.2 822.0 342.3 539.6 761.2 1134.5 251.6 330.2 560.5 1908.6 650.6 1826.1 297.5 598.1 3644.2 11.3 13.1 13.9 30.9 11.3 14.2 19.7 18.9 21.3 18.6 24.8 29.9 7.4 32.1 73.2 0.3 185.2 12.0 1.2 0.0 1.8 0.4 10.3 11.7 4.2 5.7 18.0 3.7 0.0 9.8 438.4 0.2 0.0 16.9 113.1 4.7 42.8 9.6 1.2 63.9 0.5 16.3 68.3 10.9 19.9 7.0 309.1 0.7 12.5 24.0 264.4 0.0 0.5 0.5 0.0 401.2 337.6 290.9 1.2 466.1 23.2 17.8 535.7 23.7 471.7 0.5 1.5 6.8 2.4 1.9 102.4 42.0 0.1 1.5 13.8 1.2 0.0 3.1 6.2 2.7 1.6 2.2 11.8 13.5 375.3 0.5 0.4 4.0 LDAH "C2orf43, FLJ21820" ENSG00000118961 "Lipid droplet associated hydrolase" Q9H6V9 2 20684014-20823130 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034729, HPA034730" Approved NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "HPA034729: AB_10603684, HPA034730: AB_2674304" "unprognostic (1.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" "unprognostic (2.21e-2)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.09e-6)" "unprognostic (3.57e-2)" "unprognostic (1.36e-1)" "unprognostic (1.27e-2)" "unprognostic (6.45e-2)" "unprognostic (2.44e-1)" "prognostic favorable (1.18e-4)" "unprognostic (1.05e-1)" "unprognostic (2.31e-1)" "unprognostic (2.22e-1)" "unprognostic (3.97e-2)" 7.3 14.1 5.1 7.3 6.8 5.0 7.6 4.8 5.6 7.9 6.8 10.8 7.4 7.3 9.3 8.0 6.2 6.8 4.3 5.3 6.4 16.8 12.1 5.5 11.1 5.7 5.1 8.0 7.4 9.4 5.8 8.7 5.8 7.0 11.7 8.3 6.9 6.2 1.2 6.1 6.5 8.1 5.9 9.0 7.8 5.0 6.0 11.7 8.2 1.7 13.4 9.7 6.0 7.7 20.2 18.3 45.6 0.0 18.6 24.6 28.5 17.9 12.2 14.5 11.1 19.8 12.3 25.3 0.0 13.1 25.4 16.9 34.8 12.9 14.9 31.6 17.2 37.1 16.6 30.5 19.0 28.2 8.9 20.9 18.9 14.0 3.6 19.7 27.7 33.8 49.7 18.6 25.5 13.0 41.1 19.4 29.1 41.7 0.0 33.1 36.6 28.8 29.0 29.4 25.0 37.9 11.8 18.7 19.9 37.9 15.9 19.7 25.6 13.0 6.6 17.0 10.7 22.7 45.2 11.6 25.3 26.8 24.6 0.9 3.2 0.3 6.6 4.9 4.3 7.8 6.5 5.6 5.8 5.5 5.9 5.9 0.2 5.5 3.9 5.4 6.1 4.2 5.1 6.8 4.8 5.6 5.3 6.4 5.7 5.1 5.8 5.9 6.0 7.7 5.0 16.0 10.6 0.0 9.3 0.0 3.4 0.0 5.7 9.3 5.3 3.9 2.8 7.2 4.3 7.3 16.7 12.0 4.6 3.4 7.9 7.4 8.7 4.2 10.9 6.3 3.6 13.3 0.0 6.4 11.6 5.1 9.7 6.1 6.3 14.8 8.6 7.9 9.0 11.8 0.0 6.0 0.0 9.8 0.0 2.7 7.5 5.5 0.0 0.0 4.7 15.0 5.2 0.0 0.0 6.5 5.5 6.8 9.9 3.7 5.0 12.0 0.0 9.6 6.6 4.2 5.4 4.3 5.2 7.7 0.0 11.5 6.7 15.8 6.1 3.6 LEMD3 MAN1 ENSG00000174106 "LEM domain containing 3" Q9Y2U8 12 65169583-65248355 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025078, HPA076986" Uncertain Supported "Nuclear membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nuclear membrane" "HPA025078: AB_10601908, HPA076986: AB_2686821" "unprognostic (2.10e-2)" "unprognostic (6.83e-3)" "unprognostic (1.63e-3)" "unprognostic (1.76e-3)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (1.68e-3)" "unprognostic (7.22e-2)" "unprognostic (3.06e-2)" "unprognostic (4.16e-2)" "unprognostic (8.89e-2)" "unprognostic (2.43e-1)" "prognostic favorable (2.30e-4)" "unprognostic (4.37e-2)" "unprognostic (3.93e-1)" "unprognostic (1.35e-1)" "unprognostic (1.72e-1)" 9.3 7.3 6.6 10.5 8.0 20.8 10.6 12.2 9.4 8.6 6.9 10.4 9.6 12.2 8.8 8.1 9.3 6.9 7.2 8.5 6.3 9.6 9.5 9.3 13.5 6.0 6.9 11.9 9.8 14.7 5.3 7.2 6.4 9.4 10.0 16.6 9.3 7.7 8.7 8.0 9.4 8.3 6.9 11.4 9.7 15.6 6.9 13.6 10.6 9.6 12.3 8.9 8.1 7.7 19.7 10.9 17.1 17.2 11.8 13.6 11.7 22.4 12.0 11.0 9.5 13.7 12.4 53.2 14.1 13.9 8.5 25.8 18.5 16.0 15.9 12.8 21.4 21.7 10.2 10.5 9.0 33.4 15.1 9.9 16.9 13.1 17.6 15.5 13.1 14.6 28.9 24.6 15.6 11.5 17.5 17.3 23.5 8.9 11.1 40.6 16.8 26.8 13.8 21.4 17.8 10.9 22.5 22.7 14.0 16.4 22.6 26.0 18.1 13.4 14.3 12.7 15.7 17.5 17.7 32.3 11.2 16.1 16.8 1.0 0.7 1.4 1.5 0.6 2.0 1.8 2.0 2.0 1.0 1.9 1.9 2.1 0.8 1.6 0.9 2.1 1.9 0.7 6.6 8.0 12.2 9.4 8.5 6.3 6.0 6.9 6.4 6.9 6.9 7.7 21.7 38.5 21.0 29.7 29.0 32.1 19.4 10.4 14.8 20.1 15.3 11.3 14.7 8.6 13.5 11.0 18.8 8.0 32.7 20.2 0.0 10.3 2.1 16.3 18.0 17.4 14.9 16.8 50.0 13.1 4.6 18.5 13.3 19.8 22.2 12.5 14.6 13.3 6.5 16.8 58.2 13.7 12.2 13.7 16.4 3.2 15.8 16.4 17.8 49.6 16.1 20.3 17.5 53.3 52.7 14.6 14.5 12.4 23.6 18.9 7.8 4.3 19.3 21.5 6.6 23.5 19.2 43.3 35.3 17.6 39.1 14.4 21.9 13.7 11.8 22.9 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971778 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "granulocytes: 272.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.2 11.4 8.1 13.8 8.8 9.0 15.5 14.7 12.9 11.6 6.4 17.0 13.3 10.4 10.0 19.8 8.7 13.2 8.1 8.0 10.0 13.7 22.2 9.7 18.0 8.0 8.1 8.5 8.1 18.8 9.1 12.1 7.7 12.3 19.2 12.0 18.5 8.6 13.9 20.8 14.5 11.7 6.9 10.5 13.2 9.3 8.3 22.1 11.1 11.7 17.9 19.3 14.0 10.0 28.0 63.9 40.3 32.6 40.7 35.0 28.8 44.4 36.6 37.3 33.9 44.3 17.9 56.2 25.3 45.8 41.3 53.2 54.2 39.6 35.8 37.5 24.5 88.5 50.6 78.5 32.0 80.7 118.2 37.9 30.5 29.2 37.6 35.2 37.0 46.5 54.6 30.1 44.9 118.7 43.0 61.1 17.4 82.6 27.0 47.6 69.7 58.9 32.8 77.0 28.5 43.4 33.9 51.5 36.5 43.8 42.8 72.6 44.4 36.8 25.5 34.3 53.7 23.4 78.2 50.7 32.2 113.1 40.0 11.5 14.5 15.7 27.4 23.3 25.7 18.7 27.2 22.3 23.8 16.4 27.9 25.2 3.3 30.9 26.0 17.8 31.7 16.3 8.1 8.8 14.7 12.9 8.0 10.0 8.0 8.1 7.7 6.9 8.3 10.0 16.2 35.3 24.6 10.1 15.2 26.1 16.8 33.4 18.2 38.2 11.8 10.2 21.2 17.2 37.0 7.3 10.4 24.9 24.8 24.6 15.6 26.3 2.4 19.5 38.8 18.0 7.7 12.4 16.5 24.2 26.7 19.9 15.8 29.8 272.8 16.2 10.0 18.0 19.5 26.9 16.9 17.9 26.4 14.8 6.0 2.7 8.1 13.0 3.6 5.6 12.8 23.1 22.6 13.0 13.3 18.2 14.7 13.5 11.0 9.0 20.5 23.3 31.4 23.2 6.6 18.5 29.3 21.5 11.0 19.5 24.7 17.6 25.0 23.8 17.0 21.2 LEPROTL1 "my047, Vps55" ENSG00000104660 "Leptin receptor overlapping transcript like 1" O95214 8 30095408-30177208 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "T-cells: 351.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047911 Uncertain NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 34: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" "HPA047911: AB_2680206" "unprognostic (4.42e-2)" "unprognostic (1.33e-2)" "prognostic favorable (9.04e-4)" "unprognostic (1.92e-2)" "unprognostic (3.77e-2)" "unprognostic (4.56e-2)" "unprognostic (1.25e-3)" "unprognostic (5.24e-2)" "unprognostic (2.44e-1)" "unprognostic (4.73e-3)" "unprognostic (2.30e-1)" "unprognostic (9.44e-3)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.03e-1)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (2.53e-1)" 37.0 48.5 20.0 32.6 20.7 55.7 25.0 23.8 26.0 20.3 16.7 28.4 20.4 21.4 25.6 18.8 21.1 23.5 34.0 22.7 20.3 29.4 38.8 29.7 39.4 19.1 18.9 20.4 22.7 21.8 15.3 75.9 19.6 17.8 26.0 25.7 20.7 22.1 13.3 21.8 26.5 24.0 19.5 33.1 25.3 34.1 19.8 66.3 15.3 14.9 36.1 26.4 17.6 21.8 39.3 48.9 67.8 52.0 36.2 27.4 27.0 55.6 45.1 37.9 60.7 40.4 41.2 24.3 45.6 51.7 47.9 37.6 52.3 39.2 60.8 32.9 31.3 75.0 35.0 74.6 55.9 23.1 55.3 31.5 41.4 42.7 27.0 43.7 47.0 57.4 79.4 40.1 45.3 49.6 52.4 31.4 47.1 73.9 30.8 41.8 27.1 28.9 48.7 48.3 15.4 55.3 30.4 31.2 50.5 44.8 29.0 22.5 41.2 23.0 114.6 19.1 42.8 15.6 24.0 49.3 33.8 49.4 55.0 252.3 119.8 171.3 142.3 121.9 188.3 38.2 246.6 174.7 83.3 33.4 347.3 259.9 229.9 102.3 160.6 115.4 338.9 284.5 20.0 20.7 23.8 26.0 22.7 20.3 19.1 18.9 19.6 19.5 19.8 21.8 97.7 35.3 42.3 13.7 62.2 29.2 16.5 57.5 21.1 23.2 38.6 29.3 40.9 42.9 42.4 42.3 12.5 56.2 196.6 39.1 19.6 113.4 122.2 44.8 40.3 67.2 33.0 30.1 25.2 102.3 105.2 36.4 35.7 34.3 141.4 149.2 69.3 74.9 98.3 20.2 25.6 35.4 67.1 93.1 70.3 79.7 35.4 85.1 62.2 15.9 86.3 27.6 117.4 24.1 21.5 83.9 36.7 26.4 78.0 15.2 48.7 83.1 65.7 26.3 52.6 21.8 71.3 122.6 68.4 31.1 34.7 51.9 351.9 48.2 33.2 19.3 LGALS8 PCTA-1 ENSG00000116977 "Galectin 8" O00214 1 236518000-236552981 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 322.8;Late spermatids: 222.6;Syncytiotrophoblasts: 176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 118.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012734, HPA030491" Approved Approved "Plasma membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" "Plasma membrane" "HPA012734: AB_2668720, HPA030491: AB_10602345" "unprognostic (2.03e-2)" "unprognostic (1.54e-1)" "unprognostic (2.38e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (4.71e-3)" "unprognostic (3.93e-2)" "prognostic favorable (9.40e-4)" "unprognostic (9.96e-2)" "unprognostic (1.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-3)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.41e-1)" "unprognostic (1.57e-1)" "unprognostic (3.15e-2)" "unprognostic (8.21e-2)" 28.6 14.3 10.8 26.5 11.3 44.4 23.3 12.4 14.1 17.2 11.5 19.9 21.6 16.7 19.6 21.2 13.8 24.8 55.0 12.5 12.6 23.4 49.5 27.0 24.0 12.9 10.9 21.6 21.8 35.0 12.7 41.0 13.5 22.2 19.9 22.9 22.1 21.3 6.8 32.4 24.1 21.8 11.7 42.6 18.9 57.1 11.4 26.3 17.2 9.4 22.8 32.8 15.3 11.7 52.3 27.5 3.6 20.8 46.6 39.0 55.6 38.0 45.4 49.0 59.3 37.6 63.3 1.5 34.8 33.7 26.8 60.3 11.0 54.7 43.2 31.1 7.3 35.5 20.7 68.1 56.9 46.9 78.9 39.6 45.6 41.0 13.8 42.4 52.5 26.4 40.7 25.1 35.7 33.3 23.2 8.4 12.5 4.1 18.5 27.2 0.8 3.0 35.4 80.8 13.1 25.7 24.4 82.3 13.7 2.1 59.0 33.7 39.1 1.0 22.0 29.9 47.7 10.0 7.4 1.0 50.4 65.7 30.9 118.5 37.4 18.7 12.5 32.9 17.8 10.7 18.4 14.1 31.7 6.8 12.2 12.7 16.1 14.2 24.0 14.2 22.5 24.8 10.8 11.3 12.4 14.1 12.5 12.6 12.9 10.9 13.5 11.7 11.4 11.7 44.0 76.9 54.7 12.1 19.3 32.5 28.5 64.9 44.9 28.1 31.7 22.7 55.2 34.3 68.1 14.7 25.0 64.4 33.9 25.3 5.9 61.8 322.8 18.7 21.9 39.9 18.1 19.0 31.5 39.2 53.5 35.2 23.0 20.8 109.4 38.0 46.1 27.1 57.5 38.7 37.0 18.8 57.0 100.5 23.6 222.6 23.6 45.1 7.2 24.4 38.7 6.5 17.5 18.1 16.7 44.0 36.0 13.9 15.1 20.6 26.4 14.5 53.1 19.4 26.3 22.5 19.6 46.8 8.7 21.3 37.1 176.2 34.4 22.8 17.1 24.4 LIN54 "CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1" ENSG00000189308 "Lin-54 DREAM MuvB core complex component" Q6MZP7 4 82909973-83012926 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.2;Oligodendrocytes: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 117.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056606 Approved NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA056606: AB_2683187" "unprognostic (2.01e-2)" "unprognostic (1.47e-2)" "unprognostic (2.52e-2)" "unprognostic (7.11e-2)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (3.56e-3)" "unprognostic (6.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.06e-1)" "unprognostic (3.03e-1)" "unprognostic (2.60e-2)" "prognostic favorable (1.06e-4)" "unprognostic (3.02e-2)" "unprognostic (1.51e-1)" "unprognostic (9.17e-2)" "unprognostic (1.81e-2)" 3.8 3.4 2.6 4.9 4.4 13.1 4.9 5.4 5.1 5.3 0.2 6.0 5.4 4.4 3.8 10.5 3.7 3.9 4.4 2.9 3.2 6.9 8.2 3.9 6.5 4.7 3.5 5.0 2.7 5.9 2.0 6.2 4.2 3.9 6.9 10.0 3.4 4.4 4.4 5.4 4.3 4.5 3.6 4.7 4.5 6.9 3.1 12.8 10.3 5.8 8.6 4.7 3.4 7.8 16.8 9.8 15.1 17.3 7.8 7.5 11.2 26.7 18.5 19.8 18.9 11.7 18.9 18.3 14.4 27.6 13.0 12.9 20.8 8.7 24.1 19.9 9.1 16.8 14.7 13.2 6.8 20.7 117.8 6.3 5.0 21.7 10.4 6.1 12.2 17.0 18.6 35.5 19.4 11.9 44.3 8.6 6.3 20.6 6.5 23.9 16.8 12.8 9.4 14.3 15.7 8.3 16.2 25.7 10.6 9.4 11.2 13.3 9.6 23.6 17.6 22.1 12.2 17.6 14.0 30.6 13.1 12.8 18.9 3.5 2.5 5.5 3.7 2.0 4.2 1.6 3.7 4.2 1.5 2.1 4.6 3.9 5.4 4.7 6.6 1.1 4.7 2.4 2.6 4.4 5.4 5.1 2.9 3.2 4.7 3.5 4.2 3.6 3.1 7.8 7.5 6.4 5.5 10.7 7.2 12.1 3.6 2.4 9.6 8.5 5.5 5.2 6.1 4.3 3.3 5.5 2.1 4.3 8.9 11.3 0.0 3.1 37.2 7.1 6.0 4.9 4.2 15.2 23.4 3.6 4.8 4.9 6.6 12.9 2.5 5.7 5.7 7.5 6.5 5.0 22.1 4.9 2.0 6.3 7.8 14.2 2.5 8.2 8.8 12.2 4.4 7.3 7.2 18.1 60.3 4.0 3.4 4.9 17.2 3.8 4.7 6.2 4.4 8.6 13.1 6.4 6.9 3.1 3.1 14.0 12.5 3.4 9.1 3.5 5.2 8.2 LNPEP "CAP, IRAP, P-LAP, PLAP" ENSG00000113441 "Leucyl and cystinyl aminopeptidase" Q9UIQ6 5 96935394-97037513 "Enzymes, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 257.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043642 Approved "Intracellular and membrane" NA NA 9800000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA043642: AB_10964137" "unprognostic (1.52e-1)" "unprognostic (5.39e-2)" "unprognostic (7.78e-2)" "unprognostic (1.53e-2)" "unprognostic (6.38e-2)" "unprognostic (6.59e-3)" "unprognostic (6.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.11e-1)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "unprognostic (2.08e-1)" "unprognostic (3.28e-1)" "unprognostic (4.13e-3)" "unprognostic (1.46e-1)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" 11.4 4.4 8.4 12.2 10.6 16.2 8.2 17.9 8.6 6.8 4.0 8.1 5.2 6.5 5.1 9.0 5.7 5.1 12.0 8.5 10.0 8.3 4.3 7.7 19.4 10.0 9.4 8.8 4.9 15.3 5.8 9.1 10.7 8.8 7.9 9.4 6.0 8.5 11.2 16.4 8.2 7.7 8.6 12.5 7.9 4.1 9.2 17.8 8.4 12.7 18.7 7.0 7.0 10.3 10.7 11.9 5.4 5.6 32.5 15.4 6.2 10.5 13.8 12.0 18.1 9.9 16.4 52.2 19.1 14.1 33.7 13.4 6.8 20.1 12.5 18.2 3.8 12.9 8.2 7.3 8.4 15.5 16.9 12.0 12.5 17.5 13.3 13.6 12.8 11.6 5.6 32.7 13.9 9.6 18.1 10.9 1.1 3.4 6.2 12.7 19.8 7.9 44.9 21.2 10.2 2.7 12.8 11.4 6.4 5.2 34.1 20.2 26.6 17.6 9.6 13.9 16.3 7.3 17.4 45.6 16.1 14.5 8.2 4.3 2.6 3.6 5.9 4.2 5.0 2.3 4.4 4.6 2.8 3.1 4.2 4.7 3.1 9.0 11.2 2.6 4.2 3.6 8.4 10.6 17.9 8.6 8.5 10.0 10.0 9.4 10.7 8.6 9.2 10.3 43.4 35.3 41.3 52.2 91.0 59.4 21.3 28.4 37.5 58.9 24.9 18.8 80.8 22.8 27.2 36.8 125.1 12.3 108.4 20.7 5.9 15.4 3.6 21.4 28.9 33.6 25.7 38.9 47.5 14.4 24.3 36.6 30.1 28.9 25.9 29.3 30.7 16.7 16.2 23.5 50.9 29.6 22.4 49.3 35.9 5.3 32.9 52.0 21.4 45.9 59.7 33.6 257.5 49.3 73.9 21.5 17.5 46.6 44.9 27.4 16.6 10.7 25.8 38.4 26.3 46.8 36.6 29.4 27.5 44.4 47.2 27.4 97.3 31.1 25.6 23.2 LPCAT2 "AGPAT11, AYTL1, FLJ20481, LysoPAFAT" ENSG00000087253 "Lysophosphatidylcholine acyltransferase 2" Q7L5N7 16 55509072-55586666 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.3;thyroid gland: 86.3" "Cell type enhanced" "Detected in many" "granulocytes: 173.3;Microglial cells: 224.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 151.4;eosinophil: 199.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 199.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 115.9;HaCaT: 89.2;HL-60: 103.0;HMC-1: 161.7;hTERT-RPE1: 162.9;WM-115: 117.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007891, HPA008433" Enhanced Supported Supported "Endoplasmic reticulum,Lipid droplets" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Endoplasmic reticulum" "Lipid droplets" "HPA007891: AB_1845223, HPA008433: " "unprognostic (1.43e-1)" "unprognostic (2.44e-2)" "prognostic favorable (3.43e-4)" "prognostic favorable (8.03e-6)" "unprognostic (2.91e-1)" "unprognostic (9.65e-3)" "unprognostic (8.12e-3)" "unprognostic (3.26e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (3.18e-3)" "unprognostic (9.16e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" 9.8 9.0 5.6 14.4 7.7 88.3 12.2 10.6 5.2 14.0 10.7 9.0 7.4 18.5 36.7 7.8 8.8 10.5 5.7 4.8 8.5 10.9 3.9 10.4 5.0 13.7 8.5 15.8 5.4 13.6 1.0 16.0 15.9 7.0 9.3 7.7 8.4 28.6 2.2 12.0 9.1 15.0 12.7 11.8 9.0 4.1 7.9 3.5 86.3 5.8 4.0 9.5 7.5 22.4 33.5 4.2 3.5 0.3 10.8 4.1 5.6 14.1 13.5 6.8 6.9 7.5 115.9 0.0 46.6 19.9 5.5 89.2 2.2 19.4 10.9 9.1 9.6 34.2 10.2 17.3 4.1 103.0 161.7 2.1 19.2 7.5 6.3 162.9 53.5 1.8 1.5 0.4 11.6 2.1 0.0 41.8 5.1 9.5 0.4 10.4 3.8 5.1 6.8 12.9 2.2 25.3 27.1 10.8 19.9 15.8 4.6 25.8 60.3 0.3 0.1 6.9 9.6 0.6 0.2 0.2 0.5 49.4 117.8 151.4 17.5 199.2 0.0 27.4 0.0 0.0 0.0 0.0 21.0 0.1 0.0 0.0 47.0 0.0 39.1 0.7 0.0 6.5 5.6 7.7 10.6 5.2 4.8 8.5 13.7 8.5 15.9 12.7 7.9 22.4 68.6 6.4 25.7 2.9 1.1 15.4 37.2 68.3 17.1 5.5 8.8 33.9 2.2 4.3 22.3 68.0 10.4 0.7 3.3 7.0 1.9 8.3 1.7 6.4 4.8 41.0 1.2 9.7 8.1 9.7 7.5 20.7 10.2 13.9 173.3 0.4 12.1 2.0 36.5 0.0 11.7 12.2 18.3 71.9 57.7 3.1 16.4 74.4 17.8 224.9 40.6 24.0 0.0 4.5 66.5 32.8 23.0 12.8 1.0 9.0 3.4 3.5 8.1 5.3 0.0 20.0 4.2 49.6 24.0 14.2 15.3 1.9 5.6 7.0 11.6 17.6 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 89.2;Inhibitory neurons: 117.6;Microglial cells: 183.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 37.1" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 15.1 5.0 4.7 10.7 4.7 8.9 14.6 37.1 6.2 15.9 4.2 15.2 7.9 16.3 7.7 10.0 11.8 12.6 8.4 5.7 6.1 14.9 12.2 13.8 16.3 6.5 7.0 10.1 5.6 5.4 5.8 18.2 7.8 10.8 10.0 10.3 10.0 12.0 3.9 17.9 11.6 17.6 7.9 14.6 13.0 4.6 6.8 18.5 6.5 7.5 15.7 13.5 9.7 7.5 7.4 10.4 9.2 9.6 6.6 12.5 23.6 12.4 16.1 15.0 14.2 23.5 12.3 23.4 3.4 11.7 9.8 10.4 7.1 12.5 21.6 24.2 6.6 21.0 4.3 11.1 8.2 13.8 34.5 7.9 9.7 13.9 16.8 12.3 13.1 15.6 4.2 6.9 11.2 14.2 14.8 17.3 5.2 46.3 5.5 8.0 10.0 6.3 28.1 7.5 14.5 14.6 7.0 6.8 18.8 16.2 5.3 18.3 12.5 8.8 6.0 11.0 11.9 1.3 3.7 10.6 10.3 11.9 10.8 0.6 0.9 0.9 1.5 0.7 0.8 2.2 1.1 1.0 0.8 2.7 0.8 0.9 0.3 2.5 0.5 1.0 0.8 0.9 4.7 4.7 37.1 6.2 5.7 6.1 6.5 7.0 7.8 7.9 6.8 7.5 61.5 6.4 6.1 24.8 26.7 37.5 10.5 6.2 27.3 8.3 12.0 11.8 7.2 17.2 6.5 22.0 22.9 13.4 8.4 6.8 9.8 8.3 1.6 5.4 6.5 32.5 1.8 9.9 89.2 4.2 12.7 14.3 18.8 13.7 27.9 2.8 17.5 9.3 13.4 3.3 117.6 10.6 8.2 16.9 30.7 2.1 13.1 12.3 30.2 183.6 8.4 5.5 8.2 64.8 9.7 13.5 5.5 17.0 12.4 12.9 8.0 8.4 2.6 8.5 13.1 15.6 18.6 1.7 4.1 15.9 33.2 9.7 14.7 15.3 7.8 9.2 LRCH3 MGC4126 ENSG00000186001 "Leucine rich repeats and calponin homology domain containing 3" Q96II8 3 197791226-197888436 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 139.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 38.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 38.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012380, HPA017299" Uncertain Enhanced Cytosol "Intracellular and membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" Cytosol "HPA012380: AB_1853260, HPA017299: AB_2669576" "unprognostic (1.25e-1)" "unprognostic (4.92e-1)" "unprognostic (1.43e-1)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.29e-1)" "unprognostic (4.13e-1)" "unprognostic (9.85e-2)" "unprognostic (1.64e-1)" "unprognostic (2.06e-2)" "unprognostic (1.79e-3)" "unprognostic (3.29e-2)" "unprognostic (2.67e-1)" "unprognostic (5.59e-2)" "unprognostic (1.32e-1)" 13.1 10.2 7.7 12.0 11.9 8.0 11.4 18.7 9.1 16.2 7.3 16.3 7.0 15.5 7.7 10.7 13.7 10.2 14.6 7.7 12.5 8.2 10.3 11.9 17.0 9.8 8.1 18.8 9.5 12.2 12.3 10.1 8.5 13.9 10.2 19.2 12.0 12.1 19.3 10.8 12.8 14.8 6.0 13.9 11.2 13.1 10.1 15.5 9.7 11.5 18.7 14.8 13.8 15.7 30.5 10.0 28.8 17.5 28.9 35.2 11.0 21.5 25.6 25.3 31.5 26.0 15.5 16.1 33.5 24.9 40.7 19.1 25.7 21.2 34.5 13.3 14.4 29.8 16.2 19.2 18.9 21.4 19.3 25.0 10.9 24.7 31.9 23.0 30.7 14.7 18.1 27.5 23.4 25.1 15.9 7.8 19.3 15.8 22.3 16.0 17.6 10.6 11.3 19.4 14.2 14.4 28.5 18.5 20.1 26.4 39.0 17.1 30.1 19.4 12.0 24.4 22.2 24.5 26.9 15.2 19.8 28.0 20.3 38.9 4.7 10.1 7.4 6.9 6.0 9.3 5.8 6.3 4.1 6.6 5.3 7.5 2.3 7.1 6.9 3.5 6.1 5.4 7.7 11.9 18.7 9.1 7.7 12.5 9.8 8.1 8.5 6.0 10.1 15.7 19.2 32.1 27.0 64.6 29.7 10.6 18.1 11.4 8.0 56.0 11.6 8.5 15.4 14.3 17.0 9.2 56.3 8.5 25.8 10.4 1.9 10.1 12.8 12.2 22.9 20.8 6.0 11.1 69.8 9.9 6.6 23.8 10.7 16.4 11.4 23.0 34.6 14.2 9.0 38.7 86.1 11.0 8.2 17.6 17.9 9.6 25.1 14.6 17.8 66.5 30.8 19.8 27.8 102.1 139.2 14.1 9.5 28.6 15.1 15.9 7.1 5.2 15.1 43.1 19.7 31.7 22.8 18.0 17.2 9.4 10.5 6.0 19.9 17.0 11.0 14.7 LRRC40 FLJ20331 ENSG00000066557 "Leucine rich repeat containing 40" Q9H9A6 1 70144805-70205579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026564 Approved Approved Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli "HPA026564: AB_2250054" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "prognostic favorable (4.54e-4)" "unprognostic (6.42e-2)" "unprognostic (6.65e-3)" "unprognostic (3.94e-2)" "unprognostic (7.69e-3)" "unprognostic (9.90e-2)" "unprognostic (3.40e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-2)" "unprognostic (2.50e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-3)" "unprognostic (1.95e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 9.7 8.4 5.7 9.0 6.6 16.3 11.0 8.3 8.4 7.7 2.3 9.0 14.6 10.3 6.5 9.5 5.4 8.4 11.7 7.0 6.3 14.1 23.6 8.2 13.2 4.6 4.8 8.3 7.1 6.8 3.5 12.0 5.1 8.6 9.7 9.9 5.6 6.9 7.4 7.7 13.5 11.2 5.3 9.3 6.9 11.9 5.3 14.0 8.2 10.0 12.6 9.8 5.1 6.8 26.4 10.9 42.1 33.3 15.1 16.6 25.4 25.0 18.2 37.0 45.4 16.0 14.5 35.4 21.4 19.6 36.6 19.0 100.0 22.3 50.2 28.5 20.0 26.8 18.6 25.9 19.0 35.4 6.2 13.8 12.7 24.7 24.6 17.1 21.7 22.2 33.6 16.7 31.7 6.8 42.8 27.4 55.5 17.3 22.5 33.8 43.5 22.9 34.1 16.0 21.5 21.7 30.2 29.9 28.6 29.6 14.3 19.8 27.2 26.0 20.8 39.7 28.7 14.0 14.4 57.2 21.0 36.6 27.3 5.4 4.6 5.5 5.5 6.0 7.3 7.2 5.8 5.3 6.0 6.7 6.8 5.8 0.7 7.6 5.8 4.6 7.8 4.5 5.7 6.6 8.3 8.4 7.0 6.3 4.6 4.8 5.1 5.3 5.3 6.8 13.9 12.8 12.6 22.2 15.1 12.9 7.8 10.5 17.1 16.4 6.9 6.0 10.4 8.6 9.2 14.7 6.2 16.9 23.2 6.9 11.7 12.7 1.3 6.0 12.1 11.3 23.3 17.2 41.1 8.9 13.3 12.7 5.1 10.8 15.2 11.3 13.2 21.4 11.9 15.2 40.1 6.5 20.3 11.7 12.1 3.0 10.2 9.4 5.4 15.9 13.4 7.6 8.2 22.6 30.9 9.2 4.1 10.1 11.7 5.1 13.2 24.1 6.4 12.5 19.7 12.9 12.9 25.1 28.3 11.7 11.1 7.3 15.8 10.4 8.1 5.0 LRRC57 FLJ36812 ENSG00000180979 "Leucine rich repeat containing 57" Q8N9N7 15 42537820-42548802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 60.5;Rod photoreceptor cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040894 Approved Approved Mitochondria,Cytosol NA NA 26000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Mitochondria, Cytosol" "HPA040894: AB_10794996" "unprognostic (8.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.84e-2)" "unprognostic (4.77e-2)" "unprognostic (4.16e-2)" "unprognostic (4.78e-2)" "unprognostic (2.57e-1)" "unprognostic (1.32e-1)" "unprognostic (3.31e-2)" "unprognostic (3.73e-2)" "prognostic favorable (2.15e-4)" "unprognostic (7.45e-2)" "unprognostic (7.23e-2)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" 7.7 7.3 4.8 5.5 4.6 22.0 7.5 4.8 8.5 7.3 3.3 9.3 6.5 7.7 5.5 9.6 8.3 5.3 6.9 6.1 3.1 8.0 6.1 8.6 6.6 3.6 3.4 8.6 7.3 14.0 6.0 7.9 4.1 6.6 10.7 14.9 8.0 5.8 6.0 9.6 8.1 7.3 3.2 6.7 7.8 5.7 3.7 9.6 7.0 6.9 7.4 6.8 8.6 5.4 14.7 11.0 19.5 13.8 16.5 12.7 9.7 20.5 11.2 14.7 15.4 23.3 11.0 6.8 13.8 16.9 16.5 22.7 13.2 16.7 14.7 12.8 12.2 27.7 23.6 10.7 14.7 17.8 15.0 14.0 22.8 13.2 17.1 10.1 23.7 17.3 21.9 14.5 13.6 6.6 9.8 7.5 4.6 26.6 8.5 15.1 19.6 10.5 9.8 24.4 9.8 11.9 24.8 16.3 11.8 12.7 16.1 19.6 24.3 16.5 11.4 17.5 15.5 11.9 36.4 29.0 8.9 16.4 21.0 36.9 9.7 32.0 7.4 14.6 9.3 5.8 7.2 7.2 10.2 7.1 5.8 7.3 12.2 16.9 19.3 5.9 8.5 6.9 4.8 4.6 4.8 8.5 6.1 3.1 3.6 3.4 4.1 3.2 3.7 5.4 16.3 9.6 10.8 6.8 10.4 5.7 13.6 6.5 6.8 13.6 9.6 8.1 11.1 15.7 7.3 9.2 60.5 11.6 18.8 16.4 13.7 10.9 18.7 13.5 13.8 17.3 12.5 15.8 17.1 9.8 19.3 12.7 9.2 13.2 14.5 10.2 19.2 7.5 14.1 20.2 8.8 13.1 6.1 14.2 4.8 20.0 9.6 13.1 7.2 7.5 21.9 21.1 20.6 11.6 8.3 15.2 15.9 16.1 8.4 12.4 15.2 8.4 14.8 87.4 6.6 16.9 10.1 7.8 6.4 11.4 5.5 15.9 11.3 18.4 12.2 12.8 LTN1 "C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294" ENSG00000198862 "Listerin E3 ubiquitin protein ligase 1" O94822 21 28928144-28992956 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 213.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029143, CAB034164, HPA055604" Uncertain Enhanced Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859" "unprognostic (3.67e-2)" "unprognostic (7.07e-2)" "unprognostic (7.78e-2)" "unprognostic (3.99e-1)" "unprognostic (1.42e-2)" "unprognostic (3.66e-3)" "unprognostic (5.38e-2)" "unprognostic (5.40e-2)" "unprognostic (9.98e-2)" "unprognostic (4.45e-2)" "unprognostic (2.85e-2)" "unprognostic (1.13e-1)" "unprognostic (9.87e-2)" "unprognostic (1.72e-1)" "unprognostic (8.22e-2)" "unprognostic (4.57e-2)" "unprognostic (1.52e-1)" 7.7 8.4 4.5 9.3 7.8 16.5 12.4 7.0 6.2 9.3 5.3 9.2 8.8 10.7 10.2 9.1 7.0 7.4 7.7 4.1 6.6 8.3 11.0 7.4 12.0 6.1 5.9 10.1 9.4 9.9 3.9 18.6 6.7 12.7 10.6 11.6 10.1 8.1 9.5 9.4 9.0 9.1 6.2 10.3 11.0 13.6 6.1 11.3 12.1 11.2 10.5 8.3 5.9 13.1 20.4 8.6 17.5 7.9 14.6 19.9 17.7 16.8 13.6 14.2 19.4 12.1 16.5 13.3 8.0 15.1 12.2 10.2 18.8 13.8 25.5 15.7 13.0 39.8 11.9 9.7 11.0 13.3 14.8 13.9 12.1 20.1 16.6 13.9 15.2 9.5 33.0 31.0 16.4 6.3 8.6 12.9 25.1 16.8 10.1 11.4 34.9 28.0 16.0 17.3 9.5 19.7 19.3 14.5 17.0 16.3 14.8 18.6 20.2 12.4 22.9 16.8 14.3 25.1 25.1 18.5 19.3 28.3 15.0 12.6 4.9 7.9 6.3 7.6 5.2 5.8 4.2 4.2 4.9 5.1 4.5 3.4 8.6 7.0 10.7 3.1 5.0 2.6 4.5 7.8 7.0 6.2 4.1 6.6 6.1 5.9 6.7 6.2 6.1 13.1 42.1 16.0 22.6 36.6 30.7 30.2 26.3 22.8 30.7 28.4 22.8 17.4 25.8 12.8 24.0 11.0 33.3 19.3 26.8 18.4 1.9 14.4 213.7 21.6 45.9 27.5 22.7 18.7 47.1 14.0 18.8 30.3 38.2 36.2 27.8 24.2 14.3 19.7 13.2 42.1 54.8 18.9 22.4 18.1 13.2 73.1 26.8 23.5 12.4 25.3 28.2 44.9 18.6 53.8 90.8 20.2 14.2 21.1 43.9 31.5 16.6 16.9 22.6 30.5 13.1 29.3 28.6 46.8 23.9 30.1 32.0 29.8 30.5 34.3 20.8 29.8 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Phagocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.3;retina: 27.9" "Cell type enhanced" "Detected in all" "monocytes: 277.4" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 12.2" "Group enriched" "Detected in many" 5 "granulocytes: 12.2;monocytes: 6.1" "Cell line enhanced" "Detected in many" "HDLM-2: 30.8;SK-MEL-30: 27.1;THP-1: 99.5;U-937: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Yes No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: AB_2682129, HPA055725: AB_2682898" "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 5.2 2.7 2.0 8.5 2.7 31.3 6.4 10.1 3.3 7.1 9.1 4.5 3.0 4.3 2.7 4.2 3.9 5.1 2.2 2.0 2.5 3.6 5.5 5.5 7.5 2.2 2.6 4.5 2.2 6.2 1.8 4.6 2.5 3.4 4.3 27.9 4.3 3.3 1.7 9.7 3.3 4.4 1.1 10.8 7.7 6.1 3.3 25.7 6.4 3.8 6.5 5.7 5.2 3.4 8.6 1.9 0.9 2.0 12.7 14.4 1.3 3.1 12.5 3.3 3.1 0.0 2.3 1.1 1.2 6.8 7.7 4.1 1.2 1.6 2.9 30.8 2.7 2.8 1.9 0.6 2.3 4.2 3.7 4.8 7.8 4.0 10.0 4.8 2.8 1.3 0.2 1.7 2.6 0.4 5.3 8.7 0.2 1.6 0.9 0.4 1.2 0.0 9.2 9.2 5.4 1.1 3.4 0.2 27.1 1.0 1.2 99.5 5.8 2.4 1.1 2.8 2.8 2.1 0.1 0.2 4.1 38.0 7.0 0.4 2.9 5.7 0.6 3.4 0.8 1.0 0.2 0.7 1.7 1.4 0.2 0.4 12.2 1.7 6.1 0.2 0.2 0.7 2.0 2.7 10.1 3.3 2.0 2.5 2.2 2.6 2.5 1.1 3.3 3.4 66.3 19.2 41.1 71.2 70.9 71.0 89.8 14.6 18.8 67.4 17.6 15.6 11.6 15.7 28.4 11.0 93.8 6.7 77.3 25.0 11.7 6.6 24.6 22.6 23.8 51.2 9.6 21.0 151.5 12.3 5.0 27.0 41.3 22.4 112.5 9.4 26.0 15.4 31.9 52.2 155.9 14.3 28.5 65.6 81.3 17.7 28.0 111.4 120.9 159.3 277.4 25.6 88.6 112.1 81.6 39.6 24.2 21.8 37.3 56.0 12.7 10.9 26.7 162.5 13.1 31.2 22.7 93.3 28.0 18.7 65.1 8.8 71.3 13.6 7.6 98.5 MAT2B "MATIIbeta, SDR23E1" ENSG00000038274 "Methionine adenosyltransferase 2B" Q9NZL9 5 163503114-163519354 "Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037721, HPA037722" Uncertain Approved "Plasma membrane" NA NA 1100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 59: Non-specific - Transcription" "Plasma membrane" "HPA037721: AB_10672389, HPA037722: AB_10671718" "unprognostic (1.22e-2)" "unprognostic (2.80e-2)" "unprognostic (1.80e-3)" "unprognostic (1.64e-1)" "unprognostic (5.06e-1)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (9.72e-2)" "unprognostic (1.68e-1)" "unprognostic (5.19e-3)" "unprognostic (3.57e-2)" "prognostic favorable (4.51e-7)" "unprognostic (1.06e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-3)" 36.6 54.6 31.1 64.7 32.4 31.1 50.5 35.3 39.8 46.9 37.5 61.5 86.9 45.4 59.4 40.9 66.7 42.1 75.3 32.8 33.7 104.8 82.7 56.1 102.6 32.2 35.3 73.3 23.9 69.2 22.0 48.9 33.3 46.1 66.5 47.8 64.3 53.2 57.8 34.6 84.4 44.4 34.6 84.5 57.2 31.7 33.3 89.6 81.4 63.7 92.7 60.9 33.2 34.0 72.4 60.0 100.6 55.1 73.4 72.9 62.2 61.8 68.5 67.7 99.4 41.5 128.5 74.8 127.6 66.0 99.5 56.6 84.8 125.4 89.1 254.5 69.6 67.3 63.3 62.1 95.9 71.0 44.7 60.4 101.1 86.1 66.4 81.8 149.5 76.6 54.8 90.8 84.0 40.7 99.2 85.9 38.6 43.9 40.0 112.4 49.2 123.4 111.7 76.6 40.4 57.9 82.8 58.2 93.8 44.1 76.5 95.1 121.2 73.6 48.5 51.8 107.7 78.4 82.3 68.3 54.1 129.1 51.3 619.4 227.5 477.4 321.5 274.3 355.8 359.1 351.2 349.3 204.6 345.3 352.7 341.4 357.8 401.5 302.4 167.2 528.3 689.9 31.1 32.4 35.3 39.8 32.8 33.7 32.2 35.3 33.3 34.6 33.3 34.0 24.9 48.1 43.3 8.8 90.1 42.7 35.1 75.6 129.1 23.2 26.0 20.7 57.7 41.5 48.1 44.1 8.4 61.3 62.8 49.2 62.6 38.8 39.0 63.5 36.2 38.9 15.0 79.3 15.0 26.2 29.7 34.6 36.2 44.2 28.4 28.1 35.7 58.3 45.3 18.5 12.8 40.8 61.1 83.3 55.3 13.3 34.5 48.5 42.7 18.7 70.6 41.7 80.3 9.0 16.2 28.9 38.1 31.2 65.7 46.8 53.4 103.7 72.6 17.6 46.0 21.7 35.6 23.6 30.5 69.8 36.2 37.6 84.2 23.3 51.3 45.7 MATR3 "KIAA0723, MGC9105, MPD2, VCPDM" ENSG00000015479 "Matrin 3" P43243 5 139293674-139331677 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" RNA-binding "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 155.9;Inhibitory neurons: 160.2;Langerhans cells: 122.3;Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 162.4;Respiratory ciliated cells: 127.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033552, HPA036564, HPA036565" Supported Approved Nucleoplasm "Intracellular and membrane" NA NA 260000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (9.33e-2)" "unprognostic (6.57e-2)" "unprognostic (8.37e-2)" "unprognostic (7.53e-2)" "unprognostic (7.20e-2)" "unprognostic (4.32e-3)" "unprognostic (1.03e-1)" "unprognostic (3.56e-2)" "unprognostic (2.96e-2)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (9.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (3.86e-2)" "unprognostic (7.90e-2)" 112.9 127.9 145.2 93.6 156.1 323.5 161.0 172.2 224.5 144.1 109.6 106.3 76.9 166.6 124.0 103.3 131.1 115.3 111.4 158.4 146.1 150.1 112.9 115.2 157.9 126.2 132.1 199.3 102.8 168.6 95.1 122.9 131.4 130.2 106.5 223.4 93.5 133.2 119.6 82.0 90.0 142.4 144.8 124.5 89.1 114.9 139.3 221.7 190.5 114.0 170.2 133.5 91.2 156.3 209.0 191.1 559.5 260.7 192.4 212.5 283.2 172.2 300.9 300.4 347.5 273.1 208.8 351.2 236.8 244.1 284.8 135.8 376.8 269.6 403.0 278.4 189.1 236.5 205.0 285.0 183.2 262.5 174.4 222.5 203.7 247.4 226.3 247.1 296.1 219.4 216.9 170.3 313.8 186.7 496.0 285.8 303.6 205.2 182.6 304.7 416.4 217.8 278.0 316.5 279.5 348.7 248.3 176.7 264.6 426.3 194.4 254.5 192.2 272.0 177.7 180.6 246.3 171.0 300.4 423.0 189.8 226.5 268.0 187.0 71.2 116.3 109.6 82.2 134.8 116.3 114.3 124.6 92.6 97.7 124.4 116.5 34.7 150.9 106.7 50.7 136.1 159.8 145.2 156.1 172.2 224.5 158.4 146.1 126.2 132.1 131.4 144.8 139.3 156.3 0.1 44.8 50.2 83.6 17.6 114.6 0.8 99.2 15.9 1.8 0.3 0.3 0.7 0.0 92.0 0.0 2.1 1.2 0.0 27.6 0.0 0.0 0.3 0.2 0.2 13.6 83.5 15.5 155.9 0.0 1.0 17.5 5.1 0.4 100.3 0.1 0.0 0.0 1.3 1.7 160.2 35.3 87.5 0.0 122.3 0.6 0.6 4.7 103.2 60.9 0.1 0.7 0.0 117.6 162.4 0.1 12.4 0.7 7.3 0.7 0.8 0.2 127.9 1.3 0.0 1.0 33.3 1.1 0.5 15.1 111.2 0.8 21.8 0.5 41.9 1.0 MBD4 MED1 ENSG00000129071 "Methyl-CpG binding domain 4, DNA glycosylase" O95243 3 129430947-129440179 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002031 Supported Supported "Nuclear speckles" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Nuclear speckles" "HPA002031: AB_1079319" "unprognostic (2.70e-2)" "unprognostic (3.48e-3)" "unprognostic (1.18e-2)" "unprognostic (6.37e-2)" "unprognostic (4.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.70e-2)" "unprognostic (3.25e-2)" "unprognostic (2.02e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (2.18e-4)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.73e-6)" "unprognostic (9.27e-2)" "unprognostic (1.59e-2)" "unprognostic (8.58e-2)" "unprognostic (3.35e-2)" 18.6 18.4 16.8 34.0 18.4 44.2 21.6 19.6 20.7 33.2 16.8 19.3 23.7 23.3 24.8 16.4 19.3 21.3 25.3 17.0 17.4 25.4 38.0 22.9 66.5 17.5 17.2 30.3 22.9 18.1 19.3 19.7 17.7 18.7 22.9 19.6 19.5 17.8 25.8 23.7 27.5 19.7 17.3 39.2 27.8 17.3 18.4 30.0 19.3 22.3 74.0 18.5 17.5 20.6 46.2 27.4 32.5 36.5 36.8 32.8 37.5 39.0 36.9 36.7 43.3 33.8 30.1 64.6 31.1 24.5 33.7 40.7 25.2 24.1 44.2 37.0 16.6 38.9 32.0 24.6 58.7 71.2 49.2 39.1 33.8 31.2 27.4 36.5 35.1 37.2 43.9 47.1 27.5 43.3 41.4 50.0 28.7 38.8 23.5 38.7 19.2 44.7 40.9 22.7 36.5 20.3 49.3 25.3 42.5 28.0 32.3 62.5 23.6 34.5 26.3 37.6 26.2 31.9 20.9 111.9 29.4 40.1 29.2 80.3 25.0 35.2 31.1 23.1 24.0 116.5 33.2 30.9 21.0 110.8 40.6 33.3 43.0 28.9 30.0 25.2 31.5 25.6 16.8 18.4 19.6 20.7 17.0 17.4 17.5 17.2 17.7 17.3 18.4 20.6 36.5 19.2 52.9 15.3 111.2 17.3 32.5 38.4 29.6 37.0 26.7 29.6 35.9 27.1 36.4 44.1 18.8 49.2 61.4 22.4 45.0 32.1 19.8 49.6 41.2 33.5 33.6 46.3 18.1 69.0 46.2 35.6 55.0 45.0 58.9 33.1 31.4 32.1 71.8 21.9 12.8 27.5 40.7 41.8 24.7 10.6 32.9 48.0 21.4 24.4 62.9 21.2 54.6 14.1 22.0 39.3 23.4 36.5 75.5 31.1 29.4 55.5 39.5 46.3 39.5 39.6 30.9 49.5 71.6 30.4 19.6 37.1 54.2 33.2 26.3 35.6 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 44.0;Spermatocytes: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040411, HPA041594" Uncertain Supported "Centriolar satellite,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Centriolar satellite" Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favorable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 5.3 5.7 6.3 9.5 7.2 16.5 9.1 6.8 7.2 9.0 13.2 25.7 4.8 13.9 11.2 4.3 18.2 5.9 4.7 5.7 7.5 8.1 4.6 6.4 13.0 8.5 9.1 9.6 5.3 7.1 9.4 5.6 8.2 9.3 9.8 29.2 6.4 13.9 3.0 3.7 7.1 13.0 9.2 9.4 6.6 20.6 7.3 15.2 10.0 3.3 13.0 10.9 6.4 8.5 8.4 6.9 13.0 12.7 6.3 8.5 10.0 11.0 6.1 17.2 15.7 8.3 3.8 19.3 7.1 5.0 8.4 8.6 9.0 5.9 19.4 25.4 8.6 42.5 9.1 5.7 9.8 23.8 16.1 3.9 7.6 11.6 11.2 9.3 9.9 21.9 8.2 21.1 10.0 6.1 33.7 16.7 6.9 8.3 8.4 32.8 11.7 5.7 8.2 7.3 11.8 6.3 10.6 6.3 11.1 10.3 15.1 16.9 5.2 13.7 6.0 8.7 10.3 10.9 34.0 13.3 7.2 15.3 8.9 9.9 5.1 15.0 5.0 12.0 8.1 7.5 6.5 5.2 4.4 6.9 7.6 6.2 3.3 7.2 19.4 2.5 6.7 5.7 6.3 7.2 6.8 7.2 5.7 7.5 8.5 9.1 8.2 9.2 7.3 8.5 8.3 3.2 4.6 14.0 12.9 4.8 3.9 5.3 5.2 16.0 8.0 9.0 10.8 2.8 6.8 7.3 0.0 4.7 13.2 2.8 9.8 4.8 26.0 35.4 16.0 6.6 2.4 25.2 12.5 3.5 4.2 5.7 5.6 5.3 7.0 12.0 6.1 4.9 6.3 8.4 11.7 2.8 10.2 4.7 5.1 13.5 9.0 14.5 16.0 8.4 7.3 25.7 18.6 9.5 18.7 3.0 4.7 13.5 9.3 1.8 1.8 10.4 44.0 34.6 6.6 7.4 8.2 56.3 22.3 6.3 4.1 0.3 13.9 8.6 4.9 1.7 MED1 "CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2" ENSG00000125686 "Mediator complex subunit 1" Q15648 17 39404285-39451272 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 206.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017696, HPA052818" Approved Supported Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB017696: AB_1128703, HPA052818: AB_2681962" "unprognostic (1.77e-1)" "unprognostic (1.63e-1)" "unprognostic (9.26e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.50e-1)" "unprognostic (7.86e-2)" "unprognostic (1.95e-3)" "unprognostic (4.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.78e-2)" "unprognostic (2.00e-1)" "unprognostic (5.94e-2)" "unprognostic (9.40e-2)" "unprognostic (5.79e-2)" 10.3 8.7 7.2 11.3 7.7 12.9 10.6 8.5 8.2 9.7 7.4 10.6 7.7 11.0 5.9 9.8 9.3 7.6 9.6 6.9 7.4 8.8 9.0 8.7 13.3 7.2 7.3 11.3 7.9 16.8 6.0 10.4 7.5 8.3 9.5 8.0 8.6 7.7 13.7 11.1 9.7 11.2 7.4 11.2 8.6 10.7 7.7 16.9 9.1 12.2 14.7 10.9 9.1 8.8 20.1 24.5 32.5 22.7 23.1 23.7 25.8 24.0 25.6 30.6 30.1 24.9 20.1 51.4 26.2 28.9 37.2 38.3 38.0 22.9 50.0 49.2 31.8 32.3 24.1 24.0 24.4 59.8 33.9 22.1 23.6 39.3 55.0 20.1 28.1 30.6 42.1 28.4 25.7 10.7 56.5 23.2 20.9 19.4 15.1 41.3 43.1 22.9 18.5 22.4 20.3 23.2 30.9 206.2 27.6 28.0 38.5 33.4 23.7 24.8 31.1 28.1 42.3 25.3 36.4 53.6 24.3 28.4 32.0 1.3 1.4 1.8 1.6 1.4 1.9 2.2 1.8 1.8 1.5 2.0 1.8 2.1 1.2 1.9 0.8 1.5 1.5 1.0 7.2 7.7 8.5 8.2 6.9 7.4 7.2 7.3 7.5 7.4 7.7 8.8 18.8 25.6 13.9 10.1 24.7 27.1 14.2 13.1 19.4 13.7 18.0 13.8 18.9 12.8 21.0 9.2 14.6 17.2 20.6 12.7 3.9 12.3 7.9 19.0 27.1 21.2 13.8 26.9 13.4 12.0 12.8 19.7 10.7 27.0 9.5 19.9 17.2 20.2 14.9 11.8 13.9 14.8 16.2 20.0 16.5 7.7 14.6 16.4 21.4 11.2 21.0 13.5 17.5 11.1 16.0 13.7 12.1 18.0 20.2 19.9 9.4 8.5 17.4 12.0 19.7 26.1 21.2 22.3 17.0 21.7 32.7 22.2 22.8 18.7 15.0 18.7 MED13 "KIAA0593, THRAP1, TRAP240" ENSG00000108510 "Mediator complex subunit 13" Q9UHV7 17 61942605-62065278 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067939 Supported Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA067939: AB_2685928" "unprognostic (7.26e-2)" "unprognostic (4.50e-2)" "prognostic favorable (1.43e-4)" "unprognostic (8.79e-2)" "unprognostic (1.69e-2)" "unprognostic (3.56e-1)" "unprognostic (1.33e-1)" "unprognostic (5.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.97e-1)" "unprognostic (1.88e-1)" "unprognostic (3.92e-2)" "unprognostic (2.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.21e-1)" "unprognostic (4.51e-3)" "unprognostic (2.30e-1)" 12.4 9.6 7.9 10.7 12.4 34.1 11.2 16.4 9.6 12.3 11.3 12.5 11.5 11.8 8.8 11.2 9.3 12.7 8.8 9.2 6.9 13.6 22.1 10.9 12.7 9.5 9.8 13.5 12.5 17.6 5.5 15.3 10.6 10.2 12.7 17.8 10.0 8.9 19.4 11.4 10.6 11.9 8.0 11.5 12.2 19.5 10.2 20.7 15.9 28.1 12.7 13.3 8.4 15.3 24.9 29.0 22.0 18.0 19.8 21.4 16.7 13.4 19.4 26.5 25.5 22.2 13.2 26.4 12.3 21.2 19.9 15.0 28.2 17.5 36.9 17.2 16.6 43.1 20.9 14.3 20.7 38.1 19.3 16.6 19.8 29.0 32.8 19.1 20.3 20.4 35.8 43.9 18.3 41.8 34.6 11.4 11.7 28.9 14.8 28.1 56.2 16.2 18.6 28.8 17.3 32.6 28.0 8.0 17.5 21.7 28.8 26.7 25.6 30.2 44.3 15.9 25.6 21.2 25.8 35.4 16.0 16.7 17.6 1.1 1.1 1.3 1.3 0.5 1.6 1.0 1.3 1.4 1.1 1.5 0.9 1.6 4.0 1.4 2.9 2.8 1.6 0.4 7.9 12.4 16.4 9.6 9.2 6.9 9.5 9.8 10.6 8.0 10.2 15.3 54.7 64.1 54.0 107.7 37.7 78.0 45.9 23.6 45.5 52.3 45.8 28.1 27.8 52.9 36.6 23.9 45.9 19.1 57.2 57.9 9.8 16.7 47.4 48.1 63.7 42.0 44.3 42.3 96.9 20.0 11.7 45.2 35.7 83.3 26.0 42.0 35.3 45.5 19.1 62.2 107.3 41.7 32.6 30.5 78.6 60.1 30.7 52.0 32.0 89.0 36.7 36.5 24.7 135.2 136.7 28.6 38.4 32.7 41.1 62.6 33.4 19.1 29.9 40.3 32.9 81.6 45.9 48.1 22.6 48.0 81.7 43.4 40.7 32.3 32.9 81.0 MED13L "KIAA1025, THRAP2, TRAP240L" ENSG00000123066 "Mediator complex subunit 13L" Q71F56 12 115957905-116277693 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 303.9;Excitatory neurons: 311.5;Inhibitory neurons: 321.0;Microglial cells: 427.2;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 305.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "T-47d: 124.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039445 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Golgi apparatus" "HPA039445: AB_10673532" "unprognostic (1.81e-2)" "unprognostic (1.87e-2)" "unprognostic (3.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (8.62e-3)" "unprognostic (1.54e-1)" "unprognostic (5.08e-2)" "unprognostic (1.83e-2)" "unprognostic (6.82e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (4.64e-1)" 18.4 7.9 5.5 15.8 7.3 52.7 20.8 27.0 6.3 15.8 5.3 12.9 10.3 20.5 6.5 13.8 12.5 13.2 11.5 6.4 5.9 12.4 7.9 14.4 14.6 9.2 7.3 24.3 17.5 15.3 5.5 16.3 6.9 12.7 13.5 12.6 14.8 12.8 18.6 19.0 13.4 15.9 6.3 16.6 12.2 13.8 7.7 39.1 18.0 25.8 16.2 13.1 12.7 10.7 16.9 33.2 19.6 16.9 23.6 42.0 16.5 15.8 21.3 23.7 16.3 25.2 5.9 13.3 13.6 29.0 14.5 9.9 20.4 14.2 29.6 24.3 14.0 26.9 10.0 7.2 26.2 24.8 28.6 30.6 21.8 26.8 40.7 17.4 15.9 28.2 28.9 11.4 18.7 21.8 42.1 22.2 10.5 7.1 8.2 28.7 25.0 24.8 11.1 18.4 17.7 12.4 14.2 7.8 15.0 34.9 124.8 39.9 20.7 26.0 16.8 17.2 19.5 17.9 9.7 21.6 12.0 22.3 12.8 1.5 0.6 1.5 0.2 0.3 0.2 0.3 0.5 0.2 0.7 0.7 0.3 0.4 3.5 0.3 0.4 1.1 0.0 0.1 5.5 7.3 27.0 6.3 6.4 5.9 9.2 7.3 6.9 6.3 7.7 10.7 84.4 64.1 54.9 303.9 47.5 99.2 38.4 21.7 70.6 52.4 51.4 42.4 35.6 21.5 35.5 25.8 54.2 9.4 38.5 30.5 3.9 13.5 84.0 42.5 115.2 56.9 31.3 49.6 311.5 26.0 19.6 56.0 29.0 96.7 14.0 93.4 53.6 30.6 21.1 57.2 321.0 31.8 14.2 48.7 60.6 47.2 92.2 60.5 32.0 427.2 56.4 22.8 17.5 352.8 305.4 26.8 21.0 67.0 65.6 49.4 22.7 12.3 27.2 44.6 46.0 61.9 57.0 20.3 23.3 48.0 101.6 14.2 30.5 23.7 25.9 51.0 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 4 "cerebellum: 2.3;cerebral cortex: 1.3;white matter: 1.7" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046619 Approved "Nuclear speckles,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavorable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 1.3 0.9 0.2 1.5 0.4 1.5 1.0 2.3 1.3 1.4 1.2 1.5 0.4 1.8 1.0 1.0 1.5 0.6 1.7 0.3 0.2 0.9 0.5 1.1 1.1 0.4 0.2 1.6 1.4 0.5 0.8 1.3 0.3 1.0 0.5 1.1 1.0 0.7 1.6 1.1 2.1 1.0 0.1 2.3 1.7 0.9 0.4 1.3 0.9 1.1 1.0 1.0 1.0 1.7 3.3 1.1 2.7 5.9 3.3 0.4 5.3 7.3 2.5 4.7 2.8 5.9 6.6 5.3 11.6 0.6 1.3 9.8 2.5 1.4 1.3 6.5 2.9 6.0 3.7 1.7 1.7 10.5 10.1 1.3 3.4 3.5 2.1 1.1 1.9 1.4 5.5 3.4 2.7 1.0 12.3 3.1 5.1 0.7 0.8 9.5 7.8 4.4 2.8 2.3 9.7 12.3 5.8 4.7 2.8 0.6 7.2 2.5 6.5 7.2 5.7 9.9 6.3 4.9 10.1 3.9 1.9 7.2 8.5 3.3 3.0 7.6 4.0 3.7 4.5 8.2 5.1 5.0 3.8 5.8 5.2 2.9 3.3 6.7 2.2 4.5 5.3 3.5 0.2 0.4 2.3 1.3 0.3 0.2 0.4 0.2 0.3 0.1 0.4 1.7 7.7 6.4 9.3 16.3 32.1 30.1 39.6 19.4 25.6 24.6 10.1 4.6 15.5 14.3 19.5 7.3 16.7 39.3 25.5 12.4 1.9 15.8 1.0 9.3 14.9 14.2 26.8 9.7 25.8 9.7 27.4 17.2 17.3 13.6 10.8 22.9 16.8 8.6 14.5 15.2 27.7 13.4 16.2 15.5 27.0 3.0 15.8 12.8 14.2 19.7 18.4 13.4 23.7 22.1 25.1 10.4 14.8 21.4 25.6 26.9 13.8 2.7 19.4 43.9 65.7 19.3 16.4 23.1 16.3 18.1 25.7 34.1 28.1 10.4 17.6 36.3 MED23 "CRSP130, CRSP3, DRIP130, MRT18, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628242 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 72.0;Inhibitory neurons: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA070341: AB_2686257" "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 7.7 10.5 3.4 11.5 3.7 22.0 14.3 9.8 5.0 12.0 3.7 10.6 11.4 13.3 10.6 8.5 11.0 8.9 6.5 3.5 3.6 10.3 7.9 9.9 14.8 2.4 2.8 14.2 10.7 18.3 6.0 11.0 3.1 11.7 12.4 11.5 12.7 11.6 7.4 11.5 10.6 10.4 2.7 12.8 11.6 10.5 3.5 18.0 14.4 10.1 15.3 10.1 7.8 6.4 7.2 7.8 18.2 23.0 22.1 16.8 16.7 17.6 19.8 16.0 23.0 8.2 9.8 15.9 12.5 18.2 15.4 12.6 9.9 11.4 24.7 18.1 13.8 16.6 14.9 14.0 16.0 27.8 27.1 14.9 13.3 17.7 17.8 18.6 20.1 16.9 21.7 16.2 17.0 11.0 21.3 17.4 8.7 12.3 7.8 18.9 11.4 9.6 12.2 10.4 13.6 12.3 12.6 17.4 11.6 20.9 4.8 19.3 20.4 11.8 13.3 19.0 16.2 17.0 12.3 22.6 14.5 12.6 16.1 4.9 4.5 7.6 5.5 4.6 8.3 4.7 5.5 6.2 5.6 4.2 5.5 5.1 3.6 12.9 3.3 2.9 6.6 3.9 3.4 3.7 9.8 5.0 3.5 3.6 2.4 2.8 3.1 2.7 3.5 6.4 16.3 19.2 9.6 24.8 21.5 9.2 6.3 11.9 13.6 23.7 15.5 10.9 6.5 8.6 15.7 23.9 16.7 8.7 23.7 15.5 3.9 7.6 2.1 14.8 14.7 13.9 14.4 12.0 72.0 7.7 6.8 12.5 14.3 16.6 14.0 18.3 14.3 12.4 8.1 11.8 67.1 17.4 6.1 17.6 9.5 3.2 14.3 12.8 5.4 36.5 16.9 7.7 21.6 42.3 60.8 9.1 14.9 10.1 19.4 10.7 14.7 8.5 13.4 24.4 13.1 13.8 10.2 13.5 5.3 12.0 8.7 7.8 20.7 14.6 14.3 12.8 MED4 "DRIP36, HSPC126, TRAP36, VDRIP" ENSG00000136146 "Mediator complex subunit 4" Q9NPJ6 13 48053323-48095131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006232 Approved Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA006232: AB_1079351" "unprognostic (1.10e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-1)" "unprognostic (2.80e-1)" "unprognostic (5.79e-1)" "unprognostic (2.56e-2)" "unprognostic (4.09e-1)" "unprognostic (7.97e-2)" "unprognostic (7.34e-3)" "unprognostic (3.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-3)" "unprognostic (6.54e-3)" "unprognostic (1.94e-2)" "unprognostic (1.84e-1)" 44.2 34.1 26.5 34.0 26.0 78.6 46.7 33.6 35.1 37.2 25.2 41.3 40.6 40.3 43.5 41.1 31.2 32.9 49.4 26.5 26.7 38.4 51.4 36.9 46.7 25.7 25.5 31.9 27.4 43.2 31.4 45.6 27.0 36.7 46.4 41.4 33.6 38.5 57.7 39.9 41.1 43.2 25.7 35.9 33.9 55.9 26.2 63.7 41.1 58.4 55.5 43.4 35.8 28.4 40.2 25.8 86.1 47.8 55.8 71.4 59.5 57.1 70.9 66.8 47.1 49.3 66.9 65.2 16.0 60.5 41.3 59.6 63.1 54.2 86.7 85.0 51.9 85.6 49.5 77.6 51.7 128.1 76.4 49.6 75.2 39.7 58.2 65.2 63.1 64.8 61.9 40.7 75.5 40.6 121.3 121.4 85.4 128.2 33.5 87.4 58.3 52.9 87.0 61.7 38.0 61.2 46.5 57.8 63.4 55.5 49.3 94.6 51.1 37.5 43.4 47.0 52.7 39.2 61.7 100.2 32.2 65.9 72.6 105.0 65.5 106.3 74.6 70.0 82.6 65.4 84.2 76.6 64.5 58.0 80.4 77.0 69.8 86.6 74.3 58.5 101.6 91.2 26.5 26.0 33.6 35.1 26.5 26.7 25.7 25.5 27.0 25.7 26.2 28.4 71.3 96.1 53.4 12.7 71.1 91.3 72.8 164.9 34.7 51.5 48.1 42.9 100.8 60.1 116.5 57.0 16.7 116.4 96.0 51.7 152.6 79.4 87.9 46.4 69.8 73.8 26.9 106.9 24.7 63.4 104.4 74.1 31.6 60.5 98.1 43.9 59.3 66.8 70.3 37.0 20.1 51.2 124.1 51.9 65.4 185.6 76.7 51.2 78.2 14.0 136.6 65.2 102.0 20.1 20.4 66.8 67.4 77.5 46.5 69.7 66.1 100.1 62.8 50.2 52.6 58.7 78.7 141.4 162.8 48.6 97.3 134.9 79.4 61.1 56.9 71.5 MED6 NY-REN-28 ENSG00000133997 "Mediator complex subunit 6" O75586 14 70581257-70600690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030764, HPA069039" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA030764: AB_2673601, HPA069039: AB_2686070" "unprognostic (1.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (6.93e-2)" "unprognostic (2.86e-1)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (3.15e-2)" 13.0 14.9 13.3 14.0 13.3 21.6 17.2 22.5 17.3 14.8 10.6 13.2 11.8 14.8 17.7 17.2 15.0 12.2 14.6 12.6 13.8 11.5 16.8 13.0 24.3 10.3 11.6 19.0 11.2 12.2 12.1 15.3 10.8 11.2 13.0 22.0 12.3 12.4 23.2 18.6 12.2 14.4 10.1 15.0 12.4 13.7 12.9 24.3 14.8 22.6 26.5 16.4 13.9 13.3 81.0 43.5 56.1 24.2 29.6 32.0 44.9 39.6 42.7 60.8 60.3 43.8 48.9 60.9 22.7 34.6 36.0 37.9 67.5 41.0 64.4 44.0 35.7 44.8 31.6 59.5 36.0 39.5 34.4 36.1 47.2 43.1 39.7 26.7 48.1 45.8 42.3 37.4 45.2 60.3 56.7 53.2 41.9 56.7 53.7 46.5 51.9 32.0 37.8 42.4 37.9 40.3 41.8 44.3 47.0 32.6 69.2 49.1 37.7 49.7 71.2 24.8 37.3 39.2 63.7 85.8 43.1 34.1 34.7 19.1 16.2 24.6 17.6 18.9 20.9 17.9 23.1 20.3 18.5 20.2 21.3 21.7 15.8 22.6 22.9 13.9 23.4 14.1 13.3 13.3 22.5 17.3 12.6 13.8 10.3 11.6 10.8 10.1 12.9 13.3 36.7 19.2 25.7 16.0 48.7 19.4 34.2 50.3 28.5 73.5 23.0 21.1 7.4 12.8 34.5 18.4 79.2 39.1 49.4 13.9 5.9 30.3 7.6 22.7 24.9 27.6 22.1 22.5 27.1 23.1 44.3 30.1 24.5 30.5 46.3 29.5 25.4 15.0 26.2 26.9 24.2 14.0 20.3 19.2 15.4 6.3 27.1 21.4 17.8 16.9 30.4 38.5 47.4 18.6 18.6 27.2 19.5 29.3 41.6 38.3 22.5 14.1 37.2 97.7 26.3 28.0 26.4 25.3 37.7 23.5 20.0 49.0 44.7 25.2 14.8 39.2 METTL14 KIAA1627 ENSG00000145388 "Methyltransferase like 14" Q9HCE5 4 118685392-118715433 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038002 Supported Supported Nucleoplasm Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA038002: AB_10672401" "unprognostic (4.48e-1)" "unprognostic (5.13e-2)" "unprognostic (5.98e-3)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.83e-1)" "unprognostic (3.75e-2)" "unprognostic (4.40e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-2)" "unprognostic (3.64e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (1.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-3)" "unprognostic (7.76e-3)" 8.9 8.8 5.2 8.6 6.0 19.5 11.5 6.8 6.3 8.8 5.5 8.8 8.8 11.7 10.7 8.9 8.8 7.7 8.3 4.8 6.3 10.2 14.9 9.1 11.6 5.5 5.2 12.7 7.8 10.9 8.2 9.0 6.3 9.7 8.2 11.7 7.6 8.0 8.4 10.9 9.2 9.2 5.4 10.8 7.9 15.1 5.7 12.5 10.6 7.7 11.0 8.5 7.9 7.4 19.6 8.9 19.0 17.8 11.7 14.7 13.8 17.1 13.0 12.6 14.4 12.9 22.8 22.0 9.8 12.0 12.6 9.4 16.2 14.1 16.1 17.5 9.8 18.5 11.4 14.4 13.3 30.2 21.2 13.1 15.8 14.6 9.6 16.5 11.5 17.4 20.1 18.2 17.5 13.2 29.7 24.7 16.2 16.7 7.7 16.8 23.7 11.2 13.8 12.7 15.4 17.3 12.0 22.0 17.2 17.2 10.0 28.5 15.8 18.1 16.6 16.3 13.7 15.2 17.0 24.9 12.9 16.5 15.1 37.7 12.8 29.0 17.0 19.6 19.3 24.3 17.8 17.7 15.3 25.3 21.0 19.0 10.3 21.8 23.7 12.1 20.8 13.7 5.2 6.0 6.8 6.3 4.8 6.3 5.5 5.2 6.3 5.4 5.7 7.4 18.6 25.6 25.9 14.7 20.6 10.8 18.3 10.6 16.5 16.8 13.4 12.6 15.7 17.2 20.8 23.9 22.9 18.7 28.3 13.7 11.7 11.9 96.9 14.5 21.7 17.3 12.1 8.4 18.7 15.6 10.2 16.8 9.2 18.0 22.1 18.3 16.4 32.1 12.1 8.4 17.0 15.2 6.1 17.9 7.6 16.7 18.6 13.3 7.2 14.0 14.0 13.4 25.7 14.1 26.9 14.8 13.0 13.9 8.2 17.1 15.4 20.6 15.2 25.4 13.1 15.3 15.5 42.2 28.1 12.4 11.9 15.3 20.6 17.0 12.8 16.0 METTL16 "METT10D, MGC3329" ENSG00000127804 "Methyltransferase like 16" Q86W50 17 2405562-2511891 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020352, HPA059798" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA020352: AB_1853828, HPA059798: AB_2684128" "unprognostic (4.94e-3)" "unprognostic (2.86e-2)" "unprognostic (2.29e-2)" "unprognostic (5.66e-3)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (3.35e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-1)" "prognostic favorable (3.06e-4)" "unprognostic (5.35e-2)" "unprognostic (4.85e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-1)" "unprognostic (1.61e-1)" "unprognostic (2.68e-2)" 6.8 6.2 4.4 6.6 6.2 8.8 7.8 5.1 5.2 7.2 4.3 6.0 5.3 9.5 5.7 5.9 9.1 4.9 7.2 4.0 4.4 6.3 3.8 7.0 8.3 4.7 5.2 12.3 7.5 10.1 4.5 4.2 4.9 7.4 5.8 7.7 6.6 7.0 6.6 6.4 5.2 8.5 5.0 6.9 4.7 5.4 4.8 10.4 9.3 7.4 8.3 6.4 5.3 7.9 9.0 25.3 12.7 12.9 9.7 12.1 12.3 11.8 9.6 12.4 10.3 34.5 6.1 28.1 11.9 10.1 13.3 12.5 30.2 15.3 16.8 11.0 20.7 14.2 21.2 16.0 10.8 13.3 11.0 10.2 14.0 17.3 24.9 8.5 13.0 16.1 19.1 14.8 8.4 11.0 19.1 7.8 14.9 10.9 10.1 31.8 13.8 12.7 9.2 8.3 6.8 11.4 16.7 9.3 9.0 13.5 11.9 8.6 10.2 11.6 7.3 16.3 16.3 8.3 11.3 19.4 15.5 11.1 15.8 1.6 2.1 0.8 3.5 1.4 4.4 3.5 3.3 3.4 1.5 2.9 4.9 3.7 0.0 1.3 1.0 2.0 2.3 1.4 4.4 6.2 5.1 5.2 4.0 4.4 4.7 5.2 4.9 5.0 4.8 7.9 17.5 12.8 33.5 19.2 25.7 11.5 21.4 12.6 9.6 28.7 14.9 14.1 15.8 15.7 25.8 7.3 45.9 8.9 19.3 11.8 13.7 9.9 20.8 18.8 21.7 13.9 20.4 6.3 20.9 10.8 9.1 18.9 15.3 15.0 24.7 25.5 17.5 9.2 10.4 26.9 21.6 13.7 10.2 10.0 5.9 7.6 14.9 11.6 8.8 17.8 13.7 20.2 30.9 23.6 42.2 9.7 6.3 12.8 14.5 20.1 23.2 9.0 26.3 37.4 6.6 28.0 21.3 11.8 16.7 14.7 12.8 6.0 25.5 28.7 16.8 17.0 METTL18 "AsTP2, C1orf156, HPM1, MGC9084" ENSG00000171806 "Methyltransferase like 18" O95568 1 169792529-169794963 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035314 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Cytosol "HPA035314: AB_10601146" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" "unprognostic (3.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (5.67e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (3.65e-1)" "unprognostic (3.06e-2)" "unprognostic (3.03e-2)" "prognostic favorable (3.28e-4)" 5.6 5.3 5.4 6.2 5.7 4.0 10.5 6.5 6.8 5.8 5.7 6.5 5.2 6.0 8.7 5.2 7.5 4.8 6.1 5.0 5.5 7.4 6.2 5.5 14.1 5.4 5.5 9.2 4.9 22.4 3.4 6.0 5.7 6.8 6.2 7.3 6.3 5.9 4.3 6.2 6.0 5.0 5.8 8.8 7.3 6.5 5.5 10.3 9.0 6.9 11.6 5.6 3.8 6.7 13.0 7.5 11.6 8.3 6.6 12.2 8.6 5.9 6.9 7.8 6.6 9.6 20.7 22.2 16.2 7.7 10.8 14.5 11.5 13.6 9.9 14.0 9.9 15.9 6.6 8.0 13.7 16.9 7.2 5.6 14.2 7.5 8.1 7.6 14.2 16.8 17.1 10.8 10.1 6.3 18.0 11.1 14.9 27.7 18.7 13.0 12.0 16.8 11.7 12.9 8.6 13.4 13.2 14.4 18.2 17.1 19.3 18.1 6.7 9.3 9.0 9.9 13.8 19.8 27.6 29.9 7.1 13.4 9.9 18.2 9.5 23.1 24.8 10.6 31.7 21.6 27.1 28.8 10.0 24.2 31.8 30.9 5.5 24.0 6.6 7.7 34.5 18.3 5.4 5.7 6.5 6.8 5.0 5.5 5.4 5.5 5.7 5.8 5.5 6.7 5.8 3.2 4.6 1.0 9.5 1.5 6.1 10.8 1.8 7.4 4.6 5.2 5.0 2.8 8.5 5.5 0.0 13.7 4.5 3.7 25.4 12.1 16.9 3.7 5.1 8.3 3.0 8.6 1.4 8.0 5.5 5.5 2.0 2.8 7.0 13.4 7.5 2.9 7.7 6.7 1.9 3.6 10.2 5.9 3.2 5.4 6.2 3.7 5.4 2.8 2.6 12.0 14.4 1.5 4.0 5.3 5.7 5.3 2.5 3.1 5.7 11.6 10.9 8.5 0.0 6.1 6.5 16.7 10.2 2.4 0.9 11.5 10.1 10.0 5.5 4.2 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA 23000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: AB_2676001" "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 15.0 22.4 12.8 8.6 16.3 19.1 19.2 21.9 19.0 18.6 2.9 15.0 9.3 19.5 20.6 14.1 15.6 14.2 9.9 14.7 10.5 16.8 17.5 12.1 12.4 10.6 11.4 18.5 13.7 20.5 5.3 21.1 10.9 19.3 18.7 20.0 11.5 16.4 4.3 16.4 11.6 16.4 11.3 10.5 15.7 21.3 15.5 7.5 18.3 2.4 11.6 15.3 10.3 17.7 12.4 11.1 21.5 22.9 30.9 28.9 17.9 38.1 19.4 28.4 33.1 9.6 19.0 9.2 7.2 41.8 19.9 11.2 18.5 22.8 25.5 28.2 25.5 30.0 16.0 10.8 39.3 6.2 24.3 22.5 19.6 25.3 18.1 27.4 23.1 21.7 18.6 7.6 28.5 13.4 13.2 7.5 7.8 19.9 21.6 6.5 12.5 6.4 32.1 9.2 17.6 19.2 18.5 17.5 16.1 19.2 20.4 13.4 23.9 18.5 14.4 31.4 11.2 45.6 18.8 15.7 21.2 13.6 15.1 2.6 1.7 1.5 2.2 3.5 1.8 1.3 1.5 2.4 1.9 1.9 1.0 2.0 1.5 1.7 4.0 2.0 3.1 1.5 12.8 16.3 21.9 19.0 14.7 10.5 10.6 11.4 10.9 11.3 15.5 17.7 17.3 22.4 14.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 9.7 7.4 0.0 0.0 3.7 14.7 0.0 18.7 10.7 0.0 19.6 11.6 0.0 8.2 18.1 5.2 0.0 0.0 0.0 8.3 17.0 7.5 0.0 9.7 1.3 11.5 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 9.0 0.0 0.0 4.0 0.0 0.0 17.7 11.7 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 32.7 3.0 13.7 0.0 0.0 MIS12 "hMIS12, KNTC2AP, MGC2488, MTW1" ENSG00000167842 "MIS12 kinetochore complex component" Q9H081 17 5486285-5490814 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 117.7;Late spermatids: 235.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044482 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "HPA044482: AB_10963834" "unprognostic (3.86e-2)" "unprognostic (4.85e-2)" "unprognostic (1.36e-1)" "unprognostic (4.22e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (4.68e-2)" "unprognostic (2.34e-3)" "unprognostic (3.41e-2)" "prognostic favorable (8.00e-4)" "unprognostic (4.13e-3)" "unprognostic (3.00e-3)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (3.65e-2)" 11.9 11.3 10.2 16.1 12.6 17.6 15.5 11.0 12.3 12.1 10.6 12.1 12.2 13.6 31.7 10.1 13.3 10.1 9.7 9.6 10.5 13.8 16.3 10.9 21.5 11.7 11.7 11.9 14.8 10.6 13.8 10.7 12.7 12.0 14.0 28.1 11.0 12.9 13.6 10.4 13.9 13.1 10.7 18.2 11.7 15.0 11.1 26.1 18.8 12.9 21.2 13.3 8.8 15.8 19.0 21.8 45.4 28.7 18.5 18.4 23.4 26.9 20.1 40.6 36.2 20.4 14.0 47.7 22.9 14.4 19.7 42.2 36.9 25.3 41.3 28.0 24.9 26.7 42.1 24.0 32.6 15.7 31.0 18.4 38.3 34.9 54.3 19.4 21.4 36.8 29.9 46.5 26.0 11.9 34.8 15.6 25.6 24.6 19.4 31.6 44.2 23.0 16.3 19.3 15.7 30.8 28.3 13.2 30.0 32.8 20.0 13.1 14.2 25.8 20.7 22.6 34.0 22.1 21.6 26.8 23.2 22.6 23.9 6.5 8.5 6.6 14.6 9.8 15.5 11.9 12.3 14.4 9.7 9.2 15.5 14.8 4.4 16.1 13.8 12.9 8.8 10.3 10.2 12.6 11.0 12.3 9.6 10.5 11.7 11.7 12.7 10.7 11.1 15.8 13.6 12.8 15.3 14.0 21.0 12.9 25.8 9.7 19.4 14.4 15.4 12.3 7.6 14.3 12.3 5.5 14.6 13.1 18.7 16.5 23.5 10.4 117.7 11.0 13.1 14.2 21.4 16.8 7.0 7.1 12.7 12.8 10.2 10.3 32.4 11.7 10.0 13.0 10.1 5.0 7.2 20.7 18.3 9.9 17.2 235.3 5.9 9.9 10.6 6.5 7.3 19.9 17.5 7.1 22.2 9.9 19.8 9.4 23.7 19.8 7.9 7.6 13.9 22.1 19.7 16.7 12.2 27.2 11.5 11.7 18.0 21.9 19.5 11.3 13.4 20.6 MLLT3 "AF-9, AF9, YEATS3" ENSG00000171843 "MLLT3 super elongation complex subunit" P42568 9 20341669-20622499 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Astrocytes: 144.6;Excitatory neurons: 284.0;Inhibitory neurons: 288.4;Intestinal goblet cells: 112.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 254.3;Oligodendrocytes: 216.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "NK-cells: 5.1;T-cells: 16.3" "Cell line enriched" "Detected in many" 5 "HEL: 316.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001824 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Cytosol "HPA001824: AB_1079394" "unprognostic (3.31e-1)" "unprognostic (2.22e-1)" "unprognostic (1.23e-3)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.01e-3)" "unprognostic (2.12e-1)" "unprognostic (3.92e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.85e-1)" "unprognostic (4.81e-2)" "unprognostic (1.40e-2)" "unprognostic (1.68e-1)" 6.7 15.4 11.6 10.0 16.0 37.3 12.7 9.7 16.4 11.7 2.6 28.8 8.1 12.6 10.6 8.8 12.8 13.9 8.9 17.4 10.9 12.3 2.4 12.6 11.3 6.4 7.8 11.9 4.8 10.1 9.8 11.9 6.6 12.7 37.8 8.2 25.3 12.8 11.1 7.0 15.7 12.3 6.4 6.9 20.1 4.2 9.1 24.3 27.2 11.1 8.3 10.6 6.3 12.0 8.7 24.4 8.4 9.6 19.8 11.7 5.4 22.3 37.8 9.6 11.5 22.8 8.2 36.1 11.9 10.6 3.2 4.4 8.5 38.0 9.2 68.0 23.6 316.4 68.3 12.3 13.8 4.9 20.1 9.4 15.4 3.8 25.3 34.7 9.8 13.8 0.4 42.5 21.7 6.8 24.9 18.6 5.1 50.8 6.8 0.0 15.4 8.8 50.0 13.4 27.2 11.0 18.1 10.2 10.1 8.4 9.3 11.9 6.5 0.0 5.6 6.0 8.3 18.4 18.7 13.1 0.4 10.6 4.8 2.3 0.4 0.6 4.5 0.3 4.3 0.6 8.6 6.5 0.9 1.4 16.3 10.3 0.1 5.1 0.4 0.6 10.8 3.6 11.6 16.0 9.7 16.4 17.4 10.9 6.4 7.8 6.6 6.4 9.1 12.0 20.0 28.9 30.0 144.6 8.0 8.3 15.9 18.7 21.1 7.8 21.2 12.3 13.5 18.6 32.5 22.0 33.3 0.9 17.3 23.5 13.7 29.2 3.0 10.3 17.5 13.7 33.0 28.4 284.0 8.2 6.1 18.0 23.0 19.5 12.0 8.7 11.4 2.2 2.4 5.0 288.4 112.3 16.2 1.9 6.5 7.4 13.7 7.1 23.2 114.3 2.7 31.9 17.5 254.3 216.6 27.3 23.6 9.4 18.2 14.5 13.8 9.0 11.7 2.2 0.0 25.2 21.6 1.0 10.5 14.2 8.4 1.6 33.3 9.8 27.0 15.7 MORC3 "KIAA0136, NXP2, ZCW5, ZCWCC3" ENSG00000159256 "MORC family CW-type zinc finger 3" Q14149 21 36320189-36386148 "Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018406, HPA034848" Approved Enhanced Nucleoplasm,Mitochondria NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Mitochondria "HPA018406: AB_1858988, HPA034848: AB_2674359" "unprognostic (4.01e-3)" "unprognostic (4.86e-2)" "unprognostic (4.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (6.29e-2)" "unprognostic (6.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.53e-1)" "unprognostic (6.40e-2)" "unprognostic (8.61e-2)" "unprognostic (1.18e-3)" "unprognostic (1.38e-2)" "unprognostic (3.91e-1)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" 11.2 7.5 6.3 17.3 7.9 34.5 13.9 13.6 7.7 14.6 4.7 10.9 10.9 17.3 9.4 17.7 12.0 12.6 11.6 6.4 6.6 9.4 14.1 12.9 20.3 7.2 6.2 23.8 11.1 10.4 6.5 17.2 8.0 13.6 11.6 7.7 11.5 11.8 17.7 14.9 11.0 13.9 8.6 18.6 13.0 10.8 7.2 19.4 11.7 15.8 20.0 15.4 13.8 11.8 19.7 7.8 19.1 12.8 16.5 16.3 25.1 17.9 30.0 20.3 17.5 12.8 12.9 9.4 7.0 19.9 21.0 9.8 12.9 16.9 18.8 18.7 10.3 37.2 8.2 7.2 11.4 23.4 34.7 12.0 21.3 18.3 26.5 22.2 14.5 14.6 31.0 24.3 14.9 5.8 14.1 9.8 14.2 24.9 7.9 16.4 7.5 17.8 6.6 20.1 7.1 17.4 22.2 12.3 22.8 14.3 14.9 16.3 23.3 17.7 4.9 14.3 15.2 10.9 9.8 8.9 12.7 32.3 13.2 32.5 8.9 19.5 9.1 10.9 9.0 11.3 9.9 8.6 8.8 12.6 12.6 9.1 13.5 9.9 13.6 5.7 13.4 7.9 6.3 7.9 13.6 7.7 6.4 6.6 7.2 6.2 8.0 8.6 7.2 11.8 29.0 28.9 24.1 44.4 49.6 68.3 65.7 33.1 36.5 19.4 19.6 17.4 20.4 14.3 28.9 22.0 8.4 16.1 44.3 14.7 3.9 17.8 51.7 20.9 30.1 24.1 11.4 63.3 36.4 12.5 19.7 31.0 19.4 28.0 47.5 22.4 16.8 16.5 17.5 16.8 37.1 17.1 18.3 26.8 56.8 18.3 18.6 35.8 24.9 52.5 41.4 12.2 40.2 41.7 55.3 23.3 14.5 26.7 17.1 42.0 9.5 7.1 33.5 12.2 13.1 44.8 41.5 33.5 31.4 45.8 81.7 25.2 44.6 16.7 11.1 68.1 MR1 HLALS ENSG00000153029 "Major histocompatibility complex, class I-related" Q95460 1 181033425-181061938 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048304 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" "HPA048304: AB_2680347" "unprognostic (6.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.31e-2)" "unprognostic (1.96e-1)" "unprognostic (8.66e-3)" "unprognostic (4.37e-2)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.18e-1)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.05e-2)" "unprognostic (7.40e-3)" "unprognostic (4.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.07e-2)" 8.6 9.6 3.2 14.2 3.3 11.1 9.7 2.2 3.5 10.2 5.8 6.7 7.4 9.5 9.6 9.6 10.4 12.7 6.2 3.1 3.8 9.9 10.6 18.0 14.6 4.7 3.3 13.6 3.7 14.0 8.9 13.5 3.7 10.9 8.1 1.5 5.9 10.5 2.1 8.7 6.9 12.5 3.8 12.3 8.7 2.6 4.4 20.2 16.7 3.8 15.2 16.3 7.4 4.8 7.9 5.4 0.1 4.6 32.2 38.8 13.9 15.5 42.2 12.7 21.5 2.2 31.9 9.7 31.6 28.1 9.9 20.5 0.7 18.3 11.1 29.6 5.2 14.2 5.6 9.8 10.8 11.5 40.6 25.2 49.6 18.9 20.3 23.7 1.3 17.8 26.7 25.6 24.9 8.8 12.1 8.3 0.1 0.1 0.8 13.7 0.3 27.3 13.9 23.1 0.2 0.3 8.2 14.8 10.9 6.0 15.4 24.6 8.1 12.5 1.7 21.8 7.7 42.2 15.3 17.9 11.7 14.7 1.2 32.6 21.8 22.9 16.3 27.4 14.6 14.3 14.6 14.6 18.8 18.3 10.8 16.2 14.7 19.0 23.6 10.2 17.0 15.2 3.2 3.3 2.2 3.5 3.1 3.8 4.7 3.3 3.7 3.8 4.4 4.8 4.4 19.2 32.4 8.8 14.7 5.0 8.3 32.6 12.0 0.8 7.7 6.1 4.1 8.6 20.9 14.7 0.0 17.5 15.9 1.6 5.9 10.8 0.3 5.9 12.1 4.9 2.4 11.4 3.1 6.4 9.5 12.8 2.6 7.3 17.1 13.5 3.6 8.9 25.8 0.0 1.7 2.7 32.6 25.2 9.1 0.4 10.8 25.3 7.2 11.2 30.8 4.1 26.8 0.0 0.5 7.5 4.5 12.0 9.1 7.4 2.2 2.4 15.3 0.6 0.0 8.6 9.2 0.4 1.6 10.9 5.4 24.5 15.7 22.4 3.5 13.4 MRE11 "ATLD, MRE11A" ENSG00000020922 "MRE11 homolog, double strand break repair nuclease" P49959 11 94415570-94493885 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Meiosis" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes, Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002691, CAB004081" Supported Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB004081: AB_2145100, HPA002691: AB_1079409" "unprognostic (5.59e-3)" "unprognostic (4.35e-2)" "unprognostic (8.55e-2)" "unprognostic (2.76e-2)" "unprognostic (9.82e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (8.66e-3)" "unprognostic (6.96e-3)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.22e-1)" "unprognostic (8.06e-3)" 9.1 6.1 3.4 11.7 3.7 22.6 13.9 6.8 3.4 8.8 6.0 7.6 6.8 11.7 8.9 7.1 7.9 7.3 5.0 3.3 3.5 6.0 6.4 7.7 12.6 5.1 4.4 11.1 7.5 5.6 3.1 12.1 3.8 9.3 11.5 6.3 7.8 7.3 5.0 15.6 7.7 9.9 4.0 12.7 7.3 8.3 4.4 14.3 7.4 5.4 16.1 8.5 7.4 6.7 21.5 21.5 39.9 5.0 13.1 18.2 22.8 29.4 19.0 25.9 30.6 39.4 43.3 55.8 47.0 15.3 32.5 40.1 33.7 22.1 34.1 37.5 20.0 48.7 31.5 22.7 6.0 32.7 33.6 12.8 13.4 33.7 21.0 11.7 23.0 26.8 34.9 35.6 20.9 15.5 33.2 30.5 13.0 49.3 23.3 29.0 35.3 28.1 16.8 29.6 14.1 19.8 40.6 26.0 8.6 33.2 43.4 19.3 16.9 38.7 28.6 33.9 21.5 8.8 33.2 54.4 10.4 50.3 31.5 5.7 8.0 6.5 8.2 10.0 8.3 6.4 6.0 8.9 11.6 6.9 5.1 8.4 3.8 8.6 8.4 8.7 8.8 6.7 3.4 3.7 6.8 3.4 3.3 3.5 5.1 4.4 3.8 4.0 4.4 6.7 23.6 28.9 14.3 0.0 6.3 0.0 0.0 0.0 0.0 0.0 12.5 13.7 0.0 0.0 9.3 9.2 0.0 39.2 20.8 0.0 3.9 11.4 0.0 19.5 22.2 8.4 0.0 0.0 0.0 8.1 15.8 8.9 0.0 16.3 17.7 34.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 8.8 0.0 0.0 6.1 0.0 0.0 6.5 11.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 28.0 7.2 16.8 0.0 0.0 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810063 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 119.6;Theca cells: 114.9" "Cancer enhanced" "Detected in all" "testis cancer: 31.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes 15000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 11.7 22.7 9.3 17.7 13.7 24.0 16.2 15.0 12.7 15.5 12.7 13.0 9.0 27.7 10.2 11.7 17.8 10.9 9.3 8.9 11.5 12.1 19.8 11.6 28.4 12.7 11.7 53.0 31.3 17.0 9.8 20.3 13.0 15.0 12.4 21.6 10.8 15.6 10.5 13.1 9.8 27.2 10.7 12.7 10.9 35.3 11.3 36.3 17.2 11.2 31.0 12.8 12.2 19.9 116.5 77.6 128.4 37.5 42.3 46.3 67.9 63.6 51.1 60.2 59.8 67.2 41.4 158.1 84.5 59.5 82.0 46.0 130.3 74.3 82.1 80.7 69.0 117.0 60.8 71.1 28.8 131.5 37.8 38.6 28.3 60.7 41.6 53.8 40.8 5.3 115.9 69.8 61.8 85.5 144.2 80.1 130.7 81.3 37.7 219.6 204.3 84.7 44.5 76.2 92.8 100.3 79.1 40.4 42.7 124.3 54.6 42.6 33.4 72.2 92.3 54.6 80.6 63.8 79.3 276.2 61.9 77.9 42.4 7.7 3.7 3.8 4.8 6.2 5.5 4.3 5.5 5.0 5.5 4.2 8.4 4.5 2.5 5.9 6.4 2.7 5.3 3.6 9.3 13.7 15.0 12.7 8.9 11.5 12.7 11.7 13.0 10.7 11.3 19.9 19.8 28.9 21.4 5.9 19.2 25.2 22.0 12.3 31.9 25.4 14.4 15.1 8.6 2.8 21.8 7.3 35.5 35.6 20.7 7.4 3.9 15.7 46.4 27.1 31.1 18.4 4.8 47.1 8.5 9.6 21.8 24.0 8.6 31.7 17.7 119.6 13.6 10.2 13.0 15.2 12.1 9.7 20.3 5.6 13.2 17.5 25.4 16.8 3.6 7.5 10.0 22.7 8.2 9.5 27.4 9.1 3.7 22.6 31.1 16.1 2.6 6.7 22.1 31.4 6.6 27.4 33.0 54.3 48.8 22.0 17.5 9.6 19.8 114.9 12.1 11.7 MTBP ENSG00000172167 "MDM2 binding protein" Q96DY7 8 120445400-120542133 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Excitatory neurons: 14.7;Oligodendrocytes: 16.1;Spermatocytes: 16.2;Spermatogonia: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA025694, HPA050594" Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 22: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA025694: AB_1854169, HPA050594: AB_2681185" "unprognostic (1.92e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-1)" "unprognostic (3.53e-4)" "unprognostic (1.20e-1)" "unprognostic (5.40e-3)" "unprognostic (2.77e-6)" "unprognostic (3.99e-3)" "unprognostic (1.50e-2)" "unprognostic (7.86e-3)" "unprognostic (3.38e-3)" "unprognostic (3.29e-1)" "unprognostic (5.20e-10)" "unprognostic (3.41e-3)" "unprognostic (2.51e-1)" "unprognostic (3.02e-2)" "unprognostic (5.86e-2)" 1.3 1.1 1.0 2.5 1.2 4.0 2.6 3.6 1.7 1.6 0.7 1.7 1.5 2.1 2.4 1.4 1.7 1.2 0.6 1.0 0.9 1.0 0.8 1.3 4.3 1.0 1.0 2.4 0.9 1.0 0.8 2.1 1.2 1.5 2.6 4.3 1.1 1.0 0.7 3.0 1.3 2.0 0.9 1.8 1.1 5.0 1.1 4.6 0.8 0.8 4.0 1.0 1.3 1.4 15.3 4.5 14.6 6.0 2.1 3.5 7.1 11.4 6.5 16.4 21.0 4.9 8.3 13.8 11.2 3.8 4.9 13.0 13.9 6.8 20.3 11.5 10.6 11.6 6.7 5.6 1.1 12.4 8.6 1.3 2.9 12.7 8.1 2.5 7.3 12.6 7.6 10.2 9.7 6.9 19.8 7.6 6.5 12.0 9.0 11.3 15.0 9.8 3.9 5.3 7.4 8.6 7.7 44.8 7.0 7.9 8.5 8.9 4.5 7.0 12.7 9.0 18.6 3.9 8.9 8.0 6.6 15.1 8.3 0.0 0.1 0.1 0.3 0.6 0.5 0.7 0.5 0.7 0.2 0.5 0.8 0.7 0.0 0.5 0.3 0.0 0.7 0.3 1.0 1.2 3.6 1.7 1.0 0.9 1.0 1.0 1.2 0.9 1.1 1.4 1.6 0.0 1.5 7.5 2.9 0.8 1.7 1.5 1.8 0.0 1.4 1.3 1.1 0.0 1.1 1.8 0.0 2.3 2.5 0.5 0.0 0.9 0.8 1.3 2.6 1.1 0.0 12.8 14.7 1.8 3.0 2.5 2.6 1.5 2.5 5.0 1.8 0.9 1.6 0.0 9.1 0.9 0.0 0.3 1.8 0.4 1.5 1.7 1.8 3.7 1.0 0.0 2.1 9.0 16.1 0.6 0.1 1.2 2.3 1.2 0.3 0.3 2.4 0.0 0.0 5.6 2.6 16.2 10.2 1.4 0.6 0.7 3.3 1.5 0.8 0.8 MTERF1 MTERF ENSG00000127989 "Mitochondrial transcription termination factor 1" Q99551 7 91692008-91880702 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044894, HPA069560" Uncertain Supported Mitochondria NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Mitochondria "HPA044894: AB_10966284, HPA069560: AB_2686154" "unprognostic (5.57e-2)" "unprognostic (7.31e-2)" "unprognostic (2.15e-2)" "unprognostic (1.50e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (3.15e-3)" "unprognostic (1.25e-2)" "unprognostic (1.46e-3)" "unprognostic (7.62e-2)" "unprognostic (2.67e-1)" "unprognostic (5.19e-2)" "unprognostic (3.21e-2)" "unprognostic (1.14e-1)" "unprognostic (3.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.22e-3)" 4.7 6.1 4.0 7.9 5.1 10.1 9.2 4.7 5.1 5.5 4.1 7.6 7.0 7.0 7.6 7.3 5.9 5.4 5.9 4.2 5.2 8.4 11.3 5.2 14.0 4.5 4.1 8.3 5.9 6.5 5.0 7.1 5.0 6.1 7.8 6.5 7.5 5.9 5.0 6.3 6.8 6.1 4.1 9.7 8.1 6.6 4.8 11.4 7.5 8.9 13.3 5.7 5.8 6.8 17.3 15.0 13.3 9.0 12.2 13.9 12.6 14.2 14.3 15.8 19.6 16.9 17.7 36.8 11.9 11.0 21.3 15.2 21.3 13.4 23.9 1.9 14.5 16.1 17.2 13.4 11.6 29.3 15.7 17.2 16.3 15.8 18.5 11.4 12.9 8.1 31.2 15.0 18.1 22.2 31.5 27.0 22.2 20.1 16.5 9.3 19.2 23.4 15.8 17.5 12.8 23.4 13.9 30.1 29.0 24.3 10.9 19.4 9.5 18.4 22.2 25.4 14.9 19.4 21.9 48.7 13.0 9.4 26.9 46.0 12.9 18.5 14.6 11.2 18.5 22.0 19.2 21.9 14.1 23.9 26.1 20.7 6.2 16.1 13.5 11.2 20.1 15.1 4.0 5.1 4.7 5.1 4.2 5.2 4.5 4.1 5.0 4.1 4.8 6.8 5.5 9.6 10.6 6.2 10.5 0.0 3.9 0.0 14.8 0.0 5.3 6.7 5.3 5.7 2.5 3.7 0.0 9.3 8.0 3.4 5.9 5.9 1.5 4.5 7.0 4.9 1.2 8.2 7.9 5.2 6.3 6.2 7.7 4.0 5.1 8.3 6.4 9.6 5.1 0.0 7.2 2.6 0.0 6.0 0.0 2.1 6.8 5.9 0.0 5.6 7.1 0.0 10.3 8.0 15.2 4.1 3.1 7.2 12.6 3.9 7.2 8.2 1.5 0.0 13.1 5.0 5.3 14.0 10.5 6.3 0.0 4.5 8.0 8.5 4.1 2.7 MTMR6 ENSG00000139505 "Myotubularin related protein 6" Q9Y217 13 25246222-25287488 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (8.68e-2)" "unprognostic (1.50e-2)" "unprognostic (1.21e-2)" "unprognostic (2.31e-3)" "unprognostic (1.91e-1)" "unprognostic (9.19e-2)" "unprognostic (3.21e-1)" "unprognostic (1.45e-1)" "unprognostic (3.41e-2)" "unprognostic (1.82e-2)" "unprognostic (1.69e-1)" "unprognostic (2.94e-1)" "unprognostic (1.71e-3)" "unprognostic (2.04e-1)" "unprognostic (1.18e-1)" "unprognostic (5.06e-2)" "unprognostic (1.30e-1)" 13.4 19.0 9.6 14.2 10.6 31.9 12.5 10.6 14.2 10.7 6.1 10.9 8.5 12.2 7.7 10.8 8.7 12.8 15.6 11.0 11.8 14.8 13.4 13.0 15.0 11.1 9.6 9.3 12.8 16.3 6.1 12.2 11.0 12.9 12.1 21.9 16.1 13.3 11.8 7.7 8.8 15.8 10.4 14.2 10.9 18.6 10.4 16.7 15.3 14.9 14.4 14.3 6.5 14.0 12.3 12.6 20.3 17.3 21.2 22.1 9.9 38.0 42.6 36.9 28.9 8.4 21.4 18.8 11.0 35.7 18.7 14.9 13.1 22.5 42.6 22.7 8.6 23.1 8.4 6.9 25.5 48.5 40.8 15.9 25.9 26.8 35.8 21.1 30.4 24.8 10.9 20.9 37.5 8.7 27.8 13.1 6.1 23.6 9.4 11.8 28.5 25.9 26.7 14.2 10.7 15.2 12.4 21.8 20.2 19.2 8.4 30.2 39.4 22.6 11.6 25.2 22.5 11.3 14.0 24.6 11.4 18.6 37.6 22.9 9.8 8.0 5.8 14.0 7.4 6.5 6.1 6.2 7.9 4.2 6.2 6.4 18.9 6.0 13.0 4.7 8.9 8.9 9.6 10.6 10.6 14.2 11.0 11.8 11.1 9.6 11.0 10.4 10.4 14.0 24.5 16.0 32.1 20.5 44.3 11.0 8.0 8.7 8.0 0.0 16.7 10.4 29.5 8.6 11.9 16.5 0.0 5.8 21.8 14.5 13.7 13.1 64.0 19.0 18.9 20.7 16.7 6.1 29.4 15.0 6.9 16.7 14.8 10.5 19.0 10.6 27.1 23.1 16.3 0.0 63.9 16.0 12.2 40.5 27.7 23.4 12.5 36.4 19.6 26.2 28.1 0.0 5.2 33.2 51.6 22.3 10.0 19.9 28.3 10.2 7.3 31.3 26.6 0.0 0.0 20.4 17.7 62.1 20.4 10.3 11.9 8.2 26.3 17.5 12.3 11.9 MYNN "SBBIZ1, ZBTB31, ZNF902" ENSG00000085274 Myoneurin Q9NPC7 3 169773396-169789716 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045149 Approved Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA045149: AB_10960839" "unprognostic (7.13e-2)" "unprognostic (2.28e-2)" "unprognostic (3.67e-2)" "unprognostic (2.19e-2)" "unprognostic (1.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.09e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.77e-1)" "unprognostic (8.25e-3)" "unprognostic (1.25e-3)" "unprognostic (1.34e-3)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.36e-3)" 6.0 5.3 3.4 6.5 4.1 14.8 9.7 7.2 4.5 7.9 4.4 5.7 5.1 10.3 6.3 7.1 6.8 6.2 5.8 3.1 3.4 6.8 7.9 6.4 8.7 3.0 3.5 10.0 7.3 8.4 3.6 7.1 3.3 7.2 7.0 15.3 6.3 6.3 7.9 7.8 6.8 8.4 3.5 7.9 7.0 9.9 3.4 7.6 8.5 10.8 9.8 7.4 5.5 5.2 13.1 6.0 6.9 13.6 14.2 12.2 8.7 8.6 12.4 13.0 14.3 7.3 13.1 19.7 15.3 9.4 10.3 10.2 12.5 10.9 17.2 17.7 9.8 18.4 9.1 7.2 12.0 17.1 12.9 10.8 13.9 7.9 22.8 10.5 11.7 8.6 7.9 18.9 13.0 11.0 10.1 8.8 10.4 16.1 6.6 11.1 9.7 21.4 8.6 22.1 9.6 11.3 10.4 23.5 14.8 9.0 29.0 12.5 8.7 11.9 5.4 11.1 16.6 21.6 16.4 26.8 9.5 10.6 11.7 22.2 4.8 11.2 7.3 5.2 10.0 8.1 8.4 7.1 5.5 7.9 10.0 7.7 6.7 10.8 4.5 5.5 9.1 7.7 3.4 4.1 7.2 4.5 3.1 3.4 3.0 3.5 3.3 3.5 3.4 5.2 25.8 28.9 21.6 10.7 25.2 41.3 31.1 21.4 46.7 9.0 14.9 12.1 14.7 14.3 20.3 11.0 22.9 14.6 20.1 9.8 13.7 10.4 46.3 15.8 14.8 20.3 14.3 14.5 15.6 9.4 17.0 16.6 19.4 20.3 7.6 12.7 11.4 7.3 8.2 10.1 15.0 8.4 20.3 7.5 14.0 12.6 17.1 12.3 16.0 13.1 12.7 13.3 19.6 12.5 14.0 9.9 9.4 18.8 31.6 18.1 12.2 12.3 18.3 31.7 6.6 15.7 14.7 34.9 18.8 27.3 38.4 20.8 25.5 12.0 9.6 25.7 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 102.0;Suprabasal keratinocytes: 138.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 28: Keratinocytes - Keratinization" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 29.3 20.3 19.4 23.5 16.7 18.6 34.8 50.4 23.5 28.1 7.4 22.8 15.8 32.3 50.1 36.3 27.5 28.0 28.5 18.7 9.7 19.9 37.8 22.8 26.8 13.4 13.2 26.0 17.9 23.5 21.1 26.4 14.9 18.5 25.6 41.4 20.7 20.9 8.0 66.7 17.1 25.2 14.9 19.8 37.9 26.0 13.8 21.2 37.9 17.2 26.3 31.2 24.2 25.9 35.5 25.8 65.0 22.6 24.5 42.7 111.0 35.5 55.7 26.4 29.8 62.8 38.4 39.6 40.6 28.3 48.9 88.4 37.4 45.9 51.8 126.1 31.0 46.7 96.3 30.2 15.8 19.8 22.4 24.6 70.4 55.9 17.1 37.4 41.5 23.9 46.3 33.2 40.6 17.4 28.7 20.0 22.8 38.4 35.2 35.0 46.7 15.9 19.3 34.5 57.9 46.9 41.8 13.9 37.3 82.8 11.4 30.6 29.0 54.5 43.0 31.0 21.6 25.7 30.3 29.5 57.3 17.6 43.7 0.0 1.3 0.6 1.3 1.1 1.9 0.7 1.3 1.7 0.9 0.4 1.4 1.5 2.9 2.6 3.7 0.8 3.3 0.8 19.4 16.7 50.4 23.5 18.7 9.7 13.4 13.2 14.9 14.9 13.8 25.9 24.1 6.4 21.2 14.0 5.9 102.0 23.1 24.6 31.3 26.1 19.7 19.7 18.2 11.5 29.8 12.9 12.5 4.3 9.2 11.4 3.9 10.3 1.4 17.5 10.8 30.1 14.4 12.0 37.2 8.0 11.1 25.2 21.4 23.4 20.3 14.2 44.6 25.7 6.7 6.7 21.2 17.5 14.2 17.3 77.4 3.2 13.4 20.7 39.2 24.4 10.6 12.4 11.3 29.1 28.3 10.2 26.3 14.7 14.9 30.5 4.8 5.1 22.3 15.5 46.0 24.6 39.2 1.7 27.3 55.7 138.9 1.2 16.7 7.3 16.0 29.9 NBPF19 ENSG00000271383 "NBPF member 19" A0A087WUL8 1 149475338-149556361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 73.1;Paneth cells: 123.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (7.92e-3)" "unprognostic (9.12e-2)" "unprognostic (2.95e-2)" "unprognostic (8.53e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-3)" "unprognostic (5.59e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-4)" "unprognostic (3.54e-3)" "unprognostic (2.12e-1)" "unprognostic (1.76e-2)" "unprognostic (1.92e-5)" "unprognostic (1.10e-1)" "unprognostic (3.32e-1)" "unprognostic (8.93e-2)" "unprognostic (4.61e-2)" 38.1 9.0 11.7 31.4 5.4 55.7 28.7 3.7 35.0 25.8 37.6 19.1 10.6 28.8 24.4 24.6 29.5 16.7 10.2 9.7 3.4 14.3 18.9 27.3 30.2 5.9 10.2 48.8 33.7 17.4 3.8 14.9 8.2 24.8 21.7 57.6 20.6 15.5 15.0 63.4 13.4 30.4 0.4 36.8 13.2 28.6 19.9 33.5 20.7 18.2 26.6 19.1 9.2 7.8 62.9 16.4 33.8 18.0 65.9 55.4 16.0 29.8 22.4 20.2 19.4 14.7 21.9 18.1 7.0 45.4 26.7 27.8 47.8 27.6 30.9 32.6 26.8 51.6 49.1 5.2 13.1 51.9 18.0 38.5 12.1 58.7 73.5 27.6 13.3 25.1 12.7 27.6 43.3 45.9 28.3 31.1 30.7 17.6 25.4 25.5 35.7 29.1 12.5 30.0 2.8 7.1 71.5 23.9 13.0 47.7 44.7 70.4 80.2 40.7 30.5 23.9 46.9 23.1 14.5 54.9 45.6 35.4 12.4 15.1 22.2 7.8 8.9 8.6 6.1 3.3 5.0 3.3 4.4 7.1 6.5 8.6 24.0 9.3 7.1 16.1 2.1 2.4 11.7 5.4 3.7 35.0 9.7 3.4 5.9 10.2 8.2 0.4 19.9 7.8 2.3 51.3 59.2 61.0 12.9 0.0 18.5 0.0 19.4 8.1 13.9 7.6 22.4 2.8 9.9 3.7 27.1 1.5 24.4 2.6 1.9 21.2 57.8 13.9 13.0 2.6 1.2 12.8 7.6 6.2 7.1 14.0 4.6 23.2 20.2 9.2 2.2 7.3 6.6 3.3 6.7 3.1 0.0 40.9 0.0 8.0 32.3 43.8 0.0 12.2 73.1 16.6 36.0 22.1 0.6 10.0 123.8 30.1 17.1 6.8 6.3 0.5 11.7 48.7 19.7 15.9 12.4 30.4 6.2 33.9 0.0 1.4 26.3 2.8 6.0 11.5 NCBP1 "CBP80, NCBP, Sto1" ENSG00000136937 "Nuclear cap binding protein subunit 1" Q09161 9 97633668-97673748 "Predicted intracellular proteins, Transporters" "mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042411, HPA049031" Enhanced Supported Nucleoplasm,Cytosol NA NA 25000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" Cytosol Nucleoplasm "HPA042411: AB_2677985, HPA049031: AB_2680606" "unprognostic (4.76e-3)" "unprognostic (2.16e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (3.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.11e-2)" "unprognostic (3.84e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-2)" 10.9 11.0 11.9 16.0 13.7 29.5 11.7 28.3 13.6 10.5 13.7 15.4 12.7 11.7 10.0 12.3 8.8 11.4 12.2 11.8 11.8 11.0 16.6 9.7 19.8 11.6 11.1 12.7 13.2 10.1 10.5 14.6 11.7 12.2 17.9 30.6 10.8 10.2 18.7 15.8 12.6 11.4 11.2 13.3 13.0 16.9 10.9 21.3 15.7 14.9 18.7 14.0 10.6 17.4 57.7 40.6 44.2 41.0 30.8 30.9 41.6 41.2 25.9 40.1 37.4 54.7 30.2 49.0 17.9 41.1 38.5 62.1 72.3 51.6 57.3 33.8 22.2 45.8 58.5 34.4 30.0 60.8 43.2 23.5 25.0 47.3 35.8 28.5 42.4 35.4 68.6 27.0 68.5 43.5 44.3 33.5 46.4 85.4 39.8 41.9 100.4 20.4 33.0 42.9 55.2 35.4 44.2 38.5 23.5 37.9 23.7 38.7 35.2 31.1 28.0 61.9 44.5 21.7 34.3 25.7 27.3 48.6 40.9 14.0 10.0 9.4 7.2 13.4 8.0 5.3 7.7 7.2 12.7 6.5 6.6 8.0 2.9 12.7 13.9 4.5 7.9 7.4 11.9 13.7 28.3 13.6 11.8 11.8 11.6 11.1 11.7 11.2 10.9 17.4 9.8 6.4 11.1 34.9 13.9 13.6 6.8 9.3 13.1 21.9 7.9 5.6 23.4 10.0 13.7 9.2 20.9 13.7 9.7 16.0 3.9 8.9 20.3 12.2 16.7 10.4 9.1 21.4 26.1 6.9 15.0 11.7 17.3 13.2 8.2 12.8 7.1 16.5 11.3 21.9 25.5 12.1 14.2 12.0 9.6 9.8 6.5 12.0 5.4 12.2 15.8 8.9 11.3 20.1 24.4 9.7 7.8 7.5 15.9 7.9 9.0 5.3 15.1 23.4 6.6 10.4 11.2 29.4 14.1 14.3 7.4 14.4 15.0 9.5 10.9 8.4 NCOA2 "bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2" ENSG00000140396 "Nuclear receptor coactivator 2" Q15596 8 70109782-70403808 "Cancer-related genes, Disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 161.6;Excitatory neurons: 158.9;Inhibitory neurons: 314.8;Microglial cells: 233.3;Oligodendrocyte precursor cells: 249.8;Oligodendrocytes: 186.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060243 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nuclear bodies" "HPA060243: AB_2684229" "unprognostic (9.79e-3)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.91e-2)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (2.06e-1)" "unprognostic (7.00e-2)" "unprognostic (2.20e-2)" "unprognostic (2.63e-2)" "prognostic favorable (5.08e-4)" "unprognostic (2.52e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-1)" 8.4 8.9 8.9 9.9 10.5 23.3 13.4 8.9 10.0 10.0 1.5 10.6 11.6 10.1 29.6 15.3 10.9 8.9 15.0 13.6 13.2 14.4 23.8 10.0 11.6 8.0 6.8 16.2 7.3 15.2 7.3 12.1 7.7 12.9 10.6 26.1 11.3 12.1 8.3 10.5 12.1 9.0 4.6 12.4 10.9 14.7 9.9 15.3 12.1 15.9 12.5 10.0 9.9 6.1 13.7 16.9 18.2 10.3 16.2 16.5 18.6 7.8 7.8 5.9 5.5 8.6 15.6 16.3 3.1 14.3 9.7 8.0 22.5 10.7 6.5 38.7 17.9 28.5 8.5 13.8 8.5 5.8 7.2 14.5 11.7 7.9 11.3 9.2 4.0 11.7 9.2 24.0 6.9 13.7 14.5 5.8 9.6 15.7 7.9 14.1 7.6 10.3 9.3 22.5 13.8 10.2 13.4 7.1 11.0 12.7 16.7 10.5 5.3 8.4 10.6 10.8 4.2 31.5 17.3 15.4 8.6 7.6 12.5 3.1 1.6 2.2 2.2 2.3 1.5 1.3 1.3 1.9 1.5 2.1 1.5 1.6 5.7 1.4 5.2 0.6 2.0 1.2 8.9 10.5 8.9 10.0 13.6 13.2 8.0 6.8 7.7 4.6 9.9 6.1 20.9 12.8 25.1 161.6 27.3 16.2 8.6 10.8 17.6 25.8 29.5 17.5 34.1 28.6 25.8 25.8 52.1 22.1 26.9 30.8 11.7 9.3 6.4 23.6 26.4 17.7 25.2 28.8 158.9 12.4 12.5 21.6 21.4 38.0 22.2 23.2 22.1 65.9 17.4 74.0 314.8 17.4 10.2 46.8 17.8 7.6 19.9 28.1 21.4 233.3 23.1 14.3 19.6 249.8 186.0 12.8 14.8 22.2 49.9 15.5 22.7 17.6 19.0 33.4 26.3 22.5 20.2 13.3 16.5 18.8 21.5 31.7 36.6 10.9 17.0 15.8 NEMP1 "KIAA0286, TMEM194, TMEM194A" ENSG00000166881 "Nuclear envelope integral membrane protein 1" O14524 12 57055643-57088063 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014394 Uncertain Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA014394: AB_2204899" "unprognostic (9.24e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "unprognostic (4.97e-2)" "unprognostic (1.43e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (1.64e-1)" "unprognostic (6.61e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.63e-2)" "unprognostic (7.05e-2)" 6.2 5.1 3.3 8.0 3.5 6.8 6.3 3.6 3.9 6.6 3.7 8.7 3.8 8.2 5.3 5.6 6.3 4.3 3.0 3.2 3.3 4.3 6.1 6.3 12.2 3.3 3.2 7.2 4.0 3.7 3.5 7.8 3.7 6.8 6.8 9.3 4.5 5.2 2.3 10.8 7.5 7.4 3.3 7.3 5.4 7.7 3.2 16.1 5.4 3.0 11.6 6.5 5.7 4.2 20.0 16.8 37.5 40.5 12.3 12.0 21.5 30.2 17.1 41.1 33.3 20.0 37.2 47.2 38.1 10.4 35.0 28.8 50.4 13.0 47.0 25.3 22.9 27.9 19.5 10.6 5.2 35.0 30.7 4.1 12.3 33.8 21.0 17.1 11.6 42.2 57.5 91.2 35.0 10.9 38.5 29.7 21.0 18.8 18.4 38.5 53.2 21.5 9.0 12.2 22.3 15.1 25.7 21.3 24.1 26.4 38.5 34.7 8.3 39.0 22.5 36.4 28.6 40.8 83.2 40.5 23.1 32.9 41.1 2.4 0.5 0.8 1.1 1.5 1.5 1.9 1.2 1.5 0.5 1.6 1.8 1.6 0.2 2.4 0.9 0.9 1.2 0.8 3.3 3.5 3.6 3.9 3.2 3.3 3.3 3.2 3.7 3.3 3.2 4.2 4.7 22.4 2.6 0.0 7.1 0.0 3.1 0.0 8.0 2.6 5.0 2.9 1.6 2.8 1.8 5.5 4.2 5.0 4.1 1.4 0.0 1.8 1.2 3.3 4.4 4.0 0.0 12.2 0.0 0.8 3.6 4.4 3.1 3.7 0.0 11.1 5.7 3.6 5.8 1.7 0.0 1.8 0.0 7.1 0.0 1.0 6.2 7.2 0.0 0.0 4.4 3.5 3.1 0.0 0.0 2.0 0.7 5.3 4.9 4.1 1.0 1.3 2.9 4.0 13.1 3.6 3.4 12.2 7.4 7.6 0.0 3.0 4.1 3.1 2.2 2.4 NEMP2 TMEM194B ENSG00000189362 "Nuclear envelope integral membrane protein 2" A6NFY4 2 190504338-190534722 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 10.8;NK-cells: 14.4;Spermatocytes: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA057719 Approved Nucleoplasm NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA057719: AB_2683510" "unprognostic (3.51e-1)" "unprognostic (9.99e-2)" "unprognostic (1.11e-3)" "unprognostic (1.05e-2)" "unprognostic (2.06e-2)" "unprognostic (1.03e-1)" "unprognostic (8.65e-3)" "unprognostic (5.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.61e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.82e-2)" "unprognostic (7.76e-3)" "unprognostic (4.75e-3)" "unprognostic (1.32e-1)" 1.5 1.7 0.7 2.5 1.0 1.9 1.5 2.7 1.0 1.4 0.1 1.3 0.9 1.3 1.0 1.5 1.1 1.1 1.0 0.6 0.4 1.3 1.8 1.7 3.7 0.7 0.7 0.9 1.2 1.0 1.3 1.0 0.9 1.3 0.9 1.2 2.1 0.6 0.5 2.1 1.6 1.2 0.4 2.3 1.9 3.0 0.8 4.7 1.9 0.7 3.0 1.3 1.6 1.4 5.0 2.7 1.8 2.3 1.0 2.7 4.7 3.5 3.0 3.4 4.3 4.0 6.8 7.3 2.3 1.8 2.4 8.7 2.8 7.6 6.9 5.4 2.4 5.2 2.6 2.8 2.6 5.7 1.7 2.8 3.1 15.9 4.1 3.2 1.6 8.0 4.6 8.3 6.8 2.3 6.3 2.7 1.9 2.7 2.9 2.6 3.9 3.4 3.1 3.7 3.2 2.7 5.6 0.6 5.6 3.0 1.4 6.1 2.9 7.7 6.0 1.5 3.9 4.5 5.4 3.8 6.0 5.8 5.7 0.0 0.4 0.0 1.5 0.4 2.0 1.3 1.7 1.3 0.5 1.9 2.7 2.3 0.1 1.3 0.3 1.9 3.1 1.2 0.7 1.0 2.7 1.0 0.6 0.4 0.7 0.7 0.9 0.4 0.8 1.4 4.5 0.0 0.6 0.0 5.9 0.0 2.1 0.0 4.0 5.5 2.0 1.3 1.6 0.0 0.0 1.8 0.0 3.0 10.8 0.2 0.0 2.0 4.5 0.9 3.3 4.0 0.0 4.6 0.0 2.0 3.1 4.1 2.0 1.2 1.3 5.4 3.9 3.4 2.9 3.3 0.0 1.0 0.0 3.3 0.0 6.2 2.8 3.1 0.0 0.0 2.4 2.5 14.4 0.0 0.0 0.7 1.8 1.2 9.5 2.1 0.6 2.3 0.0 2.0 0.0 4.9 5.1 17.0 6.1 3.9 0.0 1.2 6.4 5.3 1.7 2.2 NIPBL "DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2" ENSG00000164190 "NIPBL cohesin loading factor" Q6KC79 5 36876769-37066413 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040834, HPA058239" Approved Supported Nucleoplasm,Vesicles,Cytosol No No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Vesicles, Cytosol" "HPA040834: AB_10796562, HPA058239: AB_2683650" "unprognostic (4.92e-2)" "unprognostic (9.77e-2)" "unprognostic (5.28e-2)" "unprognostic (8.10e-2)" "unprognostic (9.38e-2)" "unprognostic (6.02e-2)" "unprognostic (7.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.85e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (1.04e-1)" "unprognostic (3.40e-2)" 11.5 9.4 5.6 14.7 8.6 25.1 13.5 12.0 7.3 12.9 7.8 12.2 10.0 13.4 6.6 11.4 10.5 11.1 7.7 5.3 5.9 11.6 12.7 11.9 16.5 7.3 6.6 17.6 13.1 19.6 5.0 13.9 8.2 11.1 12.2 22.4 11.2 10.7 9.5 14.2 13.2 12.4 6.3 15.3 13.4 14.2 6.9 29.8 17.2 14.3 16.7 12.6 7.5 11.1 22.5 13.1 33.3 15.6 20.7 22.3 24.4 17.6 19.3 18.9 15.7 18.2 22.6 33.5 11.3 21.6 22.2 19.2 28.9 15.9 27.0 27.9 14.7 40.9 57.4 13.3 14.0 48.4 26.4 16.5 19.3 21.3 28.1 18.1 24.0 20.8 39.3 24.5 17.9 10.8 33.8 18.1 16.0 12.9 11.3 28.2 51.9 13.0 13.1 31.4 24.5 17.2 84.6 22.5 18.0 26.2 23.0 27.3 26.3 24.9 27.1 21.0 13.3 17.7 25.5 39.1 13.6 32.4 19.1 10.9 2.9 4.3 3.2 2.2 3.0 2.8 2.7 2.9 2.3 3.1 2.9 3.3 7.7 2.8 3.3 3.4 2.1 1.6 5.6 8.6 12.0 7.3 5.3 5.9 7.3 6.6 8.2 6.3 6.9 11.1 80.6 131.4 108.6 169.8 84.8 48.4 66.2 34.2 58.1 62.6 43.6 49.4 87.0 38.6 63.3 33.1 77.2 44.1 107.1 45.9 5.9 55.5 13.4 72.9 75.7 74.1 41.5 85.4 179.2 46.7 34.1 64.3 61.2 91.7 84.0 77.7 44.6 28.2 37.1 40.4 165.5 46.3 38.7 51.8 46.6 15.1 66.5 86.7 24.9 236.1 103.3 49.2 97.9 229.2 303.7 55.0 48.6 56.4 84.5 66.4 45.2 12.2 65.2 72.8 52.6 102.9 80.1 185.8 133.6 58.2 47.0 75.9 92.0 73.8 42.9 88.0 NKAPD1 "C11orf57, FLJ10726" ENSG00000150776 "NKAP domain containing 1" Q6ZUT1 11 112074086-112085150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1;Endometrial stromal cells: 35.4;Proximal tubular cells: 32.9;Theca cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039493, HPA039892" Approved Approved Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA039493: AB_10795036, HPA039892: AB_10795372" "unprognostic (5.93e-2)" "unprognostic (3.24e-1)" "unprognostic (6.45e-3)" "unprognostic (1.80e-1)" "unprognostic (1.45e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.45e-2)" "unprognostic (8.61e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (7.05e-3)" "unprognostic (1.15e-2)" "unprognostic (2.86e-1)" "unprognostic (8.24e-2)" "unprognostic (1.41e-1)" 14.2 11.4 9.5 11.6 10.2 13.0 16.7 12.9 11.8 12.1 8.4 12.2 11.3 15.3 11.8 13.9 13.7 11.8 13.0 9.4 10.4 14.6 11.8 11.0 14.2 9.6 9.7 20.1 12.3 14.1 7.7 15.8 10.5 10.7 11.6 33.4 13.7 11.2 18.6 12.1 11.0 12.5 9.6 12.6 11.5 13.6 9.7 16.9 16.0 10.1 14.0 11.5 9.6 11.4 19.5 12.8 26.6 42.9 26.8 31.0 19.5 28.0 23.8 23.1 26.4 39.8 34.2 54.1 41.8 25.3 26.1 27.4 32.1 30.1 30.0 39.0 22.3 41.6 12.7 19.2 24.8 63.3 26.3 31.8 40.5 27.8 63.7 35.1 20.9 44.0 62.4 32.5 23.4 11.8 57.0 39.2 26.5 32.7 28.3 43.5 32.7 44.6 26.6 17.3 22.1 40.4 29.0 35.3 26.1 23.3 44.2 25.9 21.4 30.7 34.4 19.1 24.5 24.5 58.4 111.4 13.0 58.6 31.7 9.1 7.3 4.8 9.8 7.8 10.2 8.4 10.4 6.8 8.1 9.1 10.9 9.5 4.2 13.4 8.9 20.6 9.0 4.8 9.5 10.2 12.9 11.8 9.4 10.4 9.6 9.7 10.5 9.6 9.7 11.4 19.9 32.1 20.7 0.0 9.4 0.0 0.0 0.0 0.0 0.0 24.5 21.0 0.0 0.0 17.3 16.5 0.0 19.6 15.1 0.0 13.7 20.2 0.0 26.0 35.4 8.7 0.0 0.0 0.0 21.4 17.8 11.3 0.0 20.9 8.8 21.8 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 13.9 0.0 0.0 0.0 0.0 20.0 0.0 0.0 5.0 0.0 0.0 32.9 17.5 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 20.0 6.0 35.6 0.0 0.0 NOL11 DKFZP586L0724 ENSG00000130935 "Nucleolar protein 11" Q9H8H0 17 67717931-67744531 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022010 Supported Supported Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA022010: AB_2267158" "unprognostic (6.81e-2)" "unprognostic (2.85e-2)" "prognostic favorable (1.00e-6)" "unprognostic (3.07e-3)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (2.59e-6)" "unprognostic (1.37e-2)" "unprognostic (1.25e-3)" "unprognostic (4.77e-3)" "unprognostic (8.74e-2)" "unprognostic (4.41e-3)" "unprognostic (6.55e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (8.44e-2)" "unprognostic (3.11e-1)" 12.4 8.2 5.0 14.4 5.5 20.8 16.3 9.6 13.0 14.8 6.1 14.8 12.2 15.0 12.7 14.9 14.5 12.7 12.3 5.0 5.3 15.5 18.9 9.8 22.9 5.8 5.4 14.8 14.4 15.6 3.3 17.8 5.9 11.9 15.5 10.3 9.4 11.3 15.5 11.9 10.9 15.6 5.8 12.6 10.2 11.5 5.8 19.7 15.2 17.0 24.5 18.4 6.0 8.9 54.3 63.4 45.7 29.6 21.1 25.3 52.2 37.1 28.6 71.0 58.5 53.5 36.2 86.5 26.8 36.4 47.1 38.4 112.9 54.0 105.7 26.8 92.7 57.9 36.3 48.3 24.7 74.8 34.0 19.8 34.2 52.7 36.9 20.7 67.8 39.1 96.6 25.8 58.8 49.2 89.1 29.6 50.6 61.0 74.4 63.6 101.4 59.8 31.0 57.6 39.4 37.8 32.8 84.7 40.3 63.3 60.5 44.0 26.5 64.3 44.7 21.7 75.7 16.2 45.5 93.7 26.4 54.8 37.6 12.8 6.3 4.6 9.7 7.6 10.4 10.6 10.2 11.9 8.9 13.0 16.4 11.9 0.8 13.1 7.7 6.5 11.8 9.4 5.0 5.5 9.6 13.0 5.0 5.3 5.8 5.4 5.9 5.8 5.8 8.9 25.5 28.9 18.6 10.4 33.7 33.4 38.9 30.5 27.9 21.9 15.8 11.8 18.6 21.5 27.8 9.2 14.6 45.4 33.8 13.1 11.7 23.5 1.7 17.1 28.9 26.0 27.5 24.2 11.3 17.8 37.1 25.0 20.4 18.7 24.1 31.9 16.8 25.3 20.3 25.2 11.4 16.8 26.4 11.8 11.8 4.3 20.8 15.7 17.8 8.4 19.5 15.8 21.6 13.0 16.3 16.6 9.2 19.2 17.4 24.9 12.2 28.6 24.8 32.7 6.6 25.9 21.8 30.2 35.0 26.8 33.2 33.0 32.0 27.0 21.9 25.4 NOL8 "C9orf34, FLJ20736, Nop132" ENSG00000198000 "Nucleolar protein 8" Q76FK4 9 92297358-92325636 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044440, HPA062922" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoli "Mitotic chromosome" "HPA044440: AB_10963212, HPA062922: " "unprognostic (3.44e-2)" "unprognostic (1.67e-1)" "unprognostic (9.72e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (9.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.85e-1)" "unprognostic (6.16e-3)" "unprognostic (5.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.69e-2)" "unprognostic (5.38e-2)" "unprognostic (4.58e-1)" "unprognostic (5.53e-2)" 8.6 5.8 4.2 8.0 5.8 6.8 10.0 5.0 5.3 8.2 5.2 8.6 6.0 9.8 7.4 8.7 7.4 6.5 6.8 4.1 5.3 7.2 5.5 6.9 12.0 5.6 5.4 11.2 7.1 12.6 3.2 7.6 5.6 7.4 8.3 5.8 7.8 8.5 6.3 7.2 5.9 9.9 4.6 9.8 6.2 6.1 6.0 12.6 10.5 6.2 12.6 8.6 5.1 7.1 18.9 27.1 13.4 24.2 28.5 24.3 19.8 19.7 14.9 20.9 18.7 11.2 18.5 54.2 16.3 20.1 33.8 39.9 43.5 25.8 22.3 36.3 21.4 37.1 25.9 22.4 20.3 63.2 30.5 24.0 23.5 22.0 31.6 16.7 23.7 16.3 60.7 17.1 22.5 29.7 42.7 24.8 21.4 28.4 26.8 29.8 37.9 23.0 10.6 13.4 23.0 12.3 25.3 25.1 18.0 17.3 9.5 21.2 24.9 18.3 14.0 26.7 25.0 17.7 37.5 26.7 18.5 37.4 26.6 18.9 8.3 11.3 11.4 10.8 15.8 13.0 11.3 11.8 12.1 12.9 13.3 11.7 3.1 13.2 15.7 10.2 13.8 7.1 4.2 5.8 5.0 5.3 4.1 5.3 5.6 5.4 5.6 4.6 6.0 7.1 25.4 19.2 33.4 15.7 33.8 13.0 18.4 15.3 21.1 17.9 14.7 20.6 28.4 14.3 19.8 11.0 10.4 19.5 37.7 10.1 15.6 23.5 13.9 17.9 46.2 23.9 9.0 37.6 12.1 12.9 20.1 25.8 23.9 20.8 52.4 30.6 16.1 11.5 26.5 28.6 12.5 16.9 6.1 17.7 12.1 9.4 32.0 23.9 10.6 18.7 34.5 12.4 43.3 15.6 25.9 16.1 11.2 23.7 36.5 23.3 10.3 15.8 21.2 17.7 6.6 29.3 21.5 73.3 50.2 25.4 15.9 14.6 30.1 33.4 20.3 12.2 NPAT "E14, p220" ENSG00000149308 "Nuclear protein, coactivator of histone transcription" Q14207 11 108157215-108222638 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045908, HPA066370" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA045908: AB_2679493, HPA066370: AB_2685665" "unprognostic (6.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (5.37e-2)" "unprognostic (2.60e-2)" "unprognostic (4.89e-2)" "unprognostic (7.38e-2)" "unprognostic (5.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.04e-2)" "unprognostic (4.14e-2)" "unprognostic (2.76e-3)" "unprognostic (1.97e-1)" "unprognostic (1.86e-1)" "unprognostic (5.76e-2)" "unprognostic (1.93e-1)" 4.6 4.2 1.6 8.1 2.1 4.5 6.9 7.4 2.8 6.4 3.9 5.4 4.1 6.7 5.9 4.6 4.6 4.7 4.3 1.4 2.4 5.6 5.6 5.4 14.9 2.6 3.0 7.6 3.1 6.8 3.2 6.6 2.4 5.6 6.2 6.6 4.4 4.4 3.1 5.2 4.9 5.1 2.2 9.9 5.9 7.0 2.3 12.0 8.3 5.3 13.3 7.0 3.8 3.0 7.9 6.3 9.7 12.1 11.7 8.5 7.9 11.6 14.6 10.0 14.9 13.0 16.8 13.5 15.2 7.3 11.2 14.6 13.4 11.7 17.8 12.2 5.3 22.5 6.8 6.7 5.0 17.0 14.3 8.1 6.7 17.6 11.2 7.8 14.3 15.5 21.2 6.5 14.1 3.9 21.0 9.1 8.0 12.6 8.7 14.3 13.6 18.5 6.4 11.3 10.3 9.5 14.9 8.8 11.3 10.1 10.0 8.3 11.8 17.3 9.3 10.3 10.5 4.5 6.1 51.9 4.3 12.4 13.7 6.8 1.6 2.9 4.9 2.6 5.5 4.1 5.7 6.3 1.8 4.3 8.9 7.5 1.9 5.3 2.9 1.5 4.6 3.2 1.6 2.1 7.4 2.8 1.4 2.4 2.6 3.0 2.4 2.2 2.3 3.0 23.1 19.2 13.2 24.2 40.8 16.3 16.4 10.5 27.3 16.5 12.0 7.6 15.2 4.3 13.2 12.9 29.2 10.3 32.8 5.6 1.9 8.4 4.9 11.1 15.0 21.1 10.3 29.5 25.5 6.8 8.2 15.9 12.2 14.2 19.6 16.7 22.9 9.1 7.4 10.1 32.2 7.9 8.2 13.0 12.8 3.2 15.8 13.8 8.8 19.7 14.5 11.8 27.8 19.6 24.3 6.8 6.5 17.0 37.8 14.1 7.1 5.6 10.9 16.9 6.6 19.8 13.1 26.2 32.5 14.0 13.2 14.1 35.3 14.9 8.7 15.9 NPIPB4 ENSG00000185864 "Nuclear pore complex interacting protein family member B4" C9JG80 16 21834569-21880827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Astrocytes: 149.5;Early spermatids: 150.6;Excitatory neurons: 255.3;Inhibitory neurons: 182.5;Microglial cells: 391.6;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 217.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.09e-3)" "unprognostic (3.51e-3)" "unprognostic (4.01e-2)" "unprognostic (1.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (3.66e-1)" "unprognostic (1.76e-1)" "unprognostic (4.05e-3)" "unprognostic (6.04e-8)" "unprognostic (3.37e-1)" "unprognostic (7.78e-2)" "unprognostic (2.32e-1)" "unprognostic (5.46e-3)" 25.3 18.6 29.4 26.3 11.2 88.8 24.9 45.3 24.1 28.1 0.0 27.0 17.3 20.5 71.0 19.4 27.8 17.6 21.3 12.1 5.1 25.0 30.4 27.6 38.8 8.3 4.6 24.4 22.4 6.6 23.6 14.8 8.9 28.8 27.8 31.2 23.3 11.8 28.5 104.5 36.7 13.0 0.0 41.1 26.5 20.8 14.8 17.3 31.9 7.5 27.1 20.6 24.8 9.0 14.0 18.6 17.3 13.7 12.2 17.3 29.3 16.7 5.1 5.5 8.9 38.6 19.2 27.2 12.4 14.5 5.1 15.5 9.4 14.0 10.9 10.9 8.7 10.5 56.2 53.0 8.0 44.2 26.9 13.0 16.8 14.6 24.3 11.3 12.1 21.2 23.3 22.8 8.4 40.0 16.9 27.7 20.8 4.5 9.9 25.4 10.3 15.3 6.2 13.6 17.2 10.5 11.1 12.8 8.2 16.3 16.9 12.9 26.9 29.1 14.7 14.0 14.7 11.6 11.9 27.8 9.2 20.4 14.0 3.1 0.9 0.3 0.7 0.5 0.6 1.0 1.0 0.5 0.2 2.7 0.8 0.9 1.4 2.2 0.6 2.0 0.2 0.2 29.4 11.2 45.3 24.1 12.1 5.1 8.3 4.6 8.9 0.0 14.8 9.0 7.1 3.2 16.8 149.5 4.3 7.6 1.2 0.9 3.4 5.1 1.3 0.9 2.1 0.0 6.1 0.0 4.2 0.5 7.6 1.7 0.0 1.0 150.6 5.1 5.4 3.6 1.2 4.4 255.3 0.6 0.3 3.6 6.1 8.8 10.8 3.0 1.4 0.8 0.7 1.7 182.5 2.1 2.0 1.2 5.2 25.3 0.3 4.3 0.0 391.6 2.8 1.2 3.1 207.6 217.1 1.4 3.0 0.4 5.9 0.7 1.0 0.1 3.9 6.4 0.0 3.1 3.1 1.5 0.5 2.3 8.4 0.8 7.0 1.8 2.2 0.7 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 57.1;Club cells: 50.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 58.6 36.5 63.2 66.8 37.2 136.4 58.0 69.0 90.4 67.1 6.8 61.8 36.5 41.8 124.9 41.2 54.9 27.7 50.9 24.8 27.4 49.0 38.4 77.0 82.6 22.1 37.3 57.1 49.4 14.7 50.4 29.3 22.9 58.9 47.3 115.7 56.7 22.8 78.4 212.1 90.9 25.3 2.6 84.6 50.9 41.0 57.1 43.1 75.5 17.7 61.0 45.9 58.8 33.2 31.3 25.7 16.3 23.3 27.8 24.9 35.4 18.9 6.3 11.5 13.9 35.4 53.3 43.9 34.7 17.4 11.3 24.5 41.2 21.3 19.0 53.8 17.2 16.1 85.6 66.1 27.5 83.5 29.1 30.1 20.9 23.0 41.1 20.6 18.3 45.0 43.5 52.8 10.3 57.6 26.6 101.3 46.4 4.9 11.7 44.7 12.1 51.1 18.2 18.9 21.0 14.9 23.3 36.6 19.7 32.9 19.9 30.8 71.4 39.4 17.4 31.2 30.6 35.7 18.9 54.4 15.7 63.6 14.3 6.2 2.7 2.1 3.9 1.2 1.6 6.8 3.8 2.6 1.4 7.7 4.0 3.5 6.0 2.8 2.5 5.2 2.0 1.3 63.2 37.2 69.0 90.4 24.8 27.4 22.1 37.3 22.9 2.6 57.1 33.2 30.0 28.9 57.1 1.0 20.3 14.4 11.2 3.0 17.1 16.5 10.5 7.1 34.8 4.3 50.6 5.5 10.4 5.1 22.8 3.3 0.0 3.8 7.1 19.3 20.5 23.6 1.2 17.2 0.3 1.4 2.8 20.4 22.4 32.7 10.1 21.0 8.2 2.0 4.4 6.7 0.2 3.8 0.0 8.1 16.7 2.8 10.2 25.5 5.4 1.0 14.2 5.5 12.3 0.5 0.3 5.0 4.0 6.4 21.7 13.0 4.3 1.6 31.6 23.8 0.0 32.7 22.7 3.6 2.3 14.0 11.5 5.9 29.7 9.3 3.3 10.3 NR2C2 "hTAK1, TAK1, TR2R1, TR4" ENSG00000177463 "Nuclear receptor subfamily 2 group C member 2" P49116 3 14947584-15053600 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006313 Approved Enhanced Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA006313: AB_1079503" "unprognostic (1.32e-1)" "unprognostic (3.87e-1)" "unprognostic (3.98e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "prognostic favorable (1.51e-5)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-1)" "unprognostic (1.29e-1)" "unprognostic (5.95e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-1)" "unprognostic (1.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.82e-3)" 14.1 12.4 11.4 18.0 12.0 19.1 13.6 21.6 13.3 15.7 2.5 16.9 18.4 17.1 9.8 12.4 15.3 11.3 15.7 12.4 9.0 13.9 13.0 16.8 18.0 7.6 6.1 18.6 14.2 14.2 19.2 9.7 4.6 13.7 11.7 36.2 13.5 11.5 20.1 19.5 18.8 12.8 4.7 19.9 14.8 20.7 8.7 22.4 24.3 17.9 15.7 14.4 13.7 13.5 18.3 20.2 22.8 17.7 15.8 18.8 52.0 25.8 20.7 20.5 21.0 13.0 17.4 28.0 13.2 23.3 17.9 17.9 21.2 13.3 21.2 37.1 30.0 36.8 45.8 12.0 13.4 27.3 27.3 15.0 17.2 25.9 13.4 17.1 23.5 27.2 26.6 18.7 18.3 16.2 41.9 21.3 15.1 8.6 20.7 33.4 27.1 18.8 9.9 27.1 14.5 36.1 23.5 19.4 23.2 17.9 19.5 26.7 30.5 31.6 37.2 29.1 35.6 28.4 40.0 30.4 22.7 25.6 28.2 2.7 0.9 0.7 1.6 1.2 1.5 0.8 0.9 1.0 0.9 1.8 1.2 1.1 1.2 1.0 1.1 1.5 0.9 0.6 11.4 12.0 21.6 13.3 12.4 9.0 7.6 6.1 4.6 4.7 8.7 13.5 14.0 22.4 12.2 35.9 15.7 3.7 11.1 1.0 17.1 17.4 15.1 9.7 6.2 11.5 4.7 7.3 14.6 7.8 15.2 16.5 5.9 6.6 58.8 8.0 10.3 13.4 25.1 20.4 35.5 7.2 7.3 11.5 14.3 9.1 9.5 17.2 18.9 8.2 7.8 13.5 39.9 10.2 0.0 20.1 2.3 65.4 19.3 14.2 5.4 52.5 13.6 13.9 9.2 50.8 92.2 12.3 12.4 20.7 14.2 19.6 13.0 6.8 13.7 17.2 0.0 18.8 10.3 33.9 22.2 13.3 3.1 14.9 15.3 17.0 10.4 18.4 NSD1 "ARA267, FLJ22263, KMT3B, STO" ENSG00000165671 "Nuclear receptor binding SET domain protein 1" Q96L73 5 177133025-177300213 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048431, HPA070333, HPA073705" Supported Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane" "HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239" "unprognostic (3.48e-2)" "unprognostic (7.46e-2)" "unprognostic (7.14e-3)" "unprognostic (2.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.67e-2)" "unprognostic (2.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.68e-3)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (2.09e-1)" "unprognostic (7.77e-3)" "unprognostic (3.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.51e-2)" "unprognostic (7.32e-2)" 8.7 7.2 8.9 12.0 13.4 21.2 10.9 26.2 10.4 11.1 9.8 10.1 8.4 11.5 10.3 11.4 10.1 8.0 9.1 7.7 10.0 10.6 6.6 9.2 13.7 9.7 10.8 12.3 11.3 12.8 9.0 10.7 12.2 9.3 10.8 11.9 10.4 9.6 13.6 12.0 9.4 12.0 6.6 11.3 8.9 23.2 12.0 20.2 15.5 11.5 14.7 9.3 7.9 17.5 20.5 25.9 26.0 22.8 12.5 16.1 0.9 18.2 17.9 24.6 22.8 5.7 16.6 41.7 19.9 24.8 22.7 17.0 41.9 40.0 29.7 72.9 25.9 18.6 29.5 0.2 20.7 40.4 21.2 15.2 23.6 29.4 27.3 17.5 36.4 26.0 25.9 14.3 25.2 42.3 28.3 13.1 28.5 13.7 22.5 31.0 3.4 12.9 15.9 24.4 31.6 21.9 46.7 20.1 13.8 24.1 20.2 33.0 27.4 17.1 25.0 11.0 22.6 16.7 15.7 29.5 9.9 19.3 18.7 14.7 9.0 10.5 7.2 6.1 6.0 8.5 6.1 5.0 7.2 10.3 7.5 6.0 18.6 11.3 12.2 9.4 6.4 3.4 8.9 13.4 26.2 10.4 7.7 10.0 9.7 10.8 12.2 6.6 12.0 17.5 37.4 22.4 31.4 84.9 71.7 17.0 32.8 27.2 34.1 94.4 29.8 25.7 44.5 34.3 35.0 55.2 150.1 43.6 66.1 19.7 17.6 27.8 31.9 27.1 65.7 36.4 41.9 48.3 107.0 21.2 23.7 32.7 41.8 41.9 41.7 64.0 33.5 19.9 27.7 89.2 110.3 25.6 12.2 36.8 25.7 50.3 51.0 47.1 16.0 115.2 75.0 29.2 95.8 140.8 157.5 23.7 31.0 33.1 55.8 29.4 33.6 19.2 17.3 112.3 52.6 42.9 36.1 83.7 62.1 41.8 20.6 35.4 62.0 55.9 28.2 30.0 NSD3 "FLJ20353, KMT3F, WHISTLE, WHSC1L1" ENSG00000147548 "Nuclear receptor binding SET domain protein 3" Q9BZ95 8 38269704-38382272 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 173.8;Syncytiotrophoblasts: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005659, CAB013721, HPA018893" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Mitochondria Nucleoplasm "CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833" "unprognostic (6.21e-2)" "unprognostic (3.73e-2)" "unprognostic (2.18e-2)" "unprognostic (4.12e-1)" "unprognostic (2.25e-1)" "unprognostic (1.53e-2)" "unprognostic (4.35e-2)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (5.06e-2)" "unprognostic (5.60e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.60e-2)" 22.4 14.4 10.0 24.8 13.7 60.2 23.4 28.4 20.5 24.0 0.7 22.4 24.1 22.9 17.4 22.9 23.5 24.5 13.7 12.8 22.3 20.0 16.6 20.6 35.3 3.1 4.8 36.4 20.1 24.8 17.3 33.5 5.3 20.9 26.6 23.3 19.9 24.3 14.4 19.8 26.7 19.8 0.1 26.9 29.0 14.4 10.4 38.3 27.6 16.0 31.0 23.3 23.1 18.7 62.1 34.9 58.7 39.9 40.3 46.0 43.4 50.8 55.9 43.1 49.7 18.8 33.6 73.5 45.5 35.0 41.7 36.4 47.0 40.6 61.0 29.4 27.6 93.6 28.6 22.1 41.2 41.7 32.5 24.9 40.4 39.0 78.6 40.3 50.1 79.8 67.9 47.4 41.5 22.3 122.8 35.4 40.0 48.0 16.4 55.5 64.1 23.4 30.3 47.3 33.0 44.6 41.4 35.8 35.3 37.5 45.1 31.4 48.3 44.5 46.0 67.0 30.3 41.9 53.8 69.2 37.6 41.3 33.0 37.4 11.8 21.9 17.2 5.6 11.0 43.1 25.5 15.5 9.3 60.7 31.9 13.7 57.9 19.6 3.6 12.6 43.4 7.3 10.0 13.7 28.4 20.5 12.8 22.3 3.1 4.8 5.3 0.1 10.4 18.7 75.1 67.3 57.3 0.0 57.8 0.0 0.0 0.0 0.0 0.0 73.4 69.1 0.0 0.0 30.3 51.5 0.0 101.6 101.9 0.0 23.5 73.0 0.0 109.1 81.3 28.0 0.0 0.0 0.0 61.0 173.8 33.1 0.0 97.5 8.8 99.7 0.0 0.0 44.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 49.7 0.0 0.0 0.0 0.0 64.7 0.0 0.0 48.9 0.0 0.0 31.7 34.2 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 130.8 55.6 81.7 0.0 0.0 NSUN3 FLJ22609 ENSG00000178694 "NOP2/Sun RNA methyltransferase 3" Q9H649 3 94062980-94131832 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036181 Uncertain NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA036181: AB_10602715" "unprognostic (5.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.13e-1)" "unprognostic (7.35e-4)" "unprognostic (1.44e-1)" "unprognostic (9.50e-2)" "unprognostic (1.22e-1)" "unprognostic (8.63e-3)" "unprognostic (6.94e-3)" "unprognostic (6.47e-2)" "unprognostic (2.67e-1)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.33e-2)" 2.5 2.8 2.0 2.7 2.6 3.7 2.9 2.7 2.9 2.7 1.1 3.5 3.1 2.8 3.2 2.3 2.6 2.3 2.4 1.8 1.8 2.4 3.1 2.7 3.2 1.5 1.5 3.2 3.1 2.3 2.3 2.2 1.7 2.7 3.9 3.4 2.7 2.0 1.1 3.3 3.0 2.5 1.3 3.5 3.2 3.3 1.8 3.3 3.0 1.4 2.8 2.6 2.5 2.5 2.5 2.9 3.5 2.9 2.1 3.0 1.5 3.5 2.7 3.9 4.3 1.7 2.3 3.9 4.1 2.4 2.7 3.3 3.9 2.8 5.4 6.1 2.7 6.1 4.0 2.8 2.4 6.5 5.2 2.8 3.1 3.1 3.1 3.5 3.2 4.0 2.5 5.3 3.5 2.5 5.8 3.4 3.2 2.9 3.6 4.8 6.0 3.8 3.4 2.3 6.5 4.8 3.6 2.6 3.8 2.4 4.3 4.0 3.5 3.1 3.1 1.8 4.2 4.3 5.2 6.6 4.1 5.7 4.6 5.5 1.9 2.0 2.2 1.9 2.3 2.0 2.0 2.1 1.6 1.8 2.1 2.5 3.3 2.9 2.9 2.3 2.3 1.3 2.0 2.6 2.7 2.9 1.8 1.8 1.5 1.5 1.7 1.3 1.8 2.5 8.5 6.4 3.2 34.3 13.9 3.1 7.3 11.3 9.6 8.3 5.2 3.6 4.5 4.3 12.4 7.3 10.4 6.4 11.6 11.9 5.9 8.1 79.3 9.9 9.8 8.0 2.4 32.2 27.1 7.8 3.8 7.4 13.3 7.1 2.5 10.2 7.1 6.3 6.4 11.8 29.6 9.4 12.2 10.7 4.6 26.2 4.4 9.9 3.6 30.0 10.4 13.2 10.3 38.2 42.9 8.1 9.9 4.1 7.1 5.0 12.6 9.5 12.7 7.2 6.6 5.4 7.2 8.7 8.4 6.1 3.4 4.0 10.8 9.3 6.9 7.9 NUDT21 "CFIM25, CPSF5" ENSG00000167005 "Nudix hydrolase 21" O43809 16 56429133-56452199 "Predicted intracellular proteins" "Differentiation, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 445.9;Late spermatids: 230.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019863, HPA074228" Uncertain Supported "Nuclear bodies,Centriolar satellite" NA NA 12000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies" "Centriolar satellite" "HPA019863: AB_2670299, HPA074228: AB_2686675" "unprognostic (4.95e-2)" "unprognostic (4.42e-2)" "unprognostic (4.25e-3)" "unprognostic (1.31e-1)" "unprognostic (5.85e-3)" "unprognostic (1.29e-2)" "unprognostic (8.80e-3)" "unprognostic (6.87e-3)" "unprognostic (4.09e-2)" "unprognostic (3.19e-1)" "unprognostic (3.76e-3)" "unprognostic (4.27e-2)" "unprognostic (1.39e-2)" "unprognostic (2.85e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" 29.5 32.0 23.4 37.7 27.1 64.4 39.4 27.0 28.7 39.7 19.9 39.3 49.3 39.2 27.4 39.9 35.9 28.4 31.4 28.9 32.2 42.6 37.0 27.7 56.7 20.7 22.5 55.8 32.3 40.2 22.0 38.5 25.3 29.6 40.1 36.0 30.5 32.1 28.0 25.0 34.7 34.7 22.6 34.5 34.0 71.0 22.6 58.3 37.7 37.9 65.7 39.7 26.0 26.9 143.8 79.3 144.3 116.8 78.0 110.0 131.1 96.2 112.2 135.9 94.7 167.7 146.6 193.5 98.5 90.5 84.8 129.8 190.2 116.8 206.0 67.2 78.5 126.6 73.0 146.2 63.6 183.0 124.8 65.5 83.4 113.7 80.3 78.2 127.5 145.8 137.5 69.1 111.2 88.1 195.5 130.1 178.9 106.6 133.0 286.2 196.3 165.4 94.5 121.9 161.1 107.2 184.0 88.0 77.6 99.2 107.6 106.5 74.8 107.4 153.3 93.1 104.1 103.1 120.0 364.7 71.4 117.9 100.1 32.0 24.9 32.9 28.0 26.1 27.7 22.8 29.4 26.1 25.8 20.9 27.1 27.4 27.2 25.5 29.2 19.9 49.6 22.2 23.4 27.1 27.0 28.7 28.9 32.2 20.7 22.5 25.3 22.6 22.6 26.9 30.7 28.9 37.8 23.8 45.5 60.9 52.9 78.4 47.8 19.5 46.3 34.3 39.3 27.1 54.4 42.3 18.8 63.8 29.1 29.2 66.5 63.4 445.9 32.9 40.2 45.2 31.1 69.9 26.5 86.5 90.6 45.8 25.0 38.7 35.5 35.9 48.9 39.1 67.2 35.3 27.9 57.7 20.3 58.8 50.5 230.2 44.7 42.7 37.4 13.1 61.1 25.6 18.6 18.1 34.6 62.5 36.0 41.0 70.0 60.3 49.2 78.3 47.7 24.2 39.5 33.9 59.6 217.4 96.9 67.4 60.0 68.3 49.7 39.5 64.0 70.1 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686951-68745809 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: AB_2673992" "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 15.4 11.1 5.0 17.9 6.3 24.0 17.8 8.2 6.0 12.9 6.3 13.0 10.3 16.7 14.3 10.7 13.5 9.3 11.4 4.6 5.0 10.6 11.8 12.8 25.8 5.6 5.7 16.3 9.3 11.8 6.8 13.8 5.5 12.0 16.2 14.7 10.3 12.2 11.7 15.8 12.9 14.0 5.4 15.8 11.0 20.9 5.5 25.6 10.3 12.1 25.5 12.4 10.7 7.6 53.1 66.8 77.8 56.7 22.6 28.6 84.1 56.6 32.4 83.0 68.9 67.6 43.7 96.3 53.7 27.2 36.9 59.4 88.4 41.7 109.8 90.8 65.6 110.1 46.2 57.4 14.2 97.9 35.6 15.2 19.4 66.5 43.2 29.0 50.3 54.9 133.7 67.3 52.8 64.3 81.3 85.2 85.8 20.3 64.6 81.9 93.6 57.8 36.1 55.3 45.7 46.9 62.7 46.5 34.4 60.4 69.8 46.7 31.1 45.0 45.8 53.0 69.9 29.2 62.2 115.2 34.7 70.2 54.2 10.5 9.2 14.4 17.7 12.5 23.4 18.7 17.5 19.3 10.2 18.7 21.5 19.5 2.4 30.5 23.2 8.1 20.0 11.8 5.0 6.3 8.2 6.0 4.6 5.0 5.6 5.7 5.5 5.4 5.5 7.6 18.3 12.8 17.7 13.7 38.1 17.3 18.4 28.1 25.0 23.8 12.5 11.4 13.5 12.8 18.9 9.2 18.8 30.7 30.3 12.2 11.7 22.8 45.3 12.6 18.2 20.6 8.5 64.4 23.8 17.6 30.8 19.6 16.3 10.2 15.8 35.6 15.4 7.0 17.5 13.5 20.1 12.6 42.7 13.9 16.2 9.6 38.8 18.3 19.6 15.9 27.0 16.7 36.0 21.6 34.3 22.1 9.9 21.8 22.9 19.4 10.5 6.4 21.9 29.6 13.1 18.4 18.2 89.4 51.9 18.7 17.6 14.1 27.0 24.5 16.8 12.5 NUP160 "FLJ22583, KIAA0197" ENSG00000030066 "Nucleoporin 160" Q12769 11 47778087-47848555 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 15000 "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "unprognostic (8.72e-2)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (3.23e-1)" "unprognostic (3.59e-3)" "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.94e-1)" "unprognostic (3.78e-2)" "unprognostic (3.14e-2)" "unprognostic (2.22e-2)" "unprognostic (1.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" 13.3 9.5 5.1 17.3 6.6 20.0 16.5 9.4 6.5 13.5 8.6 12.1 11.8 17.6 11.4 11.0 15.5 10.9 8.7 5.1 6.2 14.2 14.5 14.0 20.6 6.4 6.2 19.6 14.7 16.3 9.9 20.7 6.1 12.7 14.9 15.2 11.7 11.5 11.1 12.6 11.5 16.5 5.8 15.1 10.8 14.5 5.9 30.9 16.9 9.3 21.6 14.6 11.7 9.2 24.4 31.7 52.2 36.6 30.3 34.8 67.3 30.7 22.7 40.8 46.8 40.3 36.2 33.2 20.3 28.0 41.0 52.1 96.5 30.4 45.3 29.1 66.7 36.6 131.3 44.1 20.2 108.1 24.0 27.4 18.7 29.0 56.5 16.6 32.5 52.9 103.7 45.5 22.0 41.9 72.9 47.6 78.4 53.7 33.1 86.2 78.3 29.8 20.9 42.2 43.0 49.0 72.8 35.6 27.6 45.7 44.6 41.1 22.1 44.6 38.4 75.2 41.7 19.7 19.9 83.8 22.0 45.2 45.2 8.6 7.5 13.3 9.9 9.5 13.6 15.3 11.7 10.8 12.3 14.8 15.4 11.5 4.3 9.7 6.8 16.3 9.8 7.1 5.1 6.6 9.4 6.5 5.1 6.2 6.4 6.2 6.1 5.8 5.9 9.2 15.0 22.4 18.8 39.5 31.0 22.9 35.7 18.6 20.5 24.8 14.8 11.2 7.8 12.8 19.4 20.2 43.8 33.1 31.4 10.3 15.6 17.7 27.6 17.9 16.3 17.9 19.2 19.6 35.2 16.7 30.4 19.2 15.3 20.3 19.7 23.3 19.2 12.0 15.2 6.7 50.1 14.6 20.3 10.1 19.8 11.5 24.2 14.4 10.6 44.0 15.7 19.7 24.7 61.9 53.8 16.4 8.6 21.8 21.8 32.9 10.9 10.5 15.0 48.4 19.7 19.6 17.2 18.2 22.0 16.4 27.7 30.8 25.3 20.5 15.7 34.8 NUP205 "C7orf14, KIAA0225" ENSG00000155561 "Nucleoporin 205" Q92621 7 135557917-135648757 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 24000 "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "unprognostic (3.64e-2)" "unprognostic (2.13e-1)" "unprognostic (6.05e-2)" "unprognostic (3.66e-3)" "unprognostic (4.00e-1)" "unprognostic (2.96e-2)" "prognostic unfavorable (1.90e-7)" "unprognostic (2.33e-2)" "unprognostic (2.12e-2)" "unprognostic (3.27e-2)" "unprognostic (7.53e-2)" "unprognostic (4.55e-2)" "unprognostic (3.22e-2)" "unprognostic (3.23e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (1.35e-2)" 7.5 6.7 2.0 13.1 3.3 10.7 11.5 6.7 2.6 8.9 3.8 10.0 8.0 10.7 7.2 11.0 10.4 6.4 4.9 1.7 3.1 8.0 6.6 8.4 15.0 2.7 2.7 11.8 6.1 15.1 5.2 11.0 3.2 8.7 12.3 14.8 11.8 9.0 8.0 9.6 8.3 12.7 2.6 10.3 9.0 11.6 3.2 21.8 8.4 8.0 17.3 9.9 6.9 4.4 66.4 52.8 69.5 68.2 16.2 26.6 45.4 41.0 31.5 62.4 69.1 55.1 46.8 84.2 31.7 24.6 63.0 50.1 88.5 46.0 80.1 41.9 63.3 48.9 52.1 25.1 12.2 96.5 37.0 14.5 20.5 61.4 40.8 21.9 47.3 58.9 115.6 39.1 47.6 45.0 105.0 29.4 107.0 51.6 46.3 77.6 64.6 66.6 18.8 52.4 69.3 70.4 67.8 54.8 31.8 52.4 31.6 36.5 38.6 51.0 25.3 62.7 79.5 28.7 57.2 112.3 51.7 74.3 70.1 1.6 1.3 0.4 2.4 3.1 2.8 2.3 2.9 2.5 3.0 2.1 2.3 2.7 0.5 2.9 1.7 1.9 2.9 1.4 2.0 3.3 6.7 2.6 1.7 3.1 2.7 2.7 3.2 2.6 3.2 4.4 7.9 12.8 13.4 24.8 15.3 13.0 6.8 10.3 11.4 6.3 8.6 5.2 5.3 7.2 10.6 16.5 12.5 13.1 7.5 8.2 3.9 7.8 0.9 7.4 8.1 9.3 9.1 21.3 22.7 9.6 9.3 9.4 13.3 8.4 8.2 18.5 7.9 10.7 10.3 5.0 24.1 10.4 6.1 14.1 11.7 2.4 8.1 12.2 10.6 17.8 11.4 4.9 3.1 26.2 23.3 11.9 6.4 7.5 17.4 10.3 3.9 4.6 12.4 9.7 0.0 12.6 8.2 14.5 10.8 14.8 15.5 7.7 11.9 6.1 10.9 9.4 NUP37 "FLJ22618, MGC5585" ENSG00000075188 "Nucleoporin 37" Q8NFH4 12 102073103-102120120 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056300, HPA073708" Supported Approved Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA056300: AB_2683092, HPA073708: AB_2686629" "unprognostic (1.42e-3)" "unprognostic (5.39e-2)" "unprognostic (3.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.72e-4)" "prognostic unfavorable (7.70e-6)" "unprognostic (2.48e-3)" "unprognostic (2.37e-3)" "unprognostic (7.77e-2)" "unprognostic (2.90e-3)" "unprognostic (1.67e-2)" "unprognostic (7.47e-2)" "unprognostic (5.55e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-1)" 11.3 14.2 4.1 17.1 4.4 22.7 19.5 5.1 7.8 12.8 2.4 20.1 13.0 11.9 21.5 18.9 19.0 10.9 17.6 4.8 4.5 15.2 13.0 11.6 28.1 3.5 2.8 12.1 8.7 17.4 5.9 16.9 3.4 13.7 23.8 10.9 11.7 13.8 17.5 13.4 14.9 17.7 2.4 12.0 12.9 15.1 4.3 25.7 16.4 15.5 33.5 17.7 9.6 6.3 105.5 74.5 64.2 29.6 51.7 68.4 144.6 64.8 61.0 99.8 68.0 97.4 55.5 70.1 45.4 50.9 68.9 76.2 113.5 101.2 124.4 98.5 65.2 75.6 37.2 86.4 66.0 107.5 22.8 53.4 43.5 78.3 57.3 66.7 83.3 91.2 135.5 25.8 93.9 71.6 79.9 87.9 63.4 96.8 117.2 51.9 92.0 52.8 79.0 76.1 33.6 24.0 49.8 52.7 50.3 72.1 90.7 61.7 27.2 35.7 39.4 51.0 91.1 38.5 78.9 119.4 41.9 86.1 61.8 67.8 24.0 28.3 21.4 29.3 23.2 31.2 25.7 21.9 30.2 28.2 23.0 26.1 7.0 23.9 24.9 25.3 45.4 22.5 4.1 4.4 5.1 7.8 4.8 4.5 3.5 2.8 3.4 2.4 4.3 6.3 12.3 6.4 14.3 8.8 22.6 11.3 20.9 63.8 17.1 8.0 10.5 11.7 9.5 14.3 28.2 16.5 8.4 68.1 17.7 9.1 25.4 24.0 2.9 21.6 17.6 17.2 6.0 38.7 5.8 20.0 92.3 19.9 12.2 11.8 7.6 21.2 13.6 10.0 35.6 3.3 7.3 16.0 22.4 15.2 8.4 6.3 19.6 13.5 7.2 5.6 20.5 18.9 13.4 11.1 12.6 17.2 10.6 18.8 34.1 10.7 11.5 24.6 39.3 20.1 19.7 8.6 18.3 49.0 42.4 25.5 9.5 40.2 18.8 31.9 26.5 16.8 NUP42 "CG1, H_RG271G13.9, hCG1, NLP_1, NUPL2" ENSG00000136243 "Nucleoporin 42" O15504 7 23181841-23201011 "Metabolic proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 7.7;Cardiomyocytes: 20.3;Cytotrophoblasts: 17.1;dendritic cells: 10.5;Extravillous trophoblasts: 11.6;Hofbauer cells: 28.1;Syncytiotrophoblasts: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049036, HPA057251" Supported Nucleoplasm No No "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA049036: , HPA057251: " "unprognostic (3.81e-2)" "unprognostic (2.53e-1)" "unprognostic (3.97e-1)" "unprognostic (3.87e-1)" "unprognostic (4.16e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-3)" "unprognostic (2.16e-1)" "unprognostic (1.09e-2)" "unprognostic (1.42e-2)" "unprognostic (1.30e-3)" "unprognostic (2.07e-2)" "unprognostic (4.74e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-3)" "unprognostic (3.59e-1)" "unprognostic (1.32e-2)" 10.8 14.7 12.9 10.8 8.8 20.6 11.4 21.2 13.8 11.2 18.0 11.1 14.9 14.2 15.1 13.6 12.9 13.1 19.7 11.2 10.4 15.1 13.9 10.0 21.6 11.6 9.9 12.0 6.2 17.1 6.4 8.6 8.9 12.1 14.3 8.2 10.7 10.1 11.6 16.4 12.4 15.0 3.6 15.8 11.6 18.9 10.7 19.4 14.4 9.0 18.3 13.2 7.7 22.6 31.1 14.0 21.5 44.5 21.3 25.0 17.8 23.1 16.6 25.2 26.4 21.2 31.9 52.4 22.0 16.1 54.1 41.6 37.9 17.2 32.6 15.9 39.0 32.0 36.5 21.7 24.6 67.4 47.1 11.6 25.5 21.8 14.5 20.4 29.0 22.0 58.9 31.4 25.5 7.7 32.5 54.6 45.1 38.4 21.9 31.6 19.0 40.5 27.1 21.6 33.2 31.2 22.9 14.0 44.9 41.2 17.0 86.3 21.6 16.5 21.8 28.3 39.7 44.9 64.8 52.3 17.6 46.7 44.4 33.2 10.3 8.1 11.0 10.1 10.7 18.8 12.8 12.1 15.0 13.6 10.6 12.7 8.0 17.8 9.3 14.4 16.2 11.1 12.9 8.8 21.2 13.8 11.2 10.4 11.6 9.9 8.9 3.6 10.7 22.6 7.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 17.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 11.6 5.2 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 6.6 1.3 0.0 0.0 0.0 NUP54 ENSG00000138750 "Nucleoporin 54" Q7Z3B4 4 76114659-76148444 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035929, HPA058122" Approved Approved Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA035929: AB_10671236, HPA058122: AB_2683613" "unprognostic (6.70e-2)" "unprognostic (3.51e-2)" "prognostic favorable (8.80e-4)" "unprognostic (3.02e-1)" "unprognostic (3.58e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.51e-3)" "unprognostic (3.05e-2)" "unprognostic (1.62e-1)" "unprognostic (2.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.10e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (3.65e-3)" 17.5 13.1 6.4 15.8 7.1 35.0 23.4 11.9 9.3 22.4 6.2 19.2 16.5 23.5 18.8 18.1 20.0 15.8 12.2 6.6 7.7 15.2 22.2 16.1 22.1 6.4 6.4 24.3 16.6 15.7 7.5 24.4 6.6 18.5 20.6 12.4 14.7 18.4 12.7 19.3 16.0 20.4 7.1 16.6 16.3 21.8 6.3 28.7 20.6 14.2 24.5 21.7 15.0 9.2 42.6 14.2 52.3 37.1 44.2 40.8 45.0 42.1 61.1 62.1 63.1 36.9 58.4 64.4 34.5 42.3 33.4 27.5 57.0 47.6 76.5 42.5 31.1 38.5 19.1 36.7 41.1 75.8 44.1 37.4 33.6 48.8 50.7 27.1 52.8 41.4 67.1 38.9 44.4 35.9 81.0 39.9 81.3 51.2 14.2 61.6 81.0 25.0 37.3 39.1 31.7 26.6 38.6 45.2 35.4 39.5 18.7 47.2 35.5 48.2 43.0 58.8 52.8 25.1 10.0 60.8 35.1 44.5 44.0 10.1 8.8 9.3 13.3 10.7 18.4 9.7 14.0 13.1 12.9 10.9 14.7 14.1 4.1 26.6 12.6 9.5 14.9 8.5 6.4 7.1 11.9 9.3 6.6 7.7 6.4 6.4 6.6 7.1 6.3 9.2 26.1 22.4 16.7 25.5 31.3 35.2 42.8 29.4 32.5 13.8 18.8 19.3 11.8 14.3 17.8 11.0 20.9 41.3 30.5 13.5 29.4 25.1 12.5 24.9 31.6 23.7 14.4 35.7 42.8 27.7 47.5 26.8 17.3 34.4 24.1 23.0 19.2 13.6 21.7 8.4 42.0 20.8 16.2 16.4 24.2 7.4 27.4 20.2 17.8 18.7 28.6 12.8 35.0 34.2 54.2 19.2 17.1 25.9 30.5 34.1 14.4 20.4 19.2 22.2 32.9 24.8 26.5 46.8 39.9 30.2 29.1 39.1 31.8 21.6 24.4 36.1 NVL NVL2 ENSG00000143748 "Nuclear VCP like" O15381 1 224227334-224330189 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028207, HPA028219, HPA028224, HPA028654" Supported Enhanced Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli "HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714" "unprognostic (1.50e-1)" "unprognostic (1.61e-1)" "unprognostic (2.35e-2)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (5.77e-5)" "prognostic favorable (2.95e-4)" "unprognostic (4.43e-2)" "unprognostic (7.14e-2)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (4.10e-11)" "unprognostic (1.67e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" 7.0 7.7 5.5 8.7 5.7 9.8 10.7 7.8 7.5 9.5 6.5 9.1 6.3 9.0 7.7 7.2 8.8 5.6 5.9 5.3 6.4 8.7 6.1 8.0 12.5 5.4 5.3 10.6 8.8 9.5 10.3 13.0 5.6 9.0 10.6 12.8 7.4 7.9 6.5 15.7 8.2 8.1 4.7 10.4 7.2 6.6 5.6 13.0 10.2 5.2 12.1 8.8 8.9 7.5 28.8 15.8 31.2 25.2 11.5 16.6 31.6 22.0 16.5 30.6 27.0 23.4 23.4 39.6 22.5 14.7 11.7 26.1 37.3 22.2 31.5 30.5 47.0 16.4 25.5 11.3 20.3 39.1 28.8 13.5 16.9 26.8 28.5 14.3 19.2 23.0 48.9 23.8 19.1 21.3 30.6 18.3 47.5 20.0 26.1 34.2 37.3 24.8 17.8 19.2 27.5 22.9 34.2 53.1 31.9 25.6 24.3 32.1 19.8 23.2 14.9 27.1 42.9 15.6 33.3 39.3 15.1 30.2 24.8 13.9 7.8 8.4 11.5 11.8 11.7 13.5 11.8 9.1 8.7 9.0 9.9 10.0 0.8 11.9 16.4 9.0 9.3 7.8 5.5 5.7 7.8 7.5 5.3 6.4 5.4 5.3 5.6 4.7 5.6 7.5 10.2 22.4 23.1 21.2 14.3 5.2 4.6 7.8 4.0 14.5 7.9 8.3 10.5 7.2 12.2 1.8 10.4 21.5 12.6 26.9 13.7 9.5 10.1 10.0 11.6 9.3 4.2 7.2 32.1 8.4 14.0 9.3 5.6 7.3 16.4 13.4 4.6 4.5 10.7 10.1 31.0 12.6 10.2 6.5 5.7 3.1 9.6 8.1 5.4 26.2 8.7 9.7 15.5 24.6 43.0 7.0 23.4 10.9 12.3 3.7 7.0 8.1 16.7 20.4 0.0 8.5 10.1 17.5 11.3 7.3 4.5 18.3 12.9 11.4 14.7 3.7 OBI1 "C13orf7, FLJ13449, RNF219" ENSG00000152193 "ORC ubiquitin ligase 1" Q5W0B1 13 78614289-78659155 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034785, HPA034786" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" Cytosol "HPA034785: AB_10601496, HPA034786: AB_2674331" "unprognostic (2.99e-1)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.60e-1)" "unprognostic (7.88e-2)" "unprognostic (1.34e-2)" "unprognostic (2.83e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.84e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (4.99e-6)" "unprognostic (6.87e-2)" "unprognostic (2.01e-1)" "unprognostic (6.91e-2)" "unprognostic (2.53e-2)" 5.8 4.8 5.4 6.1 5.8 2.4 6.7 6.6 6.7 5.9 3.0 4.8 4.8 7.1 4.5 5.0 5.6 4.5 7.1 5.6 6.1 4.6 4.4 5.2 9.9 5.5 5.9 7.6 4.1 4.1 2.9 7.4 5.0 5.5 5.3 9.6 4.2 6.1 4.8 5.5 4.7 6.5 6.1 7.3 4.5 14.8 7.2 13.3 5.9 6.4 11.3 6.0 4.5 5.9 23.7 9.1 39.1 23.1 13.5 12.9 17.8 19.3 14.5 18.7 23.3 18.3 17.3 39.8 9.2 12.4 12.2 23.0 31.2 15.3 32.6 24.9 22.8 61.0 11.4 16.1 11.3 59.6 18.2 12.4 16.7 15.7 16.8 10.6 15.6 19.9 16.1 5.3 24.6 6.6 36.5 20.2 0.0 25.1 10.0 42.0 32.2 15.4 12.7 12.5 28.4 15.9 13.4 16.9 14.8 22.2 8.6 47.3 12.9 16.2 14.7 10.7 16.3 5.5 6.6 37.9 25.9 35.6 17.8 4.9 5.4 7.5 7.9 8.8 9.5 8.8 8.8 9.8 6.3 8.9 10.8 9.8 1.8 11.1 10.3 5.3 9.6 6.6 5.4 5.8 6.6 6.7 5.6 6.1 5.5 5.9 5.0 6.1 7.2 5.9 14.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 15.8 8.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 12.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 5.1 1.1 0.0 0.0 0.0 ODC1 ODC ENSG00000115758 "Ornithine decarboxylase 1" P11926 2 10439968-10448327 "Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis" "Decarboxylase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 560.8;Late spermatids: 834.9;Prostatic glandular cells: 412.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001536, CAB035996" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 51: Myeloid cells - Hemostasis" "Plasma membrane, Cytosol" "CAB035996: , HPA001536: AB_1079521" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (7.25e-3)" "unprognostic (5.21e-3)" "unprognostic (4.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (3.06e-2)" "unprognostic (4.18e-2)" "unprognostic (6.27e-2)" "unprognostic (3.04e-1)" "unprognostic (6.65e-2)" "unprognostic (1.67e-3)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (2.26e-2)" "unprognostic (5.86e-2)" 47.2 23.2 31.0 69.3 31.5 172.9 33.0 30.5 32.2 33.5 48.5 64.8 32.4 66.0 49.2 29.4 56.3 43.7 55.9 29.9 33.0 132.2 92.1 52.4 111.0 32.4 33.0 54.8 61.8 99.6 92.5 20.0 30.6 91.1 72.0 46.2 27.0 55.1 163.3 29.2 41.6 71.2 34.1 42.9 51.5 133.3 34.0 77.1 58.5 73.5 149.1 113.6 26.9 35.7 166.8 130.6 177.1 211.4 31.1 92.4 410.1 234.6 114.9 216.3 99.9 697.3 75.4 870.2 114.6 143.6 208.6 30.2 549.1 265.5 261.2 334.0 231.5 398.1 212.2 429.9 250.8 680.1 91.8 62.5 70.5 490.1 608.3 111.4 176.3 237.6 674.2 274.3 121.7 109.0 680.1 267.3 324.9 228.3 418.8 478.5 556.0 586.3 130.9 119.5 246.6 209.9 293.6 88.8 121.8 135.7 60.0 300.5 124.7 174.4 362.6 227.9 511.7 128.0 416.1 780.8 156.7 443.6 109.9 0.0 1.5 3.0 2.9 2.9 3.3 14.8 4.1 4.8 3.4 15.0 2.8 4.5 0.5 1.4 1.8 12.2 4.4 3.2 31.0 31.5 30.5 32.2 29.9 33.0 32.4 33.0 30.6 34.1 34.0 35.7 78.2 44.8 161.4 7.5 228.9 58.0 123.7 48.8 19.4 36.8 53.2 68.3 55.1 81.5 33.9 40.5 31.3 1.5 188.1 77.7 72.4 50.6 560.8 90.9 66.2 52.2 271.0 111.3 7.5 27.6 70.0 63.2 204.4 127.6 58.9 103.8 14.6 50.3 46.8 6.7 4.1 234.1 22.4 32.1 22.4 834.9 15.5 191.8 23.2 8.4 22.1 126.3 37.0 4.5 2.4 28.6 64.5 11.3 287.4 412.4 31.6 154.1 21.9 77.4 0.0 223.0 79.9 186.5 75.8 52.2 87.5 3.4 133.0 30.2 180.5 142.2 OFD1 "71-7A, CXorf5, JBTS10, RP23" ENSG00000046651 "OFD1 centriole and centriolar satellite protein" O75665 X 13734745-13769357 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "plasmacytoid DC: 64.2" "Lineage enriched" "Detected in all" 4 "dendritic cells: 64.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031102, HPA031103, HPA031104" Approved Supported Microtubules NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 44: Endometrium - Transcription" Microtubules "HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655" "unprognostic (3.10e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.10e-1)" "unprognostic (7.42e-3)" "unprognostic (2.20e-3)" "unprognostic (3.03e-3)" "unprognostic (1.82e-2)" "unprognostic (1.43e-3)" "unprognostic (2.82e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (3.32e-2)" "unprognostic (3.90e-2)" "unprognostic (1.04e-2)" "prognostic favorable (2.76e-7)" 5.8 5.9 8.3 11.7 8.7 15.6 14.6 10.8 9.8 11.2 10.1 9.4 10.2 10.5 11.5 9.9 9.6 7.3 5.9 8.2 9.4 9.6 7.2 9.2 19.1 9.7 8.3 11.2 11.2 15.3 10.9 5.3 8.9 11.7 8.2 11.2 15.6 6.5 5.2 11.8 12.8 7.6 8.2 13.9 12.2 9.9 8.4 10.1 12.9 4.1 16.8 8.5 10.4 10.0 16.0 7.1 10.3 18.4 8.4 13.0 7.7 4.9 11.3 5.7 7.3 12.8 17.7 23.2 12.5 5.9 10.6 15.3 7.5 13.7 9.2 11.6 18.9 10.8 22.3 10.8 6.4 14.4 19.1 10.4 9.1 12.9 12.7 10.6 6.4 4.2 16.5 20.4 6.4 12.6 9.9 17.3 10.8 5.8 10.2 24.9 11.9 46.6 8.9 13.5 10.5 16.6 23.2 18.5 11.6 22.7 17.5 13.0 5.8 10.0 5.2 12.1 6.3 15.1 15.1 26.9 8.3 6.4 8.3 4.3 1.7 6.2 11.6 2.2 13.4 13.7 10.1 14.2 3.8 15.4 8.3 12.5 4.7 14.1 3.1 64.2 8.6 4.4 8.3 8.7 10.8 9.8 8.2 9.4 9.7 8.3 8.9 8.2 8.4 10.0 40.2 70.5 64.1 60.4 90.8 22.4 89.3 51.8 38.1 47.9 65.9 64.1 17.8 35.8 66.7 31.3 89.6 34.5 219.8 82.3 7.9 60.2 178.6 232.2 33.0 39.5 48.6 30.1 43.3 59.3 23.4 31.2 58.1 180.8 27.3 41.1 24.7 13.3 25.2 37.0 50.2 60.3 42.7 19.8 43.0 187.4 52.2 35.1 17.8 32.8 38.2 41.3 145.2 76.9 64.5 60.7 72.9 33.8 50.5 84.4 83.8 15.3 81.3 107.2 39.5 42.4 25.2 72.7 59.9 32.6 27.3 87.0 102.2 30.7 52.2 82.8 ORC4 "HsORC4, ORC4L, Orc4p" ENSG00000115947 "Origin recognition complex subunit 4" O43929 2 147930396-148021604 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015124, HPA064562" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli" "CAB015124: AB_2157883, HPA064562: AB_2685287" "unprognostic (5.04e-2)" "unprognostic (6.56e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.98e-8)" "unprognostic (5.55e-2)" "unprognostic (8.00e-2)" "unprognostic (1.81e-2)" "unprognostic (4.92e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.10e-6)" "unprognostic (2.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.62e-1)" "unprognostic (1.95e-3)" 9.7 11.2 11.5 10.1 13.1 19.3 14.6 21.6 16.3 9.0 8.7 12.6 12.0 12.0 11.0 10.6 14.2 9.7 11.6 12.8 10.8 20.5 12.8 9.3 10.9 9.6 7.9 16.7 8.2 16.2 7.6 10.1 10.0 12.1 13.8 19.7 13.4 10.3 15.0 9.3 11.4 11.5 7.6 8.9 9.4 15.5 10.9 15.7 15.6 10.9 11.9 10.2 6.6 14.4 22.8 19.3 37.2 20.4 14.2 13.9 39.9 25.2 21.3 31.3 31.0 47.9 22.6 29.3 26.8 15.1 27.7 22.4 43.4 25.2 32.4 20.6 36.1 40.2 19.0 32.8 18.8 25.9 14.5 11.9 29.4 34.0 13.9 23.3 21.4 27.5 38.8 14.9 21.2 23.8 20.1 20.9 42.3 18.9 28.0 21.6 24.9 26.5 34.5 46.3 35.0 27.4 22.6 24.7 30.1 33.6 18.9 12.2 15.5 23.5 23.2 17.3 23.4 14.7 37.9 27.5 19.1 20.0 14.6 24.1 13.1 18.3 13.6 17.5 13.9 14.1 12.9 13.9 16.4 14.5 13.4 13.5 18.8 19.3 14.0 8.3 15.1 11.7 11.5 13.1 21.6 16.3 12.8 10.8 9.6 7.9 10.0 7.6 10.9 14.4 21.5 83.3 62.5 53.5 26.0 26.0 21.8 47.1 27.3 48.7 20.3 24.0 25.9 11.5 66.1 12.9 39.6 40.3 27.3 21.7 45.0 31.6 34.0 47.9 17.6 23.8 22.9 46.5 88.4 17.2 48.2 27.7 14.3 26.1 45.5 28.3 19.2 17.1 23.8 53.8 91.4 18.9 28.5 18.8 20.7 15.7 22.4 19.7 21.4 34.7 22.0 33.8 24.7 69.9 71.3 18.3 15.4 21.4 12.8 24.4 23.2 55.4 85.8 37.5 32.9 23.2 31.5 61.2 26.8 22.6 24.9 32.7 25.6 16.9 21.8 20.6 PAN3 ENSG00000152520 "Poly(A) specific ribonuclease subunit PAN3" Q58A45 13 28138506-28295335 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 154.6;Microglial cells: 209.9;Oligodendrocyte precursor cells: 171.4;Oligodendrocytes: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028817 Approved NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 44: Endometrium - Transcription" "HPA028817: AB_10602016" "unprognostic (3.25e-2)" "unprognostic (2.10e-1)" "unprognostic (3.55e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (7.39e-2)" "unprognostic (8.17e-2)" "unprognostic (1.52e-1)" "unprognostic (4.26e-3)" "unprognostic (5.78e-2)" "unprognostic (6.56e-2)" "unprognostic (2.29e-2)" "unprognostic (4.22e-2)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (8.54e-2)" "unprognostic (2.42e-2)" 17.1 9.8 7.8 14.2 8.9 31.3 18.1 16.4 10.8 16.1 12.2 13.9 9.6 15.3 20.6 12.5 16.1 11.0 8.5 7.9 8.1 13.4 11.0 14.6 21.5 8.5 8.4 16.3 17.0 10.1 12.5 11.8 8.9 14.1 12.6 15.8 14.8 12.1 6.8 20.1 18.7 10.8 8.6 25.8 13.0 14.2 7.9 21.5 17.4 5.7 19.4 13.1 15.3 11.8 9.9 6.2 16.8 17.9 8.2 11.6 13.9 10.1 16.1 10.5 10.0 10.3 21.2 34.9 7.1 14.9 11.8 14.4 15.1 11.9 17.8 19.8 7.9 28.3 8.7 8.9 10.9 21.6 17.0 11.5 11.9 8.9 18.1 13.5 14.2 16.2 14.1 10.4 11.6 13.6 23.6 52.2 18.0 13.6 5.9 54.5 17.9 12.8 16.7 13.2 15.8 12.5 11.9 17.3 13.9 10.3 9.2 40.6 13.8 10.5 8.9 10.3 9.8 7.9 6.1 35.6 6.2 16.2 13.1 22.8 10.1 13.4 9.0 9.6 9.6 12.3 10.2 9.2 9.8 11.4 11.5 11.1 22.5 11.9 14.4 15.6 8.7 11.2 7.8 8.9 16.4 10.8 7.9 8.1 8.5 8.4 8.9 8.6 7.9 11.8 32.3 16.0 19.5 97.9 42.9 66.3 16.2 10.2 18.8 27.3 36.1 16.9 7.8 17.2 14.8 16.5 29.2 18.1 51.1 13.6 1.9 13.6 21.3 33.2 25.7 26.8 27.1 61.0 131.4 12.5 15.9 23.7 19.4 38.5 16.5 26.3 28.9 10.7 13.7 26.9 154.6 18.0 16.2 41.4 88.0 12.4 26.4 34.7 56.9 209.9 35.4 13.7 35.0 171.4 222.3 13.6 21.5 21.8 28.9 35.0 13.2 14.3 16.6 37.8 13.1 31.6 26.2 26.5 23.0 22.5 80.7 24.1 36.1 17.1 17.0 31.2 PAPOLA PAP ENSG00000090060 "Poly(A) polymerase alpha" P51003 14 96501433-96567111 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1036.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001788 Supported Supported Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA001788: AB_1079564" "unprognostic (3.18e-1)" "unprognostic (1.30e-1)" "unprognostic (9.69e-2)" "unprognostic (7.26e-2)" "unprognostic (9.10e-2)" "unprognostic (5.10e-3)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.12e-2)" "unprognostic (2.82e-2)" "unprognostic (1.38e-3)" "unprognostic (3.13e-1)" "unprognostic (1.22e-3)" "unprognostic (3.37e-1)" "unprognostic (1.65e-1)" "unprognostic (1.77e-1)" "unprognostic (1.08e-2)" "unprognostic (4.05e-1)" 52.6 60.5 62.7 66.6 65.1 96.9 62.7 71.7 87.4 61.7 70.1 70.5 57.1 68.5 72.5 59.6 57.9 56.1 61.0 59.9 64.4 60.7 81.6 50.0 77.8 63.0 61.7 76.1 71.6 73.2 53.0 85.3 64.3 54.2 71.8 92.4 63.8 54.0 46.7 57.9 67.6 61.6 62.8 69.3 65.9 75.8 62.1 93.0 68.9 56.4 82.8 66.4 53.5 80.7 126.6 119.4 150.5 152.6 107.2 119.4 331.6 112.9 120.4 132.1 125.8 132.9 125.6 170.9 125.3 134.1 115.2 104.4 50.1 156.9 235.0 141.1 81.1 131.9 88.9 138.5 110.6 166.2 133.4 110.6 134.1 148.0 131.1 127.8 150.5 79.5 128.2 146.5 128.9 184.6 140.5 91.1 102.9 205.0 135.3 146.7 183.5 98.7 132.0 192.7 154.0 102.0 151.4 115.8 111.6 167.9 165.3 158.3 119.0 91.3 72.6 104.1 140.7 114.3 186.7 138.6 144.5 137.5 158.9 73.5 32.0 56.1 23.8 39.3 29.0 38.9 30.2 34.2 38.8 42.7 35.3 33.9 41.3 41.3 37.7 25.1 32.7 36.6 62.7 65.1 71.7 87.4 59.9 64.4 63.0 61.7 64.3 62.8 62.1 80.7 126.3 80.1 122.4 64.6 171.4 229.7 406.3 196.6 126.9 78.2 140.0 101.6 157.2 88.6 160.1 84.6 95.9 346.2 139.6 124.1 183.9 121.4 634.7 326.1 145.4 150.7 117.2 126.8 87.9 137.0 440.7 129.9 95.3 371.7 136.4 113.8 85.6 112.3 155.6 63.9 111.5 154.9 168.9 141.3 239.4 275.3 96.3 153.2 168.9 104.9 171.8 93.4 135.9 105.1 115.2 129.6 118.9 80.5 197.4 373.0 122.5 136.5 253.1 107.2 105.2 131.6 185.0 256.8 203.0 146.0 247.6 1036.0 167.8 131.2 166.1 540.3 PARN DAN ENSG00000140694 "Poly(A)-specific ribonuclease" O95453 16 14435700-14632728 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006314, CAB011673, HPA012010" Supported Supported "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976" "unprognostic (2.54e-1)" "unprognostic (3.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.99e-3)" "unprognostic (5.07e-2)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.52e-1)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (3.10e-3)" "unprognostic (1.09e-2)" 16.6 20.2 10.8 13.9 12.1 9.2 15.9 11.7 11.4 17.2 12.0 19.3 11.8 19.1 24.7 15.6 16.0 13.4 14.8 10.6 14.0 12.7 16.4 14.2 21.2 11.7 11.9 16.4 16.5 21.1 16.3 15.6 11.9 16.1 16.8 7.0 15.3 17.1 16.8 17.9 16.1 18.0 11.3 15.7 16.2 18.1 12.6 21.6 20.6 9.7 23.4 19.3 16.0 13.5 28.0 39.9 17.6 22.9 32.9 33.2 20.3 24.4 32.4 29.8 28.3 21.9 28.7 56.2 63.1 32.3 25.3 30.4 46.7 32.3 41.0 42.9 29.4 28.8 24.2 53.2 35.5 46.0 36.2 32.5 38.5 32.0 43.1 25.5 22.5 32.6 28.5 29.9 32.5 44.9 36.7 33.1 26.0 28.2 16.7 56.2 36.1 57.1 23.1 17.1 18.7 16.9 53.4 29.6 36.3 28.6 31.6 28.0 21.2 31.5 15.8 16.4 26.9 32.5 31.0 63.5 34.6 30.8 35.8 8.9 8.0 15.8 8.6 13.2 7.7 16.0 10.4 12.4 13.6 9.4 14.2 14.4 6.2 15.0 15.6 8.3 19.1 7.1 10.8 12.1 11.7 11.4 10.6 14.0 11.7 11.9 11.9 11.3 12.6 13.5 18.0 32.1 39.1 37.9 26.2 7.1 7.8 9.7 21.6 13.0 13.4 14.0 22.3 7.2 11.8 11.0 8.4 29.2 24.7 13.6 11.7 14.2 14.1 15.2 20.5 15.2 14.9 20.4 48.0 12.9 23.2 19.5 21.9 21.7 2.5 19.2 11.7 15.6 14.8 8.4 48.2 14.3 6.1 14.2 5.8 6.3 21.1 18.2 10.6 54.4 35.8 10.3 52.5 38.2 72.4 15.2 10.6 17.7 23.0 7.1 12.2 10.8 19.2 10.8 19.7 13.1 15.0 70.5 70.5 20.0 8.2 22.4 21.5 20.1 13.4 4.8 PARP11 "ARTD11, C12orf6" ENSG00000111224 "Poly(ADP-ribose) polymerase family member 11" Q9NR21 12 3791047-3873448 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026895 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026895: AB_1854980" "unprognostic (9.58e-2)" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (3.58e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (2.11e-1)" "unprognostic (7.52e-2)" "unprognostic (3.81e-2)" "unprognostic (2.87e-2)" 3.4 5.0 2.7 5.0 2.9 3.2 5.3 2.0 2.9 4.2 2.0 3.6 3.7 6.5 5.4 3.1 4.1 4.0 2.3 2.5 3.4 3.9 4.5 3.8 10.2 3.4 3.2 8.2 2.5 7.8 1.8 3.2 3.3 8.6 4.1 3.3 4.0 4.2 1.8 2.2 3.7 5.2 2.8 6.2 3.3 9.4 3.5 10.4 9.1 2.9 9.4 5.0 1.9 3.5 2.7 2.3 14.0 2.3 4.4 7.2 4.1 3.3 5.5 5.6 5.7 8.7 2.2 8.0 2.0 6.4 6.6 2.2 4.8 4.8 9.0 16.1 4.9 12.0 0.0 6.5 5.1 8.1 4.4 5.9 3.8 4.4 12.4 0.0 4.4 15.3 3.1 6.5 8.1 4.0 4.2 3.1 5.2 2.9 0.3 8.3 9.8 1.8 2.6 6.3 0.9 2.9 3.1 2.8 4.2 15.1 0.5 7.1 8.5 4.9 4.8 7.3 4.4 3.1 7.3 11.7 4.6 4.4 1.2 20.3 8.9 9.2 7.4 7.4 10.0 10.0 8.3 5.5 8.9 8.8 9.2 7.5 8.5 7.7 6.1 7.8 3.7 6.2 2.7 2.9 2.0 2.9 2.5 3.4 3.4 3.2 3.3 2.8 3.5 3.5 8.6 9.6 9.5 16.0 18.3 1.9 4.4 6.7 7.4 10.6 5.7 4.1 3.8 2.8 4.5 1.8 2.1 4.2 17.7 2.6 0.0 3.4 61.5 2.1 9.6 5.3 3.6 12.0 30.8 3.1 1.6 8.4 1.1 1.9 14.7 72.0 6.8 4.1 7.1 3.3 30.8 4.7 2.0 9.8 5.8 45.1 10.5 9.7 1.8 18.7 10.3 5.4 17.5 32.6 18.8 3.3 7.6 8.6 3.7 6.6 2.6 4.1 6.0 6.4 6.6 7.0 9.8 9.9 10.9 3.6 1.8 2.6 15.0 8.9 5.0 3.4 PAXIP1 "CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2" ENSG00000157212 "PAX interacting protein 1" Q6ZW49 7 154943687-155003124 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 12.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006694, HPA016950" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA006694: AB_1855011, HPA016950: AB_2669489" "unprognostic (2.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.14e-2)" "unprognostic (2.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (7.39e-3)" "unprognostic (2.65e-2)" "unprognostic (1.34e-3)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (3.28e-2)" "unprognostic (4.99e-3)" "unprognostic (3.98e-1)" "unprognostic (2.44e-3)" "unprognostic (2.30e-1)" 4.3 3.9 2.3 5.8 2.5 9.8 5.4 12.0 2.6 4.8 2.7 4.9 4.8 4.6 4.8 5.4 4.2 4.4 3.9 2.3 2.4 4.6 5.7 4.2 8.8 2.8 2.6 5.7 4.4 6.2 3.8 6.1 2.9 4.4 4.9 3.9 5.7 3.6 5.9 6.5 5.7 3.7 2.5 5.6 5.2 8.7 2.6 26.6 5.5 4.6 6.0 5.3 4.7 2.8 17.7 14.2 18.4 31.2 7.8 6.5 16.4 7.6 8.0 10.3 11.9 15.7 13.6 22.9 9.4 9.1 21.3 13.6 23.7 12.1 12.7 23.0 18.4 17.4 10.7 13.6 5.5 23.9 22.3 6.3 9.0 10.3 4.2 5.8 9.9 22.8 24.3 15.1 10.4 24.3 51.1 19.9 29.8 17.1 9.5 28.8 18.7 24.8 10.7 14.6 14.6 9.4 20.3 14.9 9.5 16.6 11.4 20.1 5.1 8.6 1.5 12.3 18.6 15.2 9.5 31.0 21.1 27.7 23.6 0.2 0.9 0.5 0.9 1.1 1.4 0.5 1.5 1.1 1.0 0.9 2.4 0.7 0.5 1.3 1.3 1.2 1.2 0.9 2.3 2.5 12.0 2.6 2.3 2.4 2.8 2.6 2.9 2.5 2.6 2.8 5.2 6.4 6.3 18.9 5.8 6.4 5.1 4.7 4.0 18.9 8.9 6.6 6.9 7.2 7.1 9.2 10.4 9.0 3.8 6.8 5.9 3.9 2.3 5.5 6.9 5.2 2.4 10.3 21.4 3.3 8.0 6.9 5.6 6.5 2.5 8.8 5.0 9.2 4.4 3.3 24.2 8.4 2.0 6.1 7.1 2.8 8.7 4.8 3.6 15.9 6.3 8.0 7.2 27.2 27.4 4.4 4.3 9.4 4.9 8.0 5.2 4.2 4.3 12.3 0.0 11.1 5.1 22.6 18.7 8.9 7.0 6.2 4.9 6.3 9.8 4.5 PBRM1 "BAF180, PB1" ENSG00000163939 "Polybromo 1" Q86U86 3 52545352-52685917 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015629, HPA059373" Uncertain Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA015629: AB_1855012, HPA059373: AB_2683994" "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.00e-1)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-2)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (1.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.89e-3)" "unprognostic (3.06e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-2)" "unprognostic (1.06e-1)" 21.4 12.9 6.4 20.8 11.0 24.6 16.6 18.5 8.9 21.1 13.2 17.9 15.4 22.1 16.4 22.5 19.4 16.9 18.5 6.0 11.9 11.2 18.2 17.6 22.1 10.7 9.9 29.4 12.0 14.3 8.7 20.9 11.8 18.6 18.5 20.2 13.1 17.4 15.5 17.3 14.2 25.4 8.6 18.9 16.0 14.1 10.3 42.0 26.7 22.8 22.0 20.0 12.0 19.8 32.5 20.5 71.9 35.4 34.7 35.0 50.4 44.5 29.9 49.5 43.0 23.3 21.5 78.7 6.2 51.8 40.8 21.8 63.1 33.1 59.6 85.5 34.6 74.6 38.1 18.1 49.6 62.7 54.6 33.2 37.3 55.4 35.4 38.9 48.4 60.6 43.7 41.7 50.3 11.0 103.9 18.8 43.8 22.0 34.4 53.8 45.1 40.1 20.4 62.5 48.7 53.8 52.7 12.4 41.6 43.4 23.4 35.7 56.5 46.1 34.8 40.1 54.4 30.0 51.3 73.6 28.5 49.8 46.9 9.0 4.0 9.9 3.6 2.6 3.8 2.9 3.6 4.0 4.0 5.3 5.7 3.6 2.3 3.6 8.0 8.7 3.9 1.6 6.4 11.0 18.5 8.9 6.0 11.9 10.7 9.9 11.8 8.6 10.3 19.8 49.1 41.7 61.3 95.3 44.0 40.5 35.8 28.3 43.9 45.6 40.7 30.4 61.7 30.0 39.8 23.9 47.9 36.0 67.7 36.8 19.6 37.7 39.1 61.4 54.5 47.7 35.2 82.9 76.4 46.2 36.9 39.8 42.8 46.8 29.1 61.9 33.5 47.9 53.0 30.3 84.5 35.3 28.5 61.7 47.7 17.1 34.2 65.6 48.0 80.6 67.6 29.1 49.4 87.9 135.5 49.7 29.2 58.3 76.9 37.5 18.7 18.4 58.2 44.3 26.3 54.3 69.2 48.6 35.8 43.7 51.6 50.9 50.4 45.8 39.8 37.0 PCBP2 "hnRNP-E2, HNRNPE2, HNRPE2" ENSG00000197111 "Poly(rC) binding protein 2" Q15366 12 53452102-53481162 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038356, HPA073145" Approved Supported Nucleoplasm,Cytosol NA NA 970000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA038356: AB_10697248, HPA073145: " "unprognostic (1.44e-1)" "unprognostic (2.08e-1)" "unprognostic (9.89e-2)" "unprognostic (2.92e-3)" "unprognostic (4.34e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.52e-1)" "unprognostic (2.05e-2)" "prognostic favorable (8.23e-4)" "unprognostic (3.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.35e-1)" "unprognostic (1.99e-1)" "unprognostic (8.20e-2)" 467.6 429.4 213.6 263.0 232.5 863.1 396.1 260.1 240.3 385.9 238.8 318.2 334.8 345.0 366.4 314.4 407.8 301.5 340.3 197.9 232.9 534.9 509.0 350.9 380.4 228.2 223.5 507.3 501.5 437.3 220.7 299.7 232.8 265.5 325.5 665.2 322.1 264.5 481.1 416.6 324.5 333.8 227.4 323.8 390.4 363.6 228.8 543.6 414.9 401.7 455.6 313.3 323.5 263.2 527.6 809.2 755.8 614.7 1068.5 809.3 582.3 547.0 722.3 844.6 605.4 951.9 760.5 916.9 518.6 796.7 398.6 501.2 830.1 720.1 830.0 579.1 617.4 917.3 597.0 946.0 1071.1 922.5 592.1 937.8 593.9 719.6 1147.1 1451.3 819.3 583.5 810.8 1621.9 762.9 1444.3 856.8 1030.1 975.1 447.8 559.7 690.0 686.4 1098.4 667.5 814.6 742.4 655.6 736.2 656.2 553.9 767.2 918.2 791.8 615.9 443.9 614.0 412.7 561.7 908.2 666.0 840.7 523.9 572.6 494.4 19.1 34.5 25.9 27.7 34.0 44.6 38.1 42.3 35.7 41.6 34.3 48.1 41.8 30.8 23.9 33.3 57.2 52.3 30.1 213.6 232.5 260.1 240.3 197.9 232.9 228.2 223.5 232.8 227.4 228.8 263.2 306.1 115.4 179.2 64.9 433.6 390.7 302.9 352.6 569.1 88.0 361.5 389.9 73.7 253.1 193.0 296.1 110.5 329.2 313.6 242.9 493.1 233.0 68.3 264.2 289.3 285.1 206.5 525.1 54.6 240.0 365.1 285.8 326.2 298.1 155.0 360.3 283.4 302.2 368.2 102.6 58.1 279.1 223.8 437.6 473.8 65.6 309.1 376.0 233.1 74.0 476.5 152.9 292.5 58.8 101.4 250.8 266.5 229.0 483.8 256.3 446.8 714.4 159.5 188.3 190.7 346.6 435.1 292.8 183.4 511.3 382.3 443.3 341.6 240.4 325.7 345.0 PCF11 KIAA0824 ENSG00000165494 "PCF11 cleavage and polyadenylation factor subunit" O94913 11 83156988-83187451 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 124.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040779 Supported Nucleoplasm,Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA040779: AB_2677133" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (3.99e-2)" "unprognostic (1.18e-1)" "unprognostic (3.24e-3)" "prognostic favorable (1.34e-4)" "unprognostic (3.74e-2)" "unprognostic (4.89e-3)" "unprognostic (1.12e-3)" "unprognostic (9.53e-2)" "unprognostic (6.07e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (3.91e-3)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "prognostic favorable (2.03e-5)" 20.1 13.9 9.8 23.5 15.0 42.5 23.7 29.1 13.6 19.2 6.0 19.6 16.3 22.4 15.2 19.5 17.7 17.2 13.5 9.3 10.9 14.9 16.9 22.8 32.4 13.1 12.7 28.3 17.0 16.6 10.4 16.7 14.0 18.7 19.9 26.6 15.4 16.2 26.3 27.8 20.8 23.8 10.9 28.7 16.4 24.7 12.1 33.4 24.3 19.5 29.6 17.0 13.5 17.9 26.3 18.4 29.4 25.3 34.4 33.4 23.5 24.7 18.2 23.2 17.7 31.5 25.7 58.9 18.1 18.0 21.9 25.8 43.2 17.0 22.3 42.1 14.8 34.5 26.3 22.4 19.4 40.9 36.8 23.9 32.1 17.7 25.6 31.2 23.8 38.8 40.9 27.9 21.9 27.9 38.7 45.2 30.7 44.6 20.5 36.4 37.1 35.2 20.2 38.4 24.4 27.0 30.1 23.7 24.3 26.9 23.7 28.0 24.6 33.0 16.9 24.5 16.6 25.0 45.2 124.6 14.5 26.8 26.0 14.8 7.2 14.9 10.1 6.8 8.5 10.9 6.9 7.3 6.9 9.9 7.8 8.2 17.1 13.5 5.5 7.1 5.5 5.8 9.8 15.0 29.1 13.6 9.3 10.9 13.1 12.7 14.0 10.9 12.1 17.9 96.4 41.7 63.5 58.1 90.6 53.7 79.8 30.7 101.9 48.4 84.4 81.0 42.7 35.8 43.4 46.0 33.3 30.2 90.1 49.8 25.4 22.9 203.3 55.5 70.8 66.8 31.8 62.5 32.0 18.1 26.9 58.8 40.2 83.6 37.2 48.0 56.7 21.7 37.6 55.5 37.9 51.0 26.4 57.8 41.0 40.3 60.3 87.4 28.4 45.0 52.5 34.5 58.7 40.7 72.0 19.2 46.2 45.1 69.0 71.6 83.4 14.2 29.0 55.3 39.5 227.3 66.8 46.7 17.9 100.4 62.7 39.4 81.7 42.7 50.3 71.1 PDCD2 "RP8, ZMYND7" ENSG00000071994 "Programmed cell death 2" Q16342 6 170575295-170584692 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026713, HPA075534" Approved Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 32: Non-specific - Translation" Nucleoplasm "Cytokinetic bridge" "HPA026713: AB_1855103, HPA075534: AB_2686754" "unprognostic (3.80e-3)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (4.61e-2)" "unprognostic (5.83e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (1.42e-6)" "unprognostic (9.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.25e-2)" "unprognostic (3.17e-2)" "unprognostic (3.85e-2)" "unprognostic (4.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" 26.3 25.6 18.9 30.0 19.1 35.4 43.0 20.2 23.7 27.1 18.4 31.1 32.4 25.9 39.9 32.6 33.7 23.4 22.8 19.3 20.2 33.2 32.7 23.4 43.2 19.2 20.0 29.8 45.4 29.6 16.9 28.4 19.3 25.9 38.4 17.7 31.7 30.3 36.4 25.8 25.9 28.7 19.0 27.5 30.6 19.9 19.5 42.3 34.6 27.0 50.6 32.8 21.6 19.3 50.5 36.2 53.8 126.7 75.8 82.6 59.3 58.6 66.7 67.9 75.3 65.2 43.1 90.6 46.6 64.8 90.8 70.5 116.5 97.1 98.9 74.7 127.2 128.6 46.2 119.3 91.9 161.6 83.3 75.6 93.4 86.2 138.7 71.2 95.8 123.9 260.3 57.7 84.1 109.5 113.0 116.6 77.5 161.6 54.9 79.4 41.5 117.8 103.7 29.3 98.4 102.4 66.7 107.8 71.6 58.1 54.8 162.8 73.0 33.3 71.4 80.1 105.1 76.5 96.4 97.9 62.1 154.9 87.0 4.1 12.4 11.5 14.1 12.0 16.5 14.2 15.9 14.9 17.3 13.8 15.5 14.8 5.3 18.8 15.2 15.9 20.3 12.0 18.9 19.1 20.2 23.7 19.3 20.2 19.2 20.0 19.3 19.0 19.5 19.3 47.2 12.8 15.3 9.4 54.1 49.5 76.4 14.6 40.5 36.9 58.0 59.7 27.4 52.9 14.0 29.5 12.5 63.9 82.2 29.2 78.2 55.3 17.0 36.1 38.5 38.8 47.2 64.1 13.2 74.1 71.6 32.2 32.1 33.5 15.9 59.8 44.6 28.2 49.2 16.8 12.7 44.0 22.4 41.9 33.2 15.0 49.0 40.9 35.6 8.4 62.8 34.7 84.5 8.0 12.4 58.6 36.4 40.6 58.0 103.9 47.8 83.6 16.0 35.3 19.7 43.8 55.5 33.0 85.8 58.7 46.0 46.7 60.7 60.8 68.0 84.1 PDCL "DKFZp564M1863, PhLP" ENSG00000136940 "Phosducin like" Q13371 9 122798389-122828588 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021571, HPA021647, CAB026473" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol Nucleoplasm "CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115" "unprognostic (3.51e-2)" "unprognostic (4.11e-2)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.39e-1)" "unprognostic (8.74e-3)" "unprognostic (1.77e-1)" "unprognostic (3.13e-2)" "unprognostic (1.49e-2)" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "prognostic favorable (7.00e-4)" "unprognostic (9.84e-2)" "unprognostic (1.35e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-1)" 11.0 8.7 6.8 10.4 9.5 19.4 13.0 8.5 8.7 12.1 7.3 10.2 9.3 13.4 7.7 9.8 10.3 9.5 8.8 6.5 9.2 8.8 6.4 13.1 13.1 8.8 8.4 9.9 6.8 11.0 5.0 14.1 9.2 11.1 10.5 12.4 12.8 9.2 5.9 10.6 9.1 11.3 7.4 12.7 10.7 6.7 8.5 13.1 11.6 6.9 12.3 9.2 7.5 10.6 16.9 23.2 38.4 14.4 34.1 22.5 21.4 23.1 23.8 20.9 21.2 15.2 21.9 28.1 18.7 27.5 23.0 32.3 24.1 22.6 22.7 28.0 12.1 29.2 30.1 25.3 17.4 24.6 55.3 19.7 15.8 20.7 10.3 19.3 43.3 17.6 29.7 16.1 23.1 25.8 27.1 22.2 28.4 28.8 17.6 27.8 36.5 20.9 25.6 0.0 30.8 27.4 31.3 17.3 13.8 25.1 26.5 16.8 48.4 19.4 23.0 28.4 22.8 12.0 26.7 30.5 16.6 19.6 19.0 30.4 13.8 23.9 15.2 12.5 16.2 12.7 18.2 14.1 14.5 16.0 18.5 16.4 11.4 19.8 21.8 17.0 31.3 13.4 6.8 9.5 8.5 8.7 6.5 9.2 8.8 8.4 9.2 7.4 8.5 10.6 43.0 9.6 9.2 5.2 16.7 24.2 14.7 25.4 25.6 42.6 19.9 16.0 5.7 14.3 13.4 20.2 22.9 27.6 29.1 12.9 9.8 20.7 5.5 29.9 22.3 37.5 12.6 50.5 5.8 18.0 27.3 26.7 9.7 36.3 57.1 14.4 31.8 7.6 24.9 40.4 8.2 19.0 24.4 22.6 15.7 4.1 23.0 19.3 19.6 10.3 30.4 36.1 20.6 6.6 15.4 16.5 13.2 17.0 18.2 15.8 9.1 15.3 21.9 38.2 19.7 15.8 21.6 14.5 21.9 25.8 23.2 31.9 25.9 19.9 13.5 16.5 PDIK1L CLIK1L ENSG00000175087 "PDLIM1 interacting kinase 1 like" Q8N165 1 26111165-26125555 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064157 Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA064157: " "unprognostic (1.09e-1)" "unprognostic (1.81e-3)" "unprognostic (2.99e-3)" "unprognostic (2.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.34e-3)" "unprognostic (3.93e-2)" "unprognostic (1.72e-3)" "unprognostic (7.29e-3)" "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (3.59e-1)" "unprognostic (1.34e-2)" "unprognostic (4.24e-3)" "unprognostic (2.94e-1)" "unprognostic (4.47e-1)" "unprognostic (1.78e-2)" 3.2 3.4 4.4 4.5 4.0 16.6 8.2 6.6 5.1 5.9 2.7 6.9 7.1 4.4 4.6 4.9 5.4 3.9 3.3 4.1 5.2 6.0 8.1 4.6 6.5 3.9 4.0 6.5 7.8 7.0 2.6 3.4 4.8 4.7 7.3 8.3 6.3 5.0 4.8 5.5 5.6 3.6 3.8 4.6 7.3 5.0 4.9 8.6 15.4 5.2 6.3 4.6 3.2 4.9 7.9 2.9 7.5 9.8 2.7 3.8 2.6 2.3 2.7 5.2 3.3 2.0 11.2 17.8 6.3 2.6 4.0 5.6 11.2 4.0 4.4 6.1 7.7 15.3 4.3 2.2 4.7 15.6 9.0 2.2 5.9 4.6 8.5 3.5 4.8 15.3 18.0 16.8 1.8 4.8 23.5 7.4 3.5 9.5 4.7 12.7 7.3 19.2 3.7 6.1 13.3 10.8 8.2 10.0 10.5 2.0 5.4 5.4 4.4 5.5 5.2 7.0 6.9 23.8 26.5 12.0 5.9 19.2 5.0 10.5 3.8 3.3 4.8 3.6 4.5 4.9 6.6 5.3 7.3 4.2 7.0 5.6 0.3 4.4 5.1 2.8 7.9 4.0 4.4 4.0 6.6 5.1 4.1 5.2 3.9 4.0 4.8 3.8 4.9 4.9 6.4 9.6 4.2 5.9 6.2 3.2 1.7 3.5 7.4 18.6 8.6 3.9 2.3 7.2 7.0 1.8 0.0 3.9 2.7 6.5 0.0 3.7 1.3 3.2 5.7 5.0 13.1 6.3 13.7 4.0 0.7 3.8 7.1 4.9 7.0 6.3 5.0 11.1 4.1 23.5 15.4 8.0 4.1 6.3 5.9 0.5 2.5 4.6 3.6 5.6 3.1 11.0 0.0 10.1 12.1 2.9 3.3 3.0 14.0 3.5 4.5 7.5 8.4 11.7 0.0 2.9 3.6 14.0 11.7 14.5 7.4 1.6 5.4 3.0 8.7 3.0 PDS5A "KIAA0648, PIG54, SCC-112" ENSG00000121892 "PDS5 cohesin associated factor A" Q29RF7 4 39822863-39977956 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036661, HPA036662" Enhanced Enhanced Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA036661: AB_2675233, HPA036662: AB_10696783" "unprognostic (4.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.62e-3)" "unprognostic (6.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (9.97e-3)" "unprognostic (2.97e-1)" "unprognostic (6.67e-3)" "unprognostic (3.19e-2)" "unprognostic (2.59e-2)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (1.94e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.81e-2)" 19.4 16.2 13.3 23.2 15.0 29.4 24.3 19.7 18.1 20.6 17.0 23.0 19.7 19.9 20.2 25.8 15.9 16.5 14.5 13.4 13.9 22.0 33.4 22.7 33.2 15.1 13.6 23.6 21.0 29.7 10.6 22.9 15.5 18.5 23.9 20.9 20.1 15.9 17.7 24.3 19.4 19.4 14.2 21.4 20.6 14.0 14.2 42.0 28.5 19.6 34.7 22.8 15.9 23.5 54.8 40.0 50.3 53.4 47.5 47.5 40.2 43.4 40.9 50.1 49.6 39.2 60.2 106.6 46.5 51.6 79.5 29.4 86.9 50.5 71.7 36.1 33.2 73.1 47.6 41.3 47.5 90.2 60.1 31.5 55.9 53.3 78.2 44.5 64.7 62.1 88.0 43.8 52.0 38.5 113.2 78.8 28.6 51.4 26.7 104.3 89.6 38.9 48.2 54.6 69.5 41.2 59.9 40.7 39.0 37.5 41.4 78.7 61.5 56.4 58.6 41.2 74.3 37.0 69.7 112.3 40.1 90.6 45.3 2.3 1.2 1.9 2.3 1.6 3.0 2.0 2.2 2.5 1.8 2.5 2.6 2.1 0.4 3.0 1.1 2.2 2.0 1.0 13.3 15.0 19.7 18.1 13.4 13.9 15.1 13.6 15.5 14.2 14.2 23.5 36.2 86.6 70.3 75.7 52.3 56.6 37.0 29.3 51.8 32.7 42.6 30.1 40.5 32.9 45.8 22.0 60.5 32.4 50.8 39.2 7.9 22.0 9.7 34.9 50.0 40.7 30.5 69.6 120.5 25.8 39.1 36.8 41.3 52.8 29.1 45.1 40.0 58.2 30.9 13.5 115.3 36.3 28.5 46.6 54.5 10.0 32.9 44.6 46.2 119.9 38.7 13.3 42.2 98.5 138.0 38.9 28.2 33.1 52.8 53.7 28.5 27.4 25.5 27.9 32.9 36.3 31.1 44.2 48.5 66.9 68.2 38.7 49.9 30.9 40.4 59.6 PDS5B "APRIN, AS3, CG008, FLJ23236, KIAA0979" ENSG00000083642 "PDS5 cohesin associated factor B" Q9NTI5 13 32586452-32778019 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 185.5;Inhibitory neurons: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039513, HPA040015" Supported Enhanced Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA039513: AB_10671999, HPA040015: AB_10671047" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (4.25e-2)" "unprognostic (6.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.30e-1)" "unprognostic (8.98e-2)" "unprognostic (3.29e-1)" "unprognostic (4.17e-2)" "unprognostic (1.28e-2)" "unprognostic (3.96e-2)" "unprognostic (6.29e-2)" "unprognostic (5.47e-2)" "unprognostic (9.62e-3)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.91e-2)" 11.8 8.1 3.8 9.4 6.2 23.3 12.6 7.6 14.3 18.5 0.0 13.5 6.1 19.0 13.2 7.1 12.8 7.8 7.4 7.5 8.3 9.8 9.6 10.9 13.3 0.7 0.4 15.9 7.5 9.3 9.8 10.1 0.0 12.8 8.2 11.1 8.5 9.8 11.4 10.4 10.6 11.7 0.3 13.4 9.8 12.1 0.9 20.9 10.4 8.0 10.7 10.2 11.4 10.5 12.4 7.3 32.7 17.6 15.3 11.0 9.2 20.5 13.7 17.1 17.1 10.1 20.2 45.0 7.2 10.1 17.2 16.1 23.9 12.9 20.2 36.1 9.0 40.7 13.1 14.2 9.0 37.6 24.0 8.6 6.4 14.3 12.8 11.2 13.1 17.8 14.4 29.6 15.8 15.9 45.3 28.2 24.2 25.9 8.9 45.7 45.2 15.5 11.0 10.2 8.5 20.4 23.6 23.0 9.2 19.7 22.2 24.8 26.0 16.3 15.7 11.8 12.4 9.0 10.7 37.4 7.0 25.1 24.1 3.0 2.7 4.0 3.0 2.4 3.5 3.4 3.5 3.2 3.5 4.5 3.4 3.3 3.3 2.8 3.3 2.3 2.8 1.6 3.8 6.2 7.6 14.3 7.5 8.3 0.7 0.4 0.0 0.3 0.9 10.5 50.3 16.0 30.2 86.8 33.9 28.9 23.8 14.6 34.1 42.3 24.3 17.0 26.7 21.5 24.6 27.6 25.0 24.9 35.9 17.4 5.9 14.8 14.5 24.2 79.7 42.2 31.8 22.9 185.5 16.0 18.5 46.4 19.4 19.9 23.5 55.3 23.9 28.0 18.5 47.1 222.6 21.8 16.2 39.0 38.1 13.7 67.1 31.3 35.6 131.2 39.4 15.8 34.0 154.8 155.1 14.7 17.9 62.4 43.8 23.4 15.9 12.9 31.3 20.8 72.3 46.9 51.4 49.5 60.6 17.0 29.3 6.2 37.1 41.8 21.1 17.0 PGBD2 ENSG00000185220 "PiggyBac transposable element derived 2" Q6P3X8 1 248906196-248919946 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA029888, HPA029889, HPA029890" Uncertain Approved Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Vesicles "HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002" "unprognostic (1.06e-2)" "unprognostic (8.05e-2)" "unprognostic (2.56e-2)" "unprognostic (3.03e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.08e-4)" "unprognostic (1.94e-2)" "unprognostic (2.11e-2)" "unprognostic (2.71e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.41e-1)" "unprognostic (7.91e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.05e-4)" 3.2 3.6 3.5 5.4 3.7 4.3 5.8 5.4 3.9 4.9 2.8 4.6 5.9 4.8 5.1 6.0 3.8 4.7 2.8 2.9 4.3 3.7 7.2 3.6 7.5 3.5 3.0 5.6 6.7 3.3 2.7 5.8 3.6 5.1 6.1 4.4 5.4 3.3 1.4 8.1 7.1 3.6 2.1 9.4 5.2 6.0 4.1 5.6 6.5 2.4 7.1 4.4 4.7 6.3 4.4 5.7 8.5 5.2 7.7 5.0 10.7 4.1 3.4 6.9 6.3 4.2 5.6 11.2 5.0 3.9 3.8 6.9 4.7 5.2 7.6 6.7 2.1 10.7 10.0 6.4 4.4 5.9 10.3 4.5 5.5 8.2 4.5 5.5 3.9 3.8 17.5 9.5 5.0 7.3 2.0 6.5 8.4 14.6 6.6 13.1 2.8 3.5 4.0 5.5 3.0 5.6 6.0 8.5 7.0 5.9 3.6 11.2 5.0 4.7 4.5 4.3 4.6 8.8 9.2 4.1 5.0 12.7 4.4 11.0 6.0 9.4 6.1 4.4 6.1 8.3 5.5 5.9 5.5 8.4 5.5 6.8 4.6 5.9 6.8 2.7 4.1 4.1 3.5 3.7 5.4 3.9 2.9 4.3 3.5 3.0 3.6 2.1 4.1 6.3 5.3 0.0 8.9 2.6 11.2 5.2 2.9 7.6 14.8 3.6 7.3 5.6 2.2 2.8 9.1 5.5 2.1 11.5 7.9 6.9 1.9 5.1 3.5 6.0 4.9 5.9 1.2 17.9 2.3 3.0 4.4 3.5 6.1 6.9 2.5 7.8 3.3 3.4 2.9 1.7 2.7 4.3 6.1 3.3 4.4 2.7 3.1 3.7 7.2 2.8 4.6 3.2 6.2 6.0 4.3 2.2 6.0 1.9 5.7 2.8 9.0 3.0 4.6 2.7 0.0 4.0 5.6 14.5 10.2 7.9 6.5 27.8 7.8 4.8 5.1 2.1 PHC3 "EDR3, FLJ12729, FLJ12967, HPH3" ENSG00000173889 "Polyhomeotic homolog 3" Q8NDX5 3 170086732-170181749 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 156.5;Rod photoreceptor cells: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039162, HPA062031" Approved Supported Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA039162: AB_10671038, HPA062031: AB_2684666" "unprognostic (4.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (5.04e-2)" "unprognostic (1.19e-2)" "unprognostic (8.71e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-3)" "unprognostic (3.26e-2)" "unprognostic (3.70e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (9.58e-3)" "unprognostic (2.76e-2)" 9.1 7.4 3.7 12.7 9.1 50.8 10.5 29.3 8.9 9.0 6.3 10.5 11.2 12.2 8.1 12.4 10.2 12.9 8.1 2.0 14.3 9.7 8.7 9.7 18.1 6.5 2.9 14.9 11.3 15.1 5.4 8.4 7.8 11.6 11.3 42.0 8.9 8.6 8.7 8.5 12.3 13.5 0.0 13.9 11.8 11.5 5.5 16.8 16.6 14.0 14.1 11.8 7.4 14.0 35.0 32.3 6.9 11.6 19.2 19.4 12.8 14.6 16.5 14.8 18.2 21.6 17.0 16.5 34.8 20.5 19.7 17.1 15.3 14.1 26.6 38.3 14.2 28.5 30.2 10.0 11.3 35.4 14.8 14.0 8.1 22.1 31.0 10.9 11.1 12.7 6.9 45.0 14.6 32.3 16.2 7.4 7.2 11.3 11.9 12.0 29.5 24.0 7.4 38.7 7.5 4.6 48.1 29.8 9.8 4.5 34.6 27.0 22.3 20.5 12.1 17.1 25.4 43.0 37.6 48.1 12.8 13.1 12.6 9.5 7.0 25.7 16.2 11.2 13.8 16.8 15.2 14.1 7.8 21.6 15.6 13.8 10.2 13.3 7.3 26.0 20.2 7.5 3.7 9.1 29.3 8.9 2.0 14.3 6.5 2.9 7.8 0.0 5.5 14.0 26.8 22.4 31.9 77.4 46.2 14.1 16.9 16.1 19.9 36.3 16.4 12.1 22.7 18.6 18.7 27.6 60.5 15.5 45.9 11.1 0.0 8.9 5.5 18.7 34.5 21.3 7.8 28.8 108.2 7.5 9.6 25.1 25.0 19.0 12.7 35.9 19.6 17.8 11.1 53.8 103.2 14.1 16.2 21.6 22.6 3.8 29.5 22.5 19.6 105.9 25.5 21.9 32.0 103.0 156.5 10.4 16.7 27.8 45.6 22.8 16.4 10.7 24.1 126.2 6.6 29.8 26.4 21.0 19.3 17.8 15.9 18.3 40.4 25.7 14.4 19.6 PHF20L1 "CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B" ENSG00000129292 "PHD finger protein 20 like 1" A8MW92 8 132775358-132848807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025060, HPA028417" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Plasma membrane" "HPA025060: AB_10599822, HPA028417: AB_10602278" "unprognostic (9.12e-3)" "unprognostic (2.29e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-3)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (7.53e-2)" "unprognostic (9.66e-2)" "unprognostic (1.24e-2)" "unprognostic (8.85e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.83e-2)" 12.1 14.0 8.0 13.5 9.6 24.9 10.9 10.4 11.3 11.6 9.9 9.2 9.4 11.4 10.0 11.6 7.9 10.7 17.5 8.0 6.4 10.7 13.4 10.3 11.8 6.5 6.7 11.3 8.9 15.7 8.7 12.4 6.7 9.9 10.1 12.5 9.6 8.0 16.7 7.7 9.9 11.5 5.7 11.5 9.3 13.5 7.2 25.6 22.7 18.5 12.4 12.8 8.9 9.8 20.9 20.6 33.1 19.1 25.3 29.9 11.9 30.1 23.4 20.2 19.7 11.5 14.0 23.8 25.6 30.3 17.4 12.0 22.5 16.0 24.9 40.4 16.1 25.5 24.3 8.2 26.6 20.7 17.6 22.5 19.4 21.1 31.1 19.5 22.6 37.2 32.1 36.4 30.4 21.0 67.6 9.2 14.7 23.8 27.1 32.6 22.1 20.6 16.5 17.8 81.4 23.8 19.1 13.5 24.5 13.8 26.5 23.0 29.6 32.6 25.9 21.5 29.1 21.5 29.9 30.3 28.8 35.8 29.6 3.5 3.8 7.0 2.1 2.4 2.1 2.1 1.9 2.5 3.6 2.2 2.8 2.2 12.6 3.0 3.6 2.9 2.5 1.5 8.0 9.6 10.4 11.3 8.0 6.4 6.5 6.7 6.7 5.7 7.2 9.8 65.9 25.6 51.6 74.4 51.1 33.6 52.6 48.2 40.9 55.7 40.5 38.0 88.5 25.8 57.2 36.8 43.8 29.7 92.9 35.1 23.5 37.3 81.2 39.8 73.4 55.2 43.7 37.9 133.9 31.3 32.0 51.6 41.8 48.9 60.2 60.1 36.0 33.4 36.6 53.8 192.2 29.0 44.7 39.6 49.3 49.5 40.0 84.2 23.2 83.4 67.5 50.9 78.2 104.5 117.5 40.6 26.4 42.9 66.6 40.4 41.5 25.7 30.8 54.1 46.0 68.1 58.9 115.1 45.9 44.9 36.2 45.0 65.8 61.4 30.9 66.7 PHF3 ENSG00000118482 "PHD finger protein 3" Q92576 6 63635802-63779336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024676, HPA025763" Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA024676: AB_10599736, HPA025763: AB_10600987" "unprognostic (4.33e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.23e-2)" "unprognostic (2.89e-1)" "unprognostic (6.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.19e-2)" "unprognostic (1.76e-2)" "unprognostic (1.84e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (3.37e-1)" 19.6 18.2 12.5 16.9 18.9 39.5 21.4 32.2 15.3 20.6 11.7 16.7 16.0 22.8 17.5 12.8 16.7 16.1 13.7 11.0 15.4 19.7 28.0 16.0 21.6 17.4 13.7 32.2 18.4 23.8 12.2 24.3 19.4 18.2 17.6 27.7 15.2 15.9 20.3 16.5 16.1 15.5 14.5 21.3 18.3 14.3 14.7 30.6 26.1 22.9 18.1 15.4 16.8 30.5 35.8 17.5 28.1 17.0 27.3 29.6 28.6 23.0 32.5 16.9 22.3 24.0 16.6 44.0 19.3 20.7 24.4 15.3 27.7 23.9 27.8 35.2 23.3 52.5 21.7 38.2 24.7 45.3 20.7 21.4 21.2 24.0 34.1 29.1 19.8 23.0 58.4 39.9 17.4 21.2 19.5 23.9 16.3 22.9 10.4 33.7 25.6 21.2 20.5 21.0 30.8 22.7 27.7 12.5 20.1 30.7 21.3 41.2 28.2 25.9 30.4 20.0 27.6 33.9 37.6 41.0 11.9 35.6 20.3 15.5 6.2 7.1 7.6 8.0 7.4 7.3 7.1 6.1 5.5 8.9 10.0 7.6 14.4 5.0 11.5 6.7 5.5 4.4 12.5 18.9 32.2 15.3 11.0 15.4 17.4 13.7 19.4 14.5 14.7 30.5 87.9 157.0 133.2 76.0 108.0 54.9 62.1 42.2 71.7 67.9 49.4 56.8 95.2 34.3 88.6 46.0 47.9 47.6 91.2 50.1 15.6 48.4 40.5 68.8 93.7 61.1 43.1 63.1 71.1 37.6 31.5 77.2 60.6 84.3 103.0 85.5 41.7 47.1 28.8 50.5 80.5 46.1 28.5 46.2 33.2 26.5 81.1 65.3 23.2 70.3 69.6 47.4 74.2 76.9 129.8 29.8 40.5 56.8 92.4 64.1 55.5 36.4 72.9 66.8 59.2 103.7 58.5 103.0 69.3 48.4 42.9 31.2 97.1 114.2 49.4 51.0 PHF6 "BFLS, BORJ, CENP-31, KIAA1823, MGC14797" ENSG00000156531 "PHD finger protein 6" Q8IWS0 X 134373312-134428791 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001023 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA001023: AB_1079606" "unprognostic (2.38e-3)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (3.04e-3)" "unprognostic (6.03e-3)" "unprognostic (5.20e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.81e-1)" "unprognostic (4.85e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (1.09e-1)" "unprognostic (5.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" 6.7 18.0 6.6 14.2 7.9 8.4 10.8 10.3 9.3 8.3 6.2 9.1 8.9 9.7 32.7 8.2 7.9 6.6 6.7 7.1 8.4 10.2 7.7 6.8 25.3 8.3 7.8 33.3 9.5 16.3 6.2 9.3 8.4 9.2 10.3 12.0 13.2 11.0 5.0 8.3 8.8 8.1 8.6 13.3 9.3 9.2 7.7 20.8 13.2 6.8 29.8 8.6 7.1 11.5 28.2 22.9 98.7 40.8 17.9 22.9 18.7 27.6 22.1 29.1 35.6 13.9 28.5 45.1 61.8 16.9 28.3 24.6 69.4 31.3 48.6 37.2 32.1 44.3 37.7 16.1 19.2 44.2 23.3 15.3 23.2 31.7 39.2 29.1 41.1 43.1 32.6 21.8 35.8 18.7 71.3 21.8 30.1 38.3 31.0 69.6 36.0 34.5 30.7 33.8 34.1 39.9 21.2 19.3 29.5 29.0 18.0 24.0 31.5 26.8 19.2 34.0 42.9 11.1 27.3 60.5 17.7 51.4 34.3 5.9 6.3 4.1 8.0 6.6 8.7 18.7 8.2 7.3 9.5 12.4 9.6 8.2 2.6 11.0 8.4 11.7 9.1 5.5 6.6 7.9 10.3 9.3 7.1 8.4 8.3 7.8 8.4 8.6 7.7 11.5 25.5 22.4 18.4 13.1 42.7 13.0 14.3 28.7 22.2 22.4 17.5 20.3 16.3 11.5 17.8 16.5 18.8 11.8 27.1 9.9 23.5 14.2 3.7 13.0 29.1 18.7 11.4 31.3 27.8 13.8 7.6 17.2 14.8 18.7 24.6 149.5 20.0 15.2 15.1 18.5 23.4 12.5 10.2 15.5 10.2 3.1 20.8 20.2 7.2 29.0 25.3 27.9 21.6 33.2 46.7 14.4 18.7 15.4 23.1 12.3 9.5 19.8 16.5 19.7 26.3 21.0 21.9 10.3 22.0 25.7 11.5 4.7 22.6 69.3 17.7 11.5 PHIP "BRWD2, DCAF14, FLJ20705, ndrp, WDR11" ENSG00000146247 "Pleckstrin homology domain interacting protein" Q8WWQ0 6 78934419-79078254 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019140, HPA019838" Approved Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA019140: AB_2670073, HPA019838: AB_2670287" "unprognostic (1.58e-1)" "unprognostic (1.60e-1)" "unprognostic (9.43e-2)" "unprognostic (8.47e-3)" "unprognostic (1.05e-1)" "unprognostic (2.01e-3)" "unprognostic (3.50e-3)" "unprognostic (5.03e-2)" "unprognostic (4.03e-2)" "unprognostic (6.40e-3)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.55e-2)" 8.5 5.7 7.6 8.4 9.9 29.4 12.0 18.8 9.3 11.0 6.0 8.5 5.8 11.1 8.4 6.2 9.8 6.3 6.6 6.6 9.0 6.1 4.8 8.8 11.0 8.8 8.7 11.7 8.4 8.5 9.4 7.9 9.2 8.7 7.7 20.5 8.5 7.0 9.7 8.9 7.9 7.1 8.3 9.9 8.1 6.4 8.5 13.1 7.8 8.4 9.1 8.4 9.2 14.0 13.6 10.8 25.2 24.6 9.6 13.7 14.6 14.3 11.3 12.0 15.1 13.4 8.2 22.3 11.1 9.0 10.1 12.2 19.1 9.1 20.1 32.2 13.9 25.0 20.7 10.0 4.4 28.2 15.4 8.4 7.9 14.4 14.3 10.1 12.9 14.0 25.5 20.8 11.7 9.1 11.0 21.0 15.9 7.0 11.8 18.9 32.3 9.7 12.9 18.0 24.7 15.8 19.0 14.4 9.2 16.0 11.2 37.6 15.2 13.9 9.8 6.8 23.8 14.2 14.9 12.3 5.9 17.9 21.2 10.0 4.2 7.7 4.4 3.0 4.7 6.1 5.3 5.0 2.9 6.6 5.8 4.6 14.4 4.6 5.7 5.3 4.8 2.1 7.6 9.9 18.8 9.3 6.6 9.0 8.8 8.7 9.2 8.3 8.5 14.0 64.4 70.5 109.9 181.8 92.5 63.2 88.9 56.7 48.9 183.4 53.7 52.2 58.6 54.3 95.9 55.2 152.2 85.4 95.3 52.1 1.9 71.6 33.8 94.6 75.1 74.5 72.7 80.4 168.9 47.2 91.0 77.3 59.7 58.4 115.2 76.6 71.0 21.3 51.0 181.7 196.4 58.2 71.2 83.8 75.6 17.2 101.2 83.3 49.8 154.6 134.7 84.4 83.4 154.3 346.1 58.1 49.1 87.6 124.8 81.5 46.7 19.0 148.4 174.1 52.6 97.9 87.4 127.3 53.6 50.1 56.4 102.1 92.9 50.5 62.1 104.5 PHYKPL "AGXT2L2, MGC15875" ENSG00000175309 "5-phosphohydroxy-L-lysine phospho-lyase" Q8IUZ5 5 178208471-178232802 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036461, HPA063608" Approved Approved Mitochondria Yes No 160000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA036461: AB_10670717, HPA063608: AB_2685059" "unprognostic (3.29e-3)" "unprognostic (2.60e-1)" "unprognostic (5.51e-2)" "unprognostic (9.75e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-2)" "unprognostic (3.29e-1)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "prognostic unfavorable (3.82e-5)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.41e-3)" 23.2 10.6 7.4 16.4 8.2 14.9 14.0 6.8 8.6 12.3 8.3 23.9 20.7 14.3 15.8 11.1 13.9 14.4 15.5 6.7 8.3 17.5 42.2 15.8 24.5 11.4 8.3 12.5 15.6 13.7 5.2 16.3 10.0 13.7 30.8 3.4 13.8 12.0 19.6 10.7 24.8 18.5 7.6 17.2 15.5 5.9 9.5 25.1 19.7 18.7 23.6 13.7 9.6 11.7 9.6 3.8 9.0 3.6 21.6 17.4 13.9 5.6 6.2 7.6 11.8 9.7 11.7 13.0 18.4 17.6 9.7 6.2 7.7 14.3 8.5 24.0 8.7 15.6 18.0 7.1 35.1 9.2 11.4 19.6 15.0 9.3 22.4 14.9 24.9 18.6 11.8 26.7 11.3 13.1 13.1 5.5 1.9 11.5 12.4 9.1 4.3 25.0 13.4 8.3 5.7 5.4 9.2 5.2 9.4 10.2 5.5 7.4 9.9 7.8 7.0 5.1 6.2 18.8 5.5 7.2 2.2 9.2 5.2 16.7 41.7 36.9 20.3 46.8 20.4 28.4 22.2 22.9 53.4 26.3 27.3 22.2 9.2 23.7 47.2 70.9 28.6 33.2 7.4 8.2 6.8 8.6 6.7 8.3 11.4 8.3 10.0 7.6 9.5 11.7 23.1 19.2 14.3 31.6 63.0 10.7 43.1 16.1 25.0 21.9 17.2 14.5 17.4 37.1 13.0 23.9 25.0 18.4 72.5 96.1 19.6 24.6 21.7 13.2 27.7 26.2 19.2 30.7 20.7 18.6 20.2 33.4 76.9 13.8 12.7 38.4 31.1 30.1 31.7 15.2 17.9 40.8 6.1 37.1 22.9 55.3 42.6 43.3 24.9 36.5 61.1 25.0 70.0 29.1 45.2 15.1 64.5 25.2 51.4 30.3 119.2 43.1 13.6 26.4 13.1 34.5 23.6 37.2 25.9 14.6 10.4 22.0 58.9 36.3 39.2 36.6 PIAS1 "DDXBP1, GBP, GU/RH-II, ZMIZ3" ENSG00000033800 "Protein inhibitor of activated STAT 1" O75925 15 68054309-68198603 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 248.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005743, CAB012304" Supported Approved Microtubules NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Microtubules "CAB012304: AB_777265, HPA005743: " "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.40e-1)" "unprognostic (6.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.75e-1)" "unprognostic (4.21e-2)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-3)" "unprognostic (6.93e-2)" "unprognostic (6.35e-2)" "unprognostic (1.31e-1)" "unprognostic (9.28e-2)" 10.2 10.2 5.6 14.1 7.0 23.2 11.7 11.9 9.4 15.3 5.7 12.0 12.0 14.7 13.9 15.1 14.0 12.7 11.5 7.6 8.3 10.8 9.7 14.9 18.2 4.8 4.9 22.7 11.3 12.5 6.5 12.9 4.9 15.5 11.1 21.3 10.4 17.7 12.4 12.6 12.3 13.6 4.7 15.3 12.7 20.6 6.9 24.9 18.8 16.3 17.6 14.1 10.8 7.0 13.1 17.6 27.9 13.6 16.4 16.8 8.4 19.6 19.8 21.1 23.6 14.7 19.2 24.6 13.1 16.5 13.5 35.5 41.5 10.7 22.7 14.2 15.5 29.6 17.3 16.3 10.7 29.0 23.0 15.2 30.5 13.7 12.4 16.2 15.1 14.1 20.7 18.3 16.3 10.7 24.1 15.0 15.8 14.4 9.9 21.2 26.8 24.1 13.8 16.4 23.3 9.8 13.1 12.1 13.4 25.4 10.7 26.9 13.5 18.3 19.3 10.6 14.6 13.6 19.2 26.2 11.4 30.2 13.7 33.8 31.4 41.9 18.7 23.9 19.3 20.8 18.7 19.8 30.7 19.5 22.3 19.6 70.8 19.2 25.7 16.7 21.5 27.3 5.6 7.0 11.9 9.4 7.6 8.3 4.8 4.9 4.9 4.7 6.9 7.0 38.7 109.0 58.4 106.7 91.5 38.0 58.2 29.4 132.1 72.2 30.3 25.1 28.3 45.8 35.9 12.9 106.3 35.5 61.3 35.2 21.5 32.5 67.1 23.5 48.2 42.0 27.6 41.0 165.7 22.6 20.4 37.5 43.8 27.2 56.3 30.6 40.0 34.9 45.8 48.8 136.6 30.2 14.2 102.4 38.8 33.4 123.6 62.6 21.4 248.3 104.9 57.8 56.7 120.1 126.2 25.5 25.0 113.6 59.3 48.3 38.1 20.0 25.0 64.8 32.9 47.7 31.6 66.7 45.4 51.1 33.0 36.0 67.6 22.6 22.4 64.5 PIK3C3 Vps34 ENSG00000078142 "Phosphatidylinositol 3-kinase catalytic subunit type 3" Q8NEB9 18 41955234-42087830 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 114.9;Inhibitory neurons: 104.1;Oligodendrocytes: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040718 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA040718: AB_10793862" "unprognostic (1.26e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" "unprognostic (3.55e-3)" "unprognostic (6.15e-2)" "unprognostic (3.61e-2)" "unprognostic (6.00e-3)" "unprognostic (1.91e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.86e-2)" "unprognostic (6.41e-2)" "prognostic favorable (4.97e-4)" "unprognostic (1.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-3)" 10.9 16.1 6.8 12.0 10.0 15.9 16.4 18.2 11.5 13.2 12.7 11.7 8.9 15.0 16.6 11.8 12.2 12.1 11.5 7.3 7.8 16.2 14.3 11.7 14.1 8.3 7.0 17.0 9.0 18.6 8.0 17.2 9.9 12.8 13.7 16.7 10.9 12.5 12.2 11.4 10.6 13.9 8.7 13.3 11.5 18.0 7.6 18.5 15.3 16.2 15.8 15.1 9.9 12.9 16.2 11.3 27.8 21.3 31.6 33.8 17.1 31.4 39.8 24.7 33.2 5.4 8.0 10.0 17.6 31.8 19.4 26.0 22.1 17.5 34.2 16.3 15.5 20.8 15.4 21.7 26.3 30.9 22.1 37.3 25.8 23.2 29.9 37.9 25.6 19.9 20.9 12.2 34.3 5.3 13.6 19.8 20.4 6.0 8.1 81.9 21.0 26.1 28.3 17.1 24.2 28.1 10.2 7.3 22.2 30.8 10.8 24.8 33.7 33.3 9.7 7.4 14.6 33.3 42.2 11.3 27.5 41.4 18.0 20.5 9.9 21.2 9.2 11.0 10.3 11.4 9.3 11.5 10.2 10.1 11.8 8.9 19.2 12.1 12.5 5.8 17.0 8.2 6.8 10.0 18.2 11.5 7.3 7.8 8.3 7.0 9.9 8.7 7.6 12.9 22.4 22.4 36.9 70.2 21.1 11.5 10.8 15.3 15.4 28.2 11.5 11.0 23.5 4.3 27.3 14.7 20.9 20.6 26.8 13.8 7.9 14.4 28.6 16.9 22.4 19.9 4.9 19.1 114.9 10.3 13.3 22.4 13.7 18.3 17.1 25.4 17.2 13.4 15.6 55.5 104.1 11.5 16.2 17.9 10.1 13.2 14.6 20.9 7.2 58.1 21.5 26.2 13.4 83.4 115.6 14.3 10.0 24.0 18.2 14.5 12.9 12.3 22.4 22.5 19.7 25.4 18.9 20.0 18.6 14.3 11.4 27.4 23.8 24.7 10.6 15.9 PIK3CA PI3K ENSG00000121879 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" P42336 3 179148114-179240093 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Lipid metabolism, Phagocytosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 126.7;Inhibitory neurons: 122.0;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009985, CAB017804" Approved Supported Mitochondria,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol Mitochondria "CAB017804: , HPA009985: AB_1079610" "unprognostic (1.81e-1)" "unprognostic (2.77e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-3)" "unprognostic (6.49e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-3)" "unprognostic (5.21e-2)" "unprognostic (4.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.48e-1)" "unprognostic (9.74e-2)" "unprognostic (3.82e-2)" 14.7 7.9 3.1 8.1 3.7 12.4 8.5 9.7 8.3 8.7 0.3 6.7 4.2 8.3 4.8 7.9 5.7 8.4 9.5 3.7 3.6 8.2 7.1 7.9 9.2 5.1 4.2 10.3 4.3 11.5 3.4 11.1 5.1 7.3 5.8 12.4 4.5 7.1 7.1 5.5 5.3 8.9 2.3 8.8 5.8 6.1 3.7 13.7 7.9 13.0 9.2 8.6 5.8 6.4 19.9 6.5 9.6 9.2 22.7 27.7 6.5 10.8 16.5 10.9 16.0 5.1 13.0 16.1 21.7 10.8 14.1 5.9 8.4 9.8 16.5 32.0 6.2 22.4 5.2 4.4 10.7 13.1 12.6 16.8 10.6 12.4 15.0 13.4 15.8 12.9 10.6 17.3 18.9 6.9 10.9 8.5 8.0 8.8 7.8 13.9 10.0 16.7 8.5 10.0 5.2 9.9 13.1 10.8 16.1 9.1 19.0 11.1 21.1 10.4 6.5 18.1 13.3 9.3 13.8 29.0 11.3 9.6 5.4 1.3 1.2 0.4 1.2 1.0 0.8 1.5 0.8 0.6 0.8 1.6 1.0 0.8 2.2 0.7 0.9 0.9 0.8 0.3 3.1 3.7 9.7 8.3 3.7 3.6 5.1 4.2 5.1 2.3 3.7 6.4 31.3 32.1 26.8 60.7 28.3 14.7 17.9 11.2 2.2 27.9 14.4 15.2 18.5 5.7 15.9 7.3 31.3 10.2 17.9 8.7 1.9 10.7 2.0 14.1 21.7 25.6 2.4 9.2 126.7 13.9 6.1 23.5 8.6 21.6 31.6 19.9 33.5 21.9 11.1 38.7 122.0 10.3 14.2 23.5 24.3 3.4 32.6 20.9 14.2 75.9 24.5 17.4 18.6 130.2 84.2 16.9 10.8 39.5 15.1 34.6 9.5 14.8 20.1 27.1 26.3 25.7 28.6 11.8 10.2 9.8 14.9 8.8 19.9 19.6 9.2 32.0 PIKFYVE "FAB1, KIAA0981, MGC40423, p235, PIP5K, PIP5K3, ZFYVE29" ENSG00000115020 "Phosphoinositide kinase, FYVE-type zinc finger containing" Q9Y2I7 2 208266255-208358746 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 82.0;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042604 Uncertain NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "HPA042604: AB_10796580" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.88e-1)" "unprognostic (3.03e-1)" "unprognostic (2.04e-2)" "prognostic favorable (6.81e-4)" "unprognostic (6.82e-3)" "unprognostic (6.45e-2)" "unprognostic (1.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.77e-1)" "unprognostic (2.10e-2)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" 10.4 7.9 7.6 12.0 7.6 28.8 8.1 14.3 9.3 9.1 10.5 6.1 6.0 9.3 11.9 6.3 6.4 7.2 7.4 7.7 7.3 10.6 10.5 7.8 17.4 8.0 7.4 10.0 22.2 11.1 6.0 9.7 6.9 11.5 7.4 17.3 6.5 8.0 6.5 8.2 7.3 8.9 7.4 15.1 8.0 14.0 8.9 19.3 12.2 9.0 16.1 8.2 5.8 11.1 8.0 7.9 18.3 14.3 18.1 21.4 8.5 9.6 19.5 11.1 15.0 11.3 6.6 9.2 9.8 16.6 21.7 8.0 16.1 10.8 18.8 7.9 10.1 33.0 15.6 10.2 13.7 29.5 28.5 16.0 11.5 13.0 24.1 18.5 18.3 24.1 22.7 16.1 14.0 3.4 26.9 22.1 15.2 6.1 5.9 9.9 14.2 12.7 14.2 11.5 5.8 13.8 10.6 6.8 19.2 21.4 4.3 31.3 21.2 13.8 9.2 9.4 9.0 11.2 14.2 19.2 11.1 25.2 13.9 0.9 0.5 0.4 0.9 0.4 0.5 4.4 1.2 1.4 0.5 3.2 0.9 1.1 0.7 3.2 0.7 1.2 0.9 0.3 7.6 7.6 14.3 9.3 7.7 7.3 8.0 7.4 6.9 7.4 8.9 11.1 18.8 25.6 16.2 58.8 82.0 15.3 6.7 7.8 25.6 21.9 10.5 6.6 17.5 11.5 10.6 11.0 16.7 8.1 14.4 8.1 5.9 5.4 10.4 11.3 19.4 18.8 18.6 25.5 72.6 4.3 5.7 15.7 16.3 21.7 36.1 18.0 18.2 19.4 14.4 10.1 67.9 9.6 4.1 29.9 32.5 8.3 18.6 28.5 10.6 48.7 19.1 13.5 16.5 80.9 81.7 8.5 5.9 13.5 10.3 18.1 14.3 9.9 9.2 19.7 13.1 15.4 18.9 30.5 23.0 14.8 15.3 7.3 21.5 13.3 8.8 11.4 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 80.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 80.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 19.3 16.5 9.3 17.6 14.2 48.7 24.1 20.7 10.9 16.4 17.0 23.9 30.5 23.6 25.0 24.7 18.1 17.1 14.1 9.5 9.7 16.9 20.5 20.4 18.2 12.3 10.4 31.2 15.5 22.3 10.1 24.7 12.7 20.3 30.0 26.7 16.3 15.4 9.8 20.3 30.8 18.5 10.1 19.0 20.9 10.5 12.6 17.8 26.1 13.4 17.4 21.3 15.4 17.6 61.1 23.8 45.2 27.3 29.8 33.6 29.6 35.3 32.2 38.5 39.8 25.3 42.5 23.9 41.0 33.6 47.3 46.7 44.7 26.6 52.4 8.6 33.0 17.7 49.3 21.4 26.2 17.6 5.1 27.7 27.1 30.2 36.3 30.6 44.7 18.6 29.9 16.8 42.2 12.2 20.5 15.2 22.8 23.1 27.1 19.3 68.8 9.8 34.3 117.9 22.0 14.5 52.7 29.8 45.7 33.9 22.5 15.7 42.2 32.5 29.2 42.1 37.2 9.2 8.6 16.6 13.6 17.1 12.6 15.3 9.9 16.6 5.7 5.9 5.1 8.0 5.1 5.3 5.0 9.3 6.6 5.6 80.5 3.5 8.0 8.6 4.6 2.7 9.3 14.2 20.7 10.9 9.5 9.7 12.3 10.4 12.7 10.1 12.6 17.6 104.7 41.7 57.8 102.5 52.5 48.4 44.3 33.3 75.1 85.4 60.2 67.9 50.8 38.6 47.9 69.9 89.6 42.9 48.1 101.5 11.7 61.2 2.6 63.7 68.7 59.5 44.3 57.7 134.2 60.7 33.1 53.1 85.6 84.6 15.8 107.0 47.5 39.4 24.2 65.6 130.8 64.3 32.6 35.8 27.9 6.6 54.3 44.9 32.0 178.0 57.3 50.5 22.6 117.1 146.4 77.6 98.1 48.2 54.8 64.7 84.0 26.7 49.1 150.5 39.5 62.8 55.5 43.6 34.6 83.0 52.4 37.4 44.8 90.2 65.0 124.2 PMS2 "H_DJ0042M02.9, HNPCC4, MLH4, PMSL2" ENSG00000122512 "PMS1 homolog 2, mismatch repair system component" P54278 7 5970925-6009106 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010235, HPA066490, HPA070310" Approved Enhanced Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250" "unprognostic (5.13e-2)" "unprognostic (6.55e-3)" "unprognostic (1.54e-1)" "unprognostic (1.43e-3)" "unprognostic (5.14e-2)" "unprognostic (1.29e-1)" "unprognostic (7.36e-2)" "unprognostic (1.02e-1)" "unprognostic (7.43e-2)" "unprognostic (2.35e-1)" "unprognostic (1.86e-1)" "unprognostic (7.38e-2)" "prognostic favorable (1.23e-5)" "unprognostic (5.31e-2)" "unprognostic (2.01e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-2)" 5.3 5.1 6.7 5.3 7.2 5.8 6.5 6.3 7.6 4.8 2.8 4.8 5.7 4.9 5.0 5.3 5.7 4.0 4.1 7.4 5.8 10.4 4.7 4.4 8.4 5.3 5.6 5.7 3.9 11.0 4.6 4.8 5.5 5.2 4.7 8.4 5.7 5.5 4.5 11.9 5.3 5.3 4.4 5.9 5.0 4.0 5.2 8.8 9.2 3.5 8.9 5.1 4.9 7.0 15.1 16.7 12.9 32.2 9.0 13.6 10.9 7.8 5.8 6.6 5.6 14.0 9.9 28.2 8.7 10.9 17.2 19.6 19.2 6.6 8.0 11.3 7.2 12.0 12.5 10.1 15.9 15.8 9.4 15.1 14.8 5.4 22.3 11.4 13.7 15.2 22.9 12.6 11.9 15.5 5.2 17.1 13.3 7.6 9.6 16.3 15.3 14.0 16.4 11.0 11.9 25.7 13.3 23.0 16.2 18.0 27.1 11.8 12.4 9.3 21.2 14.2 14.6 19.8 32.8 27.5 7.2 15.3 22.9 5.0 2.9 1.9 4.5 4.1 4.9 3.4 3.5 3.8 3.0 3.4 4.4 3.4 1.4 2.3 1.8 3.1 3.4 3.4 6.7 7.2 6.3 7.6 7.4 5.8 5.3 5.6 5.5 4.4 5.2 7.0 12.2 12.8 8.2 11.4 13.6 5.0 9.3 10.9 15.9 13.2 10.7 11.3 3.2 12.8 9.7 11.0 22.9 9.4 15.2 1.8 35.2 5.5 9.9 11.0 14.6 10.1 5.4 8.4 14.0 3.3 6.3 6.6 8.2 11.8 5.1 11.4 7.9 7.6 5.2 30.3 12.2 2.2 10.2 7.1 5.9 6.6 12.8 6.3 7.2 5.6 8.7 7.8 20.6 3.5 8.3 4.7 2.6 10.1 9.6 12.6 2.2 39.5 9.3 14.3 26.3 10.0 8.0 34.5 11.7 10.5 8.1 12.7 11.4 11.9 2.6 11.1 PNRC2 ENSG00000189266 "Proline rich nuclear receptor coactivator 2" Q9NPJ4 1 23956839-23963462 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027820, HPA045837" Uncertain Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Golgi apparatus" "HPA027820: AB_10602147, HPA045837: AB_2679467" "prognostic favorable (6.02e-4)" "unprognostic (5.99e-2)" "unprognostic (3.15e-3)" "unprognostic (2.10e-2)" "unprognostic (3.58e-1)" "unprognostic (4.45e-3)" "prognostic unfavorable (7.97e-5)" "unprognostic (4.05e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.92e-3)" "unprognostic (1.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-1)" "unprognostic (4.44e-2)" "prognostic favorable (4.05e-4)" 82.7 82.5 49.5 80.6 52.1 141.0 78.5 53.4 62.0 69.6 56.1 98.1 99.5 87.4 68.6 62.8 58.3 80.5 75.2 49.6 51.9 99.6 66.8 76.0 137.0 52.6 50.7 79.3 52.2 94.3 34.8 103.3 54.4 70.5 92.2 56.2 55.0 56.9 49.8 46.1 84.2 71.8 50.9 87.5 81.9 33.7 51.9 133.5 122.2 63.6 109.5 100.1 51.4 57.8 107.8 42.0 179.5 124.9 121.5 110.7 68.6 116.7 103.7 132.7 106.1 122.7 132.5 291.7 111.5 74.8 49.9 93.5 121.6 101.8 146.7 208.6 78.7 277.5 131.8 130.2 103.3 272.1 122.3 83.9 125.8 109.2 101.0 86.8 130.3 148.4 239.6 159.5 79.0 87.5 169.4 103.3 243.8 101.7 76.5 189.7 116.7 125.0 134.8 113.8 107.4 93.5 101.0 85.7 123.7 130.9 93.6 168.6 105.3 85.6 82.2 84.6 75.4 133.7 164.8 197.6 58.0 259.0 89.8 230.8 112.7 126.8 103.5 115.0 108.8 129.1 112.5 112.2 109.1 131.1 124.9 106.8 74.2 108.6 112.2 77.4 129.4 178.3 49.5 52.1 53.4 62.0 49.6 51.9 52.6 50.7 54.4 50.9 51.9 57.8 119.0 185.9 109.2 11.4 122.5 13.3 231.7 2.0 99.0 33.6 110.5 109.6 84.8 58.6 62.2 62.5 18.8 129.8 104.7 160.5 238.7 90.5 6.9 86.0 96.1 97.3 100.4 157.0 7.9 127.8 101.4 128.7 66.3 130.9 76.5 84.1 86.7 30.0 68.6 20.2 6.4 109.3 0.0 82.3 10.9 14.2 78.9 109.0 1.8 13.1 81.8 66.9 127.7 6.0 11.8 119.2 157.7 81.3 48.8 187.6 90.3 112.0 56.1 28.7 46.0 104.3 104.5 21.2 24.4 97.8 12.6 141.7 104.0 203.9 110.2 314.0 POGLUT1 "9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi" ENSG00000163389 "Protein O-glucosyltransferase 1" Q8NBL1 3 119468963-119494708 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Gastrulation "Developmental protein, Glycosyltransferase, Transferase" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 81.2;monocytes: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037855, HPA037856" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Endoplasmic reticulum" "HPA037855: AB_10672728, HPA037856: AB_2732477" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-1)" "unprognostic (2.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (6.52e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.02e-7)" "unprognostic (3.08e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-3)" "prognostic favorable (2.23e-4)" 6.8 7.2 5.9 7.8 6.1 3.1 7.7 6.0 8.2 7.1 6.9 6.8 4.2 9.0 7.8 5.6 6.0 4.7 5.9 5.9 7.2 5.7 6.6 5.6 10.8 6.6 6.5 5.5 7.9 9.5 4.9 8.2 6.6 5.4 7.2 4.2 4.6 11.6 3.2 10.0 7.8 10.4 6.1 9.0 5.4 2.5 7.2 9.7 5.6 3.4 10.8 8.5 6.3 6.7 10.8 7.1 11.7 13.1 29.5 16.8 8.6 16.7 16.7 12.3 18.4 11.5 6.9 16.5 22.2 21.4 10.6 11.9 15.9 16.8 20.4 14.4 10.6 19.3 11.1 12.9 19.1 21.3 21.7 17.5 9.6 13.3 18.0 15.7 15.5 11.2 10.5 19.7 13.9 10.9 12.5 20.7 12.4 18.6 13.8 12.2 12.2 24.0 11.6 13.9 12.7 20.0 8.1 4.9 13.4 11.7 13.2 17.8 19.7 13.1 8.0 3.8 8.9 27.1 25.2 21.7 11.1 20.6 18.8 2.9 16.4 13.9 16.2 15.7 18.7 13.9 18.2 17.0 20.7 10.1 21.1 20.0 1.2 29.5 10.8 11.5 22.3 15.0 5.9 6.1 6.0 8.2 5.9 7.2 6.6 6.5 6.6 6.1 7.2 6.7 19.1 0.0 6.2 11.4 15.7 16.8 7.3 17.4 16.5 13.6 9.7 8.5 5.2 14.3 10.1 20.2 6.2 10.6 17.1 5.2 0.0 6.9 0.7 5.5 19.3 16.1 9.5 8.4 32.7 5.3 14.7 14.5 9.2 7.0 17.7 11.3 13.6 12.5 8.4 5.0 31.6 11.7 22.4 11.9 81.2 0.2 8.7 16.6 12.4 6.5 151.4 10.3 21.6 23.6 25.8 5.0 8.3 17.0 14.1 8.0 8.5 6.0 6.5 13.0 13.1 16.7 13.4 1.5 1.5 13.9 14.9 6.6 15.5 17.4 13.9 5.9 POLA1 "NSX, p180, POLA" ENSG00000101868 "DNA polymerase alpha 1, catalytic subunit" P09884 X 24693873-24996986 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "DNA replication, Host-virus interaction" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease variant, Dwarfism, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Excitatory neurons: 42.3;Inhibitory neurons: 65.7;Microglial cells: 57.1;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 97.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002947, CAB012274" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "CAB012274: , HPA002947: AB_1079652" "unprognostic (6.92e-2)" "unprognostic (4.43e-3)" "unprognostic (3.27e-3)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.87e-1)" "unprognostic (9.25e-3)" "unprognostic (2.48e-2)" "unprognostic (8.41e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-2)" "unprognostic (3.08e-1)" 3.7 2.0 1.9 4.8 2.5 7.3 5.1 2.2 1.8 4.3 0.8 4.1 2.4 4.2 1.4 3.9 3.7 2.1 3.5 1.3 1.9 2.9 2.0 3.1 6.8 2.3 2.3 5.8 2.8 3.4 1.8 5.6 2.4 3.1 5.2 3.7 3.0 3.5 4.9 4.0 3.5 4.8 2.2 3.5 3.7 2.6 2.1 11.9 3.1 3.1 7.7 3.7 3.8 2.6 32.7 24.6 30.3 24.1 5.2 6.5 6.9 23.6 12.7 25.0 28.3 20.4 17.0 41.1 7.7 9.6 23.4 26.0 59.7 18.7 33.6 21.1 24.8 31.0 42.8 13.5 2.4 41.6 15.5 4.1 3.6 31.2 8.4 5.8 13.0 20.8 28.7 20.0 16.8 22.4 45.2 7.2 30.7 20.3 19.1 39.0 81.5 30.7 7.1 21.1 27.9 16.7 28.1 11.2 11.6 33.0 25.7 11.5 10.1 21.3 14.9 42.4 22.6 11.6 18.1 32.7 12.4 18.3 24.9 0.0 0.2 0.2 0.6 1.4 0.8 1.0 0.8 1.0 0.7 0.4 0.4 0.5 0.0 0.8 0.2 0.2 0.9 0.5 1.9 2.5 2.2 1.8 1.3 1.9 2.3 2.3 2.4 2.2 2.1 2.6 5.8 9.6 6.5 38.5 5.2 2.8 4.6 1.8 5.7 3.9 4.7 4.3 11.8 0.0 7.2 1.8 2.1 6.1 3.2 2.5 3.9 3.2 0.2 3.2 4.7 6.3 4.2 24.2 42.3 3.0 4.9 4.6 4.6 3.8 9.5 8.3 3.3 3.4 4.4 1.7 65.7 4.2 4.1 4.4 1.5 1.7 6.2 4.5 0.0 57.1 3.7 4.8 5.2 59.3 97.7 1.4 1.2 3.4 8.6 2.0 2.3 1.6 6.1 7.4 6.6 9.2 6.0 6.4 4.5 5.5 2.3 2.3 4.9 5.0 4.2 2.4 POM121C ENSG00000272391 "POM121 transmembrane nucleoporin C" A8CG34 7 75416786-75486299 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043809, HPA049817" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (9.11e-2)" "unprognostic (1.27e-1)" "unprognostic (2.85e-1)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-2)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-3)" "unprognostic (2.03e-1)" "unprognostic (5.06e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-1)" "unprognostic (1.44e-2)" "unprognostic (4.00e-2)" 14.9 14.0 3.5 15.5 3.8 28.9 14.2 8.0 9.3 13.8 2.4 14.2 12.0 16.6 9.0 15.9 14.1 12.0 13.9 7.0 4.9 13.1 13.2 12.9 18.2 2.2 3.1 18.7 18.1 16.8 13.4 16.4 2.0 13.0 12.9 26.3 14.3 11.5 19.6 17.7 14.0 15.1 0.3 15.5 14.0 12.5 5.2 17.6 16.7 10.7 19.9 14.3 14.3 5.5 41.8 34.1 46.3 89.0 17.1 19.0 30.4 29.7 27.3 23.7 22.8 41.2 26.5 73.4 12.0 32.6 37.2 36.7 39.6 36.7 38.9 49.9 55.1 36.4 39.6 27.8 22.5 97.0 49.5 16.2 22.8 36.3 26.8 34.5 24.6 29.9 103.8 39.8 38.9 41.8 59.5 49.3 36.9 32.0 38.4 53.0 30.7 37.6 13.1 56.0 51.4 67.4 34.3 54.0 23.8 41.5 47.1 34.2 27.4 57.4 30.6 42.2 62.3 42.4 54.4 88.2 37.3 49.1 53.9 0.2 0.4 0.5 1.1 0.5 1.0 0.8 0.9 0.3 0.3 1.0 0.5 0.6 1.2 0.9 0.3 1.1 0.2 0.6 3.5 3.8 8.0 9.3 7.0 4.9 2.2 3.1 2.0 0.3 5.2 5.5 23.1 35.3 26.2 29.4 27.8 18.0 11.8 13.4 33.6 30.7 21.3 23.4 12.6 21.5 21.4 12.9 68.8 13.4 27.2 12.3 5.9 11.8 2.1 14.2 21.3 20.7 28.7 33.9 59.2 17.1 10.2 21.0 31.6 18.3 7.6 28.6 16.8 15.1 12.0 25.2 60.2 17.4 14.2 16.4 15.8 3.8 18.0 21.7 7.2 35.6 17.1 21.3 37.0 28.1 45.6 18.8 8.0 15.4 37.8 24.6 10.0 9.6 18.7 29.4 13.1 26.1 17.4 19.2 12.4 32.9 18.5 17.0 34.0 22.0 17.0 19.7 POP1 ENSG00000104356 "POP1 homolog, ribonuclease P/MRP subunit" Q99575 8 98117293-98159835 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066194 Supported Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA066194: AB_2732742" "prognostic unfavorable (2.54e-4)" "unprognostic (9.42e-2)" "unprognostic (5.96e-3)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.26e-6)" "prognostic unfavorable (9.88e-4)" "unprognostic (4.85e-1)" "unprognostic (1.47e-1)" "unprognostic (3.79e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-1)" 2.1 1.6 1.7 3.5 1.5 1.5 2.1 3.4 2.3 1.4 1.2 1.9 1.5 1.7 1.4 3.0 1.8 1.3 1.6 1.3 1.2 2.0 1.9 1.6 3.6 1.1 1.4 2.9 1.7 1.7 1.5 1.2 1.1 1.5 4.8 2.4 1.4 1.3 1.7 3.0 1.6 1.8 0.8 2.1 1.9 3.1 1.6 2.6 1.5 1.2 4.4 2.5 1.5 1.8 21.9 12.9 13.8 12.8 4.8 3.3 9.1 18.3 15.2 18.7 13.8 13.4 13.8 15.3 25.6 12.9 9.0 14.3 40.3 18.2 18.9 11.1 17.0 30.0 10.2 9.2 2.1 16.4 18.4 2.8 3.3 20.8 8.2 5.7 14.8 7.2 17.0 13.5 17.7 17.4 23.8 8.3 10.4 25.1 17.6 19.4 7.5 11.0 13.5 11.5 32.8 7.7 8.4 14.2 6.4 7.9 19.2 6.0 18.4 16.3 11.6 20.8 36.5 13.3 13.6 32.7 12.8 17.3 14.6 9.4 5.1 3.9 7.4 5.7 6.0 4.9 5.4 5.0 5.0 8.1 6.8 6.5 0.8 3.8 2.9 6.2 4.9 2.1 1.7 1.5 3.4 2.3 1.3 1.2 1.1 1.4 1.1 0.8 1.6 1.8 2.3 3.2 3.9 10.7 4.7 3.7 8.2 3.8 4.0 7.0 2.5 2.3 3.9 0.0 3.8 5.5 0.0 4.1 4.1 2.7 5.9 8.8 13.8 2.4 6.4 4.2 0.0 5.0 17.7 5.9 3.4 5.8 6.6 2.9 1.3 5.9 1.8 5.4 3.4 1.7 19.0 1.7 2.0 2.4 0.8 3.0 5.3 3.3 0.0 3.7 7.9 2.7 10.3 8.5 11.0 7.8 1.0 4.5 5.2 4.8 1.1 8.5 2.6 9.5 6.6 4.0 6.1 7.7 19.1 9.8 2.4 3.0 4.4 6.1 3.9 5.1 PPHLN1 ENSG00000134283 "Periphilin 1" Q8NEY8 12 42238447-42459715 "Predicted intracellular proteins" "Keratinization, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 337.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038902, HPA038903" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Golgi apparatus" "HPA038902: AB_10674844, HPA038903: AB_2676263" "unprognostic (4.06e-2)" "unprognostic (1.66e-1)" "unprognostic (6.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.80e-1)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.28e-7)" "unprognostic (2.85e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-2)" "unprognostic (1.58e-1)" "unprognostic (4.42e-3)" "prognostic unfavorable (5.06e-5)" "unprognostic (3.16e-1)" "unprognostic (3.08e-1)" "unprognostic (3.22e-3)" "unprognostic (2.04e-2)" 26.0 30.5 21.9 34.9 23.2 51.9 33.2 23.4 26.6 27.7 22.1 29.0 23.2 31.0 31.9 28.2 28.3 28.6 35.7 23.3 22.9 30.1 30.5 28.0 58.4 17.7 19.7 34.1 19.2 25.9 22.9 29.8 20.4 26.0 31.7 25.8 25.9 28.3 34.1 25.9 28.8 33.9 18.9 36.2 25.7 56.1 23.5 52.8 27.4 31.2 59.1 37.0 22.4 23.3 60.7 54.7 63.5 53.4 56.0 61.3 55.8 68.3 79.1 71.8 59.1 89.1 74.3 99.0 86.4 74.6 33.9 53.6 66.2 72.4 87.6 87.3 68.9 159.5 53.8 81.9 58.8 190.4 88.0 74.4 71.9 57.5 54.6 80.3 89.5 87.3 79.2 76.0 78.9 46.3 107.8 111.7 55.0 166.0 54.2 90.4 73.7 93.3 111.7 50.7 44.7 66.0 61.1 48.7 60.1 60.7 75.1 90.7 63.1 41.5 74.5 39.9 60.7 87.4 129.9 163.3 69.8 337.5 27.7 51.7 23.9 44.1 32.7 26.7 39.4 44.3 41.9 44.5 43.8 35.8 37.9 38.1 14.9 44.6 25.9 41.5 61.5 22.6 21.9 23.2 23.4 26.6 23.3 22.9 17.7 19.7 20.4 18.9 23.5 23.3 28.9 41.7 51.8 46.0 78.4 75.8 68.1 116.9 44.9 60.2 30.8 31.0 32.5 40.0 70.7 42.3 29.2 88.1 77.4 31.8 37.2 62.3 243.3 47.5 56.1 48.1 33.6 58.5 128.7 68.3 75.4 47.0 24.5 60.7 57.0 238.1 36.0 35.5 52.9 37.0 93.2 35.8 71.2 40.6 65.4 76.7 58.4 49.1 64.0 49.6 92.9 46.3 72.1 64.3 85.0 71.4 42.1 52.3 63.4 46.4 45.8 55.6 58.6 60.5 52.6 44.6 47.9 120.3 58.8 50.3 59.1 44.2 81.8 84.0 42.4 50.7 PPIL3 CyPJ ENSG00000240344 "Peptidylprolyl isomerase like 3" Q9H2H8 2 200870907-200889303 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040765, HPA062187" Approved Approved Nucleoplasm,Nucleoli NA NA 120000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA040765: AB_2677125, HPA062187: AB_2684706" "unprognostic (8.96e-3)" "unprognostic (6.07e-2)" "unprognostic (5.34e-2)" "unprognostic (8.16e-2)" "unprognostic (2.69e-2)" "unprognostic (9.61e-2)" "unprognostic (8.31e-2)" "unprognostic (8.05e-2)" "unprognostic (1.40e-2)" "prognostic favorable (1.19e-4)" "unprognostic (5.23e-2)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" "unprognostic (2.21e-2)" "unprognostic (4.87e-2)" 13.0 16.4 15.2 19.8 14.9 35.1 25.4 17.0 22.3 15.7 13.9 19.0 14.6 20.2 28.4 18.6 22.5 13.0 18.2 14.6 16.8 18.4 21.9 15.0 32.2 15.7 15.5 35.4 12.1 14.0 14.9 17.7 16.8 15.1 19.5 25.8 17.1 18.2 18.0 18.0 18.1 12.4 15.4 17.5 19.0 21.1 15.5 30.1 20.8 11.1 32.5 16.2 12.5 18.2 19.9 18.3 53.0 23.5 42.5 90.8 17.5 32.0 35.3 37.1 37.2 13.0 37.5 19.5 32.0 35.4 41.9 24.6 19.3 38.1 33.2 41.4 43.8 84.0 48.3 90.6 21.3 79.7 39.8 32.7 37.7 30.3 47.1 62.0 25.3 38.4 67.4 46.3 46.3 32.4 61.7 67.2 32.9 19.8 28.9 23.3 30.5 29.1 49.6 30.4 22.2 21.1 31.3 29.9 51.7 62.3 24.6 36.9 34.2 51.4 28.8 31.2 26.2 45.5 51.0 94.2 39.6 36.2 33.7 36.2 17.5 19.7 17.5 16.4 25.5 35.2 20.9 17.7 30.9 26.7 25.3 27.6 4.5 31.8 23.1 25.6 30.3 14.6 15.2 14.9 17.0 22.3 14.6 16.8 15.7 15.5 16.8 15.4 15.5 18.2 12.5 0.0 11.5 16.0 33.6 31.7 43.1 71.5 37.5 12.0 23.7 28.2 18.5 15.7 30.4 16.5 10.4 50.3 24.8 9.7 56.7 26.0 44.1 16.1 21.4 16.2 9.5 25.5 19.3 16.1 51.6 22.1 16.3 13.4 26.0 17.2 13.6 19.4 47.0 3.3 18.1 25.3 48.8 32.1 59.1 9.5 36.7 26.8 28.4 9.4 30.2 23.1 37.0 15.1 19.7 18.2 18.1 28.2 24.5 15.9 25.4 59.7 28.7 11.9 19.7 18.2 39.6 45.7 22.6 34.5 46.3 30.8 31.1 8.9 29.4 35.6 PPIL4 ENSG00000131013 "Peptidylprolyl isomerase like 4" Q8WUA2 6 149504495-149546043 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, RNA-binding, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031599, HPA031600" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "HPA031599: AB_2673950, HPA031600: AB_10600928" "unprognostic (6.12e-2)" "unprognostic (4.90e-2)" "unprognostic (3.85e-2)" "unprognostic (8.42e-2)" "unprognostic (7.53e-2)" "unprognostic (6.36e-3)" "unprognostic (2.91e-3)" "unprognostic (2.22e-1)" "unprognostic (4.22e-2)" "unprognostic (1.09e-1)" "unprognostic (2.38e-1)" "unprognostic (4.62e-2)" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (8.50e-2)" "unprognostic (7.94e-2)" 19.6 19.2 12.3 15.6 15.0 36.4 20.3 19.8 18.3 18.1 9.6 15.4 14.2 20.1 25.7 13.7 16.5 18.9 15.9 13.1 18.0 17.9 22.9 16.1 17.2 10.6 12.8 27.3 14.8 18.8 18.8 22.7 10.9 19.2 16.0 13.1 15.8 15.2 10.7 14.4 14.6 14.7 11.1 17.4 16.4 16.3 17.0 18.5 25.7 11.5 17.1 20.9 16.9 15.8 22.7 12.0 41.0 34.7 23.8 30.9 38.1 43.8 41.1 46.4 49.2 25.1 22.8 23.8 29.4 33.9 27.9 20.1 31.5 16.5 73.1 34.7 29.7 26.4 27.0 43.9 37.3 49.2 21.6 24.3 27.8 47.6 39.7 26.2 25.7 17.1 58.1 14.0 36.5 24.2 28.1 41.8 32.6 22.6 18.5 37.2 37.7 11.9 35.6 17.0 24.1 18.4 52.0 22.4 31.7 28.2 26.5 35.1 31.0 30.8 24.3 55.1 42.3 18.4 9.9 37.0 26.3 38.7 45.5 34.1 17.1 20.4 15.1 19.9 21.0 23.7 19.5 17.5 18.2 17.9 24.5 18.8 14.5 32.0 19.3 17.9 23.7 16.5 12.3 15.0 19.8 18.3 13.1 18.0 10.6 12.8 10.9 11.1 17.0 15.8 54.8 67.3 70.7 25.1 49.7 48.8 56.4 49.0 30.7 46.2 29.5 34.9 45.6 18.6 59.7 46.0 8.4 50.4 48.4 16.9 43.0 42.0 24.4 57.6 55.7 43.2 23.3 25.4 37.3 26.3 46.2 76.2 20.9 48.2 77.1 30.9 33.5 21.3 37.3 28.6 34.7 22.9 48.8 25.2 43.8 12.0 61.8 38.3 40.9 21.5 45.5 42.0 28.8 27.2 41.1 32.2 21.9 56.1 29.4 33.8 19.7 37.6 71.9 37.1 52.6 66.1 70.5 75.9 59.3 22.5 45.3 65.3 53.4 47.7 22.3 43.0 PPIP5K2 "CFAP160, DFNB100, HISPPD1, KIAA0433, VIP2" ENSG00000145725 "Diphosphoinositol pentakisphosphate kinase 2" O43314 5 103120149-103212799 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hearing "Kinase, Transferase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 160.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037895, HPA038442" Approved Approved Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA037895: AB_2675724, HPA038442: AB_10673173" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (1.93e-1)" "unprognostic (8.83e-2)" "unprognostic (1.60e-3)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.60e-2)" "unprognostic (8.59e-3)" "unprognostic (1.39e-1)" "unprognostic (2.12e-1)" "unprognostic (4.32e-2)" "unprognostic (1.29e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (8.80e-2)" 15.7 19.1 6.8 22.0 7.9 51.6 25.1 18.9 13.9 22.2 5.8 28.1 18.3 20.6 21.2 17.1 14.5 20.4 19.5 6.7 8.9 20.3 29.2 16.2 25.5 15.4 11.9 26.1 26.7 23.0 18.1 16.7 15.1 16.3 25.5 19.2 17.1 15.4 4.2 17.2 16.5 18.4 6.1 23.9 22.5 15.1 7.3 27.9 23.3 7.7 24.5 17.8 13.9 10.7 27.4 25.3 50.8 65.2 40.8 53.4 47.8 63.5 39.3 34.2 47.6 20.9 48.3 67.6 56.2 60.9 52.7 16.5 43.9 33.2 57.5 53.7 23.5 84.7 44.3 33.4 29.0 72.1 70.4 34.5 23.4 52.0 46.1 31.2 40.0 42.5 84.9 57.0 53.1 21.3 60.9 44.6 55.4 12.7 64.4 58.6 46.7 89.3 36.8 31.5 29.6 40.1 43.5 39.9 40.7 34.0 33.5 48.9 42.7 55.8 25.7 56.0 45.1 38.1 87.3 91.3 31.5 116.0 51.2 41.7 21.5 39.6 13.0 22.9 15.8 19.5 12.6 14.2 25.6 16.1 16.1 17.0 19.7 17.8 32.4 15.5 12.3 11.1 6.8 7.9 18.9 13.9 6.7 8.9 15.4 11.9 15.1 6.1 7.3 10.7 35.8 48.1 23.1 49.3 39.3 13.6 12.8 13.7 31.9 38.5 26.1 26.4 48.9 18.6 29.6 16.5 45.9 12.7 35.7 29.7 5.9 11.6 5.6 25.4 44.7 28.7 16.3 70.7 88.4 17.0 19.2 33.0 33.6 30.6 43.6 49.2 14.6 20.6 30.6 16.8 160.3 24.2 16.2 39.5 22.4 6.7 29.5 43.3 12.4 49.6 47.5 14.5 27.8 62.8 67.0 16.9 19.1 23.7 56.6 12.1 13.3 22.6 25.1 25.2 6.6 30.3 28.1 39.7 21.6 31.6 15.8 26.0 31.6 38.7 30.1 12.6 PPP1R8 "ard-1, ARD1, NIPP-1, NIPP1, PRO2047" ENSG00000117751 "Protein phosphatase 1 regulatory subunit 8" Q12972 1 27830782-27851676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027406, HPA027417, HPA027452" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles" Nucleoplasm "HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490" "unprognostic (5.61e-2)" "unprognostic (2.55e-1)" "unprognostic (4.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-2)" "unprognostic (9.09e-3)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.82e-2)" "unprognostic (2.14e-3)" "unprognostic (2.20e-1)" "unprognostic (3.16e-2)" "unprognostic (9.16e-2)" "unprognostic (6.26e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-2)" "unprognostic (4.86e-2)" "unprognostic (2.58e-2)" 24.0 17.1 23.7 23.8 26.3 38.8 27.2 26.0 27.8 25.1 20.8 23.3 19.6 28.4 21.3 26.1 26.7 20.8 23.8 22.9 25.1 19.6 21.5 21.1 35.5 25.0 25.0 33.0 20.7 25.2 15.8 25.2 25.7 21.0 25.1 28.0 18.9 25.7 25.3 23.2 21.4 30.6 26.0 25.9 19.7 24.0 24.2 41.0 25.2 37.0 36.4 29.5 20.5 30.5 57.8 40.0 85.3 55.8 52.6 54.7 48.9 60.5 63.3 101.5 81.6 45.2 64.5 81.9 41.6 69.3 39.5 50.9 101.3 56.6 73.2 69.3 61.7 107.2 53.3 67.2 52.9 99.9 73.0 48.0 60.7 92.4 81.8 45.4 61.3 68.9 92.4 54.3 61.2 37.6 109.6 58.6 105.9 50.7 46.2 88.4 70.5 78.2 54.9 52.2 59.5 54.0 74.5 57.5 73.4 43.5 50.5 61.7 50.9 49.6 45.3 78.9 57.2 50.0 82.2 102.8 48.5 127.6 65.0 17.2 9.1 8.5 12.4 9.5 14.3 9.8 9.7 13.7 8.8 9.9 10.5 10.2 5.4 14.3 11.4 6.7 10.8 13.2 23.7 26.3 26.0 27.8 22.9 25.1 25.0 25.0 25.7 26.0 24.2 30.5 11.3 16.0 10.0 2.9 21.3 17.3 21.4 33.4 7.4 22.0 12.0 9.8 13.4 8.6 24.2 5.5 2.1 47.6 19.6 15.4 31.3 30.6 33.7 9.8 15.2 17.8 11.5 20.6 8.4 25.9 41.2 17.1 12.2 11.1 26.0 16.8 19.6 20.2 26.3 8.4 8.6 15.0 28.5 18.0 11.5 30.0 23.9 14.1 10.6 4.7 35.6 21.5 25.7 10.6 16.0 31.9 14.7 17.0 14.3 24.6 14.3 25.7 18.1 16.9 26.3 16.2 20.0 35.4 43.2 16.5 14.1 43.9 17.4 28.8 16.2 21.2 PPP2CA "PP2AC, PP2Calpha" ENSG00000113575 "Protein phosphatase 2 catalytic subunit alpha" P67775 5 134194332-134226073 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Meiosis "Hydrolase, Protein phosphatase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003848, HPA043236" Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 22: Epithelial cell types - Mixed function" "CAB003848: AB_562203, HPA043236: AB_2678379" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "unprognostic (1.60e-2)" "unprognostic (3.35e-3)" "unprognostic (1.26e-1)" "unprognostic (3.21e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.59e-3)" "unprognostic (1.57e-1)" "unprognostic (2.02e-1)" "unprognostic (1.34e-2)" "unprognostic (1.31e-1)" "unprognostic (5.24e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" 47.9 53.1 52.1 42.9 55.1 124.8 46.6 60.6 66.3 38.9 44.9 51.4 46.1 46.6 36.1 71.5 39.0 44.6 90.1 57.8 53.5 57.3 62.1 39.4 58.6 48.6 51.4 30.0 44.3 87.1 26.1 52.2 53.7 37.8 47.1 58.6 36.5 40.4 75.3 54.1 44.5 57.8 54.7 40.0 41.3 34.7 53.6 92.4 48.1 73.1 76.7 75.4 41.0 59.5 157.0 128.8 180.8 97.9 92.1 98.2 126.2 144.1 123.3 214.8 215.4 249.1 119.6 136.5 131.7 134.4 242.9 79.7 175.6 208.6 250.2 123.9 100.1 96.9 142.4 156.5 136.3 97.1 84.2 91.7 141.5 169.0 166.6 107.0 153.5 135.1 97.2 99.1 165.1 112.5 154.9 95.0 98.9 123.6 77.3 136.5 179.6 132.6 130.0 173.4 142.9 99.6 148.9 55.1 166.9 179.7 112.2 112.3 109.2 123.3 69.1 99.6 206.5 88.5 171.6 217.0 83.2 125.9 130.3 43.0 64.7 75.6 46.8 63.1 59.2 53.1 53.2 62.5 77.3 54.7 60.6 57.2 71.3 75.5 67.0 41.5 72.4 95.8 52.1 55.1 60.6 66.3 57.8 53.5 48.6 51.4 53.7 54.7 53.6 59.5 58.7 51.3 47.6 27.1 103.3 239.0 187.4 90.1 121.8 43.9 93.6 53.0 111.2 55.8 63.1 57.0 22.9 152.1 89.0 68.7 107.6 109.7 34.6 85.8 83.2 81.1 87.1 89.0 36.6 87.6 171.3 78.0 77.5 106.1 62.2 44.6 51.8 65.9 111.4 50.5 35.7 62.0 69.2 88.2 194.6 29.8 38.5 95.8 104.9 24.4 115.6 62.9 51.5 36.7 48.9 101.7 56.6 45.5 120.9 143.3 64.9 114.8 53.0 31.4 19.7 76.8 97.6 91.4 85.8 112.4 234.4 309.8 110.6 53.3 69.7 176.7 PPP4R3B "FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2" ENSG00000275052 "Protein phosphatase 4 regulatory subunit 3B" Q5MIZ7 2 55547292-55618880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001233, CAB017185" Approved Supported "Nucleoplasm,Nuclear speckles,Centrosome" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" Centrosome "CAB017185: , HPA001233: AB_1080033" "unprognostic (9.60e-2)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-2)" "unprognostic (6.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (3.27e-2)" "unprognostic (8.27e-3)" "unprognostic (7.62e-2)" "unprognostic (1.07e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (6.03e-4)" "unprognostic (9.73e-2)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" 29.0 27.4 14.8 28.2 15.1 25.8 29.1 20.9 16.9 26.8 20.0 28.1 31.6 23.7 19.3 31.7 32.3 24.7 14.3 13.8 16.9 33.4 48.0 23.4 38.1 15.0 16.3 25.7 32.1 27.4 12.5 24.5 16.2 24.9 27.7 35.3 28.1 23.2 14.7 29.6 32.1 21.8 15.9 28.7 30.8 23.7 15.1 42.2 33.0 20.3 38.7 26.7 16.9 18.7 42.8 33.0 35.6 30.0 37.2 38.9 49.1 34.0 35.9 28.2 24.0 39.5 40.9 57.7 67.5 32.7 44.8 36.4 39.9 27.5 41.4 84.6 16.7 56.7 30.0 52.9 60.3 66.0 45.6 29.8 64.9 34.1 60.1 36.9 45.0 31.6 55.2 57.4 37.7 50.9 42.8 43.7 35.1 55.9 25.3 40.1 53.6 44.6 39.3 43.8 43.4 26.9 36.8 49.9 54.8 23.5 31.6 52.0 36.3 43.3 56.8 21.6 47.2 59.1 47.3 22.3 40.8 61.3 47.2 25.6 16.5 26.9 20.4 20.9 23.2 18.1 21.2 21.6 18.4 18.6 24.5 21.5 19.6 22.5 23.0 9.9 24.0 23.9 14.8 15.1 20.9 16.9 13.8 16.9 15.0 16.3 16.2 15.9 15.1 18.7 46.8 44.8 41.3 0.0 61.8 0.0 48.9 0.0 44.3 44.1 42.7 27.9 0.0 31.5 29.1 16.5 33.3 30.6 51.4 25.3 39.2 32.4 9.5 85.1 43.2 32.9 18.2 46.7 0.0 41.0 28.5 33.9 43.8 39.6 30.3 39.0 26.0 52.5 26.2 53.8 0.0 29.4 0.0 37.7 0.0 7.6 28.0 44.9 0.0 0.0 47.9 53.1 49.4 0.0 0.0 35.4 24.1 36.1 57.2 57.4 46.1 52.9 62.7 38.5 6.6 54.9 28.4 39.1 25.7 53.3 0.0 47.7 56.3 44.6 29.0 57.2 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 6600 "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030" "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 28.7 28.0 20.4 31.1 26.7 53.0 31.1 35.0 23.1 27.2 29.4 33.4 27.3 30.9 23.3 32.6 26.2 30.7 32.9 20.0 21.9 29.2 31.9 28.1 37.0 24.2 23.4 38.4 22.7 42.9 24.1 34.7 24.8 32.4 33.5 33.8 28.3 26.1 48.8 29.9 31.0 34.5 21.8 32.9 30.0 36.9 23.1 44.4 43.9 49.0 36.6 32.7 26.4 34.6 72.8 83.6 85.0 59.6 44.5 44.9 66.3 62.0 59.7 70.7 64.2 148.3 71.3 83.4 59.4 58.1 74.3 66.6 94.6 70.2 92.3 81.4 40.6 96.1 83.0 49.8 42.6 92.3 82.5 44.8 46.1 72.6 78.0 39.6 65.3 65.4 83.1 59.7 51.1 96.5 92.8 70.8 42.9 142.1 49.5 86.1 116.0 80.9 46.9 103.8 47.8 57.4 88.5 68.8 128.7 70.4 102.4 48.5 65.3 69.1 65.0 74.4 53.4 47.1 71.2 107.0 50.1 40.1 75.1 14.5 9.9 13.2 11.8 13.3 11.4 11.3 12.6 11.7 6.4 12.8 13.7 12.8 14.1 10.1 15.8 13.2 13.2 6.8 20.4 26.7 35.0 23.1 20.0 21.9 24.2 23.4 24.8 21.8 23.1 34.6 41.5 44.8 37.6 134.8 39.6 33.1 25.4 17.6 25.6 49.8 32.1 24.9 42.3 25.8 33.1 27.6 56.3 19.4 36.6 40.9 15.6 15.4 65.8 33.3 33.1 31.0 30.5 35.6 133.3 16.7 17.0 29.8 36.7 43.1 27.8 31.6 29.6 25.3 17.5 26.9 155.0 29.6 16.2 24.9 27.6 24.8 31.1 29.4 21.4 163.9 22.1 28.6 17.5 186.0 213.6 23.9 36.2 31.6 35.9 37.9 29.4 16.1 25.9 50.2 19.7 29.0 30.2 33.8 31.0 29.2 35.5 32.8 38.6 28.6 26.5 42.2 PPWD1 KIAA0073 ENSG00000113593 "Peptidylprolyl isomerase domain and WD repeat containing 1" Q96BP3 5 65563236-65587549 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019353, HPA019360" Enhanced Supported "Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies" "HPA019353: AB_1855668, HPA019360: AB_1855669" "unprognostic (3.31e-2)" "unprognostic (2.07e-2)" "unprognostic (6.78e-2)" "unprognostic (2.85e-1)" "unprognostic (9.61e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.37e-1)" "unprognostic (4.97e-2)" "unprognostic (1.09e-1)" "unprognostic (7.84e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.72e-4)" "unprognostic (2.40e-1)" "unprognostic (1.18e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" 15.0 12.1 12.3 18.2 14.6 27.6 17.2 16.5 16.4 17.3 13.4 14.7 13.4 19.0 17.8 13.5 16.1 15.7 13.5 12.4 13.2 13.0 15.5 14.9 30.0 13.6 12.8 22.9 14.0 15.5 14.7 19.6 13.4 15.0 19.2 14.7 12.7 13.7 13.2 22.2 17.1 13.2 12.9 22.6 14.4 18.1 13.0 32.9 16.3 15.6 26.0 13.7 15.2 18.5 36.5 23.6 35.1 35.2 30.6 36.9 38.8 34.5 25.3 36.5 45.5 37.8 35.4 41.5 28.5 24.3 49.1 32.3 38.4 35.5 49.8 35.7 32.3 26.0 40.0 31.1 25.9 23.9 26.4 29.2 15.3 35.5 25.5 27.0 32.3 31.6 35.3 28.8 28.8 35.8 40.0 31.6 24.7 15.2 13.3 35.4 46.7 35.1 21.2 29.5 18.1 14.8 34.8 14.5 33.1 26.8 21.5 30.8 24.9 20.2 29.2 22.4 52.9 17.1 26.3 45.5 22.3 35.8 21.4 35.0 15.1 31.6 26.1 19.3 32.0 25.8 29.1 29.9 21.2 19.1 36.1 31.0 14.3 26.5 24.0 11.8 38.1 23.4 12.3 14.6 16.5 16.4 12.4 13.2 13.6 12.8 13.4 12.9 13.0 18.5 25.1 28.9 22.4 28.1 36.0 12.4 14.9 15.4 18.2 14.2 9.1 12.8 19.8 7.2 22.1 11.0 8.4 27.7 27.0 6.9 9.8 8.7 76.8 16.4 28.7 20.7 9.6 21.5 37.2 7.7 14.4 21.1 15.8 13.8 11.4 32.6 18.9 6.0 11.8 6.7 46.8 14.9 8.2 16.4 11.9 41.7 20.2 15.2 14.2 23.4 22.6 11.8 23.7 42.3 67.1 8.9 14.7 18.8 29.4 6.6 10.0 7.9 17.8 20.9 6.6 19.9 17.8 32.5 33.7 13.2 11.8 25.2 35.4 15.8 11.4 9.0 PRDM10 "KIAA1231, MGC131802, PFM7" ENSG00000170325 "PR/SET domain 10" Q9NQV6 11 129899706-130002835 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026997, HPA061749" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center, Vesicles" "HPA026997: AB_1855681, HPA061749: " "unprognostic (4.40e-2)" "unprognostic (2.17e-1)" "unprognostic (5.32e-3)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (1.52e-3)" "unprognostic (2.19e-2)" "unprognostic (2.48e-1)" "unprognostic (1.87e-3)" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (5.69e-2)" "unprognostic (4.88e-1)" "unprognostic (6.23e-2)" "unprognostic (1.51e-1)" 2.8 2.4 2.5 3.1 2.5 7.9 4.2 7.4 3.3 3.2 2.8 3.4 3.4 3.0 3.3 4.0 2.6 2.8 2.0 2.9 3.4 2.2 3.5 3.0 3.9 1.8 1.8 3.4 3.1 3.4 4.6 2.6 1.9 3.4 3.9 4.7 3.1 2.5 6.7 6.2 3.7 2.5 0.9 3.1 4.0 2.4 3.3 6.7 3.0 3.8 4.0 2.6 3.4 4.0 4.7 6.1 7.7 5.1 3.4 4.1 5.1 3.9 5.0 3.2 4.1 6.2 4.8 17.8 4.5 4.6 4.4 6.1 6.4 3.2 5.2 6.6 5.5 12.3 7.5 5.0 2.2 10.9 44.8 2.9 7.1 4.8 3.1 4.9 5.7 5.0 7.0 6.6 4.7 5.2 6.7 5.7 5.9 6.3 4.4 6.5 4.8 2.9 4.7 8.0 8.3 4.3 5.7 6.4 1.7 4.3 4.5 4.8 5.7 7.2 3.4 3.8 5.1 1.7 3.0 25.1 3.2 6.1 5.9 2.4 2.2 6.0 2.6 2.5 2.6 6.8 2.1 2.2 2.1 3.6 3.1 1.4 6.3 4.4 2.7 2.1 2.9 1.4 2.5 2.5 7.4 3.3 2.9 3.4 1.8 1.8 1.9 0.9 3.3 4.0 2.7 3.2 2.7 22.5 3.2 6.1 2.6 1.8 6.8 3.7 3.5 2.2 2.7 1.5 2.0 0.0 0.0 1.5 2.5 6.3 0.0 1.2 3.0 2.9 2.7 1.8 1.8 8.6 21.3 1.1 1.2 2.7 4.6 3.2 1.3 2.7 1.1 2.3 1.6 1.7 21.2 3.1 2.0 3.1 2.9 4.1 2.5 2.8 0.0 13.1 2.1 1.0 1.0 13.6 21.6 0.9 3.2 1.9 2.4 4.6 3.1 1.0 2.3 2.7 0.0 3.9 3.4 0.8 0.8 7.2 5.1 0.5 3.5 1.7 2.7 5.8 PRIM2 PRIM2A ENSG00000146143 "DNA primase subunit 2" P49643 6 57314805-57646850 "Plasma proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 30.6" "Cell type enhanced" "Detected in many" "Microglial cells: 70.3;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046566 Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA046566: AB_2679701" "unprognostic (1.24e-1)" "unprognostic (1.55e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (3.08e-1)" "unprognostic (6.24e-2)" "prognostic unfavorable (3.44e-5)" "unprognostic (2.31e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.00e-5)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.89e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" 4.3 3.3 3.9 6.6 4.6 15.0 6.9 6.0 4.3 5.6 6.9 6.9 6.0 7.2 6.9 4.3 6.2 4.3 3.3 3.9 5.6 3.9 5.0 4.8 10.6 4.2 4.7 7.2 4.0 3.9 1.9 7.5 4.4 30.6 8.4 4.0 4.2 5.6 2.3 5.8 5.2 8.0 2.8 5.5 4.8 6.5 4.5 15.3 4.4 2.4 11.8 5.8 4.1 7.1 44.8 17.7 34.1 37.6 16.8 29.5 27.3 53.1 48.8 57.0 74.7 26.6 21.1 39.4 27.7 66.6 39.6 27.9 30.2 29.2 71.6 35.1 24.2 47.6 22.7 43.0 7.3 43.5 27.4 12.1 12.0 61.0 20.3 14.2 26.9 44.1 46.2 38.9 48.3 28.2 49.8 37.6 22.0 37.1 17.2 34.7 46.9 31.2 21.0 20.7 24.5 19.2 31.5 15.9 21.3 38.9 33.3 47.4 17.9 54.7 55.5 106.2 44.2 14.4 29.3 47.2 26.6 50.5 30.4 0.7 1.9 1.8 4.1 3.7 4.3 3.5 3.5 5.4 3.0 4.0 2.8 5.7 1.4 5.2 4.2 5.1 4.7 2.1 3.9 4.6 6.0 4.3 3.9 5.6 4.2 4.7 4.4 2.8 4.5 7.1 5.9 0.0 2.7 30.0 11.2 4.0 6.7 4.1 11.4 5.6 6.2 4.2 1.1 2.8 4.6 3.7 12.5 17.0 15.1 4.3 3.9 5.1 10.3 4.9 7.1 5.0 1.2 26.5 38.0 5.2 22.0 6.9 4.1 6.0 12.0 13.7 4.2 3.5 9.3 6.7 32.6 6.5 10.2 6.6 6.4 3.7 6.5 7.0 0.0 70.3 7.3 4.8 17.5 56.8 54.5 4.9 5.3 6.8 12.7 7.1 4.4 1.8 4.1 5.6 19.7 4.9 6.8 10.1 11.2 8.7 3.0 5.7 13.6 8.0 8.6 5.3 PRKAA1 AMPKa1 ENSG00000132356 "Protein kinase AMP-activated catalytic subunit alpha 1" Q13131 5 40759379-40798374 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 292.5;Late spermatids: 478.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005050, HPA035409, HPA064946" Supported Supported "Nuclear speckles,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear speckles" Cytosol "CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390" "unprognostic (2.07e-1)" "unprognostic (1.41e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (3.97e-1)" "unprognostic (1.05e-1)" "unprognostic (3.51e-2)" "unprognostic (7.53e-2)" "unprognostic (1.66e-2)" "unprognostic (2.88e-1)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (2.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.10e-2)" 33.3 21.0 7.9 27.2 9.6 52.6 30.2 10.3 11.0 26.7 12.3 30.0 35.4 26.3 18.6 20.6 21.0 33.5 20.2 6.9 11.3 32.0 49.9 27.4 29.2 11.8 9.9 19.1 23.1 32.0 9.2 21.2 12.2 31.9 34.7 19.0 27.4 24.7 16.9 23.1 30.9 26.4 10.2 27.8 33.7 41.1 10.0 21.8 32.3 19.9 23.9 28.8 17.8 10.3 28.4 28.9 22.8 30.2 55.0 57.0 21.6 47.3 48.1 34.7 30.8 27.6 35.9 16.6 21.4 48.8 45.3 22.4 21.3 43.1 64.9 49.2 19.2 33.1 66.1 22.1 45.3 31.9 33.5 52.8 20.6 46.5 47.5 38.4 52.1 21.0 15.9 46.7 52.4 13.6 29.7 24.9 9.9 28.9 34.6 24.5 48.7 24.6 53.3 47.5 19.6 19.7 83.0 54.3 28.8 12.3 28.4 26.0 56.0 62.1 33.5 36.2 39.2 18.5 15.4 19.6 38.9 67.9 33.9 17.0 6.5 12.8 8.9 7.9 11.5 8.2 8.4 8.6 6.4 7.9 10.1 9.0 15.4 10.9 9.3 1.9 11.6 6.5 7.9 9.6 10.3 11.0 6.9 11.3 11.8 9.9 12.2 10.2 10.0 10.3 47.3 41.7 26.5 19.2 34.1 24.1 24.7 40.5 15.4 20.3 36.1 17.9 18.3 42.9 43.4 47.8 35.5 13.8 45.8 44.1 7.9 27.9 292.5 19.7 35.8 42.4 21.1 25.4 24.5 44.9 13.7 36.2 36.7 20.7 18.3 17.8 37.1 83.4 20.0 15.2 30.3 28.8 42.7 25.3 28.5 478.5 30.4 24.1 35.6 24.4 40.9 15.4 44.3 30.7 43.8 36.0 32.8 25.9 23.4 33.4 33.7 35.4 42.9 27.9 0.0 22.7 43.1 82.8 17.6 19.9 32.7 18.6 44.0 19.2 36.9 35.0 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056674-107067636 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 308.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA059424: AB_2684012" "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 4.9 10.0 5.7 7.2 5.6 4.2 8.0 5.6 5.7 6.1 13.8 7.9 6.1 7.0 8.0 6.8 8.8 6.0 3.9 5.2 6.9 12.0 7.1 4.6 9.6 6.1 6.5 8.6 10.9 9.6 8.4 7.3 5.3 8.5 7.2 6.4 6.5 7.8 1.8 5.6 7.2 5.9 5.5 8.3 7.4 6.6 8.2 10.3 7.0 3.1 8.7 7.9 5.0 6.0 13.6 0.2 25.7 11.3 16.6 18.4 7.0 17.8 13.2 16.9 17.2 17.2 9.2 33.1 24.1 16.5 9.2 18.9 23.9 26.2 13.3 0.0 25.4 20.0 35.6 25.0 16.5 41.6 11.9 17.4 14.2 15.2 15.5 11.4 14.8 18.5 27.1 5.0 15.4 308.1 24.5 14.6 11.1 10.6 24.6 30.8 56.0 12.6 41.3 27.1 47.8 58.3 24.2 34.5 12.1 15.5 24.0 30.7 17.2 12.5 25.5 26.3 26.8 5.4 4.0 5.7 18.4 19.3 10.2 2.1 10.4 1.9 7.9 11.9 9.5 7.4 8.3 7.6 14.1 10.3 11.5 11.9 0.6 17.4 12.0 17.2 9.2 9.3 5.7 5.6 5.6 5.7 5.2 6.9 6.1 6.5 5.3 5.5 8.2 6.0 3.0 0.0 4.4 1.3 6.2 4.5 6.9 9.7 8.6 14.2 8.9 5.0 2.6 5.7 5.8 14.7 0.0 18.3 8.5 3.3 27.4 10.3 1.2 5.2 6.2 4.7 17.5 15.8 1.5 7.4 14.6 6.7 4.6 4.9 1.3 9.4 7.5 2.4 10.0 15.2 2.2 7.4 8.2 7.0 1.6 3.0 8.7 3.8 1.8 3.7 3.9 6.9 3.1 2.0 2.2 4.7 8.5 9.1 2.0 5.1 4.1 18.4 7.4 5.1 13.1 5.9 6.3 9.1 8.1 8.9 6.1 7.1 5.0 13.7 10.3 5.4 PRORP "KIAA0391, MRPP3" ENSG00000100890 "Protein only RNase P catalytic subunit" O15091 14 35121846-35277622 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.8;dendritic cells: 1.1;Hofbauer cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 13: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 24: Non-specific - Transcription regulation" Mitochondria Nucleoplasm "HPA020459: AB_2670449" "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 11.3 17.0 11.0 17.0 12.2 12.2 13.9 12.4 16.1 13.6 16.6 19.9 15.3 8.4 16.7 19.2 11.8 10.4 13.7 11.4 12.1 25.0 24.9 12.5 21.2 13.2 12.5 7.0 10.6 19.3 9.7 11.0 12.8 10.6 20.8 6.2 13.1 9.6 15.1 17.3 14.5 11.9 11.6 13.6 13.6 12.1 13.1 31.1 15.6 17.1 22.5 15.4 11.9 14.4 47.5 34.9 23.6 33.1 25.1 21.0 22.7 31.1 25.3 35.9 26.1 35.8 26.3 53.0 39.0 27.2 9.9 33.9 43.8 47.3 36.5 39.2 12.9 22.6 24.9 77.9 25.2 27.2 23.0 28.3 37.7 33.9 31.6 30.2 50.0 41.3 38.4 13.6 42.5 54.9 46.0 33.3 26.8 30.4 33.4 42.9 40.4 28.1 52.6 44.6 24.0 25.0 40.0 43.3 26.8 29.0 55.4 23.9 44.5 30.7 25.7 22.1 25.8 15.5 40.4 53.9 14.5 32.0 32.5 30.9 10.3 7.2 30.3 9.6 43.9 20.1 47.3 32.8 13.8 14.4 41.6 30.1 14.4 24.7 8.2 20.4 56.1 24.3 11.0 12.2 12.4 16.1 11.4 12.1 13.2 12.5 12.8 11.6 13.1 14.4 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 PRPF18 hPrp18 ENSG00000165630 "Pre-mRNA processing factor 18" Q99633 10 13586939-13630859 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037599, HPA047950" Supported Approved "Nuclear speckles,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" Cytosol "HPA037599: AB_10795137, HPA047950: AB_2680221" "unprognostic (5.82e-2)" "unprognostic (7.86e-3)" "unprognostic (4.07e-2)" "unprognostic (1.20e-2)" "unprognostic (3.00e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (6.12e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-3)" "unprognostic (2.82e-2)" "unprognostic (2.20e-1)" "unprognostic (8.09e-2)" "unprognostic (1.63e-1)" 14.6 15.9 8.4 14.4 9.7 43.0 19.6 12.2 10.4 12.8 8.9 16.0 16.9 14.0 28.1 15.8 11.7 15.5 14.3 8.5 10.8 20.7 21.9 14.9 18.2 8.7 8.7 12.9 17.0 18.7 10.7 17.4 8.7 14.3 18.1 10.1 14.3 13.0 23.2 14.3 16.5 15.1 8.6 13.6 15.0 18.8 9.1 25.0 23.6 22.2 19.7 16.4 12.3 10.1 29.5 21.7 18.9 16.4 25.9 24.7 23.5 33.6 16.6 35.9 34.2 20.8 43.8 24.4 18.3 31.1 16.3 23.8 25.1 27.8 41.3 36.3 24.9 28.4 18.5 16.3 30.7 22.6 32.9 19.4 44.3 31.3 15.4 21.9 35.3 35.0 29.9 32.1 33.1 30.5 42.2 15.6 17.8 29.0 10.7 29.8 22.8 30.6 23.9 12.6 13.2 32.7 26.6 18.8 29.1 23.0 29.0 36.6 30.2 22.2 26.1 36.5 25.5 31.2 35.8 34.8 32.8 27.9 15.4 27.2 27.3 36.5 27.7 25.1 24.0 26.9 24.8 23.9 27.4 25.8 26.4 32.6 40.3 39.7 37.4 23.3 33.5 16.8 8.4 9.7 12.2 10.4 8.5 10.8 8.7 8.7 8.7 8.6 9.1 10.1 24.5 19.2 22.4 14.7 32.8 45.6 24.0 35.7 25.0 13.5 22.6 15.0 9.4 30.0 32.9 22.0 10.4 30.5 28.7 21.1 41.1 30.9 29.8 27.5 22.8 21.1 12.6 25.9 27.0 29.1 40.4 18.9 19.4 22.0 27.1 10.5 16.4 28.4 26.0 21.9 25.3 21.8 46.8 20.7 18.0 16.5 17.7 19.4 24.9 18.7 29.7 20.2 36.0 28.1 29.3 33.7 28.9 13.2 27.1 16.2 30.2 50.6 31.8 21.7 19.7 20.8 18.3 105.8 41.1 17.1 46.9 41.7 33.2 11.6 19.0 25.8 PRPF3 "hPrp3, Prp3, RP18, SNRNP90" ENSG00000117360 "Pre-mRNA processing factor 3" O43395 1 150321479-150353233 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027226, HPA067116" Approved Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA027226: AB_1855770, HPA067116: AB_2685783" "unprognostic (2.75e-1)" "unprognostic (3.00e-1)" "unprognostic (2.20e-1)" "unprognostic (2.77e-1)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.59e-5)" "unprognostic (7.89e-2)" "unprognostic (7.13e-3)" "unprognostic (1.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (6.77e-3)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.78e-3)" 26.0 24.7 18.1 22.3 20.2 44.8 27.0 23.2 23.1 27.5 22.8 25.2 16.9 25.0 26.7 22.2 25.7 13.8 19.5 17.8 21.4 29.0 30.4 24.3 28.6 19.7 18.9 34.1 23.8 17.6 27.0 20.9 19.3 27.5 19.6 43.5 21.7 19.5 22.2 23.8 24.6 18.7 17.3 33.8 19.1 20.1 19.7 30.9 32.0 14.9 28.5 24.3 24.3 21.6 44.8 47.5 47.1 30.3 31.0 33.5 63.8 45.6 31.9 69.1 47.5 36.6 40.8 58.7 29.7 37.6 64.4 51.5 86.1 32.2 61.7 29.7 38.3 50.7 72.1 35.2 30.7 62.5 31.6 24.6 43.7 59.0 50.5 32.9 42.7 39.0 61.3 34.8 50.0 66.5 52.3 55.0 67.6 114.3 41.9 75.1 38.5 38.8 28.5 26.7 40.3 35.7 37.9 44.2 34.9 63.3 52.9 150.5 34.3 43.2 33.3 36.7 75.8 33.1 62.8 64.7 28.8 56.2 45.9 9.3 9.0 13.3 14.9 11.8 14.6 13.0 10.8 9.8 9.5 10.0 11.0 11.4 5.3 11.5 21.8 7.6 9.1 8.3 18.1 20.2 23.2 23.1 17.8 21.4 19.7 18.9 19.3 17.3 19.7 21.6 26.1 35.3 23.4 31.6 26.1 11.7 13.1 13.0 10.8 30.4 10.8 10.8 13.2 11.5 19.7 11.0 18.8 16.1 22.9 15.8 13.7 15.6 11.5 13.2 20.0 22.5 2.4 19.0 19.5 11.9 16.0 16.3 17.9 17.8 22.8 25.5 14.6 11.0 12.1 32.0 17.5 17.5 4.1 8.6 11.8 5.3 20.2 14.5 10.6 15.0 14.2 27.8 17.5 18.1 28.4 13.4 9.5 18.4 12.4 12.6 12.6 5.0 20.6 42.6 13.1 19.1 21.2 44.3 23.5 11.6 10.1 20.0 24.0 11.3 11.6 10.0 PRPF38A "FLJ14936, Prp38" ENSG00000134748 "Pre-mRNA processing factor 38A" Q8NAV1 1 52404602-52420836 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053099, HPA058407" Uncertain Enhanced Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA053099: AB_2682044, HPA058407: AB_2683709" "unprognostic (1.29e-1)" "unprognostic (6.12e-2)" "prognostic favorable (7.16e-4)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (3.83e-5)" "unprognostic (3.83e-2)" "unprognostic (7.84e-3)" "unprognostic (7.06e-2)" "unprognostic (1.62e-1)" "unprognostic (9.69e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (6.54e-3)" "unprognostic (3.35e-1)" "unprognostic (1.89e-1)" "unprognostic (2.82e-1)" 9.0 8.1 11.8 10.7 12.2 19.3 13.3 16.2 14.2 12.1 10.5 11.2 8.4 14.1 9.8 9.5 11.4 7.1 7.4 11.3 12.3 10.4 7.9 9.7 15.7 12.2 12.5 17.3 7.9 8.9 9.6 9.9 12.1 10.1 12.1 17.6 8.4 9.0 6.7 11.4 10.7 9.0 11.6 11.2 8.2 8.9 11.8 21.1 12.2 8.1 15.0 8.7 10.3 13.5 17.6 8.5 29.8 14.3 11.5 11.3 17.6 11.8 8.0 19.1 18.3 15.5 8.5 36.2 12.0 8.1 14.8 12.8 42.6 12.8 24.7 19.8 32.4 48.7 31.1 16.3 14.2 54.8 17.2 8.7 11.2 20.9 20.0 14.5 16.3 25.9 45.4 9.2 11.5 9.9 42.5 32.8 36.6 18.6 19.7 41.3 44.8 30.3 16.9 10.4 19.7 24.0 23.8 19.3 23.8 20.0 13.6 43.8 12.9 10.8 16.2 16.3 23.5 17.4 26.6 35.7 15.9 47.0 14.0 12.3 6.2 8.9 7.4 7.1 10.2 7.2 8.3 9.1 7.9 6.5 11.3 8.8 4.8 11.1 7.5 4.3 8.9 5.7 11.8 12.2 16.2 14.2 11.3 12.3 12.2 12.5 12.1 11.6 11.8 13.5 37.5 41.7 32.1 8.5 49.1 53.0 92.7 48.8 33.6 35.9 34.4 32.1 29.9 22.8 41.1 16.5 93.8 60.5 52.6 69.9 35.2 36.9 84.6 36.8 34.3 47.6 35.8 44.6 6.7 29.4 77.9 33.8 20.4 31.6 60.1 43.1 34.6 19.3 40.0 25.2 7.2 42.7 32.6 35.8 40.0 18.6 25.7 34.4 30.2 1.9 40.4 49.4 70.0 7.1 7.4 27.0 49.1 33.4 47.3 47.0 61.2 34.9 28.3 47.8 52.6 53.8 33.2 109.8 55.1 38.1 56.0 103.4 57.6 44.7 62.2 67.9 PRR14L "C22orf30, MGC50372" ENSG00000183530 "Proline rich 14 like" Q5THK1 22 31676256-31750140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062645 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA062645: AB_2684817" "unprognostic (2.87e-1)" "unprognostic (1.34e-1)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.42e-2)" "unprognostic (2.13e-1)" "unprognostic (1.37e-2)" "unprognostic (4.10e-2)" "unprognostic (8.86e-3)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (4.90e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.48e-2)" "unprognostic (4.14e-3)" 3.8 3.6 3.1 5.4 4.1 8.6 5.6 5.8 3.8 4.5 8.5 6.3 4.3 4.3 4.2 5.7 5.1 3.3 3.2 3.5 2.4 4.3 4.2 4.5 6.9 2.0 2.1 6.9 4.1 6.6 4.7 5.3 1.9 4.0 7.0 4.9 4.2 3.7 2.8 6.9 4.7 5.0 0.6 5.6 5.9 5.5 3.7 7.6 5.3 4.6 7.2 4.8 4.0 6.5 11.4 10.8 11.6 11.5 10.4 9.7 12.0 6.1 7.2 9.4 8.7 9.9 4.1 12.9 5.8 12.0 7.0 11.0 22.9 9.1 9.7 17.3 9.7 7.8 9.7 8.0 8.8 24.3 16.2 8.7 9.0 13.0 11.2 8.1 13.3 10.1 12.0 8.3 9.9 10.8 8.6 7.7 13.4 16.3 4.1 12.8 18.5 7.4 7.8 12.8 16.0 9.4 14.2 8.5 7.8 13.6 7.5 9.6 12.7 5.7 11.4 7.7 8.4 12.8 16.4 9.5 8.9 11.7 8.9 9.1 4.3 5.4 2.9 5.1 2.6 3.5 1.8 2.4 3.3 3.1 2.6 2.8 8.1 2.9 11.8 3.7 2.7 1.8 3.1 4.1 5.8 3.8 3.5 2.4 2.0 2.1 1.9 0.6 3.7 6.5 18.1 22.4 20.3 31.0 18.1 7.5 13.4 18.5 16.5 11.9 16.0 12.3 22.2 10.0 28.7 11.0 20.9 19.0 21.1 29.5 9.8 19.3 7.4 25.9 27.3 16.2 10.2 14.3 48.0 17.1 14.2 15.6 25.0 24.4 26.6 56.6 11.7 18.4 14.6 15.2 38.8 19.4 10.2 21.3 9.2 5.9 14.9 21.2 1.8 35.6 24.7 12.1 20.6 21.6 46.7 24.6 13.9 8.2 12.4 19.3 20.3 11.9 23.2 11.7 13.1 21.9 15.6 14.0 18.4 19.9 9.7 22.2 14.4 27.9 18.5 20.3 PSMA5 ZETA ENSG00000143106 "Proteasome 20S subunit alpha 5" P28066 1 109399042-109426448 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028392, HPA028398, HPA028441" Approved Supported Cytosol NA NA 20000000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003" "unprognostic (3.82e-2)" "unprognostic (3.09e-3)" "prognostic favorable (1.45e-5)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.52e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (5.95e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-3)" "unprognostic (4.20e-3)" "unprognostic (3.05e-1)" "unprognostic (1.07e-3)" "unprognostic (3.99e-2)" "unprognostic (2.34e-1)" "unprognostic (8.81e-3)" "unprognostic (1.05e-1)" 3.5 4.7 5.1 4.3 6.2 3.8 6.8 4.0 7.7 5.8 2.7 7.4 7.5 5.5 8.6 6.8 9.1 5.4 7.7 6.8 6.7 10.9 20.2 5.9 12.7 5.0 4.7 5.2 3.2 5.9 1.4 6.9 4.5 5.4 8.5 4.8 5.0 6.2 6.1 6.2 6.7 6.5 4.1 4.8 5.2 3.5 5.3 6.4 10.2 5.1 9.3 6.1 0.9 6.6 10.1 11.7 6.2 5.7 17.6 16.9 12.6 4.9 29.8 23.2 17.9 15.0 5.5 28.1 7.8 21.2 4.2 5.7 13.8 13.7 16.1 10.7 13.1 13.4 7.7 12.4 14.0 15.2 5.3 8.5 12.3 12.7 14.3 6.2 15.0 8.2 17.1 6.5 12.4 18.6 54.4 10.3 5.7 7.0 16.5 4.4 16.9 7.4 19.0 11.5 7.3 5.2 10.5 16.2 8.9 5.0 5.9 14.1 11.7 4.6 4.6 7.9 10.3 3.6 11.6 19.7 20.0 26.0 7.4 11.0 4.3 3.1 7.7 6.3 8.4 5.7 9.0 8.3 5.9 4.7 9.7 9.7 1.4 7.2 6.1 4.2 11.4 7.0 5.1 6.2 4.0 7.7 6.8 6.7 5.0 4.7 4.5 4.1 5.3 6.6 68.9 41.7 56.8 9.4 77.4 63.6 73.5 231.0 38.1 32.6 59.5 75.7 89.5 75.8 120.9 42.3 6.2 227.0 114.5 82.1 140.8 164.9 82.0 157.6 74.1 71.6 56.3 85.0 21.7 183.0 181.4 60.4 74.9 81.9 82.4 77.7 51.4 117.4 166.9 13.5 18.4 144.1 168.9 57.8 73.6 23.4 67.7 86.3 58.7 15.0 184.8 50.2 114.4 13.0 20.2 191.6 103.5 62.1 113.1 122.2 138.0 205.6 172.4 31.7 46.0 56.1 182.6 120.3 89.1 70.4 65.9 241.2 106.1 121.4 135.3 104.2 PSMD5 "KIAA0072, S5B" ENSG00000095261 "Proteasome 26S subunit, non-ATPase 5" Q16401 9 120815496-120842951 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003216 Uncertain Approved Nucleoplasm,Cytosol No No 250000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" Cytosol Nucleoplasm "HPA003216: AB_1079709" "unprognostic (7.72e-2)" "unprognostic (5.20e-2)" "unprognostic (2.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.44e-3)" "unprognostic (8.02e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-1)" "unprognostic (3.45e-2)" "unprognostic (2.04e-3)" "unprognostic (4.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.87e-1)" 15.0 16.5 8.8 13.4 8.4 20.4 23.4 12.0 9.8 15.9 8.5 14.5 12.6 16.4 13.9 16.6 14.1 12.5 9.4 8.4 10.2 13.5 20.5 14.6 15.9 9.3 9.4 15.2 14.3 10.7 9.8 12.7 9.5 18.1 14.3 11.7 17.9 14.3 9.1 19.7 12.5 18.6 8.9 12.0 14.3 13.8 9.7 14.5 14.3 11.2 19.0 17.1 12.1 12.8 35.0 44.3 20.7 38.6 44.9 44.1 24.4 49.4 38.1 45.3 41.5 38.7 21.7 35.4 22.1 50.2 36.1 50.5 0.0 48.9 52.5 33.1 5.3 29.7 59.2 21.6 33.9 10.2 10.6 37.3 30.6 44.2 47.4 22.7 26.9 37.7 110.2 22.6 42.8 42.9 31.5 21.0 30.6 82.6 31.4 28.0 45.0 28.0 42.1 30.0 28.8 18.3 61.8 50.2 24.7 15.2 60.5 24.5 41.5 0.1 25.0 19.3 45.3 13.0 14.8 38.0 28.6 33.4 41.1 19.3 18.1 15.6 19.8 20.9 21.6 22.2 22.7 23.9 17.7 17.8 21.9 16.9 9.7 18.7 23.7 12.7 32.7 18.1 8.8 8.4 12.0 9.8 8.4 10.2 9.3 9.4 9.5 8.9 9.7 12.8 14.3 9.6 17.0 20.2 16.7 12.4 11.8 11.7 21.1 11.6 18.9 13.5 8.1 11.5 17.5 9.2 12.5 12.1 15.3 13.6 11.7 12.9 7.7 8.1 20.6 13.7 7.8 17.2 28.4 13.4 11.7 18.4 14.8 11.9 14.5 11.8 17.2 24.9 11.8 5.0 24.5 14.1 8.2 16.1 13.9 4.7 13.1 12.7 14.2 15.0 12.3 9.9 10.3 34.2 29.0 17.1 10.1 16.1 16.0 14.1 10.5 16.8 8.1 10.3 6.6 11.7 16.3 22.4 21.3 27.0 13.5 10.9 17.3 17.7 11.0 9.7 PTDSS1 "KIAA0024, PSS1, PSSA" ENSG00000156471 "Phosphatidylserine synthase 1" P48651 8 96261902-96336995 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016852 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" "Endoplasmic reticulum" Nucleoplasm "HPA016852: AB_1855878" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (7.48e-2)" "unprognostic (5.68e-3)" "prognostic unfavorable (1.08e-5)" "prognostic unfavorable (9.83e-4)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.19e-1)" "unprognostic (2.29e-3)" "unprognostic (4.78e-2)" "unprognostic (1.79e-1)" "unprognostic (4.08e-2)" "unprognostic (3.55e-2)" 1.6 2.2 1.6 3.4 2.0 4.9 3.1 1.2 2.6 3.5 0.8 3.4 4.1 2.1 2.8 3.7 2.5 3.1 7.2 1.8 1.0 3.7 4.6 2.6 5.6 0.5 0.6 3.6 2.7 8.0 0.6 4.6 1.3 1.9 2.9 0.9 2.0 3.5 2.9 3.2 3.2 3.6 0.2 2.6 1.4 1.9 2.0 3.6 4.5 3.0 5.2 2.6 1.1 1.4 14.9 11.6 2.0 5.5 4.2 8.5 3.4 10.6 15.5 10.6 7.5 4.6 4.2 24.9 9.5 10.5 2.1 6.0 14.1 11.1 16.1 12.5 10.3 24.5 19.8 2.5 4.3 17.8 8.1 7.2 10.9 14.4 10.2 2.7 7.0 7.6 12.5 12.3 9.7 4.4 14.0 3.0 3.1 5.1 11.1 10.9 10.1 18.8 5.7 12.5 8.6 3.5 3.9 3.4 1.4 2.3 8.2 6.3 11.8 9.1 5.5 6.3 12.3 2.5 13.3 11.8 5.7 19.3 7.5 10.5 2.6 1.5 1.7 1.6 2.5 1.7 2.8 2.2 4.0 2.2 2.5 1.8 0.9 3.2 1.7 1.2 1.7 6.7 1.6 2.0 1.2 2.6 1.8 1.0 0.5 0.6 1.3 0.2 2.0 1.4 12.4 19.2 9.1 8.8 50.5 31.6 18.9 22.6 42.7 10.2 22.9 18.4 94.5 14.3 15.6 11.0 10.4 78.4 23.6 11.9 1.9 20.5 60.1 6.6 9.1 22.9 5.4 38.3 29.3 44.9 54.1 18.0 14.8 9.3 32.4 17.6 34.2 32.1 45.9 5.0 29.2 17.1 10.2 45.3 31.5 52.2 23.3 36.0 19.6 15.9 39.3 4.7 29.9 21.1 8.7 23.9 11.9 25.9 45.5 21.4 16.6 19.0 5.2 4.7 0.0 13.8 15.8 12.1 18.8 33.1 33.5 80.9 34.3 14.6 34.8 16.3 PUM2 "KIAA0235, PUMH2" ENSG00000055917 "Pumilio RNA binding family member 2" Q8TB72 2 20248691-20352234 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030316, HPA049670" Approved Enhanced Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Cytosol "HPA030316: AB_10610289, HPA049670: AB_2680845" "unprognostic (2.41e-1)" "unprognostic (8.77e-2)" "unprognostic (1.97e-1)" "unprognostic (2.31e-2)" "unprognostic (9.89e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (3.86e-2)" "unprognostic (1.23e-1)" "unprognostic (4.49e-3)" "unprognostic (1.05e-2)" "unprognostic (6.87e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (2.41e-1)" "unprognostic (4.81e-2)" "unprognostic (2.87e-2)" 27.6 29.8 29.7 33.4 31.7 33.4 41.7 42.5 32.7 36.2 32.4 36.5 34.4 36.3 32.8 39.2 29.7 27.1 33.1 31.1 30.9 36.8 43.1 33.2 48.6 26.0 29.3 44.6 27.4 41.4 8.3 40.3 26.1 37.3 37.0 66.8 33.0 33.1 21.5 47.2 35.6 32.3 29.1 42.6 35.8 24.9 31.6 70.5 57.6 32.6 47.6 38.0 18.3 37.6 72.4 50.0 65.3 46.1 40.2 40.5 65.9 49.2 53.6 48.4 42.2 43.5 33.0 96.3 11.0 44.9 58.2 38.9 61.4 35.6 71.2 87.0 38.2 105.0 35.3 62.2 43.4 107.2 93.3 29.7 79.7 42.1 77.4 45.5 53.1 57.1 75.0 82.9 57.3 35.5 93.6 65.9 55.8 68.3 31.5 80.6 110.9 73.8 45.0 68.1 55.9 76.6 42.2 58.3 48.1 43.4 33.0 61.5 52.5 58.6 58.5 38.3 64.6 93.3 123.0 181.8 35.3 75.8 51.4 11.5 4.0 5.8 6.0 5.2 7.1 4.8 6.7 7.5 4.2 5.3 7.3 6.0 11.6 7.7 7.3 3.7 5.8 3.7 29.7 31.7 42.5 32.7 31.1 30.9 26.0 29.3 26.1 29.1 31.6 37.6 43.6 35.3 51.6 89.5 57.6 79.7 32.2 26.4 74.0 94.6 46.9 30.5 46.5 32.9 33.8 47.8 62.6 36.3 43.6 44.0 11.7 16.6 10.1 33.9 35.6 45.0 34.6 41.0 134.7 15.5 16.9 36.5 43.8 45.9 20.3 53.0 41.4 56.3 29.1 58.9 153.5 43.2 38.7 70.7 44.2 5.8 34.2 44.9 32.0 144.3 42.7 26.8 43.3 155.3 186.0 22.6 28.1 26.4 54.7 57.8 33.9 29.7 39.5 72.3 32.9 40.5 47.6 16.8 16.6 75.2 106.3 52.0 50.1 31.2 40.2 56.6 PURB PURBETA ENSG00000146676 "Purine rich element binding protein B" Q96QR8 7 44876299-44885530 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048766 Supported Nucleoplasm NA NA 150000 "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA048766: " "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (9.49e-2)" "unprognostic (4.96e-2)" "unprognostic (2.18e-1)" "unprognostic (8.44e-3)" "unprognostic (1.53e-1)" "unprognostic (1.72e-1)" "unprognostic (1.88e-3)" "unprognostic (2.01e-1)" "unprognostic (4.12e-1)" "unprognostic (5.66e-2)" "unprognostic (4.29e-2)" "unprognostic (7.96e-2)" "unprognostic (1.41e-1)" "unprognostic (3.22e-2)" 10.6 7.8 8.2 10.7 9.5 13.5 11.7 17.4 10.7 10.4 7.4 12.7 7.5 10.7 7.5 11.3 9.3 7.8 8.1 9.7 7.0 9.2 8.6 10.4 10.2 6.9 8.1 9.9 8.4 10.9 7.5 13.1 6.9 10.3 7.4 25.0 9.0 9.1 12.2 14.1 8.9 9.7 7.3 9.8 8.9 5.9 7.9 13.4 11.5 9.2 10.4 9.7 9.3 11.1 16.4 9.0 15.9 30.0 14.5 22.9 10.6 22.1 17.3 16.3 15.7 13.6 12.4 24.4 18.9 25.7 38.6 29.6 15.0 19.6 32.1 20.0 12.2 12.2 23.2 7.7 14.5 19.4 18.7 18.9 24.6 31.2 22.7 17.3 17.5 19.8 21.8 22.2 34.6 22.7 16.2 24.2 24.7 11.0 15.7 13.2 48.0 16.0 13.5 27.7 15.7 22.2 22.1 45.5 14.0 19.0 30.5 21.9 29.7 28.4 31.2 18.6 37.7 38.8 36.6 7.7 21.2 22.3 38.5 0.4 0.2 0.3 0.3 0.1 0.3 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.1 8.2 9.5 17.4 10.7 9.7 7.0 6.9 8.1 6.9 7.3 7.9 11.1 50.1 38.5 40.9 17.0 20.1 69.8 39.5 21.5 35.9 65.3 40.1 29.6 19.8 27.1 28.1 18.4 33.3 19.0 38.9 19.1 9.8 19.6 21.3 45.4 59.1 41.7 20.4 9.2 24.0 22.5 12.0 26.9 23.9 53.7 36.8 33.0 36.0 14.6 16.4 53.8 23.9 18.1 30.5 25.7 108.3 16.9 20.8 53.8 17.8 20.6 21.9 40.2 21.6 18.6 42.4 28.9 12.3 19.9 16.0 46.0 13.5 12.0 28.3 57.0 46.0 61.0 44.6 25.6 11.8 43.4 86.1 18.9 23.8 21.6 23.3 44.1 PUS7L DKFZP434G1415 ENSG00000129317 "Pseudouridine synthase 7 like" Q9H0K6 12 43718992-43758793 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056203, HPA058750" Uncertain Approved "Nucleoli,Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Nucleoli "HPA056203: AB_2683064, HPA058750: AB_2683807" "unprognostic (3.41e-3)" "unprognostic (1.03e-1)" "unprognostic (2.51e-3)" "unprognostic (1.83e-1)" "unprognostic (3.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.87e-4)" "unprognostic (1.11e-1)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.49e-1)" "unprognostic (2.54e-2)" "unprognostic (1.80e-3)" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" 2.7 3.1 3.3 4.9 3.6 3.5 5.4 6.8 5.2 4.1 0.3 3.8 3.8 3.6 3.7 4.8 2.9 3.8 2.7 2.9 2.6 3.1 3.2 2.4 5.7 2.6 2.0 4.7 4.3 4.4 4.1 4.0 2.7 4.0 4.5 11.7 4.0 3.5 1.7 3.7 3.6 3.1 1.1 3.4 3.9 3.0 3.2 5.1 5.7 1.7 5.9 3.4 2.7 3.7 11.2 8.3 7.2 4.1 4.9 17.4 12.8 9.6 8.1 12.6 9.6 29.9 7.9 25.7 11.9 11.9 7.3 9.9 10.5 9.7 21.5 7.9 6.5 18.8 9.2 11.2 6.1 30.3 11.7 7.2 7.1 13.1 13.5 11.6 9.2 14.9 33.3 10.9 29.7 4.5 15.8 7.8 13.3 0.0 8.8 14.7 16.9 15.4 5.6 8.5 12.1 3.9 11.9 12.8 5.1 8.5 15.1 8.4 6.7 12.8 8.4 15.0 15.2 9.6 17.7 25.5 11.8 49.1 4.3 6.4 1.9 2.2 2.1 1.7 2.7 2.1 2.3 2.3 2.1 2.8 2.0 2.9 1.3 2.5 1.6 2.3 1.0 1.5 3.3 3.6 6.8 5.2 2.9 2.6 2.6 2.0 2.7 1.1 3.2 3.7 30.5 9.6 17.2 29.0 41.1 11.6 19.0 30.8 22.8 68.9 24.2 16.0 12.3 14.3 21.2 25.8 68.8 34.3 34.4 13.5 41.1 20.4 2.5 14.9 28.5 23.3 19.3 25.2 49.5 23.2 23.3 26.5 28.5 18.9 17.1 43.7 16.8 20.8 20.4 43.7 79.5 25.2 18.3 25.0 10.5 4.2 20.2 20.3 12.4 15.0 24.6 33.1 35.0 41.7 51.2 18.2 17.0 26.7 48.7 16.9 19.6 22.7 9.2 106.1 19.7 28.1 18.1 25.2 35.3 19.9 11.1 24.2 32.7 36.3 30.0 13.9 PWP1 IEF-SSP-9502 ENSG00000136045 "PWP1 homolog, endonuclein" Q13610 12 107685799-107713162 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038708 Approved "Nucleoli rim,Golgi apparatus" Yes No "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli rim" "Golgi apparatus" "HPA038708: AB_2676163" "unprognostic (7.06e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (9.65e-4)" "prognostic unfavorable (1.40e-5)" "unprognostic (1.97e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.00e-1)" "unprognostic (6.95e-2)" "unprognostic (6.13e-2)" "unprognostic (1.10e-2)" 29.7 20.9 18.6 26.4 19.0 31.9 33.7 18.8 23.6 24.9 29.5 27.7 17.7 30.3 24.8 28.7 24.7 20.4 17.3 18.9 19.1 30.4 32.2 21.4 32.0 17.4 18.0 32.8 25.8 33.0 17.8 29.5 20.0 25.2 26.0 26.9 24.4 27.5 22.9 28.8 21.7 32.3 18.1 23.7 23.1 30.1 18.8 33.2 25.9 17.6 37.4 31.4 24.5 19.0 71.0 86.9 51.8 49.4 70.9 77.2 68.5 72.9 81.9 100.8 84.8 88.5 32.9 108.8 38.4 112.9 68.4 60.7 70.8 77.0 99.2 54.7 80.6 82.9 50.5 103.2 72.7 101.8 56.9 70.2 69.1 93.5 83.0 79.0 119.8 66.0 110.8 29.8 109.1 78.3 71.6 99.3 62.0 64.8 141.2 58.3 61.2 101.4 62.7 98.3 58.4 46.9 59.6 42.4 104.1 64.8 75.3 49.7 94.9 76.7 38.9 63.0 84.1 42.5 62.8 84.9 34.3 55.3 68.7 29.4 20.8 16.2 41.7 27.8 37.8 68.5 40.6 43.9 35.0 64.1 34.5 47.9 6.6 44.2 34.4 47.3 48.6 29.7 18.6 19.0 18.8 23.6 18.9 19.1 17.4 18.0 20.0 18.1 18.8 19.0 44.1 41.7 38.1 13.7 80.1 48.4 52.3 70.6 36.5 50.4 41.0 41.3 22.1 25.8 48.9 27.6 37.5 69.1 48.4 14.6 58.7 69.7 24.4 34.5 47.3 52.0 21.0 52.2 15.6 63.0 74.5 51.6 30.5 35.8 57.6 41.5 43.5 52.0 46.2 33.7 19.0 31.9 26.4 34.3 28.0 11.1 50.4 33.2 30.2 4.7 75.2 41.4 38.1 15.1 16.7 68.0 19.8 44.0 46.0 50.2 24.5 70.8 42.8 46.2 26.3 41.8 50.9 124.3 79.2 41.9 49.7 45.7 44.0 45.8 34.1 40.5 R3HDM1 "KIAA0029, R3HDM" ENSG00000048991 "R3H domain containing 1" Q15032 2 135531455-135725270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 1088.8;Inhibitory neurons: 296.7;Oligodendrocyte precursor cells: 198.0;Oligodendrocytes: 173.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 5 "cerebral cortex: 53.0" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030936 Approved Nucleoplasm,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "HPA030936: AB_10670835" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (8.16e-3)" "unprognostic (1.10e-3)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-3)" "prognostic unfavorable (8.02e-4)" "unprognostic (3.51e-2)" "unprognostic (9.52e-2)" "unprognostic (5.51e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (5.83e-7)" "unprognostic (1.16e-2)" "unprognostic (7.23e-2)" "unprognostic (4.32e-3)" "unprognostic (2.47e-1)" 10.3 10.5 0.0 13.6 7.7 23.2 8.2 0.0 53.0 9.5 0.0 11.8 7.2 10.1 9.6 9.5 8.2 9.6 7.9 10.5 0.0 9.0 9.7 7.9 18.1 0.0 0.0 7.7 13.0 22.8 20.1 6.7 0.0 8.0 15.1 17.7 7.0 8.8 22.7 8.4 9.1 13.1 0.0 10.8 8.6 22.8 0.0 43.6 13.2 15.6 20.9 12.0 7.2 0.0 50.7 30.5 42.1 49.0 22.2 30.0 24.8 31.1 32.2 30.5 33.2 54.7 34.2 79.8 24.0 44.3 22.2 22.3 55.6 57.5 53.3 50.4 27.9 64.3 37.0 55.1 26.5 55.4 39.9 28.5 25.2 53.7 68.5 27.7 49.8 85.2 67.9 66.4 35.4 52.0 96.5 38.0 32.6 37.6 35.4 56.8 29.1 47.6 30.3 43.9 42.9 33.3 49.9 20.2 22.0 36.5 27.1 29.4 37.0 28.1 27.8 35.7 39.3 52.7 78.8 74.1 31.6 44.7 36.7 3.5 6.9 2.8 5.1 7.3 4.9 5.5 5.3 7.6 9.9 3.6 5.1 5.9 1.0 9.1 6.7 11.2 8.5 4.4 0.0 7.7 0.0 53.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 6.4 3.1 125.7 20.1 7.9 7.2 9.9 10.8 39.3 11.0 9.7 16.0 14.3 14.1 7.3 20.9 8.1 31.2 5.4 19.6 8.8 46.7 6.8 27.0 15.6 22.9 30.7 1088.8 7.4 10.4 11.5 15.8 12.6 18.3 25.9 11.7 14.2 12.2 26.9 296.7 11.7 14.2 19.5 13.8 44.7 13.7 18.8 7.2 98.4 21.9 8.6 22.6 198.0 173.5 8.3 6.3 11.3 33.7 10.0 5.3 13.4 4.3 40.5 0.0 14.7 25.3 26.5 24.5 20.3 9.7 3.1 23.4 36.6 11.5 6.8 RAB3GAP2 "DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69" ENSG00000118873 "RAB3 GTPase activating non-catalytic protein subunit 2" Q9H2M9 1 220148293-220272453 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Cataract, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026273, HPA027299" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "Plasma membrane" "HPA026273: AB_1856007, HPA027299: AB_1856008" "prognostic unfavorable (3.05e-4)" "unprognostic (2.80e-3)" "unprognostic (1.76e-2)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (7.00e-2)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (4.63e-2)" "unprognostic (2.13e-1)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.17e-1)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 10.1 9.0 6.3 9.6 6.7 10.2 11.2 11.4 7.8 8.7 23.5 8.8 7.8 9.4 8.4 9.0 7.0 7.9 9.3 7.3 9.3 11.7 10.0 8.6 12.6 6.7 6.9 9.6 8.6 18.6 6.2 11.5 9.0 8.5 8.3 18.1 9.2 7.9 8.7 7.9 7.8 9.3 5.7 9.2 9.4 6.6 7.5 13.1 12.8 12.2 14.4 9.1 6.0 9.1 21.3 15.8 18.9 14.3 21.2 25.1 21.4 21.4 20.3 18.9 22.2 14.7 17.3 26.4 14.8 20.9 14.3 19.9 19.8 16.4 21.8 22.1 12.9 20.6 21.5 13.8 27.9 29.8 20.3 20.0 18.4 18.5 28.5 21.2 17.6 11.4 36.2 16.6 21.6 6.0 23.0 10.5 40.8 11.4 9.3 12.5 26.0 23.7 16.1 17.3 18.8 22.7 22.2 21.4 35.3 20.3 22.4 28.0 25.7 20.6 9.6 14.4 23.2 14.6 19.2 22.8 17.7 24.6 24.8 10.0 2.8 5.6 4.8 3.6 5.9 4.8 4.7 6.2 3.8 3.8 4.1 4.9 1.8 2.8 3.9 2.4 6.0 3.3 6.3 6.7 11.4 7.8 7.3 9.3 6.7 6.9 9.0 5.7 7.5 9.1 28.5 41.7 21.9 60.7 30.4 11.6 13.6 15.8 17.6 57.9 18.9 16.3 34.8 32.9 23.4 25.8 68.8 18.5 30.6 23.8 5.9 17.4 4.3 21.4 27.7 22.3 35.4 18.7 106.8 16.7 13.5 23.4 20.4 28.5 19.6 40.8 28.9 24.2 25.4 42.1 105.1 22.1 16.2 29.0 9.4 2.8 18.0 22.2 14.2 68.4 25.2 39.8 26.8 82.0 81.5 21.7 14.2 25.9 24.7 21.0 19.4 14.9 17.2 50.5 6.6 24.1 20.4 17.7 13.6 17.5 9.8 23.1 27.1 23.6 19.3 13.2 RAD21 "hHR21, KIAA0078, SCC1" ENSG00000164754 "RAD21 cohesin complex component" O60216 8 116845934-116874776 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 424.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020044, CAB022065, HPA073277" Supported Enhanced Nucleoplasm NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "CAB022065: , HPA020044: AB_1856035, HPA073277: " "unprognostic (7.85e-2)" "unprognostic (4.92e-1)" "unprognostic (3.05e-1)" "unprognostic (5.43e-3)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.86e-3)" "unprognostic (8.99e-2)" "unprognostic (8.80e-2)" "unprognostic (5.58e-3)" "unprognostic (3.56e-2)" "unprognostic (4.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" 75.4 80.5 62.9 74.0 74.5 206.0 71.9 74.7 75.7 50.5 56.7 73.1 57.3 67.6 54.6 71.2 50.6 49.4 89.8 58.1 74.3 68.2 64.7 67.9 122.8 70.0 69.3 67.8 41.9 82.3 33.8 90.1 75.2 57.5 82.5 114.2 56.9 65.0 76.6 54.0 60.4 60.2 71.9 75.5 56.4 88.7 67.2 177.2 80.9 95.5 119.5 59.7 44.5 97.1 301.6 143.9 277.3 156.7 136.5 117.0 124.2 202.1 191.4 220.8 202.4 119.8 275.2 438.6 109.4 146.0 117.4 162.4 238.5 132.1 257.6 589.1 153.1 447.6 167.2 153.7 85.5 145.7 253.1 100.2 106.0 129.4 156.0 146.1 176.4 625.8 183.6 595.6 193.1 181.1 665.4 86.2 163.6 385.4 179.2 241.8 201.5 223.4 133.5 173.3 348.2 179.1 212.2 569.4 140.6 144.5 238.3 178.5 128.5 154.6 223.5 164.4 217.1 313.3 383.9 391.9 132.8 206.7 189.7 35.3 7.9 28.0 17.4 8.7 17.5 14.4 20.3 20.6 9.0 12.8 20.8 20.6 29.7 14.3 12.7 7.6 43.7 11.4 62.9 74.5 74.7 75.7 58.1 74.3 70.0 69.3 75.2 71.9 67.2 97.1 115.7 256.4 157.1 24.5 111.2 95.6 77.5 62.5 78.0 75.4 65.8 53.0 155.2 51.5 101.0 55.2 31.3 142.4 118.1 90.4 43.0 54.0 258.0 67.0 86.7 97.0 84.4 249.8 39.3 44.9 157.0 89.4 57.1 88.2 153.5 112.9 75.0 72.1 67.9 67.3 48.1 72.7 69.2 93.1 100.0 424.9 116.5 93.4 69.4 45.9 110.8 112.5 77.2 41.2 58.3 63.5 66.3 106.5 124.0 100.0 35.7 59.4 70.5 67.9 72.3 88.6 85.3 33.2 88.6 103.7 100.4 113.7 134.1 85.5 94.1 95.5 RAMAC "C15orf18, FAM103A1, HsT19360, MGC2560, RAM, RAMMET" ENSG00000169612 "RNA guanine-7 methyltransferase activating subunit" Q9BTL3 15 82986210-82991057 "Predicted intracellular proteins" "mRNA capping, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 108.2;Extravillous trophoblasts: 82.2;Hofbauer cells: 69.4;Syncytiotrophoblasts: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041923, HPA041948" Supported Supported Nucleoplasm No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041923: AB_10796467, HPA041948: AB_10797270" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" "unprognostic (5.30e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (3.63e-3)" "unprognostic (2.09e-2)" "unprognostic (4.72e-2)" "unprognostic (7.46e-3)" "unprognostic (9.57e-2)" "unprognostic (2.72e-2)" "unprognostic (9.47e-2)" "unprognostic (2.45e-1)" 12.9 14.8 10.9 16.4 11.4 30.1 26.1 12.9 14.8 16.6 11.6 18.4 14.5 18.2 30.1 24.1 19.5 13.4 14.8 11.6 12.2 16.8 24.2 13.0 23.0 11.6 11.3 20.6 16.4 18.8 12.9 25.9 11.3 18.0 19.3 19.9 18.2 15.2 29.1 21.5 13.4 16.8 11.6 14.1 19.0 15.6 11.1 23.3 18.2 20.2 28.9 20.8 15.6 11.6 34.1 44.7 44.3 27.1 23.5 15.9 32.7 33.7 33.5 37.6 30.4 49.4 42.9 16.8 45.8 29.2 45.4 37.9 77.1 32.4 40.6 42.0 49.7 52.7 22.7 58.7 33.3 38.0 44.9 34.9 61.4 30.6 38.5 28.7 23.6 28.5 62.8 33.9 39.8 35.7 29.5 48.3 52.0 45.0 21.1 33.4 38.2 26.0 49.0 64.6 41.1 42.0 34.6 36.7 87.0 71.5 58.6 47.9 16.8 27.5 34.9 26.1 48.8 53.1 104.0 41.8 25.2 50.7 34.5 138.6 59.2 98.2 47.9 57.0 51.8 64.8 54.1 52.3 56.1 61.1 53.9 53.4 117.4 70.4 62.8 51.6 69.9 65.9 10.9 11.4 12.9 14.8 11.6 12.2 11.6 11.3 11.3 11.6 11.1 11.6 18.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 19.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 82.2 10.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 92.9 2.7 0.0 0.0 0.0 RANBP6 ENSG00000137040 "RAN binding protein 6" O60518 9 6011025-6015625 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043748, HPA052684" Approved Supported Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Vesicles "HPA043748: AB_10796796, HPA052684: AB_2681913" "unprognostic (1.47e-2)" "unprognostic (8.86e-2)" "unprognostic (1.70e-1)" "unprognostic (6.01e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.89e-2)" "prognostic favorable (1.34e-7)" "unprognostic (2.42e-1)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (2.61e-1)" 8.6 11.4 8.3 12.9 8.8 31.0 11.4 11.5 12.4 7.7 18.4 7.1 7.5 8.8 7.0 7.9 7.3 7.6 12.4 9.3 10.8 13.4 15.2 8.4 17.0 11.2 9.7 9.6 7.8 13.6 5.0 8.9 11.9 9.7 7.1 21.6 8.6 8.5 16.3 9.9 8.6 10.3 9.2 13.1 11.1 5.9 10.0 19.6 12.0 16.1 16.2 8.7 5.6 10.3 25.1 13.6 27.2 23.4 23.6 18.6 14.6 30.9 21.9 26.8 21.6 7.5 7.7 33.5 8.4 24.7 13.1 14.0 24.2 28.2 29.7 80.1 13.9 88.3 53.0 15.6 13.9 34.2 17.9 20.2 15.2 16.5 16.3 21.1 31.3 30.1 6.9 27.3 25.8 8.4 24.3 54.8 12.3 9.0 11.0 25.6 16.7 15.7 28.1 17.6 13.2 19.9 14.7 11.0 8.7 22.3 17.7 23.0 37.6 25.1 14.9 12.4 29.4 16.3 27.8 31.5 14.4 19.8 9.3 5.1 4.5 3.7 2.6 6.3 2.5 2.5 3.8 2.8 2.7 1.9 4.4 4.2 1.3 2.8 5.2 3.1 5.2 2.9 8.3 8.8 11.5 12.4 9.3 10.8 11.2 9.7 11.9 9.2 10.0 10.3 11.3 9.6 8.1 8.8 11.5 10.3 6.6 10.1 13.1 18.0 8.1 5.6 24.4 8.6 16.3 11.0 2.1 8.8 12.0 4.1 7.9 8.6 1.6 12.2 16.5 13.1 9.5 8.6 15.9 10.9 4.1 8.3 16.8 17.7 10.8 10.1 10.0 13.7 4.4 11.8 19.0 3.2 2.0 10.5 6.0 1.2 6.5 7.2 1.8 8.4 7.2 15.9 9.2 3.0 20.5 7.5 3.8 6.8 11.8 5.7 1.8 12.5 8.7 23.1 0.0 11.6 10.2 10.1 9.3 9.8 9.5 6.6 13.3 12.7 4.8 7.3 RASA2 GAP1M ENSG00000155903 "RAS p21 protein activator 2" Q15283 3 141487027-141615344 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035374, HPA035375" Approved Approved Vesicles "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" Vesicles "HPA035374: AB_10602122, HPA035375: AB_2674596" "unprognostic (1.85e-1)" "unprognostic (8.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.36e-3)" "unprognostic (9.62e-3)" "unprognostic (2.57e-1)" "unprognostic (1.38e-1)" "unprognostic (9.21e-2)" "unprognostic (4.23e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (7.62e-7)" "unprognostic (1.17e-1)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.34e-5)" 7.3 4.7 5.1 15.4 6.0 21.9 10.0 7.1 6.4 9.8 3.2 6.6 5.3 8.4 7.3 7.3 7.8 6.7 4.6 5.3 4.9 5.8 5.1 9.7 21.3 4.0 3.6 9.7 5.2 4.4 6.2 8.3 3.5 6.5 7.2 14.6 8.1 5.0 3.8 11.2 8.5 6.0 3.1 12.4 5.4 4.7 4.7 13.3 6.0 3.3 17.2 8.8 8.8 5.6 24.6 4.5 9.5 7.2 10.2 12.6 13.5 17.4 34.0 11.0 13.5 10.5 7.9 15.6 11.7 15.2 10.6 10.0 6.8 7.5 20.0 8.5 6.7 8.4 3.8 3.8 5.4 16.1 21.0 7.3 6.6 10.0 11.8 13.3 14.1 13.1 7.7 19.7 11.0 3.6 21.2 13.0 11.1 8.1 3.2 7.9 16.0 19.5 10.9 8.7 3.3 6.9 13.8 12.1 13.0 9.8 6.0 12.0 11.9 12.9 5.9 18.1 7.8 31.9 10.0 20.9 11.3 10.8 6.4 12.8 4.9 5.3 14.8 5.0 14.8 8.9 13.2 15.3 4.6 13.5 21.6 17.2 19.2 15.7 8.9 3.6 13.2 8.0 5.1 6.0 7.1 6.4 5.3 4.9 4.0 3.6 3.5 3.1 4.7 5.6 24.2 44.8 23.6 59.4 55.1 21.5 52.0 15.8 21.1 16.2 22.0 17.5 7.4 8.6 21.4 12.9 37.5 20.0 104.9 21.7 1.9 16.8 120.3 26.3 19.7 22.7 15.7 17.5 196.9 16.5 6.6 20.4 11.2 60.7 31.6 29.6 20.3 9.6 12.5 30.3 123.1 15.2 8.2 32.5 24.6 12.7 13.7 34.3 12.4 94.6 19.8 15.3 68.0 112.1 94.4 31.8 21.7 14.3 94.9 53.4 10.4 9.1 15.5 50.7 6.6 26.4 27.2 28.2 15.3 17.5 27.4 13.1 88.3 4.6 18.7 62.5 RBAK ZNF769 ENSG00000146587 "RB associated KRAB zinc finger" Q9NYW8 7 5045821-5069487 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071231 Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA071231: AB_2686370" "unprognostic (2.82e-2)" "unprognostic (1.98e-2)" "unprognostic (7.40e-2)" "unprognostic (1.85e-2)" "unprognostic (5.04e-1)" "unprognostic (4.32e-1)" "unprognostic (2.62e-1)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (5.91e-2)" "unprognostic (6.84e-2)" "unprognostic (5.10e-2)" "unprognostic (1.28e-1)" "unprognostic (2.50e-1)" "unprognostic (3.66e-2)" "unprognostic (6.12e-3)" "unprognostic (5.75e-2)" 4.3 3.8 4.1 4.4 4.0 3.7 5.8 6.7 5.4 4.7 3.7 4.6 4.5 5.2 4.7 5.8 4.4 3.7 4.3 3.8 4.5 4.4 6.5 4.0 6.4 4.5 5.0 4.8 5.5 6.9 3.9 4.5 4.4 4.7 4.9 8.4 4.6 4.7 4.2 6.0 5.1 4.4 4.2 5.1 5.0 2.9 4.8 5.6 5.5 6.1 6.7 4.1 4.6 4.8 8.9 6.7 9.2 17.0 6.6 6.1 7.5 5.5 4.3 5.3 6.3 8.3 5.4 10.5 4.5 6.4 10.0 10.8 10.4 8.5 8.2 2.3 7.4 7.7 9.2 6.9 7.0 12.9 8.9 5.9 9.9 5.3 11.8 7.7 5.3 6.1 16.2 3.7 6.7 15.7 3.2 11.9 14.5 3.0 7.0 5.3 14.9 7.7 6.1 11.3 9.4 15.4 7.7 12.6 11.5 11.7 7.7 15.3 4.5 6.3 10.0 7.3 9.1 11.4 9.7 9.2 6.3 9.5 8.2 0.0 0.2 0.4 0.5 0.4 0.7 0.3 0.4 0.3 0.3 0.3 0.5 0.4 0.0 0.5 0.1 0.4 0.3 0.1 4.1 4.0 6.7 5.4 3.8 4.5 4.5 5.0 4.4 4.2 4.8 4.8 7.4 0.0 8.2 0.0 6.5 4.2 3.4 4.7 5.2 8.2 6.1 3.9 13.4 7.2 7.3 0.0 10.4 2.8 7.9 5.1 1.9 5.9 1.1 7.5 10.1 6.1 4.9 11.6 0.0 5.8 2.2 6.7 8.6 6.9 5.7 11.7 7.9 5.3 3.7 21.9 0.0 5.6 2.0 8.2 4.0 1.4 8.1 5.2 3.6 0.0 5.7 6.0 5.2 0.0 0.0 6.0 3.8 8.6 6.7 5.9 5.6 3.7 8.8 8.2 0.0 8.8 7.0 5.0 3.2 7.5 7.0 1.9 6.4 9.1 6.1 4.2 RBBP5 "RBQ3, SWD1" ENSG00000117222 "RB binding protein 5, histone lysine methyltransferase complex subunit" Q15291 1 205086142-205122015 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049042, HPA058085" Uncertain Supported Nucleoplasm,Nucleoli No No "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nucleoli" "HPA049042: AB_2680610, HPA058085: AB_2683600" "unprognostic (8.72e-2)" "unprognostic (6.35e-2)" "unprognostic (2.14e-2)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-1)" "unprognostic (4.61e-3)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "unprognostic (6.90e-2)" "unprognostic (3.78e-3)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "unprognostic (4.88e-2)" 6.3 8.2 4.7 7.2 5.3 9.5 7.9 6.4 6.4 7.8 2.7 7.0 7.1 8.1 7.5 7.0 7.5 6.1 6.4 5.7 5.3 12.4 11.0 6.6 11.3 3.4 3.8 9.5 8.2 9.4 6.1 6.5 3.8 6.9 8.0 9.8 7.6 6.9 8.7 8.5 6.7 7.1 4.3 9.3 6.7 6.1 4.5 13.2 9.8 9.9 12.8 7.5 5.2 6.4 16.3 16.9 16.0 19.0 21.8 12.5 17.3 15.2 12.9 19.0 18.8 17.9 19.1 25.3 11.3 11.1 15.5 18.2 26.9 10.1 22.4 21.6 14.5 21.2 16.4 14.6 14.1 26.9 16.6 10.1 12.9 17.6 15.0 12.7 15.4 17.9 41.6 25.2 16.0 15.0 26.1 11.3 26.1 14.2 27.9 22.9 33.9 31.6 13.2 11.7 25.0 20.1 21.3 22.3 19.2 19.0 24.2 14.9 11.8 15.6 16.6 23.1 20.2 12.2 18.3 30.6 13.9 16.5 24.5 22.0 4.9 7.9 8.0 6.4 8.5 7.8 7.4 8.1 5.4 6.2 7.1 8.7 11.6 8.2 8.3 6.0 8.1 3.5 4.7 5.3 6.4 6.4 5.7 5.3 3.4 3.8 3.8 4.3 4.5 6.4 14.7 19.2 12.2 11.4 31.0 26.9 9.7 5.9 15.9 14.5 18.9 14.6 7.1 8.6 13.4 22.0 29.2 9.1 25.2 15.8 9.8 12.1 7.3 13.1 14.0 13.2 12.1 23.1 19.9 11.6 10.7 13.5 9.7 21.0 13.9 25.6 17.2 21.8 10.9 16.8 15.7 14.0 10.2 15.6 25.9 3.2 12.8 17.9 19.6 8.4 15.6 12.6 15.5 14.6 21.2 13.6 9.8 16.1 25.9 13.5 14.7 28.8 13.2 18.3 19.7 21.9 14.1 10.2 20.4 14.6 33.8 10.8 27.9 12.6 15.8 13.4 RBL1 "cp107, p107, PRB1" ENSG00000080839 "RB transcriptional corepressor like 1" P28749 20 36996349-37095997 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.3;Inhibitory neurons: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054962, HPA056525" Enhanced Enhanced Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA054962: AB_2682652, HPA056525: AB_2683165" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" "unprognostic (1.30e-2)" "unprognostic (3.70e-3)" "unprognostic (2.13e-1)" "unprognostic (1.51e-1)" "unprognostic (6.25e-5)" "unprognostic (6.91e-2)" "unprognostic (7.19e-3)" "unprognostic (1.20e-1)" "unprognostic (4.49e-3)" "unprognostic (3.23e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (3.15e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-2)" "unprognostic (1.26e-1)" 2.0 1.6 1.2 4.8 2.6 14.5 2.8 8.3 1.8 2.3 0.7 2.8 2.4 2.8 1.3 2.9 1.9 2.0 1.8 1.0 1.9 1.6 1.4 2.2 7.3 2.0 1.9 4.4 2.4 2.6 1.1 3.4 2.2 2.0 3.5 4.0 1.5 1.4 6.9 3.1 2.5 2.8 1.4 3.4 2.7 3.1 2.0 8.8 2.7 7.9 6.7 2.0 2.2 3.4 24.8 15.8 19.4 13.1 4.9 6.4 12.4 28.2 12.6 23.9 24.6 16.8 13.5 27.5 7.9 11.8 14.0 23.8 17.5 18.2 39.7 9.7 9.4 27.2 18.1 14.3 3.0 35.3 18.2 3.0 2.5 31.6 11.1 4.0 13.6 17.9 20.1 25.8 13.7 10.5 33.1 11.7 5.7 12.5 15.3 21.3 57.7 20.9 5.5 12.2 4.6 11.5 30.8 17.6 8.2 6.2 11.3 25.3 9.1 42.0 15.9 38.9 24.8 8.6 16.4 27.7 30.2 24.4 21.1 0.9 0.7 1.4 2.7 0.8 2.3 3.0 3.0 2.5 1.3 2.1 3.2 2.7 0.3 2.2 1.2 3.0 4.5 0.9 1.2 2.6 8.3 1.8 1.0 1.9 2.0 1.9 2.2 1.4 2.0 3.4 3.5 6.4 11.0 10.4 8.7 2.4 1.5 1.7 4.0 5.9 2.5 1.7 2.9 1.5 6.1 0.0 2.1 5.9 6.5 1.8 0.0 1.8 1.5 2.2 4.3 3.3 1.2 23.3 14.7 1.1 5.1 4.6 2.6 2.9 8.8 9.0 2.2 1.4 4.5 3.3 22.8 1.9 0.0 3.0 3.2 0.6 2.1 6.8 1.8 6.5 4.7 3.1 7.2 19.6 18.5 0.9 3.6 3.0 14.1 0.8 1.0 0.7 0.9 12.2 6.6 8.5 4.1 17.5 8.7 5.3 1.3 3.8 11.7 6.4 3.5 0.9 RBM12 "HRIHFB2091, KIAA0765, SWAN" ENSG00000244462 "RNA binding motif protein 12" Q9NTZ6 20 35648925-35664956 "Disease related genes, Predicted intracellular proteins" RNA-binding "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043258, HPA043621" Enhanced Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA043258: AB_2678395, HPA043621: AB_2678584" "unprognostic (8.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-3)" "unprognostic (7.57e-2)" "unprognostic (1.04e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (7.96e-2)" "unprognostic (8.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.47e-2)" "unprognostic (3.34e-2)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (4.44e-1)" "unprognostic (3.92e-1)" "unprognostic (6.87e-2)" 24.5 20.2 2.6 28.7 3.5 30.2 22.6 23.2 8.0 18.2 7.6 24.5 20.3 28.6 12.4 23.4 26.6 23.7 18.4 2.9 9.6 17.7 18.5 22.9 39.9 4.1 4.1 39.0 19.9 25.2 13.9 30.2 3.7 23.4 24.1 27.4 19.3 19.3 19.2 17.6 20.2 28.5 0.9 27.0 22.2 23.0 6.2 50.6 23.0 17.2 44.8 36.4 17.0 10.4 87.9 57.6 121.3 74.5 29.1 57.0 74.5 47.7 56.1 65.5 64.0 80.4 60.3 157.5 51.8 96.0 68.3 60.7 144.8 121.9 83.3 74.8 52.2 132.0 56.6 54.2 50.0 145.1 67.9 82.0 61.7 75.2 49.7 41.8 73.9 84.0 128.1 73.9 58.0 64.3 172.8 40.8 88.4 56.7 59.2 104.2 149.0 77.0 47.0 142.2 63.9 82.9 85.1 66.0 64.3 99.2 85.1 52.4 104.9 54.8 81.0 54.3 71.7 79.7 93.4 165.3 48.3 55.3 72.9 6.7 10.5 8.9 11.7 11.6 13.6 12.2 10.4 13.7 12.7 11.5 10.7 9.8 7.5 9.9 9.8 8.1 10.1 11.5 2.6 3.5 23.2 8.0 2.9 9.6 4.1 4.1 3.7 0.9 6.2 10.4 22.6 25.6 24.1 0.0 28.7 29.6 23.8 17.4 19.4 15.8 19.4 19.3 22.5 17.2 19.2 3.7 27.1 21.5 35.8 17.1 1.9 14.9 4.8 20.7 24.0 18.7 24.6 25.2 0.0 17.8 18.5 22.6 11.2 24.9 26.6 31.5 20.0 14.0 18.5 8.4 0.0 20.4 20.3 24.6 20.6 4.8 14.6 25.7 16.0 0.0 23.7 13.5 21.6 0.0 0.0 21.0 14.6 16.6 22.9 18.5 15.0 9.8 25.3 14.4 6.6 28.0 22.6 15.1 17.4 21.8 29.5 17.5 29.7 18.7 19.8 27.8 RBM12B ENSG00000183808 "RNA binding motif protein 12B" Q8IXT5 8 93729356-93741017 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 15.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024398, HPA053050" Uncertain Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA024398: AB_1856109, HPA053050: AB_2682026" "unprognostic (4.57e-2)" "unprognostic (7.72e-2)" "unprognostic (3.39e-1)" "unprognostic (3.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.66e-2)" "unprognostic (2.40e-3)" "unprognostic (3.05e-1)" "unprognostic (3.92e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.54e-2)" "unprognostic (1.84e-3)" "unprognostic (9.15e-2)" "unprognostic (4.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.62e-2)" 6.6 7.2 3.2 14.8 4.3 9.2 11.7 15.2 5.2 11.4 3.5 8.9 9.1 14.3 8.9 8.5 11.7 8.4 9.3 3.1 6.6 8.9 6.4 8.5 19.8 4.0 2.1 21.8 7.8 9.4 5.6 13.4 2.8 13.0 9.4 24.7 10.2 8.4 5.5 8.5 9.0 8.3 1.5 13.6 10.6 17.6 2.5 16.3 15.9 6.2 16.9 8.4 7.1 10.8 26.0 19.3 48.3 34.4 11.7 22.3 23.4 21.4 15.8 23.9 24.9 14.6 34.6 45.5 33.2 12.0 25.4 26.0 42.3 11.3 26.7 32.3 21.8 59.0 48.2 12.6 13.7 22.2 28.7 14.6 14.2 15.7 15.5 15.8 16.4 26.6 49.4 37.0 21.3 15.0 41.3 17.3 0.2 19.6 20.4 30.2 34.2 15.0 12.3 21.9 31.6 25.0 23.0 7.2 17.8 33.0 27.5 16.7 32.0 22.2 33.3 16.3 22.3 43.0 34.2 38.3 15.8 31.0 38.0 15.0 2.3 4.4 2.3 2.0 3.5 1.5 3.0 2.4 2.2 2.1 4.1 3.5 3.3 3.0 2.4 2.9 3.8 2.1 3.2 4.3 15.2 5.2 3.1 6.6 4.0 2.1 2.8 1.5 2.5 10.8 16.8 6.4 8.1 23.2 17.9 4.0 7.1 7.2 11.4 31.8 9.9 9.1 11.8 10.0 6.6 12.9 43.8 7.9 13.7 5.5 3.9 6.9 1.4 11.3 21.4 12.8 15.7 17.7 23.7 4.8 4.8 13.5 7.7 12.8 0.0 30.3 11.4 8.4 4.7 45.4 26.6 9.2 8.2 11.1 5.8 2.4 12.5 8.9 5.4 21.5 15.9 21.9 17.5 32.6 40.2 6.8 7.1 10.1 8.7 8.8 5.9 5.0 12.5 32.1 19.7 23.2 13.1 19.1 10.9 7.3 4.3 4.0 11.8 13.5 8.0 4.9 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893204-22919182 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favorable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 31.8 37.9 35.8 34.1 38.5 53.2 40.7 55.0 42.0 46.0 48.4 38.3 30.7 53.4 39.3 39.6 59.4 39.1 33.6 35.8 42.9 44.2 40.7 42.0 44.8 38.6 38.5 57.9 39.2 83.2 40.6 46.7 37.0 39.0 41.7 52.2 38.0 40.1 29.1 36.3 37.3 45.9 37.7 45.4 39.2 31.3 43.4 57.9 54.5 40.7 50.6 43.5 37.7 45.0 55.9 86.3 86.6 45.4 46.5 39.6 36.1 59.9 81.3 114.0 88.8 39.6 66.6 93.0 45.8 55.8 54.8 77.3 98.3 50.3 92.2 73.1 81.2 43.7 65.8 2.8 72.9 84.6 68.9 51.0 68.3 65.8 43.4 63.4 64.4 45.5 56.5 58.3 56.6 71.1 93.8 38.0 38.7 84.8 80.3 80.1 71.8 56.6 44.0 78.0 59.5 66.3 89.8 68.8 38.6 56.6 50.8 49.6 59.8 19.3 33.3 47.5 56.1 55.1 77.0 87.6 32.4 48.2 71.7 40.1 47.7 50.7 37.1 37.0 25.1 29.3 26.3 32.2 49.5 34.7 31.5 28.2 136.6 59.7 49.7 24.6 30.0 32.0 35.8 38.5 55.0 42.0 35.8 42.9 38.6 38.5 37.0 37.7 43.4 45.0 36.8 44.8 48.3 12.1 82.3 18.4 44.7 28.4 27.9 66.4 38.7 35.9 24.3 68.6 42.7 33.1 116.7 53.0 53.8 48.8 45.0 36.3 9.5 55.1 36.8 39.5 65.4 54.1 13.5 33.5 48.0 32.0 36.7 41.4 70.9 27.2 53.2 37.2 31.5 50.5 16.1 39.3 20.3 54.9 33.6 11.9 35.4 40.4 16.0 19.7 70.8 52.4 102.0 18.6 15.3 39.7 55.1 28.2 42.2 29.1 57.3 33.1 64.0 164.2 32.9 47.8 32.1 52.0 64.3 22.0 21.0 101.4 64.0 28.1 42.3 27.8 RBM26 "ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17" ENSG00000139746 "RNA binding motif protein 26" Q5T8P6 13 79311824-79406477 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 251.4;Oligodendrocytes: 253.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040252 Approved Approved "Nuclear speckles" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles" "HPA040252: AB_10672895" "unprognostic (5.55e-2)" "unprognostic (4.55e-1)" "unprognostic (2.65e-1)" "unprognostic (3.09e-2)" "unprognostic (3.03e-1)" "unprognostic (2.57e-1)" "unprognostic (3.05e-3)" "unprognostic (2.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (5.87e-6)" "unprognostic (8.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic favorable (8.20e-4)" 21.7 26.0 17.1 28.5 21.8 37.2 25.6 32.0 30.1 24.9 13.7 21.0 18.6 28.2 28.1 20.9 24.2 17.5 18.8 19.5 18.3 20.3 21.1 21.5 40.4 14.2 14.4 32.8 27.9 19.2 30.2 24.2 15.0 21.2 21.9 40.9 23.7 18.6 26.0 32.4 28.5 20.3 13.8 33.7 25.0 30.0 16.7 29.9 25.4 19.4 34.2 20.8 21.5 22.2 55.3 29.1 70.1 35.9 30.7 32.2 38.1 37.0 30.9 37.5 38.7 39.1 45.9 82.1 29.5 27.3 24.7 51.4 53.0 36.3 54.2 49.6 56.3 63.4 68.0 35.8 23.9 119.9 48.6 21.9 29.6 38.6 53.3 34.4 39.8 50.5 49.0 26.8 41.9 18.7 73.3 63.3 43.6 49.3 16.9 72.9 57.5 43.8 34.9 31.4 53.2 35.6 31.8 38.2 23.4 42.4 34.4 99.0 38.0 31.8 31.7 25.9 38.0 38.5 36.0 100.0 51.6 66.0 38.6 3.8 1.4 2.8 2.9 2.0 3.0 3.7 2.8 2.7 0.8 5.5 4.2 3.7 2.0 2.3 1.5 2.6 3.3 1.0 17.1 21.8 32.0 30.1 19.5 18.3 14.2 14.4 15.0 13.8 16.7 22.2 50.2 57.7 83.5 148.9 80.9 34.7 35.1 25.0 47.8 63.7 36.5 31.0 42.1 35.8 35.6 25.8 73.0 34.3 72.4 34.8 9.8 25.4 49.2 29.0 59.9 43.3 49.1 41.9 251.4 26.0 31.5 41.6 32.1 36.6 55.8 75.9 60.0 40.3 32.9 57.2 170.8 39.2 32.6 53.7 23.0 27.3 65.0 41.6 16.0 137.7 58.0 37.9 56.7 217.6 253.0 27.0 31.5 47.4 65.8 51.1 28.4 19.6 37.7 72.0 52.6 71.3 43.1 102.3 78.1 47.3 35.5 23.0 54.8 57.7 37.5 33.7 RBM27 "ARRS1, KIAA1311, Psc1, ZC3H20" ENSG00000091009 "RNA binding motif protein 27" Q9P2N5 5 146203605-146289223 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035944, HPA036422" Approved Approved "Nuclear speckles" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 48: Smooth muscle cells - ECM organization" "Nuclear speckles" "HPA035944: AB_10670672, HPA036422: AB_10669987" "unprognostic (8.18e-2)" "unprognostic (3.17e-1)" "unprognostic (6.04e-2)" "unprognostic (7.03e-2)" "unprognostic (2.75e-2)" "unprognostic (2.04e-3)" "prognostic unfavorable (8.58e-4)" "unprognostic (4.73e-2)" "unprognostic (4.59e-2)" "unprognostic (1.65e-2)" "unprognostic (1.19e-2)" "unprognostic (2.90e-2)" "unprognostic (1.16e-2)" "unprognostic (4.49e-2)" "unprognostic (5.51e-2)" "unprognostic (6.67e-3)" "unprognostic (4.09e-3)" 7.3 5.4 4.1 8.4 4.2 19.5 9.4 7.0 4.9 8.3 4.0 7.8 7.5 9.3 8.0 7.3 7.4 5.9 7.0 3.9 4.8 8.0 10.6 6.7 11.7 3.5 4.5 10.9 6.0 8.9 3.6 9.2 4.0 7.6 8.3 9.4 6.3 6.4 7.2 7.2 7.3 7.6 4.3 9.4 8.6 10.1 4.6 12.6 10.9 9.2 11.3 9.3 5.9 4.9 15.0 12.1 15.3 24.8 13.1 12.5 17.7 10.9 12.3 15.7 17.2 21.3 18.9 31.7 8.4 12.5 21.5 15.3 23.1 25.2 27.7 24.3 10.2 21.7 12.9 14.9 14.4 34.3 24.1 11.7 13.0 16.9 29.9 12.1 14.2 14.9 24.3 18.7 15.0 13.5 25.0 17.4 21.2 16.5 13.6 22.2 23.7 21.9 16.0 16.6 19.1 13.1 22.5 21.7 17.8 15.6 25.3 18.7 13.5 16.6 17.6 12.5 17.8 17.7 18.1 36.6 12.5 24.7 15.7 1.7 0.8 1.6 1.4 1.3 1.6 1.2 1.4 1.6 1.1 1.4 1.8 1.5 1.2 1.8 1.5 1.3 1.5 0.7 4.1 4.2 7.0 4.9 3.9 4.8 3.5 4.5 4.0 4.3 4.6 4.9 12.7 16.0 17.6 20.5 13.1 66.2 9.5 52.6 6.2 11.2 13.0 8.6 17.3 5.7 32.3 14.7 10.4 9.2 17.6 10.1 1.9 7.8 32.4 15.1 11.8 15.7 10.8 11.8 32.2 6.8 8.3 17.0 11.2 13.9 22.1 12.2 11.4 12.1 11.2 15.2 31.4 13.8 30.5 20.4 40.6 6.6 11.5 14.1 19.6 28.1 16.9 8.4 12.3 28.6 43.8 11.5 8.7 14.7 7.3 17.4 9.9 7.9 36.8 8.7 0.0 16.5 24.1 31.4 13.2 12.0 62.1 9.7 15.7 9.8 12.5 19.7 RBMX "hnRNP-G, HNRNPG, RNMX" ENSG00000147274 "RNA binding motif protein X-linked" P38159 X 136848004-136880764 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Cancer-related genes, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" Nucleoplasm "HPA057707: AB_2683508" "unprognostic (1.53e-1)" "unprognostic (1.52e-3)" "unprognostic (2.12e-3)" "unprognostic (1.14e-2)" "unprognostic (2.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (5.59e-2)" "unprognostic (1.05e-2)" "unprognostic (1.68e-2)" "unprognostic (4.87e-2)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (1.57e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.64e-3)" 81.0 57.0 35.7 80.8 39.3 172.5 119.7 40.5 39.7 108.8 36.9 82.9 77.8 142.0 85.9 64.5 116.5 68.2 72.2 33.9 36.2 77.7 66.5 71.8 117.8 40.7 36.4 242.9 86.8 76.6 48.9 80.4 40.8 83.9 101.6 82.0 68.5 82.1 126.2 69.6 75.5 118.2 38.8 89.1 71.8 34.8 35.1 210.8 92.5 103.9 145.6 89.1 77.9 51.9 235.0 250.2 448.6 201.0 109.6 184.3 261.2 227.7 246.3 308.4 324.6 268.8 228.3 422.9 229.2 163.9 193.3 152.9 481.9 238.3 353.6 184.2 226.8 324.6 240.9 289.9 95.9 358.0 285.6 152.5 113.1 240.6 333.6 236.3 252.7 392.0 296.6 210.3 254.4 297.9 526.3 240.5 285.7 248.1 207.0 430.9 300.2 262.0 229.6 275.2 260.8 281.7 181.9 162.4 213.8 263.6 186.8 237.7 161.7 173.5 188.0 121.7 294.8 149.2 214.9 444.3 123.9 256.7 242.6 131.6 158.5 90.6 142.1 192.8 199.7 194.5 184.8 170.4 175.6 187.4 231.9 192.5 25.3 173.9 178.9 106.4 203.9 302.6 35.7 39.3 40.5 39.7 33.9 36.2 40.7 36.4 40.8 38.8 35.1 51.9 112.1 112.2 139.0 55.2 223.0 151.9 209.0 151.6 128.1 112.4 229.8 208.0 100.5 153.0 167.3 88.3 95.9 187.2 200.3 80.1 154.6 157.2 10.9 83.5 147.4 130.5 202.9 195.7 33.2 148.8 269.4 156.6 75.4 84.3 268.8 212.7 204.5 119.3 117.0 92.5 41.2 170.9 81.4 223.2 112.2 10.5 171.8 109.0 96.0 27.2 176.9 99.4 157.6 57.3 56.5 108.0 99.1 133.2 124.0 108.2 140.0 120.3 123.3 137.9 92.1 159.7 161.6 33.8 81.2 94.6 122.3 111.5 195.5 135.0 216.4 157.4 RC3H2 "FLJ20301, FLJ20713, MNAB, RNF164" ENSG00000056586 "Ring finger and CCCH-type domains 2" Q9HBD1 9 122844556-122905359 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" "Repressor, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042863, HPA062144" Approved Enhanced Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" Vesicles "HPA042863: AB_2678204, HPA062144: AB_2732677" "unprognostic (6.05e-2)" "unprognostic (7.87e-2)" "unprognostic (7.24e-2)" "unprognostic (1.66e-1)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "prognostic favorable (5.50e-4)" "unprognostic (1.36e-1)" "unprognostic (1.68e-1)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" 11.9 8.9 8.8 12.1 10.8 32.5 10.4 14.0 10.0 13.5 4.4 10.4 9.9 11.9 8.1 13.0 9.7 11.0 13.8 10.9 7.9 12.7 13.4 11.5 18.5 7.1 7.4 11.2 6.8 15.8 9.6 14.6 7.6 9.7 11.2 16.0 9.0 9.1 11.8 10.0 9.4 13.9 7.1 14.1 11.8 11.6 8.0 18.8 12.9 15.3 17.2 14.4 9.0 10.5 17.3 26.2 33.5 18.2 17.4 19.8 17.8 22.0 24.4 25.2 21.8 31.2 18.8 28.8 16.7 29.8 30.1 40.9 35.4 25.1 27.7 13.4 13.5 16.4 44.4 21.3 23.1 19.9 26.5 19.9 25.5 24.3 34.6 22.0 35.6 25.4 24.1 21.6 32.9 23.9 20.2 14.7 17.7 24.9 21.8 19.7 54.8 19.4 25.8 13.9 38.3 25.8 39.2 24.9 21.2 22.8 29.2 17.2 33.9 20.5 17.3 27.7 39.8 14.0 25.4 32.1 22.3 18.2 23.1 10.0 4.6 6.0 6.1 7.3 5.1 4.3 4.8 6.0 4.1 5.8 4.5 4.5 8.0 4.0 6.7 6.5 5.1 2.8 8.8 10.8 14.0 10.0 10.9 7.9 7.1 7.4 7.6 7.1 8.0 10.5 33.8 41.7 32.8 20.9 27.7 11.0 13.6 20.0 20.5 19.2 15.6 10.5 34.8 12.8 17.3 9.2 37.5 15.7 26.6 18.9 3.9 12.0 5.9 27.6 30.9 28.3 23.3 22.7 38.4 11.4 15.2 18.4 23.9 40.1 17.1 21.9 29.6 19.5 9.6 28.6 35.1 19.8 12.2 27.4 19.4 9.5 13.4 21.4 14.2 30.9 26.1 16.9 24.7 35.2 39.3 23.5 9.0 18.0 22.5 24.3 14.8 12.0 17.7 20.2 19.7 16.3 24.1 30.7 17.9 23.3 14.8 23.0 28.8 15.4 14.7 27.3 RCAN3 DSCR1L2 ENSG00000117602 "RCAN family member 3" Q9UKA8 1 24502351-24541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 33.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 88.0;Enteroendocrine cells: 82.1;T-cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 38.2" "Lineage enriched" "Detected in all" 7 "T-cells: 38.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034533, HPA064289" Enhanced Approved "Nucleoli fibrillar center,Nuclear speckles" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 34: Non-specific - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" "Nucleoli fibrillar center" "HPA034533: AB_10601481, HPA064289: AB_2685232" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (4.01e-2)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "unprognostic (4.20e-3)" "unprognostic (3.41e-3)" "unprognostic (3.66e-2)" "unprognostic (6.42e-2)" "unprognostic (2.47e-1)" "unprognostic (1.72e-3)" "unprognostic (7.44e-2)" "unprognostic (3.52e-3)" "unprognostic (9.83e-2)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "unprognostic (4.71e-2)" 3.7 1.9 3.3 12.3 4.0 7.0 7.1 27.0 4.7 4.5 3.2 6.7 6.9 3.0 6.4 12.4 14.4 5.5 3.4 1.8 7.3 3.9 1.7 8.0 19.9 9.3 7.3 0.6 15.7 6.3 6.3 2.1 9.3 33.8 6.7 11.5 11.6 2.3 1.8 11.2 6.1 3.5 4.5 9.3 17.2 2.1 6.6 16.1 12.3 3.0 19.5 7.0 6.0 6.9 17.6 13.9 0.2 4.3 3.5 8.4 15.6 11.8 6.4 9.5 9.0 4.3 23.0 13.1 10.8 19.9 7.4 16.4 12.0 14.8 10.2 12.9 7.3 1.4 3.8 13.1 2.2 4.6 11.5 2.9 10.8 3.8 4.6 7.9 1.9 16.2 2.0 0.5 4.1 6.3 12.1 6.7 17.7 13.4 10.2 4.7 0.2 0.4 6.9 17.9 35.6 8.8 9.7 12.0 37.2 7.9 12.8 8.9 13.6 11.2 13.2 0.6 8.2 18.2 22.8 17.5 4.5 18.0 12.9 3.5 1.8 2.2 1.2 1.0 10.0 5.2 24.9 9.0 3.0 5.1 33.1 17.7 0.6 4.0 0.4 2.1 38.2 7.9 3.3 4.0 27.0 4.7 1.8 7.3 9.3 7.3 9.3 4.5 6.6 6.9 19.7 19.2 13.3 0.0 32.4 14.1 27.3 8.9 11.4 43.0 29.9 36.8 6.4 25.8 15.8 20.2 64.6 4.0 18.9 16.4 13.7 19.0 1.2 88.0 6.8 8.6 82.1 2.5 1.6 28.2 10.3 6.0 26.5 34.1 16.5 14.8 7.1 2.2 8.5 25.2 6.7 14.4 14.2 8.4 28.0 0.0 1.8 23.0 30.2 5.6 31.5 9.1 6.2 0.0 21.2 43.2 11.3 1.2 22.0 53.9 4.3 1.0 67.7 34.5 0.0 4.7 10.4 0.7 17.5 26.9 21.7 5.3 106.8 0.1 12.2 26.3 RESF1 "C12orf35, FLJ10652, FLJ20696, GET, KIAA1551, UTA2-1" ENSG00000174718 "Retroelement silencing factor 1" Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 73.9" "Cell type enhanced" "Detected in some" "Adipocytes: 35.8;B-cells: 43.7;dendritic cells: 88.1;Hofbauer cells: 34.1;Plasma cells: 66.6;T-cells: 21.5" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 212.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 212.8" "Cell line enhanced" "Detected in all" "SuSa: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Nucleoli rim" "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 14.3 7.1 2.5 50.7 3.1 21.8 13.9 7.5 10.9 28.9 2.2 14.0 23.8 23.2 9.1 10.6 38.1 19.3 8.1 1.8 3.3 9.1 24.9 17.1 70.2 4.1 2.8 73.9 6.7 9.8 4.0 37.9 5.0 9.2 13.8 7.0 8.2 11.2 4.1 9.1 27.3 16.0 2.0 45.3 20.5 13.2 3.6 60.7 12.6 11.9 62.5 17.7 8.6 5.1 7.6 13.3 22.5 8.6 10.1 12.0 33.6 9.1 9.0 6.0 6.9 50.6 48.9 36.4 21.9 7.6 21.5 9.6 31.3 6.0 8.4 27.1 4.4 51.1 6.7 6.7 19.7 37.0 79.2 6.5 9.0 7.1 11.6 25.4 50.3 24.0 29.5 56.1 6.8 3.7 52.6 15.6 48.3 28.4 5.5 24.1 21.4 16.0 6.3 14.0 9.0 8.1 11.7 6.0 6.0 112.9 20.8 40.5 32.0 6.7 10.4 11.5 9.6 33.9 38.1 44.8 3.6 20.6 7.4 55.5 14.7 15.4 42.2 16.1 40.3 33.6 38.0 40.7 12.3 26.8 44.1 43.8 212.8 30.6 18.1 7.7 38.9 20.4 2.5 3.1 7.5 10.9 1.8 3.3 4.1 2.8 5.0 2.0 3.6 5.1 35.8 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 15.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 2.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 5.1 21.5 0.0 0.0 0.0 REST "DFNA27, NRSF, XBR" ENSG00000084093 "RE1 silencing transcription factor" Q13127 4 56907876-56966808 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006079, CAB068222" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "CAB068222: AB_2665651, HPA006079: AB_1079801" "unprognostic (7.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (1.39e-1)" "unprognostic (7.47e-3)" "unprognostic (2.30e-1)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.32e-3)" "unprognostic (1.73e-1)" "prognostic favorable (9.50e-5)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" 6.9 5.5 5.7 9.4 6.5 24.8 9.8 6.3 7.5 8.8 9.4 6.9 6.4 9.3 8.9 8.2 7.8 7.9 7.6 5.0 5.2 10.9 11.5 8.0 13.4 8.0 6.6 11.2 7.7 13.8 0.5 9.9 7.8 10.0 7.0 7.5 7.8 8.1 5.2 8.9 6.3 8.0 6.6 10.7 8.2 12.3 6.8 18.1 10.9 6.5 13.6 8.7 2.1 7.4 10.8 13.0 17.4 18.2 13.2 16.0 22.7 15.6 13.8 16.0 14.7 11.5 16.5 24.5 23.5 16.8 10.7 9.8 13.2 16.3 24.4 12.6 8.1 22.0 9.4 12.5 16.2 29.0 13.5 16.5 14.6 15.1 16.0 20.5 20.1 19.0 14.3 26.3 19.0 17.3 31.5 21.3 15.2 12.3 8.9 30.0 14.5 8.1 19.0 18.3 0.3 8.1 17.8 18.8 14.6 24.8 19.3 20.3 28.7 20.4 18.1 12.4 14.2 10.8 7.8 15.1 13.2 16.7 10.8 7.4 2.5 7.2 6.2 3.9 6.2 11.6 6.9 5.9 5.2 21.1 10.8 4.4 2.8 6.1 7.9 6.0 9.4 2.5 5.7 6.5 6.3 7.5 5.0 5.2 8.0 6.6 7.8 6.6 6.8 7.4 38.1 70.5 60.2 18.6 51.1 57.1 51.9 33.3 99.6 1.6 42.6 35.2 50.2 42.9 43.3 29.5 81.3 58.0 65.2 21.4 23.5 58.4 9.7 67.3 64.3 50.5 3.6 54.7 0.1 38.2 57.1 40.8 23.9 63.4 51.4 56.3 47.2 31.0 32.2 0.0 0.2 23.5 44.7 36.2 37.9 11.9 39.4 44.0 21.4 12.2 78.0 45.1 71.1 11.1 21.1 45.8 29.0 36.9 44.3 44.3 22.1 24.4 43.3 36.1 32.9 56.5 56.0 58.3 53.8 55.0 45.7 66.4 66.6 62.3 26.1 48.7 RFC1 "A1, MHCBFB, PO-GA, RFC140" ENSG00000035928 "Replication factor C subunit 1" P35251 4 39287456-39366375 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" Neuropathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009520, HPA046116, HPA069306" Supported Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115" "unprognostic (8.23e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.43e-5)" "unprognostic (4.15e-2)" "unprognostic (4.08e-2)" "unprognostic (3.38e-2)" "unprognostic (7.48e-2)" "unprognostic (3.30e-1)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-2)" "unprognostic (4.14e-2)" "unprognostic (1.62e-3)" "unprognostic (4.48e-2)" "unprognostic (1.31e-1)" "unprognostic (5.41e-2)" "unprognostic (1.47e-2)" 15.6 19.0 13.7 16.7 19.2 33.1 22.2 15.4 15.6 16.9 12.0 15.3 13.3 19.2 17.4 13.8 14.6 12.2 16.5 13.5 14.9 20.8 25.5 18.2 30.2 16.5 15.6 26.1 29.0 31.4 14.7 14.6 18.0 17.8 14.8 24.3 16.6 16.1 11.6 14.9 13.8 17.1 15.4 17.0 14.9 11.8 14.8 28.0 23.1 15.9 30.2 13.5 14.1 25.5 43.5 19.4 53.7 44.1 25.4 32.0 27.5 49.1 44.6 49.2 58.2 37.8 43.1 106.5 32.4 33.2 52.8 20.7 49.8 42.6 78.5 19.5 33.9 48.0 35.6 34.7 30.6 67.5 30.7 24.6 33.8 49.9 55.3 39.1 38.8 52.1 48.0 22.1 37.9 17.5 99.7 43.4 33.0 26.8 24.2 78.1 97.8 33.7 21.4 30.1 37.6 36.4 29.1 11.3 37.6 33.4 29.8 37.5 30.0 40.3 49.6 37.8 63.1 31.0 45.8 101.3 33.1 69.3 41.2 8.2 8.6 3.8 13.7 6.9 10.1 14.6 11.7 11.9 6.9 16.1 13.8 12.2 3.9 12.6 8.9 14.3 11.5 5.5 13.7 19.2 15.4 15.6 13.5 14.9 16.5 15.6 18.0 15.4 14.8 25.5 65.5 64.1 120.6 33.0 62.9 20.6 37.9 26.5 47.3 67.8 60.5 62.4 86.1 45.8 37.0 57.0 60.5 43.1 83.8 30.6 72.4 54.8 73.0 45.9 79.1 56.1 30.0 57.9 22.0 66.0 48.5 54.9 28.1 60.0 25.9 82.2 57.8 82.0 30.7 85.8 32.1 58.2 12.2 44.3 16.6 32.3 82.0 35.1 16.0 22.5 58.1 82.7 107.1 38.7 95.7 51.1 34.2 91.7 75.0 50.0 36.1 124.2 32.6 83.3 59.2 61.6 54.6 49.0 66.5 38.2 21.3 32.2 63.7 70.8 49.1 44.5 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56245082 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 108.4;Excitatory neurons: 149.4;Inhibitory neurons: 164.0;Microglial cells: 91.8;Oligodendrocyte precursor cells: 187.0;Oligodendrocytes: 169.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035462, HPA057957" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152, HPA057957: " "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 3.4 5.9 3.9 5.6 3.5 8.5 5.2 11.6 4.0 5.2 1.3 4.0 5.3 5.6 5.3 4.7 5.7 4.0 3.2 3.0 4.4 3.5 4.0 4.8 8.9 3.5 3.3 6.3 3.2 5.7 2.7 5.4 3.7 4.6 5.0 11.0 3.8 5.3 8.8 9.9 4.5 5.7 3.0 7.4 4.8 8.7 3.5 15.2 5.1 9.8 9.3 5.7 2.9 4.2 7.7 15.6 31.3 22.0 11.0 13.9 7.6 6.6 9.1 8.3 13.1 8.4 6.3 24.0 9.7 9.9 7.7 20.9 18.7 14.7 11.1 13.3 6.6 31.5 19.0 17.6 11.6 24.1 4.6 12.0 21.7 9.0 19.5 12.2 14.7 24.1 14.2 12.7 11.9 9.8 21.3 6.9 13.4 5.9 4.5 23.1 20.0 19.8 9.2 24.0 16.4 18.8 8.2 8.3 9.4 21.5 7.1 15.3 11.9 21.8 11.3 5.1 13.2 10.2 11.4 27.6 7.8 22.2 9.7 2.0 0.2 0.5 0.5 0.3 0.6 0.5 0.6 0.7 0.4 0.4 0.4 0.6 0.0 0.5 0.2 0.5 1.1 0.3 3.9 3.5 11.6 4.0 3.0 4.4 3.5 3.3 3.7 3.0 3.5 4.2 8.6 6.4 13.4 108.4 9.7 13.4 4.4 9.5 20.5 16.2 9.9 7.5 6.5 2.8 6.2 7.3 10.4 4.2 7.3 5.3 3.9 3.4 19.9 7.2 10.3 9.4 4.8 17.1 149.4 4.7 1.4 6.8 4.6 6.4 12.6 14.2 7.9 8.9 5.6 16.8 164.0 5.7 10.2 9.5 8.8 15.9 6.5 8.8 5.4 91.8 8.4 5.1 2.1 187.0 169.7 3.7 6.0 10.5 7.9 6.6 4.3 4.2 8.5 9.1 0.0 13.2 7.0 6.6 6.8 16.8 17.6 1.6 9.0 10.6 6.8 5.6 RFXAP ENSG00000133111 "Regulatory factor X associated protein" O00287 13 36819222-36829104 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding SCID "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032035 Approved "Nuclear speckles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA032035: AB_2674120" "unprognostic (2.03e-1)" "unprognostic (9.69e-2)" "unprognostic (7.40e-2)" "unprognostic (3.13e-1)" "unprognostic (5.14e-3)" "unprognostic (4.45e-3)" "unprognostic (1.15e-2)" "prognostic favorable (2.26e-5)" "unprognostic (1.45e-1)" "unprognostic (2.94e-1)" "prognostic favorable (4.18e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "prognostic favorable (4.91e-4)" "unprognostic (2.81e-2)" "unprognostic (4.09e-1)" "unprognostic (5.99e-3)" 4.3 3.4 3.8 5.0 4.2 6.0 4.7 6.8 5.2 6.3 2.5 5.1 3.1 6.8 5.1 3.0 5.8 4.1 3.5 3.9 3.5 3.3 2.6 4.3 6.7 3.3 3.7 7.0 4.6 6.2 4.6 3.7 3.5 5.2 4.1 5.5 4.8 3.8 4.3 3.5 4.4 5.8 4.0 5.1 4.2 6.5 3.4 8.3 5.8 3.0 5.4 4.0 3.8 4.3 7.4 1.8 10.4 14.7 3.8 5.2 6.7 5.9 6.2 10.9 6.7 5.2 5.9 32.3 4.8 5.4 9.6 6.7 10.8 3.6 12.2 24.4 17.9 15.5 8.6 10.2 6.9 28.7 10.9 4.8 6.3 5.3 4.0 3.1 8.3 24.4 9.0 6.4 3.3 3.6 28.8 20.5 11.1 6.4 3.2 24.9 19.3 9.8 4.6 4.5 8.5 10.6 5.7 3.8 4.7 6.3 3.9 16.9 6.5 2.8 6.1 9.8 5.5 6.0 5.3 24.2 7.9 19.6 4.5 0.0 0.0 0.5 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.3 0.2 0.0 3.8 4.2 6.8 5.2 3.9 3.5 3.3 3.7 3.5 4.0 3.4 4.3 6.6 3.2 3.9 11.1 10.4 3.6 3.3 2.5 7.4 14.5 4.9 4.4 3.6 1.5 2.7 3.7 2.1 6.4 11.1 2.0 15.6 4.2 5.3 4.3 7.5 7.0 7.2 16.0 26.4 5.5 2.8 9.8 4.6 3.0 10.2 10.9 7.9 2.2 3.1 23.5 27.5 2.8 2.0 1.9 7.4 4.1 11.1 4.1 7.2 7.5 5.5 20.8 17.5 11.1 23.9 2.8 2.5 10.9 6.4 1.5 3.3 1.4 2.2 18.0 6.6 13.1 10.0 20.1 25.8 2.8 2.0 1.2 11.7 8.2 3.6 0.8 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: AB_2675361, HPA036888: AB_2675362" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 6.1 5.0 4.4 7.4 8.4 21.7 10.0 13.8 7.0 6.5 2.6 5.6 4.3 8.2 4.0 5.6 5.6 5.6 3.5 4.6 5.1 5.5 6.7 5.1 8.5 4.4 5.1 11.2 7.0 6.8 3.5 8.0 5.4 6.0 6.1 8.2 7.7 5.0 7.5 7.2 4.6 6.2 4.9 6.5 6.1 11.0 4.5 10.7 9.1 9.5 7.9 7.3 4.6 13.8 20.8 17.4 26.8 20.5 10.7 13.8 25.9 24.8 18.0 21.6 25.5 28.9 16.4 39.2 21.7 17.3 17.9 21.3 41.2 17.1 36.1 27.8 19.8 63.4 21.4 21.0 11.2 64.7 20.2 10.3 11.3 38.8 28.7 12.3 21.3 23.5 52.2 32.6 22.1 13.8 38.3 22.9 43.2 11.2 22.9 38.4 42.1 26.1 11.6 24.9 24.2 18.8 32.0 14.6 16.5 18.8 12.9 23.1 27.0 32.9 22.8 20.3 26.7 16.0 29.6 55.4 15.3 25.5 22.5 6.3 2.5 3.0 4.3 1.7 4.9 4.0 3.6 3.2 1.8 3.1 4.8 3.7 2.8 7.7 3.5 1.6 2.8 1.7 4.4 8.4 13.8 7.0 4.6 5.1 4.4 5.1 5.4 4.9 4.5 13.8 53.1 96.1 49.7 41.1 43.5 49.3 47.5 21.9 33.0 48.2 30.4 29.8 38.2 28.6 38.0 14.7 31.3 39.2 40.3 19.6 1.9 38.5 22.6 38.0 61.7 48.0 25.0 84.3 68.5 21.9 35.9 51.3 34.7 65.0 34.1 88.6 27.1 19.7 23.0 47.1 72.4 30.9 14.2 26.4 27.0 14.0 43.8 37.6 30.2 48.7 44.1 35.8 32.0 73.9 126.3 29.9 23.5 34.3 45.1 53.2 14.9 12.9 21.3 42.8 85.5 106.5 51.2 122.8 113.1 28.9 41.6 40.9 45.3 58.9 34.6 45.4 RMI1 "BLAP75, C9orf76, FLJ12888" ENSG00000178966 "RecQ mediated genome instability 1" Q9H9A7 9 83980798-84004074 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 70.0;Late spermatids: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021661 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" "HPA021661: " "unprognostic (9.59e-2)" "unprognostic (7.96e-2)" "unprognostic (6.72e-3)" "unprognostic (3.03e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.65e-1)" "unprognostic (3.39e-3)" "unprognostic (1.32e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.68e-3)" "unprognostic (3.42e-1)" "unprognostic (2.42e-1)" "unprognostic (9.24e-2)" 2.5 8.3 2.9 6.0 3.2 3.9 4.5 4.6 3.4 3.2 6.0 6.6 6.2 3.5 5.6 4.9 5.8 2.8 3.4 2.4 5.8 4.4 5.8 3.3 10.2 3.3 3.3 4.4 5.8 7.7 3.7 3.6 3.5 4.8 7.4 7.0 6.0 3.1 3.7 5.1 6.8 3.3 3.2 6.4 6.2 8.9 3.8 10.2 6.0 3.9 9.6 3.6 2.4 3.8 25.2 14.9 33.6 12.4 5.5 7.7 33.9 24.1 13.6 20.7 19.4 7.5 17.0 55.4 8.5 12.4 21.7 36.9 22.0 12.3 25.3 29.2 6.1 23.0 12.1 11.8 7.7 42.6 23.1 7.4 7.8 17.6 12.6 6.7 11.1 28.2 16.7 26.3 23.2 18.1 54.4 17.4 31.3 31.6 15.7 47.8 33.9 21.0 10.8 10.4 30.4 19.3 21.3 18.6 9.8 15.4 19.4 20.8 6.6 22.9 14.7 23.2 20.1 11.6 25.6 20.2 14.6 19.7 26.4 14.2 4.5 8.8 1.8 5.5 2.2 2.8 2.1 1.9 7.2 2.6 2.2 2.5 7.8 2.8 6.5 2.2 3.0 2.6 2.9 3.2 4.6 3.4 2.4 5.8 3.3 3.3 3.5 3.2 3.8 3.8 5.4 9.6 5.1 10.1 5.9 2.7 3.2 4.3 4.0 4.1 4.3 3.3 8.5 2.8 9.0 1.8 4.2 7.9 2.1 6.1 5.9 5.5 70.0 13.9 6.5 3.8 6.7 24.4 7.1 3.0 16.2 3.3 8.2 10.2 4.5 9.0 5.0 13.3 8.1 10.1 11.2 9.8 0.0 10.7 4.3 62.1 2.1 7.4 12.4 8.4 8.5 7.7 5.2 26.2 12.6 2.7 5.6 2.2 7.8 4.2 8.9 4.9 11.1 5.2 0.0 3.3 3.4 34.0 22.6 6.9 4.8 4.2 4.4 7.7 10.1 2.4 RNASEL "PRCA1, RNS4" ENSG00000135828 "Ribonuclease L" Q05823 1 182573634-182589256 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002633, CAB010906" Approved Supported Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB010906: AB_477444, HPA002633: AB_1856314" "unprognostic (3.46e-2)" "unprognostic (9.10e-2)" "unprognostic (7.74e-2)" "unprognostic (1.13e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.43e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.81e-1)" 5.6 6.4 3.2 8.8 3.5 3.6 5.9 3.4 3.9 6.6 3.7 8.1 7.0 6.5 9.6 6.2 5.2 6.9 3.4 2.9 3.4 6.2 3.5 6.9 9.6 3.4 3.5 11.3 3.1 7.9 5.4 6.9 3.6 7.2 9.0 5.7 5.0 8.3 2.0 5.4 8.0 7.1 2.8 8.9 7.8 2.2 3.6 8.0 9.1 4.5 9.9 6.0 6.3 3.3 2.6 3.6 1.5 0.6 7.9 13.7 2.8 4.9 6.1 4.9 4.5 2.1 5.6 5.6 8.4 5.6 2.2 4.7 3.6 5.1 1.9 4.5 3.1 6.6 1.3 0.3 4.1 12.4 12.5 9.8 11.4 2.6 0.7 3.1 2.1 8.2 2.4 4.2 4.3 3.8 3.6 5.1 1.2 8.4 1.0 5.3 1.2 2.9 5.2 3.4 0.7 0.2 4.4 5.3 4.3 3.9 5.4 13.6 2.8 2.5 2.0 2.7 2.7 3.7 1.3 0.7 4.0 7.5 3.8 41.7 14.8 53.1 9.4 15.8 12.4 10.3 11.1 10.1 12.4 7.9 17.3 12.8 55.3 10.9 30.3 14.7 10.0 10.5 3.2 3.5 3.4 3.9 2.9 3.4 3.4 3.5 3.6 2.8 3.6 3.3 4.5 6.4 4.2 5.2 6.5 1.0 2.9 4.9 1.2 4.3 2.8 2.4 1.3 1.5 9.0 3.7 4.2 4.2 8.2 14.8 7.9 6.7 0.0 2.5 9.6 5.1 2.4 4.8 4.2 1.8 3.7 6.4 7.7 3.4 5.7 5.5 3.9 1.6 6.2 1.7 6.6 9.3 8.2 9.7 1.2 0.8 2.8 5.8 0.0 1.9 7.3 8.7 5.2 6.0 3.6 2.2 3.2 6.4 2.7 3.5 7.2 7.3 9.1 6.1 19.7 5.8 5.2 0.4 0.9 4.5 1.0 2.6 7.5 12.1 4.0 4.6 RNF111 "ARK, Arkadia, DKFZP761D081, FLJ38008" ENSG00000157450 "Ring finger protein 111" Q6ZNA4 15 58865175-59097419 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 81.6;Inhibitory neurons: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038576, HPA038577" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA038576: AB_10964492, HPA038577: AB_10960052" "unprognostic (7.30e-2)" "unprognostic (2.60e-2)" "unprognostic (2.39e-1)" "unprognostic (3.37e-1)" "unprognostic (7.94e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.21e-1)" "unprognostic (5.10e-2)" "unprognostic (6.12e-3)" "unprognostic (3.10e-2)" "unprognostic (1.42e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (9.74e-2)" 8.2 7.5 2.0 11.8 3.1 17.3 7.8 8.7 5.3 8.6 1.4 7.2 8.4 9.0 6.7 11.4 8.7 9.3 7.3 3.5 4.7 8.8 10.5 8.4 10.8 1.4 1.7 11.4 9.2 11.9 4.3 11.4 2.1 8.7 7.2 12.5 8.1 8.3 9.5 8.2 8.0 8.3 1.2 11.0 9.0 9.4 3.2 11.5 11.6 11.8 13.3 10.3 7.2 4.3 13.8 31.3 19.6 16.8 16.6 18.5 16.7 17.6 20.6 17.2 22.0 13.9 8.9 16.8 19.4 24.8 14.7 26.3 5.3 13.1 21.3 17.6 11.1 20.9 12.6 10.7 18.0 12.3 22.6 14.7 14.0 18.6 20.4 15.6 19.5 15.4 19.7 16.4 21.5 6.7 16.3 7.9 16.1 4.3 12.0 16.2 27.9 13.8 13.1 24.2 16.0 23.3 15.8 15.5 14.7 22.7 12.2 14.9 22.6 27.4 22.8 14.5 17.1 11.8 17.3 19.9 16.7 19.5 21.1 11.4 15.0 15.7 7.0 11.0 7.1 11.8 7.2 6.5 8.3 10.9 7.9 6.3 41.0 5.6 13.0 7.9 10.0 3.4 2.0 3.1 8.7 5.3 3.5 4.7 1.4 1.7 2.1 1.2 3.2 4.3 11.7 3.2 14.4 34.6 31.9 20.1 12.3 7.3 26.7 12.2 13.0 10.2 19.7 7.2 10.6 12.9 8.4 9.0 12.8 10.0 3.9 12.6 27.6 14.4 15.1 15.3 16.2 11.6 81.6 6.9 10.5 15.0 17.3 15.8 15.8 12.3 17.9 11.2 13.4 10.1 80.4 10.0 12.2 19.8 15.7 7.5 7.8 21.2 12.4 56.2 22.7 8.4 16.5 65.4 66.2 12.9 11.4 14.7 19.5 14.5 11.6 9.9 14.9 13.6 26.3 15.1 13.6 13.8 8.9 27.3 19.9 32.0 21.4 11.8 9.2 21.2 RNF6 DKFZp686P0776 ENSG00000127870 "Ring finger protein 6" Q9Y252 13 26132115-26222314 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 99.1;Late spermatids: 191.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039343, HPA040048" Approved Supported "Nuclear membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear membrane" "HPA039343: AB_2676456, HPA040048: AB_10672969" "unprognostic (3.22e-1)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.45e-1)" "unprognostic (1.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.68e-2)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "unprognostic (7.63e-2)" "unprognostic (6.13e-2)" "unprognostic (1.39e-1)" "unprognostic (4.21e-2)" "unprognostic (2.70e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (7.70e-2)" "unprognostic (8.47e-2)" 18.9 17.3 12.4 18.7 13.3 32.5 17.9 13.4 18.4 13.4 13.5 18.4 17.5 12.4 13.7 18.5 14.5 13.7 13.7 13.9 11.7 18.2 16.6 16.2 22.4 10.4 13.5 11.5 14.1 22.3 10.7 19.9 11.5 16.0 18.5 26.6 13.5 13.9 21.2 17.3 18.8 15.7 10.8 19.7 17.2 33.6 13.7 25.3 17.5 15.3 23.8 18.3 10.1 11.5 33.3 28.9 10.7 15.8 36.3 28.2 23.9 56.3 45.2 35.4 24.9 36.4 41.8 59.5 27.3 53.5 31.5 43.7 30.2 45.3 58.4 57.7 19.2 64.8 23.9 31.3 56.6 68.7 65.4 26.8 86.1 39.8 84.2 34.3 36.0 25.5 25.6 0.1 55.3 30.0 38.5 39.8 8.7 59.5 19.8 30.4 41.5 23.7 43.6 43.3 19.3 11.9 29.9 54.0 54.1 24.8 20.7 66.3 47.6 30.4 18.6 41.1 40.5 14.8 14.9 34.9 27.8 38.4 40.7 46.6 14.5 34.7 15.6 18.4 17.1 18.6 17.1 17.7 17.6 12.5 16.8 14.8 9.7 20.0 23.3 9.1 19.2 14.2 12.4 13.3 13.4 18.4 13.9 11.7 10.4 13.5 11.5 10.8 13.7 11.5 20.9 22.4 19.8 6.8 26.5 30.5 12.7 17.5 14.8 22.2 15.1 10.5 13.5 5.7 19.7 7.3 25.0 20.2 31.6 24.8 33.2 15.1 99.1 37.4 16.9 23.0 11.4 24.8 14.4 15.4 21.8 16.1 17.3 19.9 26.6 12.1 17.5 12.3 17.5 30.3 17.2 15.5 24.4 22.4 19.9 191.0 14.6 23.0 14.2 12.2 21.6 24.9 29.9 11.6 16.2 24.4 20.1 11.3 18.0 22.0 15.8 21.4 40.1 43.2 26.3 21.6 14.5 83.5 29.1 19.2 29.1 42.1 26.2 17.1 12.6 23.5 RNGTT "hCAP, HCE, HCE1" ENSG00000111880 "RNA guanylyltransferase and 5'-phosphatase" O60942 6 88609897-88963618 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA capping, mRNA processing" "Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 108.6;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 94.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003750 Approved Approved Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA003750: AB_1856383" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (2.82e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.48e-3)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (3.76e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-3)" "unprognostic (9.83e-2)" "unprognostic (6.55e-2)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" 5.3 6.7 4.9 8.2 4.9 9.5 5.6 9.1 5.7 5.2 2.6 4.6 4.2 5.2 3.6 7.2 4.1 3.7 5.3 5.1 7.0 5.3 6.9 4.4 17.2 4.6 5.2 4.8 2.9 6.4 4.9 5.0 5.1 5.3 5.4 10.6 3.5 4.9 5.2 4.4 5.2 6.1 4.6 7.6 4.2 9.3 7.3 14.7 5.6 6.4 17.3 6.2 4.8 5.3 9.2 14.0 21.1 26.2 12.0 12.6 12.4 20.2 13.4 16.4 20.4 15.9 6.8 23.1 16.2 14.9 21.5 11.1 24.7 16.5 29.7 31.8 19.0 30.5 11.4 12.2 9.5 33.2 16.6 7.7 13.8 16.8 15.9 13.6 14.7 12.7 30.9 18.1 23.8 12.0 14.6 22.8 12.5 15.0 11.7 28.6 32.0 13.3 14.0 14.2 12.3 17.3 16.8 9.8 11.1 19.7 10.8 31.8 11.5 13.0 12.0 14.7 27.9 16.1 31.6 13.2 18.9 23.8 24.1 5.2 4.1 7.6 7.8 5.9 7.8 22.9 8.6 9.7 5.8 22.8 9.7 10.1 3.4 10.9 5.5 4.0 9.0 5.4 4.9 4.9 9.1 5.7 5.1 7.0 4.6 5.2 5.1 4.6 7.3 5.3 8.9 0.0 16.2 54.5 60.4 8.3 10.7 6.0 10.8 22.4 6.5 6.1 10.7 7.2 12.9 12.9 39.6 10.4 19.7 8.0 0.0 6.3 17.9 7.9 12.1 7.0 9.1 7.6 108.6 4.9 9.9 9.7 15.8 12.4 8.8 11.0 7.5 10.3 7.8 15.2 110.2 7.0 4.1 9.1 7.3 5.2 5.9 13.6 3.6 69.3 9.8 7.2 18.6 96.5 94.3 7.2 5.1 7.9 42.3 8.6 4.6 6.3 10.1 43.4 6.6 15.8 9.5 23.3 20.1 10.7 8.7 11.8 24.6 8.0 6.7 7.4 RNMT RG7MT1 ENSG00000101654 "RNA guanine-7 methyltransferase" O43148 18 13726660-13764556 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039409 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center" "HPA039409: AB_10795289" "unprognostic (3.02e-1)" "unprognostic (1.07e-2)" "unprognostic (3.48e-1)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (3.04e-1)" "unprognostic (6.17e-3)" "unprognostic (1.43e-1)" "unprognostic (3.76e-2)" "unprognostic (1.42e-3)" "unprognostic (9.45e-2)" "unprognostic (9.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.78e-1)" 10.9 9.6 11.8 12.6 12.1 43.3 15.3 12.2 13.0 11.3 17.2 11.6 8.5 14.0 11.5 11.3 11.2 9.0 20.3 12.1 14.2 11.6 11.2 9.5 14.4 13.6 15.2 17.2 12.1 13.0 13.9 15.2 14.8 11.6 10.4 27.4 12.1 10.5 18.4 14.2 10.5 12.5 10.9 12.1 10.6 16.7 11.7 14.9 17.5 15.6 15.2 11.4 10.7 12.6 24.9 14.4 27.4 20.9 20.0 25.1 19.2 19.9 24.7 20.3 27.4 17.3 11.7 27.7 23.9 20.6 31.6 9.8 32.7 28.6 34.0 15.4 17.6 21.0 14.8 16.4 21.9 54.9 17.1 19.4 30.5 21.4 59.9 26.6 15.9 31.1 31.8 26.9 23.3 15.4 35.2 19.7 21.0 50.1 11.2 22.7 29.0 37.9 18.6 19.2 21.1 31.7 22.5 16.4 38.1 27.8 14.3 22.6 16.5 40.6 56.8 33.3 21.5 53.8 63.6 56.9 29.9 20.8 20.6 45.1 17.6 12.8 16.7 14.6 13.6 23.9 15.8 14.2 11.8 25.7 20.5 16.2 9.8 14.1 17.3 29.5 19.0 5.6 11.8 12.1 12.2 13.0 12.1 14.2 13.6 15.2 14.8 10.9 11.7 12.6 62.5 73.7 29.9 48.6 148.5 70.4 67.3 97.9 75.1 115.6 50.7 56.1 56.5 35.8 56.5 46.0 123.0 66.3 143.4 46.5 68.4 51.0 75.4 85.2 88.3 43.7 74.8 37.4 75.3 48.0 59.2 71.6 66.3 113.9 34.9 85.6 40.7 38.5 39.8 106.0 83.9 56.3 85.5 59.4 63.6 21.1 72.7 78.8 49.8 45.0 68.0 51.0 60.8 56.8 78.9 56.1 47.0 60.9 99.7 72.3 49.0 64.8 48.0 148.3 39.5 85.6 60.0 111.4 115.1 50.7 68.3 126.4 113.1 48.8 50.0 50.3 RPA2 ENSG00000117748 "Replication protein A2" P15927 1 27891524-27914746 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 162.3;Spermatogonia: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016538, HPA026306, HPA026309" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572" "unprognostic (2.59e-1)" "prognostic favorable (4.33e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "prognostic favorable (8.12e-4)" "unprognostic (4.29e-3)" "unprognostic (2.03e-2)" "unprognostic (8.62e-3)" "unprognostic (1.68e-1)" "unprognostic (1.58e-2)" "unprognostic (2.31e-1)" "unprognostic (3.59e-2)" "unprognostic (9.13e-2)" "unprognostic (2.30e-1)" "unprognostic (2.18e-3)" "unprognostic (2.82e-2)" 28.4 25.0 33.3 39.7 35.1 40.7 43.8 33.4 42.4 32.0 37.4 26.6 18.5 33.7 43.4 32.3 49.1 30.6 39.2 34.5 36.1 32.4 31.8 28.7 75.1 33.7 33.2 52.0 21.0 40.7 31.3 30.2 33.9 28.7 30.2 43.8 24.0 31.3 72.3 40.3 26.1 30.7 36.7 42.3 25.6 63.7 34.0 53.4 52.9 63.2 67.6 30.3 24.9 36.7 60.9 57.4 86.4 68.5 59.3 52.8 57.2 106.1 70.3 130.0 113.5 80.2 72.7 148.9 69.4 41.1 48.4 55.8 126.5 60.3 122.4 121.0 126.0 174.3 73.0 71.3 30.9 229.7 115.1 24.6 33.2 123.8 62.3 40.3 59.1 133.1 196.2 127.1 75.7 63.6 163.9 105.1 181.7 115.1 122.0 115.0 128.7 74.2 49.1 65.2 78.3 75.8 123.3 47.3 100.7 68.1 50.9 71.8 36.6 32.2 73.0 186.2 76.3 105.8 251.0 135.8 81.4 213.5 64.3 322.3 97.4 290.0 279.7 80.0 304.4 272.5 252.9 257.4 112.1 232.0 287.4 282.7 100.1 294.1 106.5 172.3 255.5 435.5 33.3 35.1 33.4 42.4 34.5 36.1 33.7 33.2 33.9 36.7 34.0 36.7 26.5 22.4 15.7 10.4 64.0 21.0 28.5 47.1 16.5 28.4 25.7 27.8 29.0 24.3 30.4 22.0 2.1 95.2 77.8 10.1 35.2 35.0 49.0 14.6 18.8 27.9 13.8 39.1 8.8 20.6 67.3 34.8 7.1 15.1 60.9 33.3 26.4 16.6 51.9 8.4 8.4 14.0 71.2 31.5 27.6 22.6 41.3 34.1 37.4 7.5 86.7 100.0 95.8 9.5 14.3 29.5 10.4 46.3 32.6 19.3 11.2 23.6 28.8 34.5 32.9 48.0 24.7 162.3 183.5 20.6 22.4 55.7 59.9 33.9 19.3 20.1 RPA3 REPA3 ENSG00000106399 "Replication protein A3" P35244 7 7636518-7718607 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 428.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005708 Approved NA NA 17000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA005708: AB_1856411" "unprognostic (2.06e-2)" "unprognostic (2.27e-2)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (7.20e-3)" "unprognostic (3.75e-2)" "prognostic unfavorable (5.16e-5)" "unprognostic (5.31e-2)" "unprognostic (2.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-1)" "unprognostic (1.20e-1)" "unprognostic (7.41e-2)" "unprognostic (1.08e-1)" "unprognostic (7.24e-2)" "unprognostic (2.61e-1)" "unprognostic (5.83e-2)" 16.4 25.7 12.4 22.9 14.4 46.2 24.4 14.3 19.7 12.5 19.9 25.2 15.8 10.5 37.1 19.6 25.5 10.6 20.5 12.3 15.7 35.7 40.5 14.6 37.9 13.9 13.1 12.7 15.4 46.4 27.2 16.4 15.3 11.5 19.9 34.1 14.5 13.6 18.7 13.3 18.4 9.6 14.7 23.4 20.8 22.5 13.8 51.8 19.3 12.5 35.6 16.3 12.5 15.7 174.1 95.9 94.8 102.3 35.2 31.9 67.2 47.6 44.3 73.0 116.2 92.3 153.1 88.4 45.2 36.0 235.9 129.2 64.5 85.9 106.4 41.1 112.0 48.1 111.9 189.2 15.3 102.5 38.9 23.4 29.9 85.0 59.6 36.0 41.9 168.6 119.5 132.6 70.8 257.0 83.9 198.1 149.9 104.9 125.1 98.3 154.9 141.6 52.3 84.0 70.5 86.8 88.2 91.6 51.0 137.9 122.0 107.4 19.3 60.5 169.1 99.8 113.7 102.7 199.9 167.7 89.7 119.3 118.5 17.9 25.3 27.2 34.1 40.8 40.9 75.4 55.7 44.0 31.9 76.9 45.6 46.3 22.2 29.7 49.0 61.6 68.5 35.7 12.4 14.4 14.3 19.7 12.3 15.7 13.9 13.1 15.3 14.7 13.8 15.7 35.6 38.5 39.5 2.9 93.2 40.5 65.0 160.8 41.5 24.1 54.7 73.9 39.0 60.1 89.5 71.7 10.4 152.2 53.2 61.9 273.9 84.8 96.9 144.8 34.9 35.7 25.3 218.2 5.2 105.4 257.5 43.3 39.8 61.8 53.9 43.2 36.0 154.5 131.4 16.8 5.6 75.1 83.4 48.7 54.2 24.4 39.1 49.9 56.9 1.9 68.2 63.7 56.7 6.0 5.8 64.1 70.4 24.5 75.8 25.9 74.3 428.6 269.9 44.7 6.6 34.7 46.9 112.7 65.9 59.6 34.4 66.2 68.7 46.1 90.5 66.2 RPAP3 "FLJ21908, hSpagh, spag, Tah1" ENSG00000005175 "RNA polymerase II associated protein 3" Q9H6T3 12 47661249-47706030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038311, HPA038312" Enhanced Enhanced Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA038311: AB_10671527, HPA038312: AB_10672512" "unprognostic (5.76e-2)" "unprognostic (2.25e-1)" "unprognostic (1.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.28e-2)" "unprognostic (4.47e-1)" "prognostic unfavorable (2.01e-5)" "unprognostic (9.89e-2)" "unprognostic (9.87e-3)" "unprognostic (6.34e-2)" "unprognostic (9.48e-2)" "unprognostic (1.28e-2)" "unprognostic (2.01e-2)" "unprognostic (8.35e-2)" "unprognostic (5.11e-1)" "unprognostic (3.29e-1)" "unprognostic (1.35e-2)" 10.0 10.6 6.1 19.1 6.0 12.7 15.8 8.4 7.1 12.7 6.5 12.5 13.8 13.9 14.6 13.6 14.6 12.1 16.2 5.7 7.6 13.0 15.4 10.2 29.6 6.2 8.6 19.4 8.5 17.3 8.2 13.1 7.8 12.9 12.8 11.1 9.7 12.5 22.8 11.2 12.6 15.4 6.4 17.4 11.0 15.8 7.9 23.5 13.8 23.7 29.2 16.9 9.2 7.8 42.6 39.1 46.5 32.1 24.5 34.7 39.2 41.4 42.5 51.4 43.8 54.5 47.2 93.9 55.6 37.0 37.0 41.5 40.7 24.6 59.5 50.2 38.0 63.3 25.1 26.6 21.1 68.0 42.4 17.1 29.6 60.2 21.7 41.7 32.6 36.2 70.6 28.0 45.9 30.5 58.7 48.9 49.9 39.1 33.2 46.9 56.1 46.0 41.9 38.3 33.5 24.3 48.5 39.4 41.9 49.0 40.5 40.4 23.5 35.4 47.0 39.3 46.5 21.8 43.7 66.5 33.3 148.5 22.3 3.7 10.6 32.9 10.2 20.5 10.5 20.9 11.5 11.1 14.3 17.9 14.5 13.3 19.7 13.3 25.8 9.9 15.7 9.0 6.1 6.0 8.4 7.1 5.7 7.6 6.2 8.6 7.8 6.4 7.9 7.8 16.8 12.8 17.6 11.4 30.0 13.3 14.8 20.3 24.5 18.1 18.3 19.3 41.7 11.5 21.2 11.0 8.4 23.4 33.7 7.3 23.5 17.3 9.5 51.3 23.4 13.8 13.1 18.3 15.3 19.7 16.3 21.0 15.3 26.9 12.0 22.5 8.6 18.0 18.3 11.8 12.7 12.2 14.2 19.2 16.9 7.1 21.8 24.9 7.2 14.0 44.0 13.4 25.7 16.1 16.8 11.7 16.8 20.7 31.0 7.5 9.6 30.2 30.1 14.8 6.6 16.8 18.2 48.0 37.1 22.7 10.2 17.0 21.3 18.0 14.6 9.1 RSBN1 "FLJ11220, ROSBIN" ENSG00000081019 "Round spermatid basic protein 1" Q5VWQ0 1 113761832-113812476 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042124, HPA049484" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear bodies, Vesicles" "HPA042124: AB_10794644, HPA049484: AB_2680787" "unprognostic (3.26e-2)" "unprognostic (1.32e-1)" "unprognostic (1.15e-3)" "unprognostic (2.13e-1)" "unprognostic (3.66e-2)" "unprognostic (2.30e-2)" "unprognostic (5.06e-2)" "unprognostic (6.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.96e-1)" "unprognostic (1.51e-2)" "unprognostic (4.67e-2)" "unprognostic (1.43e-1)" "unprognostic (1.24e-1)" "unprognostic (1.15e-3)" 6.4 6.0 4.6 7.7 4.7 34.4 8.2 12.7 6.1 7.9 2.8 8.4 6.2 10.3 6.5 7.3 7.9 6.4 5.2 4.2 5.3 8.0 6.4 7.5 10.6 3.1 3.7 14.2 11.0 11.0 5.1 6.6 3.2 7.9 8.6 13.7 6.8 6.9 8.0 7.5 7.5 7.0 3.9 9.2 6.8 10.7 4.3 12.3 9.0 7.9 10.5 6.4 5.5 5.2 14.6 4.1 13.7 8.2 8.0 9.2 6.6 5.1 10.9 10.1 10.5 4.9 4.3 12.7 7.9 6.3 4.6 6.2 9.8 6.2 16.4 12.3 7.1 9.6 4.4 5.6 6.0 18.1 9.9 7.0 6.7 8.6 8.2 8.6 8.1 14.0 14.7 7.7 7.5 14.9 14.7 10.8 11.6 4.6 6.9 26.3 13.4 6.6 6.0 6.2 13.8 11.0 9.7 9.4 8.7 6.8 4.5 12.1 9.7 9.0 9.7 13.5 8.3 10.3 8.2 15.9 9.3 10.9 15.4 53.3 14.5 25.6 29.1 11.7 29.3 32.2 31.2 27.2 12.8 33.1 31.9 26.2 29.0 25.4 13.4 27.3 30.6 12.6 4.6 4.7 12.7 6.1 4.2 5.3 3.1 3.7 3.2 3.9 4.3 5.2 37.4 35.3 20.1 16.0 52.7 74.7 39.2 26.9 45.5 90.0 35.0 46.7 21.5 24.3 29.6 25.8 66.7 26.3 68.0 55.5 19.6 22.3 25.6 26.2 39.4 38.9 49.4 37.5 34.3 26.0 24.1 41.5 17.9 28.8 36.1 23.4 32.5 18.7 19.2 97.6 34.2 58.5 28.5 26.3 37.7 9.0 50.4 25.7 40.9 30.9 35.0 56.7 62.8 33.7 34.6 21.2 54.0 49.7 34.7 44.3 40.2 17.2 27.8 106.5 39.5 43.8 54.9 96.8 37.0 34.3 65.1 31.5 84.8 24.2 52.7 37.8 RSBN1L "FLJ42526, FLJ45813, MGC71764" ENSG00000187257 "Round spermatid basic protein 1 like" Q6PCB5 7 77696459-77783022 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 349.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 60.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 60.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020406, HPA020413" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Plasma membrane" "HPA020406: AB_1856488, HPA020413: AB_2253910" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (2.41e-1)" "unprognostic (1.72e-1)" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (2.43e-2)" "prognostic favorable (3.74e-4)" "unprognostic (1.27e-2)" "unprognostic (3.78e-2)" "unprognostic (1.25e-1)" "unprognostic (9.02e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-3)" "unprognostic (1.53e-3)" 7.3 6.4 8.7 11.5 9.1 8.2 12.1 19.0 12.1 10.3 10.2 11.3 9.0 12.5 10.3 10.8 9.5 7.3 5.6 8.5 10.5 9.1 11.3 10.5 16.1 8.2 9.0 14.5 11.2 10.3 6.9 9.9 8.6 10.3 11.7 30.2 9.6 11.4 8.2 7.8 10.4 11.0 9.0 15.0 11.0 26.3 8.6 18.3 16.5 7.6 15.0 9.6 8.2 11.6 15.8 11.9 19.6 34.5 13.4 17.0 9.5 11.5 12.4 16.0 18.2 14.9 27.6 32.4 4.4 12.0 20.2 13.4 26.8 15.0 22.8 17.7 14.4 25.8 18.4 14.7 11.3 32.1 23.3 12.2 10.7 14.7 16.0 12.1 13.5 21.2 35.7 33.0 16.8 18.2 27.7 32.1 14.0 20.3 10.6 28.3 19.6 34.2 10.0 20.5 22.9 24.0 17.5 31.4 12.6 19.9 19.2 16.9 12.9 23.9 21.9 14.5 17.7 14.7 16.7 51.6 11.4 29.2 16.0 21.6 7.4 13.5 9.5 5.8 7.3 11.0 8.4 7.1 4.4 13.5 7.8 8.6 60.6 6.4 6.7 13.9 9.3 2.6 8.7 9.1 19.0 12.1 8.5 10.5 8.2 9.0 8.6 9.0 8.6 11.6 53.6 57.7 60.3 27.1 85.0 78.8 102.1 76.1 88.8 246.8 52.1 57.3 22.1 61.5 84.4 55.2 235.6 52.7 101.5 77.1 39.2 38.1 271.3 55.5 63.3 60.8 77.5 47.7 44.3 50.4 34.1 55.6 51.5 45.6 70.3 51.3 49.2 56.5 43.7 158.2 47.5 104.6 57.0 48.1 69.0 85.2 101.5 46.4 64.0 34.7 59.0 83.2 132.8 53.8 50.1 35.1 62.7 119.6 74.6 56.7 49.6 28.4 72.0 349.9 72.3 44.2 73.0 108.0 156.7 56.2 75.3 38.7 90.2 61.7 79.1 84.0 RSF1 "HBXAP, p325, RSF-1, XAP8" ENSG00000048649 "Remodeling and spacing factor 1" Q96T23 11 77659996-77821017 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022626, HPA046129, HPA057547, HPA064567" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289" "unprognostic (2.67e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (4.35e-3)" "unprognostic (5.00e-3)" "unprognostic (5.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.19e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.71e-1)" "unprognostic (2.22e-1)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" 12.5 17.9 10.8 16.5 12.9 25.7 15.4 43.9 13.7 17.1 1.5 12.8 9.4 20.0 8.9 14.1 14.5 16.6 14.0 8.7 15.4 14.3 11.7 13.2 15.3 8.3 8.5 26.3 16.9 17.3 6.5 18.5 8.5 15.4 12.6 25.9 10.2 13.4 11.7 9.3 10.8 17.5 8.0 16.3 13.5 23.8 12.0 22.6 22.3 13.4 13.5 17.0 8.4 15.5 27.7 18.2 62.0 33.3 20.6 25.9 23.3 31.7 31.0 25.5 31.4 48.0 37.5 46.7 33.2 22.3 39.4 28.1 36.8 23.8 47.7 33.4 16.3 43.9 25.1 13.0 19.6 42.2 30.0 21.8 17.5 35.0 55.8 29.7 32.7 15.2 72.8 43.0 29.7 18.7 29.7 23.4 36.1 32.9 24.8 49.1 107.5 30.6 13.5 35.5 37.3 37.6 48.8 19.1 18.5 32.2 34.3 20.6 41.2 45.0 38.8 71.0 23.1 25.7 35.7 106.3 11.9 28.1 34.5 49.3 17.8 32.8 27.4 16.9 18.8 34.3 16.6 17.6 14.2 35.0 22.7 22.9 46.4 23.7 30.1 32.0 17.0 7.5 10.8 12.9 43.9 13.7 8.7 15.4 8.3 8.5 8.5 8.0 12.0 15.5 100.3 118.6 113.5 99.6 98.0 90.5 69.3 89.7 93.9 123.0 68.8 85.1 97.1 54.3 84.3 73.5 75.0 57.8 85.1 53.0 46.9 79.2 112.4 72.9 95.2 96.5 85.6 71.8 129.4 55.3 50.6 90.5 51.0 86.0 95.5 132.5 79.9 46.2 45.6 146.4 129.3 64.7 71.2 62.9 68.5 40.3 126.8 66.5 56.9 98.4 93.9 124.6 120.5 157.8 144.7 73.1 63.4 118.1 74.8 97.6 44.1 38.2 69.7 97.6 105.2 99.3 100.4 114.8 109.4 57.2 84.0 67.5 99.9 141.7 58.1 91.6 SAAL1 FLJ41463 ENSG00000166788 "Serum amyloid A like 1" Q96ER3 11 18069935-18106087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039003, HPA039004" Approved Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA039003: AB_2676303, HPA039004: AB_10673602" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (4.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (5.76e-2)" "unprognostic (4.10e-3)" "unprognostic (1.53e-2)" "unprognostic (4.75e-2)" "unprognostic (7.26e-2)" "unprognostic (3.36e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.78e-5)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (3.72e-1)" "unprognostic (1.87e-1)" 6.0 5.3 4.9 8.2 4.8 19.1 10.0 5.6 6.1 6.2 4.3 9.6 8.0 7.5 7.7 6.6 5.6 4.8 6.5 4.6 5.0 5.4 8.3 4.9 14.6 4.8 5.3 8.2 8.1 5.4 5.2 7.0 4.9 6.0 11.9 8.2 5.6 5.8 5.8 5.7 6.7 9.6 4.8 7.5 6.7 12.8 5.1 13.7 6.1 7.2 15.6 7.8 6.1 5.7 27.1 41.5 29.5 40.5 19.5 21.8 24.6 29.9 20.4 44.8 52.8 57.8 10.1 73.0 15.5 16.9 62.3 34.9 56.9 48.5 62.6 32.5 57.4 33.6 24.9 35.0 15.9 57.1 28.6 15.2 22.2 28.7 42.9 16.8 38.5 62.8 50.5 23.9 37.2 36.2 66.7 54.2 38.5 41.7 39.0 65.7 51.8 25.4 25.7 31.4 36.4 34.3 26.9 28.4 36.4 37.1 18.2 25.9 15.8 51.0 35.0 29.4 43.2 11.6 37.7 80.6 21.2 45.2 47.5 11.1 12.9 4.3 14.0 15.4 13.5 16.5 16.2 12.3 22.3 11.7 12.3 13.3 0.6 10.4 14.6 11.4 20.9 10.8 4.9 4.8 5.6 6.1 4.6 5.0 4.8 5.3 4.9 4.8 5.1 5.7 7.6 0.0 10.8 7.5 15.9 4.6 7.8 16.0 9.6 9.0 7.2 6.9 8.5 2.8 7.4 1.8 2.1 22.0 13.6 6.3 5.9 9.6 21.9 4.4 8.0 8.7 28.1 11.1 8.5 10.2 23.1 8.0 4.6 4.2 14.0 15.3 5.7 4.6 16.1 0.0 9.5 10.7 8.2 10.9 7.3 3.5 8.1 7.7 5.4 6.5 10.7 6.5 4.1 15.1 11.7 6.6 7.5 7.9 17.3 3.8 6.9 7.7 6.0 8.5 6.6 6.1 10.5 41.5 24.9 8.3 5.4 10.4 9.9 10.1 15.1 6.1 SART3 "KIAA0156, p110, RP11-13G14, TIP110" ENSG00000075856 "Spliceosome associated factor 3, U4/U6 recycling protein" Q15020 12 108522214-108561400 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028840, HPA044322" Approved Supported Nucleoplasm No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA028840: , HPA044322: AB_2678895" "unprognostic (1.72e-1)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (2.74e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.38e-1)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (7.91e-2)" "unprognostic (1.61e-1)" "unprognostic (6.36e-2)" 14.6 15.1 14.0 18.5 14.0 25.5 14.8 17.6 15.1 18.8 12.2 15.9 12.6 19.3 13.7 19.2 17.4 11.9 13.9 13.7 14.6 13.9 16.1 14.5 26.3 12.5 12.9 23.8 13.2 18.3 18.9 15.4 13.0 16.5 15.2 20.3 14.1 14.5 17.8 19.0 17.2 13.9 13.5 19.8 15.1 16.8 14.5 25.7 18.8 15.1 23.2 15.5 16.0 16.8 34.5 61.5 45.4 53.8 24.2 18.9 43.6 29.3 35.8 50.1 37.2 51.5 23.4 51.3 20.1 26.4 32.2 32.0 68.2 33.9 44.1 61.8 43.0 74.1 40.9 47.9 39.2 74.0 44.4 26.4 31.4 31.9 46.8 38.1 30.8 42.1 85.7 33.7 30.9 34.6 69.9 57.5 90.2 27.6 59.9 67.3 44.7 59.3 26.1 57.5 56.8 40.3 45.0 17.0 30.7 38.7 49.0 51.1 26.0 39.0 21.0 30.1 30.7 42.6 68.3 75.6 34.1 42.2 46.2 6.9 6.2 6.4 8.3 5.1 9.9 7.7 6.3 8.3 9.0 7.1 9.4 6.0 1.6 8.6 7.6 6.1 10.5 7.9 14.0 14.0 17.6 15.1 13.7 14.6 12.5 12.9 13.0 13.5 14.5 16.8 14.7 19.2 24.5 16.0 25.9 14.7 16.3 15.4 16.5 42.0 11.5 11.4 19.9 10.0 23.4 18.4 35.5 21.4 21.1 12.0 7.9 14.7 53.6 15.1 21.6 20.0 12.5 23.1 22.1 12.7 14.0 17.1 15.3 15.9 17.7 21.9 11.7 12.5 13.2 35.3 22.2 9.3 24.4 14.1 13.8 30.8 10.2 17.0 16.0 16.9 18.6 23.4 14.4 19.1 24.9 13.5 7.7 17.7 29.6 16.1 9.5 8.2 27.4 39.1 32.9 22.0 18.0 27.2 31.1 19.6 18.0 23.7 24.2 19.1 14.0 17.0 SASS6 "DKFZp761A078, FLJ22097, SAS-6, SAS6" ENSG00000156876 "SAS-6 centriolar assembly protein" Q6UVJ0 1 100083563-100132955 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028187 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "HPA028187: AB_10602220" "unprognostic (1.57e-1)" "unprognostic (2.52e-1)" "unprognostic (3.07e-2)" "unprognostic (2.06e-2)" "unprognostic (1.31e-1)" "unprognostic (3.02e-3)" "unprognostic (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (8.43e-3)" "unprognostic (4.73e-2)" "unprognostic (6.56e-2)" "unprognostic (3.71e-2)" "unprognostic (7.76e-8)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.54e-1)" 1.3 1.2 1.0 2.9 1.2 6.0 2.8 1.6 1.5 1.6 0.8 2.2 2.8 2.0 2.2 2.1 1.4 1.0 1.0 0.8 1.0 1.0 1.4 1.3 4.2 1.1 1.2 1.8 1.4 3.9 1.6 2.0 1.1 2.1 3.0 5.7 1.8 1.5 1.3 2.1 2.2 1.8 1.1 2.1 2.1 6.7 1.0 4.3 1.5 0.9 3.6 1.4 1.6 1.3 17.0 5.2 13.1 11.5 1.5 2.6 19.3 10.7 4.7 13.5 15.6 9.0 8.5 18.5 8.0 3.7 8.0 14.8 18.0 6.5 18.6 8.9 17.8 16.2 10.9 11.3 0.9 26.8 14.5 1.3 2.8 11.4 9.0 2.7 7.3 12.2 25.8 17.6 6.7 4.8 22.2 12.9 17.5 11.1 10.7 16.1 25.9 9.4 6.5 8.1 9.5 14.0 9.9 17.0 8.7 9.4 8.6 15.9 3.8 9.5 11.6 10.9 14.9 7.4 18.5 24.6 7.7 17.7 5.3 3.9 0.1 1.0 0.7 0.6 0.9 1.6 0.8 0.7 0.5 0.7 0.7 0.6 0.7 0.6 0.5 0.2 0.9 0.3 1.0 1.2 1.6 1.5 0.8 1.0 1.1 1.2 1.1 1.1 1.0 1.3 7.2 0.0 2.3 8.5 12.8 4.0 2.8 7.1 6.8 19.4 8.4 9.4 2.9 7.2 5.9 1.8 16.7 13.6 13.5 2.4 1.9 7.5 15.7 7.4 5.8 5.8 4.2 33.2 7.6 5.6 17.3 7.0 7.1 5.4 5.7 15.0 6.8 3.1 9.1 8.4 9.6 4.8 14.2 8.4 4.7 6.2 8.1 5.8 1.8 5.6 6.1 13.3 20.6 5.0 16.1 6.2 2.7 10.9 19.7 4.5 2.2 4.3 4.9 23.0 0.0 12.6 5.9 77.4 36.0 11.9 4.1 5.1 7.9 4.0 8.8 2.1 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630" "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 31.1 21.2 22.3 41.7 29.6 89.6 40.1 38.7 23.7 28.0 36.5 31.6 29.4 34.5 41.2 26.7 26.6 30.9 30.0 19.7 25.2 29.9 42.4 31.0 54.7 30.2 26.5 37.7 23.5 39.8 17.2 31.5 32.5 29.4 34.9 60.8 27.0 24.9 35.2 40.3 31.7 29.2 25.9 43.0 29.6 29.0 26.3 44.4 34.7 38.6 49.8 31.8 23.6 38.3 56.4 49.4 60.6 50.7 41.0 55.7 56.0 64.7 52.6 54.8 39.3 180.3 60.1 116.7 71.0 69.3 32.3 54.0 62.4 52.2 61.9 62.1 42.1 108.8 64.5 47.0 32.3 115.6 70.4 46.4 54.7 47.2 71.1 62.9 57.1 50.0 85.1 62.3 70.3 51.9 87.2 63.4 47.0 0.6 67.4 70.2 81.7 57.9 52.4 70.5 34.2 35.0 71.9 60.8 35.0 47.6 56.4 123.4 71.6 55.9 46.3 42.5 34.9 44.4 36.0 187.9 47.0 245.0 21.8 39.4 19.6 29.5 21.7 19.9 19.9 28.6 20.6 21.3 16.0 28.2 22.2 20.0 51.5 21.3 23.5 30.2 20.8 12.9 22.3 29.6 38.7 23.7 19.7 25.2 30.2 26.5 32.5 25.9 26.3 38.3 180.2 176.3 164.0 91.4 200.4 128.5 127.6 87.4 132.1 134.9 101.8 96.8 187.4 88.6 131.7 79.1 127.2 86.3 229.6 96.1 54.8 117.8 57.7 133.3 148.7 146.2 103.3 118.4 75.3 107.9 72.5 135.3 69.3 152.4 222.7 224.7 114.5 138.9 109.8 107.7 81.7 123.3 67.1 158.0 160.9 39.2 121.8 157.3 67.6 141.5 211.7 105.2 185.3 119.6 122.4 103.4 103.4 103.8 126.4 121.6 97.2 83.5 149.6 198.4 124.9 176.3 129.7 157.6 82.5 116.4 120.5 61.0 170.6 114.2 107.5 145.0 SCAF8 "KIAA1116, RBM16" ENSG00000213079 "SR-related CTD associated factor 8" Q9UPN6 6 154733378-154834244 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035601, HPA035602" Enhanced Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA035601: AB_2674698, HPA035602: AB_10673220" "unprognostic (4.60e-3)" "unprognostic (3.67e-2)" "unprognostic (7.90e-3)" "unprognostic (2.50e-2)" "unprognostic (6.18e-2)" "unprognostic (1.13e-1)" "unprognostic (1.01e-2)" "unprognostic (3.41e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.61e-4)" "unprognostic (3.65e-1)" "unprognostic (2.08e-1)" "unprognostic (9.08e-2)" "unprognostic (2.66e-1)" "unprognostic (1.52e-1)" "unprognostic (2.42e-1)" "unprognostic (1.11e-1)" 19.2 11.8 7.9 15.6 10.3 37.2 18.9 17.8 9.9 18.2 2.7 14.9 12.7 22.1 16.4 13.2 17.4 13.6 14.8 6.9 8.5 16.6 15.4 16.2 22.6 7.3 8.5 27.0 14.9 21.3 10.2 18.9 6.2 16.9 17.6 23.2 15.6 15.6 18.7 18.3 14.3 20.3 6.8 19.1 15.2 23.5 8.7 26.8 21.3 19.1 20.8 15.3 14.7 10.4 16.2 15.3 44.6 27.1 29.3 29.8 27.2 25.7 35.8 33.1 33.4 24.2 16.0 49.7 20.4 29.6 29.4 21.1 39.5 33.8 44.2 21.7 19.7 44.6 16.0 29.8 33.8 41.7 28.8 32.3 35.0 29.0 45.0 25.7 28.6 21.6 52.6 29.4 30.8 29.1 44.6 28.2 31.0 24.4 11.3 42.3 24.4 27.1 28.1 29.0 27.4 32.3 26.7 34.7 19.9 32.1 22.8 47.8 26.3 18.8 23.0 24.6 26.2 27.2 21.7 54.0 23.4 25.6 30.0 0.6 1.5 1.8 2.8 2.0 2.8 2.4 3.0 2.9 1.7 2.6 3.0 2.7 1.9 3.1 3.8 1.6 4.0 1.4 7.9 10.3 17.8 9.9 6.9 8.5 7.3 8.5 6.2 6.8 8.7 10.4 23.1 25.6 18.1 89.8 22.6 12.6 12.2 11.9 17.6 19.5 14.6 12.4 33.9 7.2 11.7 12.9 25.0 11.1 23.2 15.8 1.9 11.3 3.6 18.8 25.4 16.6 13.1 18.7 105.4 11.8 8.8 17.5 23.0 25.0 34.2 29.3 18.5 11.6 13.3 13.5 114.2 14.1 6.1 20.8 9.7 5.4 16.4 16.6 10.6 119.9 13.5 16.1 8.2 121.2 145.8 13.6 11.8 12.4 13.7 13.7 11.7 6.5 15.8 21.4 26.3 24.5 16.3 21.4 21.2 14.8 10.7 10.7 19.2 19.5 16.1 15.4 SENP6 "KIAA0797, SUSP1" ENSG00000112701 "SUMO specific peptidase 6" Q9GZR1 6 75601509-75718281 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024376 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA024376: AB_1856678" "unprognostic (9.86e-2)" "unprognostic (1.20e-2)" "unprognostic (4.84e-2)" "unprognostic (1.87e-2)" "unprognostic (6.38e-3)" "unprognostic (7.33e-2)" "unprognostic (1.13e-2)" "unprognostic (2.97e-1)" "unprognostic (3.93e-2)" "unprognostic (5.32e-3)" "unprognostic (7.81e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.78e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.83e-5)" "unprognostic (1.72e-1)" 25.1 22.6 12.8 24.6 16.8 37.9 31.4 47.6 15.5 28.6 7.5 26.6 20.9 33.0 22.1 25.3 26.8 26.0 22.6 9.6 14.3 28.5 28.0 26.4 28.5 11.9 11.9 40.5 27.0 39.4 22.3 33.4 12.8 29.3 26.0 31.4 21.8 28.9 25.5 25.2 20.5 31.9 12.3 28.9 24.9 33.8 12.0 32.4 41.9 30.1 30.4 29.7 21.2 22.3 23.8 24.5 54.3 39.1 41.3 54.6 40.3 41.9 46.5 34.6 43.1 33.9 22.4 40.1 38.6 48.7 40.9 29.8 51.6 28.0 53.1 59.2 44.2 60.8 28.9 31.7 57.3 53.5 42.8 42.6 45.6 32.6 71.8 41.9 58.2 32.8 74.9 43.2 43.0 29.0 21.4 28.6 33.1 31.9 20.4 39.7 28.7 59.0 36.7 35.0 47.2 48.7 35.8 31.3 36.4 43.5 28.2 50.1 49.0 30.8 33.4 15.9 43.8 48.9 52.4 31.4 15.4 49.8 33.1 7.5 8.0 20.8 7.3 8.4 10.5 9.1 7.4 9.9 8.9 10.5 10.5 9.6 14.9 10.1 14.7 11.0 6.9 6.3 12.8 16.8 47.6 15.5 9.6 14.3 11.9 11.9 12.8 12.3 12.0 22.3 76.7 67.3 128.3 158.0 74.0 46.5 65.0 27.6 78.6 58.8 53.0 59.6 76.7 31.5 70.9 29.5 91.8 33.0 73.8 43.2 17.6 33.7 40.4 62.9 78.1 57.9 27.6 50.5 152.6 33.7 29.4 69.3 51.0 62.9 65.1 74.2 42.1 32.0 29.5 60.6 177.3 35.6 24.4 43.2 41.5 35.6 70.8 57.7 35.6 149.9 68.4 56.6 50.4 218.1 228.9 32.1 29.9 63.2 62.8 63.4 32.6 26.8 47.2 65.7 26.3 98.9 73.7 107.7 61.7 61.4 48.4 41.2 67.2 66.0 46.3 66.8 SENP7 ENSG00000138468 "SUMO specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 44.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 44.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027259, HPA071998" Approved Supported "Nucleoplasm,Nuclear bodies,Centrosome,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Nuclear bodies, Centrosome, Cytosol" "HPA027259: AB_1856679, HPA071998: " "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 15.1 9.7 9.7 13.7 12.7 24.7 16.9 21.8 11.8 15.8 9.7 12.5 7.3 26.8 14.7 7.8 16.1 14.2 9.5 9.3 12.3 11.4 8.7 12.8 23.1 13.9 11.7 26.3 12.8 16.9 10.2 19.4 14.0 12.7 10.8 26.0 8.9 11.5 11.2 20.8 12.4 14.7 10.1 16.9 14.1 9.1 11.5 20.5 17.5 11.2 17.7 11.8 11.4 20.3 9.2 6.1 29.4 16.4 5.6 8.2 5.3 5.2 3.8 8.5 10.4 4.0 8.3 7.0 7.9 5.1 7.8 9.1 9.4 4.8 17.0 13.0 2.7 12.7 5.1 5.5 4.5 7.4 12.2 6.4 8.5 4.3 9.6 7.6 12.2 13.4 10.5 17.6 8.1 6.1 13.7 8.6 6.0 4.8 6.3 15.2 8.0 6.4 10.1 5.2 11.3 8.8 4.8 4.8 6.5 15.0 8.0 9.8 10.2 11.8 7.1 3.9 5.2 12.2 7.8 16.4 4.1 9.7 9.8 44.1 5.9 5.9 5.8 5.4 7.3 6.4 7.8 5.8 4.8 9.0 10.3 7.1 17.3 9.3 6.3 4.1 6.9 6.1 9.7 12.7 21.8 11.8 9.3 12.3 13.9 11.7 14.0 10.1 11.5 20.3 44.5 16.0 24.9 78.4 33.0 9.1 8.4 7.4 21.1 48.3 14.4 12.2 21.6 2.8 18.4 16.5 20.9 5.8 30.8 5.4 5.9 8.1 4.1 33.1 48.5 28.4 13.1 18.7 62.4 5.2 2.7 23.4 21.4 34.1 37.2 28.6 32.9 10.3 8.2 52.2 109.6 6.5 12.2 20.5 9.5 4.0 18.3 19.1 10.6 80.6 13.6 16.7 35.0 157.3 134.4 6.9 4.1 19.5 23.5 4.8 7.0 8.5 27.5 33.8 46.0 29.7 23.3 22.8 19.9 13.4 9.9 2.5 41.0 21.1 5.9 6.1 SETD2 "FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A" ENSG00000181555 "SET domain containing 2, histone lysine methyltransferase" Q9BYW2 3 47016429-47164113 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042451 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA042451: AB_10806239" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (6.08e-2)" "unprognostic (1.01e-1)" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.40e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.19e-2)" "unprognostic (2.45e-1)" "unprognostic (7.84e-2)" "prognostic favorable (7.99e-6)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (8.79e-2)" "unprognostic (5.43e-2)" 9.9 6.5 8.2 10.7 10.5 23.8 10.3 24.1 8.3 12.6 10.8 9.7 9.1 13.3 6.1 9.8 11.0 8.5 7.2 6.2 6.7 10.8 10.0 9.4 13.5 8.3 8.5 15.3 13.3 16.2 2.2 11.4 8.4 10.2 11.0 10.6 9.6 9.7 11.1 9.0 10.3 11.9 8.1 11.4 10.7 13.1 7.9 19.2 15.5 14.5 13.3 9.8 4.0 12.8 21.1 13.2 25.4 14.5 15.3 18.9 11.3 17.9 17.0 20.8 19.9 15.4 13.8 43.5 11.6 25.5 20.0 12.4 29.5 17.6 27.6 27.5 12.2 47.3 24.8 12.4 11.7 34.1 26.5 15.2 17.3 20.7 24.6 15.3 20.1 22.8 29.9 16.6 17.8 9.5 26.7 8.5 20.6 9.4 15.4 17.5 25.6 23.2 12.4 26.6 10.9 17.6 29.5 11.8 12.0 17.2 12.9 27.5 26.7 24.6 18.1 21.5 29.9 22.0 25.4 43.7 14.2 19.6 14.6 1.3 1.2 2.9 2.0 1.1 1.1 2.2 1.2 1.6 1.4 2.5 1.7 1.6 3.3 3.6 1.1 1.5 0.6 0.6 8.2 10.5 24.1 8.3 6.2 6.7 8.3 8.5 8.4 8.1 7.9 12.8 50.5 48.1 58.8 115.9 58.3 33.3 22.6 15.6 54.1 40.5 31.0 29.1 67.2 27.1 53.2 11.0 41.7 20.3 58.2 32.6 11.7 20.9 26.1 62.8 63.0 41.2 22.1 38.9 131.4 22.4 12.7 39.2 56.6 66.2 58.8 68.9 23.6 29.8 16.8 26.9 129.4 28.2 14.2 28.8 26.5 35.1 30.4 42.7 17.8 148.9 37.9 22.7 43.3 113.1 143.2 23.7 22.3 33.1 54.0 31.2 24.6 11.5 49.7 39.9 13.1 56.1 42.6 71.0 29.3 60.2 35.7 18.5 65.3 57.1 29.5 34.7 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated histone lysine methyltransferase 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 341.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: AB_2683731" "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 13.5 11.3 7.1 15.2 8.2 18.1 16.7 12.8 8.9 14.4 8.7 13.4 12.5 18.1 13.1 11.8 15.3 11.5 8.2 6.7 7.9 11.7 11.5 13.4 19.6 8.2 7.6 19.4 13.3 15.7 8.6 17.7 7.6 11.4 15.5 14.2 12.3 12.2 16.4 14.4 13.7 16.5 6.0 19.9 13.4 25.1 8.4 21.6 15.5 11.7 20.3 13.1 12.7 10.3 22.9 26.3 37.1 24.6 17.5 23.2 61.7 18.6 21.2 26.2 22.2 17.9 31.1 44.9 24.9 20.7 10.4 28.1 35.0 20.0 20.7 21.8 43.3 25.5 27.3 20.8 24.7 45.3 23.2 30.5 22.0 21.8 34.8 26.6 31.2 28.3 43.4 35.6 18.9 44.1 31.6 26.4 51.1 32.1 20.6 36.3 24.3 33.4 20.1 25.9 27.1 49.1 28.4 32.9 22.5 44.5 35.7 60.4 21.2 15.3 15.7 17.0 26.3 36.6 42.3 341.6 15.7 15.7 15.1 6.9 8.3 5.7 5.8 11.6 6.1 6.1 5.3 6.6 9.7 8.3 5.7 5.9 4.8 6.3 8.5 6.5 3.5 4.3 7.1 8.2 12.8 8.9 6.7 7.9 8.2 7.6 7.6 6.0 8.4 10.3 8.5 6.4 14.0 15.3 15.3 5.5 9.3 6.6 10.2 11.0 9.8 10.7 5.5 10.0 7.8 7.3 18.8 13.9 8.8 6.6 3.9 7.6 26.1 10.8 13.3 8.3 3.6 9.2 19.6 5.7 8.5 9.1 10.2 10.7 7.6 17.9 11.4 8.1 9.9 6.7 19.4 9.7 12.2 17.2 5.1 31.0 10.2 13.9 1.8 23.4 14.4 6.2 14.4 15.6 23.5 8.1 9.5 9.8 8.9 8.2 7.6 6.4 11.0 10.4 6.6 10.2 10.3 24.4 15.9 10.9 5.1 10.0 10.2 14.6 10.7 7.8 SETDB2 "C13orf4, CLLD8, CLLL8, KMT1F" ENSG00000136169 "SET domain bifurcated histone lysine methyltransferase 2" Q96T68 13 49444374-49495003 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012190, HPA071677" Approved Approved Nucleoplasm No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "CAB012190: AB_2186195, HPA071677: AB_2686430" "unprognostic (1.77e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-2)" "unprognostic (4.20e-1)" "unprognostic (3.70e-3)" "unprognostic (3.74e-2)" "unprognostic (3.44e-3)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.09e-3)" "unprognostic (7.95e-2)" "prognostic favorable (1.92e-7)" "unprognostic (2.83e-2)" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" 5.3 8.9 4.2 10.4 4.6 8.2 11.1 5.7 5.2 7.4 6.2 7.5 6.4 9.0 6.1 5.9 6.3 7.7 10.5 4.7 4.1 8.1 8.0 8.1 16.7 3.4 3.9 16.0 7.1 7.8 3.9 6.3 3.6 7.6 9.3 9.5 8.2 6.9 2.5 7.8 7.2 7.5 3.8 13.1 8.0 15.3 4.7 10.1 11.1 5.3 13.9 6.4 4.7 5.5 3.0 2.0 6.0 6.2 8.3 9.3 3.0 8.4 10.5 7.4 6.9 12.5 7.1 37.1 1.6 5.5 5.5 6.0 6.4 5.7 7.2 8.5 5.6 12.9 5.7 7.6 11.7 19.9 7.1 7.3 10.2 5.6 18.5 8.0 6.3 11.8 5.7 5.0 6.8 2.6 7.6 14.8 3.2 7.9 4.8 14.6 7.5 8.0 6.8 2.8 3.1 3.5 3.7 5.2 18.2 5.1 4.4 17.0 3.8 7.0 2.5 9.4 3.4 6.1 8.9 19.4 2.2 15.9 3.3 3.0 2.7 3.3 4.2 3.6 3.6 5.4 4.4 4.4 4.9 5.5 6.1 4.7 0.9 5.1 3.0 3.4 6.5 2.8 4.2 4.6 5.7 5.2 4.7 4.1 3.4 3.9 3.6 3.8 4.7 5.5 7.8 28.9 13.3 18.6 26.9 6.9 5.7 3.9 7.4 14.4 8.0 7.4 23.2 10.0 8.0 5.5 27.1 5.6 17.0 9.7 9.8 4.0 22.1 8.6 14.7 8.8 11.5 8.8 32.9 4.2 3.3 8.5 9.7 6.8 6.3 18.8 6.4 7.6 17.1 13.5 30.4 7.0 6.1 21.5 19.8 16.5 9.9 26.4 14.2 15.9 13.8 11.0 20.6 24.1 21.5 3.6 3.7 8.2 28.9 3.5 6.7 5.5 9.8 28.1 0.0 7.5 7.7 25.5 13.1 9.2 6.0 2.9 17.3 30.7 8.6 2.5 SETX "ALS4, AOA2, KIAA0625, SCAR1, Sen1" ENSG00000107290 Senataxin Q7Z333 9 132261356-132354986 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis" "Helicase, Hydrolase" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024105, HPA057269" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Cytokinetic bridge" "HPA024105: AB_2671437, HPA057269: AB_2683389" "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (3.23e-1)" "unprognostic (2.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-2)" "unprognostic (4.86e-2)" "unprognostic (1.64e-2)" "unprognostic (2.06e-2)" "unprognostic (1.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.32e-1)" "unprognostic (6.76e-3)" "unprognostic (2.47e-1)" "unprognostic (1.13e-1)" "unprognostic (5.64e-3)" "unprognostic (6.42e-2)" 13.7 9.5 6.2 19.9 8.8 16.8 13.9 9.8 6.3 13.2 7.7 13.1 10.6 12.7 11.1 10.6 10.9 12.7 10.5 5.1 7.8 11.9 16.7 15.4 27.4 8.7 7.0 13.0 9.2 18.3 6.0 14.3 9.6 13.0 12.8 13.2 9.0 12.7 12.9 12.3 13.2 12.8 8.0 27.6 12.9 31.9 7.7 25.4 33.0 12.8 26.3 15.7 8.5 13.2 15.1 19.9 22.5 24.4 28.3 34.1 13.5 19.6 21.9 15.6 14.6 21.1 16.8 25.6 9.4 36.9 38.3 30.2 22.8 17.0 17.0 24.6 9.9 26.9 22.7 18.4 26.5 41.8 31.2 24.0 26.2 26.6 23.6 19.1 25.4 17.8 31.7 20.0 18.3 21.8 25.9 15.8 24.2 25.4 15.4 24.2 32.6 17.2 17.1 19.5 14.0 21.4 32.4 14.2 18.2 29.7 19.7 21.2 29.3 32.5 14.0 22.1 19.0 12.2 22.0 38.6 14.9 16.3 17.8 10.5 4.4 4.7 5.3 4.1 5.6 5.5 3.9 4.1 3.3 6.9 4.2 3.7 15.1 5.2 4.9 5.0 3.2 2.3 6.2 8.8 9.8 6.3 5.1 7.8 8.7 7.0 9.6 8.0 7.7 13.2 76.2 60.9 45.7 75.1 85.6 30.2 34.6 26.6 38.7 31.2 24.1 22.7 61.3 17.2 43.9 20.2 29.2 13.7 96.8 37.6 3.9 20.0 7.6 62.7 68.0 58.7 14.5 25.5 73.7 14.7 10.6 52.9 44.4 89.7 58.2 38.3 51.4 33.0 28.8 67.3 64.8 30.6 16.2 73.1 37.6 13.8 30.7 75.5 12.4 131.2 75.8 20.7 87.6 65.9 113.0 23.2 31.9 36.1 61.8 49.3 25.6 18.5 54.4 28.7 13.1 44.9 42.5 145.2 38.5 35.1 33.5 9.4 65.9 53.7 26.9 46.4 SF3A3 "PRP9, PRPF9, SAP61, SF3a60" ENSG00000183431 "Splicing factor 3a subunit 3" Q12874 1 37956975-37990075 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032054, HPA032055" Supported Supported "Nucleoplasm,Nuclear speckles" NA NA 57000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" Nucleoplasm "HPA032054: AB_10602184, HPA032055: AB_2674130" "unprognostic (1.56e-1)" "unprognostic (1.21e-1)" "unprognostic (7.08e-3)" "unprognostic (6.19e-3)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "prognostic unfavorable (2.11e-8)" "unprognostic (1.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.74e-3)" "unprognostic (9.18e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (2.52e-3)" "unprognostic (8.39e-2)" "unprognostic (2.24e-1)" "unprognostic (3.68e-2)" 24.6 23.4 22.3 29.2 22.6 57.9 31.7 24.1 29.0 25.6 23.2 25.1 20.4 30.5 33.7 23.3 27.5 19.1 18.6 22.0 22.8 26.0 27.4 22.9 39.0 22.6 22.6 32.1 20.3 30.6 16.2 25.4 22.9 24.9 30.0 29.9 23.5 28.8 49.6 29.2 21.4 31.7 22.3 27.4 20.0 27.5 23.4 43.4 26.9 27.4 44.6 28.1 18.8 24.0 84.4 57.0 108.1 90.8 63.3 57.7 129.6 82.2 69.1 131.9 106.4 97.2 84.4 165.8 68.1 73.6 51.6 71.5 136.7 108.6 162.3 74.9 125.7 206.3 92.3 86.7 57.9 261.1 93.5 54.9 75.4 135.5 88.4 58.6 89.9 112.6 176.1 60.0 95.2 53.2 131.4 123.0 268.0 80.4 89.9 156.8 197.0 110.7 59.4 83.5 95.8 69.4 104.2 47.1 83.9 95.1 54.0 90.3 82.0 70.3 79.6 64.9 157.2 57.6 89.5 166.4 65.6 215.6 92.1 37.2 41.3 28.4 56.1 53.3 55.0 54.9 65.3 56.7 53.1 68.9 69.4 58.9 4.6 56.2 61.8 32.5 75.5 61.7 22.3 22.6 24.1 29.0 22.0 22.8 22.6 22.6 22.9 22.3 23.4 24.0 37.3 51.3 35.0 11.4 42.2 47.3 38.6 46.6 55.2 37.0 21.3 27.7 22.7 20.0 42.3 22.0 22.9 59.1 40.7 12.1 39.2 44.4 37.9 23.7 42.4 35.8 15.6 53.6 15.7 38.1 69.2 41.6 15.3 25.3 42.4 43.0 25.0 23.6 51.5 26.9 14.9 23.9 34.6 28.0 39.8 14.0 39.7 34.2 39.2 6.5 82.9 45.6 44.3 11.1 11.5 35.4 13.1 54.2 41.5 28.5 19.0 29.2 27.8 38.6 39.5 47.2 68.3 120.8 55.2 36.5 41.8 33.0 42.9 53.5 31.4 24.0 SF3B3 "KIAA0017, RSE1, SAP130, SF3b130" ENSG00000189091 "Splicing factor 3b subunit 3" Q15393 16 70523791-70577670 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041134, HPA042986" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No 50000 "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA041134: AB_2677317, HPA042986: AB_10960386" "unprognostic (3.39e-2)" "unprognostic (1.53e-1)" "unprognostic (7.47e-2)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (1.06e-2)" "unprognostic (7.67e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (6.97e-2)" "unprognostic (2.29e-1)" "unprognostic (3.28e-2)" "unprognostic (1.60e-1)" "unprognostic (8.76e-2)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" 15.7 11.2 7.9 19.2 8.2 22.2 13.8 15.9 9.6 16.3 11.4 17.1 13.6 17.0 10.2 19.9 16.4 11.6 12.1 8.8 9.7 12.5 12.3 11.7 24.3 7.0 6.9 22.3 13.8 16.8 7.9 14.1 7.5 11.6 13.2 16.3 12.6 10.7 23.6 19.9 12.9 16.0 6.5 13.9 13.2 10.2 10.4 23.7 14.5 11.7 26.6 14.2 14.4 12.0 72.4 72.6 93.4 65.3 45.5 41.6 74.0 66.3 55.5 84.5 67.3 75.6 55.8 97.1 52.6 51.8 49.9 81.4 98.0 55.7 133.0 31.5 71.1 75.1 56.7 81.0 30.6 106.1 83.9 39.8 40.1 93.9 68.8 54.1 50.9 55.3 104.6 34.2 67.4 87.5 92.9 51.6 85.2 44.8 41.9 163.2 73.3 109.7 26.9 96.4 81.4 59.8 217.7 33.8 33.8 39.2 73.9 53.0 52.7 61.9 67.8 49.2 71.6 37.4 90.4 260.7 40.9 66.9 61.3 23.4 26.1 28.1 35.8 30.8 39.3 28.4 33.1 37.5 35.3 34.3 38.8 33.7 8.3 35.5 31.2 19.1 40.2 37.4 7.9 8.2 15.9 9.6 8.8 9.7 7.0 6.9 7.5 6.5 10.4 12.0 18.9 25.6 25.7 16.6 33.0 22.4 23.2 23.4 13.1 35.5 20.5 18.3 29.3 14.3 25.4 23.9 14.6 33.6 21.6 19.7 7.9 20.7 6.3 17.8 31.9 25.4 21.1 36.8 23.2 23.2 34.7 24.2 20.4 17.5 17.7 52.3 17.5 23.6 23.6 40.4 26.5 21.8 24.4 20.6 12.8 10.3 33.8 19.2 17.8 24.4 22.7 19.4 25.7 26.2 26.7 24.9 14.0 33.1 25.1 30.2 18.1 15.7 18.8 26.7 6.6 30.2 18.8 28.7 33.3 37.6 26.1 25.4 28.3 48.2 31.6 24.7 SFI1 "KIAA0542, PISD, PPP1R139" ENSG00000198089 "SFI1 centrin binding protein" A8K8P3 22 31488688-31618588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 119.5;Rod photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "unprognostic (7.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.82e-3)" "unprognostic (3.51e-2)" "unprognostic (2.56e-1)" "unprognostic (1.77e-1)" "prognostic favorable (5.80e-4)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (2.11e-2)" "prognostic favorable (1.31e-4)" 3.4 6.1 3.3 7.8 2.0 13.0 4.7 10.4 5.0 5.0 1.5 5.6 8.6 4.1 4.1 4.1 5.5 3.4 2.4 1.8 4.0 5.0 2.9 4.6 12.2 2.4 1.5 5.2 5.0 3.9 10.0 2.6 2.4 5.5 2.7 8.5 5.3 3.3 1.4 5.7 9.4 2.2 0.8 9.5 5.5 10.0 3.2 10.6 6.3 0.7 6.5 4.8 4.4 2.9 11.3 7.0 6.4 7.9 3.5 3.3 4.0 8.9 3.7 6.1 7.5 6.4 7.7 17.3 3.4 2.8 3.9 10.4 3.2 5.6 4.2 14.2 10.1 4.2 16.9 7.8 4.6 16.9 13.5 2.5 3.7 6.9 4.5 5.1 5.5 16.0 5.4 8.4 5.1 17.0 11.8 10.3 2.4 8.1 4.2 12.8 7.5 12.5 3.7 11.8 9.6 5.4 7.6 10.8 7.4 2.4 8.1 7.2 10.4 8.6 7.8 7.5 6.4 9.9 7.8 9.2 8.6 8.8 6.9 8.5 1.2 3.1 9.1 1.3 4.1 4.1 7.3 10.6 1.4 3.5 9.9 8.9 5.5 9.3 5.0 1.7 5.9 5.5 3.3 2.0 10.4 5.0 1.8 4.0 2.4 1.5 2.4 0.8 3.2 2.9 7.2 6.4 26.2 17.6 17.6 4.0 7.9 6.8 5.7 45.7 9.7 8.0 2.7 8.6 17.3 16.5 35.5 8.8 21.8 21.7 1.9 7.3 14.2 16.1 5.7 8.9 11.4 17.9 30.5 5.1 2.3 5.6 17.9 18.0 20.3 15.5 7.1 2.9 4.9 119.5 30.9 25.0 6.1 9.1 8.2 5.1 5.3 9.4 3.6 19.7 8.6 7.1 34.0 10.6 17.1 7.6 15.5 1.9 19.1 7.0 34.6 3.2 31.3 68.7 0.0 9.6 5.7 28.9 27.6 2.7 3.3 18.9 35.2 2.6 10.0 6.3 SHOC2 "KIAA0862, SOC-2, SOC2, SUR-8, SUR8" ENSG00000108061 "SHOC2 leucine rich repeat scaffold protein" Q9UQ13 10 110919593-111013666 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009164, HPA048134" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA009164: AB_1079960, HPA048134: " "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" "unprognostic (4.23e-3)" "unprognostic (3.27e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (6.09e-2)" "unprognostic (5.56e-2)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (4.33e-2)" "unprognostic (1.01e-1)" "unprognostic (3.70e-3)" "unprognostic (6.97e-3)" "unprognostic (8.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.67e-1)" 25.0 16.3 16.4 22.5 17.8 45.7 19.3 19.3 22.1 20.3 12.0 20.4 16.4 20.7 21.0 21.6 16.4 20.1 19.5 19.4 22.3 21.9 23.7 17.9 29.9 16.6 21.7 19.8 20.4 30.3 14.6 20.8 22.0 18.0 21.5 19.7 14.2 17.5 21.3 15.4 18.4 23.3 16.4 22.2 17.3 36.4 18.2 26.9 25.2 26.8 31.2 25.0 14.8 15.5 29.2 17.8 22.7 38.2 50.9 51.2 14.5 35.0 51.9 31.9 38.5 16.5 25.8 63.1 17.1 62.8 19.9 24.1 27.8 25.0 46.2 34.7 16.5 28.8 25.7 16.2 37.0 49.6 49.4 57.3 38.6 36.9 69.1 43.6 32.8 22.1 18.3 43.8 45.7 15.6 24.7 38.9 14.1 15.6 18.6 34.8 45.2 18.1 33.3 19.4 11.7 23.4 30.7 15.0 34.9 25.8 77.2 41.5 33.3 25.6 22.6 32.5 24.3 40.2 44.0 100.1 30.6 50.3 18.6 52.3 22.8 33.5 12.6 26.8 15.5 30.3 14.8 15.0 22.3 24.4 15.6 15.2 65.8 19.5 27.8 15.2 19.2 23.9 16.4 17.8 19.3 22.1 19.4 22.3 16.6 21.7 22.0 16.4 18.2 15.5 73.8 54.5 48.1 35.6 95.4 55.8 35.2 37.5 27.9 27.6 51.4 39.1 83.6 45.8 42.3 31.3 16.7 22.2 77.5 80.8 64.6 48.5 44.2 65.1 54.6 63.5 26.3 67.5 59.9 59.2 23.0 50.7 49.5 54.9 73.4 20.2 53.2 69.0 29.4 30.3 53.1 36.2 46.8 78.3 67.3 89.7 65.6 76.0 49.8 57.1 116.5 31.5 57.7 46.3 61.0 64.0 51.6 80.9 53.4 37.1 51.7 67.7 57.0 32.7 72.3 59.9 58.7 108.8 69.3 38.1 69.9 60.6 65.8 17.0 30.1 49.7 SHPRH "bA545I5.2, FLJ90837, KIAA2023" ENSG00000146414 "SNF2 histone linker PHD RING helicase" Q149N8 6 145864245-145964423 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Helicase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 210.6;Oligodendrocytes: 164.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034854, HPA044852" Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" Cytosol "HPA034854: AB_10964488, HPA044852: " "unprognostic (3.10e-2)" "unprognostic (4.46e-2)" "unprognostic (5.61e-3)" "unprognostic (1.53e-2)" "unprognostic (7.40e-3)" "unprognostic (2.20e-2)" "unprognostic (2.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (5.03e-1)" "unprognostic (7.90e-2)" "unprognostic (6.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" "unprognostic (3.01e-1)" 4.9 4.2 3.1 4.7 3.7 4.2 7.2 18.4 5.1 5.4 3.2 4.3 4.2 7.7 6.0 4.3 5.2 4.6 3.5 3.0 2.5 5.5 4.6 4.2 6.9 2.8 2.6 12.2 3.9 6.7 2.0 4.5 4.5 5.5 5.0 16.3 5.8 5.1 4.2 9.7 4.5 5.7 2.5 6.4 5.4 7.6 2.9 7.2 8.4 5.2 5.8 4.3 3.3 5.5 4.2 3.2 15.3 9.1 7.0 7.3 7.2 4.9 3.9 5.9 7.6 7.0 2.9 14.5 5.9 3.7 4.6 7.0 9.5 6.9 7.7 6.5 10.9 14.6 7.6 6.1 5.2 31.2 8.6 5.2 7.8 5.6 8.0 5.8 6.4 10.0 20.3 7.9 5.1 3.7 19.8 11.6 10.3 6.9 5.4 14.1 23.6 5.0 8.0 4.1 12.6 8.8 8.7 7.9 5.4 10.5 4.2 14.6 7.2 3.7 7.0 7.4 5.8 6.4 9.4 17.1 3.9 13.0 6.0 0.7 0.9 1.9 1.7 0.9 1.5 1.5 1.4 1.1 1.1 2.5 1.5 1.3 0.0 1.5 1.0 2.0 1.4 0.5 3.1 3.7 18.4 5.1 3.0 2.5 2.8 2.6 4.5 2.5 2.9 5.5 31.4 28.9 23.4 106.7 31.0 21.2 17.9 14.5 19.4 117.2 21.5 20.3 17.2 20.0 20.7 22.0 210.6 16.1 34.6 9.1 7.9 18.6 20.4 20.9 52.8 26.0 19.2 15.3 131.0 12.9 7.0 25.9 23.9 18.1 13.3 145.7 15.7 20.5 12.0 94.2 140.3 14.7 6.1 21.4 9.8 8.0 50.7 19.8 14.2 93.7 30.6 40.7 36.0 143.7 164.6 15.9 8.8 34.3 23.5 18.8 17.2 7.5 14.9 158.5 72.3 47.1 39.1 83.2 65.0 16.5 19.7 6.6 26.4 61.5 18.0 12.5 SHQ1 "FLJ10539, Shq1p" ENSG00000144736 "SHQ1, H/ACA ribonucleoprotein assembly factor" Q6PI26 3 72749277-72861914 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 113.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042792 Uncertain Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA042792: AB_10959736" "unprognostic (1.10e-2)" "unprognostic (1.03e-1)" "prognostic favorable (2.83e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.05e-1)" "unprognostic (4.54e-3)" "unprognostic (9.21e-3)" "unprognostic (3.19e-2)" "unprognostic (8.89e-2)" "unprognostic (6.78e-3)" "unprognostic (3.76e-1)" "unprognostic (5.28e-2)" "unprognostic (7.30e-3)" "unprognostic (3.59e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" 5.9 7.0 7.3 8.1 10.1 9.2 8.1 7.1 7.6 6.7 6.1 8.8 6.7 7.1 11.4 6.4 10.7 5.6 10.1 5.1 6.6 7.4 8.0 6.2 8.9 7.1 7.0 7.6 7.0 8.5 4.6 5.3 7.4 5.7 8.7 5.5 5.7 6.0 9.1 7.5 6.1 8.0 5.2 7.0 6.4 10.0 8.0 15.3 8.2 8.6 10.0 8.4 5.1 10.4 13.5 18.1 12.0 20.3 15.7 19.2 12.1 21.8 15.8 22.4 24.6 14.5 10.7 22.4 10.2 15.2 18.2 10.9 24.9 20.5 27.5 20.1 19.6 23.3 14.1 17.3 15.9 39.7 18.8 19.2 15.4 33.1 13.6 10.4 21.2 35.8 19.0 13.5 18.5 20.2 113.4 14.1 33.9 41.5 22.7 27.1 18.8 17.3 19.7 17.6 7.6 30.4 20.3 14.3 10.6 16.0 14.7 14.9 15.1 18.0 17.5 30.1 19.5 24.9 53.8 32.7 16.1 32.0 18.3 0.9 11.9 4.3 14.2 13.5 19.1 13.7 15.8 15.4 12.3 13.3 17.7 15.4 0.5 24.2 12.3 17.6 14.4 14.5 7.3 10.1 7.1 7.6 5.1 6.6 7.1 7.0 7.4 5.2 8.0 10.4 5.9 12.8 6.9 8.8 8.3 13.3 4.3 6.9 5.7 7.5 7.2 5.3 9.5 4.3 6.5 5.5 0.0 6.1 9.9 4.3 7.9 8.6 6.9 11.5 9.6 9.1 4.2 10.3 12.1 6.1 7.9 7.1 5.6 8.0 15.2 6.6 11.4 7.6 6.9 3.3 13.5 6.8 4.1 6.6 6.2 1.9 5.9 5.7 5.4 20.6 4.1 3.2 2.1 16.1 33.9 6.5 4.3 5.7 6.1 5.1 4.7 5.7 16.2 5.4 0.0 8.0 5.9 9.1 19.5 10.8 10.2 5.7 7.6 14.8 9.3 3.9 SIKE1 "FLJ21168, SIKE" ENSG00000052723 "Suppressor of IKBKE 1" Q9BRV8 1 114769479-114780685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024177, HPA025726" Supported Approved "Vesicles,Focal adhesion sites" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "Focal adhesion sites" Vesicles "HPA024177: AB_1848798, HPA025726: AB_1848800" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (3.53e-2)" "unprognostic (4.52e-3)" "unprognostic (4.10e-1)" "unprognostic (6.04e-2)" "unprognostic (3.37e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-2)" "unprognostic (2.52e-2)" "unprognostic (1.94e-2)" "unprognostic (7.91e-2)" "unprognostic (2.38e-2)" "unprognostic (3.86e-2)" "unprognostic (9.06e-2)" "unprognostic (2.95e-3)" "unprognostic (1.05e-1)" 8.8 6.9 5.9 9.7 6.0 9.8 9.6 8.5 6.7 9.1 5.7 8.6 9.8 9.4 7.6 7.7 6.0 6.9 7.3 4.9 7.7 10.8 12.2 6.8 12.1 7.0 6.8 8.6 6.8 9.7 4.9 9.6 7.0 7.6 9.4 8.0 7.3 7.5 6.7 13.4 8.5 9.2 6.4 9.5 8.4 5.6 8.2 13.6 10.1 7.4 12.0 7.2 5.6 7.1 16.3 4.4 22.9 21.2 27.6 21.4 22.0 13.9 12.4 18.9 25.3 12.2 9.1 30.6 12.5 11.8 8.0 15.7 24.3 16.7 27.0 19.4 13.3 16.4 13.9 15.6 26.3 18.8 12.9 21.0 19.6 14.1 22.4 13.6 17.5 26.2 25.2 17.7 15.7 62.7 37.1 19.9 52.1 10.5 12.3 21.2 43.7 15.3 16.0 13.5 15.7 18.5 20.0 23.2 25.5 20.8 12.6 72.0 13.9 15.6 19.0 26.8 19.0 16.4 14.1 29.1 23.7 31.1 34.0 6.0 1.7 2.0 2.2 2.3 2.8 2.0 2.2 2.2 2.2 2.1 2.6 2.8 1.2 2.6 2.4 2.7 1.7 1.4 5.9 6.0 8.5 6.7 4.9 7.7 7.0 6.8 7.0 6.4 8.2 7.1 29.2 25.6 14.8 13.1 32.7 31.9 26.7 40.0 30.1 10.7 22.7 23.2 41.0 20.0 30.2 31.3 10.4 29.7 43.9 30.3 50.9 27.1 34.8 20.1 34.9 26.3 18.6 29.9 16.2 25.7 33.6 27.9 18.8 26.8 19.7 77.1 27.1 40.0 27.7 8.4 19.7 21.4 48.8 19.7 26.6 58.1 28.3 24.8 23.2 4.7 25.4 15.8 32.0 10.1 16.6 31.1 18.3 19.9 37.7 30.5 25.7 62.8 21.3 16.1 19.7 26.5 28.8 35.5 39.6 33.0 36.4 36.0 37.4 48.3 21.2 23.6 SIN3A "DKFZP434K2235, KIAA0700" ENSG00000169375 "SIN3 transcription regulator family member A" Q96ST3 15 75369379-75455842 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004506, HPA047213, HPA062123" Enhanced Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-1)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (8.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (3.52e-1)" 19.2 12.4 10.0 19.8 10.9 42.5 18.0 21.0 11.7 21.0 12.5 19.6 13.8 25.6 16.6 19.1 24.3 17.4 14.8 9.6 13.3 15.1 16.0 18.0 25.9 11.7 12.0 30.0 15.3 22.5 12.1 20.1 10.3 19.7 16.1 24.1 16.6 20.7 16.6 21.5 16.3 19.6 8.3 22.1 16.5 29.6 14.0 43.2 27.2 18.7 26.3 20.2 16.7 10.8 31.2 63.6 55.5 36.7 27.0 28.4 32.1 22.9 35.3 33.0 35.2 35.2 41.2 67.8 23.3 34.0 45.0 54.5 81.2 34.4 35.9 55.0 42.1 64.0 46.2 27.9 20.5 61.4 52.5 34.7 26.1 38.5 39.8 34.0 30.0 47.5 51.5 73.2 27.0 36.2 60.7 39.1 54.2 41.3 26.3 60.5 73.3 41.8 23.6 56.4 43.7 43.7 56.6 25.0 31.0 53.0 38.1 47.9 26.4 40.6 54.5 27.2 34.3 49.8 85.0 70.8 24.2 61.2 23.2 2.9 4.2 5.9 6.3 3.8 9.6 7.0 8.1 8.1 5.2 7.7 8.2 7.2 7.3 8.1 7.4 3.5 7.7 5.7 10.0 10.9 21.0 11.7 9.6 13.3 11.7 12.0 10.3 8.3 14.0 10.8 26.0 35.3 32.4 13.7 35.8 39.4 23.6 21.2 60.9 19.7 36.5 25.4 13.4 17.2 30.5 27.6 31.3 23.5 29.0 17.8 5.9 15.1 10.1 35.7 30.8 32.1 17.3 24.4 19.2 12.8 11.1 24.4 15.3 42.1 29.9 30.1 26.0 17.4 13.2 20.2 18.3 19.0 10.2 21.3 31.7 5.8 23.0 19.5 10.6 27.2 18.8 16.8 24.7 16.6 24.1 14.1 14.0 20.3 33.1 29.8 13.7 9.2 33.4 33.8 13.1 34.7 24.7 42.1 42.7 37.5 53.1 21.9 34.6 21.2 19.2 19.4 SLC12A6 "ACCPN, KCC3" ENSG00000140199 "Solute carrier family 12 member 6" Q9UHW9 15 34229784-34338060 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" Neuropathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 15.2;neutrophil: 23.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 23.4" "Cell line enhanced" "Detected in many" "HaCaT: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034563 Uncertain Approved Vesicles,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "HPA034563: AB_10603887" "unprognostic (3.53e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (3.60e-1)" "unprognostic (3.55e-2)" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.58e-2)" "unprognostic (1.83e-1)" "prognostic favorable (3.33e-6)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (3.87e-2)" "unprognostic (1.41e-1)" 6.4 4.0 5.9 11.5 7.4 26.8 5.5 7.2 7.9 11.9 2.5 5.5 7.3 5.2 7.0 18.8 4.6 5.2 7.3 6.5 7.3 15.9 3.9 9.1 10.1 8.9 7.3 4.2 3.5 3.1 5.6 4.3 9.3 3.5 6.1 31.1 6.4 3.8 10.6 7.6 9.1 4.9 6.6 12.9 6.7 25.9 7.7 15.5 9.0 10.9 11.6 8.3 17.6 8.4 4.4 5.2 3.1 4.7 10.0 11.4 2.4 5.9 15.1 4.9 7.1 3.1 7.2 3.1 5.9 7.2 4.3 44.0 7.9 5.3 5.8 1.2 5.1 24.6 14.0 7.0 6.4 14.5 24.6 6.9 9.1 14.1 29.1 10.9 14.9 6.8 5.4 6.8 6.7 1.6 1.6 11.0 2.4 3.8 5.7 7.1 5.5 3.3 5.5 11.2 7.2 5.0 7.1 0.2 1.5 7.1 2.8 4.8 9.4 5.9 4.2 21.0 1.4 6.4 6.8 1.9 6.6 10.5 2.2 15.2 1.4 2.6 0.6 1.8 0.4 1.4 0.9 0.9 0.9 2.4 1.6 1.4 23.4 0.7 0.8 1.0 3.2 1.0 5.9 7.4 7.2 7.9 6.5 7.3 8.9 7.3 9.3 6.6 7.7 8.4 16.4 22.4 21.0 30.0 32.0 1.1 4.5 1.5 7.4 15.3 5.2 4.3 8.7 5.7 4.2 5.5 85.5 3.2 11.5 8.6 0.0 5.6 15.6 9.8 7.4 17.7 6.7 35.9 47.7 4.7 1.6 7.0 17.9 22.4 5.1 8.4 16.1 7.5 13.2 8.4 52.0 7.0 2.0 37.1 3.8 8.3 8.1 25.6 0.0 50.6 34.5 8.7 15.5 40.7 58.4 13.1 9.7 8.6 29.9 6.5 18.3 16.4 4.2 56.6 19.7 7.0 4.0 39.9 21.2 14.8 0.9 1.1 18.0 4.1 7.4 43.6 SLC25A40 MCFP ENSG00000075303 "Solute carrier family 25 member 40" Q8TBP6 7 87833568-87876360 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055197 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA055197: AB_2682735" "unprognostic (4.19e-2)" "unprognostic (1.01e-1)" "unprognostic (7.30e-2)" "unprognostic (2.15e-1)" "unprognostic (8.80e-2)" "unprognostic (4.03e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.73e-1)" "unprognostic (3.51e-2)" "unprognostic (3.45e-2)" "unprognostic (1.83e-1)" "unprognostic (5.78e-2)" "prognostic favorable (1.52e-5)" "unprognostic (8.42e-2)" "unprognostic (2.45e-1)" "unprognostic (2.88e-2)" "unprognostic (4.85e-2)" 4.8 7.0 4.0 8.5 4.3 7.6 8.0 6.4 6.5 5.9 2.6 7.8 6.6 6.8 6.1 5.8 6.2 5.5 9.7 4.6 4.6 8.2 6.7 5.9 10.6 4.7 4.9 8.6 4.3 9.4 3.6 3.8 4.9 8.6 9.6 8.7 6.0 5.1 6.3 8.1 7.1 5.3 2.9 8.9 7.1 4.8 6.0 9.6 7.1 5.2 9.9 5.2 4.2 5.0 20.3 5.3 16.3 6.3 6.5 10.4 4.8 14.3 12.6 10.1 14.7 4.6 28.2 23.8 9.1 7.1 16.3 8.7 8.0 8.2 14.5 15.1 4.0 12.6 12.3 5.7 6.2 30.8 16.2 6.3 5.8 9.2 7.2 8.5 11.0 18.9 13.9 34.0 17.5 8.6 35.7 25.6 7.6 16.6 5.9 17.6 20.6 21.0 14.7 10.8 8.0 19.2 18.4 17.8 14.1 13.1 8.7 24.0 7.7 17.3 12.8 27.2 13.8 18.7 21.6 30.6 12.0 37.0 36.1 9.1 3.5 5.0 1.1 3.7 1.8 1.5 1.6 1.6 3.9 1.7 1.7 1.6 1.9 4.0 4.0 1.0 1.9 1.5 4.0 4.3 6.4 6.5 4.6 4.6 4.7 4.9 4.9 2.9 6.0 5.0 5.8 3.2 5.3 33.0 12.3 7.5 6.1 4.0 12.0 5.7 8.3 5.2 16.6 12.8 7.7 7.3 10.4 8.6 10.5 9.6 15.6 3.8 10.0 5.7 5.0 5.9 3.0 17.9 35.2 3.9 8.4 5.7 9.2 6.4 5.1 9.1 6.1 8.1 11.1 3.3 37.0 8.9 6.1 28.6 4.1 3.9 7.8 19.4 21.4 19.7 17.5 4.5 5.2 32.2 30.8 6.5 13.8 10.9 18.8 3.5 7.2 8.6 5.2 4.9 13.1 4.6 4.4 9.0 5.0 10.4 8.0 3.7 9.4 9.1 10.0 5.5 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144174-93197991 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 5.8 7.4 4.2 9.3 4.6 19.4 4.6 8.1 5.8 5.1 6.2 5.4 2.0 7.1 2.1 5.3 4.8 5.7 6.0 4.0 8.5 9.4 7.8 6.0 5.3 7.2 6.9 5.7 5.7 6.5 7.7 6.2 7.7 4.9 6.4 15.3 3.7 5.9 2.4 4.1 3.1 8.1 5.5 4.1 4.3 4.3 6.1 7.3 8.8 2.3 6.7 6.9 3.6 7.0 10.4 18.2 36.5 7.3 12.7 25.6 20.5 17.6 29.2 25.6 31.0 14.6 33.1 12.5 9.9 16.5 13.3 12.5 11.4 6.5 23.4 21.1 13.3 14.5 35.3 9.8 10.0 36.6 20.6 12.4 20.0 14.9 9.2 12.0 14.0 17.6 1.3 0.2 26.5 2.6 16.3 27.4 14.8 4.0 18.4 7.2 21.7 5.1 8.7 15.1 33.6 43.8 25.7 9.9 6.4 26.4 18.0 10.6 15.7 48.0 14.8 28.6 26.0 5.1 10.9 0.0 10.9 15.0 25.4 0.1 4.9 5.3 0.8 2.6 1.0 0.9 0.6 1.0 1.9 1.0 1.5 1.0 1.5 0.5 1.7 0.7 0.5 1.1 4.2 4.6 8.1 5.8 4.0 8.5 7.2 6.9 7.7 5.5 6.1 7.0 11.9 12.8 11.5 35.9 29.5 30.7 43.2 9.7 25.6 21.2 10.3 8.0 11.5 20.0 7.1 20.2 22.9 10.7 13.6 3.1 35.2 24.4 9.9 15.5 19.2 18.5 27.6 5.5 66.8 43.6 25.8 21.9 18.8 5.7 4.5 29.0 13.2 9.1 13.6 26.9 71.0 19.6 10.2 52.3 47.1 4.2 18.0 50.1 21.4 27.2 42.8 20.7 13.4 45.2 59.4 33.2 6.3 15.4 22.1 70.4 0.4 16.2 20.8 24.2 6.6 18.0 18.1 7.3 3.3 11.8 32.0 16.3 15.7 20.6 4.3 30.6 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 68.5" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 571.3;Rod photoreceptor cells: 547.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 59.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 59.2" "Cell line enhanced" "Detected in many" "HeLa: 66.6;RPTEC TERT1: 111.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.9 25.6 1.7 8.4 6.9 54.7 8.5 5.0 7.7 11.3 0.0 3.9 0.9 10.4 0.0 6.7 6.7 9.4 24.4 3.5 3.8 12.2 1.5 20.5 7.5 9.6 6.6 28.9 2.3 2.5 7.4 7.9 6.7 4.3 2.4 68.5 17.1 7.2 30.9 18.3 17.1 6.9 1.7 15.6 9.4 3.7 11.0 4.5 9.3 8.7 9.1 8.1 6.1 6.8 4.1 18.4 4.6 10.1 11.6 5.7 15.9 4.3 26.4 8.4 6.2 8.8 5.6 12.6 4.5 10.9 11.7 4.3 4.5 10.1 16.5 3.7 9.7 8.8 66.6 24.2 0.0 3.7 22.3 1.9 2.6 7.8 1.6 7.7 14.5 6.2 10.1 3.5 18.6 8.1 9.4 20.3 6.1 7.1 10.8 6.1 7.3 24.9 111.8 28.5 7.2 4.6 3.1 3.2 0.6 36.8 11.5 4.5 15.3 9.7 3.9 5.2 6.2 3.9 6.0 7.1 19.3 6.6 23.2 5.6 9.2 8.6 2.5 7.3 1.3 4.0 2.7 3.0 2.8 2.1 0.5 0.6 59.2 1.8 9.4 1.4 8.7 4.6 1.7 6.9 5.0 7.7 3.5 3.8 9.6 6.6 6.7 1.7 11.0 6.8 42.7 6.4 21.5 1.3 16.4 49.3 17.1 51.5 43.9 126.1 9.5 6.9 4.2 7.2 52.8 20.2 571.3 3.0 14.5 0.5 0.0 12.0 19.6 82.1 23.0 29.4 14.4 9.4 17.4 8.2 15.8 13.5 29.0 126.9 13.3 2.5 11.7 0.6 27.2 10.1 18.5 3.5 46.8 60.1 59.5 16.6 17.4 58.8 17.8 32.8 110.9 30.8 10.3 3.0 23.9 31.1 12.6 17.3 13.3 17.6 51.3 23.3 69.5 547.8 0.0 11.4 8.3 0.4 1.3 15.7 23.9 5.1 25.5 46.8 3.6 16.8 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 48.6 52.6 38.0 38.6 42.4 37.5 46.5 46.2 36.7 43.2 35.6 47.5 36.7 38.6 41.0 55.0 46.8 39.6 53.8 32.9 48.6 43.3 35.6 46.7 44.5 50.2 43.2 52.5 40.4 44.6 20.3 42.7 51.9 36.4 48.7 70.5 36.7 44.8 57.4 34.0 37.4 47.9 47.8 47.5 45.2 51.5 42.4 72.4 75.7 55.5 55.2 53.8 31.1 59.4 81.1 113.7 68.0 66.2 106.1 128.5 77.4 86.1 102.7 87.9 101.8 43.8 75.6 124.8 60.3 110.0 123.0 86.6 77.2 96.1 116.9 136.4 39.3 106.4 164.4 71.9 123.2 149.6 104.1 95.8 121.4 75.5 172.9 102.1 98.6 99.7 50.3 101.6 109.6 52.7 103.4 71.6 33.6 4.4 26.7 74.4 98.9 85.9 197.8 137.2 62.8 73.3 103.7 70.1 85.7 65.8 53.5 97.7 111.4 129.5 74.2 35.6 63.6 99.0 102.7 108.3 89.6 99.9 97.1 58.8 33.6 38.7 23.8 38.5 29.8 16.7 32.3 29.9 32.8 13.9 35.3 27.6 34.1 38.6 33.0 23.3 40.5 31.6 38.0 42.4 46.2 36.7 32.9 48.6 50.2 43.2 51.9 47.8 42.4 59.4 55.0 44.8 36.1 55.8 36.3 54.4 44.1 38.3 54.1 48.0 44.2 30.2 49.2 41.5 45.5 77.3 212.7 48.2 53.0 42.8 39.2 36.5 68.1 58.6 53.0 53.1 51.0 36.4 63.4 43.5 40.3 40.5 44.4 68.1 21.5 80.0 56.4 29.6 43.9 35.3 50.5 46.1 38.7 57.3 41.8 131.9 41.7 48.7 51.6 104.9 63.9 44.8 72.1 96.0 130.0 44.0 31.6 53.4 34.5 66.1 37.9 39.5 41.8 88.1 32.9 53.5 39.6 37.2 39.4 59.2 61.8 69.5 47.4 41.7 42.3 77.2 SMARCA5 "hISWI, hSNF2H, ISWI" ENSG00000153147 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5" O60264 4 143513702-143557486 "Predicted intracellular proteins, Transcription factors" "Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 307.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005227, HPA008751" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli fibrillar center" "CAB005227: AB_2191863, HPA008751: AB_1857268" "unprognostic (9.21e-3)" "unprognostic (7.99e-2)" "unprognostic (4.99e-3)" "unprognostic (8.03e-2)" "unprognostic (8.96e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (4.20e-2)" "unprognostic (1.82e-1)" 16.9 26.0 15.1 21.1 20.1 32.7 17.6 17.6 17.3 18.1 13.5 17.2 14.9 20.4 20.5 14.1 14.6 19.3 17.1 13.0 16.6 16.7 16.8 27.9 27.0 17.9 16.8 21.2 16.4 22.6 13.5 22.8 19.1 18.1 17.9 26.4 12.4 17.0 15.3 11.1 16.4 18.4 18.3 22.8 16.2 32.6 16.0 29.9 23.1 15.3 25.7 22.7 11.0 26.0 33.4 25.8 92.5 58.5 53.4 38.4 55.5 41.5 49.4 59.5 50.0 44.3 45.8 90.0 27.9 35.7 23.7 26.0 85.9 38.9 57.1 60.2 30.2 67.7 36.9 36.7 39.3 84.2 38.3 34.0 27.8 42.1 36.0 34.5 46.9 45.1 62.0 55.4 39.2 30.1 98.7 29.4 75.7 55.6 36.6 108.2 59.1 29.4 46.6 40.4 73.6 62.2 54.0 37.9 49.5 69.2 27.4 39.1 50.0 38.9 29.7 41.0 41.2 60.0 77.4 106.8 30.6 69.5 40.3 5.8 10.7 16.0 12.7 12.8 15.3 11.4 13.1 14.2 13.3 11.2 13.4 13.6 9.4 15.8 21.5 10.0 16.7 11.5 15.1 20.1 17.6 17.3 13.0 16.6 17.9 16.8 19.1 18.3 16.0 26.0 77.3 307.7 291.0 30.7 95.7 46.4 78.9 50.6 55.2 93.9 56.4 49.0 104.1 31.5 96.9 44.1 64.6 70.6 125.6 39.8 39.2 77.9 63.2 104.5 127.1 74.3 79.9 85.4 42.5 61.4 66.4 73.8 46.4 94.2 103.1 97.3 39.3 25.4 44.8 85.8 41.7 41.3 69.2 51.9 49.4 27.9 60.3 79.2 30.2 27.2 98.6 84.7 55.6 37.7 85.2 66.0 35.3 62.1 93.9 57.7 36.6 36.8 109.6 116.4 52.6 113.9 88.3 144.4 130.8 47.4 40.9 102.1 107.9 118.7 46.2 71.2 SMARCAD1 "DKFZP762K2015, ETL1, KIAA1122" ENSG00000163104 "SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1" Q9H4L7 4 94207611-94291292 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016737 Approved Enhanced Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA016737: AB_1857271" "unprognostic (5.01e-2)" "unprognostic (5.83e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (8.41e-3)" "unprognostic (9.08e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (2.45e-1)" "unprognostic (3.49e-3)" "unprognostic (3.55e-1)" "unprognostic (2.57e-2)" "unprognostic (7.72e-2)" "unprognostic (2.99e-2)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (3.20e-3)" 10.0 9.5 7.1 11.2 7.8 7.5 15.2 12.0 8.5 10.6 7.5 9.4 9.7 14.5 12.6 10.5 10.7 10.3 7.6 7.3 8.6 11.7 9.8 9.7 16.0 7.2 7.4 14.2 8.7 11.7 11.0 14.1 7.7 11.1 12.3 14.6 8.9 10.0 7.3 20.8 9.5 11.8 7.7 11.9 10.8 12.2 8.2 18.6 15.0 6.8 14.2 11.2 9.7 9.9 15.0 18.6 59.1 38.1 16.5 26.6 30.1 26.8 24.3 21.8 20.3 18.2 23.7 37.8 17.7 23.1 19.8 12.9 42.3 22.4 30.7 29.8 18.7 27.5 20.5 27.2 24.4 41.2 28.9 27.8 17.8 27.3 34.9 27.0 33.7 33.3 46.7 15.5 32.4 12.3 69.1 21.3 40.1 19.1 9.4 40.1 33.6 19.6 24.6 18.4 33.8 49.9 20.1 32.8 28.6 36.7 17.1 26.9 32.3 27.6 29.9 17.1 20.3 21.8 34.8 45.1 25.7 21.2 34.8 2.7 1.3 0.2 2.3 1.7 2.5 2.9 2.6 2.6 2.4 2.4 2.8 3.3 0.0 4.5 1.7 2.1 2.3 1.3 7.1 7.8 12.0 8.5 7.3 8.6 7.2 7.4 7.7 7.7 8.2 9.9 19.0 12.8 11.3 56.2 16.7 11.7 6.5 12.8 25.6 20.9 15.5 13.2 12.7 4.3 24.7 9.2 16.7 13.5 20.1 7.1 1.9 12.4 2.1 27.6 32.3 17.8 9.0 25.5 86.5 10.0 11.8 19.9 17.9 17.9 24.0 29.5 13.2 13.5 10.8 18.5 82.5 12.9 14.2 14.6 5.4 3.1 14.3 13.7 3.6 47.8 12.6 8.1 17.5 86.5 99.5 15.0 6.3 18.4 16.4 7.7 4.4 15.5 26.8 18.8 6.6 21.1 16.2 25.9 34.8 18.7 9.7 9.6 17.3 26.2 12.6 5.8 SMARCAL1 "HARP, HHARP" ENSG00000138375 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1" Q9NZC9 2 216412414-216483053 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Helicase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020337 Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA020337: AB_2670410" "unprognostic (4.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.65e-1)" "unprognostic (2.20e-2)" "unprognostic (3.39e-2)" "unprognostic (2.68e-2)" "prognostic unfavorable (5.22e-4)" "unprognostic (4.35e-3)" "unprognostic (3.31e-2)" "unprognostic (2.33e-1)" "unprognostic (1.36e-1)" "unprognostic (7.46e-2)" "unprognostic (2.00e-2)" "unprognostic (2.67e-1)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (3.16e-1)" 9.2 9.8 7.5 8.9 10.3 9.1 8.8 8.0 9.7 10.6 7.6 8.0 6.8 10.7 7.5 9.8 11.0 9.5 8.9 8.0 9.0 7.2 6.7 7.9 13.1 10.6 9.1 16.3 8.2 10.8 9.3 9.1 10.6 8.1 7.4 5.6 8.0 8.9 10.5 10.6 7.9 10.1 8.4 9.7 8.0 10.3 10.2 15.1 10.2 10.6 11.9 8.8 9.0 14.2 16.7 16.3 22.2 12.7 21.5 25.1 21.3 22.0 22.7 23.0 26.1 26.7 20.3 15.0 21.8 27.6 28.8 12.3 19.1 24.4 30.5 45.7 18.9 42.8 12.0 19.9 22.0 11.5 23.9 16.7 25.7 24.9 24.4 24.0 27.6 23.5 42.6 15.8 26.3 12.3 22.2 26.8 16.1 14.7 8.9 24.6 14.6 9.3 18.2 11.4 18.4 11.9 12.0 9.1 18.7 38.2 12.4 18.1 21.3 28.3 13.0 13.7 13.9 18.0 18.6 13.3 28.8 15.6 20.2 25.9 9.5 14.1 12.2 10.5 11.6 9.6 11.5 14.3 14.9 9.2 9.6 11.8 1.7 21.0 18.1 18.0 14.7 8.5 7.5 10.3 8.0 9.7 8.0 9.0 10.6 9.1 10.6 8.4 10.2 14.2 6.3 6.4 6.1 20.2 8.2 0.9 3.3 4.6 8.6 5.1 4.3 3.4 5.0 7.2 3.7 0.0 0.0 10.4 6.7 3.4 5.9 7.4 14.5 10.4 7.2 7.0 3.6 11.4 20.6 3.8 12.2 8.0 5.6 5.8 17.7 11.0 4.2 3.2 9.7 8.4 30.8 3.7 2.0 8.9 3.1 13.7 6.2 6.2 1.8 12.2 10.1 4.7 10.3 24.6 35.9 4.0 13.3 8.6 7.0 1.3 4.7 5.8 4.4 4.8 13.1 6.0 6.8 7.7 4.4 5.3 1.3 7.3 6.5 7.5 5.3 2.0 SMARCD1 "BAF60A, CRACD1, Rsc6p" ENSG00000066117 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1" Q96GM5 12 50085200-50100707 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Chromatin regulator" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004101 Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Vesicles "HPA004101: AB_1080026" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "prognostic unfavorable (2.53e-8)" "unprognostic (3.62e-2)" "unprognostic (1.44e-1)" "unprognostic (4.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" "unprognostic (2.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" 25.8 28.1 25.2 23.2 27.6 44.0 24.9 24.4 27.0 23.5 20.8 22.0 23.2 27.9 27.1 27.5 23.8 17.9 18.3 26.3 23.8 25.3 19.0 23.9 35.0 25.7 25.7 26.4 22.5 47.3 19.7 28.9 25.3 23.2 27.2 25.1 24.3 21.8 16.9 24.3 27.8 28.8 24.8 31.3 20.5 23.8 25.8 57.2 26.8 16.1 47.6 23.5 21.7 27.6 28.4 47.6 134.8 75.8 41.1 38.9 68.1 35.1 62.0 100.3 58.2 130.0 42.1 109.4 51.0 67.2 44.4 35.4 112.9 91.5 87.3 84.4 87.0 107.2 49.4 75.8 49.3 95.0 41.1 40.2 60.2 59.8 107.4 66.1 119.5 114.0 93.1 64.8 50.6 67.7 137.6 54.0 166.0 43.2 76.6 165.5 34.9 96.0 57.3 66.1 71.4 121.3 73.1 35.2 139.3 100.4 79.4 78.7 70.4 50.1 56.0 31.7 69.9 91.6 88.2 95.4 40.6 37.7 56.9 3.4 1.2 2.2 2.9 1.2 2.9 3.6 1.6 2.0 1.8 2.7 1.0 3.3 0.5 1.7 1.9 3.5 2.7 1.2 25.2 27.6 24.4 27.0 26.3 23.8 25.7 25.7 25.3 24.8 25.8 27.6 29.7 0.0 9.6 11.1 42.9 16.6 22.3 17.7 42.7 33.7 33.2 30.2 6.5 15.7 20.5 27.6 20.9 21.1 39.6 21.6 52.8 32.8 4.3 20.0 36.9 30.1 31.1 25.7 9.3 29.0 19.4 17.8 14.8 30.5 16.5 40.0 17.5 15.1 17.3 26.9 10.5 18.2 10.2 14.4 13.1 9.1 16.4 16.8 17.8 7.5 27.1 26.5 29.9 11.1 17.1 36.8 14.8 16.1 28.9 28.8 19.5 47.9 9.4 28.8 32.9 31.6 28.2 28.4 36.5 31.3 19.6 11.1 30.0 26.8 19.1 15.9 SMARCE1 BAF57 ENSG00000073584 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1" Q969G3 17 40624962-40648654 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" Neurogenesis "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003916, CAB037318" Supported Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB037318: AB_476780, HPA003916: AB_1857279" "unprognostic (7.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.09e-2)" "unprognostic (8.06e-3)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (4.48e-1)" "unprognostic (1.25e-2)" "unprognostic (2.20e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-2)" "unprognostic (2.04e-1)" "unprognostic (9.80e-2)" "unprognostic (5.93e-2)" "unprognostic (7.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-2)" 39.4 22.2 10.5 37.8 11.9 43.2 35.6 10.6 13.3 45.9 14.3 40.2 38.9 56.2 28.3 43.6 39.0 41.4 40.1 9.2 11.7 31.2 31.5 36.1 49.6 13.7 10.7 58.6 35.4 38.3 13.3 48.4 13.2 34.2 38.5 17.5 33.6 42.1 42.5 27.7 39.3 57.4 11.7 40.5 30.9 31.5 11.2 76.1 40.8 44.7 54.2 46.8 26.2 16.5 86.5 139.6 169.1 126.5 87.7 125.5 82.8 105.9 145.4 122.1 91.0 92.7 72.7 135.9 149.6 145.3 81.0 114.5 106.1 112.3 145.1 128.3 138.0 97.2 73.4 165.2 87.8 179.8 94.5 109.3 87.6 97.7 140.6 122.1 133.4 106.5 144.2 52.2 118.2 96.5 331.6 37.1 95.4 70.8 68.6 183.3 190.2 103.7 147.5 144.9 134.6 130.0 94.5 269.4 86.6 181.5 161.5 111.4 109.7 98.1 107.6 89.7 132.6 97.7 122.8 204.5 100.0 80.9 154.9 106.3 64.4 88.2 91.7 67.8 95.0 99.8 82.4 96.1 77.9 112.3 68.3 79.3 26.5 124.7 82.2 80.3 114.7 112.2 10.5 11.9 10.6 13.3 9.2 11.7 13.7 10.7 13.2 11.7 11.2 16.5 41.4 48.1 45.1 13.1 67.5 38.1 43.0 69.5 65.4 75.8 19.7 20.2 53.0 38.6 61.5 20.2 16.7 101.8 68.7 38.7 15.6 41.5 27.1 34.9 47.0 60.4 96.5 84.1 17.1 32.3 75.7 72.4 44.9 32.1 74.0 41.3 62.8 44.0 51.6 82.4 18.8 53.5 65.1 42.9 39.6 11.8 90.4 30.9 24.9 19.7 63.2 63.3 105.0 26.7 32.7 35.7 46.7 82.4 44.2 36.5 52.8 30.5 59.3 37.1 39.5 62.7 57.0 49.7 50.9 63.3 40.1 114.8 53.8 35.3 62.5 34.3 SMC3 "BAM, bamacan, CSPG6, HCAP, SMC3L1" ENSG00000108055 "Structural maintenance of chromosomes 3" Q9UQE7 10 110567695-110606048 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Spermatocytes: 994.2;Spermatogonia: 799.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043206 Approved Supported Nucleoplasm NA NA 630000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA043206: AB_2678362" "unprognostic (3.40e-1)" "unprognostic (1.73e-2)" "unprognostic (9.05e-2)" "unprognostic (3.00e-2)" "unprognostic (3.73e-2)" "unprognostic (8.89e-3)" "unprognostic (9.74e-3)" "unprognostic (8.06e-2)" "unprognostic (5.31e-2)" "unprognostic (6.32e-2)" "unprognostic (3.53e-2)" "unprognostic (1.17e-2)" "unprognostic (8.73e-3)" "unprognostic (7.22e-2)" "unprognostic (5.18e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" 19.5 13.3 9.0 18.7 10.9 43.9 19.1 18.5 11.7 18.5 11.7 18.3 15.5 20.3 15.7 19.2 16.5 11.1 12.9 8.6 10.2 14.0 15.3 14.5 25.2 10.2 9.4 25.7 19.6 20.0 14.2 20.7 10.4 14.0 16.7 27.6 16.2 15.2 21.1 20.6 19.4 16.9 9.6 18.6 14.7 38.1 9.5 39.2 16.5 14.1 24.3 15.5 17.8 12.7 73.1 44.5 95.4 67.8 30.7 26.3 40.9 57.7 56.7 51.9 50.7 56.4 59.7 94.2 24.5 38.6 40.0 56.5 68.7 35.0 78.6 77.3 60.1 76.5 56.2 51.2 30.8 109.8 56.6 21.1 28.0 57.4 89.5 48.5 38.8 31.7 61.7 70.4 45.4 38.1 85.2 58.3 66.1 38.6 35.1 71.1 171.5 51.4 32.4 31.7 53.7 61.8 62.0 17.7 48.6 61.8 28.5 53.1 40.1 41.6 65.5 47.6 84.4 40.9 38.8 99.6 37.5 103.9 34.8 20.7 6.1 15.8 9.6 8.4 12.1 11.0 11.3 10.6 6.8 11.0 11.3 11.2 6.5 12.6 7.6 8.7 14.5 6.2 9.0 10.9 18.5 11.7 8.6 10.2 10.2 9.4 10.4 9.6 9.5 12.7 74.9 80.1 62.0 16.6 73.5 60.5 53.2 64.1 34.7 81.3 44.3 49.9 64.5 47.1 64.4 55.2 75.0 119.6 94.3 29.8 25.4 96.9 56.9 52.0 65.0 74.9 40.7 104.6 26.2 45.6 111.4 66.0 20.9 49.0 56.3 124.9 40.4 31.9 59.1 60.6 29.2 40.7 54.9 37.9 42.5 34.6 115.2 49.8 37.4 19.7 96.1 54.9 98.9 33.2 43.4 53.0 70.1 114.0 65.0 44.7 70.7 30.3 68.3 78.9 184.1 102.0 110.6 994.2 799.1 48.1 64.5 49.1 80.9 112.7 51.9 37.5 SMC5 "KIAA0594, SMC5L1" ENSG00000198887 "Structural maintenance of chromosomes 5" Q8IY18 9 70258978-70354873 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054900 Supported Supported "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA054900: AB_2682634" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-2)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (8.04e-3)" "unprognostic (2.15e-2)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.23e-1)" "unprognostic (3.36e-2)" "unprognostic (7.30e-2)" "unprognostic (1.71e-2)" "unprognostic (2.73e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" 10.2 7.7 4.3 15.0 4.8 26.0 16.6 10.4 5.0 12.2 9.0 15.0 13.5 15.2 12.8 10.8 12.3 12.9 9.9 4.2 6.1 8.0 14.8 12.8 18.5 5.2 5.7 25.2 19.4 10.4 9.6 14.8 5.7 11.4 16.9 8.3 17.1 8.7 13.8 9.0 13.9 10.7 4.2 12.0 14.5 13.5 4.9 18.2 14.3 8.2 16.1 16.4 11.3 7.8 43.9 10.8 26.6 16.2 15.1 28.3 20.9 29.8 25.8 15.9 17.3 4.1 23.3 43.7 9.5 22.5 13.9 39.3 28.9 19.8 31.7 19.9 10.3 25.5 18.3 13.1 19.2 41.8 25.3 19.9 13.5 21.5 24.5 25.4 16.9 25.8 19.1 17.1 29.9 6.7 55.4 14.7 20.4 33.5 14.9 32.4 43.6 13.7 16.1 21.3 18.9 14.2 29.5 18.7 8.3 19.2 11.2 17.6 18.6 21.3 22.4 29.2 41.2 20.9 29.9 29.9 17.9 21.6 25.9 14.1 5.6 10.4 8.5 6.3 8.0 8.4 7.3 8.1 4.6 8.2 8.0 7.4 3.7 8.1 7.6 8.7 8.4 4.0 4.3 4.8 10.4 5.0 4.2 6.1 5.2 5.7 5.7 4.2 4.9 7.8 48.9 57.7 70.3 61.7 54.6 45.6 102.0 30.3 59.7 26.8 39.2 34.0 34.6 41.5 62.0 20.2 29.2 32.1 65.2 38.8 9.8 61.3 47.9 65.3 58.9 37.6 28.1 29.0 72.2 54.8 37.5 62.1 40.8 89.1 51.8 52.5 16.1 25.9 16.4 38.7 66.4 34.8 20.3 22.9 30.8 15.9 53.4 37.9 24.9 74.0 65.4 17.2 54.6 85.5 94.6 68.3 37.9 59.5 40.6 105.5 23.6 11.7 51.0 35.7 26.3 66.2 52.2 80.0 55.0 52.5 41.9 35.6 56.7 58.4 45.0 105.8 SMG8 "C17orf71, FLJ10587, FLJ23205" ENSG00000167447 "SMG8 nonsense mediated mRNA decay factor" Q8ND04 17 59209400-59215239 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024841 Approved Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA024841: AB_10600790" "unprognostic (2.68e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-3)" "unprognostic (9.91e-2)" "unprognostic (8.59e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (1.91e-1)" "unprognostic (1.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-3)" "unprognostic (4.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-1)" 5.9 7.0 5.0 6.4 5.3 10.9 8.5 5.7 6.8 7.4 5.5 6.0 5.9 7.4 6.9 6.5 8.5 5.1 7.5 5.3 6.4 7.1 7.7 6.3 9.5 5.2 5.7 11.2 5.2 9.4 4.1 9.2 5.8 6.6 6.0 4.6 6.3 6.9 8.3 7.3 5.4 7.2 5.7 7.4 5.9 7.5 6.2 10.2 8.1 8.4 10.1 6.7 3.9 6.3 16.2 22.6 17.4 17.5 21.4 18.0 23.5 23.1 23.5 31.7 27.3 15.5 14.1 23.8 35.2 22.1 24.6 19.2 28.3 21.4 30.6 31.5 27.0 27.3 12.2 22.2 24.6 26.8 22.6 23.6 26.2 23.2 17.2 21.0 21.1 14.7 33.5 12.2 22.0 36.2 25.9 12.4 17.1 23.3 22.0 17.3 26.0 22.5 14.9 11.5 15.4 24.9 16.2 8.9 19.3 21.7 26.9 18.7 20.5 11.9 27.0 13.0 20.8 23.7 36.3 27.3 15.2 14.0 19.8 26.7 18.6 9.6 8.7 24.2 10.2 10.0 8.1 8.3 15.0 6.2 8.0 7.3 4.7 10.2 26.4 5.0 8.3 9.0 5.0 5.3 5.7 6.8 5.3 6.4 5.2 5.7 5.8 5.7 6.2 6.3 1.0 3.2 2.6 4.6 3.8 0.6 0.3 0.9 1.8 0.8 0.7 0.4 0.9 0.0 1.8 0.0 0.0 1.0 1.2 2.4 0.0 2.7 0.3 1.6 1.9 1.8 1.8 1.3 3.4 2.8 1.0 1.6 3.1 1.6 5.7 1.5 1.1 1.0 0.8 3.3 3.7 0.5 0.0 2.4 0.0 0.0 0.9 2.4 0.0 0.0 2.3 0.6 1.0 4.5 5.0 2.9 6.3 0.7 3.6 0.2 0.8 0.6 3.5 1.1 0.0 1.6 3.0 1.2 1.3 3.1 0.6 1.4 2.3 2.1 1.5 0.3 SNRNP200 "ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD" ENSG00000144028 "Small nuclear ribonucleoprotein U5 subunit 200" O75643 2 96274338-96321271 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029321 Approved Supported Nucleoplasm NA NA 78000 "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA029321: AB_10604096" "unprognostic (2.63e-2)" "unprognostic (1.45e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (2.48e-3)" "unprognostic (1.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (6.46e-2)" "unprognostic (2.61e-2)" "unprognostic (1.82e-1)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" 26.5 21.8 11.2 38.1 11.3 58.8 38.6 16.9 12.1 31.9 25.5 29.6 29.4 41.0 20.2 29.5 39.8 25.8 26.9 9.9 11.1 28.8 29.3 29.3 43.2 13.1 10.3 53.2 34.3 52.4 19.7 39.2 12.0 31.6 34.6 67.6 35.1 33.0 47.4 30.8 30.3 38.5 12.2 36.5 30.6 40.4 9.8 73.5 37.4 38.7 52.3 30.1 21.6 14.6 97.8 107.7 144.1 106.1 63.1 57.1 131.5 67.3 80.6 119.5 112.9 197.3 69.3 169.3 101.3 83.3 178.9 74.9 264.4 88.8 130.8 94.3 139.4 221.6 169.8 106.7 40.9 171.2 92.4 58.1 53.7 133.2 112.0 61.3 97.3 98.3 198.2 112.3 68.3 82.3 158.8 49.4 182.8 77.9 102.4 185.0 139.3 107.4 43.8 145.4 159.8 150.5 107.7 88.7 65.4 165.0 86.4 100.5 86.2 98.3 117.2 101.3 96.2 101.0 134.0 207.6 66.2 109.0 106.2 16.7 4.7 6.0 7.9 5.0 8.9 5.7 6.0 9.5 5.6 6.1 5.2 7.1 4.7 7.3 6.1 5.8 6.8 5.5 11.2 11.3 16.9 12.1 9.9 11.1 13.1 10.3 12.0 12.2 9.8 14.6 47.3 44.8 53.9 21.9 57.4 29.6 27.2 35.5 38.1 79.3 40.2 42.4 35.2 54.3 46.2 51.5 104.3 43.2 64.2 43.4 5.9 42.6 29.3 42.4 48.7 44.8 46.7 54.1 21.2 46.7 36.1 37.9 52.0 48.8 25.3 79.0 40.4 49.4 35.1 87.5 21.1 40.6 34.6 31.9 33.2 18.2 57.5 35.2 17.8 16.9 45.2 79.1 73.2 17.1 16.7 46.1 30.7 55.3 68.3 34.8 47.3 17.9 50.7 135.2 65.7 54.7 45.5 77.6 56.0 38.7 33.0 44.6 71.6 53.3 49.4 30.3 SNRNP40 "HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57" ENSG00000060688 "Small nuclear ribonucleoprotein U5 subunit 40" Q96DI7 1 31259568-31296788 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026527, HPA027345" Supported Supported "Nuclear speckles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear speckles" "HPA026527: AB_1858814, HPA027345: AB_2239703" "unprognostic (2.31e-3)" "unprognostic (5.63e-2)" "unprognostic (5.24e-3)" "unprognostic (1.36e-1)" "unprognostic (1.14e-3)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.73e-6)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" "unprognostic (2.50e-1)" "unprognostic (1.22e-1)" "unprognostic (8.57e-2)" "unprognostic (2.34e-2)" "unprognostic (1.78e-2)" "unprognostic (5.93e-2)" "unprognostic (4.31e-2)" "unprognostic (6.24e-2)" 17.9 18.9 10.7 21.2 14.6 30.0 20.7 15.5 12.6 17.7 10.3 20.6 16.4 20.1 21.7 19.1 22.5 13.1 14.2 10.4 12.5 17.6 19.3 15.8 35.4 14.5 13.3 20.8 13.0 18.0 15.9 22.3 15.4 20.1 22.1 19.1 15.0 20.8 20.9 18.5 17.6 21.7 13.7 21.3 16.6 21.2 12.8 40.3 18.0 18.1 40.2 24.0 16.7 20.1 71.6 53.6 95.5 78.6 46.7 38.4 66.2 58.8 57.4 104.7 101.9 76.7 69.8 91.8 56.4 46.1 53.9 66.4 145.7 69.8 105.9 99.2 109.3 135.2 72.1 83.9 58.4 150.0 59.3 36.2 54.7 102.1 75.6 34.4 86.1 80.2 129.0 52.9 60.5 51.6 111.3 87.9 171.6 71.1 76.5 87.3 134.5 71.1 44.2 57.7 65.1 63.6 92.3 47.4 116.2 88.0 47.2 94.9 59.5 57.9 85.2 81.5 112.9 43.5 57.1 126.1 47.1 139.3 96.4 102.8 75.8 82.3 98.6 97.3 113.1 93.8 95.1 98.2 93.0 82.6 101.1 115.1 16.4 110.5 92.0 78.4 110.2 161.1 10.7 14.6 15.5 12.6 10.4 12.5 14.5 13.3 15.4 13.7 12.8 20.1 44.1 3.2 6.1 14.7 51.5 53.0 50.2 90.8 41.5 15.6 24.4 30.6 16.5 21.5 32.5 16.5 18.8 108.7 35.7 11.9 43.0 42.5 7.1 21.0 27.5 39.4 34.8 80.8 23.7 35.9 91.3 38.1 28.5 13.9 34.3 36.2 28.9 22.3 56.2 10.1 24.3 18.6 69.2 20.7 48.6 5.4 26.8 31.5 42.7 15.0 44.7 23.8 44.3 23.6 49.0 36.4 20.2 34.3 40.6 55.0 17.0 45.0 27.6 22.2 32.9 31.0 35.1 105.5 89.7 39.6 54.8 61.3 52.4 45.9 36.9 40.6 SNRPE Sm-E ENSG00000182004 "Small nuclear ribonucleoprotein polypeptide E" P62304 1 203861599-203871152 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 34000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" "unprognostic (1.13e-1)" "unprognostic (1.30e-1)" "unprognostic (4.35e-2)" "unprognostic (8.32e-3)" "unprognostic (4.87e-1)" "unprognostic (3.01e-3)" "unprognostic (2.86e-3)" "unprognostic (3.31e-2)" "unprognostic (1.59e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.34e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (4.38e-5)" "unprognostic (3.54e-1)" "unprognostic (1.31e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-3)" 36.5 50.0 37.5 50.4 39.6 87.2 65.7 43.3 61.3 41.4 43.9 52.5 31.8 42.4 59.5 39.1 38.5 24.1 34.5 38.2 41.2 47.3 46.1 25.6 50.0 38.0 39.8 64.7 38.0 37.6 24.9 39.3 40.5 29.6 41.5 37.8 33.0 29.2 39.9 31.0 33.9 27.2 41.1 33.3 35.7 22.4 38.0 100.4 27.8 22.3 58.2 51.4 33.9 43.4 262.9 85.4 307.0 157.4 64.6 131.4 179.1 187.1 111.6 159.9 147.5 103.1 200.6 258.4 154.3 111.9 164.0 185.7 258.1 206.8 205.2 105.1 120.4 166.4 169.8 144.5 106.8 375.6 168.1 113.7 55.7 190.1 176.1 151.4 146.4 288.3 310.0 155.7 138.9 150.7 372.6 360.0 413.1 175.6 91.4 242.9 295.0 303.9 201.5 96.1 160.9 210.2 130.5 275.7 347.6 271.2 203.7 261.7 98.4 127.6 216.4 115.9 341.7 130.7 184.3 574.1 125.6 198.3 146.9 14.6 22.6 13.7 19.7 21.1 30.2 24.0 26.7 20.9 34.1 21.5 26.7 26.3 7.4 37.0 25.4 46.0 23.1 19.1 37.5 39.6 43.3 61.3 38.2 41.2 38.0 39.8 40.5 41.1 38.0 43.4 125.2 128.2 116.4 5.5 153.6 244.1 284.5 442.3 101.3 48.5 190.2 204.1 73.3 204.5 226.4 128.8 14.6 454.6 146.1 92.2 424.6 408.6 23.1 179.9 197.6 173.5 163.4 176.9 8.1 473.8 612.3 159.3 72.4 188.6 112.7 190.0 138.5 278.7 300.7 57.2 7.7 241.2 341.8 172.9 177.6 34.8 237.0 117.6 172.5 5.6 304.5 149.7 212.1 7.5 8.8 421.8 136.7 164.0 97.7 351.2 113.4 434.3 162.7 48.3 98.6 272.0 240.4 217.7 239.5 128.8 256.0 225.1 126.2 178.5 313.8 294.1 SNRPG Sm-G ENSG00000143977 "Small nuclear ribonucleoprotein polypeptide G" P62308 2 70281362-70293740 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064152, HPA067814" Supported Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA064152: AB_2685199, HPA067814: AB_2685903" "unprognostic (6.42e-2)" "unprognostic (7.89e-2)" "unprognostic (6.10e-2)" "unprognostic (5.42e-2)" "unprognostic (1.29e-1)" "unprognostic (1.11e-3)" "unprognostic (1.75e-3)" "unprognostic (2.28e-2)" "unprognostic (3.60e-3)" "unprognostic (6.19e-2)" "unprognostic (1.00e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.08e-6)" "unprognostic (4.37e-2)" "unprognostic (1.33e-1)" "unprognostic (8.96e-2)" "unprognostic (1.41e-2)" 66.9 92.0 55.9 85.9 58.0 118.0 85.1 58.4 85.7 50.4 60.2 87.9 62.1 55.2 103.0 95.5 45.6 40.5 102.2 55.3 58.3 97.1 95.5 59.8 100.7 58.9 58.0 49.2 53.1 69.5 60.4 83.8 59.5 53.7 80.3 92.7 59.2 46.0 88.3 43.5 63.2 51.6 59.1 76.6 61.1 60.1 58.4 139.9 61.2 83.8 96.9 91.4 56.3 63.1 398.0 414.3 412.2 240.0 146.5 157.1 369.0 255.4 230.5 332.8 307.2 718.7 258.1 355.1 180.6 202.2 404.9 253.9 415.1 355.7 356.7 333.2 404.5 474.0 256.6 875.4 194.0 602.3 313.6 140.2 198.1 312.8 308.8 135.0 341.5 301.1 645.3 254.8 266.9 479.0 541.5 961.8 430.4 489.9 340.2 350.4 507.9 419.0 483.9 367.1 238.1 204.4 235.9 201.1 295.8 250.7 202.1 470.1 232.9 235.3 440.2 246.3 520.4 188.1 228.3 731.8 211.1 510.0 260.9 163.1 168.5 181.1 144.2 219.2 147.4 209.1 193.4 168.8 202.5 166.0 157.8 188.9 88.1 135.8 222.4 273.0 230.1 264.8 55.9 58.0 58.4 85.7 55.3 58.3 58.9 58.0 59.5 59.1 58.4 63.1 191.7 201.9 198.9 7.2 237.0 299.1 340.3 625.6 143.4 88.8 192.3 239.1 145.7 178.7 314.8 202.3 33.3 655.3 175.7 249.1 534.1 389.6 51.0 253.2 184.7 209.1 186.6 319.4 7.4 391.5 818.7 173.3 119.3 188.4 213.3 140.7 175.3 391.8 390.8 65.6 8.7 301.5 370.2 186.6 270.8 45.4 175.8 194.0 224.1 5.6 329.1 446.1 208.1 4.5 13.8 434.1 271.6 159.1 251.9 366.1 226.5 676.1 401.8 91.4 184.1 181.3 244.4 340.7 367.4 236.6 318.2 521.5 220.2 125.9 324.1 375.1 SOS1 "GF1, GINGF, HGF" ENSG00000115904 "SOS Ras/Rac guanine nucleotide exchange factor 1" Q07889 2 38981549-39124345 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 226.6;Inhibitory neurons: 224.0;Microglial cells: 161.1;Oligodendrocyte precursor cells: 173.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 134.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005396 Uncertain Approved Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "CAB005396: AB_2270724" "unprognostic (6.68e-2)" "unprognostic (2.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.14e-3)" "unprognostic (4.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.74e-3)" "unprognostic (4.55e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-3)" "unprognostic (7.61e-2)" "unprognostic (5.59e-2)" "unprognostic (1.33e-2)" 17.5 8.4 8.2 14.8 10.2 10.8 9.8 14.1 10.3 13.1 6.8 11.0 14.7 14.3 10.3 12.3 11.2 13.5 9.5 9.7 10.8 11.0 11.9 11.0 16.9 9.5 10.2 20.1 9.1 17.1 0.1 17.0 9.5 13.4 12.9 13.2 9.0 12.2 13.7 9.4 15.6 13.8 6.7 12.5 11.5 10.3 8.7 15.4 15.1 16.4 17.8 13.5 0.1 10.6 24.8 15.1 22.8 16.2 29.1 35.0 23.8 15.3 18.7 12.0 11.4 16.3 14.6 35.8 10.3 20.1 18.5 14.4 26.9 13.9 22.1 36.3 11.9 55.5 12.8 22.0 11.8 17.9 134.9 21.6 20.5 16.3 15.8 19.5 18.9 8.1 23.9 16.4 15.4 13.5 19.4 15.8 14.3 30.4 10.4 21.5 20.5 10.5 12.1 19.8 22.0 22.0 18.3 32.3 18.2 18.5 10.4 9.3 21.5 19.8 16.0 15.7 15.4 19.3 20.9 18.4 15.8 17.3 12.0 0.0 0.5 1.4 1.3 0.7 1.9 1.6 1.3 1.4 0.4 1.0 1.5 1.4 0.6 2.7 0.9 0.6 0.9 0.4 8.2 10.2 14.1 10.3 9.7 10.8 9.5 10.2 9.5 6.7 8.7 10.6 72.3 16.0 31.2 120.5 20.9 20.8 15.5 10.9 19.9 19.0 18.4 16.9 33.9 18.6 17.8 9.2 10.4 10.2 27.6 19.5 1.9 11.0 64.9 30.0 36.6 43.2 12.0 12.8 226.6 11.9 8.4 22.9 21.4 34.0 3.8 30.0 12.8 18.6 10.3 8.4 224.0 16.9 26.4 19.1 13.2 11.4 22.7 19.9 7.2 161.1 19.6 15.1 26.8 173.4 125.2 14.2 14.6 21.8 37.5 25.3 28.0 12.8 20.4 11.2 6.6 27.1 22.7 11.3 7.0 17.1 25.3 10.4 33.2 18.4 17.0 28.4 SOX4 ENSG00000124766 "SRY-box transcription factor 4" Q06945 6 21593751-21598619 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 73.4" "Cell type enhanced" "Detected in many" "Ductal cells: 1128.5;Granulosa cells: 1047.5;Ionocytes: 1320.3;Pancreatic endocrine cells: 1288.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 45.7" "Group enriched" "Detected in all" 5 "dendritic cells: 45.7;granulocytes: 33.3;monocytes: 22.0" "Cell line enhanced" "Detected in many" "AN3-CA: 254.1;MOLT-4: 229.9" "Region enhanced" "Detected in all" "olfactory bulb: 54.2" HPA029901 Approved Supported Nucleoplasm,Mitochondria NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 11.8 4.3 4.7 9.2 5.0 24.0 17.9 8.8 6.7 21.5 2.8 11.9 12.5 57.8 15.0 5.4 13.5 20.4 6.4 4.2 6.5 16.8 6.4 19.3 5.8 3.5 5.0 51.7 10.2 3.6 4.1 6.1 4.1 14.5 14.4 6.4 17.5 6.8 3.5 8.8 11.6 17.4 4.0 5.4 17.5 9.9 7.1 73.4 8.6 6.1 7.4 21.1 7.7 4.2 8.5 24.4 60.5 254.1 22.0 5.5 98.7 3.8 7.8 4.6 4.1 16.7 16.5 2.9 100.2 6.2 3.5 25.1 32.0 17.9 3.3 36.6 66.8 2.7 11.5 11.2 3.5 9.0 2.1 9.6 18.1 2.1 7.3 64.1 72.3 138.8 0.6 0.2 5.2 20.6 229.9 21.6 45.3 12.7 23.1 99.7 5.3 0.4 44.1 78.3 78.9 141.2 35.9 41.1 14.0 74.9 20.1 30.9 55.7 7.1 23.1 1.7 18.6 1.5 0.1 71.8 2.4 30.6 28.5 33.3 19.3 2.1 0.5 11.7 0.1 7.0 0.3 0.3 8.7 6.6 2.2 1.6 0.8 7.4 22.0 45.7 2.1 4.7 4.7 5.0 8.8 6.7 4.2 6.5 3.5 5.0 4.1 4.0 7.1 4.2 235.0 198.7 50.4 0.7 36.2 112.5 129.2 660.7 676.7 99.7 586.1 676.5 297.4 423.2 457.3 154.5 12.5 74.8 104.4 247.6 66.5 1128.5 6.1 669.0 624.2 264.5 340.8 114.3 3.2 604.4 409.4 247.3 313.0 650.9 60.6 1047.5 119.2 6.8 35.5 48.8 4.6 263.0 1320.3 78.0 266.7 12.2 12.2 94.0 243.7 3.7 91.4 189.1 17.5 70.4 1.0 1288.2 153.8 11.3 40.9 151.1 76.7 132.5 162.1 31.6 6.6 234.2 439.9 4.9 236.8 400.7 93.1 30.2 36.6 69.6 299.4 272.5 SP3 SPR-2 ENSG00000172845 "Sp3 transcription factor" Q02447 2 173880850-173965702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004580, HPA032145, HPA032146" Supported Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (2.39e-3)" "unprognostic (2.50e-1)" "unprognostic (4.92e-2)" "unprognostic (5.54e-3)" "unprognostic (6.36e-2)" "unprognostic (2.76e-3)" "unprognostic (3.27e-1)" "unprognostic (5.01e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.46e-5)" "unprognostic (2.78e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.69e-1)" 32.6 19.8 15.8 35.2 16.0 53.1 43.1 21.3 19.8 50.9 16.1 34.3 26.9 45.1 34.6 32.1 37.1 28.9 23.8 14.2 17.1 29.7 40.1 29.9 46.1 16.9 16.7 40.3 24.9 43.1 13.2 49.1 16.4 31.9 38.9 21.0 26.1 30.4 22.5 38.5 29.6 36.3 16.3 38.6 27.0 25.2 15.5 68.0 47.5 33.7 53.8 33.7 28.0 18.5 41.6 34.5 74.6 45.8 91.8 82.3 83.5 47.5 67.1 62.2 66.1 56.8 59.7 65.1 39.3 65.0 46.3 41.0 57.8 46.0 91.7 55.2 21.2 65.9 33.9 54.0 45.5 60.4 48.9 60.6 53.2 72.9 63.6 48.4 49.4 51.3 51.4 86.8 65.7 44.4 84.0 49.9 66.1 60.1 37.8 74.2 68.5 53.0 48.4 55.8 67.8 48.1 67.1 38.1 52.4 81.7 30.0 80.0 44.1 70.6 61.8 47.5 50.4 58.8 46.7 85.8 53.0 41.6 67.2 8.9 9.4 13.0 11.6 7.0 12.9 9.5 12.3 12.3 9.9 7.4 13.8 12.8 27.3 21.9 10.3 6.2 13.8 9.9 15.8 16.0 21.3 19.8 14.2 17.1 16.9 16.7 16.4 16.3 15.5 18.5 36.1 19.2 22.9 44.7 55.2 57.6 31.7 25.7 64.9 29.1 36.8 23.4 18.8 14.3 23.3 20.2 27.1 30.9 67.9 37.9 11.7 18.6 4.3 22.3 57.8 33.9 30.5 31.7 52.7 19.3 42.7 43.9 17.9 29.5 23.5 31.3 32.2 43.8 24.6 23.5 50.7 28.8 20.3 54.1 72.8 7.1 45.4 55.6 42.7 81.5 39.0 30.5 46.4 60.3 74.7 30.8 22.9 36.9 63.7 34.2 22.1 24.4 26.6 20.2 19.7 40.4 53.4 10.5 20.4 48.6 57.0 34.6 50.8 26.0 29.0 59.0 SP4 "HF1B, MGC130008, MGC130009, SPR-1" ENSG00000105866 "Sp4 transcription factor" Q02446 7 21428043-21514822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010246, HPA040395" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "CAB010246: AB_2194481, HPA040395: AB_2676959" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" "unprognostic (6.04e-2)" "unprognostic (8.28e-2)" "unprognostic (9.14e-2)" "unprognostic (8.51e-2)" "unprognostic (1.09e-2)" "unprognostic (7.85e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.15e-3)" "unprognostic (1.89e-1)" "unprognostic (6.04e-3)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "unprognostic (6.18e-2)" "unprognostic (7.80e-3)" 1.9 2.5 2.1 4.5 3.2 6.8 3.6 10.0 2.5 3.7 1.4 2.0 1.7 5.5 3.0 2.2 4.3 2.5 3.8 1.7 2.8 2.9 2.1 3.5 6.5 2.4 1.8 11.3 2.3 7.2 2.5 2.0 1.9 4.0 2.4 8.9 2.2 2.7 3.6 1.9 2.4 2.9 2.1 5.9 2.9 3.8 2.7 13.5 7.8 7.6 6.8 2.9 1.7 4.4 3.6 2.2 6.7 10.6 2.1 1.4 2.0 3.4 2.2 3.6 4.7 5.5 3.5 14.1 2.3 2.0 9.6 4.2 10.0 2.9 6.9 4.6 4.5 6.5 4.6 2.1 1.5 5.4 7.7 1.4 2.4 3.8 4.3 1.8 7.1 9.6 9.5 9.2 2.9 1.3 13.8 3.7 17.5 6.4 2.7 33.1 11.6 4.6 1.2 2.2 8.8 11.0 7.1 3.0 2.5 6.6 3.6 4.0 3.2 5.7 8.3 3.5 6.5 14.0 15.0 21.0 3.4 8.7 8.1 5.7 0.8 8.9 6.9 1.0 8.2 3.7 6.4 6.6 1.0 5.9 8.2 6.9 2.1 3.9 2.1 1.8 8.4 3.8 2.1 3.2 10.0 2.5 1.7 2.8 2.4 1.8 1.9 2.1 2.7 4.4 11.0 3.2 9.0 19.6 21.8 12.6 11.6 2.5 14.2 17.5 10.0 7.5 9.7 8.6 5.7 0.0 8.4 0.9 13.1 1.6 0.0 2.2 7.0 5.4 7.0 7.8 10.7 21.9 31.0 2.2 1.3 6.3 5.6 7.9 5.1 10.8 10.8 4.6 1.8 18.5 31.3 2.2 2.0 6.0 6.4 4.8 5.6 6.0 7.2 27.2 4.5 10.3 18.6 50.3 60.2 1.7 12.3 6.8 7.1 7.7 1.2 2.0 1.6 21.0 0.0 17.3 6.9 7.3 8.4 4.8 11.1 1.5 22.2 2.8 3.1 5.3 SPEN "KIAA0929, MINT, RBM15C, SHARP" ENSG00000065526 "Spen family transcriptional repressor" Q96T58 1 15836095-15940456 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015825, HPA050257" Supported Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA015825: AB_1856823, HPA050257: AB_2681065" "unprognostic (3.91e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (3.06e-2)" "unprognostic (6.93e-3)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (4.88e-3)" "unprognostic (1.71e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (1.83e-1)" 15.3 8.6 11.3 11.5 14.6 23.2 14.0 22.6 12.9 13.3 4.8 12.0 8.8 14.4 8.5 13.3 15.5 8.0 10.8 10.4 14.6 9.6 11.0 14.8 12.9 14.2 12.4 21.3 17.5 16.4 10.7 11.8 11.4 11.1 9.1 15.1 12.8 9.9 20.5 17.3 13.4 9.8 8.0 12.7 11.0 10.3 12.6 16.6 15.6 19.8 13.3 13.0 13.6 20.7 25.4 20.9 26.1 19.6 25.0 15.2 13.8 12.9 16.6 13.5 11.4 19.3 19.5 35.6 15.0 25.1 15.9 36.0 24.0 22.6 21.4 32.1 68.5 44.6 20.5 12.4 11.3 37.1 20.8 11.2 15.9 20.2 28.9 12.9 15.5 26.5 47.1 35.9 11.1 14.0 30.7 14.7 11.6 14.4 15.9 29.5 25.1 21.9 7.5 22.4 20.5 19.9 36.2 17.4 14.8 11.6 6.5 18.4 28.9 12.8 15.5 24.4 18.5 21.5 15.0 39.6 12.2 29.2 17.9 7.4 1.9 1.6 1.4 1.7 0.9 1.3 1.1 1.0 0.5 3.0 0.9 1.0 8.5 1.1 1.3 2.8 0.9 0.5 11.3 14.6 22.6 12.9 10.4 14.6 14.2 12.4 11.4 8.0 12.6 20.7 55.7 80.1 85.3 68.9 69.4 104.6 44.9 18.3 90.5 67.1 35.0 27.9 52.6 30.0 43.2 5.5 52.1 12.2 52.8 44.4 3.9 18.5 7.0 90.4 67.4 51.6 31.7 47.1 57.2 17.6 15.0 45.9 41.8 146.5 62.6 34.3 20.0 32.6 15.2 95.9 66.0 27.4 8.2 34.6 69.6 4.9 27.4 53.2 21.4 64.6 56.3 28.3 68.0 51.8 88.7 23.6 34.6 35.7 74.5 46.7 16.8 7.5 29.4 53.2 19.7 85.7 56.6 59.5 45.9 89.8 101.6 15.7 52.3 33.1 32.8 56.3 SRBD1 FLJ10379 ENSG00000068784 "S1 RNA binding domain 1" Q8N5C6 2 45388680-45612165 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030567, HPA030568" Approved Approved Mitochondria,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Mitochondria, Cytosol" "HPA030567: AB_10611244, HPA030568: AB_10601856" "unprognostic (1.16e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-3)" "unprognostic (2.46e-1)" "unprognostic (8.20e-3)" "unprognostic (4.14e-1)" "unprognostic (8.69e-3)" "unprognostic (9.74e-2)" "unprognostic (7.11e-2)" "unprognostic (9.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.76e-1)" "unprognostic (3.42e-3)" "unprognostic (3.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (2.29e-1)" 6.8 5.6 1.9 7.2 2.5 6.5 7.6 2.1 1.9 9.8 3.5 7.1 5.7 7.2 11.8 4.7 5.4 5.6 5.8 1.7 2.5 7.6 8.7 6.5 7.5 2.5 2.3 5.4 7.3 12.2 3.7 6.8 2.8 7.4 8.0 3.7 5.2 5.7 3.1 3.8 5.4 6.8 2.4 8.6 8.1 9.0 2.5 11.5 10.2 4.9 7.5 5.3 3.9 2.8 18.7 9.5 19.1 12.9 6.9 15.0 15.1 14.1 12.2 13.2 12.1 8.0 7.8 16.1 10.2 10.1 9.8 8.7 19.0 17.9 24.3 22.1 10.6 21.4 7.4 17.3 8.1 17.9 12.1 9.3 7.2 15.7 18.2 5.8 16.2 5.8 15.6 11.9 19.8 17.0 24.3 13.8 21.9 12.0 10.3 16.5 27.5 14.7 15.0 12.1 16.8 13.7 12.3 13.1 14.0 9.9 8.2 6.4 14.9 18.4 14.7 9.0 12.3 12.5 4.9 9.6 10.4 17.6 13.5 3.9 6.2 13.1 5.4 7.0 4.8 5.3 4.0 6.3 6.1 4.6 5.4 5.0 2.3 8.3 12.3 5.7 4.5 4.3 1.9 2.5 2.1 1.9 1.7 2.5 2.5 2.3 2.8 2.4 2.5 2.8 10.9 19.2 7.7 28.7 13.0 3.6 3.5 6.2 8.6 7.9 8.7 8.0 8.8 8.6 10.6 3.7 4.2 8.4 15.7 5.9 9.8 8.3 3.5 11.5 20.7 9.3 7.2 15.8 22.0 9.1 7.1 10.9 20.9 9.9 8.2 11.0 7.9 13.8 9.6 13.5 32.7 9.7 0.0 22.5 3.9 2.5 7.5 13.8 7.2 46.9 13.7 12.9 13.4 48.2 51.8 4.6 6.3 6.4 19.8 2.9 5.9 10.8 7.8 14.7 13.1 12.9 10.2 37.5 28.4 9.5 3.8 5.6 12.8 16.6 5.1 2.2 SRFBP1 "BUD22, FLJ25286, p49, Rlb1, STRAP" ENSG00000151304 "Serum response factor binding protein 1" Q8NEF9 5 121961975-122075570 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042737 Approved Approved "Nucleoli rim" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli rim" "HPA042737: AB_10796583" "unprognostic (8.94e-2)" "unprognostic (1.80e-1)" "unprognostic (4.68e-2)" "unprognostic (1.61e-2)" "unprognostic (4.14e-1)" "unprognostic (1.18e-1)" "unprognostic (5.07e-3)" "unprognostic (2.03e-1)" "unprognostic (8.96e-3)" "unprognostic (6.31e-3)" "prognostic unfavorable (5.31e-4)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (1.78e-1)" "unprognostic (4.71e-1)" "unprognostic (1.43e-1)" "unprognostic (8.45e-2)" 6.8 4.3 2.3 6.3 3.0 6.2 9.1 3.6 2.6 6.3 2.3 5.3 4.9 6.2 4.3 6.9 5.2 5.1 4.6 1.9 2.3 7.2 6.9 4.7 7.4 2.9 3.2 4.8 4.3 7.4 1.7 6.3 3.1 5.4 5.7 4.2 5.0 4.7 6.3 3.8 4.1 5.8 2.8 6.1 4.6 4.5 3.2 5.4 8.3 6.9 6.5 7.7 3.5 4.1 14.7 10.6 9.5 15.2 10.7 9.9 15.9 13.8 10.0 14.8 17.3 8.7 14.2 18.4 15.6 8.6 25.5 10.5 15.7 18.8 27.5 26.4 8.9 17.7 7.0 9.0 11.5 20.6 14.0 12.0 14.2 18.7 18.3 7.1 16.3 9.3 16.5 14.5 15.7 6.8 14.4 6.6 14.1 11.6 6.9 14.6 22.6 19.4 16.5 14.9 9.9 9.2 12.7 12.5 24.2 11.8 12.7 12.2 11.9 22.8 13.8 16.4 20.3 7.7 15.5 20.8 13.0 16.4 20.4 0.6 7.0 2.8 6.0 12.7 7.8 10.3 6.7 6.8 9.6 8.8 7.8 10.7 0.9 7.8 10.4 9.0 6.8 4.3 2.3 3.0 3.6 2.6 1.9 2.3 2.9 3.2 3.1 2.8 3.2 4.1 45.5 16.0 15.2 15.7 32.4 19.2 36.7 27.8 12.0 38.7 19.7 26.3 14.3 18.6 26.2 14.7 25.0 20.6 21.2 8.0 41.1 33.0 35.2 29.5 37.5 25.2 16.2 22.9 26.2 20.2 19.7 24.2 16.3 27.8 44.4 24.9 8.6 9.4 20.0 47.1 24.3 11.2 12.2 8.1 11.7 7.5 24.2 22.9 19.6 23.4 16.6 29.8 21.6 35.7 34.0 20.2 9.7 26.7 10.7 35.1 4.4 34.8 17.8 28.6 13.1 41.3 28.3 29.6 27.4 18.3 19.0 12.9 19.0 30.5 19.6 27.8 SRP72 ENSG00000174780 "Signal recognition particle 72" O76094 4 56467617-56503681 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Ribonucleoprotein "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034621 Approved NA NA 23000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" "HPA034621: AB_10601593" "unprognostic (1.96e-2)" "unprognostic (1.40e-2)" "prognostic favorable (3.83e-4)" "unprognostic (2.75e-1)" "unprognostic (1.76e-2)" "unprognostic (9.40e-2)" "prognostic unfavorable (3.25e-6)" "unprognostic (7.76e-3)" "unprognostic (2.88e-2)" "unprognostic (4.09e-3)" "unprognostic (4.60e-3)" "unprognostic (9.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (1.13e-2)" "unprognostic (3.35e-1)" 37.7 31.6 13.9 41.2 15.0 73.5 49.8 15.1 18.1 41.4 20.5 39.1 29.3 40.8 29.5 42.3 33.0 33.5 25.2 14.2 19.1 33.4 45.4 32.1 49.5 14.9 18.8 45.0 47.7 43.4 16.4 48.3 16.8 31.1 41.1 27.3 43.8 32.7 33.3 34.3 31.6 44.6 15.9 39.1 33.6 27.2 14.9 52.8 54.3 35.7 55.6 46.6 23.7 18.6 109.1 82.0 101.6 98.7 63.2 90.0 98.0 157.2 125.0 129.3 102.7 91.2 120.5 167.6 105.6 132.2 68.2 61.1 126.9 133.4 152.3 44.3 74.0 146.4 90.3 86.0 115.7 284.4 116.3 85.8 175.9 138.0 243.3 112.1 117.1 126.4 216.1 157.0 124.9 84.2 168.6 73.9 88.2 135.1 86.1 149.2 81.9 127.0 88.5 101.7 62.9 104.5 99.8 193.4 88.5 81.3 77.0 102.3 142.7 106.8 143.3 110.4 165.2 111.8 56.9 181.2 114.9 148.3 132.2 43.0 64.3 38.7 50.4 70.8 65.1 52.8 50.9 51.1 82.1 48.5 49.4 49.9 8.4 59.5 57.5 61.4 60.8 58.7 13.9 15.0 15.1 18.1 14.2 19.1 14.9 18.8 16.8 15.9 14.9 18.6 78.5 73.7 72.5 17.0 84.7 97.3 93.7 103.5 47.3 61.6 65.8 80.4 45.2 54.3 87.9 27.6 18.8 120.8 97.0 30.5 66.5 121.1 86.3 38.9 87.2 83.7 53.2 113.8 30.2 131.2 197.3 84.0 39.3 73.3 101.9 94.5 63.9 80.1 100.4 57.2 32.4 94.8 69.2 109.4 78.9 116.1 65.3 83.4 58.7 28.1 122.4 54.5 72.1 29.1 35.6 111.8 48.7 66.5 156.6 131.7 43.5 71.1 54.6 37.7 39.5 92.9 106.7 48.2 86.5 73.2 100.9 166.5 71.1 111.0 89.0 115.2 SSBP3 "CSDP, FLJ10355, SSDP, SSDP1" ENSG00000157216 "Single stranded DNA binding protein 3" Q9BWW4 1 54225433-54413479 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA071780: " "unprognostic (1.44e-2)" "prognostic favorable (2.48e-9)" "unprognostic (1.06e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.94e-1)" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.59e-2)" "unprognostic (3.93e-2)" "unprognostic (3.34e-1)" "unprognostic (7.08e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-3)" "unprognostic (2.50e-1)" "unprognostic (6.45e-2)" "unprognostic (2.08e-1)" "unprognostic (1.96e-1)" 26.3 46.1 35.4 21.2 45.9 42.0 15.1 32.5 72.6 49.4 8.0 29.6 28.6 48.4 20.1 31.3 40.2 26.4 24.9 47.7 24.4 19.6 27.5 20.1 19.9 15.9 21.3 103.8 21.3 13.8 5.5 27.9 15.4 32.8 25.5 37.8 23.0 36.0 30.7 39.8 29.3 35.3 15.1 28.2 45.7 27.0 20.9 67.8 15.5 15.8 19.8 19.1 19.4 44.0 13.4 9.6 91.9 56.9 43.2 26.1 153.4 30.0 31.3 13.1 11.2 18.9 11.2 8.6 45.9 31.1 11.7 39.6 49.1 19.1 16.0 69.9 21.7 96.5 47.0 28.0 36.8 25.1 47.4 39.1 20.1 23.1 6.0 25.3 66.4 64.7 97.5 17.2 18.1 19.4 136.2 66.6 161.2 51.4 40.8 94.5 37.7 33.0 24.2 15.2 117.1 70.1 35.3 59.9 19.7 83.1 27.0 38.6 61.7 24.9 36.9 37.1 20.2 29.3 32.7 20.5 43.3 90.8 10.9 0.0 1.2 3.3 5.6 0.7 3.5 0.9 4.4 4.9 1.1 0.3 5.8 5.8 0.1 0.6 0.7 0.4 0.4 1.7 35.4 45.9 32.5 72.6 47.7 24.4 15.9 21.3 15.4 15.1 20.9 44.0 31.8 12.8 12.1 31.6 6.8 29.7 37.2 13.8 15.9 97.4 16.9 36.6 17.4 41.5 14.9 23.9 8.4 56.9 36.1 73.6 9.8 30.2 36.5 65.5 38.4 37.4 111.7 60.8 100.0 25.2 46.9 41.4 47.4 48.2 7.6 93.1 47.5 97.8 26.0 42.1 37.1 78.5 14.2 33.9 25.4 42.5 91.6 19.2 23.2 38.4 21.5 68.5 51.5 45.2 78.4 64.6 33.9 136.9 10.0 20.4 38.7 10.8 27.7 48.5 26.3 21.2 37.2 2.9 35.8 27.2 25.9 23.7 20.2 144.9 46.2 30.8 STAG1 "SA-1, SA1, SCC3A" ENSG00000118007 "Stromal antigen 1" Q8WVM7 3 136336236-136752403 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035015, HPA058653" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies" "HPA035015: AB_10603117, HPA058653: AB_2683787" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (1.41e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-1)" "unprognostic (4.62e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-3)" "unprognostic (1.29e-2)" "unprognostic (1.71e-1)" "unprognostic (5.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.58e-1)" "unprognostic (5.97e-2)" "unprognostic (2.83e-2)" 13.7 9.1 7.6 12.3 8.8 15.7 15.6 17.0 8.3 16.9 9.9 13.5 9.6 19.3 10.6 10.8 13.5 10.3 10.5 6.5 8.7 12.0 10.8 11.2 14.7 9.3 7.8 21.9 12.4 13.7 5.0 17.6 9.0 10.8 14.4 13.2 11.6 12.1 15.0 13.7 11.0 16.1 8.8 11.8 10.0 8.9 7.8 22.5 15.8 15.8 15.9 12.0 11.5 11.2 34.6 17.6 29.1 25.1 21.5 36.8 15.7 37.9 48.4 35.0 33.0 30.2 14.9 26.9 23.3 39.7 28.1 23.4 31.6 17.3 47.4 33.2 14.9 28.8 25.1 16.7 16.3 50.6 27.7 23.4 19.3 25.6 28.6 20.3 27.5 28.8 18.7 52.7 22.3 29.5 33.6 16.4 19.0 23.7 13.9 29.6 31.6 35.7 19.1 24.5 14.2 22.8 40.8 16.0 17.5 15.0 22.9 21.2 23.3 40.1 29.0 36.0 33.9 39.1 28.9 59.5 24.6 17.0 26.2 4.0 3.0 4.6 4.4 3.0 4.6 6.4 3.7 4.0 2.8 4.4 4.1 3.3 8.7 5.5 3.5 4.5 4.8 2.1 7.6 8.8 17.0 8.3 6.5 8.7 9.3 7.8 9.0 8.8 7.8 11.2 44.5 25.6 24.2 95.6 42.4 40.0 31.4 18.7 38.7 43.8 24.8 26.7 10.8 22.8 23.5 16.5 39.6 29.3 39.5 42.1 11.7 20.7 2.8 23.7 59.5 34.1 18.7 29.7 161.8 22.2 26.7 33.8 23.9 39.6 22.2 30.3 31.4 21.5 18.6 28.6 166.8 27.9 8.2 16.9 22.0 4.8 49.4 25.1 16.0 231.4 27.2 25.6 42.2 223.2 188.4 27.4 17.5 32.4 53.1 27.2 24.2 13.2 14.5 68.1 26.3 67.1 36.2 54.8 50.5 27.5 36.7 31.7 39.2 16.0 23.4 24.3 STAG2 "SA-2, SA2, SCC3B" ENSG00000101972 "Stromal antigen 2" Q8N3U4 X 123960212-124422664 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002857 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA002857: AB_1079861" "unprognostic (1.62e-1)" "unprognostic (1.01e-2)" "unprognostic (6.75e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-2)" "unprognostic (2.70e-2)" "unprognostic (3.77e-2)" "unprognostic (9.67e-3)" "unprognostic (4.68e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-1)" "unprognostic (3.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.81e-1)" "unprognostic (2.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.97e-1)" 27.9 22.9 20.7 34.2 26.3 72.8 41.5 32.6 24.1 33.3 30.4 28.8 23.8 35.7 28.3 26.8 30.1 25.2 21.5 18.0 22.6 33.7 28.5 28.6 45.0 26.2 21.9 46.0 31.7 51.9 12.0 35.8 27.8 29.8 28.2 45.5 26.5 29.6 23.3 26.1 26.5 25.8 24.2 37.4 28.5 8.0 21.2 81.4 49.3 36.0 44.3 28.4 17.6 39.6 62.6 56.9 84.5 53.0 34.9 52.3 54.4 58.0 61.8 58.5 73.2 53.8 65.1 115.0 79.6 52.3 65.5 55.6 173.6 48.8 82.5 81.9 74.7 106.6 110.8 35.7 35.6 140.7 80.0 42.2 46.4 69.5 111.4 50.2 49.7 114.2 105.4 118.9 43.1 67.8 180.6 62.9 44.5 55.8 84.4 125.9 112.0 96.1 44.9 117.3 75.7 60.6 131.2 47.7 66.9 59.2 28.9 62.2 61.5 0.3 31.1 69.4 66.6 50.9 82.2 141.6 36.8 84.3 60.3 28.2 15.2 28.0 15.0 18.9 17.8 15.0 15.6 14.6 19.1 19.0 21.3 17.5 44.5 18.8 23.1 16.5 13.5 10.0 20.7 26.3 32.6 24.1 18.0 22.6 26.2 21.9 27.8 24.2 21.2 39.6 71.1 64.1 56.6 42.4 80.9 56.2 61.5 31.5 72.3 51.0 58.0 48.4 44.9 37.1 50.6 44.1 60.5 32.2 113.4 42.9 21.5 42.3 1.1 65.1 70.4 62.3 58.1 77.0 41.8 38.2 32.7 64.5 39.8 79.3 58.1 53.6 59.3 42.2 36.0 45.4 51.9 35.0 28.5 71.4 65.0 4.2 65.9 89.9 33.8 70.3 91.4 61.2 97.9 69.4 114.0 54.9 29.3 69.2 73.8 81.4 28.0 35.7 51.4 62.9 65.7 104.0 60.3 14.8 15.4 51.0 56.1 71.4 87.2 49.5 38.9 83.6 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023302-132075943 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 70.0;epididymis: 56.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 140.1;U-937: 144.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Yes No 360000 "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: AB_2684163" "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 6.0 2.5 1.0 15.2 2.7 70.0 6.0 1.7 1.3 6.8 2.5 11.5 9.6 46.6 56.3 13.1 7.4 5.6 1.4 0.7 1.5 3.5 5.2 7.2 26.2 0.8 0.8 2.1 3.7 23.5 5.0 25.2 0.7 20.0 11.6 0.2 7.3 35.8 0.9 7.8 6.9 38.1 0.6 13.2 12.2 2.2 3.8 41.3 3.7 1.2 23.5 11.8 7.4 0.7 32.9 11.3 1.3 0.0 5.2 4.9 72.0 1.0 4.0 0.5 0.6 30.1 29.0 44.6 19.4 7.3 22.1 36.5 80.8 51.1 0.0 39.1 66.6 64.6 25.9 28.4 4.7 135.3 5.1 6.9 30.0 0.1 33.7 15.1 14.2 60.0 29.2 40.4 12.2 29.0 140.1 124.9 64.4 22.0 4.3 99.9 39.7 57.9 32.6 51.8 26.6 29.6 19.2 17.0 0.9 54.9 22.0 35.4 0.3 12.8 13.7 39.0 47.9 31.0 52.0 49.8 11.7 144.8 6.5 59.1 9.5 31.6 22.8 12.4 22.4 14.5 15.2 19.6 11.3 12.6 19.7 20.6 18.2 41.0 22.7 4.2 7.2 20.4 1.0 2.7 1.7 1.3 0.7 1.5 0.8 0.8 0.7 0.6 3.8 0.7 0.9 22.4 15.6 0.0 24.7 0.0 36.4 0.0 6.8 0.0 5.9 10.9 1.3 5.7 8.1 11.0 0.0 55.2 42.7 6.5 3.9 4.5 0.6 7.4 1.8 1.7 1.2 12.8 2.0 7.1 34.7 9.6 15.3 17.9 11.4 0.5 1.4 4.4 11.8 0.0 1.4 4.8 0.0 8.8 0.0 0.4 3.4 17.3 0.0 2.8 13.5 0.0 53.5 0.0 0.2 10.9 4.0 2.2 14.5 33.6 1.9 1.5 6.6 0.0 6.6 6.7 3.6 1.8 2.5 16.1 0.0 59.1 27.4 0.6 6.5 18.2 STRBP "FLJ11307, ILF3L, SPNR" ENSG00000165209 "Spermatid perinuclear RNA binding protein" Q96SI9 9 123109500-123268586 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 415.7;Inhibitory neurons: 256.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 157.0;U-698: 141.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020651 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA020651: AB_1857616" "unprognostic (1.92e-2)" "unprognostic (3.56e-2)" "unprognostic (4.47e-2)" "unprognostic (4.07e-1)" "unprognostic (9.06e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (5.89e-2)" "unprognostic (1.10e-1)" "unprognostic (8.11e-2)" "unprognostic (1.10e-1)" "unprognostic (8.86e-2)" "prognostic favorable (1.70e-10)" "unprognostic (3.25e-2)" "unprognostic (1.80e-1)" "unprognostic (1.07e-1)" "unprognostic (2.13e-1)" 3.9 4.4 4.8 11.5 6.1 14.4 12.6 8.8 17.5 9.1 8.6 17.5 15.4 6.2 18.9 16.3 14.8 6.9 5.5 5.1 6.0 11.7 8.1 6.6 29.5 2.6 5.2 3.8 12.1 37.6 15.3 5.5 2.3 9.0 17.0 22.0 15.8 6.9 5.3 5.5 14.0 5.6 2.2 11.0 11.0 37.6 8.1 24.0 17.6 2.9 35.1 7.4 6.7 8.8 24.7 22.7 30.8 16.6 3.9 2.0 40.6 6.3 1.8 9.6 7.1 24.5 28.6 157.0 13.1 4.9 42.7 22.6 36.3 13.1 15.3 23.1 18.3 33.9 23.9 24.2 7.6 70.4 9.0 1.3 16.1 2.6 11.0 4.4 11.9 46.6 71.6 67.7 2.9 38.2 59.0 31.0 40.8 56.0 17.8 94.5 26.4 51.3 22.8 19.4 45.8 16.5 26.3 28.2 23.0 36.0 37.3 45.3 7.0 1.7 14.3 16.9 19.0 80.4 92.9 141.5 8.5 26.9 11.4 3.8 0.4 1.1 1.3 0.2 1.2 8.1 1.2 1.3 0.4 6.3 1.7 1.3 1.2 2.0 0.6 5.1 1.0 0.7 4.8 6.1 8.8 17.5 5.1 6.0 2.6 5.2 2.3 2.2 8.1 8.8 7.1 19.2 28.8 62.7 94.2 8.9 22.9 7.6 14.8 39.5 29.9 16.1 28.0 21.5 26.0 16.5 87.6 18.3 34.5 33.7 17.6 20.8 80.4 81.5 23.5 9.7 32.4 38.9 415.7 19.0 10.0 5.5 15.8 42.4 12.0 16.7 10.8 15.2 9.8 16.8 256.3 25.2 12.2 2.1 14.0 32.4 5.3 8.3 17.8 88.1 8.2 47.1 5.2 100.5 52.1 18.2 25.7 4.9 52.9 25.3 32.5 17.9 92.5 61.6 0.0 5.5 8.8 128.7 34.4 40.0 10.4 12.9 17.9 5.1 29.8 32.2 SUCO "C1orf9, CH1, OPT, SLP1" ENSG00000094975 "SUN domain containing ossification factor" Q9UBS9 1 172532349-172611833 "Predicted membrane proteins" Osteogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 83.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047251 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA 45000 "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoli fibrillar center, Cytosol" "HPA047251: AB_2679999" "unprognostic (1.28e-2)" "unprognostic (6.38e-3)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (4.57e-2)" "unprognostic (1.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.20e-2)" "unprognostic (7.05e-2)" 9.8 11.9 8.4 9.4 10.3 83.3 14.4 7.9 10.3 13.3 8.6 9.1 10.0 12.1 61.9 8.8 15.7 11.6 9.2 7.5 9.9 12.0 6.9 9.5 9.7 8.2 10.2 17.9 26.1 27.1 13.1 16.9 8.3 13.5 9.4 35.5 14.7 24.5 3.0 12.1 15.2 9.4 9.2 8.9 13.2 24.6 8.9 14.0 17.6 4.6 9.9 12.8 8.0 11.4 30.2 13.1 37.9 34.0 19.1 18.2 42.8 35.9 20.9 22.3 27.0 23.9 31.5 15.0 21.1 20.6 22.9 46.4 16.3 14.0 38.1 8.4 11.8 11.8 8.2 14.7 22.2 19.1 15.9 16.5 14.1 27.6 22.4 69.0 19.7 17.0 7.7 20.8 33.9 7.2 12.8 12.9 34.5 34.6 30.4 12.5 22.0 9.8 34.6 41.6 20.2 26.1 16.6 28.3 31.9 64.8 27.5 20.5 25.9 20.2 21.2 19.5 36.9 30.9 26.5 26.7 19.2 9.9 32.4 6.5 3.5 6.3 4.3 3.2 4.2 4.5 3.9 3.7 2.9 5.2 4.3 4.4 3.2 5.9 3.9 4.2 3.2 2.4 8.4 10.3 7.9 10.3 7.5 9.9 8.2 10.2 8.3 9.2 8.9 11.4 20.9 48.1 30.9 40.5 30.4 26.3 32.4 22.6 59.2 43.0 40.5 31.2 30.1 14.3 39.0 27.6 50.1 38.8 35.6 14.2 3.9 15.0 40.7 30.4 29.4 22.2 26.4 48.6 32.3 32.0 27.3 29.1 29.6 56.9 13.9 25.7 15.0 15.2 13.3 47.1 43.8 30.7 18.3 13.1 17.2 55.8 45.7 22.7 26.6 34.7 18.7 63.5 18.6 82.4 66.3 25.0 7.1 28.2 61.9 38.8 34.0 13.2 37.0 53.8 26.3 29.6 23.0 73.6 36.7 28.9 27.0 49.4 37.4 30.0 11.2 34.7 SUPT16H "CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68" ENSG00000092201 "SPT16 homolog, facilitates chromatin remodeling subunit" Q9Y5B9 14 21351476-21384019 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022551, HPA049787" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 27000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nucleoli fibrillar center" "CAB022551: , HPA049787: AB_2680881" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (7.12e-2)" "unprognostic (7.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.38e-3)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (4.91e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.48e-3)" "unprognostic (1.02e-1)" "unprognostic (7.58e-3)" "unprognostic (9.05e-2)" "unprognostic (5.87e-3)" 29.3 24.8 9.7 36.6 11.1 42.3 35.9 18.8 13.9 34.2 8.2 30.6 23.1 41.1 19.5 29.0 32.0 24.1 24.1 9.7 15.6 28.6 22.4 26.3 51.2 11.3 12.0 43.6 22.6 46.2 13.5 32.1 12.0 29.9 35.1 44.4 20.9 32.6 21.8 28.9 25.9 36.6 10.7 32.9 26.3 43.3 12.1 56.8 33.3 24.6 51.8 35.6 20.1 12.3 147.8 136.9 185.5 136.6 85.5 81.7 131.4 130.3 103.2 155.5 145.4 133.9 129.5 311.3 48.5 96.5 99.7 153.9 237.2 118.9 234.0 99.8 100.9 188.7 121.9 195.1 87.0 270.1 134.7 73.4 72.6 131.0 146.3 75.4 107.7 174.2 158.1 129.4 131.3 99.9 253.6 85.8 207.1 136.2 134.1 270.3 210.6 168.0 63.9 160.8 183.8 157.2 209.8 125.3 81.1 118.7 69.2 127.9 91.1 135.0 113.4 85.0 143.3 128.8 230.2 306.7 49.9 158.0 104.9 35.6 18.3 28.2 29.6 23.9 34.7 31.2 27.9 33.2 23.7 27.4 31.3 32.2 15.0 34.0 31.1 22.2 28.4 25.2 9.7 11.1 18.8 13.9 9.7 15.6 11.3 12.0 12.0 10.7 12.1 12.3 41.5 64.1 55.9 24.2 51.6 35.6 44.3 51.5 45.5 48.9 46.3 49.7 64.2 22.8 50.3 53.3 47.9 65.1 73.6 28.4 25.4 71.0 142.5 52.0 124.3 46.9 23.4 74.6 27.4 61.1 63.9 61.1 29.6 61.7 84.2 73.4 29.3 32.0 41.9 55.5 30.1 31.2 40.7 34.9 25.2 96.1 59.7 40.7 17.8 20.6 90.9 53.3 64.9 16.1 25.2 68.9 15.2 59.8 39.5 46.1 16.5 30.4 40.2 41.1 19.7 78.5 69.5 128.9 152.8 45.1 41.5 45.6 56.3 61.6 43.0 35.7 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937007-32001038 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies" "HPA057436: AB_2683439" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 12.3 11.8 6.3 18.8 6.3 45.4 15.0 11.1 8.5 11.6 6.8 14.9 16.0 15.2 12.0 14.0 11.0 12.0 10.3 5.4 5.8 16.4 18.1 12.6 33.0 5.4 5.9 11.4 11.5 19.8 6.6 18.7 5.6 13.3 16.4 26.5 10.5 12.2 8.1 13.0 15.3 14.7 5.2 18.4 15.2 27.4 6.1 38.5 18.3 11.0 30.0 15.6 9.0 7.1 46.5 40.4 37.2 42.9 21.1 26.8 38.2 44.2 38.8 53.0 63.7 30.9 25.5 100.7 33.2 27.7 45.4 40.1 56.0 25.5 85.7 35.8 54.0 69.9 32.9 22.3 24.8 111.5 68.7 18.7 28.1 53.1 40.4 32.1 33.1 47.3 68.8 135.6 46.2 16.2 133.3 64.4 21.3 32.4 24.4 78.5 95.3 81.9 31.1 44.6 47.5 37.1 71.3 22.7 43.3 25.8 66.0 91.5 24.7 41.9 38.0 50.8 69.3 73.5 98.4 122.5 30.7 67.4 38.7 0.6 0.7 1.6 1.4 1.1 1.1 2.4 1.6 1.6 0.6 1.8 1.5 2.1 1.6 1.8 0.7 1.9 1.8 0.4 6.3 6.3 11.1 8.5 5.4 5.8 5.4 5.9 5.6 5.2 6.1 7.1 44.5 41.7 45.8 43.1 50.1 58.5 50.2 21.8 31.9 77.6 54.2 36.8 32.3 27.1 32.6 35.0 108.4 61.5 65.2 24.0 17.6 28.3 16.2 52.8 55.8 45.1 29.4 93.6 71.6 21.9 53.1 35.1 31.1 54.2 15.8 41.4 38.2 42.3 32.9 62.2 69.5 31.8 10.2 42.1 58.2 13.9 26.8 47.3 24.9 45.0 73.1 45.7 38.1 75.4 71.3 27.8 15.4 25.6 66.2 62.8 21.5 26.6 29.6 80.9 13.1 47.2 38.4 121.7 128.9 48.6 71.7 69.5 52.5 52.8 35.6 66.7 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 73.8;parathyroid gland: 87.6" "Cell type enhanced" "Detected in many" "B-cells: 91.3;Hofbauer cells: 73.1;Kupffer cells: 96.7;Macrophages: 95.2;Microglial cells: 114.3;monocytes: 92.5;Plasma cells: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "classical monocyte: 77.3;eosinophil: 83.5;intermediate monocyte: 64.0;memory B-cell: 74.5;myeloid DC: 85.1;naive B-cell: 58.4;neutrophil: 112.1;NK-cell: 30.0;non-classical monocyte: 60.2;plasmacytoid DC: 63.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 125.8;HEL: 72.8;HL-60: 101.6;HMC-1: 64.1;REH: 84.4;THP-1: 76.8;U-698: 58.8;U-937: 70.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" No NA 290000 "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.4 4.6 4.1 42.5 4.1 50.9 6.8 4.5 4.9 7.7 4.2 20.1 30.8 4.1 16.1 17.5 17.0 12.9 2.9 3.8 5.0 11.2 4.5 20.6 61.8 7.1 5.8 1.7 9.1 87.6 2.4 12.0 7.0 3.8 20.5 0.7 8.4 4.2 1.0 9.9 36.3 9.3 6.6 40.3 19.1 6.9 7.1 49.7 25.6 2.4 73.8 17.5 8.3 9.8 22.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 14.3 125.8 3.5 0.0 4.2 19.1 2.7 10.2 0.0 0.0 17.0 72.8 0.0 0.0 0.0 101.6 64.1 0.0 14.0 0.0 1.4 0.0 0.0 15.5 2.0 9.9 0.0 15.4 0.1 44.4 0.7 47.0 0.0 84.4 0.1 34.6 2.6 18.6 6.4 5.7 0.1 8.7 0.1 0.3 7.9 76.8 0.2 0.0 0.4 0.1 0.1 0.2 0.0 58.8 0.0 70.3 0.0 5.3 77.3 83.5 0.3 64.0 0.3 74.5 0.2 0.2 85.1 58.4 0.2 0.1 112.1 30.0 60.2 63.2 0.1 44.6 4.1 4.1 4.5 4.9 3.8 5.0 7.1 5.8 7.0 6.6 7.1 9.8 0.5 12.8 20.2 0.0 91.3 3.4 3.7 8.7 12.0 1.4 6.3 2.8 1.6 14.3 12.8 14.7 0.0 1.3 70.4 16.5 15.6 15.0 7.1 10.7 1.0 2.1 10.3 37.9 0.4 12.5 2.6 2.1 22.4 12.6 43.6 0.0 3.3 1.0 73.1 0.0 0.7 24.4 0.0 96.7 28.8 6.2 0.6 95.2 12.4 114.3 92.5 0.0 62.8 1.5 0.5 18.2 25.1 0.0 83.1 2.5 31.4 0.4 10.4 0.2 6.6 0.7 2.3 0.8 0.7 30.4 5.7 1.4 8.3 0.0 31.1 8.0 TADA1 "ADA1, hADA1, HFI1, STAF42, TADA1L" ENSG00000152382 "Transcriptional adaptor 1" Q96BN2 1 166856510-166876264 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028651 Approved Supported "Nucleoplasm,Focal adhesion sites,Cytosol" No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Focal adhesion sites, Cytosol" "HPA028651: AB_10602476" "unprognostic (9.53e-3)" "unprognostic (2.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (7.09e-2)" "unprognostic (5.99e-3)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.98e-2)" "unprognostic (3.64e-2)" "unprognostic (2.73e-2)" "unprognostic (6.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-2)" 5.1 8.9 9.6 6.1 10.3 19.4 9.2 9.9 12.4 7.7 8.1 8.4 7.7 9.3 7.6 8.3 8.6 5.3 8.6 10.1 9.3 11.6 26.7 6.2 10.4 7.8 8.3 11.0 6.4 10.9 6.2 8.2 8.8 7.9 9.1 17.0 8.1 7.1 9.8 8.0 8.4 7.6 9.2 6.9 7.5 10.8 9.3 13.2 7.5 10.6 10.1 6.6 5.8 11.2 15.7 14.9 27.4 16.3 8.1 10.4 16.2 8.1 9.9 13.2 11.4 13.7 12.5 29.9 15.4 9.6 10.7 11.8 22.3 14.3 10.6 18.9 21.3 9.9 11.9 22.5 12.0 28.3 17.4 7.9 16.3 8.0 19.9 9.6 11.0 22.2 35.9 17.6 10.5 10.9 34.9 22.5 41.6 25.2 16.5 29.1 12.0 37.9 18.0 20.9 17.5 30.6 14.6 18.7 17.5 25.0 25.3 29.3 8.3 10.8 12.4 11.9 17.3 24.9 36.3 56.3 7.5 12.6 10.4 2.9 12.7 13.8 20.7 12.9 22.9 20.2 22.2 23.6 20.7 20.8 27.9 22.3 2.1 27.5 10.4 13.3 23.4 24.7 9.6 10.3 9.9 12.4 10.1 9.3 7.8 8.3 8.8 9.2 9.3 11.2 2.7 9.6 2.7 7.8 8.4 6.1 4.7 3.9 6.2 7.6 4.9 4.6 10.3 2.8 4.1 3.7 8.4 6.1 4.9 4.4 5.9 3.9 4.0 4.8 4.6 4.3 7.2 13.7 9.6 4.0 7.7 4.8 6.6 4.4 5.1 6.1 3.3 20.3 4.2 1.7 10.5 6.1 0.0 5.3 5.1 1.7 4.4 2.6 1.8 3.7 6.9 6.8 4.1 7.5 17.7 3.8 1.7 3.0 7.5 6.2 5.3 7.0 4.3 6.0 0.0 6.1 4.1 5.2 12.9 7.6 5.1 7.3 7.3 1.9 5.9 4.2 TAF1A "SL1, TAFI48" ENSG00000143498 "TATA-box binding protein associated factor, RNA polymerase I subunit A" Q15573 1 222557902-222589933 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054334 Approved Supported Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA054334: AB_2682453" "unprognostic (3.01e-1)" "prognostic unfavorable (9.26e-6)" "unprognostic (7.98e-2)" "unprognostic (9.59e-3)" "unprognostic (1.22e-1)" "unprognostic (8.98e-3)" "unprognostic (3.88e-3)" "unprognostic (3.10e-3)" "unprognostic (4.79e-2)" "unprognostic (2.93e-1)" "unprognostic (3.86e-3)" "unprognostic (2.25e-1)" "unprognostic (2.41e-4)" "unprognostic (8.43e-2)" "unprognostic (1.76e-1)" "unprognostic (2.35e-3)" "unprognostic (9.06e-2)" 3.0 3.4 2.0 4.8 2.1 2.7 3.2 2.3 2.3 3.0 1.6 2.0 2.5 4.1 3.0 2.6 2.8 2.7 1.9 1.7 2.8 2.1 1.8 2.8 6.5 2.4 2.0 6.8 1.9 1.9 2.5 4.4 2.3 3.2 2.6 4.0 2.0 2.7 1.2 2.1 2.4 2.5 2.1 4.4 3.4 6.4 2.1 4.4 5.1 1.3 5.6 5.3 2.5 3.0 13.8 7.3 19.5 6.8 6.6 5.8 17.2 9.1 7.0 10.8 13.2 7.8 14.8 12.6 17.4 3.2 8.6 13.7 13.1 5.6 15.2 8.3 9.9 7.5 6.3 7.5 7.4 18.2 3.3 3.0 6.0 12.1 15.4 5.1 4.5 8.7 23.4 5.6 14.9 5.0 21.6 13.0 39.5 15.8 21.0 13.2 39.1 12.2 4.5 7.3 11.1 23.1 14.0 8.1 10.1 9.9 4.6 9.1 6.1 10.9 10.9 19.4 23.2 6.8 6.6 16.5 9.7 11.7 14.7 1.8 1.5 2.1 3.2 2.5 4.7 5.2 2.8 2.9 1.5 7.4 3.3 4.1 0.3 3.0 2.5 5.3 2.5 1.7 2.0 2.1 2.3 2.3 1.7 2.8 2.4 2.0 2.3 2.1 2.1 3.0 3.1 0.0 1.1 6.5 8.6 8.5 6.4 3.9 6.8 10.2 3.1 3.6 1.5 2.8 1.9 3.7 6.2 7.2 4.6 2.4 1.9 2.9 2.5 3.0 6.1 2.7 1.2 3.8 5.2 0.7 6.7 6.0 4.1 3.0 1.3 7.7 1.1 2.0 4.4 6.7 7.1 3.0 0.0 3.8 1.0 1.3 5.6 4.7 0.0 3.7 2.7 3.8 2.1 8.0 8.0 1.3 1.8 2.2 4.4 8.0 0.9 1.3 2.6 8.5 6.6 4.5 4.3 11.5 12.1 4.9 2.8 5.9 4.7 4.2 3.2 8.8 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843443-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 7.2 7.6 4.1 8.4 4.1 7.1 8.7 5.3 4.2 6.9 6.4 5.9 5.1 9.7 6.6 9.6 9.6 7.2 4.8 3.8 5.1 13.3 6.3 8.7 11.4 3.9 5.4 5.7 4.4 14.7 3.7 13.0 3.7 9.0 5.7 9.0 8.1 9.0 2.8 8.6 4.2 8.1 3.8 7.1 6.1 11.0 5.4 11.4 10.5 3.4 12.7 7.9 6.0 4.7 25.1 20.4 29.2 9.6 14.1 21.2 52.7 29.9 23.3 25.3 23.3 19.1 18.1 27.1 13.6 21.3 26.7 15.0 26.9 31.7 27.3 31.3 35.9 31.5 8.9 28.3 19.5 22.1 32.4 17.0 16.5 21.4 28.5 20.8 37.4 14.8 19.8 27.2 25.0 15.3 16.6 20.1 37.7 15.6 17.5 10.2 27.2 8.0 24.9 24.3 12.3 33.6 23.5 28.9 21.9 18.9 10.4 17.4 20.4 31.9 39.8 31.1 35.7 14.9 19.9 39.7 18.4 24.8 26.7 3.6 9.1 6.2 12.1 15.5 12.1 11.1 10.2 14.3 13.4 11.7 6.3 10.0 0.5 10.2 12.4 10.6 11.1 5.2 4.1 4.1 5.3 4.2 3.8 5.1 3.9 5.4 3.7 3.8 5.4 4.7 12.5 19.2 22.0 22.2 13.1 16.2 29.9 17.9 19.9 24.5 8.0 6.1 4.0 2.8 26.0 12.9 27.1 25.0 12.6 2.4 13.7 19.5 11.6 26.8 21.0 15.4 1.8 10.5 38.8 18.9 37.4 18.4 13.7 17.3 8.8 12.7 6.8 4.7 12.7 15.2 27.1 3.3 8.2 12.0 11.5 3.8 19.0 14.6 0.0 15.0 15.5 25.5 15.5 32.6 23.5 15.7 3.8 13.2 16.6 9.5 1.7 26.5 29.7 21.0 19.7 15.9 16.2 47.6 33.9 19.7 13.2 23.7 15.1 24.8 4.4 18.7 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271" "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 10.0 9.3 2.5 18.2 3.0 16.4 12.6 5.0 6.7 7.7 1.2 9.5 13.7 14.1 9.0 9.5 7.7 15.4 7.1 2.9 3.5 6.8 6.9 8.1 20.6 2.3 0.6 13.8 20.9 5.3 4.9 18.0 2.3 9.9 12.5 8.2 10.1 7.3 8.0 11.4 13.3 9.1 0.5 11.9 11.9 5.5 1.7 10.9 10.1 7.1 13.1 13.8 7.2 7.8 18.2 8.6 17.5 17.9 14.0 47.8 29.2 27.0 11.5 18.4 13.8 28.6 38.8 32.6 34.0 15.6 12.6 44.3 21.5 25.9 21.2 10.6 7.8 34.8 55.6 20.2 16.4 31.9 25.1 19.5 25.8 16.0 35.7 35.0 23.7 22.7 24.2 50.4 22.8 5.0 25.8 66.4 12.1 16.7 9.6 23.3 19.1 30.9 22.7 17.4 10.7 19.5 10.8 38.2 16.5 19.3 32.7 12.4 28.7 26.9 30.5 44.2 28.7 22.9 26.2 32.5 11.2 36.9 10.3 44.2 16.7 28.8 17.3 12.5 17.7 39.1 24.9 19.8 12.0 39.8 28.4 24.1 42.7 18.1 10.8 26.1 18.2 5.2 2.5 3.0 5.0 6.7 2.9 3.5 2.3 0.6 2.3 0.5 1.7 7.8 106.7 89.8 95.5 20.9 246.1 244.2 252.4 66.6 255.0 86.6 129.4 130.9 26.2 134.4 105.3 29.5 39.6 176.0 162.5 94.5 45.0 95.2 19.9 144.9 184.9 121.3 110.2 98.4 41.6 146.3 170.2 147.1 125.4 245.6 104.4 257.2 63.1 54.2 69.3 69.0 38.2 148.0 24.4 103.7 153.6 16.5 128.6 112.0 80.0 24.4 102.1 34.8 89.6 35.2 44.0 110.4 87.5 67.7 162.2 269.2 71.1 101.5 67.7 78.2 72.3 187.4 123.1 49.0 71.5 251.4 203.0 160.9 182.3 119.7 174.1 356.8 TAF2 "CIF150, TAF2B, TAFII150" ENSG00000064313 "TATA-box binding protein associated factor 2" Q6P1X5 8 119730774-119832841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "unprognostic (1.69e-2)" "unprognostic (9.33e-3)" "unprognostic (3.79e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (8.12e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.44e-2)" "unprognostic (1.52e-1)" "unprognostic (1.33e-3)" "unprognostic (1.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" 9.2 10.9 4.2 11.2 5.6 14.6 10.6 12.2 6.4 10.3 6.4 9.1 8.8 12.6 11.0 9.5 8.6 9.8 7.1 4.4 6.2 10.6 12.1 7.9 14.2 4.9 4.8 11.2 8.2 11.7 6.5 13.1 5.4 9.4 10.4 10.0 7.7 9.7 7.0 10.8 8.6 11.3 5.0 11.3 9.9 13.7 4.9 15.8 10.6 8.5 14.8 12.5 8.4 7.2 41.3 24.0 27.1 25.1 22.3 24.1 16.9 31.9 26.3 34.7 43.6 15.3 22.9 46.4 27.5 29.1 19.5 26.2 42.1 19.3 49.3 53.2 25.4 58.0 21.7 17.1 35.3 27.9 33.8 22.6 16.9 34.3 39.9 19.0 34.6 24.0 44.4 25.3 32.8 23.2 52.9 12.0 20.4 29.6 27.2 30.6 22.4 25.2 20.7 29.7 35.9 21.1 28.5 88.3 22.6 23.5 26.3 20.7 27.0 23.6 39.1 22.7 46.3 43.2 55.3 57.5 29.0 36.5 22.8 12.5 4.2 7.4 6.0 5.5 5.4 4.7 6.2 6.2 5.5 4.1 5.6 5.8 2.6 6.5 8.1 3.3 7.8 4.4 4.2 5.6 12.2 6.4 4.4 6.2 4.9 4.8 5.4 5.0 4.9 7.2 19.6 12.8 18.8 41.4 23.5 18.7 18.7 14.2 23.3 15.8 15.8 11.7 12.3 11.5 16.7 22.0 20.9 18.1 18.0 10.2 3.9 10.1 2.6 16.7 27.9 19.0 9.6 15.8 56.0 10.7 12.8 18.5 21.4 26.4 21.5 18.2 13.2 17.9 12.5 8.4 52.7 12.8 10.2 14.7 12.9 3.9 15.5 15.8 8.8 37.5 11.7 7.7 21.6 53.3 59.0 11.5 9.8 18.0 23.6 18.2 9.0 15.7 22.3 14.9 13.1 21.3 17.4 34.8 35.5 27.8 20.6 21.1 21.0 17.8 12.0 19.7 TAF8 "FLJ32821, TAF(II)43, TBN" ENSG00000137413 "TATA-box binding protein associated factor 8" Q7Z7C8 6 42050513-42087461 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031730, HPA031731, HPA031734" Supported Enhanced Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994" "unprognostic (7.41e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.46e-3)" "unprognostic (3.08e-1)" "unprognostic (2.23e-2)" "unprognostic (2.46e-1)" "unprognostic (3.53e-1)" "unprognostic (2.01e-3)" "unprognostic (6.74e-2)" "unprognostic (8.22e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (2.42e-2)" "unprognostic (2.26e-2)" 13.7 9.8 5.9 12.8 6.4 21.1 10.8 4.2 6.8 8.5 7.8 9.8 10.5 8.8 6.8 10.1 7.5 8.4 18.0 5.3 5.3 11.3 8.6 9.5 15.6 6.4 5.5 8.0 7.4 16.0 6.6 12.7 5.3 9.0 9.2 8.7 9.5 8.9 16.9 8.5 8.5 10.1 4.4 11.6 10.8 7.9 6.4 23.6 13.9 15.4 15.0 9.8 8.6 7.1 17.2 18.4 14.9 16.7 16.5 15.1 13.6 7.9 13.7 20.4 20.9 31.8 10.0 26.2 16.4 11.5 20.9 12.5 24.5 16.7 15.7 22.6 23.6 33.4 23.3 15.7 20.2 19.5 23.4 20.6 13.0 14.6 18.4 10.0 23.0 31.8 41.7 26.6 11.5 22.7 17.9 29.2 9.3 45.5 8.4 36.1 17.7 20.2 18.0 13.9 15.4 13.7 14.3 11.0 15.7 12.2 16.5 23.6 21.2 18.1 18.8 8.2 16.3 23.0 24.4 55.5 8.3 21.2 10.4 23.0 17.0 27.0 16.0 18.2 11.1 18.2 14.4 12.6 17.8 18.3 14.7 14.4 19.9 10.8 37.4 26.5 13.4 11.0 5.9 6.4 4.2 6.8 5.3 5.3 6.4 5.5 5.3 4.4 6.4 7.1 16.8 19.2 21.1 14.0 17.2 7.0 13.1 14.8 14.2 16.0 14.1 10.4 28.6 10.0 17.4 11.0 31.3 22.1 21.0 12.3 31.3 9.5 12.0 26.5 12.8 16.9 9.0 21.9 7.6 9.9 8.6 11.7 6.6 47.4 19.0 14.2 9.7 9.6 13.5 21.9 8.2 13.3 14.2 21.6 9.5 17.5 14.9 13.1 7.2 13.1 19.3 10.7 33.0 18.6 14.2 8.8 8.3 11.7 19.0 14.4 10.5 16.5 9.8 23.2 13.1 10.6 13.3 15.3 12.9 12.0 8.4 21.5 19.8 19.4 11.1 15.0 TARBP1 "TRM3, TRMT3, TRP-185" ENSG00000059588 "TAR (HIV-1) RNA binding protein 1" Q13395 1 234391313-234479179 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 209.4;Inhibitory neurons: 161.5;Oligodendrocyte precursor cells: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020810, HPA024632" Uncertain Approved "Nuclear speckles" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles" "CAB020810: , HPA024632: AB_1857770" "unprognostic (3.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.75e-1)" "unprognostic (3.47e-1)" "unprognostic (8.26e-2)" "unprognostic (2.44e-3)" "unprognostic (8.45e-3)" "unprognostic (5.22e-3)" "unprognostic (3.72e-2)" "unprognostic (5.52e-2)" "unprognostic (2.56e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.14e-10)" "unprognostic (5.72e-2)" "unprognostic (1.82e-1)" "unprognostic (4.38e-2)" "unprognostic (4.27e-2)" 4.8 5.2 3.9 7.4 4.0 11.1 9.1 5.5 5.0 4.9 0.1 6.1 6.5 4.9 7.6 6.3 7.6 5.7 3.8 3.7 2.9 5.6 3.9 6.2 10.3 0.4 0.8 2.7 7.7 6.1 6.3 8.3 1.1 7.4 9.0 7.3 9.3 4.5 6.3 7.9 5.8 4.6 0.7 7.5 8.3 4.8 4.3 6.7 6.2 7.1 11.4 3.7 4.2 4.1 18.9 12.9 8.3 9.7 13.6 18.5 17.2 7.9 5.9 10.1 7.4 6.2 12.0 16.3 8.2 6.0 8.7 12.1 9.7 9.9 9.7 16.0 14.9 9.0 14.0 9.1 4.3 39.7 7.6 7.7 8.9 7.3 4.1 7.8 10.5 21.6 11.5 10.2 7.1 3.9 16.5 19.4 17.7 20.1 5.3 28.7 4.9 16.0 6.8 10.8 8.9 10.6 10.8 14.0 12.1 5.5 9.0 39.9 7.1 9.3 1.2 10.4 16.1 27.0 19.0 7.2 6.0 18.3 14.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.0 0.5 0.3 0.0 0.3 0.0 1.1 0.0 0.0 3.9 4.0 5.5 5.0 3.7 2.9 0.4 0.8 1.1 0.7 4.3 4.1 12.4 41.7 22.7 53.8 14.6 6.2 4.1 7.4 7.4 35.1 18.4 18.9 5.8 5.7 13.3 7.3 37.5 20.1 23.3 7.2 1.9 4.7 21.5 13.8 13.6 11.1 11.5 16.4 209.4 5.7 17.6 10.1 16.3 9.9 3.8 13.2 12.1 7.7 9.0 57.2 161.5 12.2 10.2 6.6 9.2 3.6 5.6 11.4 10.6 39.4 8.0 7.7 10.3 115.1 72.3 8.8 6.5 6.0 6.3 6.5 5.8 4.3 27.9 17.1 0.0 12.7 7.8 4.1 8.6 11.5 8.2 11.9 12.8 12.8 19.6 4.8 TASOR "C3orf63, FAM208A, KIAA1105, RAP140, se89-1, TASOR1" ENSG00000163946 "Transcription activation suppressor" Q9UK61 3 56620133-56683237 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 25.0;Cardiomyocytes: 31.4;Cytotrophoblasts: 14.5;dendritic cells: 12.1;Extravillous trophoblasts: 9.9;Fibroblasts: 10.7;Hofbauer cells: 20.7;Syncytiotrophoblasts: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006735, HPA017142" Uncertain Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA006735: AB_1852384, HPA017142: AB_1852382" "unprognostic (1.46e-1)" "unprognostic (7.97e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (2.30e-3)" "unprognostic (9.31e-2)" "unprognostic (3.91e-2)" "unprognostic (5.93e-2)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (1.73e-1)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-1)" "unprognostic (2.74e-1)" 9.5 8.4 4.0 15.4 8.4 11.8 11.4 8.7 5.3 12.0 1.7 11.7 10.0 12.3 7.4 11.1 13.1 11.7 6.2 2.2 3.6 10.2 7.9 11.3 20.7 5.1 5.6 14.2 12.4 21.1 4.4 9.4 6.0 9.3 12.4 9.9 8.9 9.4 2.6 7.1 11.3 12.3 5.9 14.7 12.8 29.2 4.5 21.3 18.8 6.9 19.3 12.5 3.8 12.0 49.2 19.2 29.2 23.0 15.5 26.7 14.6 21.4 22.0 20.1 21.1 15.8 35.8 77.3 7.9 21.6 33.9 19.1 29.3 25.1 29.2 38.3 14.8 30.4 27.3 7.1 10.9 32.2 46.1 12.9 20.6 19.6 35.1 23.7 26.5 28.8 29.8 43.3 26.0 17.3 39.8 6.4 16.3 25.9 29.0 20.9 28.9 25.9 19.0 35.5 19.3 23.9 46.9 18.5 23.2 16.6 30.6 36.7 28.6 25.9 23.7 23.8 33.1 39.2 58.5 38.6 30.1 46.7 35.0 0.6 0.8 1.1 1.2 0.6 0.7 0.7 1.0 1.2 1.0 1.1 1.1 1.2 0.2 0.9 0.7 0.7 1.0 0.6 4.0 8.4 8.7 5.3 2.2 3.6 5.1 5.6 6.0 5.9 4.5 12.0 25.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 14.5 12.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 9.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 9.2 2.1 0.0 0.0 0.0 TBC1D5 KIAA0210 ENSG00000131374 "TBC1 domain family member 5" Q92609 3 17157162-18444817 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035125, HPA035126" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "Golgi apparatus" "HPA035125: AB_2674479, HPA035126: AB_10670696" "unprognostic (1.87e-1)" "unprognostic (3.57e-1)" "unprognostic (2.86e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (4.30e-3)" "unprognostic (3.07e-2)" "unprognostic (3.31e-1)" "unprognostic (3.56e-2)" "unprognostic (6.27e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "prognostic favorable (1.75e-7)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (5.72e-2)" "unprognostic (7.07e-2)" 17.9 17.4 13.7 17.0 21.1 25.2 18.6 18.2 15.5 20.1 6.0 13.5 10.8 17.6 12.1 16.8 22.5 19.2 15.8 13.8 16.1 19.9 14.7 18.0 23.1 21.9 17.7 28.1 18.3 25.7 8.5 17.5 22.8 14.0 13.9 10.9 14.1 16.4 9.3 14.0 13.8 18.3 18.3 24.0 13.8 18.9 16.0 20.3 30.0 11.3 23.2 14.8 10.1 29.9 26.3 28.8 23.2 22.0 45.0 65.5 25.4 27.6 39.7 17.7 15.3 14.0 23.2 48.5 29.1 56.3 27.1 8.0 20.6 33.6 36.6 43.0 7.9 46.6 11.1 16.5 28.8 45.7 39.0 42.6 39.3 38.5 23.2 39.8 40.9 28.3 29.6 43.6 43.5 17.6 22.5 10.5 19.1 16.8 30.0 48.9 29.6 34.7 26.3 20.0 8.8 41.0 52.5 12.2 18.6 21.7 34.6 37.6 44.7 48.7 21.6 25.6 30.4 25.2 36.6 46.7 37.5 42.3 46.5 11.7 8.1 11.9 5.8 6.5 7.5 10.3 4.4 4.2 9.2 11.3 3.2 3.8 10.4 4.3 6.3 5.8 5.2 4.8 13.7 21.1 18.2 15.5 13.8 16.1 21.9 17.7 22.8 18.3 16.0 29.9 40.4 16.0 35.0 226.6 56.0 18.4 20.0 15.8 42.7 20.3 23.0 19.9 18.6 25.8 27.8 14.7 10.4 17.1 28.9 9.2 5.9 17.7 64.1 19.6 28.9 30.7 13.1 31.3 333.2 9.9 16.7 32.5 20.4 28.2 18.9 31.5 34.6 19.9 21.4 35.3 350.5 13.4 10.2 35.6 22.9 40.2 30.7 34.9 14.2 324.2 23.2 26.6 32.0 341.8 565.6 12.3 9.1 30.5 20.7 9.8 13.7 15.9 16.3 22.3 6.6 34.0 20.4 20.7 25.5 28.4 17.0 8.2 30.0 35.5 14.5 17.6 TBL1XR1 "C21, DC42, FLJ12894, IRA1, TBLR1" ENSG00000177565 "TBL1X receptor 1" Q9BZK7 3 177019340-177228000 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 280.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019182 Supported Approved Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA019182: AB_1857800" "unprognostic (4.11e-2)" "unprognostic (3.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.27e-3)" "prognostic favorable (5.16e-5)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (3.75e-1)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (3.13e-3)" "unprognostic (2.50e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (5.83e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" 18.8 20.3 7.2 24.4 12.7 30.2 21.7 13.9 11.8 24.9 8.5 31.0 24.6 16.9 9.2 21.2 22.4 23.2 32.6 16.0 3.3 22.3 24.5 19.6 31.3 8.1 8.5 20.9 12.1 27.3 2.9 21.0 4.9 25.6 24.4 42.7 16.1 14.8 12.9 17.1 18.7 19.4 8.6 22.9 22.3 19.1 8.4 45.5 47.1 25.3 36.3 25.3 10.3 15.0 96.8 41.2 61.1 39.7 56.2 65.8 44.2 26.1 52.3 30.3 36.3 48.9 76.2 98.9 132.9 43.6 58.4 61.2 42.9 63.2 58.7 97.5 14.5 56.2 66.8 30.3 49.7 91.0 29.6 95.3 35.9 37.3 90.6 53.8 48.5 68.5 44.8 189.9 42.8 31.0 81.7 14.0 38.1 59.8 32.2 53.9 72.6 124.6 33.1 119.5 24.8 38.7 43.3 35.9 49.8 37.3 113.0 74.3 60.5 48.9 35.3 28.8 65.6 89.8 117.6 280.7 32.9 66.2 56.1 14.3 3.7 3.8 5.6 6.2 5.9 7.5 6.9 7.3 4.6 7.3 5.9 7.4 12.9 7.4 5.5 12.4 8.3 5.3 7.2 12.7 13.9 11.8 16.0 3.3 8.1 8.5 4.9 8.6 8.4 15.0 55.1 73.7 60.7 128.0 56.5 91.5 55.1 90.6 62.0 113.6 69.2 42.2 101.9 47.1 80.3 104.8 125.1 28.9 70.0 84.7 29.4 52.2 7.4 90.9 59.0 65.5 85.3 60.4 228.9 43.8 35.1 81.8 44.4 134.5 25.3 65.9 48.5 66.6 37.8 116.1 167.6 72.6 59.0 91.1 75.0 9.0 64.0 69.4 65.8 184.6 55.8 47.6 41.2 241.8 269.4 66.7 43.7 73.0 75.1 144.9 41.5 67.3 83.9 81.6 46.0 76.3 54.4 12.9 61.4 88.1 111.8 27.5 66.0 41.6 84.6 83.6 TCEA1 "GTF2S, SII, TCEA, TF2S, TFIIS" ENSG00000187735 "Transcription elongation factor A1" P23193 8 53966552-54022456 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043786 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA043786: AB_10959468" "unprognostic (5.35e-2)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (2.11e-3)" "unprognostic (3.34e-2)" "unprognostic (1.17e-1)" "unprognostic (3.72e-2)" "unprognostic (1.77e-1)" "unprognostic (4.14e-2)" "unprognostic (1.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.80e-3)" "unprognostic (1.10e-1)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" 52.7 46.0 44.1 56.5 47.5 81.2 62.2 44.7 58.3 55.3 42.5 49.7 47.1 55.6 45.8 53.9 52.4 42.6 35.9 42.0 46.0 59.8 90.4 46.7 98.3 47.2 44.6 61.9 68.4 80.0 28.2 49.3 47.0 59.0 50.7 49.0 56.5 54.2 42.0 49.8 46.9 52.4 47.5 49.5 52.2 36.8 44.2 72.4 124.2 41.7 112.6 54.6 41.4 55.1 161.3 157.9 138.1 145.7 99.3 121.8 100.9 122.1 147.3 143.5 160.2 91.4 131.0 392.5 136.9 147.0 152.5 120.9 182.3 116.6 212.9 225.0 88.5 293.6 71.5 139.5 309.7 116.8 122.7 88.5 308.1 137.4 606.2 121.3 128.2 132.9 191.1 334.0 135.5 75.6 245.8 83.3 229.1 265.0 47.1 185.1 48.2 72.5 204.0 107.0 129.9 95.5 101.9 91.0 356.3 132.2 129.6 132.6 110.6 106.1 96.3 120.6 114.5 201.1 134.4 260.9 184.9 133.2 152.1 82.3 64.1 78.7 103.9 63.1 98.3 213.8 107.0 96.7 81.8 174.1 93.9 99.3 23.1 97.5 60.6 116.7 153.0 73.5 44.1 47.5 44.7 58.3 42.0 46.0 47.2 44.6 47.0 47.5 44.2 55.1 94.7 89.8 106.2 24.2 253.2 135.5 128.3 98.9 257.2 77.0 129.2 124.3 23.9 82.9 109.4 99.3 89.6 115.5 143.8 61.0 168.3 121.0 86.4 126.9 145.4 92.5 87.2 330.7 17.7 109.9 125.1 118.8 111.6 124.4 98.7 75.7 66.4 160.7 87.7 57.2 20.1 96.6 118.0 89.5 134.2 191.0 134.8 124.2 117.4 17.8 132.5 166.0 170.0 22.1 29.7 121.1 71.6 132.8 341.1 146.0 72.2 207.6 110.6 104.5 78.9 102.6 130.4 94.9 103.1 237.2 150.6 112.1 154.8 108.5 88.1 148.6 TCEANC MGC17403 ENSG00000176896 "Transcription elongation factor A N-terminal and central domain containing" Q8N8B7 X 13653189-13681964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000337, HPA001013" Uncertain Approved "Nuclear speckles" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 6: Erythroid cells - Oxygen transport" "Nuclear speckles" "HPA000337: , HPA001013: AB_1079371" "unprognostic (1.44e-1)" "unprognostic (2.21e-3)" "unprognostic (1.74e-2)" "unprognostic (4.45e-2)" "unprognostic (2.21e-3)" "unprognostic (2.29e-3)" "unprognostic (4.03e-2)" "unprognostic (4.29e-6)" "unprognostic (3.82e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-5)" "unprognostic (1.68e-1)" "unprognostic (1.25e-3)" "unprognostic (1.19e-1)" "unprognostic (1.38e-1)" "unprognostic (5.10e-3)" "unprognostic (1.11e-4)" 1.5 1.2 1.3 1.0 1.4 4.5 2.5 2.0 1.8 1.5 1.2 1.2 1.1 1.5 3.0 0.8 1.8 1.0 1.5 1.4 1.4 1.5 1.7 1.7 2.7 1.5 1.4 2.5 1.5 1.2 1.3 1.2 1.5 1.5 1.5 2.8 1.8 1.2 1.7 1.5 1.4 1.5 1.3 2.5 1.2 1.0 1.6 2.9 2.0 1.5 2.0 1.1 1.1 1.9 0.4 1.1 1.2 2.1 2.5 3.0 0.4 0.3 1.0 1.0 0.4 0.4 0.8 1.3 1.1 0.8 0.6 0.6 1.1 0.6 0.2 1.4 1.5 0.7 0.6 0.6 1.4 1.1 1.3 2.6 1.0 0.6 4.2 1.5 0.3 1.3 1.4 2.2 1.4 0.9 1.8 1.1 1.6 0.6 0.3 1.4 1.1 2.8 0.5 0.7 1.2 1.1 1.1 1.2 1.6 1.5 1.2 1.0 0.5 0.9 0.4 0.8 0.1 1.8 1.1 1.0 1.2 0.6 0.4 7.2 1.6 4.2 2.6 1.4 3.0 3.5 2.8 3.5 1.3 3.6 3.4 3.1 2.1 1.6 1.5 2.3 3.7 1.9 1.3 1.4 2.0 1.8 1.4 1.4 1.5 1.4 1.5 1.3 1.6 1.9 2.9 0.0 1.1 1.6 3.8 0.3 1.0 1.2 1.8 3.5 2.3 2.0 2.6 1.5 2.3 3.7 2.1 2.2 7.3 1.3 3.9 1.5 0.0 2.2 2.6 1.5 2.4 19.0 1.7 0.9 0.8 1.8 1.1 2.0 5.1 2.1 1.8 3.9 2.0 1.7 2.2 2.5 2.0 2.8 2.0 0.2 3.4 1.8 0.0 2.8 3.1 4.9 6.2 0.5 2.5 0.5 1.8 2.2 7.3 1.2 2.7 3.2 2.0 2.3 0.0 1.7 2.6 1.1 1.2 0.9 0.3 3.3 4.8 2.1 1.3 0.9 TCF12 "bHLHb20, HEB, HsT17266, HTF4, p64" ENSG00000140262 "Transcription factor 12" Q99081 15 56918623-57299281 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 319.8;Microglial cells: 440.3;Oligodendrocyte precursor cells: 618.3;Oligodendrocytes: 1512.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004432, HPA065827" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear speckles" "CAB004432: AB_671267, HPA065827: AB_2685564" "unprognostic (1.19e-1)" "unprognostic (1.11e-1)" "unprognostic (8.26e-2)" "unprognostic (1.65e-1)" "unprognostic (2.07e-3)" "unprognostic (1.11e-1)" "unprognostic (6.63e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (7.83e-2)" "unprognostic (7.26e-3)" "unprognostic (5.57e-3)" "prognostic unfavorable (5.24e-5)" "unprognostic (2.03e-1)" "unprognostic (2.93e-1)" "unprognostic (3.15e-2)" "unprognostic (1.41e-1)" 26.1 21.5 29.2 23.4 45.5 21.2 29.5 37.1 34.0 75.6 17.2 26.7 28.4 47.9 24.3 26.6 46.3 37.1 21.8 30.5 32.6 28.4 25.0 28.9 26.0 43.1 39.3 43.3 19.7 44.0 11.5 33.4 38.3 32.0 30.3 29.4 23.3 28.3 20.5 21.3 28.4 44.1 34.5 25.0 25.5 27.4 35.5 133.0 29.0 26.6 28.1 31.2 22.4 55.7 25.4 50.8 204.5 70.6 90.0 79.0 36.1 52.2 89.6 45.1 58.9 34.0 20.3 35.5 42.3 78.3 33.4 30.4 84.3 37.3 56.7 47.5 29.8 71.7 52.7 40.4 62.4 46.1 36.1 69.4 66.2 42.9 112.2 60.1 81.0 163.0 81.7 46.8 61.8 9.5 109.4 25.0 57.5 26.4 20.9 143.2 234.9 33.9 61.5 53.1 43.6 121.2 58.7 21.0 52.0 65.3 33.6 93.9 63.2 75.5 57.5 32.2 78.2 24.6 49.7 59.4 40.8 86.3 90.9 27.4 13.8 11.3 17.4 17.9 14.3 13.4 14.0 16.5 20.0 14.7 16.2 14.8 1.5 16.8 26.3 8.4 23.0 14.1 29.2 45.5 37.1 34.0 30.5 32.6 43.1 39.3 38.3 34.5 35.5 55.7 35.5 54.5 19.6 212.9 37.7 26.6 20.6 14.2 44.9 13.8 24.0 20.4 19.3 14.3 21.2 16.5 35.5 10.4 20.6 17.0 13.7 16.0 23.7 25.9 148.0 38.2 9.0 34.9 117.7 11.8 15.5 42.3 52.0 33.3 23.4 26.9 25.7 18.2 27.5 13.5 319.8 16.8 10.2 38.1 30.0 19.9 25.7 33.0 14.2 440.3 17.4 29.0 18.6 618.3 1512.7 15.9 18.4 34.6 29.1 23.4 20.0 15.3 15.9 23.3 46.0 39.9 36.5 22.2 15.0 33.6 33.8 13.0 28.4 16.5 20.1 18.2 TGIF2-RAB5IF TGIF2-C20orf24 ENSG00000259399 "TGIF2-RAB5IF readthrough" 20 36574553-36612384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "unprognostic (7.38e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (5.58e-2)" "unprognostic (2.62e-2)" "unprognostic (1.94e-1)" "unprognostic (7.39e-2)" "unprognostic (2.22e-2)" "unprognostic (6.57e-3)" "unprognostic (3.97e-2)" "unprognostic (2.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.46e-2)" "unprognostic (2.69e-1)" "unprognostic (2.93e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" 0.7 0.9 0.8 4.5 0.8 3.8 1.6 1.0 3.4 2.1 1.9 0.7 1.2 1.9 1.6 0.2 3.0 1.1 0.3 0.8 1.0 1.3 1.7 0.8 1.4 1.2 0.9 2.0 0.3 1.8 0.2 1.8 1.4 0.6 0.8 1.9 2.4 1.1 0.1 0.3 1.0 2.8 1.3 1.8 0.8 2.6 0.9 2.8 0.7 0.0 3.6 1.8 0.4 1.6 4.0 1.5 25.5 11.1 2.6 0.6 1.5 1.0 4.0 6.8 5.1 9.5 6.0 2.0 2.0 3.6 2.0 2.0 18.9 0.0 8.8 6.5 2.8 5.0 3.7 9.7 1.2 6.0 1.1 1.1 2.5 2.8 5.5 9.3 5.0 11.4 1.6 9.8 1.5 7.9 15.0 3.3 4.4 2.3 0.6 11.8 2.0 6.2 1.0 3.3 2.7 8.2 1.3 6.9 3.1 2.8 7.5 13.0 1.5 1.1 0.7 0.3 2.6 3.0 1.5 8.4 0.2 6.9 4.5 0.0 0.5 0.0 0.7 0.6 0.7 1.2 0.1 0.0 1.0 1.4 0.9 1.0 0.9 0.6 0.1 0.9 0.1 0.3 0.8 0.8 1.0 3.4 0.8 1.0 1.2 0.9 1.4 1.3 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TGS1 "NCOA6IP, PIMT" ENSG00000137574 "Trimethylguanosine synthase 1" Q96RS0 8 55773446-55826445 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025024, HPA029824" Supported Supported Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Cytosol "HPA025024: AB_1854330, HPA029824: AB_2673212" "unprognostic (4.13e-2)" "unprognostic (7.46e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.70e-2)" "unprognostic (1.60e-2)" "unprognostic (4.94e-2)" "unprognostic (9.32e-2)" "unprognostic (3.15e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (8.62e-2)" "unprognostic (7.23e-2)" "unprognostic (3.42e-1)" "unprognostic (2.85e-2)" 5.9 4.0 1.8 5.0 1.4 7.2 5.5 3.8 2.3 5.0 2.5 4.9 3.1 5.9 4.1 5.7 5.8 4.1 3.5 1.5 1.5 5.5 4.0 4.5 8.5 1.2 1.3 6.0 4.0 6.8 4.0 4.2 1.3 4.5 4.6 2.5 4.9 5.7 7.4 6.4 5.5 4.6 1.1 5.7 4.5 4.9 1.6 9.5 5.4 2.6 8.5 7.3 5.1 1.9 12.0 9.0 10.2 12.7 9.7 8.2 10.3 10.9 11.6 11.9 12.3 8.5 10.7 27.7 7.0 8.5 8.5 10.8 24.3 14.7 16.3 17.2 8.7 31.6 10.6 5.1 13.1 16.8 9.4 9.7 10.1 11.4 22.7 5.2 9.5 16.0 24.8 9.9 9.6 9.4 36.0 10.6 35.0 16.8 3.6 26.4 7.1 8.2 10.6 12.0 10.6 13.3 19.4 8.0 10.4 10.5 10.9 9.7 9.7 8.4 10.6 9.8 10.4 8.5 6.3 32.1 8.5 13.6 11.3 5.0 2.7 4.3 5.1 2.8 6.0 4.6 4.8 4.7 2.4 4.8 5.2 5.2 3.4 3.3 3.9 5.2 4.2 2.6 1.8 1.4 3.8 2.3 1.5 1.5 1.2 1.3 1.3 1.1 1.6 1.9 29.8 48.1 35.2 15.7 41.6 37.0 36.8 25.7 35.3 30.6 21.8 34.7 15.5 20.0 37.9 51.5 22.9 29.6 30.4 10.8 3.9 20.3 3.7 28.2 42.6 27.2 10.7 49.2 28.9 25.2 26.7 32.4 23.4 27.6 50.0 24.3 20.7 17.2 20.3 21.9 30.0 23.3 16.2 16.8 12.2 4.6 29.5 22.2 7.2 12.2 26.1 27.7 29.9 34.7 19.9 22.2 12.1 23.0 32.7 42.3 10.9 17.7 25.5 29.5 26.3 40.5 25.7 88.2 78.3 33.5 26.1 22.4 41.2 35.2 22.5 31.9 THAP12 "DAP4, P52rIPK, PRKRIR, THAP0" ENSG00000137492 "THAP domain containing 12" O43422 11 76349956-76381132 "Plasma proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 42.4;dendritic cells: 31.6;Endometrial stromal cells: 34.7;Theca cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 241.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008758, HPA077077" Approved Approved Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA008758: AB_1855714, HPA077077: " "unprognostic (2.79e-1)" "unprognostic (9.79e-2)" "unprognostic (1.16e-3)" "unprognostic (6.47e-2)" "unprognostic (8.85e-3)" "unprognostic (1.23e-1)" "unprognostic (4.03e-3)" "unprognostic (1.08e-1)" "unprognostic (6.68e-3)" "unprognostic (1.48e-1)" "unprognostic (1.57e-2)" "unprognostic (2.65e-2)" "unprognostic (7.98e-2)" "unprognostic (2.06e-1)" "unprognostic (3.95e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-2)" 25.7 21.9 13.8 20.1 14.2 33.4 29.7 13.6 16.3 21.4 13.2 24.1 19.9 24.2 21.1 11.2 19.0 16.7 17.2 14.4 13.8 19.6 19.5 21.8 33.0 13.1 14.2 20.3 41.6 14.2 9.5 26.2 13.1 17.1 25.7 37.2 15.6 19.0 31.7 14.5 20.0 22.0 13.9 26.0 21.5 18.1 14.2 30.6 22.1 32.9 28.7 20.4 15.0 13.6 37.7 29.3 54.6 31.1 36.4 51.5 33.4 38.0 38.9 46.4 40.8 58.9 38.9 100.8 57.1 36.2 40.7 36.5 67.4 44.6 73.9 78.3 21.5 72.2 20.2 27.4 40.2 92.3 34.9 37.1 57.8 41.3 76.9 28.1 40.7 70.5 85.3 55.3 42.0 40.4 81.4 51.9 22.7 98.5 31.8 60.3 124.7 105.0 27.1 38.8 53.1 35.6 36.7 40.1 20.5 36.5 40.6 35.8 36.7 55.4 91.7 114.2 33.9 49.9 56.6 241.7 13.3 50.8 30.6 0.7 1.5 1.7 4.5 1.6 5.2 3.3 4.7 5.0 2.1 3.6 3.4 4.4 0.5 5.6 1.5 0.9 4.7 1.7 13.8 14.2 13.6 16.3 14.4 13.8 13.1 14.2 13.1 13.9 14.2 13.6 42.4 25.6 25.3 0.0 13.6 0.0 0.0 0.0 0.0 0.0 29.6 24.0 0.0 0.0 6.2 11.0 0.0 14.2 31.6 0.0 13.7 10.9 0.0 13.6 34.7 9.8 0.0 0.0 0.0 26.4 21.5 11.3 0.0 19.3 7.6 24.5 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 8.3 0.0 0.0 0.0 0.0 14.1 0.0 0.0 7.6 0.0 0.0 16.3 5.8 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 16.3 13.4 34.4 0.0 0.0 TIPRL "dJ69E11.3, MGC3794, TIP41, TIPRL1" ENSG00000143155 "TOR signaling pathway regulator" O75663 1 168178962-168202109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027995, HPA054282" Approved Supported Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Vesicles, Cytosol" "HPA027995: AB_10602900, HPA054282: AB_2682435" "unprognostic (3.18e-2)" "unprognostic (1.05e-1)" "unprognostic (5.05e-2)" "unprognostic (3.17e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-3)" "prognostic unfavorable (1.60e-4)" "unprognostic (5.82e-2)" "unprognostic (3.32e-2)" "unprognostic (1.12e-2)" "unprognostic (4.30e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.45e-8)" "unprognostic (3.23e-1)" "unprognostic (1.57e-1)" "unprognostic (5.55e-2)" "unprognostic (8.61e-2)" 16.3 14.9 15.5 19.6 16.3 33.8 21.0 15.0 20.1 17.7 12.8 22.2 19.0 23.2 16.8 20.1 14.3 16.8 23.7 16.8 17.0 17.8 22.5 14.9 22.2 14.0 13.4 17.4 15.9 27.4 13.6 17.5 14.4 18.4 22.0 14.7 12.0 17.3 24.4 16.3 18.5 22.7 13.4 16.3 15.4 18.2 15.1 30.1 17.4 23.0 19.9 18.7 13.6 15.7 69.4 31.0 45.9 41.6 36.7 53.1 27.5 50.5 53.0 54.6 48.4 48.3 50.1 49.0 68.2 48.7 40.1 81.8 34.5 49.3 52.6 47.2 36.4 47.3 29.2 22.9 64.5 94.7 62.0 43.2 62.8 47.4 62.7 36.0 58.1 75.4 69.0 66.3 47.7 25.4 84.9 49.0 37.0 96.7 54.2 41.1 47.0 66.4 49.7 33.9 29.6 66.1 39.3 54.6 102.2 51.6 59.9 96.3 53.4 45.6 52.4 43.6 69.7 72.2 80.5 108.1 29.8 61.4 53.4 71.6 26.7 36.8 22.0 32.1 22.1 27.3 25.7 23.8 31.6 27.6 22.8 22.4 34.5 29.6 33.9 23.4 36.0 28.2 15.5 16.3 15.0 20.1 16.8 17.0 14.0 13.4 14.4 13.4 15.1 15.7 52.1 25.6 20.4 9.4 39.7 48.2 42.1 70.4 50.1 27.3 31.3 36.2 46.3 22.8 40.7 22.0 16.7 44.2 49.0 37.1 29.4 68.5 53.4 36.0 50.1 43.4 24.0 32.6 41.6 88.9 62.8 47.3 24.5 30.8 40.0 35.2 36.0 33.5 65.1 52.2 37.9 33.9 44.7 26.6 41.1 15.4 37.6 42.6 30.2 19.7 61.0 43.9 51.5 22.1 21.3 69.7 27.7 38.0 37.1 43.3 35.9 77.2 36.1 20.8 26.3 35.4 51.1 151.5 51.6 56.0 41.8 29.0 48.0 84.5 38.5 37.5 TMEM199 "C17orf32, MGC45714, VMA12, VPH2" ENSG00000244045 "Transmembrane protein 199" Q8N511 17 28357642-28363683 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027051 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" "HPA027051: AB_10600915" "unprognostic (3.01e-1)" "unprognostic (3.45e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (9.98e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.78e-1)" "unprognostic (6.38e-3)" "unprognostic (1.09e-1)" "unprognostic (9.25e-2)" "unprognostic (2.75e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-3)" "unprognostic (5.95e-2)" 8.3 11.9 9.2 10.3 10.4 13.3 8.6 10.1 13.0 9.1 9.6 9.0 7.4 9.5 9.6 10.6 8.0 6.2 9.3 9.5 10.5 12.9 14.4 8.5 12.7 10.2 10.1 8.0 8.9 15.5 11.7 9.5 10.1 9.8 7.9 13.9 9.5 6.8 7.2 11.6 9.0 6.2 9.5 13.2 8.9 7.8 10.4 12.8 10.8 7.5 11.2 8.8 8.8 12.0 12.2 20.4 19.6 16.7 7.9 6.8 16.5 14.8 9.5 20.6 18.5 48.9 9.6 17.6 14.8 11.0 26.4 20.6 21.8 13.9 18.0 32.8 19.6 13.0 17.7 23.6 15.9 18.7 22.0 9.7 12.6 19.6 13.0 12.2 10.2 16.1 21.6 21.8 15.4 24.1 21.3 25.6 16.2 21.0 13.9 17.2 24.4 16.3 15.5 20.2 24.8 26.0 17.8 45.6 27.1 20.1 28.7 16.9 14.0 17.4 13.5 15.0 25.3 29.3 38.9 16.2 21.6 11.4 22.2 28.5 24.2 20.0 15.1 25.2 16.6 17.1 13.1 13.4 20.0 16.0 16.4 14.5 18.9 15.6 23.0 14.0 14.9 19.1 9.2 10.4 10.1 13.0 9.5 10.5 10.2 10.1 10.1 9.5 10.4 12.0 12.4 32.1 8.6 8.8 21.0 5.7 10.5 34.3 15.4 13.8 14.3 14.4 5.6 12.8 23.5 9.2 8.4 40.2 15.5 21.1 43.0 40.2 3.7 12.0 11.4 14.6 15.6 12.2 11.0 31.4 38.1 10.6 7.7 10.9 7.6 11.9 17.5 26.8 51.3 11.8 10.5 15.7 32.6 22.9 9.5 4.5 11.5 22.4 21.4 6.5 45.0 19.1 25.7 7.5 13.7 35.4 19.4 6.4 15.1 13.1 20.3 54.0 15.1 14.0 13.1 8.6 14.2 26.5 35.4 14.0 8.8 48.4 15.2 14.7 13.0 11.4 TMEM209 "FLJ14803, NET31" ENSG00000146842 "Transmembrane protein 209" Q96SK2 7 130164713-130207770 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031678 Uncertain Approved "Nuclear membrane,Nuclear speckles,Vesicles" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nuclear membrane, Nuclear speckles, Vesicles" "HPA031678: AB_10603135" "unprognostic (3.03e-1)" "unprognostic (5.06e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (5.98e-2)" "unprognostic (1.25e-1)" "unprognostic (1.66e-1)" "unprognostic (3.19e-1)" "unprognostic (6.00e-2)" "unprognostic (2.34e-3)" "unprognostic (1.11e-1)" "unprognostic (3.48e-1)" "unprognostic (1.68e-2)" "unprognostic (3.24e-1)" 8.9 15.3 4.1 8.4 6.2 9.6 10.6 7.2 6.5 7.4 13.0 11.0 8.8 10.8 9.5 5.5 9.6 6.4 6.2 4.0 5.2 8.6 10.4 9.2 11.9 6.1 6.1 10.2 8.5 15.1 4.4 9.5 6.4 8.3 11.2 13.3 7.9 8.4 5.2 7.2 10.7 9.0 5.9 10.5 7.6 15.0 5.4 14.2 16.2 7.7 12.1 7.6 4.3 9.6 23.4 21.8 29.3 36.7 16.8 17.2 21.4 20.8 20.9 18.3 24.7 23.0 39.2 34.6 15.1 13.3 34.5 34.2 34.7 24.2 33.0 42.7 20.0 17.9 34.0 16.5 29.6 38.2 17.2 18.9 24.6 37.0 36.8 11.4 14.5 35.1 58.9 38.2 23.2 30.2 73.2 23.6 44.1 20.9 19.4 38.9 33.1 57.4 19.1 29.3 26.2 40.0 47.5 75.8 31.3 22.7 23.7 25.6 11.4 33.0 13.1 35.4 50.6 51.7 81.6 70.4 54.7 43.4 53.0 16.1 12.2 13.8 22.0 18.3 23.0 18.3 22.3 20.2 12.0 17.3 25.6 22.3 1.8 19.5 16.8 14.9 24.6 15.1 4.1 6.2 7.2 6.5 4.0 5.2 6.1 6.1 6.4 5.9 5.4 9.6 12.3 3.2 12.3 11.4 15.3 4.7 4.0 8.2 6.8 13.6 8.8 5.2 8.6 10.0 9.8 9.2 4.2 8.9 15.2 7.2 1.9 6.4 33.5 9.6 8.0 9.5 13.8 25.9 10.4 9.1 9.3 7.5 7.7 10.4 10.1 10.0 9.7 9.4 7.9 5.0 13.0 11.9 8.2 13.1 4.4 8.5 6.5 7.8 7.2 15.0 7.7 18.1 8.2 10.6 20.9 7.6 11.6 5.3 11.0 5.3 13.4 4.9 9.8 14.6 0.0 9.0 5.9 16.6 16.0 6.4 5.4 6.6 13.1 12.1 9.5 3.7 TMEM87A DKFZP564G2022 ENSG00000103978 "Transmembrane protein 87A" Q8NBN3 15 42210447-42273584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018104, HPA018189" Enhanced Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA018104: AB_1858135, HPA018189: AB_2205198" "unprognostic (7.07e-2)" "unprognostic (1.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.05e-2)" "unprognostic (2.49e-1)" "unprognostic (6.39e-3)" "unprognostic (1.19e-2)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-3)" "unprognostic (1.38e-1)" "unprognostic (3.41e-2)" "unprognostic (7.90e-2)" "unprognostic (2.19e-1)" "unprognostic (5.49e-3)" "unprognostic (3.63e-1)" 31.8 26.3 23.7 26.1 37.7 88.2 97.7 32.0 29.5 40.2 17.7 56.5 26.6 38.6 49.3 48.2 45.3 32.4 19.7 23.5 26.3 27.1 24.5 72.8 25.4 36.7 29.4 35.4 34.9 47.9 14.2 42.7 38.7 79.8 60.9 26.1 64.7 36.6 24.9 50.2 26.9 38.0 32.5 23.1 38.6 33.0 28.8 24.8 75.9 22.2 30.9 42.0 34.3 59.1 41.0 20.5 30.5 27.0 58.5 50.3 47.7 55.1 82.0 53.5 52.0 29.8 87.5 17.4 52.9 59.9 60.5 104.0 28.3 51.2 42.8 46.8 25.0 35.6 51.5 33.5 63.4 65.6 48.3 52.3 112.1 39.5 65.3 50.6 41.9 30.1 39.4 67.4 51.7 26.3 21.3 38.8 25.7 60.8 29.3 33.5 46.6 36.8 34.5 127.4 33.7 41.2 53.1 70.1 49.9 24.0 27.4 62.4 41.3 104.4 25.5 68.1 82.6 46.8 95.0 36.5 40.1 47.9 66.8 58.3 26.9 31.2 29.0 32.3 33.3 27.6 35.6 34.0 24.4 24.4 33.6 33.5 15.2 42.4 34.7 22.4 42.2 26.0 23.7 37.7 32.0 29.5 23.5 26.3 36.7 29.4 38.7 32.5 28.8 59.1 66.2 125.0 264.0 46.0 48.9 68.6 90.2 78.8 58.1 31.2 148.7 105.9 13.9 45.8 98.0 49.7 50.1 78.1 57.5 77.7 1.9 63.7 5.6 57.0 67.0 54.6 32.2 34.5 41.7 64.2 72.7 64.0 50.0 124.7 59.5 42.9 51.0 34.4 41.6 20.2 48.2 74.1 67.1 39.2 37.0 7.9 41.0 41.3 62.2 45.0 60.1 61.8 52.5 74.4 177.5 56.1 62.4 53.8 47.6 118.5 36.6 15.5 86.4 63.0 85.5 77.0 59.0 59.4 61.4 79.1 65.5 110.4 54.8 53.3 76.9 105.6 TMF1 "ARA160, TMF" ENSG00000144747 "TATA element modulatory factor 1" P82094 3 69019827-69052339 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 508.1;Late spermatids: 544.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008729 Approved Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA008729: AB_1080310" "unprognostic (2.71e-1)" "unprognostic (2.11e-2)" "unprognostic (8.02e-3)" "unprognostic (7.19e-2)" "unprognostic (2.74e-1)" "unprognostic (6.75e-3)" "unprognostic (6.73e-3)" "unprognostic (1.79e-1)" "unprognostic (4.62e-2)" "unprognostic (2.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.83e-2)" "unprognostic (1.50e-1)" "unprognostic (1.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.51e-2)" "unprognostic (1.01e-1)" 10.3 10.6 4.4 14.0 5.2 26.2 14.1 6.2 5.5 13.3 12.3 12.5 12.9 14.8 14.1 11.5 12.9 14.1 9.2 4.3 5.3 12.6 11.0 12.0 16.0 5.3 5.1 12.6 13.6 15.6 9.9 16.5 5.2 14.5 14.2 12.5 17.4 10.3 9.8 9.7 14.8 11.6 5.1 12.8 14.0 19.4 5.4 9.6 20.9 8.3 14.8 13.5 7.9 6.1 19.5 8.3 7.8 7.9 20.7 26.4 17.5 24.6 23.6 16.1 19.2 11.9 14.1 7.4 3.9 25.1 11.3 10.5 10.2 10.8 26.4 14.3 7.6 14.4 11.0 14.1 18.5 16.3 19.7 15.6 17.0 21.4 19.3 17.1 17.5 6.0 8.8 11.8 21.2 11.1 9.5 14.1 6.8 12.3 4.4 7.8 9.9 10.4 21.0 15.4 5.4 8.3 20.2 14.2 15.4 10.4 10.7 19.4 23.1 15.8 6.7 27.9 14.8 13.2 13.6 7.2 24.1 16.6 13.1 4.8 2.4 5.1 3.1 2.0 2.1 2.6 2.8 2.7 2.1 3.1 2.9 2.6 5.3 2.7 3.4 2.4 3.1 1.6 4.4 5.2 6.2 5.5 4.3 5.3 5.3 5.1 5.2 5.1 5.4 6.1 49.2 64.1 78.9 21.9 84.7 37.5 37.6 41.7 39.3 43.4 46.2 35.8 36.9 38.6 86.4 42.3 37.5 39.6 108.4 48.8 15.6 52.4 508.1 150.4 92.8 43.1 55.6 45.0 32.2 56.2 58.7 70.0 54.6 86.2 74.7 51.7 29.3 19.7 28.4 35.3 38.4 61.6 38.7 31.8 54.4 544.8 51.0 55.1 35.6 32.8 66.7 41.5 59.8 36.2 40.9 50.6 40.8 62.1 129.3 64.8 49.4 25.1 200.5 52.1 32.9 62.8 56.8 116.2 39.3 30.6 39.5 80.6 94.5 54.5 38.5 85.7 TMSB15A "TMSL8, TMSNB" ENSG00000158164 "Thymosin beta 15A" P0CG34 X 102513682-102516739 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.0;prostate: 15.8" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 12.8;Granulosa cells: 25.9;Prostatic glandular cells: 13.8;Smooth muscle cells: 13.5;Spermatogonia: 19.8" "Group enriched" "Detected in many" 4 "glioma: 20.1;prostate cancer: 56.4;testis cancer: 14.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 571.5;HAP1: 110.2;MOLT-4: 113.4;NTERA-2: 148.0;RH-30: 259.9;SH-SY5Y: 148.1" "Low region specificity" "Detected in all" NA NA 130000 "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (5.33e-3)" "unprognostic (3.09e-2)" "unprognostic (1.70e-2)" "unprognostic (5.82e-3)" "unprognostic (1.34e-1)" "unprognostic (4.03e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (6.88e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-3)" "unprognostic (2.96e-4)" "unprognostic (2.14e-1)" "unprognostic (7.83e-2)" "unprognostic (2.07e-1)" 1.0 1.0 1.1 1.1 1.2 1.0 5.1 1.7 2.1 5.1 1.4 0.9 0.4 5.0 0.7 0.3 1.9 1.2 1.9 1.2 1.1 2.4 0.1 7.1 4.0 1.3 1.0 4.7 0.9 0.8 0.8 0.5 1.3 15.8 1.1 1.4 3.9 1.2 0.3 0.5 0.6 2.3 1.1 0.4 0.5 4.8 1.2 13.0 5.9 0.3 2.8 0.7 2.3 1.1 0.1 0.0 571.5 107.7 2.4 0.3 0.2 12.4 0.7 1.7 4.8 0.0 0.7 0.0 1.3 2.1 28.5 0.0 110.2 0.7 1.2 0.0 5.6 10.3 1.7 0.3 0.3 0.2 10.1 1.4 0.0 1.1 0.0 14.3 6.7 5.5 1.0 0.0 41.2 0.1 113.4 0.2 148.0 0.0 1.4 0.2 259.9 0.0 11.7 0.2 98.1 148.1 14.0 0.9 0.3 22.0 1.4 3.2 2.4 0.3 62.6 1.4 10.5 11.8 2.1 0.0 6.7 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 1.2 1.7 2.1 1.2 1.1 1.3 1.0 1.3 1.1 1.2 1.1 1.4 0.0 0.0 0.0 0.0 0.8 0.9 0.1 1.8 0.3 7.3 12.8 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.0 0.5 0.3 0.5 5.6 1.2 0.0 0.8 0.0 0.0 0.5 4.6 0.0 1.2 0.0 25.9 2.5 0.0 0.5 0.0 0.0 0.6 0.0 0.6 0.5 0.1 0.3 0.1 1.8 0.0 0.0 0.7 1.0 0.5 0.0 0.0 0.1 2.6 0.3 13.8 0.1 0.4 0.0 0.1 6.6 1.2 13.5 3.4 19.8 1.8 0.0 0.3 0.7 0.9 0.9 1.0 TOE1 hCaf1z ENSG00000132773 "Target of EGR1, exonuclease" Q96GM8 1 45340052-45343973 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 36.6;Spermatocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053775, HPA069119" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA053775: AB_2682259, HPA069119: AB_2686090" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (7.15e-3)" "unprognostic (1.90e-2)" "unprognostic (3.33e-1)" "prognostic favorable (9.05e-4)" "prognostic unfavorable (6.12e-9)" "unprognostic (4.67e-2)" "unprognostic (4.84e-2)" "unprognostic (2.37e-2)" "unprognostic (6.03e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.71e-4)" "prognostic favorable (9.98e-4)" "unprognostic (1.81e-1)" "unprognostic (1.41e-2)" "unprognostic (2.08e-1)" 4.8 5.1 4.9 5.9 4.9 8.0 5.5 4.8 6.1 3.7 4.8 6.8 6.7 6.7 8.4 3.7 5.4 3.5 3.7 4.7 5.4 4.7 5.5 5.1 7.9 5.1 5.0 6.2 4.8 7.5 3.2 6.8 5.1 5.0 8.2 4.1 5.3 5.0 3.0 3.9 5.0 6.5 5.0 5.8 5.6 11.8 5.4 9.0 7.1 2.4 8.3 5.5 3.3 5.1 15.8 9.1 16.5 15.7 7.6 5.9 23.9 15.6 12.9 26.6 24.7 16.7 9.6 29.9 12.1 16.2 23.4 15.9 21.0 22.5 21.3 19.6 17.3 36.0 21.9 15.6 7.3 23.7 17.2 8.8 4.8 28.4 17.8 9.4 19.5 22.5 28.4 19.6 18.9 14.6 34.8 18.4 31.1 20.6 14.2 24.9 24.5 13.6 11.5 28.7 13.9 13.4 14.5 36.3 27.5 25.7 9.8 33.2 14.6 12.6 23.3 19.1 29.7 15.0 19.4 19.9 14.8 26.5 14.7 20.0 5.8 6.2 7.3 6.9 8.4 5.9 6.3 7.3 6.0 8.4 6.4 7.0 0.6 4.1 6.1 5.2 8.6 5.1 4.9 4.9 4.8 6.1 4.7 5.4 5.1 5.0 5.1 5.0 5.4 5.1 6.5 6.4 4.8 2.3 12.4 1.8 6.3 8.8 4.6 10.7 4.5 5.0 1.8 7.2 8.1 7.3 12.5 36.6 9.2 9.2 7.9 5.4 13.9 2.1 6.2 9.0 3.0 14.1 2.5 6.2 13.8 6.6 4.6 3.4 11.4 10.5 8.6 5.0 9.3 8.4 2.7 7.3 8.2 3.5 2.6 9.4 6.8 6.2 3.6 1.9 12.3 13.1 9.2 2.0 2.1 3.4 10.7 6.4 7.0 6.5 8.8 7.9 4.7 18.3 13.1 8.0 7.1 51.7 18.9 3.8 1.4 22.7 9.0 10.2 6.9 4.6 TOP2B ENSG00000077097 "DNA topoisomerase II beta" Q02880 3 25597905-25664907 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Autism spectrum disorder, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 569.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004601, HPA024120, HPA050441" Supported Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127" "unprognostic (2.90e-2)" "unprognostic (5.17e-2)" "unprognostic (7.21e-3)" "unprognostic (2.42e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (7.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" "unprognostic (1.49e-1)" "unprognostic (7.93e-2)" 27.1 25.5 15.3 38.9 17.6 49.1 34.7 25.2 16.5 36.2 12.0 30.1 28.8 42.9 25.5 34.1 29.7 26.2 38.5 15.3 16.0 32.1 27.7 28.0 50.4 13.5 16.2 40.6 28.8 53.2 11.7 34.4 15.1 38.7 33.3 112.3 27.1 34.2 29.9 32.4 28.6 34.2 16.4 36.4 32.1 19.5 14.6 82.5 45.8 36.7 46.6 43.7 18.5 25.3 57.6 58.6 125.9 155.3 41.1 51.7 50.1 54.4 69.6 49.4 53.9 30.1 44.6 176.9 37.1 79.2 30.5 47.7 105.6 60.5 82.5 85.5 56.7 268.5 71.2 50.6 28.9 212.8 137.4 37.1 29.7 55.3 48.2 49.8 81.7 118.6 92.0 84.3 64.4 64.0 138.5 52.5 95.9 38.5 44.1 569.9 71.0 82.6 43.9 199.5 63.2 109.7 81.1 57.4 49.9 72.2 59.7 187.1 78.7 68.3 52.6 55.2 58.9 129.6 78.6 185.1 44.9 155.6 46.5 3.2 1.4 2.8 3.0 1.7 3.3 2.0 2.9 3.1 2.2 2.5 3.3 3.0 1.0 3.9 2.6 2.8 2.3 1.1 15.3 17.6 25.2 16.5 15.3 16.0 13.5 16.2 15.1 16.4 14.6 25.3 36.4 64.1 62.7 65.3 47.3 39.1 47.9 30.9 31.3 62.4 44.4 31.9 121.5 34.3 36.1 25.8 56.3 47.8 65.8 29.9 13.7 34.3 3.6 48.0 58.8 36.6 59.3 65.6 77.8 33.4 24.5 40.2 28.5 45.1 34.1 71.4 25.0 35.1 26.2 60.6 89.8 32.3 20.3 40.7 50.1 6.0 39.1 45.3 23.2 43.1 49.8 51.3 68.0 76.4 113.0 35.5 22.2 33.4 46.0 56.2 20.6 25.6 39.2 95.7 32.9 56.5 51.0 94.9 44.0 57.9 37.6 46.7 53.7 48.4 39.2 64.3 TOPORS "LUN, RP31, TP53BPL" ENSG00000197579 "TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase" Q9NS56 9 32540544-32552586 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 169.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 67.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 67.6" "Cell line enhanced" "Detected in all" "HEL: 90.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060640, HPA065661" Supported Supported Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA060640: AB_2684334, HPA065661: AB_2685527" "unprognostic (1.75e-1)" "unprognostic (1.73e-1)" "unprognostic (1.20e-2)" "unprognostic (1.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-2)" "unprognostic (9.94e-2)" "prognostic favorable (7.07e-4)" "unprognostic (2.70e-1)" "unprognostic (3.61e-1)" "prognostic favorable (6.64e-6)" "unprognostic (1.22e-1)" "unprognostic (5.95e-2)" "unprognostic (3.13e-1)" "unprognostic (2.92e-1)" 9.8 9.8 5.4 8.4 6.3 25.2 12.4 10.5 8.5 10.3 7.3 9.2 8.3 11.4 10.0 9.9 7.6 8.7 6.8 5.4 6.6 13.2 16.2 9.3 9.3 6.1 6.1 15.3 8.6 14.0 6.9 10.0 6.2 11.2 9.3 11.5 7.6 9.3 7.2 9.6 8.8 11.2 5.9 10.5 8.9 14.8 6.6 14.5 14.1 10.4 10.1 10.3 7.2 8.3 16.6 15.1 20.4 17.9 24.4 21.8 12.9 20.7 19.5 16.9 19.5 9.5 8.3 26.8 11.7 20.8 14.8 10.9 24.2 23.5 23.6 22.5 13.3 90.8 25.2 11.9 15.1 26.1 24.0 17.9 25.8 24.4 17.1 20.9 20.8 20.1 16.1 13.6 27.9 8.9 23.5 47.6 27.2 12.3 15.2 23.9 18.1 12.2 22.5 17.2 10.1 16.1 20.7 11.2 13.8 22.9 11.3 14.7 22.0 18.4 18.6 9.6 15.5 9.5 16.2 28.5 17.0 14.8 8.4 38.8 10.0 21.3 9.6 9.8 10.3 9.4 10.4 11.4 10.2 10.8 13.9 13.8 67.6 15.0 13.6 8.2 13.5 7.3 5.4 6.3 10.5 8.5 5.4 6.6 6.1 6.1 6.2 5.9 6.6 8.3 69.2 54.5 32.0 10.7 49.1 47.2 45.3 33.7 61.5 46.8 32.7 28.6 18.4 25.8 37.0 25.8 37.5 31.9 63.4 26.3 19.6 25.1 169.9 36.2 38.1 48.8 45.9 66.5 14.5 18.4 16.9 42.0 25.0 45.5 41.8 43.6 26.4 24.3 17.7 55.5 15.5 22.9 44.7 19.1 35.3 21.8 33.2 31.8 19.6 7.5 30.4 43.5 36.0 13.0 22.4 21.1 24.3 32.7 39.5 39.0 24.3 22.7 22.3 42.0 19.7 54.0 48.2 54.4 53.7 39.0 47.6 50.8 55.4 43.1 24.0 49.8 TRAPPC10 "EHOC-1, TMEM1, TRS130" ENSG00000160218 "Trafficking protein particle complex 10" P48553 21 44012309-44106552 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 81.2;Oligodendrocytes: 132.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "basophil: 9.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 9.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050423 Supported NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" "HPA050423: AB_2681123" "unprognostic (1.82e-2)" "unprognostic (4.89e-3)" "unprognostic (3.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.79e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (4.00e-1)" "unprognostic (9.70e-2)" "unprognostic (3.07e-3)" "unprognostic (2.60e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (2.76e-1)" 5.6 4.3 2.8 7.3 5.7 17.4 4.6 4.1 4.7 4.9 3.5 7.0 5.3 5.1 7.8 5.6 5.3 5.4 4.8 3.1 4.2 7.0 6.1 5.8 10.0 4.6 4.8 3.6 5.0 7.5 3.4 6.0 5.5 3.8 7.4 6.1 5.3 4.1 6.2 5.5 6.7 5.3 3.5 7.5 6.8 7.6 4.8 10.1 7.0 5.6 11.9 5.3 4.2 10.5 12.1 5.8 8.7 6.0 15.7 8.0 8.7 10.8 10.7 10.9 11.5 12.8 6.8 15.1 3.6 10.5 20.7 5.6 8.5 11.7 16.0 9.8 8.2 20.7 6.2 4.8 7.2 14.0 12.1 6.3 12.4 14.0 11.0 8.3 12.3 9.3 15.4 15.7 18.4 8.6 8.0 6.7 10.1 8.8 8.8 8.9 5.7 12.4 6.1 8.2 12.4 7.2 9.8 10.8 10.1 4.5 5.9 11.9 12.9 11.2 7.6 12.8 10.5 14.8 14.3 10.8 6.9 13.2 8.7 9.7 0.4 0.9 0.6 0.6 0.1 0.3 0.7 0.6 0.3 0.5 0.3 0.5 0.8 0.4 0.7 0.7 0.0 0.2 2.8 5.7 4.1 4.7 3.1 4.2 4.6 4.8 5.5 3.5 4.8 10.5 17.1 0.0 3.6 26.1 28.9 16.6 12.5 6.9 4.6 29.2 12.0 9.4 10.0 4.3 5.5 12.9 39.6 4.2 81.2 25.1 9.8 1.8 14.3 19.7 20.2 10.6 8.3 4.2 35.8 2.2 4.3 9.5 10.2 29.8 8.2 11.7 10.4 11.1 7.5 18.5 33.3 11.0 10.2 9.4 19.1 33.8 7.8 17.6 12.4 32.8 10.3 11.3 65.9 24.6 132.9 4.8 15.7 7.2 28.0 13.1 7.9 12.4 12.0 39.4 0.0 17.4 13.1 25.4 20.6 5.5 23.3 7.7 37.0 23.1 11.5 19.5 TRIB2 "GS3955, TRB2" ENSG00000071575 "Tribbles pseudokinase 2" Q92519 2 12716889-12742734 "Enzymes, Predicted membrane proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 104.3;Muller glia cells: 100.3" "Cancer enhanced" "Detected in all" "melanoma: 74.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 48.8" "Group enriched" "Detected in many" 8 "B-cells: 12.2;NK-cells: 19.3;T-cells: 48.8" "Cell line enhanced" "Detected in many" "AN3-CA: 183.5;HEL: 185.7;K-562: 258.0;SK-MEL-30: 189.3;WM-115: 246.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001305 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Cytosol "HPA001305: AB_1080371" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (4.31e-3)" "unprognostic (1.86e-3)" "unprognostic (6.68e-3)" "unprognostic (3.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.80e-2)" "unprognostic (3.32e-2)" "unprognostic (2.52e-3)" "unprognostic (1.67e-2)" "unprognostic (1.08e-3)" "unprognostic (1.30e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-2)" "unprognostic (2.13e-2)" 43.3 63.1 29.1 38.9 29.9 16.8 38.3 36.1 35.2 21.7 30.5 27.0 17.8 44.4 43.4 15.5 23.4 28.8 51.0 31.6 37.7 92.3 21.0 39.8 72.7 31.4 30.8 97.8 26.2 18.0 20.0 46.6 29.7 33.0 13.4 137.8 20.4 25.6 14.3 16.9 25.2 34.2 29.7 79.7 41.8 28.5 32.4 39.3 23.9 19.5 69.6 48.4 19.5 28.0 0.2 0.4 138.8 183.5 48.9 44.7 0.2 7.9 7.5 4.9 7.9 0.9 15.3 16.3 5.5 16.9 0.8 2.3 10.3 16.1 4.2 18.3 28.9 185.7 0.4 2.7 60.7 10.7 68.0 41.7 16.0 20.3 5.6 48.9 22.1 23.8 258.0 0.3 7.9 1.7 24.4 44.8 66.1 7.0 18.0 0.0 46.2 6.7 31.9 23.4 118.9 56.6 1.1 7.4 189.3 41.4 0.2 1.1 13.9 65.3 32.0 0.6 17.8 0.1 0.2 22.9 35.2 36.3 246.7 1.7 0.2 3.2 12.7 0.0 15.8 9.6 26.1 13.8 1.2 12.2 15.0 9.2 0.5 19.3 0.2 0.1 48.8 8.9 29.1 29.9 36.1 35.2 31.6 37.7 31.4 30.8 29.7 29.7 32.4 28.0 52.2 3.2 8.3 25.5 12.5 6.1 9.1 26.9 19.4 55.0 7.9 8.6 17.1 12.8 15.6 16.5 31.3 2.6 17.5 0.7 7.9 17.2 4.3 9.7 11.6 43.9 0.0 22.1 13.5 104.3 0.2 11.3 20.9 15.9 34.2 77.3 59.6 6.7 5.8 20.2 6.9 0.4 28.5 5.1 8.2 14.3 77.3 3.8 30.2 13.1 3.0 100.3 26.8 59.8 2.7 45.3 0.2 74.4 21.0 11.6 0.3 1.0 17.9 66.7 52.6 9.9 41.2 1.0 6.0 5.7 5.4 0.8 27.1 30.5 0.8 32.5 TRIM33 "FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA" ENSG00000197323 "Tripartite motif containing 33" Q9UPN9 1 114392790-114511203 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 237.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 13.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 115.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004345 Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Vesicles Nucleoplasm "HPA004345: AB_1858287" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.09e-2)" "unprognostic (8.42e-3)" "prognostic favorable (8.93e-4)" "unprognostic (1.34e-2)" "unprognostic (1.83e-1)" "unprognostic (6.75e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-2)" "unprognostic (4.84e-2)" "unprognostic (1.99e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" 9.3 8.1 10.1 10.7 11.3 25.4 13.5 18.3 16.9 12.5 8.2 9.5 8.8 15.2 29.8 11.7 9.1 10.9 8.9 11.5 9.9 13.5 12.2 10.9 13.3 8.0 9.1 14.4 12.2 15.3 7.3 16.0 8.2 12.6 10.1 18.8 10.7 11.0 8.8 14.8 8.9 11.8 8.1 12.7 11.2 25.3 9.5 17.8 14.2 10.7 12.8 11.5 9.8 11.3 30.9 16.3 30.1 22.6 12.5 13.1 51.0 15.4 16.3 20.9 22.1 18.5 12.8 32.8 15.5 18.1 13.6 17.4 27.6 18.0 28.6 24.9 16.4 31.6 21.7 21.6 13.8 40.3 25.3 12.5 12.9 24.9 25.2 16.0 17.8 27.3 40.1 22.5 20.2 115.4 40.9 17.0 40.7 11.7 16.3 34.8 45.9 10.8 14.9 47.7 20.8 21.9 29.2 34.7 27.4 19.3 15.8 21.7 20.1 14.5 23.4 33.8 21.7 15.7 15.6 33.4 20.4 23.0 42.0 13.2 1.2 6.1 2.5 1.5 2.2 3.0 2.6 2.7 1.5 1.4 2.0 3.1 3.6 4.1 2.4 3.0 1.6 0.8 10.1 11.3 18.3 16.9 11.5 9.9 8.0 9.1 8.2 8.1 9.5 11.3 31.0 19.2 33.3 70.5 35.4 52.8 28.9 28.6 25.6 75.6 35.9 23.9 29.2 30.0 32.3 55.2 98.0 64.9 53.9 33.3 1.9 21.0 237.3 50.4 37.5 33.2 52.1 37.9 120.7 23.6 34.0 28.7 30.1 90.0 37.4 55.6 40.7 44.3 29.6 26.9 108.5 30.4 30.5 50.3 47.9 97.9 49.0 37.2 19.6 79.6 42.9 31.5 54.6 116.6 101.8 31.4 34.9 36.9 31.6 47.3 26.6 17.3 31.4 58.3 32.9 38.3 32.5 60.0 31.9 31.2 55.4 87.7 42.8 48.1 31.2 55.3 TRMO "C9orf156, HSPC219" ENSG00000136932 "TRNA methyltransferase O" Q9BU70 9 97904489-97922516 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021281, HPA052197" Approved Approved Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA021281: AB_2670649, HPA052197: AB_2681758" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (1.12e-1)" "unprognostic (6.28e-2)" "unprognostic (1.08e-2)" "unprognostic (7.27e-3)" "unprognostic (1.64e-1)" "unprognostic (8.67e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-2)" "prognostic favorable (4.81e-10)" "unprognostic (1.97e-1)" "unprognostic (1.78e-1)" "unprognostic (1.74e-2)" "unprognostic (4.39e-2)" 7.5 9.4 7.4 11.3 8.5 16.4 13.6 8.1 7.8 9.0 9.3 7.2 7.0 9.1 11.8 7.8 10.4 7.5 6.6 6.8 8.2 9.9 11.3 9.2 14.6 7.8 7.7 9.0 9.7 11.6 7.8 7.5 8.2 9.5 8.1 5.5 9.6 7.7 7.3 10.3 9.3 6.4 8.0 11.9 9.3 12.0 7.5 13.8 18.4 7.8 14.0 7.1 6.5 10.2 19.4 12.1 6.5 8.0 8.1 6.7 11.2 9.7 11.0 15.3 11.6 16.9 14.0 12.1 6.4 9.7 17.1 18.0 10.6 7.6 11.8 14.6 8.4 10.0 14.8 15.3 16.7 19.4 15.8 11.7 17.0 8.5 6.9 9.2 6.9 9.5 16.0 15.3 10.7 28.1 8.3 13.3 9.1 20.7 13.4 9.8 14.5 8.7 14.5 15.5 11.5 10.1 7.1 15.4 16.6 5.5 6.8 10.5 10.6 8.4 8.5 17.7 15.0 16.3 12.6 6.1 9.0 9.8 7.7 44.4 21.1 49.4 20.4 23.4 25.4 19.4 30.8 24.6 22.6 28.8 39.7 27.9 32.4 22.9 16.1 13.1 35.1 20.1 7.4 8.5 8.1 7.8 6.8 8.2 7.8 7.7 8.2 8.0 7.5 10.2 7.5 12.8 5.3 0.0 16.7 0.0 14.6 0.0 10.2 9.1 7.3 7.6 0.0 4.3 6.8 5.5 0.0 8.9 17.5 3.5 7.9 9.1 30.6 9.3 5.4 4.9 2.4 6.9 0.0 9.6 6.9 6.0 9.2 7.1 0.0 4.1 5.3 7.3 10.8 6.7 0.0 5.6 0.0 10.7 0.0 18.3 5.0 9.7 0.0 0.0 10.7 12.1 8.2 0.0 0.0 10.3 5.7 7.2 12.0 6.1 4.9 9.9 5.8 4.9 6.6 8.6 5.2 16.7 13.3 7.8 0.0 18.3 14.6 6.6 3.9 8.1 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150498 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 8.8 8.7 6.9 12.2 9.8 5.2 14.5 9.6 9.6 11.2 6.7 9.3 11.2 13.9 11.8 8.5 9.2 7.2 8.0 6.5 9.7 8.8 8.7 7.8 18.2 8.5 9.0 13.5 11.5 12.9 6.8 10.7 8.7 10.4 11.3 21.7 9.1 8.1 13.1 14.7 10.7 10.1 7.0 14.1 10.0 9.4 8.5 11.3 12.0 6.2 14.6 9.5 10.3 14.9 17.5 10.0 16.5 11.5 8.7 16.9 18.0 18.0 7.1 13.4 11.1 11.9 7.0 28.7 21.8 14.4 8.9 15.4 30.6 14.0 23.1 29.0 24.2 17.2 23.1 11.6 15.7 30.0 15.4 11.9 15.5 25.5 33.3 8.4 12.4 21.0 36.6 17.9 13.6 6.7 24.6 15.6 23.0 16.7 19.9 26.0 25.0 15.7 11.1 13.6 10.7 17.9 16.6 15.8 21.6 16.1 9.3 26.1 13.0 17.8 11.9 15.1 24.3 22.8 20.0 34.0 20.1 23.5 7.0 0.2 5.8 3.1 10.5 6.1 13.0 19.9 11.3 10.6 7.0 18.7 16.8 14.0 2.5 7.9 5.1 12.8 8.6 5.6 6.9 9.8 9.6 9.6 6.5 9.7 8.5 9.0 8.7 7.0 8.5 14.9 13.1 25.6 17.0 34.0 29.0 9.7 14.2 14.2 19.9 38.9 10.7 7.9 11.1 12.8 22.2 14.7 29.2 14.2 18.9 8.0 13.7 10.5 20.9 14.3 21.0 15.7 20.4 11.3 23.1 6.1 10.2 13.7 11.7 8.0 21.5 18.7 17.9 11.4 7.6 28.6 32.1 9.9 18.3 10.1 7.0 6.0 24.8 10.3 10.6 25.3 14.7 16.6 41.2 33.7 97.4 8.5 9.6 18.4 9.0 12.6 13.0 10.7 20.4 44.7 19.7 16.0 13.4 47.6 21.9 12.2 11.9 7.3 21.5 15.8 13.6 10.0 TRRAP "PAF400, TR-AP, Tra1" ENSG00000196367 "Transformation/transcription domain associated protein" Q9Y4A5 7 98877933-99050831 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Autism spectrum disorder, Cancer-related genes, Deafness, Disease variant, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054376 Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Golgi apparatus" "HPA054376: AB_2682467" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (2.21e-1)" "unprognostic (4.35e-2)" "unprognostic (2.02e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (8.77e-4)" "unprognostic (1.40e-2)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "unprognostic (9.45e-2)" "unprognostic (7.02e-2)" "unprognostic (2.21e-3)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (2.96e-1)" 6.0 8.1 3.4 7.4 3.5 11.1 6.2 10.3 3.7 8.3 5.9 7.7 5.3 8.6 3.5 6.8 8.4 4.9 6.8 3.1 2.6 6.2 6.7 7.0 9.3 1.4 2.2 10.9 8.3 10.3 14.0 6.1 1.9 7.1 5.0 7.5 7.1 5.2 7.6 11.2 8.4 6.2 0.6 8.5 7.1 11.0 2.8 15.8 8.8 7.3 8.7 7.3 7.0 5.0 24.0 27.2 27.7 23.4 12.9 13.8 13.7 10.3 13.6 15.8 15.1 21.2 10.3 32.8 15.9 19.1 30.3 12.2 29.1 14.0 17.7 19.2 28.3 20.2 20.3 11.7 9.4 36.9 14.3 12.6 8.0 25.8 21.7 10.9 20.5 29.2 35.4 59.8 14.8 44.0 45.0 13.5 21.1 14.1 16.6 32.7 16.0 25.2 7.7 26.6 21.6 27.1 26.1 16.6 8.4 22.7 8.5 15.7 22.0 21.1 30.6 28.3 24.2 24.7 30.2 47.8 14.9 18.3 21.3 2.8 0.3 0.2 0.5 0.2 0.9 0.6 0.8 0.4 0.3 0.8 0.6 0.6 1.0 0.5 0.3 1.0 0.7 0.1 3.4 3.5 10.3 3.7 3.1 2.6 1.4 2.2 1.9 0.6 2.8 5.0 12.8 16.0 14.2 30.3 16.4 15.8 4.2 8.2 13.1 15.2 13.7 10.0 10.9 5.7 9.4 14.7 27.1 8.9 15.0 7.9 0.0 7.7 3.6 16.6 20.1 11.1 12.6 12.4 43.7 6.5 5.2 11.1 11.2 24.1 5.7 26.5 8.6 11.0 8.0 21.9 45.5 10.4 8.2 10.4 7.4 5.4 8.7 12.3 8.8 29.0 9.8 6.1 6.2 36.7 42.4 8.3 5.8 8.6 25.3 7.6 6.2 5.2 8.3 9.2 0.0 12.8 12.4 14.8 8.4 18.5 21.3 10.9 17.1 12.1 10.1 7.5 TTC32 ENSG00000183891 "Tetratricopeptide repeat domain 32" Q5I0X7 2 19896631-19901983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036024 Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Mitochondria Nucleoplasm "HPA036024: AB_10673493" "unprognostic (2.77e-3)" "unprognostic (5.44e-2)" "unprognostic (8.85e-2)" "unprognostic (8.80e-3)" "unprognostic (1.08e-1)" "unprognostic (2.62e-1)" "unprognostic (5.25e-2)" "prognostic favorable (9.44e-4)" "unprognostic (4.46e-2)" "unprognostic (1.48e-2)" "unprognostic (4.92e-3)" "unprognostic (6.22e-2)" "prognostic unfavorable (5.45e-6)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-2)" "unprognostic (2.27e-2)" 11.8 8.8 8.7 12.3 10.5 34.7 16.6 13.6 17.2 12.3 8.6 11.7 12.2 13.9 26.0 7.4 11.9 6.7 7.1 8.8 9.1 11.4 12.3 10.0 15.5 10.6 10.0 16.5 8.6 8.2 11.3 8.5 11.3 16.0 10.2 33.0 11.1 9.3 22.5 13.8 13.1 8.0 9.5 15.6 11.4 12.5 9.7 19.7 12.4 7.7 10.1 11.3 11.2 14.2 22.5 14.4 12.8 9.6 5.6 12.3 2.7 4.8 8.0 7.7 5.0 7.3 25.6 14.5 2.7 5.1 9.6 14.6 5.6 15.4 4.9 21.3 23.3 14.8 20.4 12.8 12.1 14.2 25.5 11.7 9.6 8.6 20.4 6.5 7.5 23.3 27.1 28.5 6.4 6.8 10.7 21.7 9.6 8.4 24.1 12.6 8.5 24.1 21.6 8.6 20.6 19.1 16.1 8.5 18.2 14.1 11.9 5.5 5.6 11.6 12.4 11.5 6.6 29.8 27.3 24.0 17.9 13.9 6.7 9.2 7.6 23.1 7.3 5.7 8.7 12.2 11.6 7.8 7.2 11.9 15.8 12.2 28.0 6.7 6.9 5.0 15.6 4.9 8.7 10.5 13.6 17.2 8.8 9.1 10.6 10.0 11.3 9.5 9.7 14.2 23.2 9.6 14.4 8.5 24.7 18.9 33.4 36.0 34.7 66.9 27.4 39.0 15.8 15.7 26.4 12.9 14.6 14.6 13.7 10.0 45.0 12.2 27.2 25.8 6.1 16.2 28.3 34.0 7.1 24.8 8.7 19.6 14.8 13.2 8.8 7.2 7.5 24.1 9.1 42.1 8.6 19.9 32.6 8.8 8.9 7.2 19.9 17.4 7.2 5.6 14.6 67.8 11.3 9.5 22.0 14.6 12.9 9.8 12.3 15.8 13.7 28.5 48.7 39.2 13.1 21.1 21.3 113.2 38.7 22.4 26.1 9.6 21.6 9.0 11.7 26.7 TTF1 ENSG00000125482 "Transcription termination factor 1" Q15361 9 132375548-132406851 "Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "DNA replication inhibitor, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054837 Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Nucleoli" "HPA054837: AB_2682621" "unprognostic (7.07e-2)" "unprognostic (5.62e-3)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-1)" "unprognostic (9.21e-3)" "unprognostic (3.08e-1)" "unprognostic (1.33e-1)" "unprognostic (6.95e-3)" "unprognostic (2.09e-2)" "unprognostic (5.93e-3)" "unprognostic (8.38e-2)" "unprognostic (3.44e-1)" "unprognostic (4.71e-2)" 8.0 5.0 7.0 6.2 7.7 16.7 9.6 9.0 8.3 7.4 6.7 9.6 4.7 8.5 9.0 6.4 7.3 5.3 13.3 6.9 7.3 6.6 4.2 7.0 10.5 7.0 7.1 8.6 6.6 7.0 5.0 6.5 7.1 7.9 6.6 8.6 6.1 7.4 13.6 7.1 6.5 7.1 6.8 7.9 6.5 9.6 7.1 18.9 10.4 10.3 10.0 7.9 6.9 8.3 12.5 11.5 16.4 14.8 9.0 11.5 14.7 14.1 10.7 16.2 12.0 11.8 13.2 20.9 11.5 10.6 18.3 29.7 18.5 10.8 17.1 13.9 12.6 9.6 17.2 9.5 9.1 25.6 14.9 7.1 12.0 13.8 10.5 13.1 14.0 34.1 19.3 17.5 12.7 19.0 59.8 15.5 30.0 22.3 16.8 37.1 22.8 24.9 13.1 10.1 14.4 24.8 19.8 14.4 10.7 15.3 17.9 13.7 13.2 25.0 15.8 21.8 16.8 8.2 24.8 25.0 14.7 20.6 25.1 17.0 5.8 12.0 6.6 6.0 8.6 13.6 8.4 7.8 3.6 12.2 9.3 7.0 20.9 8.2 7.4 11.2 9.6 3.3 7.0 7.7 9.0 8.3 6.9 7.3 7.0 7.1 7.1 6.8 7.1 8.3 26.8 25.6 21.6 12.7 35.4 9.8 21.9 26.9 7.4 27.2 11.8 15.5 40.1 25.8 18.3 18.4 60.5 23.8 33.2 14.8 19.6 28.5 22.9 26.2 21.4 29.5 12.1 68.0 12.4 21.2 22.8 17.5 15.3 16.8 22.8 28.8 27.5 8.3 18.7 30.3 10.6 15.4 20.3 22.0 12.1 6.8 23.6 17.4 1.8 14.0 30.1 20.3 41.2 9.5 19.2 25.3 18.6 25.9 14.3 22.8 16.5 19.3 29.2 55.0 26.3 21.9 24.1 47.4 61.8 7.5 8.5 25.2 28.2 16.8 19.7 24.5 TXLNG "CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX" ENSG00000086712 "Taxilin gamma" Q9NUQ3 X 16786432-16844519 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000297, HPA000841" Approved Approved Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA000297: AB_1078590, HPA000841: AB_1078589" "unprognostic (2.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.27e-3)" "unprognostic (4.78e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (6.33e-6)" "unprognostic (2.61e-2)" "unprognostic (5.27e-3)" "unprognostic (6.96e-2)" "unprognostic (3.61e-2)" "unprognostic (1.40e-2)" "unprognostic (1.58e-3)" "unprognostic (2.04e-2)" "unprognostic (2.22e-1)" "unprognostic (8.62e-2)" "unprognostic (6.00e-3)" 14.4 15.9 4.6 8.0 5.3 14.0 10.1 7.8 6.3 6.9 6.7 6.3 8.3 9.8 6.6 6.1 9.1 6.3 5.7 4.1 5.6 7.5 8.0 7.7 12.6 3.9 4.6 16.5 8.5 11.6 6.9 5.8 4.1 6.5 6.0 14.6 7.0 8.7 5.9 6.1 6.5 7.5 4.0 7.7 6.8 6.0 4.6 9.2 10.4 6.0 11.5 7.9 4.6 6.4 27.7 16.9 15.9 28.3 28.4 15.5 8.4 10.8 10.4 12.1 11.8 23.7 16.1 57.6 26.7 6.1 34.8 17.5 54.9 35.4 21.6 17.7 66.7 20.7 23.5 15.3 12.1 31.1 14.2 9.2 17.1 28.2 50.6 16.4 15.5 23.4 40.3 16.6 9.5 16.5 28.6 17.9 47.6 18.3 19.4 19.5 21.7 47.7 9.7 13.6 25.8 18.7 25.0 23.6 19.8 27.1 28.7 12.7 7.6 7.6 10.0 26.9 18.9 17.4 28.4 57.6 9.6 20.1 7.8 0.6 1.9 1.0 3.1 1.5 4.0 3.7 3.4 3.7 2.1 4.0 4.0 4.4 0.7 2.9 1.7 2.1 3.8 2.1 4.6 5.3 7.8 6.3 4.1 5.6 3.9 4.6 4.1 4.0 4.6 6.4 26.3 16.0 24.8 17.6 32.0 41.0 60.2 13.6 23.3 35.9 27.0 29.1 13.3 17.2 23.3 9.2 6.2 14.2 37.7 9.0 21.5 19.3 4.4 33.5 27.3 15.6 14.4 19.8 32.5 16.7 13.2 35.8 9.7 27.2 13.3 13.1 13.2 16.1 9.0 28.6 39.7 15.0 8.2 7.7 11.1 2.2 27.1 12.2 17.8 11.2 9.0 17.7 12.3 16.1 28.3 15.6 7.7 21.1 17.0 43.6 12.3 20.5 16.3 23.0 6.6 42.3 25.8 17.1 37.7 19.1 34.8 21.9 32.9 16.3 16.2 33.0 TXNDC9 APACD ENSG00000115514 "Thioredoxin domain containing 9" O14530 2 99318982-99340702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031844, HPA031845, HPA031846" Approved Enhanced Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916" "unprognostic (3.63e-3)" "unprognostic (4.26e-2)" "unprognostic (7.28e-2)" "unprognostic (3.12e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (9.63e-7)" "unprognostic (2.06e-2)" "unprognostic (9.09e-2)" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.32e-1)" "unprognostic (2.47e-3)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" 18.7 17.9 10.0 21.3 10.8 17.5 28.7 11.0 13.2 19.3 10.4 24.6 18.4 16.6 25.9 26.1 18.1 18.6 28.6 10.8 11.7 28.8 27.2 20.1 29.2 11.6 11.5 10.7 10.9 15.4 11.3 23.5 11.9 19.6 26.3 11.0 15.1 16.1 18.2 19.0 17.6 24.4 11.8 18.6 18.5 17.8 10.9 26.1 24.8 16.2 34.0 24.9 14.1 12.5 78.3 27.6 55.0 27.7 55.8 57.8 65.8 83.1 79.5 88.5 85.0 71.1 55.5 58.0 66.9 72.6 77.0 52.7 55.2 88.2 102.6 44.0 53.5 60.4 34.5 77.0 54.2 71.8 44.2 53.0 76.7 74.3 53.8 46.1 101.9 32.1 73.0 51.1 103.7 41.5 43.4 63.6 43.4 46.4 68.7 32.5 53.0 56.4 123.9 62.6 37.1 31.5 41.7 56.2 93.7 69.8 64.3 60.9 69.4 65.1 62.7 40.6 62.6 21.2 37.1 65.6 51.9 76.8 58.6 110.6 54.1 61.1 56.7 60.5 70.2 69.1 66.6 64.4 60.3 57.6 61.9 62.5 53.5 77.7 82.6 60.9 91.2 87.0 10.0 10.8 11.0 13.2 10.8 11.7 11.6 11.5 11.9 11.8 10.9 12.5 46.6 9.6 13.4 8.8 33.4 35.2 29.7 137.1 25.0 11.3 21.5 26.3 27.6 25.8 67.0 36.8 8.4 75.7 31.3 26.2 84.1 79.8 75.7 37.3 29.9 46.2 20.9 47.8 13.3 69.4 82.5 29.2 22.4 25.5 17.7 21.0 38.2 24.4 56.9 13.5 12.8 25.7 91.6 25.4 31.3 21.1 27.7 30.2 26.6 4.7 55.5 26.9 44.3 12.5 16.7 84.5 21.6 23.3 31.8 24.0 21.9 121.5 72.8 19.8 26.3 17.8 89.3 52.8 42.7 29.4 38.9 81.3 35.1 40.1 26.6 21.9 U2AF1L5 ENSG00000275895 "U2 small nuclear RNA auxiliary factor 1 like 5" P0DN76 21 6484623-6499261 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.0;Club cells: 14.2;granulocytes: 30.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044833, HPA052083" Supported Uncertain Nucleoplasm NA NA 28000 "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (6.54e-2)" "unprognostic (2.42e-1)" "unprognostic (2.75e-2)" "unprognostic (8.31e-3)" "unprognostic (2.80e-1)" "unprognostic (5.99e-2)" "unprognostic (2.02e-1)" "unprognostic (4.54e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.70e-1)" "unprognostic (3.42e-2)" "unprognostic (5.39e-3)" "unprognostic (3.14e-1)" "unprognostic (2.79e-2)" "unprognostic (5.98e-2)" "unprognostic (8.20e-2)" 48.0 41.4 34.1 50.7 33.1 71.5 47.4 33.0 42.7 40.8 29.2 45.3 44.2 43.2 54.4 39.6 47.4 26.1 39.8 33.3 34.7 47.7 44.4 32.0 55.4 35.1 32.9 58.1 47.6 34.9 41.7 52.8 35.0 34.2 54.1 48.7 31.8 31.0 40.1 41.5 36.4 47.5 35.4 52.3 34.3 39.6 33.7 86.5 49.4 39.0 80.9 55.6 19.9 36.2 195.0 186.6 156.9 128.0 107.5 76.0 80.6 118.0 103.5 164.3 88.2 83.2 88.6 571.9 105.2 149.3 191.6 143.2 275.3 223.6 195.6 143.0 266.8 226.8 170.8 311.9 178.1 401.0 125.5 61.1 64.6 91.6 121.6 77.5 179.7 58.4 479.7 186.2 150.5 85.4 216.3 131.2 212.7 250.6 76.2 277.6 91.4 108.7 167.9 274.8 164.7 124.3 70.3 139.5 91.0 63.8 78.1 222.5 234.7 121.5 217.1 51.1 86.7 184.5 212.6 538.1 105.0 260.3 176.3 175.4 197.4 182.8 147.0 189.1 162.2 210.7 176.6 172.2 207.3 236.6 188.1 165.4 348.0 169.9 127.9 297.9 246.3 235.8 34.1 33.1 33.0 42.7 33.3 34.7 35.1 32.9 35.0 35.4 33.7 36.2 2.6 12.8 18.0 0.0 0.8 0.0 4.2 0.0 0.0 0.2 4.7 2.7 0.0 2.8 14.2 0.0 0.0 1.4 3.2 0.4 1.9 4.8 0.7 2.8 3.1 2.9 2.4 0.0 0.0 7.1 1.9 7.5 0.0 3.6 30.3 3.8 1.4 1.2 1.1 0.0 0.0 1.5 0.0 0.8 0.0 0.2 0.3 2.9 0.0 0.0 2.9 0.5 1.0 0.0 0.0 6.4 2.1 1.2 0.9 3.8 1.5 1.7 10.2 0.4 0.0 1.8 1.5 1.9 2.0 0.0 0.0 2.1 2.0 3.9 1.4 2.0 U2SURP "fSAPa, SR140" ENSG00000163714 "U2 snRNP associated SURP domain containing" O15042 3 142964497-143060725 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037545, HPA037546, HPA061407" Enhanced Supported Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506" "unprognostic (2.01e-1)" "unprognostic (9.78e-2)" "unprognostic (8.09e-2)" "prognostic unfavorable (8.44e-4)" "unprognostic (3.11e-2)" "unprognostic (4.30e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.72e-2)" "unprognostic (1.98e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.85e-3)" "prognostic unfavorable (8.86e-7)" "unprognostic (6.71e-2)" "unprognostic (2.19e-1)" "unprognostic (3.12e-1)" "prognostic favorable (6.78e-4)" 22.1 18.2 16.6 19.3 17.1 57.6 23.4 21.9 25.1 25.0 15.9 21.3 12.9 22.6 20.8 21.5 23.9 12.3 18.1 16.2 16.8 23.2 24.3 18.8 29.9 16.4 16.1 31.7 25.2 22.5 21.5 17.8 16.6 19.8 20.1 51.8 18.5 14.5 27.4 21.9 22.0 17.5 15.1 25.7 19.9 20.4 16.2 31.3 22.5 17.7 26.1 20.9 21.9 20.8 165.4 54.2 59.7 40.1 30.9 28.3 103.9 72.8 46.4 82.2 61.2 72.7 49.7 189.2 76.0 47.5 157.0 58.2 124.0 66.1 93.2 51.8 88.0 205.1 49.9 58.3 31.7 202.1 75.3 34.4 32.0 64.3 81.9 36.4 45.4 118.5 129.5 59.1 39.0 46.3 100.4 86.8 96.7 52.8 50.4 101.9 116.2 79.0 40.8 102.8 76.5 44.5 146.1 48.2 87.1 61.2 85.3 84.8 49.5 44.1 52.2 35.1 118.0 69.4 97.5 319.8 34.9 72.1 63.1 40.2 32.7 33.3 40.9 31.7 35.1 60.1 37.1 37.0 27.0 60.7 42.4 36.6 33.3 35.5 48.2 53.9 40.5 21.6 16.6 17.1 21.9 25.1 16.2 16.8 16.4 16.1 16.6 15.1 16.2 20.8 124.4 118.6 129.4 116.2 94.8 60.8 85.7 140.5 68.9 124.2 64.4 90.3 123.8 52.9 115.6 62.5 66.7 78.9 109.9 50.0 52.8 77.2 35.1 91.5 129.4 96.4 55.2 126.0 71.7 79.8 83.7 103.8 58.1 99.1 98.1 165.5 62.8 58.5 61.3 92.5 80.7 74.7 85.5 60.2 54.6 22.0 108.7 78.4 51.6 63.7 115.9 98.1 110.2 104.5 145.8 89.6 55.7 79.7 108.7 81.9 48.0 60.6 100.2 125.4 78.9 122.8 139.4 243.6 235.6 76.9 64.8 79.1 98.6 111.6 80.7 78.4 UBA6 "FLJ10808, UBE1L2" ENSG00000033178 "Ubiquitin like modifier activating enzyme 6" A0AVT1 4 67612652-67701155 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037001 Approved Enhanced Nucleoplasm,Cytosol NA NA 12000 "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Cytosol" "HPA037001: AB_10672787" "unprognostic (2.52e-1)" "unprognostic (4.89e-2)" "unprognostic (3.97e-3)" "unprognostic (2.81e-1)" "unprognostic (3.67e-2)" "unprognostic (4.92e-2)" "unprognostic (3.55e-3)" "unprognostic (6.06e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-2)" "unprognostic (3.38e-2)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.05e-3)" 6.7 6.6 5.9 9.9 8.0 17.1 8.3 7.5 7.5 10.6 4.9 7.1 8.1 6.8 6.2 11.4 5.7 8.0 5.3 5.6 7.9 6.3 10.7 7.8 12.4 9.7 8.0 7.7 6.2 7.9 12.0 9.8 10.0 7.7 8.4 14.4 6.7 5.5 5.2 8.4 8.6 8.7 8.4 10.2 9.4 10.0 8.7 10.4 7.9 6.5 13.6 10.2 10.6 16.0 34.4 18.8 30.5 24.0 14.8 17.4 20.6 69.5 27.1 31.1 36.2 19.8 45.1 43.4 24.2 28.7 31.8 19.8 31.9 34.6 46.6 50.0 8.9 27.8 30.7 18.7 12.6 49.3 20.4 12.5 10.9 40.3 24.3 21.2 27.8 21.9 67.2 25.0 37.2 13.0 51.5 11.2 18.0 24.3 22.6 30.0 62.6 16.1 25.3 38.3 14.9 18.8 39.2 27.5 13.0 25.3 18.4 13.0 40.6 28.6 31.9 23.6 30.8 17.8 15.0 43.0 50.9 13.5 28.1 6.4 1.8 2.9 2.4 2.3 2.7 3.0 2.8 3.2 2.2 3.0 2.0 2.4 1.3 5.7 2.6 3.1 2.5 1.4 5.9 8.0 7.5 7.5 5.6 7.9 9.7 8.0 10.0 8.4 8.7 16.0 34.6 25.6 21.7 54.5 46.5 70.1 65.2 43.0 37.5 45.8 30.8 17.0 13.5 10.0 34.6 16.5 54.2 29.2 45.0 34.7 3.9 24.6 2.3 28.6 24.8 39.0 32.3 23.8 66.3 17.1 17.8 26.6 39.8 45.3 31.0 62.3 20.0 20.9 23.2 33.7 78.1 27.0 28.5 29.9 54.0 5.8 21.5 31.4 24.9 37.5 34.6 14.6 26.8 77.9 115.7 53.3 36.6 19.9 44.8 87.0 21.2 15.9 34.9 39.9 19.7 28.0 24.0 57.7 43.9 30.9 46.2 58.8 37.6 40.4 22.8 149.0 UBE2I UBC9 ENSG00000103275 "Ubiquitin conjugating enzyme E2 I" P63279 16 1308880-1327018 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003909, CAB009021, CAB079920" Approved Supported Nucleoplasm,Nucleoli NA NA 130000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (2.88e-3)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (7.60e-3)" "unprognostic (3.56e-1)" "unprognostic (7.28e-2)" "unprognostic (9.30e-2)" "unprognostic (1.57e-1)" "prognostic favorable (5.68e-4)" "unprognostic (1.15e-3)" 62.5 76.3 42.5 60.3 44.0 81.6 62.0 46.1 49.3 64.7 37.1 63.8 45.1 72.7 48.7 74.2 67.3 34.3 68.2 45.2 45.2 63.4 40.8 53.1 76.0 39.3 42.3 93.1 49.1 72.0 61.6 58.1 40.2 53.4 47.3 31.7 56.4 46.7 58.0 68.0 61.1 53.8 42.2 71.9 52.9 47.6 47.1 110.3 53.2 57.0 89.3 66.6 63.1 42.1 121.3 161.1 269.0 157.7 112.7 135.8 114.4 170.0 121.7 154.3 152.9 191.8 190.1 208.2 137.7 148.1 140.7 142.4 193.2 159.2 197.9 151.2 133.4 130.6 136.6 188.4 178.6 194.9 148.0 127.1 100.7 152.1 180.0 149.0 170.0 169.9 190.3 124.3 148.0 254.4 349.6 193.0 219.0 136.0 118.5 434.0 170.9 238.4 145.7 106.6 150.3 159.8 149.3 164.1 177.7 152.8 167.5 234.4 139.4 149.2 172.6 134.0 155.5 132.1 170.4 423.4 85.3 142.9 164.7 278.7 214.3 327.1 165.9 256.6 200.9 297.8 167.8 170.3 214.7 241.1 148.2 149.6 149.5 202.6 249.5 186.3 196.5 260.9 42.5 44.0 46.1 49.3 45.2 45.2 39.3 42.3 40.2 42.2 47.1 42.1 109.5 51.3 67.0 16.3 172.8 178.6 186.4 275.6 97.3 64.6 101.9 105.7 89.1 84.4 140.9 62.5 50.1 312.8 153.9 77.4 105.7 211.9 64.4 66.6 100.6 118.3 102.3 127.4 17.2 148.2 293.1 134.4 55.5 104.6 109.5 149.7 94.2 43.7 213.5 47.1 16.8 97.1 162.8 104.8 182.1 37.8 129.8 124.8 128.1 15.9 220.2 104.7 209.1 16.6 26.7 212.3 91.8 107.6 144.1 294.8 90.4 117.7 65.7 63.1 78.9 82.1 185.4 139.6 145.7 158.4 206.7 418.1 144.7 134.9 134.7 304.5 UBE2Q2 DKFZp762C143 ENSG00000140367 "Ubiquitin conjugating enzyme E2 Q2" Q8WVN8 15 75843307-75901078 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (1.28e-1)" "unprognostic (1.66e-2)" "unprognostic (2.45e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (1.13e-1)" "unprognostic (1.07e-3)" "unprognostic (1.32e-1)" "unprognostic (6.38e-2)" "prognostic favorable (5.73e-4)" "unprognostic (1.67e-1)" "unprognostic (1.87e-1)" "unprognostic (1.47e-3)" "unprognostic (1.01e-3)" "unprognostic (1.92e-1)" "unprognostic (1.69e-2)" "unprognostic (5.92e-2)" 24.3 26.7 18.3 16.7 19.3 40.2 24.4 20.0 28.9 25.5 15.0 37.2 9.3 24.9 18.8 22.5 17.4 22.3 29.5 18.3 21.9 22.5 7.2 19.2 18.6 21.8 22.7 22.8 19.4 17.4 16.1 29.0 22.4 30.4 19.8 39.0 25.4 20.9 23.0 16.5 15.7 30.5 22.9 21.7 19.5 21.1 19.9 21.0 31.8 16.9 17.7 27.1 17.0 24.4 23.0 35.5 30.0 22.6 42.8 56.7 47.2 50.4 57.2 32.8 37.1 18.7 30.7 22.7 36.2 73.5 27.8 18.1 58.5 33.5 39.9 24.1 23.7 28.5 20.1 24.5 48.1 28.9 15.7 40.7 37.4 23.1 33.4 46.3 46.2 40.5 11.3 33.2 70.1 18.0 24.7 27.6 22.4 3.5 25.3 29.5 47.2 9.4 51.8 36.8 27.4 21.6 42.4 39.6 55.6 42.3 25.6 40.3 60.7 40.2 36.1 27.3 17.8 36.3 68.1 17.6 15.9 44.9 25.2 31.3 6.3 21.3 9.0 7.3 11.2 8.1 11.8 9.7 5.7 7.8 9.4 7.9 0.9 14.6 10.0 2.1 8.4 6.4 18.3 19.3 20.0 28.9 18.3 21.9 21.8 22.7 22.4 22.9 19.9 24.4 54.3 3.2 6.5 17.6 29.0 50.3 27.7 12.9 33.6 30.3 39.3 26.0 32.1 18.6 17.4 23.9 135.5 55.0 42.6 9.4 23.5 23.8 95.7 18.3 47.4 40.7 18.6 19.1 15.2 16.9 126.2 38.2 12.2 28.9 20.3 27.8 36.4 4.7 23.0 6.7 22.6 30.0 26.4 25.9 51.8 36.7 24.2 34.0 37.4 17.8 30.6 20.2 68.0 30.7 29.5 22.5 10.7 29.0 43.3 58.4 1.3 39.6 9.3 160.8 26.3 28.9 42.9 64.8 64.4 34.4 46.5 110.0 36.1 28.3 17.7 38.7 UBR5 "DD5, EDD, EDD1, HYD, KIAA0896" ENSG00000104517 "Ubiquitin protein ligase E3 component n-recognin 5" O95071 8 102252273-102412759 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 239.9;Excitatory neurons: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053688 Supported Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA053688: AB_2682230" "unprognostic (3.79e-3)" "unprognostic (7.44e-3)" "unprognostic (1.25e-1)" "unprognostic (2.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (2.50e-1)" "unprognostic (1.75e-2)" "unprognostic (7.54e-3)" "unprognostic (8.29e-3)" "unprognostic (3.84e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.69e-2)" "unprognostic (2.45e-1)" 33.0 18.3 16.6 22.4 19.4 36.5 30.9 26.5 24.0 25.6 23.4 33.3 14.9 29.6 23.7 27.5 26.1 17.3 25.8 17.3 16.0 17.5 17.7 29.8 33.6 16.0 16.1 32.2 25.7 30.4 24.4 17.8 15.7 20.0 17.0 45.4 26.1 20.7 50.1 35.6 27.2 17.2 13.7 24.2 25.0 43.9 16.6 43.0 21.0 29.6 28.6 28.2 26.4 18.9 64.5 28.4 53.2 27.5 51.8 52.2 48.9 47.4 41.9 36.6 31.7 28.3 42.1 127.1 39.8 44.5 23.7 38.2 46.2 41.1 51.1 55.3 22.7 106.5 39.7 52.2 46.1 33.7 56.3 60.1 40.4 37.5 64.5 41.5 44.6 35.6 52.3 70.2 34.8 58.0 85.3 40.3 40.1 61.8 31.6 49.3 31.6 60.9 33.5 62.3 39.1 32.5 33.4 31.8 34.3 46.1 51.4 35.1 44.6 38.5 44.9 35.1 33.5 37.3 38.7 129.5 38.0 51.2 32.0 1.8 1.5 2.4 2.4 1.5 2.4 2.1 2.5 2.5 1.8 1.7 2.0 3.0 3.0 1.1 2.7 1.6 3.4 1.0 16.6 19.4 26.5 24.0 17.3 16.0 16.0 16.1 15.7 13.7 16.6 18.9 51.4 25.6 31.7 239.9 44.8 52.3 41.2 26.3 55.8 52.0 37.3 29.6 39.8 8.6 49.9 31.3 68.8 27.7 36.2 20.9 9.8 18.8 38.6 47.5 47.0 40.1 33.4 33.2 214.2 15.0 18.9 43.7 37.8 69.0 29.8 64.3 22.9 19.0 17.0 57.2 191.7 19.5 26.4 31.4 52.6 23.6 39.7 43.7 44.4 129.3 43.5 31.3 26.8 196.6 174.0 21.4 18.3 36.5 65.9 45.2 18.3 9.0 46.5 44.8 13.1 66.3 48.4 59.4 30.2 46.8 61.1 69.6 46.9 30.8 19.5 53.5 UBXN7 "KIAA0794, UBXD7" ENSG00000163960 "UBX domain protein 7" O94888 3 196347662-196432430 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048441, HPA049442" Supported Enhanced Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA048441: AB_2680394, HPA049442: AB_2680769" "unprognostic (8.36e-3)" "unprognostic (4.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-3)" "unprognostic (1.05e-1)" "unprognostic (6.64e-2)" "unprognostic (5.12e-3)" "unprognostic (1.49e-1)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (2.11e-2)" "unprognostic (2.91e-2)" "unprognostic (2.52e-2)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" 6.5 7.5 5.3 7.5 7.5 21.7 8.2 17.5 7.1 8.3 7.4 6.9 5.5 10.1 8.1 6.6 8.4 5.7 4.9 5.4 9.3 6.8 6.4 6.7 9.0 6.3 7.3 12.8 7.4 10.8 7.3 9.5 6.9 7.3 6.8 18.1 6.6 6.7 5.0 10.7 6.3 7.9 5.8 8.9 6.6 11.9 7.6 13.9 8.1 7.0 8.7 6.2 7.0 10.9 25.2 7.7 29.8 15.8 15.2 26.6 13.0 20.3 13.4 11.4 10.4 19.9 10.5 23.0 41.6 13.7 15.4 20.0 22.5 12.0 21.2 9.5 13.8 36.9 16.5 11.3 11.6 18.8 11.5 16.0 13.5 16.0 20.0 20.4 18.7 17.2 17.8 15.5 13.5 10.8 19.6 9.9 17.3 10.2 9.7 22.7 22.3 15.8 9.4 10.9 20.0 15.4 32.6 9.0 15.7 23.7 24.2 15.7 23.5 13.0 11.6 11.8 21.7 21.6 31.3 33.5 12.0 21.0 9.9 9.9 4.7 7.0 4.4 3.7 4.0 6.9 3.8 2.9 5.0 5.9 6.5 5.9 8.4 6.2 5.4 2.2 6.6 2.5 5.3 7.5 17.5 7.1 5.4 9.3 6.3 7.3 6.9 5.8 7.6 10.9 27.1 44.8 18.8 29.7 31.4 47.3 14.3 16.2 40.5 38.0 22.2 16.0 16.8 12.8 21.1 20.2 70.9 18.0 32.9 14.8 5.9 10.8 38.3 47.8 46.3 27.8 46.5 34.0 35.3 10.0 10.5 30.7 18.8 35.1 8.8 46.0 21.8 12.0 12.5 32.0 41.3 15.9 12.2 25.4 41.0 24.7 29.8 24.7 23.2 27.2 28.4 21.5 33.0 36.7 47.8 12.2 11.8 28.2 34.3 31.7 13.3 11.7 30.5 46.5 32.9 37.3 25.6 34.7 23.8 38.6 54.7 18.9 29.8 33.2 15.8 25.3 USP1 ENSG00000162607 "Ubiquitin specific peptidase 1" O94782 1 62436297-62451804 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 302.7;Spermatogonia: 206.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028387, HPA028440" Approved Supported Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA028387: AB_2672578, HPA028440: AB_10603000" "unprognostic (1.22e-1)" "unprognostic (5.36e-2)" "unprognostic (1.78e-3)" "unprognostic (4.05e-3)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (6.72e-2)" "unprognostic (1.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.33e-3)" "unprognostic (3.99e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-3)" "unprognostic (5.70e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" 13.8 10.6 12.4 21.0 14.7 53.2 23.9 20.2 15.4 16.2 11.8 19.0 17.1 20.7 16.8 17.9 16.7 11.9 12.2 11.5 13.4 14.1 13.5 16.0 32.3 12.8 13.0 26.0 16.0 18.2 10.0 14.4 13.7 16.7 20.7 34.5 14.7 15.9 11.9 19.3 17.2 17.0 14.2 19.4 16.9 51.5 12.9 48.1 20.2 16.0 31.7 13.9 11.9 17.3 85.6 25.5 96.8 53.2 21.3 25.5 57.0 79.7 52.1 93.3 101.2 41.4 39.3 151.3 57.0 43.1 83.6 48.0 80.3 53.0 128.5 79.5 63.5 124.5 82.1 42.7 23.2 132.5 60.9 13.7 33.8 84.1 62.8 25.1 44.9 100.1 92.7 125.3 66.2 38.0 136.9 50.9 88.2 48.5 52.4 131.9 166.3 93.9 34.9 60.1 103.4 58.6 89.3 70.1 86.8 64.2 41.3 79.7 32.1 72.7 80.7 109.3 112.9 52.2 78.1 171.1 49.5 104.0 67.0 22.6 9.9 26.0 12.7 10.5 16.9 15.6 15.3 13.5 12.3 11.2 14.4 12.2 17.4 17.9 14.9 12.4 15.3 10.3 12.4 14.7 20.2 15.4 11.5 13.4 12.8 13.0 13.7 14.2 12.9 17.3 35.8 48.1 31.8 6.2 58.7 62.2 34.7 32.9 75.7 49.6 41.5 46.2 34.9 24.3 34.9 16.5 22.9 43.7 52.4 22.7 19.6 34.1 173.9 37.2 32.3 39.7 8.4 85.2 10.3 34.1 59.2 43.9 15.8 33.2 27.8 41.4 30.0 18.4 31.0 35.3 11.2 33.3 30.5 27.2 38.8 81.1 50.1 34.7 26.6 7.5 56.0 49.5 62.8 10.6 17.2 27.5 12.7 41.0 63.7 56.8 22.7 17.3 41.9 86.6 52.6 59.7 42.0 302.7 206.7 73.8 64.4 33.0 59.7 21.2 39.5 35.8 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 200.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 25.8 47.5 18.7 26.6 24.5 43.5 26.4 31.0 26.4 26.9 21.6 24.4 21.7 25.3 20.4 23.0 22.3 18.9 21.6 19.3 20.4 18.2 23.8 23.1 35.1 20.1 20.4 31.1 24.6 25.2 26.9 27.3 21.7 23.5 26.0 57.0 31.2 18.6 23.1 29.5 28.7 22.9 18.5 36.0 32.5 20.6 20.8 26.9 28.6 19.5 34.5 23.1 24.6 36.0 43.9 20.5 47.0 34.0 40.1 49.0 46.4 54.0 36.5 35.3 46.6 19.1 43.2 49.1 35.6 48.8 27.5 39.2 59.0 43.4 53.6 48.3 42.1 104.3 75.7 34.5 35.5 53.0 53.7 39.8 36.6 36.1 39.7 48.1 106.1 36.2 83.8 133.2 44.0 21.9 44.2 68.5 29.7 44.5 36.8 61.3 47.2 57.3 40.7 36.2 57.1 35.6 50.4 45.7 122.7 62.3 23.4 63.0 76.1 37.7 30.9 46.7 31.8 105.6 81.7 48.1 36.3 64.5 56.6 82.1 19.5 35.0 12.2 9.4 13.9 28.6 17.8 17.9 21.1 29.8 20.5 13.1 16.8 12.2 10.9 15.3 21.4 12.6 18.7 24.5 31.0 26.4 19.3 20.4 20.1 20.4 21.7 18.5 20.8 36.0 37.9 54.5 42.1 32.0 55.4 22.2 25.1 30.3 33.0 86.5 22.2 24.5 65.3 21.5 24.4 20.2 62.6 61.4 48.3 17.8 25.4 28.5 71.4 33.3 48.5 32.5 21.7 88.1 66.4 20.0 56.3 42.0 33.1 41.4 49.9 200.4 27.5 22.1 29.2 50.5 74.2 31.3 32.6 22.6 28.1 47.7 34.8 34.4 58.7 52.5 55.9 30.7 36.0 54.3 112.3 23.8 16.4 51.6 150.1 20.7 24.1 20.2 27.3 69.2 32.9 51.7 39.8 52.7 47.4 35.1 25.7 32.6 41.8 54.8 31.6 21.6 UVRAG VPS38 ENSG00000198382 "UV radiation resistance associated" Q9P2Y5 11 75815210-76144232 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 144.6;Microglial cells: 178.9;Oligodendrocytes: 361.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016932 Uncertain NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 57: B-cells - Immune response" "HPA016932: AB_1858707" "unprognostic (3.92e-2)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (4.22e-3)" "unprognostic (2.29e-1)" "unprognostic (1.02e-1)" "unprognostic (1.15e-2)" "unprognostic (2.89e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (7.89e-2)" "unprognostic (2.18e-2)" "unprognostic (6.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (6.94e-2)" "unprognostic (3.03e-1)" 32.1 12.8 11.4 17.9 16.9 33.9 20.7 12.1 15.4 13.7 35.9 14.5 10.6 13.3 14.3 10.1 13.3 15.3 10.7 11.4 12.8 11.6 15.3 15.4 26.5 15.0 15.9 12.4 8.2 21.3 7.3 18.2 16.9 10.5 12.4 19.2 8.0 11.4 14.5 11.8 10.6 14.9 16.0 21.4 12.7 7.9 13.9 25.2 12.9 14.7 25.4 13.1 8.9 25.2 10.3 14.4 11.2 9.7 27.2 20.2 16.3 15.0 27.5 17.4 13.8 19.7 18.9 49.5 30.5 20.5 30.7 10.8 19.5 17.5 19.9 27.2 7.8 18.3 12.2 16.8 24.2 30.6 19.1 17.4 14.6 23.8 42.6 13.1 51.0 22.0 19.6 29.7 16.5 24.1 20.9 19.6 11.1 32.1 15.7 17.3 28.5 40.9 14.8 35.0 15.3 10.8 16.6 16.7 13.2 17.1 20.9 27.4 45.3 16.8 12.7 62.4 10.3 18.4 23.3 51.0 7.6 16.0 21.3 5.8 9.9 8.4 7.0 8.8 6.4 23.4 6.1 6.9 16.8 26.6 8.2 6.6 13.9 8.1 11.4 24.0 6.3 4.7 11.4 16.9 12.1 15.4 11.4 12.8 15.0 15.9 16.9 16.0 13.9 25.2 97.3 12.8 21.3 53.8 97.0 9.2 9.4 9.8 26.7 52.2 17.5 19.4 16.1 10.0 11.3 7.3 68.8 37.6 41.6 9.5 7.9 11.5 6.2 13.6 28.1 36.5 5.4 24.6 144.6 8.7 10.3 24.7 34.1 18.5 10.8 16.0 20.0 9.2 17.3 53.8 124.6 10.0 8.2 22.0 50.8 2.6 21.5 46.3 8.8 178.9 45.8 19.0 34.0 89.0 361.8 10.5 11.4 16.1 40.4 12.1 10.8 11.0 6.5 53.1 13.1 27.2 28.6 13.5 19.1 19.4 12.6 32.8 28.1 25.1 10.1 9.1 VAMP7 "SYBL1, TI-VAMP, VAMP-7" ENSG00000124333 "Vesicle associated membrane protein 7" P51809 X 155881345-155943769 "Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036733 Approved Supported Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "HPA036733: AB_10672228" "unprognostic (7.54e-3)" "unprognostic (1.35e-2)" "unprognostic (2.07e-1)" "unprognostic (1.04e-1)" "unprognostic (6.15e-3)" "unprognostic (2.70e-2)" "unprognostic (5.77e-2)" "unprognostic (7.95e-2)" "unprognostic (7.18e-2)" "unprognostic (3.38e-3)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.29e-1)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (2.97e-1)" 29.4 24.3 17.8 24.1 20.6 37.1 23.8 22.3 24.9 23.2 18.3 22.9 23.4 21.4 15.5 22.6 16.5 22.2 19.6 18.1 21.4 39.2 47.9 24.8 26.4 20.7 20.5 17.9 14.3 32.3 8.7 40.5 21.5 21.4 24.4 10.3 17.3 20.1 21.9 20.1 27.5 28.2 20.4 21.8 18.4 14.9 19.9 29.9 24.4 24.1 28.6 25.6 15.9 23.0 72.9 31.3 21.0 43.6 57.0 54.3 56.3 55.3 49.1 49.0 98.4 33.8 46.5 100.6 100.0 66.9 55.5 25.5 47.6 38.9 64.5 42.3 41.6 41.8 43.1 24.3 63.6 86.9 62.8 50.9 37.9 54.8 49.8 42.8 55.4 43.5 91.1 54.2 56.0 36.5 34.1 48.8 15.0 54.1 45.3 25.5 41.2 75.3 65.6 36.2 16.0 46.0 32.7 32.6 49.6 54.8 31.9 71.8 58.4 44.8 46.7 65.0 79.6 123.8 167.8 138.9 39.2 104.4 51.0 86.8 25.3 39.6 15.1 27.0 19.1 12.3 17.7 18.6 26.4 13.2 16.2 17.5 21.9 22.7 26.7 15.0 22.0 22.4 17.8 20.6 22.3 24.9 18.1 21.4 20.7 20.5 21.5 20.4 19.9 23.0 17.8 3.2 9.2 11.1 21.2 19.6 14.7 11.8 20.5 7.6 16.6 9.5 12.3 5.7 12.5 7.3 6.2 48.4 24.9 14.1 41.1 28.0 6.9 13.8 14.5 19.8 13.2 31.4 14.2 26.0 49.7 19.6 12.2 13.7 31.1 22.5 20.3 25.1 31.1 6.7 14.6 12.8 10.2 30.8 49.0 6.9 17.7 35.9 19.6 7.5 32.5 10.4 29.9 8.0 19.2 29.9 13.5 19.5 15.2 17.5 25.3 52.9 10.5 4.6 26.3 10.8 18.9 45.4 26.3 20.3 19.5 69.8 21.6 25.3 15.3 20.1 VIRMA "DKFZP434I116, fSAP121, KIAA1429" ENSG00000164944 "Vir like m6A methyltransferase associated" Q69YN4 8 94487689-94553529 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031530 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" Nucleoplasm "HPA031530: AB_10600818" "unprognostic (2.51e-2)" "unprognostic (7.41e-3)" "unprognostic (3.43e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (7.83e-2)" "unprognostic (7.54e-3)" "unprognostic (1.98e-3)" "unprognostic (1.27e-1)" "unprognostic (2.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (2.48e-1)" "unprognostic (1.68e-1)" "unprognostic (3.82e-2)" "unprognostic (9.87e-2)" 12.5 7.8 6.9 11.6 8.5 27.3 17.5 11.5 7.2 13.1 7.1 9.9 8.1 13.7 8.6 9.7 11.4 8.9 9.9 6.1 7.4 10.8 12.5 10.7 14.4 7.1 7.2 16.7 10.3 14.8 6.3 13.2 7.2 10.7 11.7 12.3 9.5 10.3 8.7 9.7 9.1 13.9 7.2 11.4 11.6 16.5 7.3 20.0 13.3 9.3 15.2 10.5 8.0 9.2 40.5 25.2 26.8 14.9 32.4 42.5 17.1 27.5 27.9 29.4 29.9 17.9 33.2 43.6 25.5 36.1 23.0 25.9 36.2 33.5 42.9 38.7 20.0 52.0 19.6 17.6 23.6 25.9 17.9 32.8 13.4 35.4 33.7 30.1 37.5 28.2 54.0 26.6 30.0 23.8 50.7 14.6 17.5 41.4 19.1 29.9 24.4 24.3 19.1 27.6 20.9 28.9 21.6 5.5 23.8 26.3 31.2 20.7 37.3 26.9 15.9 23.1 25.7 20.8 27.8 51.0 26.4 33.7 26.2 14.2 5.0 8.7 6.7 6.4 10.7 6.6 7.4 9.1 5.2 5.0 9.0 7.9 6.0 9.5 13.8 3.3 6.9 5.8 6.9 8.5 11.5 7.2 6.1 7.4 7.1 7.2 7.2 7.2 7.3 9.2 24.2 25.6 21.5 0.0 6.3 0.0 0.0 0.0 0.0 0.0 16.9 16.4 0.0 0.0 14.9 7.3 0.0 26.4 20.0 0.0 7.9 14.4 0.0 23.8 32.2 9.8 0.0 0.0 0.0 12.2 23.7 10.6 0.0 22.4 5.1 28.5 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 14.7 0.0 0.0 5.2 0.0 0.0 6.9 8.7 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 16.8 9.9 25.0 0.0 0.0 VPS13B "CHS1, COH1" ENSG00000132549 "Vacuolar protein sorting 13 homolog B" Q7Z7G8 8 99013266-99877580 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 160.9;Excitatory neurons: 235.2;Inhibitory neurons: 253.2;Microglial cells: 204.2;Oligodendrocyte precursor cells: 217.1;Oligodendrocytes: 238.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043865 Approved "Cell Junctions" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Cell Junctions" "HPA043865: AB_2678704" "unprognostic (4.23e-2)" "unprognostic (1.98e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-3)" "unprognostic (5.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.95e-1)" "unprognostic (1.62e-1)" "unprognostic (1.94e-1)" "unprognostic (1.65e-3)" "unprognostic (8.60e-2)" "unprognostic (5.95e-2)" "unprognostic (6.52e-2)" "unprognostic (5.19e-2)" "unprognostic (1.59e-1)" "unprognostic (8.93e-3)" "unprognostic (2.90e-1)" 4.0 3.0 2.4 4.4 3.3 13.4 4.7 4.5 3.0 5.4 8.2 3.6 2.3 7.2 3.8 4.4 4.9 4.4 2.3 2.0 1.9 3.8 3.1 3.5 4.8 3.6 2.4 8.1 3.4 6.8 2.3 4.0 3.6 4.9 3.7 6.0 3.2 4.1 2.9 4.0 3.0 5.4 2.2 4.2 3.6 4.9 4.9 7.1 4.7 4.4 5.0 4.5 3.7 5.3 8.6 6.1 7.2 5.3 13.3 15.9 3.6 5.4 9.9 5.3 7.0 3.6 4.3 4.8 6.9 9.3 3.9 3.9 5.0 5.0 9.6 7.7 4.6 10.3 6.5 2.8 4.3 5.0 7.4 10.3 4.6 8.5 12.2 7.4 7.6 7.9 7.9 12.4 6.1 5.3 10.5 2.9 2.3 8.9 2.2 8.3 5.1 9.1 3.5 8.0 2.1 6.0 8.4 4.0 4.0 6.4 7.2 5.6 10.8 7.9 7.4 7.1 4.6 5.0 6.2 12.7 6.0 7.9 5.6 3.0 1.2 2.8 1.2 1.0 1.1 3.3 1.0 0.9 0.5 1.6 1.7 1.1 6.1 0.7 2.3 0.6 1.4 0.5 2.4 3.3 4.5 3.0 2.0 1.9 3.6 2.4 3.6 2.2 4.9 5.3 15.5 19.2 12.2 160.9 24.2 8.8 7.6 9.2 15.4 15.1 8.9 7.6 12.8 10.0 11.9 3.7 37.5 4.9 21.6 7.3 0.0 4.9 8.6 10.9 42.7 11.5 9.0 22.9 235.2 4.6 4.0 18.2 28.1 12.7 3.8 10.4 6.4 5.2 6.5 11.8 253.2 11.9 8.2 15.6 11.3 9.6 27.7 17.8 7.2 204.2 15.0 9.4 17.5 217.1 238.1 4.0 11.0 20.7 19.2 6.2 9.8 2.9 8.2 12.9 0.0 15.7 14.7 23.9 7.3 13.0 9.7 4.2 19.5 14.6 7.4 5.7 VPS13C "FLJ10381, FLJ20136, KIAA1421" ENSG00000129003 "Vacuolar protein sorting 13 homolog C" Q709C8 15 61852389-62060473 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 272.2;Oligodendrocytes: 291.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043507 Uncertain Approved Microtubules NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Microtubules "HPA043507: AB_10960840" "unprognostic (1.09e-2)" "unprognostic (5.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-2)" "unprognostic (5.90e-2)" "unprognostic (2.31e-2)" "unprognostic (3.92e-1)" "unprognostic (3.18e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (3.61e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-2)" "unprognostic (3.92e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (5.58e-3)" 9.3 8.3 6.0 13.3 13.8 10.5 9.6 10.2 8.4 11.7 3.1 8.9 6.8 12.0 7.6 4.1 9.4 9.1 6.7 4.4 6.9 8.9 7.2 10.9 17.7 12.9 8.3 16.9 8.6 12.3 5.5 7.9 15.2 7.9 9.1 18.8 8.0 6.1 7.1 5.7 7.7 9.4 8.3 17.8 12.8 6.1 9.9 14.6 11.5 12.8 15.1 9.1 3.5 24.6 8.2 13.9 5.2 5.5 22.8 20.1 6.1 6.4 25.4 6.2 7.5 5.8 5.3 27.9 7.4 12.5 11.6 9.3 18.8 7.2 5.5 20.1 3.4 28.3 7.9 5.4 11.3 13.7 17.6 14.3 4.8 6.7 13.9 14.0 19.2 28.1 8.9 19.5 9.9 3.5 8.1 5.4 3.4 8.7 3.7 19.0 16.1 7.5 10.5 32.5 7.7 9.4 11.5 6.6 7.0 9.1 7.2 19.9 28.9 14.0 7.8 8.5 8.2 9.8 9.4 16.3 11.1 28.8 6.8 3.7 4.2 2.5 3.3 3.1 2.8 4.9 2.7 2.7 3.0 5.3 3.0 2.5 1.1 2.2 5.4 5.9 2.3 1.2 6.0 13.8 10.2 8.4 4.4 6.9 12.9 8.3 15.2 8.3 9.9 24.6 92.5 67.3 61.6 161.6 108.5 18.6 32.3 33.1 26.7 84.9 41.8 24.5 75.2 25.8 83.2 57.0 146.0 14.8 141.1 16.7 9.8 36.7 6.4 92.9 79.6 57.3 53.0 30.7 182.8 29.6 8.3 56.2 83.1 118.9 89.7 51.8 43.2 22.7 31.3 124.5 272.2 29.9 44.7 71.0 58.1 7.3 50.4 107.2 35.6 148.9 118.5 29.6 84.5 217.1 291.3 26.7 21.0 51.6 83.9 25.2 21.6 12.3 113.1 84.5 32.9 86.5 66.9 20.8 20.4 5.9 23.3 8.2 98.8 88.2 23.9 28.3 WASHC5 "KIAA0196, SPG8" ENSG00000164961 "WASH complex subunit 5" Q12768 8 125024260-125091819 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034216, CAB034219, HPA064649, HPA070916" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322" "unprognostic (1.98e-3)" "unprognostic (3.75e-2)" "unprognostic (8.40e-2)" "unprognostic (3.89e-3)" "unprognostic (2.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (2.54e-2)" "unprognostic (3.54e-1)" "unprognostic (5.69e-2)" "unprognostic (9.10e-3)" "unprognostic (1.53e-1)" "unprognostic (9.39e-3)" "unprognostic (5.95e-2)" "unprognostic (2.17e-1)" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" 18.1 18.6 10.5 18.5 16.9 21.3 19.6 14.9 13.2 17.2 16.5 18.5 18.1 16.2 15.7 16.6 13.3 17.8 16.1 11.1 12.5 22.9 18.5 17.1 19.6 14.7 13.7 15.6 13.0 24.8 9.5 21.2 14.6 17.4 20.1 11.4 14.3 16.1 15.9 13.6 14.7 20.2 14.0 19.3 16.1 9.5 13.8 21.8 23.3 18.5 21.0 21.1 10.3 24.7 40.0 45.4 24.9 30.6 55.3 58.8 16.3 42.0 63.6 43.0 45.8 17.0 42.1 36.1 29.1 54.1 25.3 30.6 40.2 37.7 56.8 47.5 23.1 48.1 26.5 22.8 53.8 14.8 46.6 58.7 25.1 35.5 31.2 33.2 49.9 30.9 28.3 35.6 53.0 87.6 44.3 11.8 23.7 66.7 46.7 29.8 22.4 36.7 33.2 48.5 13.1 26.3 48.8 109.2 39.5 25.8 47.3 25.5 44.7 23.6 51.9 39.4 37.7 31.7 31.2 31.7 62.4 27.5 33.4 10.4 17.0 12.5 13.5 20.9 14.3 9.5 12.8 13.9 19.7 10.6 10.1 14.3 5.8 17.2 29.3 7.2 16.9 13.0 10.5 16.9 14.9 13.2 11.1 12.5 14.7 13.7 14.6 14.0 13.8 24.7 10.9 3.2 19.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 14.4 9.3 0.0 0.0 5.0 11.0 0.0 13.4 6.9 0.0 5.9 12.2 0.0 9.9 13.5 4.9 0.0 0.0 0.0 17.2 11.0 5.4 0.0 14.8 8.8 11.1 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.9 0.0 0.0 17.2 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 12.3 3.8 9.6 0.0 0.0 WDR33 "FLJ11294, NET14, WDC146" ENSG00000136709 "WD repeat domain 33" Q9C0J8 2 127701027-127811187 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026897, HPA046527" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Nucleoli fibrillar center" "HPA026897: AB_1858803, HPA046527: AB_2679686" "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.79e-2)" "unprognostic (6.63e-2)" "unprognostic (8.32e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.13e-2)" "unprognostic (5.72e-3)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" "unprognostic (3.64e-1)" "unprognostic (2.04e-1)" "unprognostic (9.85e-2)" "unprognostic (1.03e-2)" 20.2 16.1 16.2 18.5 16.9 17.3 20.4 35.0 19.0 24.5 19.8 21.9 14.7 19.9 14.4 20.9 21.6 11.8 20.0 16.2 17.0 19.9 27.9 18.9 22.0 15.0 16.5 27.8 20.1 19.1 23.0 16.8 16.3 22.1 15.1 24.5 19.3 12.9 21.2 26.6 22.2 15.0 14.2 27.8 18.5 20.6 16.6 30.9 24.2 21.3 23.9 19.9 22.9 20.0 40.3 22.3 38.2 31.2 22.3 22.9 39.0 36.0 28.5 37.3 35.2 52.1 30.3 50.5 39.0 24.0 34.4 31.8 43.6 30.5 48.6 46.5 26.0 48.9 28.2 56.6 25.1 59.7 35.1 22.4 31.7 35.9 30.3 26.7 32.4 45.0 41.5 44.4 26.6 25.1 62.3 43.7 46.5 25.9 24.6 43.1 38.6 40.4 21.5 51.6 35.5 27.5 32.3 29.6 26.0 35.7 23.0 34.4 29.8 29.3 42.6 33.0 31.1 42.8 70.5 96.4 23.9 23.4 27.8 35.7 20.6 35.1 24.9 22.7 25.8 30.5 25.2 24.2 27.4 28.3 26.6 25.7 14.1 34.7 25.0 19.7 34.4 18.5 16.2 16.9 35.0 19.0 16.2 17.0 15.0 16.5 16.3 14.2 16.6 20.0 63.0 35.3 45.0 47.3 77.9 110.0 77.3 83.8 51.2 50.7 41.3 41.4 46.5 64.3 51.5 36.8 64.6 80.7 74.7 31.4 46.9 48.1 42.4 38.3 39.8 55.0 39.4 35.9 66.2 44.8 87.9 49.3 40.8 47.4 64.7 49.8 43.2 72.5 49.5 60.6 68.9 36.6 75.3 42.0 82.0 25.2 50.4 50.8 76.5 45.0 69.2 32.2 64.9 73.4 83.5 38.9 37.0 50.4 110.1 51.2 42.3 56.7 35.6 61.3 46.0 48.8 71.3 113.3 81.2 53.7 115.8 110.5 79.2 59.7 43.2 65.5 WDR82 "MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A" ENSG00000164091 "WD repeat domain 82" Q6UXN9 3 52254434-52288020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 185.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040427 Supported "Nucleoli rim" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli rim" "HPA040427: AB_2676979" "unprognostic (7.43e-2)" "unprognostic (3.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.15e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (2.92e-3)" "unprognostic (9.32e-2)" "unprognostic (2.04e-1)" "unprognostic (8.54e-2)" "unprognostic (1.26e-1)" 40.3 37.8 36.5 46.8 37.0 55.6 33.9 38.1 36.5 48.6 35.9 37.5 33.8 56.2 30.1 46.7 43.8 35.3 48.0 37.9 40.2 28.7 32.6 36.0 57.8 31.4 34.1 54.6 28.1 35.4 22.0 43.3 33.4 41.2 39.1 35.5 31.2 48.7 65.5 37.0 33.6 52.2 34.3 49.1 31.4 33.3 42.7 73.1 40.4 67.0 60.8 47.4 36.1 34.6 46.0 54.3 100.4 75.5 93.7 77.3 50.3 76.6 63.3 74.0 61.1 63.9 44.9 121.4 29.2 82.4 64.8 40.7 139.3 82.2 86.2 88.5 53.3 155.9 67.3 65.8 64.9 148.2 78.6 78.1 79.6 87.3 79.3 68.8 79.0 97.7 70.8 84.8 72.4 46.3 115.6 58.1 91.1 60.0 104.2 58.7 67.0 90.8 77.2 83.1 23.9 100.3 82.1 24.5 47.8 67.4 46.4 58.8 81.6 69.0 78.2 72.9 89.3 82.3 129.1 120.6 59.0 110.6 77.3 9.4 7.4 10.1 15.3 7.5 18.5 8.8 13.9 15.0 6.5 7.0 15.8 16.2 14.2 8.9 12.0 6.1 12.9 9.8 36.5 37.0 38.1 36.5 37.9 40.2 31.4 34.1 33.4 34.3 42.7 34.6 45.9 28.9 42.8 12.1 43.0 51.5 33.9 23.5 34.1 54.6 40.7 41.4 53.1 32.9 26.3 14.7 20.9 28.8 66.2 45.4 13.7 17.4 45.3 62.6 71.0 42.7 44.3 41.2 20.4 18.9 31.2 38.3 31.1 91.5 15.2 51.0 40.0 42.9 32.5 62.2 22.0 35.2 12.2 61.9 40.2 185.1 58.4 43.2 37.4 21.5 50.2 36.5 63.8 15.1 18.1 30.4 30.8 62.8 33.4 40.8 26.0 21.7 21.4 35.0 52.6 53.3 36.6 21.5 30.7 41.5 56.8 30.8 62.5 42.9 40.5 40.3 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 58: T-cells - T-cell receptor" "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favorable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 4.9 5.8 4.4 7.6 4.9 3.0 8.1 7.0 5.9 6.8 3.3 6.1 5.1 6.9 6.8 5.3 6.4 4.8 4.4 4.5 4.6 8.8 8.8 5.4 11.2 4.5 4.4 8.2 5.9 7.4 3.0 6.6 4.2 5.8 6.8 11.4 4.1 4.5 5.8 6.1 4.0 5.3 3.9 8.6 5.4 5.3 5.1 10.1 9.2 7.3 10.3 6.6 4.4 5.7 35.4 16.2 18.2 10.2 10.7 11.2 27.2 14.0 7.6 14.4 16.2 11.6 17.0 33.7 11.4 4.2 9.7 16.7 22.8 13.2 24.3 21.8 13.1 22.7 10.5 14.4 13.8 29.9 15.5 10.1 17.1 16.0 22.7 8.1 12.8 24.0 19.7 17.8 10.5 19.5 24.0 17.3 17.5 23.9 29.2 18.2 18.3 19.2 15.5 14.6 16.5 12.4 15.0 16.8 11.1 18.1 19.2 16.0 9.2 16.8 16.4 11.0 16.6 10.4 8.8 20.9 7.2 20.9 11.9 0.1 2.8 0.5 8.4 2.7 10.5 8.0 8.8 7.8 4.8 7.3 14.3 12.4 0.6 9.4 4.6 3.1 10.1 5.3 4.4 4.9 7.0 5.9 4.5 4.6 4.5 4.4 4.2 3.9 5.1 5.7 5.6 9.6 6.7 4.9 14.5 9.7 13.9 4.6 8.0 6.7 6.3 5.3 4.8 8.6 7.0 5.5 4.2 9.9 7.0 3.8 13.7 6.8 2.8 3.4 7.7 7.0 3.6 11.6 11.3 5.5 13.6 6.5 2.6 4.1 1.3 7.5 5.3 8.0 6.3 1.7 13.2 5.1 4.1 6.3 4.2 4.6 4.4 5.1 3.6 6.5 5.6 7.0 8.2 8.5 14.5 3.6 2.4 6.4 6.1 11.2 2.7 7.9 3.1 9.3 13.1 6.9 4.9 6.1 11.6 6.3 10.9 7.0 11.2 8.7 5.5 7.3 WRN "RECQ3, RECQL2" ENSG00000165392 "WRN RecQ like helicase" Q14191 8 31033788-31176138 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 74.7;Early spermatids: 116.3;Oligodendrocytes: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028661 Approved Supported "Nuclear speckles" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear speckles" "HPA028661: AB_10602255" "unprognostic (8.73e-2)" "unprognostic (9.33e-2)" "unprognostic (1.51e-3)" "unprognostic (3.85e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-2)" "unprognostic (2.21e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (1.16e-2)" "unprognostic (1.27e-2)" "unprognostic (6.63e-2)" "unprognostic (1.53e-2)" "unprognostic (6.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.00e-2)" "unprognostic (2.66e-1)" 3.0 3.6 1.7 3.2 1.7 8.2 4.8 4.1 2.4 3.0 2.6 3.5 1.5 6.4 3.2 2.7 2.9 2.4 1.7 1.6 1.7 2.1 2.5 2.4 2.5 1.8 2.1 5.2 2.6 2.0 2.1 3.6 1.8 3.5 2.9 4.4 3.5 2.6 2.1 4.1 2.5 4.2 1.2 3.1 2.3 3.0 1.9 3.2 3.2 2.2 3.0 2.6 2.3 3.1 4.4 5.9 10.8 5.3 6.7 9.8 5.0 4.7 4.9 6.4 6.6 2.7 1.5 10.0 4.6 4.3 4.4 2.4 6.4 3.8 9.7 3.3 4.3 9.6 4.9 4.4 5.4 8.7 4.3 7.1 3.7 3.6 6.2 3.9 7.7 6.1 14.5 5.0 6.8 2.0 17.5 6.6 7.7 5.1 3.2 7.5 7.5 6.7 2.9 4.4 3.3 5.2 6.9 2.7 3.8 4.9 2.9 5.3 9.1 6.2 3.8 3.1 4.9 1.4 3.0 14.6 5.5 3.8 4.2 0.8 0.2 0.3 0.3 0.1 0.4 0.5 0.5 0.3 0.2 0.5 0.3 0.4 0.3 1.1 0.1 0.1 0.3 0.1 1.7 1.7 4.1 2.4 1.6 1.7 1.8 2.1 1.8 1.2 1.9 3.1 17.5 9.6 10.6 74.7 15.1 13.5 11.7 5.3 18.8 14.5 14.7 10.5 7.5 15.7 8.8 16.5 22.9 7.1 18.0 5.3 1.9 6.7 116.3 15.8 32.3 12.5 2.4 49.2 59.7 9.8 5.7 15.2 21.9 17.1 2.5 18.5 7.1 9.7 5.3 15.2 54.9 13.8 8.2 5.3 6.6 12.8 19.0 7.8 10.6 51.5 6.9 14.3 4.1 61.3 88.6 9.1 4.2 14.3 16.6 15.3 3.9 2.7 10.0 19.8 6.6 20.2 15.3 10.9 19.2 10.1 10.2 5.6 13.0 15.2 7.7 11.0 XPO1 "CRM-1, CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61476032-61538741 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA 410000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: AB_2678229" "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 33.2 29.8 30.1 48.7 31.4 25.8 39.2 35.7 44.3 37.9 31.6 34.9 24.7 52.5 37.0 35.1 45.9 32.0 36.0 27.9 33.7 30.8 41.7 31.9 65.3 28.9 30.5 58.9 26.2 38.5 22.0 52.1 30.4 34.2 42.0 52.0 19.9 34.9 37.5 34.2 33.2 48.6 30.9 43.4 31.9 54.5 32.8 73.6 38.8 47.2 60.9 38.6 22.4 38.9 169.1 152.9 194.1 135.8 91.4 107.9 145.5 166.6 109.2 192.9 151.8 217.3 114.7 256.0 117.4 127.1 186.3 125.0 307.9 126.5 268.6 151.6 110.7 242.8 136.2 148.4 55.4 234.6 145.4 62.9 103.8 149.4 145.9 126.0 149.5 108.7 285.5 127.7 164.9 97.8 212.6 100.4 213.1 189.9 111.5 175.6 208.0 148.1 103.0 124.9 152.8 77.5 174.2 142.8 87.1 185.6 108.6 110.8 98.9 153.7 178.7 137.2 175.0 102.8 203.2 347.0 96.8 214.0 151.0 3.3 1.4 2.2 1.8 2.2 1.9 1.1 1.0 1.8 2.1 0.7 1.0 1.0 0.6 2.7 1.2 1.6 1.2 1.2 30.1 31.4 35.7 44.3 27.9 33.7 28.9 30.5 30.4 30.9 32.8 38.9 42.0 41.7 43.2 114.3 55.3 52.1 32.1 45.5 78.6 67.5 40.2 38.6 64.5 38.6 38.7 31.3 95.9 54.1 56.6 27.3 13.7 29.7 4.2 58.6 79.7 47.7 45.1 73.2 87.9 26.1 49.3 49.9 42.3 68.6 41.8 100.4 41.4 55.8 57.2 72.3 101.3 34.2 40.7 55.3 58.4 11.9 33.5 63.9 37.4 68.4 64.2 33.4 61.8 83.4 102.5 32.3 20.9 30.9 57.2 55.6 21.0 22.2 56.9 101.7 19.7 50.5 55.7 65.9 91.6 83.3 56.8 30.1 54.5 54.4 46.2 47.7 XPO7 "KIAA0745, RANBP16" ENSG00000130227 "Exportin 7" Q9UIA9 8 21919662-22006585 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043727, HPA048153" Uncertain NA NA 53000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" "HPA043727: AB_2678638, HPA048153: AB_2680289" "unprognostic (6.30e-2)" "unprognostic (1.95e-2)" "prognostic favorable (2.29e-4)" "unprognostic (6.61e-3)" "unprognostic (1.81e-1)" "unprognostic (1.33e-2)" "unprognostic (1.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.18e-1)" "unprognostic (6.81e-3)" "unprognostic (9.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.76e-2)" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" 20.0 21.8 25.1 21.9 27.2 61.9 26.6 24.5 25.7 26.5 24.7 24.7 15.9 30.7 28.5 26.5 30.5 20.3 31.3 27.9 23.2 40.3 19.2 22.5 26.8 19.7 20.7 39.7 21.7 43.4 19.9 31.8 20.3 21.3 28.3 45.0 20.6 24.7 33.2 28.0 17.7 28.6 22.4 23.2 23.6 41.0 24.3 33.4 35.5 40.5 31.2 23.9 21.6 28.4 47.8 83.2 60.7 43.9 49.9 43.3 47.9 46.2 54.3 67.2 60.4 63.6 29.1 78.0 51.5 57.6 61.0 45.5 87.9 66.2 117.8 23.7 44.7 87.5 67.9 46.9 34.0 42.3 63.9 34.0 45.9 67.1 64.0 48.8 65.5 69.1 106.0 61.0 49.9 36.8 105.6 39.4 78.3 81.2 33.0 60.5 78.3 40.9 44.3 98.0 36.7 57.9 43.8 45.3 46.4 61.2 41.2 34.7 42.9 35.0 44.5 50.3 47.0 21.4 25.9 83.0 53.5 50.9 63.1 6.4 3.4 2.6 5.1 4.6 4.3 4.5 4.5 3.9 5.1 3.2 3.4 4.3 1.6 3.4 4.3 1.8 4.9 3.9 25.1 27.2 24.5 25.7 27.9 23.2 19.7 20.7 20.3 22.4 24.3 28.4 14.8 22.4 11.4 37.5 14.6 14.3 6.3 9.0 10.2 31.8 11.8 10.7 38.1 15.7 13.5 18.4 14.6 11.5 12.0 11.2 3.9 10.3 70.5 12.0 12.0 12.4 20.9 169.5 65.8 11.2 13.4 13.1 19.9 11.3 7.6 32.1 13.6 14.1 14.4 50.5 68.8 12.0 8.2 23.9 11.3 39.7 15.5 16.8 10.6 37.5 17.3 15.3 11.3 70.4 70.9 10.7 6.5 17.7 15.7 10.3 7.8 15.3 9.8 23.5 13.1 14.9 13.2 21.6 21.4 16.0 12.1 5.6 9.4 13.2 12.8 8.5 XRCC1 RCC ENSG00000073050 "X-ray repair cross complementing 1" P18887 19 43543311-43580473 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005427, HPA006717" Supported Enhanced Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "CAB005427: AB_2215661, HPA006717: AB_1858896" "unprognostic (1.10e-2)" "unprognostic (3.51e-3)" "unprognostic (4.59e-1)" "unprognostic (2.81e-2)" "unprognostic (4.08e-1)" "unprognostic (2.68e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.07e-2)" "unprognostic (3.12e-1)" "unprognostic (7.51e-2)" "unprognostic (3.00e-2)" "unprognostic (9.54e-2)" "unprognostic (1.07e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-3)" "unprognostic (2.20e-2)" "unprognostic (5.69e-2)" 18.5 16.4 15.3 18.0 15.6 24.4 17.9 18.5 17.1 23.6 13.5 20.4 14.6 23.5 16.2 16.1 23.2 14.4 15.5 14.6 15.6 15.7 10.8 16.2 22.9 15.7 15.2 32.0 19.6 17.6 32.3 16.6 14.0 16.2 11.4 16.7 16.3 15.6 19.5 21.0 15.7 17.3 13.5 20.1 18.5 23.9 16.6 29.0 20.6 15.7 20.9 18.6 18.0 15.6 57.4 51.4 54.4 48.2 23.6 24.6 27.0 28.4 36.0 42.5 46.3 32.0 40.4 44.1 39.1 28.9 39.1 30.0 33.2 36.8 24.7 46.4 33.9 57.5 49.4 36.1 23.2 34.5 42.9 27.3 24.8 53.5 26.4 48.8 37.2 49.1 35.9 42.5 37.3 48.9 57.5 52.5 18.5 44.2 21.3 57.0 35.4 25.8 34.3 44.1 44.5 26.5 41.6 35.3 20.7 26.8 33.9 67.4 23.3 55.7 40.4 16.3 39.9 44.2 44.2 32.0 42.8 28.0 58.7 18.6 13.1 15.6 10.8 11.9 12.3 11.7 13.8 14.6 11.6 10.5 11.3 10.9 15.1 10.4 7.9 9.1 14.5 11.7 15.3 15.6 18.5 17.1 14.6 15.6 15.7 15.2 14.0 13.5 16.6 15.6 10.2 16.0 9.8 5.9 13.4 6.1 7.1 17.5 12.5 12.6 10.2 9.0 7.6 7.2 14.7 7.3 6.2 29.8 12.5 9.1 19.6 15.4 32.2 18.7 13.3 12.2 13.7 15.4 8.2 11.6 19.2 13.3 8.2 13.7 19.7 22.0 11.4 7.1 21.0 5.0 9.2 15.3 10.2 18.0 10.1 19.5 10.2 12.6 14.2 3.7 14.3 8.6 8.2 4.5 8.1 12.2 9.7 12.8 17.7 4.1 9.2 16.9 39.0 12.7 6.6 9.6 17.7 21.4 14.1 10.8 7.1 20.0 14.6 16.4 13.7 4.7 XRCC5 "KARP-1, KU80, Ku86, KUB2" ENSG00000079246 "X-ray repair cross complementing 5" P13010 2 216107464-216206303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004468, HPA025813, HPA064685" Supported Enhanced Nucleoplasm NA NA 940000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322" "unprognostic (4.23e-2)" "unprognostic (1.75e-1)" "unprognostic (9.07e-3)" "unprognostic (3.44e-3)" "unprognostic (2.44e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.10e-7)" "unprognostic (4.42e-3)" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (3.38e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-1)" "unprognostic (2.88e-2)" "unprognostic (3.58e-2)" "unprognostic (6.01e-2)" 79.6 74.0 52.8 102.4 58.4 112.0 114.6 56.0 69.9 96.4 38.1 91.0 82.2 103.3 85.3 96.8 95.8 83.2 77.1 58.1 56.4 100.2 140.6 76.6 127.8 52.4 50.7 104.0 71.7 118.4 61.4 87.1 54.4 84.7 106.6 102.0 71.6 91.3 103.1 91.6 82.3 100.1 59.1 83.9 77.0 69.5 51.0 176.8 129.2 92.7 140.9 131.7 72.7 65.6 234.4 194.9 427.0 230.5 185.5 210.9 256.6 269.9 279.2 307.1 328.5 421.0 225.7 225.6 214.8 239.1 269.2 203.5 425.2 329.5 469.7 215.0 291.0 488.5 282.9 398.0 229.2 437.1 230.0 193.5 172.1 361.2 156.6 218.4 368.0 272.1 314.4 199.7 405.9 225.9 496.7 221.7 498.0 236.0 170.6 429.8 376.7 186.5 331.9 262.6 372.6 314.6 217.8 159.9 201.1 428.5 196.7 325.8 264.2 287.3 241.5 190.6 312.3 240.0 311.4 493.6 223.4 339.5 290.0 253.2 172.7 175.0 153.6 177.1 165.3 121.2 148.1 157.0 168.0 121.6 147.6 149.1 192.7 172.9 217.4 102.1 167.5 330.4 52.8 58.4 56.0 69.9 58.1 56.4 52.4 50.7 54.4 59.1 51.0 65.6 129.0 105.8 126.3 65.6 131.0 113.7 174.0 242.4 90.5 136.7 93.6 87.1 163.0 105.8 190.0 101.2 45.9 210.5 141.6 79.8 97.8 304.3 103.0 147.4 175.4 142.4 133.3 159.4 73.9 235.8 238.8 134.1 74.5 159.1 146.7 140.2 82.8 222.5 157.3 89.2 82.4 90.7 173.0 100.5 85.3 30.0 101.5 130.7 69.4 108.7 310.9 142.0 138.0 93.0 111.4 247.9 70.3 129.4 132.5 137.4 82.8 139.9 160.1 114.0 111.7 142.9 161.3 252.2 179.2 114.7 120.3 165.5 149.7 165.3 112.0 161.2 XRN1 SEP1 ENSG00000114127 "5'-3' exoribonuclease 1" Q8IZH2 3 142306607-142448062 "Predicted intracellular proteins" "DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 119.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035005, HPA035006" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA035005: AB_10670695, HPA035006: AB_10672750" "unprognostic (3.52e-1)" "unprognostic (2.35e-2)" "unprognostic (2.49e-1)" "unprognostic (1.35e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-2)" "unprognostic (6.32e-2)" 9.0 6.8 2.9 12.2 4.5 21.2 10.7 11.4 5.5 8.4 6.4 8.2 11.0 9.8 7.8 7.0 6.2 8.0 5.5 3.2 4.0 6.8 16.2 8.6 13.1 3.8 3.2 10.1 8.1 8.8 6.0 10.5 4.2 8.8 9.4 14.6 7.4 6.1 11.7 9.4 12.4 6.6 4.5 12.8 9.0 9.3 3.9 14.4 8.7 9.7 11.3 7.7 8.2 6.8 22.1 3.9 9.6 8.6 11.1 17.0 5.9 9.9 12.9 12.3 15.2 3.6 6.1 8.9 10.3 13.3 10.0 8.6 8.6 5.2 19.2 21.4 6.5 12.7 7.3 3.5 9.6 12.8 12.7 14.0 6.1 8.8 11.7 12.1 11.4 9.7 8.0 20.4 11.7 4.5 11.2 7.6 3.0 3.4 4.4 9.0 119.2 11.4 6.5 10.8 5.7 7.3 17.3 10.4 8.2 5.9 11.9 10.8 16.0 9.0 4.7 10.3 8.7 29.1 14.2 13.7 8.4 7.2 7.9 31.0 5.8 17.2 10.0 5.4 7.1 9.8 7.7 9.1 2.9 7.2 10.1 7.0 21.2 5.9 5.0 8.0 6.2 3.1 2.9 4.5 11.4 5.5 3.2 4.0 3.8 3.2 4.2 4.5 3.9 6.8 66.1 54.5 33.3 74.7 55.9 25.6 33.7 22.7 33.6 33.7 27.2 21.0 26.5 18.6 30.2 46.0 50.1 22.9 80.8 46.5 11.7 16.5 49.9 31.9 50.7 40.6 28.2 43.6 101.6 12.5 7.8 41.8 48.4 29.0 21.5 33.7 33.9 48.0 16.3 26.9 114.2 22.5 14.2 28.9 23.0 19.1 24.8 38.8 14.2 81.5 41.4 21.0 50.4 126.7 120.4 18.6 41.9 29.0 111.7 44.0 43.4 13.2 34.2 53.9 6.6 56.0 39.9 61.8 20.5 27.6 28.3 53.5 69.8 37.1 15.0 43.8 XRN2 ENSG00000088930 "5'-3' exoribonuclease 2" Q9H0D6 20 21303331-21389825 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047118, HPA050485" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA047118: AB_2679941, HPA050485: AB_2681141" "unprognostic (9.38e-2)" "unprognostic (4.70e-2)" "unprognostic (2.07e-2)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.54e-5)" "unprognostic (7.26e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.99e-3)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (1.63e-2)" "unprognostic (1.31e-1)" 36.1 36.1 14.7 42.6 17.2 73.3 42.9 18.5 15.8 33.4 21.1 29.9 24.3 37.0 31.3 25.9 33.2 35.8 24.8 13.6 16.5 34.8 42.7 34.4 43.2 16.5 15.5 36.7 32.8 45.2 18.7 37.4 17.0 28.4 32.4 24.8 27.0 33.6 38.2 24.3 24.8 39.4 16.1 36.1 24.9 29.9 16.1 46.8 41.2 26.5 45.8 46.5 23.1 18.3 91.9 106.7 115.1 88.7 84.1 102.7 113.7 82.3 107.1 107.2 124.1 71.8 102.2 89.7 47.8 86.8 146.1 106.0 131.0 138.7 136.6 40.8 66.0 116.0 37.7 136.5 73.9 105.7 96.8 98.0 68.7 118.5 103.1 95.3 93.6 84.5 94.9 74.7 101.0 71.7 156.5 69.6 89.8 88.8 71.1 113.1 195.4 76.9 91.0 95.6 88.9 115.2 96.0 116.6 89.9 88.6 65.5 123.9 87.0 107.0 79.8 24.8 105.4 65.3 90.0 95.0 41.5 48.5 82.5 36.0 68.6 49.2 34.6 54.8 46.4 30.5 37.7 38.1 61.1 30.9 39.8 38.7 69.2 43.9 71.8 26.2 49.2 54.3 14.7 17.2 18.5 15.8 13.6 16.5 16.5 15.5 17.0 16.1 16.1 18.3 118.6 60.9 112.2 29.7 72.4 63.6 90.8 81.2 64.9 44.9 85.0 75.2 58.7 52.9 94.4 40.5 41.7 106.2 99.1 36.6 27.4 123.8 157.6 119.5 128.5 99.9 59.5 62.6 45.7 120.9 96.8 80.1 39.8 113.7 83.5 92.0 41.0 70.4 105.4 50.5 48.9 52.6 67.1 129.6 57.9 26.8 57.8 111.2 60.5 49.6 165.9 55.1 85.5 46.8 67.6 96.1 53.7 55.7 77.1 91.6 45.1 80.6 102.7 49.7 59.2 120.1 108.1 104.1 116.6 65.6 67.2 105.2 83.5 99.4 68.1 89.7 YEATS2 "FLJ10201, FLJ12841, FLJ13308, KIAA1197" ENSG00000163872 "YEATS domain containing 2" Q9ULM3 3 183697797-183812624 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 95.6;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 71.9;Oligodendrocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045891 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA045891: AB_10961271" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (3.40e-3)" "unprognostic (1.14e-1)" "unprognostic (7.49e-2)" "prognostic unfavorable (4.82e-6)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-1)" "unprognostic (8.33e-3)" "unprognostic (1.65e-3)" "prognostic unfavorable (6.90e-9)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (2.08e-2)" 7.4 4.8 5.4 8.9 7.4 14.5 7.9 8.1 8.8 8.5 0.0 9.1 5.4 9.0 4.7 8.2 10.3 6.5 6.6 6.4 5.2 6.1 3.4 10.0 12.9 2.4 3.7 15.1 5.4 9.9 8.6 11.2 3.0 8.2 6.8 15.6 8.0 7.3 5.5 8.5 7.0 11.9 1.9 8.9 5.8 8.0 4.2 16.9 9.7 4.8 11.8 8.7 8.4 7.0 38.1 11.3 32.4 14.5 15.5 22.8 35.8 22.1 17.0 32.1 37.5 27.8 13.3 34.7 39.8 19.5 49.9 23.9 31.8 21.2 32.7 28.5 18.8 35.0 12.2 13.7 23.9 26.3 19.4 15.6 16.3 23.1 27.8 32.1 33.1 35.2 14.0 28.3 24.5 10.2 38.3 20.2 29.3 13.8 22.0 53.5 30.5 42.0 12.9 16.6 31.3 22.3 16.4 55.4 29.2 27.1 27.5 17.8 28.2 29.5 21.3 15.1 25.0 26.9 22.6 57.6 22.9 25.8 21.3 0.1 4.6 1.2 1.9 2.0 1.3 1.9 1.7 1.4 1.6 1.3 1.3 1.5 8.5 1.3 7.1 2.1 0.7 1.8 5.4 7.4 8.1 8.8 6.4 5.2 2.4 3.7 3.0 1.9 4.2 7.0 13.8 35.3 2.3 41.4 7.0 2.0 3.3 7.0 8.6 19.5 5.6 7.5 10.1 5.7 5.9 5.5 10.4 4.8 7.4 4.4 0.0 5.7 2.4 10.5 18.3 15.3 8.5 6.3 95.6 4.0 9.7 9.2 7.1 9.8 7.0 42.1 7.5 3.0 7.1 13.5 62.1 6.0 6.1 8.7 6.7 3.3 9.9 10.1 1.8 40.3 6.6 5.8 5.2 71.9 80.0 7.1 3.1 9.4 9.5 5.3 4.7 1.0 11.2 15.8 0.0 10.1 10.4 3.1 12.3 8.7 3.4 2.1 8.8 9.7 4.8 2.8 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: AB_2680408, HPA050994: AB_2681300" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favorable (3.87e-4)" 26.4 22.0 16.9 36.6 22.5 34.1 32.7 35.3 20.0 39.4 23.3 33.1 25.6 45.6 35.7 26.4 38.5 25.8 32.5 16.8 18.0 33.1 15.7 31.5 57.1 20.1 18.5 45.1 28.8 35.0 30.5 27.9 21.1 36.3 29.9 50.8 29.6 21.9 33.3 51.4 36.5 28.9 19.5 42.9 28.5 21.3 18.7 49.7 40.1 29.1 45.4 30.7 31.7 32.7 46.8 36.7 63.1 41.2 33.8 52.0 32.7 37.4 38.2 24.8 24.5 27.0 99.6 50.7 27.5 28.0 34.5 56.8 39.8 39.3 33.1 49.8 35.5 13.4 89.3 15.6 27.5 42.3 17.1 36.0 55.3 18.8 41.0 44.3 31.0 25.3 35.0 56.0 36.0 23.6 41.9 46.2 34.1 33.3 47.8 62.8 34.3 27.4 29.2 64.6 30.9 54.4 38.4 49.1 30.6 35.3 46.8 23.1 31.1 53.2 38.4 35.9 26.6 27.9 36.8 39.8 46.0 29.5 41.2 1.1 8.7 8.0 11.0 9.6 14.3 20.6 13.1 14.1 12.2 21.2 17.0 17.2 7.3 17.8 11.6 15.8 12.3 8.5 16.9 22.5 35.3 20.0 16.8 18.0 20.1 18.5 21.1 19.5 18.7 32.7 17.1 57.7 33.0 32.0 44.6 34.7 46.1 25.0 34.7 32.8 15.9 11.8 38.8 20.0 39.4 22.0 29.2 17.1 13.6 12.3 23.5 22.2 6.9 13.9 29.4 22.7 27.6 8.8 18.1 16.2 8.5 27.3 15.3 14.0 8.8 25.8 20.7 6.2 12.1 28.6 22.3 15.6 26.4 15.7 19.8 7.9 27.4 19.3 16.0 16.9 18.1 21.6 14.4 25.6 40.9 18.3 13.1 27.4 26.6 25.3 12.5 14.5 42.7 35.8 19.7 41.2 25.2 43.4 22.2 25.9 35.7 12.4 22.6 18.7 16.7 28.5 ZBTB10 "FLJ12752, RINZF" ENSG00000205189 "Zinc finger and BTB domain containing 10" Q96DT7 8 80485619-80526265 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021554, HPA050569" Enhanced Enhanced Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA021554: AB_1858937, HPA050569: AB_2681179" "unprognostic (7.97e-2)" "unprognostic (3.53e-1)" "unprognostic (2.26e-1)" "unprognostic (6.67e-2)" "unprognostic (9.28e-2)" "unprognostic (8.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (4.86e-1)" "unprognostic (3.66e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.65e-3)" "unprognostic (2.40e-1)" "unprognostic (7.15e-2)" "unprognostic (2.63e-2)" 7.9 7.9 4.1 4.8 5.2 23.7 8.2 12.1 4.4 8.7 3.9 6.9 2.0 11.2 6.1 3.7 11.8 7.4 7.5 3.3 5.1 10.2 18.5 6.2 5.3 4.9 4.4 12.7 14.0 7.1 3.5 17.8 5.0 14.1 7.8 7.3 7.6 6.3 5.4 1.9 2.2 8.9 4.3 7.0 4.6 11.2 4.7 8.6 10.1 8.0 3.4 5.5 3.3 5.7 0.0 4.2 21.1 10.7 9.1 6.9 28.5 3.9 0.0 3.0 3.0 9.2 3.4 12.7 11.0 5.8 9.2 0.9 16.7 5.3 3.5 0.0 26.8 6.5 2.8 7.3 5.3 2.2 2.9 6.5 4.6 3.7 10.6 2.5 7.7 10.5 5.9 24.2 2.5 6.7 12.6 5.5 5.3 1.3 6.6 14.7 11.1 4.5 8.4 12.5 12.6 14.6 5.2 48.5 14.8 23.6 9.4 9.1 9.9 7.3 13.5 0.1 3.6 7.0 3.7 14.0 2.8 0.0 9.1 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.0 0.5 0.2 0.9 0.0 0.0 4.1 5.2 12.1 4.4 3.3 5.1 4.9 4.4 5.0 4.3 4.7 5.7 37.1 25.6 17.0 18.9 55.3 28.4 21.1 8.1 44.3 13.4 48.8 39.8 36.1 25.8 11.8 12.9 16.7 38.3 34.1 38.9 3.9 13.1 83.7 82.4 60.6 34.5 60.4 3.0 12.8 6.9 41.0 29.3 40.8 142.6 9.5 37.0 16.8 31.7 13.3 32.0 11.1 43.0 20.3 21.3 79.6 29.7 19.3 32.0 49.8 13.1 11.2 20.8 8.2 19.6 13.4 8.3 14.8 21.1 24.5 82.1 0.4 14.5 19.4 10.6 26.3 46.6 49.5 14.6 10.6 13.6 12.6 105.2 28.4 19.6 34.7 19.6 ZBTB14 "ZFP161, ZNF478" ENSG00000198081 "Zinc finger and BTB domain containing 14" O43829 18 5289019-5297053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050758, HPA070819" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol No No "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nucleoli, Cytosol" "HPA050758: AB_2681226, HPA070819: AB_2686316" "unprognostic (5.28e-2)" "unprognostic (4.37e-2)" "unprognostic (4.25e-2)" "unprognostic (2.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-2)" "unprognostic (8.64e-2)" "unprognostic (1.19e-3)" "unprognostic (4.72e-3)" "unprognostic (3.25e-2)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "unprognostic (2.03e-1)" "unprognostic (2.53e-1)" "unprognostic (3.73e-1)" "unprognostic (2.90e-2)" 10.3 8.6 9.3 14.7 10.5 9.6 12.5 11.4 12.2 9.6 7.4 10.4 8.7 9.9 16.4 12.4 10.6 12.0 8.6 8.7 9.6 11.2 13.4 11.1 24.7 9.5 10.3 15.6 14.4 12.0 4.8 9.1 9.6 9.8 10.0 7.3 12.2 12.1 8.5 14.0 9.3 8.7 10.2 16.2 11.9 5.9 9.5 21.8 15.5 8.4 21.8 9.6 5.2 11.4 9.0 11.8 15.1 11.2 11.0 14.5 10.0 8.8 13.0 12.0 10.5 11.3 11.5 31.2 7.6 10.7 13.9 8.2 11.2 13.2 12.2 6.0 6.0 12.4 11.1 10.5 7.8 15.8 14.4 11.6 10.9 8.5 7.9 13.0 19.2 22.3 8.1 10.1 12.4 9.9 23.8 10.5 13.4 11.1 6.0 14.0 9.7 9.2 10.0 10.8 13.3 13.0 13.4 8.8 14.3 15.0 10.5 17.9 10.7 15.6 12.8 12.2 13.3 6.4 6.9 19.9 16.4 13.3 14.0 9.8 5.5 14.1 8.7 7.8 8.6 7.5 11.0 10.0 8.2 10.4 11.6 11.1 1.2 7.6 7.5 6.1 7.6 7.3 9.3 10.5 11.4 12.2 8.7 9.6 9.5 10.3 9.6 10.2 9.5 11.4 8.8 6.4 6.7 5.9 8.5 2.4 1.6 2.9 5.2 7.4 5.6 4.3 3.6 1.5 2.2 5.5 0.0 5.3 6.3 5.5 5.9 4.9 0.8 4.3 5.5 7.4 1.2 9.1 2.9 3.3 5.5 4.6 0.5 3.7 15.9 6.0 11.7 6.9 7.1 5.0 3.1 5.1 8.2 7.5 4.5 2.8 5.9 6.3 1.8 1.0 7.8 10.8 6.2 2.5 6.6 3.5 4.0 5.7 2.2 2.4 5.7 5.5 2.5 5.9 0.0 6.0 5.7 1.0 9.3 4.2 3.0 2.2 8.8 5.1 5.2 1.5 ZBTB2 "bA351K16.2, KIAA1483, ZNF437" ENSG00000181472 "Zinc finger and BTB domain containing 2" Q8N680 6 151364115-151391559 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023136, HPA023137, HPA023458, HPA023487" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945" "unprognostic (1.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.93e-1)" "unprognostic (2.42e-2)" "unprognostic (8.36e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.36e-2)" "unprognostic (2.21e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (8.27e-2)" "prognostic unfavorable (9.36e-6)" "unprognostic (1.45e-1)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (7.73e-2)" 8.4 4.8 4.8 8.5 5.1 16.1 8.5 6.0 6.3 6.9 4.5 8.0 7.5 8.5 6.9 5.9 7.7 7.9 6.0 5.2 5.1 6.9 9.4 9.7 14.4 5.4 5.3 13.3 8.3 7.1 3.0 8.7 5.4 6.1 9.0 3.2 7.1 5.9 9.1 6.9 8.2 9.4 5.0 9.3 7.4 6.7 5.2 20.8 29.7 9.7 12.6 11.0 5.4 6.6 15.3 10.9 16.3 12.4 17.1 17.9 17.4 23.6 33.9 29.2 27.7 21.1 12.2 38.9 12.8 23.9 29.5 17.8 26.5 28.7 36.1 17.7 19.7 17.5 12.6 32.2 25.3 47.9 20.8 19.0 16.9 26.8 32.6 16.6 17.4 18.1 32.5 22.2 20.8 34.2 26.1 22.3 19.8 18.8 16.4 24.6 15.4 15.6 22.2 22.7 18.1 12.6 18.6 24.2 18.8 16.3 16.3 28.4 14.4 24.5 26.8 11.3 31.8 29.4 32.9 43.2 10.1 25.7 17.8 18.7 6.5 16.8 11.3 7.1 14.2 6.3 10.2 13.5 7.1 4.5 8.4 10.4 7.3 8.9 12.9 2.9 9.2 7.1 4.8 5.1 6.0 6.3 5.2 5.1 5.4 5.3 5.4 5.0 5.2 6.6 13.3 9.6 4.6 4.6 13.2 15.7 11.4 5.8 42.7 3.0 14.4 7.4 8.8 5.7 9.1 0.0 0.0 5.9 18.0 4.6 13.7 4.8 9.4 18.7 14.2 12.7 9.0 8.2 5.6 2.9 19.6 9.9 6.6 29.5 9.5 4.9 5.7 3.3 7.5 1.7 4.4 6.3 18.3 8.8 17.4 10.5 8.7 10.8 10.6 1.0 4.4 3.1 12.3 5.5 11.1 5.0 2.0 4.1 11.1 14.8 5.8 5.3 7.1 2.3 6.6 6.2 10.8 4.1 6.7 23.8 18.3 12.4 16.3 3.7 7.3 9.6 ZBTB24 "BIF1, KIAA0441, PATZ2, ZNF450" ENSG00000112365 "Zinc finger and BTB domain containing 24" O43167 6 109462594-109483219 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017872, HPA049003" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Centrosome" Yes No "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Cytokinetic bridge, Centrosome" "HPA017872: AB_2669673, HPA049003: AB_2680596" "unprognostic (8.15e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" "unprognostic (4.80e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (4.53e-2)" "unprognostic (5.09e-2)" "unprognostic (3.31e-2)" "unprognostic (1.22e-3)" "unprognostic (1.37e-1)" "unprognostic (1.75e-3)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.60e-1)" "unprognostic (6.77e-2)" 3.1 2.2 1.5 5.4 2.4 8.9 4.6 2.4 2.4 4.0 1.0 3.5 3.6 3.1 3.2 3.0 2.9 2.5 2.2 1.6 1.9 3.9 2.6 3.9 8.7 1.5 1.2 3.4 3.5 7.4 1.8 3.2 1.6 3.5 3.8 10.1 4.4 3.3 3.2 4.7 3.7 2.8 1.3 5.5 4.1 4.3 1.6 6.9 4.9 2.9 7.3 3.5 2.7 2.9 4.7 4.8 4.3 10.8 6.8 6.9 7.0 5.3 7.3 6.5 7.4 6.7 3.6 20.0 6.7 6.7 7.8 6.0 10.9 8.3 9.8 12.4 10.7 16.2 6.5 5.1 5.0 13.3 8.0 7.0 6.7 6.6 11.4 4.6 5.5 9.3 13.8 11.0 6.8 8.0 19.2 9.0 10.7 4.7 5.3 11.9 6.1 8.3 8.0 8.0 7.3 6.4 6.8 7.1 16.9 5.9 5.0 14.5 5.4 5.3 5.3 4.4 11.5 5.3 4.4 20.2 7.0 10.4 9.0 0.1 0.6 0.9 0.7 0.6 0.4 3.4 1.5 0.9 0.7 2.8 1.9 1.1 0.4 1.3 0.8 1.1 2.9 0.5 1.5 2.4 2.4 2.4 1.6 1.9 1.5 1.2 1.6 1.3 1.6 2.9 8.4 12.8 9.1 2.6 32.8 10.1 11.2 5.3 7.4 21.7 8.6 7.4 3.8 7.2 5.2 3.7 31.3 8.5 16.8 4.5 3.9 6.6 1.4 7.3 14.3 6.6 9.6 12.0 3.3 9.1 9.9 8.6 12.8 10.7 9.5 14.1 3.6 7.3 7.7 10.1 2.8 11.0 6.1 12.5 12.1 1.8 7.2 10.3 8.8 5.6 20.5 10.0 14.4 1.0 5.4 6.4 5.1 6.4 16.8 8.2 7.4 6.4 6.0 65.2 0.0 13.2 7.4 6.2 27.8 9.3 9.7 7.8 17.8 15.0 8.5 7.3 ZBTB26 ZNF481 ENSG00000171448 "Zinc finger and BTB domain containing 26" Q9HCK0 9 122915566-122931512 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 37.3;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021444 Uncertain NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 25: Spermatids - Spermatogenesis" "HPA021444: AB_1858948" "unprognostic (5.39e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-1)" "unprognostic (1.53e-1)" "unprognostic (8.48e-2)" "unprognostic (1.46e-1)" "unprognostic (1.83e-3)" "unprognostic (5.67e-3)" "unprognostic (2.48e-2)" "unprognostic (2.75e-2)" "unprognostic (8.26e-2)" "unprognostic (7.34e-2)" "unprognostic (1.96e-2)" "unprognostic (1.47e-1)" "unprognostic (2.21e-1)" "unprognostic (6.26e-2)" "unprognostic (1.81e-2)" 3.1 3.1 3.6 4.1 4.2 5.7 6.3 4.9 5.0 6.2 3.2 6.7 3.9 8.0 4.8 3.7 5.5 3.8 3.3 3.3 4.0 4.2 2.6 3.7 5.9 3.9 3.7 9.3 4.6 7.5 4.6 5.6 3.8 6.2 5.0 11.2 4.6 6.0 4.1 3.7 5.4 6.2 3.7 5.8 4.6 9.9 3.8 5.5 7.0 4.1 5.5 5.6 4.7 5.6 3.6 3.7 13.9 6.6 4.1 7.7 5.4 4.0 4.4 4.6 4.3 7.2 5.8 7.1 3.8 4.0 10.7 13.3 6.1 3.0 6.8 7.3 4.8 9.0 12.7 5.3 5.1 8.3 8.8 5.6 8.8 3.9 5.2 8.7 5.1 11.1 8.7 11.1 4.6 6.3 8.6 6.3 5.4 11.9 4.8 7.5 12.8 8.3 4.9 4.8 10.7 9.2 7.3 4.0 5.1 6.7 9.9 3.0 4.6 6.5 6.2 5.5 3.6 8.3 13.9 7.7 4.0 3.4 7.1 1.5 0.6 0.7 0.2 1.4 0.5 0.3 0.6 0.4 0.9 0.7 0.5 0.6 0.6 1.0 0.5 0.4 0.3 0.4 3.6 4.2 4.9 5.0 3.3 4.0 3.9 3.7 3.8 3.7 3.8 5.6 2.0 3.2 1.1 5.9 3.9 0.3 2.0 2.2 4.6 4.0 3.2 2.0 2.3 1.5 2.5 1.8 0.0 2.6 4.1 1.4 5.9 1.4 37.3 1.9 2.8 2.9 6.0 5.7 8.3 0.6 0.8 2.3 1.5 1.5 4.5 5.3 3.3 1.9 1.4 3.3 9.0 1.7 2.0 2.5 1.6 57.7 2.1 1.4 0.0 2.8 2.8 2.5 2.1 8.0 12.2 1.0 2.5 6.0 2.7 2.1 1.5 1.7 4.5 3.1 6.6 1.6 3.2 14.1 5.6 3.0 0.4 2.1 2.6 2.1 2.2 1.8 ZBTB39 "KIAA0352, ZNF922" ENSG00000166860 "Zinc finger and BTB domain containing 39" O15060 12 56998836-57006546 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 16.7;Early spermatids: 19.9;Horizontal cells: 21.9;Late spermatids: 20.3;Spermatogonia: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "RH-30: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016866, HPA020306" Uncertain Approved Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Vesicles "HPA016866: AB_2669470, HPA020306: AB_2670406" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (8.92e-2)" "unprognostic (2.90e-2)" "unprognostic (3.07e-1)" "unprognostic (2.68e-2)" "unprognostic (4.10e-3)" "unprognostic (1.69e-1)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-3)" "unprognostic (1.76e-1)" "unprognostic (2.34e-1)" "unprognostic (5.74e-2)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (7.00e-2)" 2.6 1.5 1.7 2.9 2.0 5.8 2.8 2.2 2.0 2.1 0.9 2.5 2.2 3.2 2.5 2.4 3.1 1.8 2.2 1.6 1.8 2.1 3.4 2.7 3.9 1.9 2.0 4.4 2.9 3.3 1.1 3.7 1.9 2.6 2.3 2.9 2.6 3.3 2.5 2.9 2.9 2.8 1.5 4.2 2.6 7.1 2.0 4.2 2.5 2.7 3.6 2.1 1.7 2.3 3.4 5.5 15.3 7.9 3.4 3.6 10.1 3.2 4.1 5.2 3.7 5.7 2.3 10.8 4.2 3.2 3.3 4.5 11.8 5.0 5.0 5.0 8.2 12.1 3.6 4.6 3.2 9.3 9.6 2.8 4.8 4.1 6.6 5.6 6.0 12.2 15.2 9.7 3.8 3.9 13.7 7.8 15.2 3.5 4.6 13.0 46.9 5.2 2.4 6.7 7.5 9.7 4.7 6.0 4.7 14.2 5.1 10.1 4.8 4.3 9.5 2.0 4.1 12.5 8.7 11.5 2.7 5.2 2.7 0.7 0.3 0.0 0.4 0.2 0.4 0.3 0.4 0.6 0.4 0.4 0.3 0.6 0.0 0.7 0.0 0.5 0.1 0.3 1.7 2.0 2.2 2.0 1.6 1.8 1.9 2.0 1.9 1.5 2.0 2.3 2.9 0.0 0.6 3.3 3.5 1.5 2.3 1.6 7.4 11.6 1.7 1.5 3.5 2.8 1.9 0.0 16.7 3.1 3.0 0.9 0.0 1.5 19.9 1.2 3.3 4.3 1.2 2.1 1.8 1.8 1.8 2.3 1.5 1.2 1.3 3.6 8.6 2.5 1.9 21.9 1.8 2.5 2.0 3.0 2.0 20.3 1.8 1.4 1.8 0.0 3.6 1.8 3.1 1.5 2.8 2.5 3.2 5.7 3.2 3.5 1.5 1.4 3.1 7.4 6.6 3.4 2.2 10.1 17.6 3.2 1.6 2.2 2.1 1.9 2.4 1.4 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favorable (2.88e-5)" 2.3 1.8 0.8 2.2 0.7 5.1 2.4 1.0 1.6 2.4 1.1 2.1 1.6 2.2 2.4 1.8 1.9 1.9 2.3 0.8 0.8 1.8 1.9 2.4 3.0 0.9 0.7 3.7 2.9 2.1 3.1 2.0 1.2 2.8 1.6 3.4 2.2 2.2 2.9 2.2 1.9 2.3 0.4 3.5 1.7 4.0 1.0 2.0 2.9 2.1 3.0 2.4 2.1 2.3 1.4 2.2 2.7 4.6 3.6 3.7 3.2 1.6 3.2 3.6 2.8 1.9 2.6 4.9 1.7 1.9 4.4 2.3 4.8 2.8 3.7 1.6 1.9 5.7 1.5 2.8 2.8 3.5 2.0 2.4 2.3 3.3 2.1 2.0 3.6 5.2 3.0 2.6 3.4 2.2 6.9 6.7 4.7 2.0 3.0 4.1 3.6 3.1 1.4 2.4 3.3 3.2 3.7 1.4 3.7 3.6 2.0 3.3 3.6 3.2 1.4 2.0 3.7 3.1 3.3 4.3 2.3 2.9 3.2 2.9 2.0 9.8 4.6 2.1 3.8 1.6 2.6 4.5 1.5 2.4 2.9 3.4 4.6 2.8 1.8 0.3 2.6 1.5 0.8 0.7 1.0 1.6 0.8 0.8 0.9 0.7 1.2 0.4 1.0 2.3 3.1 0.0 1.1 3.9 5.3 2.5 1.9 1.8 2.2 2.9 2.2 3.4 1.9 1.5 2.1 1.8 4.2 2.0 5.8 0.8 0.0 1.9 2.7 1.2 2.7 3.1 1.2 3.6 11.5 2.6 1.5 3.1 2.0 1.3 1.3 5.4 3.9 2.2 1.8 1.7 12.5 1.8 2.0 3.1 2.4 0.7 1.5 2.7 3.6 4.7 4.5 1.7 9.2 11.6 10.0 1.1 2.9 2.2 6.6 2.1 1.8 0.9 1.3 8.2 0.0 2.2 2.1 9.7 5.5 1.7 2.6 1.5 6.3 4.6 1.6 1.2 ZBTB6 "ZID, ZNF482" ENSG00000186130 "Zinc finger and BTB domain containing 6" Q15916 9 122908056-122913323 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054111, HPA076894" Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" Nucleoplasm Mitochondria "HPA054111: AB_2682384, HPA076894: AB_2686818" "unprognostic (9.74e-3)" "unprognostic (8.40e-2)" "unprognostic (1.45e-2)" "unprognostic (7.84e-2)" "prognostic favorable (2.06e-5)" "unprognostic (1.81e-1)" "unprognostic (2.39e-3)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (6.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "prognostic favorable (5.08e-4)" "unprognostic (4.31e-2)" "unprognostic (1.53e-1)" "unprognostic (2.67e-1)" "unprognostic (1.92e-2)" 4.2 4.4 3.4 7.0 3.9 3.2 6.8 5.2 5.8 5.4 2.8 5.3 5.9 6.3 4.0 4.9 5.0 4.0 5.5 3.4 3.6 4.8 4.2 4.5 9.7 3.5 3.6 7.2 4.5 6.6 2.3 4.5 3.8 4.9 4.8 7.3 4.5 4.7 6.7 5.0 5.8 4.7 4.1 6.7 5.5 5.5 3.5 7.3 7.5 7.0 9.2 5.3 2.6 5.3 5.1 5.9 9.3 8.5 9.6 9.2 9.4 8.4 10.3 8.3 7.3 6.1 6.3 8.1 5.1 7.6 7.4 22.8 9.8 10.3 10.3 11.5 7.8 8.6 11.9 5.7 9.5 11.4 14.9 7.6 15.5 7.6 12.5 10.2 7.7 10.1 9.2 9.7 12.1 9.6 11.6 7.7 11.7 15.0 9.9 6.1 25.6 11.4 8.7 8.3 11.7 15.2 13.0 12.6 8.2 9.8 15.8 7.4 7.9 9.0 7.0 9.2 9.8 17.0 21.7 2.2 10.5 7.7 9.3 10.6 1.5 2.3 1.2 1.7 1.7 1.4 1.7 1.2 1.6 1.0 2.4 2.2 2.0 2.5 2.9 0.9 2.0 1.7 3.4 3.9 5.2 5.8 3.4 3.6 3.5 3.6 3.8 4.1 3.5 5.3 5.3 6.4 3.6 3.6 6.8 2.2 3.1 2.9 3.4 8.0 4.1 2.9 3.5 7.2 6.9 1.8 10.4 2.3 7.2 3.5 0.0 2.7 9.1 4.4 7.6 4.4 3.0 2.1 4.6 2.5 1.3 5.4 4.1 3.7 7.6 5.0 6.1 3.1 2.4 6.7 5.1 3.9 4.1 7.6 4.0 4.4 3.1 4.1 1.8 3.7 4.3 8.8 2.1 6.6 6.8 2.9 2.5 7.9 3.7 4.1 2.9 4.2 5.3 10.6 6.6 5.1 5.2 6.0 5.1 4.9 2.7 1.9 5.8 5.0 3.4 3.2 ZC3H11A "KIAA0663, ZC3HDC11A" ENSG00000058673 "Zinc finger CCCH-type containing 11A" O75152 1 203795623-203854999 "Predicted intracellular proteins" "mRNA transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA026439, HPA028490, HPA028526" Approved Approved "Nuclear speckles" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (8.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.45e-2)" "unprognostic (3.35e-1)" "unprognostic (1.51e-1)" "unprognostic (3.67e-2)" "unprognostic (2.87e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "unprognostic (2.38e-1)" "unprognostic (1.13e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-2)" "unprognostic (1.41e-1)" 14.9 15.6 8.3 20.9 12.3 28.8 15.5 11.5 11.7 14.2 13.1 14.7 20.4 18.7 12.8 16.8 16.1 15.2 13.9 8.2 9.6 16.6 16.2 14.5 26.2 9.4 8.9 18.9 15.5 19.8 5.6 17.4 10.0 16.2 17.7 20.2 19.4 13.2 23.4 26.2 22.5 16.6 5.6 23.1 20.4 22.9 9.7 33.4 22.6 23.1 25.5 16.1 6.5 15.5 29.7 23.8 45.2 28.8 28.7 22.9 49.7 33.6 24.0 27.0 30.2 32.7 36.2 37.6 19.9 35.7 22.0 41.0 35.8 19.7 37.2 56.6 25.8 36.3 39.3 16.5 15.4 50.9 62.3 19.1 23.5 29.0 28.2 34.2 25.5 40.4 74.0 51.6 24.0 24.2 56.2 20.3 42.6 20.8 19.4 40.1 52.1 24.7 19.1 50.0 33.1 31.4 33.8 27.5 29.8 51.7 29.5 38.1 39.2 39.2 34.7 33.1 32.3 36.8 37.3 58.5 25.2 29.1 30.7 15.6 3.6 5.5 5.2 3.5 7.2 5.0 4.7 4.8 4.2 3.5 5.9 4.4 7.9 5.1 5.8 2.3 5.0 4.2 8.3 12.3 11.5 11.7 8.2 9.6 9.4 8.9 10.0 5.6 9.7 15.5 2.4 12.8 22.5 105.8 49.2 101.5 61.7 50.6 112.7 46.2 1.1 0.9 54.2 58.6 38.4 0.0 45.9 31.1 18.2 43.6 0.0 0.3 54.7 3.1 2.9 49.9 46.7 67.1 71.9 0.2 27.3 51.5 53.0 3.9 25.3 0.9 54.7 70.0 32.5 84.1 69.0 64.2 28.5 54.6 60.8 14.3 60.3 37.2 48.0 82.4 31.7 40.5 41.2 103.0 169.4 0.6 42.2 67.4 64.1 104.0 52.1 0.3 43.9 49.8 78.9 83.3 42.1 63.6 40.2 84.5 111.5 51.0 41.4 0.5 52.1 114.2 ZC3H7A "FLJ20318, HSPC055, ZC3H7, ZC3HDC7" ENSG00000122299 "Zinc finger CCCH-type containing 7A" Q8IWR0 16 11750586-11797258 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040808, HPA059849" Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA040808: AB_10794150, HPA059849: AB_2684141" "unprognostic (2.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.07e-1)" "unprognostic (5.64e-2)" "unprognostic (2.07e-2)" "unprognostic (5.75e-2)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (9.16e-2)" "unprognostic (1.44e-1)" "unprognostic (2.27e-2)" "unprognostic (7.27e-3)" "unprognostic (6.00e-2)" "unprognostic (1.05e-2)" "unprognostic (1.50e-2)" "unprognostic (3.55e-2)" 22.3 17.8 12.1 21.8 13.4 38.0 21.1 18.7 12.8 19.7 26.8 19.1 17.7 22.4 18.0 12.8 18.7 18.9 19.7 11.9 12.8 22.8 21.3 23.6 29.3 13.1 12.5 26.6 26.2 23.4 14.7 26.4 13.4 24.2 19.7 30.3 30.0 25.5 32.8 15.4 18.8 22.8 12.4 23.9 18.7 10.3 13.9 28.2 25.7 21.8 27.6 18.4 15.9 16.6 33.5 16.9 58.2 31.8 40.0 39.4 23.3 52.4 52.2 38.9 47.7 18.9 28.5 46.7 32.2 62.7 25.0 21.1 33.1 50.9 56.0 36.9 37.5 20.1 35.5 31.8 56.6 46.5 42.4 44.7 27.7 36.7 68.7 45.4 49.5 41.8 33.5 40.8 57.1 26.2 35.3 23.6 34.2 23.2 15.2 51.0 32.6 33.3 36.0 25.6 44.3 35.2 42.5 40.5 52.4 34.3 29.6 30.2 47.2 45.1 27.6 61.9 35.8 32.5 26.2 68.5 33.3 34.3 118.7 16.6 12.9 20.4 14.0 17.8 19.8 15.5 18.1 15.4 12.8 16.5 21.1 15.0 16.0 22.3 32.2 10.2 24.2 9.4 12.1 13.4 18.7 12.8 11.9 12.8 13.1 12.5 13.4 12.4 13.9 16.6 39.4 64.1 36.4 36.9 46.2 15.0 15.2 9.6 27.3 29.4 21.2 23.7 44.3 17.2 29.0 14.7 54.2 14.9 40.5 16.4 15.6 18.5 3.2 30.9 48.7 32.7 20.9 22.5 29.4 22.7 15.4 31.1 27.5 33.9 18.3 31.3 32.9 18.5 14.5 53.8 35.3 25.1 18.3 36.3 26.2 5.3 32.6 39.3 19.6 30.9 40.2 25.6 22.6 65.9 32.7 22.3 16.9 35.7 45.2 18.0 20.3 16.4 29.5 52.4 19.7 42.2 37.1 17.2 9.0 18.0 15.8 7.5 40.3 28.9 18.5 16.0 ZCCHC7 "AIR1, FLJ22611" ENSG00000147905 "Zinc finger CCHC-type containing 7" Q8N3Z6 9 37120574-37358149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 225.6;Inhibitory neurons: 229.6;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 250.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 124.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020600, HPA021088, HPA029522" Uncertain Enhanced Nucleoli,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" "Nucleoli, Cytosol" "HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029" "unprognostic (1.19e-3)" "unprognostic (1.21e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (7.21e-3)" "unprognostic (2.78e-1)" "unprognostic (4.27e-3)" "unprognostic (3.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.29e-2)" "unprognostic (7.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.58e-2)" "unprognostic (8.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.04e-2)" "unprognostic (5.49e-2)" 8.3 7.4 5.8 12.7 5.5 13.7 13.2 18.7 8.8 9.3 5.1 8.2 7.9 11.6 11.3 7.5 9.6 7.9 6.4 5.3 5.4 7.4 8.1 6.5 23.2 5.6 6.2 16.6 11.2 7.1 9.4 7.9 6.6 7.0 10.9 9.9 7.8 7.1 5.9 8.2 8.2 9.5 4.4 10.6 7.7 12.1 7.4 12.9 12.3 6.0 24.8 9.5 7.5 9.2 17.2 9.4 17.5 18.4 17.4 27.0 15.5 17.4 21.3 14.0 19.2 11.8 8.6 54.8 8.1 14.0 15.9 7.2 16.6 17.1 19.9 26.3 8.8 19.1 19.3 10.7 27.3 32.5 17.5 18.6 26.3 14.2 56.7 26.0 16.0 24.4 53.3 21.8 12.7 8.2 24.9 18.2 18.3 20.3 17.3 124.7 11.0 16.2 17.6 7.1 17.5 12.9 12.6 15.3 17.1 16.9 10.2 21.4 12.7 9.9 11.8 14.1 10.3 5.0 13.2 76.4 14.9 20.8 18.7 8.4 7.6 20.6 12.9 9.0 12.8 32.6 14.9 15.0 7.2 48.9 18.6 17.3 15.3 18.4 17.2 13.2 13.4 9.3 5.8 5.5 18.7 8.8 5.3 5.4 5.6 6.2 6.6 4.4 7.4 9.2 27.7 35.3 18.5 126.3 110.3 28.3 29.5 28.2 32.5 15.5 21.7 23.7 10.7 15.7 21.7 5.5 10.4 15.3 32.8 7.7 27.4 16.3 52.2 17.6 37.6 18.7 19.1 38.5 225.6 15.8 25.4 31.0 30.1 24.2 23.5 18.0 16.4 11.6 15.2 11.8 229.6 22.5 40.7 17.9 22.8 20.8 27.1 20.3 16.0 121.8 19.8 18.2 28.8 196.1 250.0 12.8 13.6 19.5 44.7 34.9 17.7 22.5 19.1 24.9 6.6 33.9 25.4 60.1 44.8 29.3 32.7 18.6 42.2 32.4 20.3 26.0 ZFC3H1 "CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2" ENSG00000133858 "Zinc finger C3H1-type containing" O60293 12 71609599-71667725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007072, HPA007151" Enhanced Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Intermediate filaments" "HPA007072: AB_1846134, HPA007151: AB_1846133" "unprognostic (3.90e-3)" "unprognostic (3.69e-1)" "unprognostic (2.78e-1)" "unprognostic (2.15e-2)" "unprognostic (9.44e-2)" "unprognostic (6.14e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (6.56e-2)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" 9.6 12.3 4.1 10.1 5.1 18.5 8.1 8.1 6.2 9.5 5.3 10.6 6.2 8.7 10.5 10.4 9.2 7.3 7.8 4.2 6.0 7.9 5.5 12.1 14.5 4.5 4.2 11.0 8.0 7.6 8.0 8.0 4.5 8.3 8.9 13.4 8.1 8.2 7.7 9.1 11.1 6.3 2.9 10.9 10.1 12.4 5.0 13.2 9.0 5.6 12.0 9.8 9.5 6.2 16.1 15.7 12.6 8.6 14.4 26.5 7.6 12.9 18.6 17.8 17.7 15.1 9.2 21.2 7.3 15.0 7.9 19.2 15.3 7.4 23.8 20.8 13.0 21.6 27.6 7.3 8.6 22.0 10.5 15.2 14.6 13.1 6.1 25.4 18.2 17.1 19.6 9.8 17.0 5.0 15.5 8.2 11.5 7.2 9.6 14.0 13.7 15.9 13.5 12.4 8.3 8.3 13.4 8.1 8.0 12.0 21.0 14.4 16.7 12.2 7.4 6.9 6.9 17.3 10.5 15.2 12.6 15.8 7.7 60.5 20.9 27.1 15.0 10.7 12.1 21.7 13.3 10.4 9.3 29.9 13.1 11.2 60.7 11.7 20.3 27.1 11.9 3.5 4.1 5.1 8.1 6.2 4.2 6.0 4.5 4.2 4.5 2.9 5.0 6.2 33.5 35.3 25.5 37.2 50.1 47.9 85.8 20.6 46.7 32.8 28.4 17.1 18.4 7.2 30.5 14.7 22.9 14.6 60.2 35.7 1.9 20.5 97.6 33.2 46.0 35.8 20.9 24.8 56.9 16.9 14.5 40.2 52.0 66.5 48.8 32.7 23.9 12.0 17.5 58.9 58.1 32.1 18.3 17.8 47.0 65.2 32.0 49.7 10.6 55.3 39.3 14.7 37.0 62.4 68.6 28.5 36.4 23.0 54.0 45.1 32.1 8.4 22.9 33.0 26.3 39.9 37.5 51.7 30.8 79.3 40.9 11.5 44.9 29.2 28.7 93.4 ZFP62 "FLJ34231, ZET, ZNF755" ENSG00000196670 "ZFP62 zinc finger protein" Q8NB50 5 180847611-180861285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048629 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Actin filaments" "HPA048629: AB_2680467" "unprognostic (2.77e-2)" "unprognostic (1.77e-1)" "unprognostic (9.18e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (1.89e-2)" "unprognostic (9.49e-2)" "unprognostic (7.11e-3)" "unprognostic (7.29e-2)" "unprognostic (3.44e-2)" "unprognostic (1.05e-2)" "unprognostic (2.14e-1)" "unprognostic (4.34e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-2)" "unprognostic (2.29e-3)" 7.8 7.1 8.1 12.6 8.9 4.5 13.8 12.8 10.5 12.1 7.0 14.2 13.4 13.6 15.0 13.1 15.4 9.6 9.4 7.5 10.3 11.4 6.6 9.5 18.7 8.4 7.5 19.7 11.2 13.7 8.6 9.8 7.9 12.9 17.2 18.3 11.6 11.4 14.2 15.7 13.5 10.4 5.8 13.9 16.0 8.9 7.8 24.9 23.6 14.1 20.2 10.8 11.2 11.0 13.7 10.5 21.2 28.4 14.9 13.5 26.4 13.8 10.4 11.0 15.3 24.9 33.5 34.2 21.7 6.2 12.9 20.0 10.2 24.7 16.6 58.2 19.0 19.3 30.8 8.4 10.2 17.2 11.0 10.6 20.0 11.5 20.8 17.1 10.2 19.6 16.0 18.0 15.2 31.8 25.2 9.5 14.8 12.5 24.6 22.2 22.3 19.3 9.3 24.4 28.1 19.1 20.1 15.3 15.1 15.0 23.0 15.4 14.6 17.0 14.8 8.3 14.0 18.7 23.4 16.8 14.1 22.9 13.5 6.9 2.1 2.6 2.5 2.9 4.8 4.4 3.4 3.6 2.2 4.8 6.1 5.5 1.0 3.4 3.5 2.5 3.7 2.9 8.1 8.9 12.8 10.5 7.5 10.3 8.4 7.5 7.9 5.8 7.8 11.0 10.5 9.6 11.0 5.5 12.2 7.1 8.9 10.8 11.4 8.2 9.4 11.9 11.4 8.6 7.2 0.0 2.1 6.2 6.8 12.9 15.6 9.7 24.3 9.5 5.8 8.3 10.3 12.4 9.1 16.5 6.7 6.7 7.1 7.9 8.8 16.3 9.7 5.0 6.4 1.7 9.3 17.6 8.2 5.9 4.0 28.0 17.1 5.4 5.4 6.5 7.8 11.4 9.2 9.0 10.1 14.9 7.8 11.7 11.8 8.3 15.3 9.8 6.6 13.1 13.1 7.4 8.2 30.0 14.8 7.2 4.7 5.6 9.9 11.0 15.8 8.5 ZFX ZNF926 ENSG00000005889 "Zinc finger protein X-linked" P17010 X 24149173-24216255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001748, HPA003877, HPA071863" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 42: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463" "unprognostic (2.60e-1)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "unprognostic (4.64e-2)" "unprognostic (1.66e-1)" "unprognostic (2.78e-1)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.90e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-1)" "unprognostic (9.22e-3)" "unprognostic (2.39e-1)" "unprognostic (4.27e-2)" "unprognostic (1.93e-1)" "unprognostic (5.95e-2)" 13.2 6.8 9.8 8.8 13.4 29.5 10.5 21.2 10.8 12.6 8.4 9.9 6.8 15.6 9.7 7.3 12.5 6.9 8.8 7.1 12.9 8.0 10.2 8.6 11.6 10.7 13.4 17.3 9.9 15.4 6.0 13.7 9.4 14.8 6.1 10.3 7.4 11.3 15.1 8.0 8.1 14.5 9.8 12.3 8.0 4.7 12.4 17.3 10.7 12.5 10.0 9.1 11.3 14.3 13.8 17.6 19.3 20.9 23.4 16.4 9.2 12.9 11.9 13.5 14.6 11.4 9.4 15.0 17.1 19.5 31.3 17.5 19.4 23.3 18.1 15.4 26.9 14.4 63.3 6.2 9.8 18.2 24.4 14.3 7.4 27.1 34.1 15.3 17.2 9.4 16.5 16.9 9.7 6.6 14.2 12.5 10.3 6.0 13.7 18.8 15.4 13.9 8.8 21.4 9.6 14.4 37.9 14.5 11.8 11.7 9.6 10.0 18.3 12.6 7.4 18.3 8.9 9.5 13.7 15.3 9.3 7.7 14.4 9.6 6.5 10.2 6.9 7.6 7.2 5.9 6.5 7.1 7.1 9.4 6.5 6.1 11.8 6.8 7.0 4.8 4.1 5.5 9.8 13.4 21.2 10.8 7.1 12.9 10.7 13.4 9.4 9.8 12.4 14.3 35.4 19.2 12.0 38.2 37.7 22.0 18.1 14.5 19.4 19.1 29.6 17.5 16.6 30.0 19.9 7.3 20.9 56.6 60.7 21.0 5.9 14.4 2.0 29.2 48.1 26.2 20.4 16.4 32.4 16.1 13.6 29.2 16.3 30.6 27.9 39.9 24.7 26.6 17.1 15.2 33.6 16.6 4.1 24.3 26.2 5.7 35.8 31.2 30.2 47.8 28.8 15.7 22.6 49.8 52.6 14.8 17.1 35.7 34.1 21.6 14.8 11.5 15.4 22.7 32.9 47.3 36.2 18.2 27.1 15.1 20.9 20.7 34.0 29.8 14.5 20.5 ZIK1 ZNF762 ENSG00000171649 "Zinc finger protein interacting with K protein 1" Q3SY52 19 57578456-57593890 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 5.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 28.8;NTERA-2: 34.3;REH: 25.6;U-266/84: 34.8" "Low region specificity" "Detected in all" HPA059975 Uncertain Approved "Intermediate filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" "HPA059975: AB_2684184" "unprognostic (2.14e-2)" "unprognostic (9.03e-3)" "unprognostic (9.42e-2)" "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (1.34e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (1.02e-1)" "unprognostic (4.18e-6)" "unprognostic (6.21e-2)" "unprognostic (5.15e-1)" "unprognostic (5.21e-2)" "unprognostic (3.50e-1)" 1.9 1.9 2.0 2.6 2.5 4.6 3.2 5.6 2.1 2.9 2.1 2.1 0.6 2.4 4.3 1.3 4.9 1.9 3.1 1.9 2.3 2.2 0.7 2.5 5.9 1.5 1.7 6.0 1.1 6.7 2.6 3.3 1.4 3.2 1.4 6.9 1.7 4.0 1.8 2.1 2.2 2.7 1.7 4.6 1.6 5.2 2.6 7.1 5.6 2.4 6.4 2.0 1.1 2.3 0.1 0.0 22.5 0.1 0.9 0.9 0.0 7.9 7.4 11.3 10.2 0.1 0.2 0.0 5.6 4.0 8.9 0.6 0.0 12.6 16.0 0.0 28.8 4.6 0.1 2.5 2.6 0.1 8.5 4.6 0.0 8.7 0.0 1.0 0.8 1.8 0.2 0.0 3.7 0.0 17.8 2.4 34.3 0.0 2.8 25.6 0.1 5.6 3.2 0.0 16.4 16.5 0.1 0.0 0.7 17.4 0.1 0.3 0.1 10.2 5.2 0.0 9.3 0.2 34.8 8.8 0.1 0.0 10.1 1.8 1.6 8.1 1.8 1.9 3.5 6.8 3.5 2.2 2.6 9.4 6.5 3.2 0.3 4.1 1.7 2.8 4.4 2.6 2.0 2.5 5.6 2.1 1.9 2.3 1.5 1.7 1.4 1.7 2.6 2.3 1.4 0.0 0.0 3.3 4.5 1.0 1.4 1.8 1.2 3.7 1.7 1.4 3.0 5.7 1.9 5.5 0.0 2.0 1.1 0.0 3.9 3.0 2.9 0.3 1.5 1.8 0.0 4.2 2.3 0.2 1.0 1.7 2.0 0.3 3.8 5.4 2.9 0.3 1.9 3.3 1.9 0.1 4.1 0.8 1.8 3.4 2.1 1.2 0.0 1.0 1.0 4.8 0.0 4.0 0.7 0.2 0.1 2.2 2.6 0.7 0.0 0.5 0.9 5.0 6.6 1.5 1.9 1.0 5.6 0.7 0.9 1.2 2.3 1.7 0.1 1.1 ZKSCAN8 "LD5-1, ZNF192, ZSCAN40" ENSG00000198315 "Zinc finger with KRAB and SCAN domains 8" Q15776 6 28141883-28159460 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003483 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm Cytosol "HPA003483: AB_1080686" "unprognostic (2.02e-1)" "unprognostic (1.45e-1)" "unprognostic (3.94e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.75e-3)" "unprognostic (4.19e-2)" "unprognostic (2.24e-3)" "unprognostic (5.34e-2)" "unprognostic (9.80e-3)" "unprognostic (4.68e-3)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-2)" "unprognostic (4.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (6.33e-3)" 11.0 7.7 4.5 8.1 6.2 14.8 11.5 8.9 7.2 11.2 7.4 11.8 6.6 15.9 13.3 5.6 11.1 7.6 7.6 4.5 5.6 7.7 7.3 9.2 10.5 5.5 5.1 17.6 9.9 12.9 8.4 9.4 6.1 10.3 8.4 17.6 9.0 11.6 8.1 7.9 10.7 10.7 5.0 10.8 9.2 9.1 5.2 13.1 10.6 8.9 10.9 10.2 7.9 9.2 9.0 5.6 26.1 25.4 15.8 14.9 8.2 9.7 18.3 12.6 15.7 6.3 5.3 19.4 15.7 9.4 10.5 7.4 16.7 6.2 17.9 11.2 14.1 17.7 11.7 13.6 14.4 21.8 12.7 15.4 10.4 12.9 19.2 21.5 12.5 16.9 27.9 7.1 12.9 4.4 15.5 18.2 9.5 2.1 6.4 17.0 16.5 15.2 8.6 10.9 19.5 24.7 11.6 5.3 11.9 14.3 5.9 11.7 10.9 18.1 10.5 6.1 13.2 17.3 13.2 15.6 5.1 14.8 9.9 2.2 0.5 0.6 1.0 1.2 1.1 0.5 0.6 0.4 0.4 1.7 1.0 0.8 0.1 1.1 2.1 0.7 0.6 0.6 4.5 6.2 8.9 7.2 4.5 5.6 5.5 5.1 6.1 5.0 5.2 9.2 6.9 3.2 9.3 11.8 9.8 4.8 2.6 3.8 14.8 9.5 8.5 5.1 8.0 7.2 5.0 7.3 6.2 4.2 11.0 2.0 0.0 3.1 3.7 5.9 10.0 8.8 7.2 9.4 11.1 2.9 2.0 9.5 4.6 7.4 5.1 12.7 8.6 10.2 4.1 6.7 12.5 4.6 4.1 11.1 6.8 5.2 9.0 6.0 1.8 15.9 5.9 6.5 4.1 26.7 17.1 3.0 2.4 9.1 9.0 4.3 2.3 3.5 6.1 9.2 0.0 9.9 7.3 11.9 8.6 8.5 2.8 2.3 7.1 7.4 3.7 1.9 ZMYM6 "Buster2, MYM, ZBED7, ZNF198L4, ZNF258" ENSG00000163867 "Zinc finger MYM-type containing 6" O95789 1 34986165-35031945 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011004, HPA071865" Approved Approved Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA011004: AB_1859075, HPA071865: AB_2686464" "prognostic favorable (1.30e-5)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" "unprognostic (3.92e-2)" "unprognostic (2.11e-6)" "unprognostic (1.77e-3)" "unprognostic (4.83e-3)" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.70e-2)" "unprognostic (9.29e-2)" "unprognostic (7.15e-2)" "unprognostic (2.28e-1)" "unprognostic (1.72e-1)" "unprognostic (4.84e-3)" 5.7 7.5 3.2 8.4 4.5 15.2 6.9 5.2 4.6 5.3 3.3 6.2 6.4 7.1 8.5 6.9 4.8 6.4 6.8 3.3 4.0 6.8 4.6 6.4 9.5 3.8 3.7 9.2 5.0 7.6 6.8 4.9 4.4 6.5 7.5 9.2 5.2 5.4 3.5 8.2 7.1 6.6 3.2 10.6 7.3 9.6 4.5 8.2 9.4 4.8 8.6 5.5 4.9 5.4 8.3 4.8 7.9 8.0 9.3 10.8 5.1 7.5 10.7 7.8 8.6 3.4 8.9 11.3 7.2 10.4 5.8 7.7 9.2 7.3 9.8 7.7 5.4 9.6 6.4 4.4 8.1 14.7 11.8 9.9 9.9 9.3 7.2 5.8 9.2 9.5 15.9 12.2 8.3 3.0 6.5 10.0 7.7 4.8 7.6 8.9 10.9 6.5 7.2 6.1 8.4 8.4 8.1 7.8 9.5 8.0 5.2 7.9 9.7 10.0 8.0 11.0 10.6 7.6 13.0 8.5 10.5 13.6 8.9 3.0 5.5 5.7 5.3 4.6 4.6 4.6 3.6 3.0 5.0 5.5 5.2 3.5 3.1 4.0 5.9 7.7 4.3 2.6 3.2 4.5 5.2 4.6 3.3 4.0 3.8 3.7 4.4 3.2 4.5 5.4 9.2 12.8 16.5 30.0 11.1 6.0 5.5 7.2 10.2 12.0 7.8 6.1 15.7 8.6 7.9 16.5 20.9 3.9 13.5 8.9 5.9 5.1 2.0 5.6 7.7 6.9 3.6 3.4 34.4 5.6 3.3 8.0 13.3 7.1 10.1 10.6 5.0 8.8 7.8 13.5 37.9 8.0 6.1 20.6 15.7 1.8 8.4 15.6 1.8 30.9 19.0 8.5 15.5 22.6 41.4 5.8 7.4 11.3 7.0 4.0 7.5 7.3 8.3 20.9 13.1 8.0 12.0 24.7 18.8 9.0 6.5 5.3 8.5 8.6 8.2 5.7 ZNF100 ENSG00000197020 "Zinc finger protein 100" Q8IYN0 19 21722771-21767579 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 77.7;Late spermatids: 68.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 30.7" HPA059135 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA059135: AB_2683918" "unprognostic (2.20e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-2)" "unprognostic (6.03e-3)" "unprognostic (2.67e-2)" "unprognostic (3.78e-2)" "unprognostic (1.64e-2)" "unprognostic (2.51e-2)" "unprognostic (7.02e-4)" "unprognostic (1.94e-3)" "unprognostic (9.27e-2)" "unprognostic (2.47e-3)" "unprognostic (3.22e-2)" "unprognostic (2.87e-2)" "unprognostic (2.84e-1)" "unprognostic (3.22e-2)" "prognostic favorable (5.47e-4)" 3.0 2.8 0.9 3.0 2.2 5.6 3.5 4.9 1.1 3.1 0.9 2.6 1.0 3.3 3.5 1.8 3.2 1.9 1.8 0.4 1.4 2.0 1.5 2.9 5.4 1.9 1.4 6.0 2.7 1.6 2.0 3.2 2.0 2.9 3.3 2.0 2.5 2.5 3.0 2.0 2.9 2.4 1.2 4.0 2.5 8.3 1.8 6.2 3.0 3.6 4.6 2.8 2.3 3.5 0.3 0.1 10.8 4.2 2.2 2.3 10.0 4.2 3.2 7.2 10.8 3.6 2.6 6.5 7.4 2.3 4.6 2.9 11.0 3.4 13.7 0.0 8.0 7.8 3.4 1.9 1.3 0.0 4.8 2.6 0.5 5.4 0.2 2.0 3.2 15.1 13.6 0.2 5.4 4.0 30.7 8.5 9.8 0.1 5.1 12.4 13.0 4.7 3.6 11.1 6.7 4.9 6.9 0.2 3.6 8.3 4.1 5.6 3.6 3.0 2.2 6.1 5.6 0.2 4.3 13.2 0.0 7.8 3.3 4.8 3.0 3.4 1.0 3.0 1.2 2.8 1.9 1.7 3.4 4.6 3.0 2.4 3.5 2.8 2.1 1.6 2.0 1.2 0.9 2.2 4.9 1.1 0.4 1.4 1.9 1.4 2.0 1.2 1.8 3.5 10.1 3.2 4.5 14.0 10.0 3.1 6.0 2.2 4.6 7.1 7.3 5.2 5.7 2.8 5.5 9.2 2.1 7.6 9.0 4.0 3.9 5.0 77.7 6.2 8.6 6.6 3.0 5.5 11.2 5.8 7.8 6.8 6.6 12.3 10.1 16.3 5.3 1.0 5.5 1.7 12.0 3.8 4.1 10.4 6.1 68.7 11.5 10.3 8.8 13.1 9.8 3.2 8.2 20.6 25.9 6.8 5.8 4.5 7.2 5.7 2.9 2.3 7.4 5.1 26.3 8.2 6.2 21.7 11.3 3.1 2.8 8.8 7.9 15.4 4.6 11.4 ZNF107 "smap-7, ZFD25, ZNF588" ENSG00000196247 "Zinc finger protein 107" Q9UII5 7 64666083-64711582 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.2" "Cell type enhanced" "Detected in many" "B-cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 47.0;REH: 49.5;U-698: 51.2" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.50e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-2)" "unprognostic (4.13e-3)" "unprognostic (1.62e-2)" "unprognostic (2.34e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (3.32e-1)" "unprognostic (1.66e-1)" "unprognostic (5.49e-2)" "unprognostic (7.15e-3)" 2.3 5.9 1.5 8.8 2.5 8.6 8.3 2.9 1.9 6.8 0.7 2.7 2.7 2.9 2.3 2.7 2.7 2.5 1.3 1.8 2.0 2.1 1.6 2.3 16.2 2.8 2.1 4.4 1.6 2.1 1.8 3.1 2.7 3.3 3.5 3.3 4.8 2.6 0.8 7.5 7.7 2.1 2.1 8.5 3.7 2.8 2.1 13.4 5.0 1.8 14.2 3.2 3.6 3.7 6.8 4.1 11.3 19.8 2.6 2.7 8.3 5.0 3.3 7.4 9.8 6.3 6.3 39.6 8.9 3.3 10.0 5.2 12.6 5.1 11.1 9.7 8.5 7.8 6.6 3.5 1.1 14.9 13.3 4.6 3.5 6.4 3.7 3.7 3.7 36.1 13.8 20.2 6.6 5.7 47.0 15.9 22.0 4.2 4.5 49.5 9.1 8.8 3.7 13.3 12.6 10.1 7.8 8.0 5.1 15.6 12.6 9.7 3.2 12.3 5.0 4.7 7.4 9.4 9.1 51.2 2.8 10.0 8.1 12.0 0.7 1.5 3.4 1.7 3.6 9.0 4.6 4.8 1.1 10.1 6.0 5.8 13.7 2.6 1.3 2.8 4.3 1.8 1.5 2.5 2.9 1.9 1.8 2.0 2.8 2.1 2.7 2.1 2.1 3.7 7.9 12.8 4.2 10.4 45.2 2.2 3.2 3.2 8.6 6.2 13.9 5.8 3.8 5.7 5.4 7.3 2.1 2.7 9.0 1.3 1.9 2.6 8.2 5.1 5.7 6.9 6.6 5.9 6.2 3.1 2.4 6.7 5.1 5.9 0.0 15.0 4.2 0.6 1.9 3.3 9.7 2.9 2.0 3.8 1.5 7.8 4.4 4.8 0.0 10.3 1.7 4.1 10.3 22.6 22.1 3.9 2.4 3.4 22.8 3.5 2.0 1.9 3.3 5.7 6.6 4.0 3.9 4.3 4.7 5.5 4.1 2.5 17.9 17.5 3.6 3.8 ZNF12 "GIOT-3, KOX3, ZNF325" ENSG00000164631 "Zinc finger protein 12" P17014 7 6688433-6706947 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 8.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063402 Supported Nucleoplasm,Centrosome NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Centrosome "HPA063402: AB_2685005" "unprognostic (2.68e-1)" "unprognostic (6.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.84e-1)" "unprognostic (8.32e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-3)" "unprognostic (1.41e-1)" "unprognostic (6.67e-2)" "unprognostic (2.89e-3)" "unprognostic (5.52e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" "unprognostic (2.10e-2)" "unprognostic (4.36e-2)" "unprognostic (8.46e-3)" 9.2 8.7 9.0 8.2 8.7 8.5 13.6 12.5 8.9 12.1 10.3 9.7 10.0 13.8 13.8 10.4 10.3 9.2 8.9 8.3 8.2 9.7 10.2 8.5 13.4 9.0 9.1 14.3 9.0 18.5 8.7 13.3 9.4 11.3 10.4 15.3 10.0 12.1 6.7 10.5 11.2 9.8 8.3 13.3 10.2 5.2 9.7 12.3 13.9 10.0 13.4 9.8 10.0 9.2 16.5 7.7 15.0 18.9 15.1 15.2 14.4 10.2 18.3 12.8 13.3 10.5 9.4 12.5 6.9 12.7 28.8 19.3 12.5 9.9 19.4 4.7 9.4 12.6 11.9 10.6 14.1 20.2 13.1 16.7 21.6 9.2 14.8 19.0 9.4 9.9 20.3 11.2 17.1 13.1 7.8 18.6 18.2 5.2 11.7 10.2 21.5 7.7 10.4 16.2 13.7 24.2 11.8 21.2 12.4 18.7 13.5 22.7 9.4 14.3 18.0 11.5 13.7 10.6 7.3 12.6 11.7 13.4 19.4 8.8 0.5 0.7 1.4 0.4 1.9 1.1 1.1 1.6 0.5 1.1 1.5 1.9 0.5 1.2 0.4 1.1 1.0 0.2 9.0 8.7 12.5 8.9 8.3 8.2 9.0 9.1 9.4 8.3 9.7 9.2 15.1 9.6 8.9 16.3 14.1 26.9 16.3 8.0 11.4 27.9 16.3 15.1 17.2 12.8 10.7 3.7 16.7 11.7 15.3 8.3 1.9 8.7 1.2 10.4 15.8 13.9 7.7 12.4 15.9 6.8 9.0 14.9 6.6 12.7 11.4 27.3 15.4 10.3 10.1 37.0 16.7 11.9 2.0 13.0 10.9 2.7 22.4 8.4 5.4 18.7 11.3 20.9 15.5 9.5 19.9 9.1 8.8 22.6 11.6 13.3 10.1 7.0 12.6 18.9 26.3 17.6 16.7 12.7 7.8 16.7 22.4 8.6 11.2 23.9 12.1 18.1 ZNF134 pHZ-15 ENSG00000213762 "Zinc finger protein 134" P52741 19 57614233-57624724 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA009064 Supported Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA009064: AB_1080668" "unprognostic (3.60e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.88e-1)" "unprognostic (4.29e-2)" "unprognostic (9.62e-2)" "prognostic unfavorable (5.21e-4)" "unprognostic (6.34e-2)" "unprognostic (1.35e-1)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (3.39e-2)" "unprognostic (1.17e-2)" "prognostic favorable (2.61e-4)" "unprognostic (1.56e-2)" "unprognostic (3.40e-1)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" 4.6 5.4 4.9 4.7 5.2 12.5 7.5 8.7 5.3 5.7 4.0 6.5 3.5 5.5 6.0 5.3 6.5 4.5 6.0 4.9 5.5 5.6 4.9 5.8 7.5 3.9 4.0 7.6 3.8 12.0 5.7 7.9 3.7 7.3 4.5 10.6 5.4 8.3 6.3 7.1 4.9 6.0 3.6 7.1 6.0 6.6 5.5 11.1 8.3 7.2 8.5 6.1 4.1 4.7 2.5 6.6 15.5 8.4 6.8 9.1 7.7 6.8 11.1 9.8 4.9 2.2 2.9 5.0 4.7 8.5 7.5 2.1 7.2 12.6 16.8 0.1 33.2 15.8 7.0 6.2 9.9 10.6 11.2 12.3 12.1 7.4 16.7 12.9 6.6 8.2 2.1 5.7 14.8 3.7 21.0 4.4 21.8 1.6 13.6 12.2 22.5 7.9 7.3 21.5 12.4 14.5 11.3 4.9 7.2 17.0 6.9 8.4 8.7 14.7 6.3 3.5 9.0 15.3 21.8 6.9 7.7 1.8 9.9 2.3 4.2 7.4 6.3 3.0 8.3 9.5 6.5 6.7 4.6 8.3 7.5 7.5 3.4 11.9 3.4 3.5 4.4 5.5 4.9 5.2 8.7 5.3 4.9 5.5 3.9 4.0 3.7 3.6 5.5 4.7 6.0 9.6 4.1 1.0 14.4 5.4 12.7 4.4 8.6 8.4 9.8 8.0 11.2 11.5 5.6 3.7 12.5 8.2 11.1 1.2 7.9 7.8 1.7 6.0 7.8 8.3 1.2 13.0 1.0 3.7 4.3 6.2 1.1 7.3 6.3 10.6 9.7 4.1 5.3 8.4 0.9 4.0 6.1 5.1 3.2 1.5 7.2 4.4 3.6 0.0 7.0 11.3 9.2 1.0 1.6 3.8 2.6 14.7 5.0 9.3 2.8 4.6 5.1 11.9 6.6 6.6 8.5 2.2 15.2 6.7 7.7 16.3 8.8 8.0 3.6 13.8 ZNF136 pHZ-20 ENSG00000196646 "Zinc finger protein 136" P52737 19 12163064-12189871 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054120 Approved Nucleoli NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoli "HPA054120: AB_2682389" "unprognostic (1.40e-1)" "unprognostic (5.90e-2)" "unprognostic (3.38e-2)" "unprognostic (1.17e-1)" "unprognostic (6.22e-2)" "unprognostic (4.68e-3)" "unprognostic (2.36e-1)" "unprognostic (9.39e-3)" "unprognostic (5.97e-3)" "unprognostic (1.71e-1)" "unprognostic (4.33e-2)" "unprognostic (5.46e-3)" "prognostic favorable (4.75e-5)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 5.6 5.6 1.9 5.9 2.7 15.5 7.6 6.1 3.7 5.8 2.6 4.4 2.7 8.4 6.0 4.1 6.5 5.4 3.9 1.7 2.8 5.8 3.9 6.0 7.6 2.7 2.4 12.0 4.6 7.2 3.0 7.0 3.1 6.7 5.4 7.2 4.4 5.2 2.2 4.5 4.6 6.4 2.1 7.9 6.7 7.4 2.7 7.9 9.0 4.3 7.1 5.3 4.7 4.0 2.7 1.6 9.3 9.8 4.9 5.6 5.5 5.2 5.4 5.3 5.1 1.8 1.0 13.4 6.8 3.7 4.7 3.0 4.3 3.0 6.0 6.8 6.8 7.4 4.5 3.0 3.6 15.6 13.1 5.9 5.5 4.4 5.6 7.0 3.4 11.5 6.0 20.6 6.1 3.6 11.4 7.5 11.0 1.0 5.8 10.1 12.0 5.1 5.1 9.6 9.8 8.7 7.8 1.7 6.1 7.7 4.1 8.9 7.3 12.9 4.6 5.6 5.2 14.6 26.1 14.7 5.2 6.0 6.6 15.3 3.4 7.9 6.3 3.3 7.9 7.8 7.5 7.3 3.9 8.1 8.1 7.0 9.4 8.2 3.9 4.4 5.4 3.8 1.9 2.7 6.1 3.7 1.7 2.8 2.7 2.4 3.1 2.1 2.7 4.0 9.3 6.4 7.0 4.6 16.4 5.5 10.5 4.7 4.0 18.6 6.3 5.8 3.1 8.6 8.2 9.2 18.8 7.6 16.5 5.4 5.9 6.0 2.2 5.9 6.4 9.0 10.2 10.8 5.0 3.8 6.8 10.1 4.1 6.6 8.2 23.4 8.9 3.1 5.7 20.2 6.7 5.6 4.1 10.0 6.9 3.1 13.4 7.8 1.8 2.8 11.6 14.3 22.6 8.0 6.0 4.2 7.4 14.7 6.1 8.9 5.0 4.1 3.5 15.9 6.6 11.3 9.5 31.5 23.7 2.4 3.1 9.9 12.5 13.6 3.9 11.2 ZNF14 "GIOT-4, KOX6" ENSG00000105708 "Zinc finger protein 14" P17017 19 19710472-19733112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049863 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA049863: AB_2680921" "unprognostic (1.04e-1)" "unprognostic (9.86e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (6.08e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favorable (7.96e-4)" "unprognostic (1.84e-3)" "unprognostic (1.04e-2)" "unprognostic (5.51e-3)" "unprognostic (1.55e-2)" "prognostic favorable (8.09e-6)" "unprognostic (1.83e-2)" "unprognostic (1.61e-1)" "unprognostic (5.17e-2)" "unprognostic (9.05e-3)" 3.0 2.6 3.4 3.3 3.7 8.3 7.3 7.1 4.4 5.6 1.4 3.1 2.2 5.2 5.2 2.7 5.1 2.8 3.8 2.8 3.6 4.7 0.8 2.7 6.8 2.3 3.2 8.7 3.2 7.6 3.3 4.2 2.8 5.4 2.8 4.8 3.8 5.1 2.0 3.6 3.1 3.4 2.3 5.3 4.1 3.5 3.8 4.9 7.8 4.4 6.5 3.6 3.2 5.0 2.8 2.7 4.7 6.1 3.1 3.4 5.6 2.9 4.0 4.2 4.5 2.7 2.1 7.6 4.7 3.0 2.4 2.8 4.9 2.9 5.2 1.9 5.6 3.5 2.0 3.5 3.7 0.1 5.2 3.3 3.0 2.9 2.5 5.5 2.6 3.7 4.2 3.5 4.2 4.7 6.6 4.1 6.1 5.3 8.1 3.4 7.6 3.6 3.0 5.6 4.6 3.3 0.0 3.3 4.7 4.0 4.6 7.3 1.7 3.6 1.0 4.3 3.8 2.7 3.5 6.5 0.2 3.9 2.2 22.4 2.7 9.4 13.3 4.7 21.0 14.9 18.1 16.6 3.8 12.0 24.8 19.9 6.1 10.1 5.8 4.4 12.7 9.1 3.4 3.7 7.1 4.4 2.8 3.6 2.3 3.2 2.8 2.3 3.8 5.0 3.6 0.0 3.7 11.4 8.5 2.4 4.4 1.5 3.4 4.6 3.2 3.4 2.8 0.0 1.4 3.7 0.0 3.4 5.3 0.4 3.9 1.7 0.6 1.5 2.1 3.4 3.0 4.8 9.7 1.3 1.5 3.5 2.6 2.5 1.3 4.7 3.3 0.2 1.8 6.7 12.5 1.4 4.1 0.8 1.4 0.9 1.8 1.8 3.6 11.2 0.3 3.8 4.1 12.5 13.7 0.8 2.5 3.8 2.8 2.2 1.0 3.0 2.9 5.7 6.6 3.2 2.9 3.4 3.0 1.5 1.4 2.2 9.5 2.2 1.3 2.5 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA003264, HPA074818" Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies, Golgi apparatus, Vesicles" "HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 9.0 6.1 8.6 11.4 10.1 18.6 9.6 17.3 9.9 10.0 10.8 9.7 9.5 10.5 14.4 9.8 10.1 8.4 9.3 7.9 9.3 8.6 9.6 9.1 15.7 9.9 8.8 13.7 7.7 7.9 7.1 10.4 11.2 8.7 9.9 16.1 8.9 8.0 17.3 10.2 8.2 9.5 9.8 11.1 7.7 16.9 9.0 18.9 14.6 11.5 14.1 11.2 8.4 14.9 20.0 18.8 23.4 15.2 18.9 17.4 21.5 21.8 17.3 16.4 17.9 26.7 24.3 19.6 9.7 17.7 14.0 22.5 23.1 17.3 24.5 20.0 27.7 18.5 27.7 18.7 15.6 25.9 17.8 15.3 20.4 22.2 19.4 21.4 16.3 17.9 20.5 23.3 18.3 17.1 24.1 10.6 26.3 23.0 19.9 21.4 21.2 12.3 14.7 24.0 16.1 15.8 24.0 16.0 14.3 20.6 14.9 14.6 15.6 21.4 15.3 15.1 19.6 11.5 21.6 33.4 13.8 14.8 12.5 39.1 24.6 57.3 28.0 24.9 25.0 23.0 24.6 22.9 20.9 18.2 22.8 19.6 45.1 19.4 28.2 10.1 29.7 19.6 8.6 10.1 17.3 9.9 7.9 9.3 9.9 8.8 11.2 9.8 9.0 14.9 17.9 6.4 12.1 6.2 14.7 26.6 34.1 12.1 17.6 9.3 8.7 13.2 15.5 7.2 10.3 5.5 8.4 10.0 17.1 10.1 3.9 12.5 20.3 18.7 14.9 13.0 6.6 25.4 8.1 11.5 16.2 14.5 9.7 16.3 14.0 7.7 6.8 7.6 9.9 5.0 7.4 6.9 14.2 8.3 22.0 10.0 11.8 15.8 10.6 12.2 16.3 15.5 17.5 7.5 9.8 14.1 7.7 6.8 15.4 20.1 6.3 7.7 15.0 14.3 59.2 18.3 16.7 50.5 21.3 12.8 23.4 18.3 18.1 7.3 7.9 26.9 ZNF154 pHZ-92 ENSG00000179909 "Zinc finger protein 154" Q13106 19 57697367-57709194 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 11.8;granulocytes: 10.8;Oligodendrocyte precursor cells: 10.6;Rod photoreceptor cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 5.2;HSkMC: 2.9;MOLT-4: 4.4;NTERA-2: 2.9;SuSa: 6.1" "Low region specificity" "Detected in all" HPA076284 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center" "HPA076284: " "unprognostic (3.32e-2)" "unprognostic (3.43e-1)" "unprognostic (1.26e-2)" "unprognostic (1.33e-1)" "unprognostic (5.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.25e-1)" "unprognostic (1.41e-2)" "unprognostic (1.27e-3)" "unprognostic (1.57e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.20e-3)" "unprognostic (9.39e-2)" "unprognostic (3.35e-1)" "unprognostic (8.38e-3)" "unprognostic (1.11e-1)" 1.3 2.8 2.4 3.2 2.8 1.2 2.1 6.4 2.8 1.4 4.9 3.6 1.1 0.8 1.5 2.1 0.9 2.0 2.9 2.6 2.8 2.2 0.7 1.6 4.9 1.6 2.2 1.4 1.4 3.6 5.1 3.1 1.2 2.2 1.3 4.6 2.4 3.5 1.6 0.8 2.5 1.4 0.9 4.6 1.2 0.9 3.1 6.1 5.8 1.5 4.4 2.4 0.8 1.5 0.1 0.2 5.2 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.1 0.2 0.3 0.1 1.3 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.2 0.8 0.1 1.8 0.3 0.4 2.9 0.0 0.3 0.0 1.8 0.1 0.2 0.2 0.3 1.2 0.1 4.4 0.2 2.9 0.1 0.1 0.2 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.0 6.1 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.3 0.1 0.2 0.0 0.2 0.0 0.8 0.1 2.0 0.2 0.0 0.6 0.4 0.2 0.4 0.1 1.0 0.3 0.3 0.6 0.5 0.0 0.5 0.0 0.2 2.4 2.8 6.4 2.8 2.6 2.8 1.6 2.2 1.2 0.9 3.1 1.5 2.0 0.0 1.9 11.8 7.5 0.4 1.5 0.5 0.6 8.1 1.9 2.2 4.2 1.5 1.0 1.8 8.4 0.2 5.5 0.1 0.0 2.5 0.0 0.5 1.4 2.7 0.0 0.4 7.3 0.2 0.2 1.2 2.0 0.8 10.8 2.2 3.6 0.2 1.6 8.4 7.2 0.0 2.0 0.6 1.7 0.2 0.3 1.2 0.0 1.9 0.7 3.4 4.1 10.6 1.4 0.1 0.0 1.5 2.5 1.3 0.0 0.2 1.3 10.3 0.0 1.5 3.6 0.6 1.1 0.5 0.4 0.3 2.6 0.3 0.0 2.0 ZNF184 ENSG00000096654 "Zinc finger protein 184" Q99676 6 27450743-27473118 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003226, HPA064793" Uncertain Supported Nucleoplasm NA NA "Cluster 13: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003226: AB_2218705, HPA064793: AB_2732722" "unprognostic (8.86e-2)" "unprognostic (5.55e-2)" "unprognostic (2.27e-3)" "unprognostic (1.70e-1)" "unprognostic (4.99e-3)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (1.74e-2)" "unprognostic (1.17e-2)" "prognostic favorable (4.41e-5)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.31e-2)" "unprognostic (5.79e-3)" 2.8 3.1 2.4 4.3 4.6 8.8 5.4 1.2 8.4 6.1 0.0 4.4 3.4 5.4 4.1 3.8 4.5 4.0 2.8 6.4 0.6 7.0 3.6 4.1 6.3 0.4 0.3 6.0 2.7 5.9 4.1 3.0 0.3 4.3 4.5 4.4 3.5 4.3 2.9 5.7 3.6 4.3 0.6 4.6 4.4 8.3 0.3 10.2 5.6 5.0 6.6 4.5 2.9 2.7 6.4 2.0 10.8 19.7 7.6 5.6 3.6 6.2 8.3 7.1 10.9 3.6 3.7 11.7 10.3 4.0 4.8 3.9 9.7 4.0 10.3 11.4 6.0 14.0 7.3 5.1 4.0 16.9 9.7 4.1 6.0 5.2 5.4 8.4 7.8 17.8 10.9 21.1 11.9 3.2 27.3 14.3 6.3 3.5 4.5 35.4 15.2 17.5 4.9 5.9 18.4 8.9 7.0 6.0 9.2 5.3 7.0 14.4 5.3 10.8 7.1 4.9 7.2 9.6 17.4 21.8 2.4 19.4 10.9 2.1 2.7 8.0 7.9 3.7 10.9 7.4 8.3 7.7 4.1 6.9 6.3 7.9 1.4 7.0 2.9 2.5 10.4 3.9 2.4 4.6 1.2 8.4 6.4 0.6 0.4 0.3 0.3 0.6 0.3 2.7 5.4 6.4 8.1 2.0 9.8 4.1 3.8 2.5 6.8 2.5 5.1 5.5 3.5 2.8 6.4 1.8 2.1 4.3 17.5 2.1 7.9 2.7 36.9 7.9 3.7 5.1 7.1 3.4 10.3 3.0 3.0 4.5 2.0 5.0 5.1 7.4 3.9 1.5 2.8 10.1 3.4 5.1 2.0 3.8 3.8 12.6 3.4 3.6 1.8 5.6 3.0 3.3 9.2 4.0 4.2 2.5 2.1 3.8 6.5 4.6 1.6 4.5 6.3 4.8 0.0 5.2 6.8 12.8 5.9 4.3 4.4 2.9 12.5 4.6 4.4 4.5 ZNF230 FDZF2 ENSG00000159882 "Zinc finger protein 230" Q9UIE0 19 44002957-44013924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA006172 Approved Mitochondria No No "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA006172: AB_2667532" "unprognostic (3.55e-3)" "unprognostic (5.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-2)" "unprognostic (3.89e-2)" "unprognostic (3.79e-2)" "unprognostic (1.35e-1)" "unprognostic (4.08e-4)" "unprognostic (2.45e-2)" "unprognostic (1.14e-2)" "unprognostic (8.59e-2)" "unprognostic (1.68e-1)" "unprognostic (4.62e-2)" "unprognostic (1.42e-5)" 2.0 2.1 1.1 2.2 1.3 3.2 3.2 2.8 2.0 2.3 1.5 2.0 1.3 2.3 2.1 1.4 2.5 1.6 1.8 1.1 1.4 1.7 2.1 2.4 3.4 1.2 1.3 4.2 1.4 2.7 2.7 2.4 1.4 2.2 2.0 4.6 1.9 2.5 0.8 2.9 2.4 1.8 1.3 3.9 1.9 1.8 1.3 4.0 3.0 1.9 3.9 2.0 1.7 1.8 2.1 1.7 3.4 3.5 2.7 3.3 1.3 2.9 2.9 2.6 4.7 1.0 1.1 1.7 1.9 2.1 1.6 1.7 2.9 2.6 3.9 2.1 3.6 2.9 4.1 1.2 1.5 3.8 2.4 2.5 2.4 2.9 3.0 3.5 1.8 2.0 0.5 0.0 2.7 1.1 4.3 2.7 2.0 1.4 1.6 3.1 4.7 0.8 1.5 2.4 1.9 4.3 4.1 1.4 2.1 2.3 1.2 8.7 2.3 4.1 3.0 1.2 2.2 2.1 2.2 0.3 2.0 2.8 2.6 6.2 3.3 8.7 3.6 4.0 3.8 4.2 4.1 3.7 3.6 4.2 4.5 4.2 11.5 2.9 2.0 2.2 3.7 2.9 1.1 1.3 2.8 2.0 1.1 1.4 1.2 1.3 1.4 1.3 1.3 1.8 4.7 0.0 2.2 1.6 8.3 2.8 2.6 3.0 4.6 8.5 3.3 3.9 6.0 10.0 3.5 3.7 16.7 4.0 9.9 2.7 3.9 3.0 2.7 2.9 3.3 4.2 1.2 2.1 4.6 2.4 3.2 4.4 2.6 1.7 1.3 4.8 3.9 2.7 3.2 8.4 3.8 2.4 10.2 4.4 3.3 1.7 6.5 3.6 3.6 3.7 7.9 5.4 7.2 2.5 4.0 1.2 0.8 4.5 1.4 2.0 4.1 1.6 2.9 9.6 6.6 3.9 4.3 13.7 7.9 2.8 2.7 3.1 6.7 3.7 3.2 2.0 ZNF253 "BMZF-1, FLJ90391, ZNF411" ENSG00000256771 "Zinc finger protein 253" O75346 19 19865882-19894674 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 25.6;Oligodendrocytes: 33.7;Rod photoreceptor cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (3.03e-2)" "unprognostic (3.54e-1)" "unprognostic (7.10e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.39e-5)" "unprognostic (4.75e-2)" "unprognostic (4.77e-2)" "unprognostic (2.80e-2)" "unprognostic (5.26e-3)" "prognostic favorable (2.19e-4)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "prognostic favorable (9.69e-5)" "unprognostic (4.88e-2)" "unprognostic (3.68e-1)" "unprognostic (1.84e-3)" "unprognostic (4.54e-3)" 3.1 4.5 1.3 4.2 3.1 2.5 8.3 7.4 4.5 6.3 0.4 4.8 4.4 5.0 4.5 2.5 6.1 3.2 4.7 1.1 4.3 7.0 4.3 3.9 8.7 2.1 1.8 13.0 4.4 8.4 3.5 4.4 2.6 6.0 5.3 19.8 5.5 5.4 7.4 3.4 4.3 2.5 1.1 6.2 5.4 3.9 2.6 9.0 14.5 10.5 8.6 4.4 3.0 4.9 0.0 0.1 17.5 14.0 2.4 2.4 7.4 2.4 1.1 4.8 5.5 2.2 4.2 12.2 8.8 2.3 4.2 2.2 0.0 0.6 6.9 1.4 4.1 0.9 1.1 3.6 2.9 0.1 0.3 3.6 3.2 3.2 0.4 6.7 0.2 0.3 7.8 6.2 7.0 5.5 20.6 4.2 18.5 0.0 2.3 19.7 10.1 10.1 6.4 9.6 10.0 10.3 10.2 2.3 2.9 13.5 6.3 14.8 0.2 6.1 0.2 4.4 3.2 9.0 8.1 19.7 0.3 0.4 3.1 13.5 1.5 4.1 5.7 2.1 7.6 9.1 7.9 7.9 3.4 9.8 15.4 10.3 1.4 7.5 1.9 4.5 6.0 4.7 1.3 3.1 7.4 4.5 1.1 4.3 2.1 1.8 2.6 1.1 2.6 4.9 3.7 9.6 3.6 7.8 9.4 0.4 1.9 1.1 1.8 12.2 3.7 4.3 5.9 4.3 4.1 5.5 6.2 5.6 6.8 2.6 17.6 6.1 12.2 4.3 5.6 5.3 7.7 4.2 16.3 2.9 3.3 4.6 1.5 5.2 2.5 9.0 3.9 2.5 2.9 13.5 22.3 2.1 0.0 2.5 1.8 1.0 5.0 2.6 1.8 8.4 1.4 12.6 11.3 25.6 33.7 2.3 2.7 4.5 6.4 1.7 1.9 6.4 6.8 26.7 0.0 4.0 4.8 7.2 7.1 1.0 0.4 4.9 7.3 9.4 3.7 1.5 ZNF254 "BMZF-5, HD-ZNF1, ZNF539, ZNF91L" ENSG00000213096 "Zinc finger protein 254" O75437 19 24033405-24129968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 113.9;Excitatory neurons: 78.6;Inhibitory neurons: 85.1;Oligodendrocyte precursor cells: 128.7;Oligodendrocytes: 107.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 68: Oligodendrocytes - Mixed function" "unprognostic (8.39e-2)" "unprognostic (2.51e-1)" "unprognostic (1.91e-1)" "unprognostic (1.31e-1)" "unprognostic (4.04e-2)" "unprognostic (6.92e-2)" "unprognostic (1.42e-1)" "prognostic favorable (8.60e-4)" "unprognostic (4.11e-3)" "unprognostic (2.23e-2)" "unprognostic (2.99e-3)" "unprognostic (1.96e-2)" "unprognostic (5.98e-3)" "unprognostic (4.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.12e-1)" "prognostic favorable (9.96e-4)" 4.2 4.9 4.2 3.8 4.8 7.6 7.6 8.9 6.3 9.1 2.4 5.9 4.2 7.5 8.6 5.3 5.9 5.3 4.8 3.6 6.7 7.7 8.8 6.0 6.9 3.9 4.5 10.9 4.3 10.9 5.9 5.6 4.6 7.7 7.3 5.4 5.2 7.0 2.3 4.2 3.9 5.0 3.5 4.9 6.5 4.5 5.9 11.8 17.0 5.7 6.2 6.2 6.0 6.0 4.1 5.4 24.3 12.2 5.0 5.5 4.2 5.3 9.5 7.5 12.3 5.7 7.8 6.1 10.4 4.7 4.4 2.3 15.6 5.0 11.3 35.1 24.2 11.6 6.5 3.3 4.5 5.6 2.4 6.3 5.3 8.7 7.0 11.3 9.9 13.7 15.9 0.0 8.9 6.9 12.3 10.2 18.4 1.5 9.7 17.4 12.8 14.3 10.3 11.9 14.4 14.0 0.0 0.4 7.3 21.0 5.9 9.1 6.9 3.5 1.0 7.4 8.1 0.2 6.8 16.0 0.0 6.6 3.4 7.5 1.3 4.3 1.9 1.4 2.0 3.4 2.5 2.1 2.2 3.2 2.8 2.5 3.1 3.2 3.1 2.7 3.3 1.2 4.2 4.8 8.9 6.3 3.6 6.7 3.9 4.5 4.6 3.5 5.9 6.0 13.3 38.5 18.5 113.9 10.8 3.4 8.7 5.9 5.2 22.1 10.1 9.1 18.7 20.0 10.6 12.9 14.6 6.7 11.0 8.6 15.6 11.8 49.5 11.2 19.7 9.3 16.8 3.8 78.6 7.4 11.1 13.3 10.2 13.2 7.0 27.3 8.9 10.5 5.7 37.0 85.1 6.0 12.2 8.1 5.2 16.8 11.8 6.8 7.2 65.6 5.1 15.7 5.2 128.7 107.5 9.5 4.4 16.6 4.1 7.7 1.8 8.8 8.5 14.3 13.1 11.3 13.4 5.8 9.6 5.2 5.3 8.8 8.7 13.4 7.0 9.4 ZNF256 BMZF-3 ENSG00000152454 "Zinc finger protein 256" Q9Y2P7 19 57940833-57947706 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 32.8" HPA055390 Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA055390: AB_2682803" "unprognostic (2.47e-2)" "unprognostic (3.43e-2)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (2.95e-2)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (3.38e-1)" "unprognostic (3.49e-3)" "unprognostic (2.32e-2)" "unprognostic (4.73e-3)" "unprognostic (2.83e-2)" "unprognostic (6.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.27e-1)" "unprognostic (3.28e-3)" 3.5 2.5 2.3 2.3 2.6 10.8 5.6 5.6 3.3 2.9 2.4 3.3 2.3 3.5 4.4 2.7 3.9 1.9 6.0 2.5 1.9 3.1 1.8 3.2 4.9 1.6 1.8 5.5 2.1 4.4 2.8 4.6 1.6 3.8 2.9 9.1 3.3 4.0 3.6 7.1 3.5 3.5 1.6 4.6 2.6 4.3 1.7 5.4 3.9 4.2 5.3 3.1 2.8 2.3 3.9 1.3 9.6 9.7 2.0 3.3 8.3 3.3 3.5 5.2 3.5 0.8 2.1 0.0 2.9 4.3 8.0 0.5 2.2 7.4 8.5 0.0 32.8 9.5 0.0 2.6 3.7 0.0 7.4 6.5 2.0 3.8 0.0 5.4 3.2 9.1 0.7 0.0 5.3 0.9 13.2 0.0 11.6 0.4 8.2 4.2 12.0 5.9 3.8 16.8 4.8 6.9 0.0 3.0 2.4 11.8 7.2 3.0 1.3 10.7 6.3 0.0 6.5 4.4 4.7 16.9 0.3 0.0 4.7 1.3 1.0 1.3 3.3 3.4 6.1 4.7 5.6 5.0 4.2 5.6 5.4 6.4 0.5 3.9 3.6 2.0 4.9 2.2 2.3 2.6 5.6 3.3 2.5 1.9 1.6 1.8 1.6 1.6 1.7 2.3 2.4 0.0 0.0 2.0 4.0 2.7 4.8 3.5 2.2 4.5 2.4 1.4 3.2 1.5 1.7 1.8 0.0 3.1 2.2 0.4 3.9 3.5 0.2 1.2 1.1 2.7 1.2 5.2 1.6 0.8 1.7 2.0 1.1 1.3 0.0 2.2 0.7 0.7 1.4 1.7 1.4 0.9 8.2 0.8 1.0 0.3 1.8 0.8 0.0 1.0 1.7 3.8 1.0 3.5 0.6 0.8 0.3 0.4 0.3 2.7 0.8 0.9 3.4 7.2 0.0 2.6 2.1 4.9 8.7 1.6 3.4 2.6 3.1 2.3 1.2 3.7 ZNF257 BMZF-4 ENSG00000197134 "Zinc finger protein 257" Q9Y2Q1 19 22052430-22091480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 9.8;Spermatocytes: 19.9;Spermatogonia: 13.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 5.1;NB-4: 4.4;NTERA-2: 12.1;RH-30: 5.2;U-698: 4.4" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (8.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (5.45e-2)" "unprognostic (3.29e-3)" "unprognostic (1.99e-3)" "unprognostic (9.40e-3)" "unprognostic (7.00e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.70e-1)" "unprognostic (2.84e-2)" "unprognostic (7.13e-2)" "unprognostic (2.34e-3)" "unprognostic (2.21e-1)" "unprognostic (2.15e-1)" "unprognostic (6.62e-4)" 0.5 0.5 0.5 1.0 0.8 4.1 1.2 1.2 1.2 1.5 0.3 0.7 0.5 1.4 1.6 0.2 0.9 0.5 0.6 0.5 0.6 0.6 0.4 0.8 2.6 1.0 0.9 2.3 2.1 1.0 0.2 2.0 1.0 1.4 0.6 0.7 0.3 0.9 0.2 0.8 0.4 0.8 0.5 1.6 1.4 2.7 0.7 1.6 2.3 0.0 1.3 1.1 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 2.3 0.6 3.6 2.9 0.0 0.5 0.0 1.4 0.1 5.1 0.0 0.0 0.0 3.7 0.0 0.1 3.6 0.4 0.0 0.1 0.0 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 3.8 4.4 12.1 0.0 1.0 0.0 5.2 3.0 0.5 0.8 0.0 1.4 0.0 0.0 0.9 1.7 0.0 2.5 0.0 0.0 0.1 0.4 0.0 0.1 2.6 4.4 0.1 0.0 0.2 2.7 0.3 1.4 0.6 0.5 0.8 2.6 1.2 0.9 0.3 2.1 1.4 0.7 1.8 1.3 0.5 0.7 0.6 0.3 0.5 0.8 1.2 1.2 0.5 0.6 1.0 0.9 1.0 0.5 0.7 1.1 1.7 0.0 0.0 1.0 3.9 1.3 1.4 0.0 1.2 1.4 2.1 1.5 1.9 0.0 1.3 7.3 0.0 4.1 1.3 0.4 9.8 1.8 4.6 1.0 1.5 2.3 0.0 0.4 2.0 2.0 5.5 1.7 1.5 1.1 2.5 9.2 3.9 0.0 1.2 5.0 1.1 0.5 2.0 0.3 1.9 2.6 1.5 1.1 0.0 5.6 0.6 1.1 3.1 8.0 4.6 0.8 0.2 1.5 0.7 1.0 0.0 3.5 1.5 0.4 0.0 1.1 1.3 19.9 13.5 0.4 1.7 3.4 2.4 2.4 0.4 1.3 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630176-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 11.3 11.4 3.4 8.7 3.9 23.1 15.4 9.0 4.6 18.0 4.8 10.2 7.5 20.1 8.1 8.4 12.4 9.6 9.2 3.6 3.8 10.3 13.2 10.1 10.0 3.1 3.0 23.7 13.7 11.1 4.5 11.5 3.6 10.6 11.5 12.4 10.5 9.9 12.6 6.6 9.5 15.1 4.0 10.3 10.3 7.8 3.5 35.9 11.5 11.6 9.9 10.9 8.5 9.8 13.4 7.4 13.6 20.9 13.3 18.7 9.9 20.2 14.3 8.2 9.3 5.4 13.6 22.7 8.4 14.5 7.9 10.0 6.7 5.3 9.9 11.6 4.1 2.4 12.5 8.2 13.3 20.4 6.6 12.8 7.6 5.6 8.0 20.6 18.3 23.0 11.9 25.7 13.0 9.6 14.4 2.3 0.0 15.6 5.8 4.3 22.2 16.1 10.1 15.4 11.2 20.0 16.9 10.5 6.7 0.7 11.4 19.9 16.2 12.1 18.2 11.3 16.1 13.2 21.6 0.0 13.7 31.0 13.2 7.8 2.6 3.5 2.1 2.2 2.0 3.4 1.9 1.7 3.6 3.2 2.0 2.4 0.4 1.8 2.0 3.6 1.9 1.0 3.4 3.9 9.0 4.6 3.6 3.8 3.1 3.0 3.6 4.0 3.5 9.8 32.4 9.6 18.9 176.6 31.1 11.1 18.3 12.9 42.7 79.8 20.5 20.7 37.9 22.8 14.6 3.7 83.4 23.0 25.5 12.2 7.9 12.0 18.3 14.3 33.0 36.5 32.3 27.5 107.2 14.0 21.5 37.5 26.0 14.2 17.7 37.8 34.2 31.1 36.6 69.0 151.3 25.7 16.2 35.6 18.1 49.5 33.2 22.9 16.0 91.8 27.0 24.9 28.8 200.1 293.3 10.5 10.4 21.1 41.4 21.1 26.8 14.2 12.8 84.5 6.6 47.4 30.8 49.4 33.8 26.8 13.9 13.3 21.4 27.7 22.2 16.3 ZNF292 "bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16" ENSG00000188994 "Zinc finger protein 292" O60281 6 87152833-87265943 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032154, HPA050618" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear membrane" "HPA032154: AB_10601930, HPA050618: AB_2681190" "unprognostic (6.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (2.08e-3)" "unprognostic (2.28e-2)" "unprognostic (2.81e-2)" "unprognostic (4.03e-2)" "unprognostic (8.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.06e-2)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.02e-1)" "unprognostic (7.36e-2)" 6.8 6.3 4.4 7.8 4.6 25.4 9.6 17.8 8.7 8.7 1.8 7.3 7.9 10.3 9.5 6.6 6.2 6.7 6.2 3.9 3.1 6.3 6.4 5.7 10.9 3.2 2.5 13.7 6.9 13.8 8.5 8.8 3.8 8.2 6.8 26.4 8.3 7.2 5.5 8.6 8.8 6.4 2.2 8.0 8.1 6.2 3.7 14.3 9.6 5.6 9.1 7.1 7.3 10.3 8.3 4.7 16.1 14.2 9.0 8.1 16.8 6.4 8.1 7.4 10.1 8.2 5.7 12.8 9.0 8.4 10.4 8.4 10.1 9.6 15.9 29.3 7.6 17.3 6.4 6.8 6.7 14.0 7.6 8.1 9.2 7.3 9.4 11.8 6.9 13.6 12.8 19.1 8.1 4.6 8.1 12.0 8.1 2.9 4.4 16.9 15.9 4.9 6.2 17.8 11.9 16.8 8.0 5.3 6.1 9.2 5.4 16.0 7.8 9.8 6.8 7.2 10.1 17.5 12.3 8.6 10.8 11.8 7.2 60.3 16.9 20.0 15.7 5.4 14.8 46.6 16.8 17.3 8.0 42.8 18.7 16.1 83.6 11.2 5.7 25.0 18.3 8.3 4.4 4.6 17.8 8.7 3.9 3.1 3.2 2.5 3.8 2.2 3.7 10.3 64.2 60.9 72.4 147.2 99.0 66.2 31.2 46.1 70.0 167.7 48.0 47.9 76.8 48.6 51.8 25.8 123.0 27.0 89.9 64.9 9.8 122.3 44.4 119.3 89.6 55.6 47.3 43.5 176.6 38.5 36.6 52.3 66.3 203.1 29.1 135.6 40.0 19.0 26.8 186.7 225.7 52.7 40.7 29.2 53.1 12.4 60.0 46.3 32.0 124.6 53.0 62.5 65.9 210.6 209.8 52.2 49.5 66.2 90.8 49.4 72.5 14.5 50.1 99.4 32.9 84.6 59.5 56.3 34.1 36.7 51.4 211.8 90.8 66.8 44.5 58.5 ZNF304 ENSG00000131845 "Zinc finger protein 304" Q9HCX3 19 57351271-57359898 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050531 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 35: Glandular cells - Unknown function" "Nuclear speckles" Cytosol "HPA050531: AB_2681160" "unprognostic (4.44e-1)" "unprognostic (1.73e-3)" "unprognostic (5.63e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (9.72e-2)" "unprognostic (2.86e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (5.97e-2)" "prognostic favorable (1.52e-7)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (4.31e-1)" "unprognostic (9.00e-3)" 4.4 6.3 4.2 3.5 4.4 4.3 6.5 6.7 6.0 4.3 3.5 4.9 2.6 5.0 7.4 5.2 5.2 4.3 6.2 4.8 4.4 4.5 3.5 5.3 5.2 3.0 3.6 6.7 2.5 10.0 5.0 5.5 3.2 5.5 3.1 5.3 4.7 6.2 5.0 6.1 3.8 5.1 3.4 6.8 3.9 4.4 4.3 7.5 7.0 5.3 7.3 4.2 3.0 4.1 6.4 3.1 7.6 9.6 6.2 5.9 4.8 6.4 9.7 7.1 16.0 0.0 3.0 5.3 3.9 7.4 3.7 2.3 4.4 8.4 10.6 1.7 20.5 8.4 8.9 4.5 4.4 4.7 5.1 7.1 11.0 7.0 9.7 7.6 4.5 11.8 2.6 0.0 7.6 1.7 10.0 2.7 5.1 0.0 9.9 6.3 12.3 6.7 5.0 13.7 6.0 6.4 6.7 5.1 4.4 6.9 6.2 6.6 5.2 9.9 5.9 3.1 6.8 8.1 7.7 7.8 6.3 0.1 5.3 2.5 1.3 1.1 1.4 1.0 2.6 2.3 2.4 2.0 1.8 1.8 1.9 2.1 0.1 2.8 2.8 0.9 2.0 1.7 4.2 4.4 6.7 6.0 4.8 4.4 3.0 3.6 3.2 3.4 4.3 4.1 5.0 0.0 0.5 4.2 3.2 6.4 0.8 1.3 4.6 4.9 6.9 5.1 4.4 7.2 4.6 0.0 0.0 1.7 2.9 1.0 1.9 1.7 1.2 3.2 1.8 4.1 0.0 0.0 8.2 1.0 0.8 1.9 1.5 4.0 0.0 5.2 10.4 2.7 1.6 3.3 6.4 1.4 4.1 2.1 2.8 1.1 1.8 1.6 3.6 2.8 0.6 1.4 1.0 3.0 2.8 0.9 0.5 2.2 1.6 1.4 0.8 1.6 6.2 2.2 0.0 2.2 2.8 2.2 4.2 5.4 5.5 1.1 2.1 5.0 1.9 1.2 ZNF318 "HRIHFB2436, ZFP318" ENSG00000171467 "Zinc finger protein 318" Q5VUA4 6 43307134-43369647 "Predicted intracellular proteins" "Meiosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.9;Spermatogonia: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.1" "Lineage enriched" "Detected in single" 4 "B-cells: 2.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027022, HPA027031" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Cytosol "HPA027022: AB_1859189, HPA027031: AB_1859190" "unprognostic (1.64e-1)" "unprognostic (3.80e-1)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (1.97e-2)" "unprognostic (3.02e-2)" "unprognostic (2.53e-3)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (3.37e-2)" "unprognostic (8.24e-2)" "unprognostic (3.47e-1)" "unprognostic (4.61e-3)" "unprognostic (3.61e-1)" "unprognostic (3.00e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-2)" 8.1 6.4 6.4 12.4 5.5 11.4 7.9 11.7 8.8 14.2 1.9 9.3 7.2 11.5 10.6 6.4 9.7 7.0 7.0 6.3 5.3 6.4 8.1 7.5 25.6 3.7 4.6 11.9 8.2 10.8 7.3 8.0 3.6 9.7 8.0 21.2 7.5 8.1 8.5 12.0 9.7 9.0 3.1 14.4 6.3 26.2 4.8 13.3 12.5 6.3 25.0 8.9 10.0 6.9 26.4 6.2 18.0 29.9 15.4 13.7 9.3 11.6 14.3 12.8 11.1 6.6 3.2 41.5 6.4 14.4 15.0 11.4 20.0 9.5 16.6 11.8 10.7 11.4 8.1 10.7 7.7 20.2 9.2 8.8 9.8 10.8 9.6 10.8 10.2 11.3 15.6 19.3 13.8 9.0 6.4 12.8 8.1 42.9 5.9 7.6 17.9 6.4 7.1 5.9 16.6 10.2 8.6 7.2 9.0 13.8 9.1 27.6 10.6 17.9 9.2 12.2 11.4 12.4 10.9 28.2 5.6 15.1 10.2 0.0 0.3 0.0 0.5 0.2 0.1 0.6 0.4 0.3 0.3 2.1 0.3 0.3 0.1 0.3 0.1 0.3 0.5 0.2 6.4 5.5 11.7 8.8 6.3 5.3 3.7 4.6 3.6 3.1 4.8 6.9 7.8 9.6 14.5 10.7 29.9 9.7 4.4 5.6 12.0 18.1 6.5 6.9 9.5 8.6 6.4 9.2 8.4 5.8 6.8 5.2 3.9 5.2 30.7 9.2 13.3 7.8 5.4 8.2 19.9 4.7 4.4 10.4 5.1 6.3 6.3 20.6 11.7 19.4 6.6 25.2 18.9 5.1 6.1 11.1 7.2 16.5 6.2 10.7 3.6 4.7 9.7 9.4 16.5 15.6 17.5 4.2 8.2 9.8 5.1 3.0 11.4 3.9 6.8 11.8 26.3 13.6 8.7 82.9 46.3 9.0 5.1 1.8 8.8 8.9 8.3 2.0 ZNF350 "ZBRK1, ZFQR" ENSG00000256683 "Zinc finger protein 350" Q9GZX5 19 51964340-51986856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 4 "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001521 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nuclear bodies" "HPA001521: AB_1080705" "unprognostic (7.26e-3)" "unprognostic (4.02e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.03e-2)" "unprognostic (4.17e-2)" "unprognostic (7.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.08e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-1)" "unprognostic (3.25e-3)" "unprognostic (6.64e-3)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (8.30e-2)" "prognostic favorable (2.54e-4)" 6.6 4.4 5.8 5.4 7.3 26.2 13.8 8.6 6.7 5.5 4.1 6.6 5.4 6.4 8.2 4.7 5.8 5.2 5.1 6.4 6.5 7.0 5.3 6.3 9.7 6.0 5.7 8.3 4.5 9.2 4.8 9.3 6.1 27.5 9.1 9.7 6.4 6.3 4.5 7.5 6.1 5.8 5.8 9.0 7.3 6.3 6.5 9.0 9.8 5.9 9.1 6.2 5.2 7.2 0.8 4.4 5.6 6.8 7.5 6.7 1.1 4.6 6.5 4.8 9.5 0.0 3.5 2.1 3.6 5.5 8.8 5.8 4.9 6.5 6.6 0.0 10.5 8.6 7.5 3.9 6.3 2.2 10.1 9.5 9.9 6.4 6.6 9.4 5.5 3.5 2.3 0.1 5.8 2.8 8.5 10.2 3.7 0.5 6.8 4.0 8.0 6.9 7.6 11.9 4.7 6.3 0.0 6.0 5.0 7.9 9.8 7.7 5.9 5.2 3.7 3.1 4.7 1.6 2.8 2.7 1.0 0.1 5.6 65.3 11.2 26.9 16.2 12.7 16.4 16.8 15.3 15.6 13.6 17.2 17.7 14.2 30.8 21.5 16.2 8.8 13.4 8.1 5.8 7.3 8.6 6.7 6.4 6.5 6.0 5.7 6.1 5.8 6.5 7.2 9.1 0.0 7.3 4.6 13.1 5.9 11.0 11.1 5.7 9.9 6.0 5.3 6.6 2.8 10.7 9.2 12.5 12.2 12.9 5.1 7.9 6.7 13.0 4.5 4.7 8.0 7.3 2.5 4.2 5.3 9.9 7.1 3.6 6.7 12.0 9.7 6.4 3.1 7.8 6.7 4.1 5.9 16.2 9.5 12.0 3.4 11.1 10.8 12.4 6.5 11.6 7.9 23.7 4.0 9.1 6.0 5.7 6.0 7.5 14.5 7.6 3.9 7.8 13.1 0.0 7.2 8.4 10.2 5.7 3.5 7.0 23.1 15.1 6.8 3.8 13.4 ZNF384 "CAGH1A, CIZ, NMP4, NP, TNRC1" ENSG00000126746 "Zinc finger protein 384" Q8TF68 12 6666477-6689572 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004051 Supported Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA004051: AB_1859228" "unprognostic (1.90e-1)" "unprognostic (5.11e-3)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (3.04e-2)" "unprognostic (1.87e-2)" "unprognostic (9.94e-2)" "unprognostic (1.35e-2)" "unprognostic (2.57e-2)" "unprognostic (3.51e-2)" "unprognostic (4.25e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.22e-1)" "unprognostic (2.06e-1)" "unprognostic (8.13e-2)" 31.4 33.2 21.9 36.2 23.2 59.9 30.7 26.9 26.4 39.8 22.9 35.1 35.1 40.6 25.1 27.9 35.8 26.1 25.9 22.5 23.8 28.9 26.3 28.6 36.0 23.5 22.3 46.3 29.8 34.7 32.6 32.5 22.3 31.9 32.7 30.2 29.9 30.0 36.7 32.1 36.8 37.8 20.8 40.2 30.9 31.7 22.8 46.7 38.4 32.3 37.6 36.7 30.8 25.4 35.4 66.2 79.9 53.7 55.2 38.9 107.1 50.0 46.4 47.3 50.3 73.3 73.6 82.9 18.5 56.4 68.5 46.6 59.8 45.9 53.6 150.8 54.0 94.9 93.0 38.6 38.9 91.2 67.5 43.0 43.6 58.3 90.1 88.9 41.5 57.4 50.6 27.9 52.4 54.8 82.6 58.3 155.0 64.1 28.7 81.0 85.4 32.2 41.9 93.6 24.8 80.4 51.8 68.4 44.1 133.5 18.0 74.5 51.9 51.6 71.4 40.9 59.6 38.5 39.6 149.9 51.0 32.4 60.0 3.7 8.5 15.4 16.4 9.8 13.4 9.7 10.7 13.4 11.5 8.0 10.2 11.6 14.4 17.0 15.3 7.6 14.5 8.3 21.9 23.2 26.9 26.4 22.5 23.8 23.5 22.3 22.3 20.8 22.8 25.4 19.2 0.0 8.7 17.3 12.5 7.9 2.6 4.4 12.0 6.0 11.1 11.9 2.6 10.0 4.7 1.8 10.4 6.7 17.9 16.5 0.0 4.6 4.3 10.2 12.9 10.7 3.6 8.0 10.3 5.0 6.8 8.2 12.8 13.5 5.7 14.7 8.9 8.3 7.0 0.0 10.4 11.8 2.0 16.6 6.0 2.7 8.4 8.6 5.4 6.5 9.9 6.1 7.2 9.0 11.8 6.8 14.4 8.6 11.4 4.8 10.6 4.3 5.6 7.8 0.0 9.3 9.3 7.1 6.5 10.7 9.8 7.3 13.2 9.0 13.4 4.6 ZNF398 "KIAA1339, P51, P71, ZER6" ENSG00000197024 "Zinc finger protein 398" Q8TD17 7 149126416-149183042 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 32.3;Inhibitory neurons: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NTERA-2: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073151 Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear membrane" "HPA073151: " "unprognostic (4.11e-1)" "unprognostic (8.56e-2)" "unprognostic (3.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (6.65e-3)" "unprognostic (2.94e-3)" "unprognostic (2.27e-2)" "unprognostic (3.64e-3)" "unprognostic (1.43e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (1.45e-1)" "unprognostic (3.97e-2)" "unprognostic (9.27e-2)" "unprognostic (9.17e-2)" "unprognostic (1.89e-1)" 3.9 3.3 1.6 3.6 1.8 7.6 4.4 6.3 3.7 4.9 0.6 4.4 3.7 4.1 4.3 6.4 4.3 3.0 3.3 1.6 2.2 3.5 3.6 3.8 4.7 0.1 0.4 4.4 4.5 5.0 4.9 3.8 0.2 4.8 3.6 7.6 4.8 5.1 4.4 6.8 3.7 4.0 0.0 4.5 4.5 8.5 1.8 5.3 3.6 4.5 5.6 4.8 5.0 2.5 9.8 9.5 7.1 13.8 10.4 7.4 8.4 5.8 8.6 7.3 8.2 7.9 5.0 12.5 6.8 10.6 6.5 8.0 12.0 8.2 5.3 7.3 14.4 8.3 7.2 5.3 7.3 9.8 8.1 8.3 12.1 8.2 8.4 5.4 5.2 4.9 11.9 4.7 8.3 13.9 13.6 10.3 47.1 9.4 8.9 10.3 7.9 9.1 5.7 19.0 9.8 10.9 9.2 11.2 5.7 7.7 6.8 10.6 6.2 7.4 1.9 13.3 7.6 12.7 6.6 9.6 9.6 8.0 7.4 2.4 0.6 2.3 1.1 0.7 1.4 1.0 0.8 1.2 0.5 0.8 1.2 1.3 1.2 0.7 0.6 0.7 1.1 0.4 1.6 1.8 6.3 3.7 1.6 2.2 0.1 0.4 0.2 0.0 1.8 2.5 3.9 6.4 4.6 19.2 6.6 7.8 4.5 4.0 5.7 8.8 5.6 3.7 5.9 0.0 5.5 5.5 6.2 4.2 7.7 4.4 0.0 3.9 23.5 7.0 8.6 5.9 1.8 8.6 32.3 2.8 4.9 5.1 12.2 7.5 4.5 7.1 3.9 2.8 3.7 3.3 31.3 3.7 2.0 5.0 3.3 25.2 7.2 3.9 8.8 21.5 4.8 4.5 3.1 20.6 28.6 4.6 2.1 9.1 10.9 6.6 3.8 3.1 6.9 11.6 0.0 6.4 4.5 21.4 13.5 10.1 8.5 3.1 5.2 4.7 3.8 9.9 ZNF416 FLJ20557 ENSG00000083817 "Zinc finger protein 416" Q9BWM5 19 57571566-57578911 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063318 Approved "Nuclear bodies,Cytosol" No No "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nuclear bodies" "HPA063318: AB_2684983" "unprognostic (1.40e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.14e-2)" "unprognostic (7.57e-3)" "unprognostic (3.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.54e-2)" "unprognostic (6.62e-3)" "unprognostic (5.37e-2)" "prognostic favorable (1.20e-5)" "unprognostic (1.31e-1)" "unprognostic (2.62e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-1)" 2.2 2.2 2.6 1.6 3.0 2.6 3.7 4.3 3.7 2.7 2.2 2.3 1.4 2.3 3.9 3.2 3.4 1.8 2.7 2.7 2.5 2.6 2.0 2.5 2.8 2.0 2.2 4.4 1.4 4.4 2.0 2.9 2.0 2.7 2.1 3.7 2.2 3.1 2.6 5.1 1.7 2.8 2.2 2.8 2.1 4.2 2.6 4.0 3.6 3.0 4.1 2.4 2.4 2.9 3.2 3.1 6.5 5.2 3.9 5.6 4.3 3.2 5.8 6.2 4.0 2.2 1.7 2.2 2.3 4.1 4.5 1.2 3.8 5.5 7.6 3.5 15.5 5.3 3.5 1.8 7.0 4.7 3.3 5.6 5.6 3.9 8.2 4.9 4.3 5.3 0.7 1.7 8.4 1.3 9.9 2.2 7.7 3.8 5.7 4.9 9.7 4.8 4.3 6.8 4.7 5.3 5.8 3.0 2.9 7.3 2.7 5.6 3.2 6.7 3.2 2.2 4.8 5.4 9.5 5.9 1.5 3.1 4.1 1.1 2.6 1.9 4.3 1.9 7.7 6.6 5.9 6.3 4.1 10.4 8.0 5.8 0.8 9.0 1.7 3.7 2.9 3.7 2.6 3.0 4.3 3.7 2.7 2.5 2.0 2.2 2.0 2.2 2.6 2.9 1.1 0.0 0.5 1.3 2.9 1.7 1.6 1.6 1.2 3.5 1.6 1.8 1.8 1.5 1.6 0.0 0.0 2.1 1.0 0.6 3.9 2.8 5.0 0.9 0.9 1.8 0.0 3.6 1.5 0.9 0.8 1.1 1.5 1.1 2.5 2.6 0.7 1.2 1.7 8.4 1.4 1.1 0.0 1.0 0.6 2.0 0.9 0.6 0.0 1.0 0.5 3.2 3.1 3.0 0.2 1.4 1.2 0.7 0.8 1.3 1.1 1.3 0.6 2.8 6.6 1.5 1.2 3.1 4.1 1.3 2.4 1.9 1.3 2.4 0.9 2.2 ZNF43 "HTF6, KOX27, ZNF39L1" ENSG00000198521 "Zinc finger protein 43" P17038 19 21804946-21852125 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 52.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 37.8" HPA050271 Uncertain NA NA "Cluster 30: Non-specific - Translation" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA050271: AB_2681070" "unprognostic (9.25e-3)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-2)" "unprognostic (1.25e-1)" "unprognostic (4.16e-3)" "unprognostic (3.61e-2)" "unprognostic (2.47e-3)" "unprognostic (4.45e-3)" "prognostic favorable (3.16e-5)" "unprognostic (2.73e-2)" "unprognostic (1.01e-1)" "unprognostic (3.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-3)" "unprognostic (1.43e-3)" 3.9 4.0 1.6 5.5 4.1 10.7 7.8 10.6 3.0 4.9 1.1 4.4 3.6 6.3 4.6 3.6 6.8 4.0 4.5 1.5 5.2 5.0 1.4 4.2 8.4 2.9 1.9 11.2 3.0 6.7 2.6 4.8 3.2 7.2 5.3 6.7 3.5 4.9 3.1 7.3 4.2 4.4 0.8 6.6 4.8 8.7 2.9 10.1 8.7 4.1 6.8 3.6 3.1 7.7 0.4 3.7 25.0 19.8 2.7 5.9 10.4 6.6 2.7 8.3 11.4 0.3 3.8 5.9 7.5 4.2 7.7 0.5 0.3 0.7 13.8 0.8 6.5 0.3 1.6 2.9 1.3 0.2 7.2 5.6 0.9 8.9 0.4 2.1 1.9 21.8 0.4 1.1 6.3 4.3 37.8 9.1 18.0 0.5 5.4 22.0 9.8 6.6 5.4 18.9 16.7 12.6 0.1 0.1 2.2 11.3 9.6 5.1 0.4 0.7 0.8 6.0 7.0 1.5 11.3 10.2 0.3 0.8 0.8 30.7 4.5 6.2 8.8 4.6 8.4 18.8 11.5 9.9 4.6 19.1 18.6 12.7 4.5 9.0 4.0 8.5 8.1 3.9 1.6 4.1 10.6 3.0 1.5 5.2 2.9 1.9 3.2 0.8 2.9 7.7 17.0 12.8 15.1 19.2 14.4 2.0 8.1 1.4 2.8 16.0 10.6 12.2 13.2 8.6 9.9 3.7 10.4 9.4 10.6 3.7 17.6 11.0 36.3 11.6 13.6 16.0 11.4 16.2 9.5 9.4 7.6 12.8 5.1 16.6 16.4 52.0 16.8 0.4 4.8 8.4 14.1 4.2 6.1 4.4 4.4 9.8 14.0 6.6 1.8 18.7 6.5 12.5 20.6 26.7 23.1 7.6 4.0 9.4 7.7 8.8 2.4 7.4 6.6 9.6 6.6 13.8 13.3 21.3 15.7 3.3 2.0 5.9 10.8 41.0 7.1 4.4 ZNF430 FLJ13659 ENSG00000118620 "Zinc finger protein 430" Q9H8G1 19 21020634-21060050 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059135 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA059135: AB_2683918" "unprognostic (2.47e-1)" "unprognostic (4.29e-1)" "unprognostic (1.38e-1)" "unprognostic (4.14e-2)" "unprognostic (1.11e-1)" "unprognostic (4.75e-3)" "unprognostic (5.86e-2)" "unprognostic (1.91e-1)" "unprognostic (1.51e-4)" "unprognostic (2.03e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.19e-1)" "unprognostic (2.31e-1)" "unprognostic (1.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.24e-3)" 3.2 3.0 3.0 5.4 4.4 12.0 5.2 7.3 3.5 4.0 0.0 3.1 3.7 4.3 8.5 6.8 3.8 3.5 1.9 1.8 2.7 2.7 1.2 3.8 10.3 3.8 2.7 12.7 4.1 7.9 1.9 3.4 3.8 4.9 4.2 2.9 3.5 3.8 1.5 7.0 3.4 3.5 1.9 6.7 4.9 3.0 3.1 9.8 8.6 2.7 7.8 4.5 4.7 5.9 6.6 1.9 8.0 5.7 6.0 11.2 7.7 6.0 6.4 8.6 8.2 3.7 6.0 10.4 5.7 5.2 5.4 3.7 0.3 6.0 13.0 3.8 7.7 7.3 4.3 3.5 2.9 2.5 14.4 5.9 7.3 5.4 9.9 6.1 6.2 10.8 8.2 12.0 7.8 3.0 17.4 7.8 8.0 3.4 12.8 11.2 10.8 6.0 6.3 9.6 8.9 5.8 1.7 0.8 5.1 7.7 3.5 12.9 4.3 4.6 2.9 8.9 7.4 6.2 7.0 13.1 2.1 7.2 4.6 19.6 4.4 15.9 8.5 5.2 10.4 10.2 10.6 10.1 3.6 13.0 13.9 11.2 10.3 10.4 5.5 6.6 11.4 4.8 3.0 4.4 7.3 3.5 1.8 2.7 3.8 2.7 3.8 1.9 3.1 5.9 16.8 9.6 12.8 16.3 48.2 28.7 23.7 13.2 21.6 33.1 11.4 11.0 4.0 5.7 9.8 18.4 20.9 12.3 50.8 8.3 1.9 11.9 0.8 11.6 17.8 14.4 10.7 16.2 13.8 8.0 10.6 15.1 13.7 33.3 17.7 45.6 16.1 0.8 10.2 23.5 18.6 7.7 12.2 16.9 17.7 1.8 15.2 20.6 3.6 11.2 19.0 8.6 28.8 23.1 31.1 13.9 7.5 11.3 27.9 26.8 7.0 1.9 12.1 19.7 0.0 13.9 14.8 18.4 16.8 33.5 35.5 9.9 40.9 32.8 9.6 50.4 ZNF439 DKFZp571K0837 ENSG00000171291 "Zinc finger protein 439" Q8NDP4 19 11848726-11883750 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;Rod photoreceptor cells: 49.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 26.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.4;U-138 MG: 15.6" HPA047845 Approved Uncertain Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (4.83e-2)" "unprognostic (3.55e-3)" "unprognostic (2.93e-2)" "unprognostic (1.19e-3)" "unprognostic (8.26e-3)" "unprognostic (7.54e-2)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "unprognostic (9.66e-4)" "unprognostic (1.00e-1)" "unprognostic (8.68e-2)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.29e-2)" 2.6 3.5 3.8 3.5 4.7 4.2 5.7 8.2 5.2 4.2 4.3 5.0 1.1 5.2 5.0 3.2 4.0 2.4 3.5 4.0 4.0 6.3 1.3 5.1 7.3 4.5 4.1 8.1 4.1 16.5 10.1 5.2 5.0 6.2 3.8 14.7 5.3 4.4 0.8 8.0 8.0 2.6 4.0 9.4 3.9 5.7 4.1 10.0 7.3 1.1 7.6 5.6 4.8 6.7 0.1 0.0 4.2 12.2 0.4 0.3 0.0 5.2 1.8 6.2 4.2 3.0 0.2 4.5 2.2 2.9 1.8 0.1 0.0 0.4 7.2 0.0 0.1 4.4 0.0 1.8 1.2 0.0 4.2 1.2 0.3 1.3 0.0 2.7 0.0 4.2 0.8 0.0 0.4 0.4 6.2 15.4 5.1 0.0 1.2 7.3 1.2 0.0 4.6 2.6 7.5 8.0 0.0 0.1 5.6 4.3 3.2 10.0 0.0 15.6 1.4 1.3 3.1 6.0 10.1 10.1 0.2 0.0 4.3 26.1 0.6 5.7 1.7 1.6 2.3 8.9 3.0 1.7 2.8 8.6 5.4 3.1 1.6 2.2 3.5 2.7 1.4 1.9 3.8 4.7 8.2 5.2 4.0 4.0 4.5 4.1 5.0 4.0 4.1 6.7 3.1 3.2 10.4 15.0 23.9 0.5 2.5 1.6 3.4 26.2 3.9 4.6 3.5 11.5 6.8 0.0 52.1 32.8 8.3 9.2 3.9 8.2 4.5 6.5 5.1 4.6 6.1 3.0 19.2 1.8 22.2 3.8 4.1 4.4 29.8 11.2 6.1 0.2 4.2 16.8 8.7 2.3 2.0 1.9 3.1 3.8 4.4 2.7 5.4 14.0 2.4 10.4 25.7 31.7 28.3 3.0 6.0 7.9 4.1 2.1 6.5 2.1 5.8 49.9 13.1 1.8 5.9 21.7 5.8 1.1 1.8 13.5 7.4 2.8 3.1 1.3 ZNF45 ZNF13 ENSG00000124459 "Zinc finger protein 45" Q02386 19 43912624-43935282 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038611, HPA075124" Uncertain Supported Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA038611: AB_10669544, HPA075124: AB_2686735" "unprognostic (1.67e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-2)" "unprognostic (1.84e-3)" "unprognostic (1.23e-1)" "unprognostic (9.31e-2)" "unprognostic (5.34e-2)" "unprognostic (1.04e-1)" "unprognostic (1.60e-3)" "unprognostic (1.91e-1)" "unprognostic (7.68e-3)" "unprognostic (5.17e-3)" "unprognostic (5.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (4.43e-2)" "unprognostic (5.82e-2)" 4.8 5.5 3.0 5.1 3.7 6.3 7.1 6.3 3.4 6.7 3.7 5.2 5.6 7.1 5.5 4.6 6.5 5.1 4.6 3.1 4.9 5.8 5.8 5.9 7.3 3.7 3.4 9.0 4.0 9.7 5.0 5.3 3.2 6.7 6.1 8.5 4.9 5.8 6.5 5.9 5.3 6.0 3.2 7.3 5.0 3.6 3.8 10.7 7.4 5.8 7.1 5.1 3.9 4.5 9.2 12.1 16.9 15.1 8.0 7.0 5.9 11.7 12.7 12.0 18.2 5.9 3.7 13.3 7.0 7.3 9.2 5.2 12.9 8.5 15.0 11.2 13.7 19.7 10.6 5.3 7.4 19.5 12.8 7.1 8.4 8.8 7.7 11.9 9.7 4.5 6.3 5.2 13.0 4.2 11.6 4.9 19.8 8.6 5.1 9.4 16.8 4.8 7.3 20.1 11.6 19.0 16.4 6.6 5.8 10.8 6.9 12.7 10.1 13.3 19.4 5.6 10.8 21.1 37.1 14.5 5.6 7.5 15.7 3.4 3.7 5.7 5.6 3.4 8.4 5.8 5.4 6.0 4.9 4.1 7.4 5.0 1.1 6.3 4.7 3.2 6.1 4.2 3.0 3.7 6.3 3.4 3.1 4.9 3.7 3.4 3.2 3.2 3.8 4.5 2.9 3.2 1.7 7.5 4.2 1.5 0.8 2.2 3.4 1.8 3.1 2.0 3.3 1.5 3.6 0.0 6.2 2.0 5.1 2.4 0.0 2.3 0.2 2.4 1.9 2.4 2.4 3.4 5.0 1.5 1.1 2.3 3.6 2.6 0.0 3.2 1.8 2.1 2.9 3.3 4.9 3.2 2.0 2.8 1.6 0.6 1.8 2.5 1.8 10.3 2.4 1.6 1.0 8.0 9.0 1.2 0.7 4.9 1.5 1.7 2.6 1.9 4.1 2.4 19.7 2.4 1.9 1.1 2.1 3.9 1.6 1.2 3.7 2.4 2.1 1.5 ZNF480 MGC32104 ENSG00000198464 "Zinc finger protein 480" Q8WV37 19 52297169-52325922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042218 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Cytosol "HPA042218: AB_10794791" "unprognostic (1.50e-2)" "unprognostic (1.43e-1)" "unprognostic (1.56e-1)" "unprognostic (1.35e-1)" "unprognostic (3.01e-2)" "unprognostic (5.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (4.22e-2)" "unprognostic (7.81e-3)" "unprognostic (4.97e-2)" "prognostic favorable (2.03e-4)" "unprognostic (3.05e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-1)" "unprognostic (1.82e-3)" 7.6 7.3 4.8 10.4 5.9 9.5 6.6 7.7 6.9 7.5 5.3 10.4 9.8 6.0 3.3 6.5 5.6 4.5 11.1 4.8 6.0 8.7 8.6 6.2 12.6 6.0 5.1 6.9 4.5 7.4 5.9 5.7 6.0 6.2 10.1 10.4 7.2 5.2 10.8 5.5 8.2 6.0 4.2 9.8 9.1 3.3 5.9 15.2 7.2 14.9 15.5 11.1 5.4 8.3 7.2 28.4 18.2 21.2 21.1 19.7 14.1 18.3 26.7 12.8 14.9 12.9 10.0 36.0 11.2 15.1 23.4 15.3 19.9 18.5 18.5 0.3 33.1 37.0 15.2 12.5 20.3 52.7 29.0 18.1 23.4 17.8 20.7 26.7 18.8 31.0 27.0 12.0 29.0 11.7 48.3 10.5 13.7 23.7 22.8 24.5 19.5 30.0 18.8 51.0 17.2 15.0 26.6 18.9 7.4 37.3 15.7 38.1 32.4 12.7 15.8 7.3 28.6 28.4 56.9 74.3 5.7 28.2 23.1 10.1 9.6 11.2 12.6 9.4 14.5 19.7 12.8 15.1 11.9 19.1 12.0 16.3 3.6 17.8 11.4 19.3 15.9 7.8 4.8 5.9 7.7 6.9 4.8 6.0 6.0 5.1 6.0 4.2 5.9 8.3 13.1 35.3 11.8 8.5 20.1 5.5 15.3 22.1 5.7 4.7 6.7 6.1 43.0 8.6 18.2 3.7 2.1 8.7 17.8 11.7 17.6 18.6 2.5 12.7 11.9 17.0 12.6 14.9 1.7 27.6 16.8 11.1 9.7 14.1 12.6 15.4 14.3 15.4 17.6 6.7 4.7 18.0 20.3 15.8 14.3 2.4 9.0 12.3 7.2 6.5 19.0 6.1 26.8 9.5 10.2 36.3 11.8 8.2 9.2 25.4 13.5 24.2 16.8 7.4 0.0 10.6 12.0 1.9 6.1 10.5 8.4 14.8 19.7 12.1 16.1 22.6 ZNF490 KIAA1198 ENSG00000188033 "Zinc finger protein 490" Q9ULM2 19 12576100-12640098 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 10.2;Gastric mucus-secreting cells: 13.7;Inhibitory neurons: 9.3;Oligodendrocytes: 10.0;Plasma cells: 14.8" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA005576 Uncertain NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" "HPA005576: AB_10602689" "unprognostic (1.81e-2)" "unprognostic (1.32e-2)" "unprognostic (3.19e-1)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-2)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (5.77e-2)" "unprognostic (9.53e-2)" "unprognostic (1.90e-2)" "unprognostic (1.38e-3)" "unprognostic (2.80e-1)" "unprognostic (7.59e-2)" "unprognostic (5.79e-2)" 0.7 1.0 2.0 1.3 1.9 1.7 1.4 2.1 2.4 1.3 0.3 1.2 1.2 1.0 2.0 0.8 1.5 1.1 0.9 1.6 2.1 1.3 1.8 1.3 2.0 1.0 0.8 1.8 1.5 1.9 0.5 1.1 1.0 1.4 1.3 2.1 1.1 1.3 0.9 1.8 0.9 0.9 0.2 2.4 1.2 1.4 1.7 2.2 2.3 1.0 2.4 1.0 0.5 2.2 0.7 0.6 1.2 3.3 3.5 2.3 1.0 0.9 1.6 1.2 1.5 1.1 1.0 1.2 2.0 1.2 0.8 0.9 1.7 1.4 1.6 1.6 1.0 1.5 1.4 1.4 1.9 2.9 3.6 1.8 1.6 1.0 2.2 1.7 1.1 1.4 1.1 1.4 1.6 1.5 2.0 2.2 1.8 0.6 1.8 1.5 1.8 2.1 1.4 1.8 2.2 1.5 1.9 1.2 1.5 1.8 1.7 1.7 1.6 3.0 0.8 2.2 1.0 4.3 3.3 1.5 1.6 1.9 2.0 5.0 1.5 2.3 2.7 2.1 2.5 2.2 1.7 2.6 1.3 2.8 1.5 2.6 1.4 3.8 2.6 3.8 2.3 1.0 2.0 1.9 2.1 2.4 1.6 2.1 1.0 0.8 1.0 0.2 1.7 2.2 1.7 0.0 1.1 7.2 7.4 0.5 0.3 1.2 2.8 1.4 1.8 1.8 1.2 1.5 1.7 0.0 0.0 0.3 2.7 0.9 1.9 0.2 3.9 1.6 3.0 1.5 0.0 3.8 10.2 0.2 0.2 2.4 13.7 2.3 5.7 1.5 0.0 1.0 0.4 0.0 9.3 0.1 0.0 1.6 1.8 1.6 0.6 2.4 3.6 6.5 0.3 0.5 1.0 4.0 10.0 0.2 0.1 0.0 14.8 0.3 0.9 0.3 0.8 0.8 6.6 0.8 2.2 0.9 1.0 4.9 0.3 0.8 6.0 1.1 0.5 0.2 ZNF506 DKFZp761G1812 ENSG00000081665 "Zinc finger protein 506" Q5JVG8 19 19785839-19821751 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (1.88e-3)" "unprognostic (4.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" "unprognostic (6.26e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (3.68e-3)" "unprognostic (4.74e-3)" "unprognostic (7.95e-2)" "unprognostic (1.52e-3)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (4.39e-2)" "unprognostic (2.37e-1)" "unprognostic (1.28e-2)" "unprognostic (2.51e-3)" 9.8 6.0 7.1 7.4 9.2 9.1 10.4 11.2 15.7 9.6 6.7 8.4 7.8 8.7 11.6 7.8 8.7 8.2 9.9 6.8 7.2 10.8 4.3 7.0 11.2 7.3 6.6 12.7 10.7 10.7 5.9 7.7 7.2 9.5 8.5 12.0 7.1 7.6 7.8 14.0 8.9 6.5 6.1 11.4 9.9 5.7 8.2 9.8 16.8 5.6 12.9 10.5 3.5 13.4 1.3 0.8 7.6 1.2 6.9 9.3 11.9 4.5 2.6 4.2 2.8 3.5 8.9 13.1 10.4 4.2 7.8 8.0 6.2 0.4 5.8 1.9 8.7 1.7 2.8 1.5 9.6 2.2 1.6 7.0 7.1 4.5 0.5 3.5 0.8 7.0 1.2 2.4 6.4 1.2 22.6 4.7 11.2 2.3 1.9 7.1 12.5 6.2 11.1 4.8 12.6 8.5 9.2 4.8 4.9 9.4 9.3 13.3 3.5 5.3 0.8 10.9 5.0 4.3 2.4 7.2 0.5 6.2 7.1 7.7 4.2 9.4 6.4 4.7 7.5 10.6 6.7 6.1 3.3 12.5 12.5 10.7 8.2 7.3 6.7 11.9 7.1 4.2 7.1 9.2 11.2 15.7 6.8 7.2 7.3 6.6 7.2 6.1 8.2 13.4 18.1 16.0 12.6 19.6 30.3 6.2 10.0 7.5 10.2 18.1 12.6 11.9 10.0 15.7 11.7 36.8 27.1 10.3 34.4 11.4 35.2 10.0 35.7 19.3 14.6 14.0 10.3 1.7 24.4 11.6 6.5 14.6 11.2 22.9 9.5 20.0 13.9 2.8 8.1 26.9 29.5 11.2 12.2 8.7 11.4 7.4 12.2 9.2 8.8 25.3 8.0 14.2 35.0 33.7 42.0 13.3 9.0 9.8 17.2 14.3 11.4 37.0 12.1 19.8 6.6 11.6 14.4 7.5 5.3 7.6 8.5 14.6 25.2 14.3 9.8 12.1 ZNF518A "KIAA0335, ZNF518" ENSG00000177853 "Zinc finger protein 518A" Q6AHZ1 10 96129715-96205288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029049 Approved Nucleoplasm Yes No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA029049: AB_2672885" "unprognostic (1.48e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-2)" "unprognostic (4.66e-2)" "unprognostic (7.61e-2)" "unprognostic (3.38e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-2)" "unprognostic (6.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" "unprognostic (8.38e-3)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (3.09e-2)" "unprognostic (1.16e-3)" 4.1 3.2 3.8 4.4 4.5 7.6 7.3 5.7 4.7 4.3 2.1 7.1 5.0 5.6 7.8 4.3 4.3 4.1 3.4 3.5 5.1 5.1 4.6 4.5 6.1 5.0 4.5 7.4 4.5 4.0 4.1 4.4 5.4 4.8 7.0 9.3 4.1 4.2 1.9 6.0 6.4 4.4 4.5 5.4 6.7 16.1 4.7 8.1 7.7 2.3 6.1 3.8 2.8 6.8 4.2 9.4 10.3 0.0 5.1 5.8 12.4 4.4 2.5 4.7 4.8 8.9 10.0 15.5 4.1 2.8 6.7 5.9 11.8 4.2 4.3 7.1 6.3 23.2 3.2 14.5 4.5 25.3 13.5 3.8 10.1 4.9 7.8 3.4 5.7 17.8 20.1 10.1 4.7 4.2 15.0 15.3 15.9 4.7 0.6 16.7 11.8 6.2 5.6 8.5 3.0 7.2 6.2 5.8 4.5 17.0 6.9 16.0 3.7 2.2 8.5 3.0 4.8 9.3 24.9 8.8 1.5 19.0 2.4 9.8 2.6 3.2 1.8 2.8 2.7 2.5 2.1 1.8 1.7 2.2 3.0 2.1 2.5 2.3 5.3 2.9 2.5 1.4 3.8 4.5 5.7 4.7 3.5 5.1 5.0 4.5 5.4 4.5 4.7 6.8 31.1 57.7 28.2 136.8 26.1 0.0 17.1 0.0 13.1 65.0 32.5 21.2 26.5 30.0 14.9 40.5 43.8 49.1 31.6 51.0 19.6 24.1 23.6 42.6 38.8 24.0 61.2 17.1 63.9 25.5 30.8 21.6 32.6 41.3 9.5 57.9 35.3 28.3 28.1 75.7 90.5 35.8 0.0 32.8 0.0 15.0 35.1 31.3 0.0 81.5 48.7 29.1 47.4 150.3 173.0 32.9 52.4 25.2 18.3 20.8 39.5 20.4 10.2 56.9 19.7 33.8 23.2 73.1 131.2 16.2 0.0 43.8 23.3 40.9 35.2 17.6 ZNF518B KIAA1729 ENSG00000178163 "Zinc finger protein 518B" Q9C0D4 4 10439880-10457426 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031215, HPA031216" Approved Approved Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA031215: AB_10600200, HPA031216: AB_10601449" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-1)" "unprognostic (7.74e-3)" "unprognostic (2.11e-1)" "unprognostic (7.99e-2)" "unprognostic (1.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.07e-1)" "unprognostic (2.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (1.27e-1)" "unprognostic (5.44e-2)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" 6.3 4.4 4.7 6.4 5.2 3.9 7.0 7.8 4.7 3.7 4.9 3.9 3.7 4.9 3.6 4.2 2.9 4.3 6.4 5.6 6.4 3.3 2.2 4.3 6.7 2.5 4.0 7.8 1.5 3.7 2.9 7.0 3.6 6.9 2.9 7.0 7.4 7.1 6.0 3.7 5.0 5.6 3.9 6.7 3.5 9.0 7.7 8.6 7.9 8.7 8.7 4.2 3.7 4.0 8.2 5.5 20.8 6.1 2.7 3.9 0.1 9.1 2.3 5.7 6.6 0.0 0.0 0.1 9.2 13.7 16.1 0.2 4.8 10.4 12.6 0.0 8.8 26.2 0.0 0.0 11.9 0.0 11.2 11.7 6.0 9.0 0.0 11.6 19.6 19.3 28.9 0.0 4.7 0.0 18.2 0.6 20.4 4.1 12.5 15.5 8.6 3.0 0.3 11.2 15.5 4.6 4.3 0.0 2.8 16.6 3.4 7.0 14.9 0.0 18.7 0.1 8.8 10.7 8.5 15.1 1.1 1.4 1.1 2.2 2.0 9.6 2.1 1.9 2.6 7.9 3.3 2.4 3.5 3.5 3.4 3.2 4.9 5.0 4.7 1.2 2.6 1.7 4.7 5.2 7.8 4.7 5.6 6.4 2.5 4.0 3.6 3.9 7.7 4.0 15.7 3.2 6.3 4.2 12.1 15.9 22.8 8.0 8.6 9.6 5.7 5.1 26.3 4.3 9.5 0.0 10.4 8.9 3.7 3.6 3.9 2.5 13.1 5.0 9.2 13.1 1.2 4.6 12.1 4.0 9.3 11.9 4.6 10.2 16.5 22.5 12.8 1.8 9.2 11.8 10.6 3.5 14.2 10.2 8.0 20.8 16.1 7.3 1.8 7.5 6.5 6.1 6.2 4.5 3.5 1.6 3.3 21.4 5.3 20.0 6.2 1.3 6.7 10.3 0.0 6.7 8.6 13.7 11.2 6.8 14.2 9.2 8.1 19.7 4.3 19.5 ZNF543 DKFZp434H055 ENSG00000178229 "Zinc finger protein 543" Q08ER8 19 57320472-57330770 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 12.5;Late spermatids: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046330 Approved Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA046330: " "unprognostic (9.20e-2)" "unprognostic (8.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.51e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-1)" "unprognostic (2.45e-2)" "unprognostic (9.86e-2)" "unprognostic (1.01e-1)" "unprognostic (6.55e-2)" "unprognostic (2.44e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.03e-5)" "unprognostic (1.94e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-1)" "unprognostic (2.84e-2)" 1.6 1.5 1.9 1.4 1.7 1.8 2.6 4.9 2.0 1.7 0.2 1.4 0.7 1.9 1.6 2.0 2.2 1.5 1.4 1.4 2.2 1.6 1.1 1.7 2.4 1.2 1.6 4.8 1.9 3.1 1.8 2.8 1.4 2.0 1.0 2.7 1.7 2.2 1.8 2.4 1.1 1.9 0.8 2.5 1.6 3.2 1.7 3.2 2.6 1.9 2.4 1.5 1.3 2.0 2.3 3.0 2.8 4.4 2.4 2.1 3.3 1.3 2.4 2.5 4.4 0.9 1.3 3.6 1.8 1.9 1.6 1.3 2.4 2.5 3.3 1.6 6.5 3.5 3.4 2.8 2.6 3.5 2.3 2.3 2.6 1.9 4.1 2.1 1.9 4.2 1.9 0.7 1.8 0.3 4.0 1.1 2.5 0.2 2.3 3.8 4.1 3.9 1.6 5.6 5.1 3.6 3.9 1.5 2.6 2.4 1.8 3.2 1.8 3.6 2.5 0.7 2.5 5.3 3.8 4.1 1.8 1.5 1.9 0.9 1.4 3.1 1.5 1.4 1.8 2.3 1.6 2.2 1.5 2.3 1.9 1.9 1.5 2.1 1.5 1.0 0.9 1.5 1.9 1.7 4.9 2.0 1.4 2.2 1.2 1.6 1.4 0.8 1.7 2.0 4.1 3.2 0.5 0.7 4.2 2.7 1.3 1.9 3.4 4.5 2.3 1.3 1.9 5.7 2.4 0.0 6.2 3.1 4.8 0.5 5.9 1.6 12.5 3.5 2.4 3.8 0.0 1.3 4.4 0.4 1.5 1.7 0.5 4.4 2.5 4.9 2.9 0.8 1.7 6.7 5.3 1.3 8.2 1.6 1.2 15.2 1.5 1.3 1.8 5.6 0.2 3.8 0.0 4.0 2.5 0.2 0.3 2.2 3.2 1.9 0.6 0.9 0.5 6.3 6.6 2.4 2.9 3.3 2.4 4.4 2.6 2.2 2.6 3.3 1.3 1.5 ZNF550 MGC41917 ENSG00000251369 "Zinc finger protein 550" Q7Z398 19 57535257-57559863 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003251 Uncertain Approved Vesicles,Microtubules NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA003251: AB_1080736" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-2)" "unprognostic (1.43e-1)" "unprognostic (2.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.61e-2)" "unprognostic (2.66e-3)" "unprognostic (3.46e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.33e-2)" "unprognostic (1.59e-1)" "unprognostic (2.69e-2)" "unprognostic (6.68e-3)" "unprognostic (1.52e-1)" 2.8 3.7 1.8 5.1 2.0 5.2 6.0 5.8 2.7 5.5 3.2 2.8 2.2 4.6 3.9 3.1 4.6 3.1 5.6 1.7 2.9 2.9 3.0 3.4 6.7 1.5 1.8 9.1 2.4 7.8 2.5 6.5 2.3 6.0 2.9 7.3 4.2 4.4 2.2 4.0 3.6 3.3 1.1 7.7 3.5 2.8 1.7 7.4 4.8 3.3 5.4 3.6 1.3 2.9 4.3 3.0 8.4 8.0 2.8 6.9 0.0 5.7 4.8 5.0 2.1 3.7 3.9 1.2 3.9 4.2 4.0 3.6 4.4 5.0 6.3 0.1 23.2 11.5 10.9 4.9 4.1 10.1 4.3 5.8 3.0 3.9 11.2 6.9 4.2 10.6 1.8 0.1 5.4 1.0 15.5 4.4 9.2 1.3 5.8 12.3 8.7 12.1 2.7 7.6 7.8 11.0 7.2 4.8 3.5 5.9 5.5 6.6 4.8 6.9 4.2 2.6 5.6 24.0 24.0 10.0 2.8 5.8 6.1 0.4 1.4 2.0 3.6 1.9 4.5 1.8 4.5 2.5 2.0 2.6 5.8 3.4 0.4 5.2 0.6 0.7 4.5 2.3 1.8 2.0 5.8 2.7 1.7 2.9 1.5 1.8 2.3 1.1 1.7 2.9 4.5 0.0 1.1 4.2 8.9 5.1 3.9 2.6 5.7 4.5 4.7 3.6 7.2 2.8 3.4 0.0 6.2 4.2 4.9 0.5 1.9 2.8 1.0 3.4 4.7 5.8 3.6 5.0 4.8 1.2 4.4 3.9 0.5 2.9 5.1 8.3 5.0 3.2 2.3 11.8 5.3 2.8 4.1 1.9 2.2 0.6 4.7 1.4 3.6 2.8 2.5 3.0 12.3 4.0 3.7 2.2 0.8 0.7 3.4 6.7 1.2 0.9 6.5 5.1 0.0 3.3 4.4 3.2 5.0 4.4 6.8 5.2 6.2 4.4 2.7 4.3 ZNF551 DKFZp686H1038 ENSG00000204519 "Zinc finger protein 551" Q7Z340 19 57681969-57717301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebellum: 6.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038187 Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 30: Non-specific - Translation" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "HPA038187: AB_2675884" "unprognostic (1.96e-1)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (6.24e-3)" "unprognostic (1.30e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (2.92e-1)" "unprognostic (5.89e-2)" "unprognostic (4.83e-3)" "prognostic favorable (1.32e-4)" "unprognostic (4.70e-2)" "unprognostic (2.73e-1)" "unprognostic (1.26e-2)" "unprognostic (1.54e-1)" 1.9 2.3 0.9 3.4 1.0 7.9 4.0 6.4 1.1 2.3 2.9 2.4 2.2 1.9 1.8 2.2 2.9 1.7 2.2 1.1 0.7 2.4 1.7 1.9 5.0 0.6 0.9 3.3 2.5 3.3 6.3 2.6 0.4 2.7 2.5 4.9 2.5 2.4 2.0 3.7 2.4 2.4 0.7 3.6 2.7 4.3 1.1 5.1 6.1 1.8 4.9 2.6 1.6 1.2 3.9 8.4 10.2 7.5 1.9 2.4 10.8 4.6 3.2 6.3 2.9 7.2 3.7 7.0 2.9 3.4 4.6 4.3 6.9 10.4 9.7 0.0 30.3 12.4 0.3 3.2 1.8 8.8 10.8 4.1 3.8 6.4 5.8 3.5 2.6 7.2 8.6 0.0 5.6 3.6 18.3 3.4 21.6 7.4 13.5 11.4 17.7 9.3 2.5 22.0 9.9 8.1 6.9 4.3 3.5 9.7 5.5 11.5 3.2 7.2 7.4 2.4 8.6 7.3 17.0 15.7 1.3 4.3 6.9 1.2 1.2 1.3 1.8 1.9 3.3 3.8 2.7 2.9 2.8 2.8 4.3 4.1 0.6 3.1 1.0 2.2 2.3 2.3 0.9 1.0 6.4 1.1 1.1 0.7 0.6 0.9 0.4 0.7 1.1 1.2 2.2 6.4 3.9 2.6 5.4 5.2 6.3 2.6 1.8 7.7 4.7 2.8 1.8 2.8 6.3 1.8 8.4 4.1 4.5 2.3 1.9 3.1 13.8 2.0 3.3 3.3 2.4 11.2 1.1 1.0 3.0 2.8 2.0 3.8 1.3 6.0 4.6 2.4 2.6 3.3 1.4 4.1 4.1 4.4 2.1 4.1 3.4 2.4 1.8 1.0 1.7 2.7 3.1 2.0 0.9 1.9 1.7 4.9 3.3 5.0 1.6 0.7 4.5 13.8 0.0 2.3 2.4 8.7 12.8 4.6 7.1 2.9 4.8 3.3 4.7 7.6 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069703-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments" No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Intermediate filaments" "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favorable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favorable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 1.5 1.9 1.2 1.8 1.5 3.9 1.9 3.1 1.7 1.6 1.5 1.5 1.1 1.7 1.6 1.7 1.9 1.3 1.2 1.3 1.0 1.8 2.2 1.4 2.6 1.4 1.1 2.4 1.8 1.7 1.5 1.5 1.5 1.5 1.4 1.9 1.4 1.4 1.4 2.0 1.7 1.6 0.9 2.3 1.8 2.1 1.4 2.4 2.1 1.0 2.5 1.6 1.5 3.1 2.1 2.2 2.3 5.0 3.1 2.1 1.9 2.1 2.2 2.3 2.8 2.8 1.3 4.4 3.6 2.3 1.8 2.9 4.0 2.3 2.3 4.0 2.6 5.6 4.7 1.5 2.1 6.0 5.9 3.0 2.3 2.4 3.7 2.3 2.0 3.8 2.2 6.7 3.1 3.0 5.0 2.1 2.2 2.0 3.0 3.6 3.6 2.4 1.7 4.9 2.7 3.2 3.1 2.4 2.3 2.0 1.9 3.1 3.9 2.2 1.7 5.0 2.3 6.8 5.8 3.9 2.4 3.1 2.0 5.6 3.1 3.8 4.6 2.9 4.7 4.1 5.0 4.0 3.1 5.4 5.8 4.9 3.5 5.9 2.7 5.7 4.3 1.7 1.2 1.5 3.1 1.7 1.3 1.0 1.4 1.1 1.5 0.9 1.4 3.1 5.5 3.2 4.4 5.2 8.3 1.5 6.9 2.7 2.2 9.4 6.1 5.8 5.4 7.2 6.1 7.3 0.0 5.9 5.8 5.4 15.6 6.2 0.9 3.4 8.9 6.9 5.4 6.1 9.2 6.2 4.2 5.6 4.6 4.6 8.2 9.4 8.6 3.8 6.1 16.8 8.9 5.8 2.0 9.8 2.9 0.5 4.4 6.0 0.0 5.6 9.0 6.1 14.4 3.5 8.8 6.1 6.2 5.7 5.9 6.8 6.1 8.1 4.3 6.8 0.0 7.8 6.7 23.2 19.9 3.6 1.3 5.7 7.7 6.7 5.5 6.9 ZNF564 MGC26914 ENSG00000249709 "Zinc finger protein 564" Q8TBZ8 19 12525373-12551542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 13.1;Oligodendrocyte precursor cells: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043998 Uncertain Approved "Golgi apparatus" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA043998: AB_10969446" "unprognostic (3.85e-2)" "unprognostic (1.40e-3)" "unprognostic (4.61e-2)" "unprognostic (2.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.26e-3)" "unprognostic (4.25e-1)" "unprognostic (2.53e-2)" "unprognostic (1.76e-3)" "unprognostic (8.69e-2)" "unprognostic (3.94e-2)" "unprognostic (5.24e-3)" "unprognostic (1.26e-5)" "unprognostic (5.77e-3)" "unprognostic (3.07e-1)" "unprognostic (4.51e-3)" "unprognostic (1.83e-2)" 4.7 3.5 4.2 3.7 5.4 4.4 7.4 11.8 6.2 5.5 3.0 7.4 6.3 6.7 6.1 3.0 6.5 3.4 5.1 5.0 3.6 7.7 5.7 4.3 6.9 5.5 4.2 6.0 3.7 7.6 3.1 5.0 5.2 6.3 7.3 7.1 4.8 6.0 6.2 5.3 7.1 4.3 3.5 6.9 6.7 3.0 4.4 7.5 7.9 8.0 7.5 5.3 4.2 9.2 4.3 1.2 4.9 6.2 7.4 5.5 6.0 4.3 6.0 5.3 7.0 3.2 2.7 5.3 5.8 3.9 3.2 4.9 2.5 4.1 5.6 4.3 4.1 3.7 3.9 6.7 5.4 6.6 6.8 5.5 10.3 2.5 6.3 5.5 4.5 5.5 7.8 2.2 6.6 5.7 5.4 3.9 5.0 4.8 5.5 3.2 5.4 4.4 5.9 6.9 3.4 3.0 5.2 2.9 6.2 7.2 4.5 11.4 4.6 8.0 2.5 5.0 3.3 7.6 9.2 4.2 2.4 4.4 3.4 15.2 7.3 18.6 11.9 10.1 11.0 14.7 10.2 10.9 9.4 11.1 11.5 10.6 13.7 11.3 13.1 7.3 9.3 7.1 4.2 5.4 11.8 6.2 5.0 3.6 5.5 4.2 5.2 3.5 4.4 9.2 1.8 0.0 1.5 6.5 6.9 0.0 0.9 0.8 2.8 2.1 1.0 1.1 0.5 5.7 1.5 0.0 4.2 1.3 3.6 1.5 3.9 1.2 0.1 2.0 1.7 1.8 0.0 4.0 8.4 0.7 0.9 1.5 7.7 1.6 0.0 4.9 2.5 1.1 1.1 0.0 8.6 1.0 0.0 1.6 0.4 0.3 0.6 1.4 1.8 13.1 2.0 2.4 5.2 11.1 8.8 1.6 1.0 0.7 5.9 1.7 2.0 0.8 6.3 4.4 0.0 2.2 1.3 1.2 2.3 1.1 0.0 1.2 4.0 1.4 0.9 1.5 ZNF573 FLJ30921 ENSG00000189144 "Zinc finger protein 573" Q86YE8 19 37735833-37817300 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.9;Inhibitory neurons: 28.1;Oligodendrocytes: 22.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042776 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" Cytosol "HPA042776: AB_10961399" "unprognostic (3.79e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (3.72e-2)" "unprognostic (3.29e-2)" "unprognostic (8.26e-2)" "unprognostic (1.10e-1)" "unprognostic (3.62e-2)" "unprognostic (3.69e-1)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (9.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (3.11e-2)" "unprognostic (2.60e-2)" 1.6 1.7 0.5 1.1 1.2 2.1 2.0 4.0 1.4 1.0 0.2 0.9 1.3 1.9 2.7 0.7 1.2 1.7 0.9 0.6 2.6 1.3 0.7 1.4 1.2 0.7 0.6 2.1 1.3 1.4 0.8 1.5 0.9 1.3 1.2 2.7 0.8 0.9 0.9 2.1 1.0 0.9 0.2 1.7 2.0 1.3 0.6 1.1 2.5 0.7 1.6 0.7 0.8 2.4 0.5 1.8 1.4 1.3 0.7 1.5 0.6 1.2 1.3 0.4 1.0 1.8 1.2 1.8 1.1 1.0 0.5 1.1 1.4 1.9 1.7 0.4 1.2 2.0 2.8 0.9 0.6 1.7 1.6 1.4 0.6 2.5 1.0 0.9 1.3 1.0 0.8 0.8 0.3 0.7 1.4 1.0 2.0 0.5 0.2 1.4 2.8 0.6 0.0 1.3 1.8 1.6 2.2 0.6 0.2 0.9 1.7 1.5 0.5 1.6 1.5 1.4 1.9 2.1 2.8 2.6 0.3 0.2 1.3 2.1 0.4 1.6 1.9 0.6 1.5 1.5 1.6 2.1 0.9 2.8 2.6 2.0 0.2 1.7 1.3 1.5 1.0 0.5 0.5 1.2 4.0 1.4 0.6 2.6 0.7 0.6 0.9 0.2 0.6 2.4 3.1 0.0 3.9 7.2 7.4 1.8 2.6 2.1 1.8 15.7 2.1 2.4 11.8 2.8 1.9 3.7 12.5 4.0 7.1 0.8 1.9 2.5 37.9 1.4 3.8 4.7 1.2 3.4 22.2 0.7 3.2 4.0 1.1 1.3 0.0 7.6 5.0 1.4 4.0 16.8 28.1 1.3 0.0 1.3 2.5 16.8 8.7 2.2 3.6 12.2 3.2 7.3 7.2 21.1 22.9 1.3 1.6 6.4 1.8 1.9 2.6 2.9 2.4 12.0 0.0 5.2 3.8 7.7 7.6 2.8 2.6 1.6 5.7 3.6 2.1 1.2 ZNF586 FLJ20070 ENSG00000083828 "Zinc finger protein 586" Q9NXT0 19 57769655-57819939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 18.9" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA030306, HPA060782" Approved Approved "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 57: B-cells - Immune response" "Nucleoli fibrillar center" Vesicles "HPA030306: AB_2673423, HPA060782: AB_2684362" "prognostic favorable (9.83e-5)" "unprognostic (1.60e-2)" "unprognostic (2.93e-1)" "unprognostic (1.72e-3)" "unprognostic (2.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.10e-2)" "unprognostic (1.02e-3)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (1.88e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (6.01e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.36e-4)" 5.2 4.3 3.6 6.3 4.0 25.4 6.9 18.9 4.1 6.1 5.9 5.6 5.9 5.9 5.0 6.6 5.9 4.9 6.0 3.6 4.6 5.3 4.8 5.8 11.8 2.4 2.2 9.0 6.5 4.2 4.8 6.9 2.0 8.4 5.9 9.3 8.9 4.1 9.7 8.3 6.5 5.8 0.3 10.4 7.2 5.0 3.0 13.4 6.2 7.2 9.8 6.5 7.2 4.3 7.2 6.0 8.6 9.6 4.1 3.7 14.4 5.0 5.3 7.0 3.8 2.8 7.2 16.1 0.4 4.6 6.6 4.7 1.6 7.2 13.1 2.4 30.9 12.2 15.1 1.6 7.5 12.0 10.4 6.4 7.5 5.2 7.6 7.9 8.5 15.6 8.0 0.7 8.3 1.7 12.3 8.2 12.8 4.8 17.3 11.9 3.2 20.2 8.3 17.8 11.9 5.9 2.3 7.4 5.8 7.4 7.1 7.6 4.6 9.2 5.1 0.3 8.8 15.4 23.0 17.1 5.0 1.3 6.6 8.0 9.6 31.5 8.4 8.0 8.2 7.0 10.8 8.9 8.9 9.7 13.3 12.2 29.5 10.1 5.4 6.6 15.1 7.3 3.6 4.0 18.9 4.1 3.6 4.6 2.4 2.2 2.0 0.3 3.0 4.3 3.9 0.0 1.5 3.6 13.6 12.1 7.9 6.6 9.6 3.6 4.9 4.2 4.8 0.0 3.3 3.7 0.0 7.1 8.5 2.1 9.8 3.4 0.9 4.3 2.8 4.5 3.0 4.4 4.0 2.0 6.9 3.4 2.6 5.7 3.8 8.6 5.0 3.5 5.5 6.7 4.7 4.0 8.2 8.2 6.8 1.1 0.9 5.6 3.6 1.9 7.1 3.1 6.2 3.0 3.4 2.1 1.7 2.6 9.2 3.6 4.4 5.9 2.2 5.2 6.6 2.6 3.8 10.4 8.7 7.0 11.4 10.0 9.2 4.5 4.0 8.5 ZNF611 MGC5384 ENSG00000213020 "Zinc finger protein 611" Q8N823 19 52702813-52735073 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "unprognostic (9.92e-3)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.94e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-2)" "unprognostic (4.02e-4)" "unprognostic (2.93e-1)" "unprognostic (2.70e-3)" "unprognostic (1.40e-2)" "unprognostic (4.06e-3)" "unprognostic (1.34e-1)" "prognostic favorable (3.33e-4)" "unprognostic (6.43e-2)" "unprognostic (3.28e-1)" "unprognostic (1.46e-1)" "unprognostic (5.40e-2)" 3.0 1.5 1.8 2.8 2.8 3.4 3.7 3.2 2.5 2.6 1.8 2.7 2.4 3.3 3.5 1.6 6.9 2.9 2.9 2.0 2.6 3.9 1.8 3.0 3.5 2.5 1.9 4.4 4.2 2.9 2.3 4.3 2.6 3.6 3.1 4.3 2.1 4.4 1.5 1.7 1.9 3.2 2.0 3.5 2.6 3.2 2.1 4.4 3.9 1.9 3.9 2.5 2.2 4.6 3.5 3.5 4.2 5.9 4.2 4.3 6.2 4.4 5.0 4.3 5.2 4.7 2.7 5.2 2.6 3.5 4.6 2.0 6.1 3.0 5.4 0.4 4.0 7.2 6.3 2.0 2.7 0.0 5.5 3.9 1.5 3.6 5.9 2.8 4.7 4.8 3.6 0.1 4.3 2.3 5.6 2.4 3.4 2.7 4.2 5.7 5.7 2.2 5.6 12.2 3.4 3.8 6.1 3.0 1.1 10.1 3.8 3.8 5.6 2.7 3.8 2.8 3.9 1.3 7.3 8.4 0.0 0.8 4.7 6.8 2.6 8.8 5.4 2.6 6.2 4.4 4.3 4.8 2.8 3.8 4.3 3.4 9.3 3.5 4.0 2.3 3.4 2.8 1.8 2.8 3.2 2.5 2.0 2.6 2.5 1.9 2.6 2.0 2.1 4.6 6.3 12.8 5.9 10.4 10.1 3.8 6.8 3.8 3.4 9.0 3.8 3.8 5.0 8.6 9.3 23.9 14.6 10.7 12.0 4.9 7.9 5.1 9.8 17.4 7.6 6.2 7.8 13.7 17.0 2.7 9.3 5.6 5.6 32.8 17.1 14.8 4.2 2.4 4.8 6.7 23.5 3.9 6.1 5.7 2.9 1.3 4.1 5.6 0.0 18.7 7.5 3.4 19.6 15.1 24.3 4.9 2.5 2.6 7.4 11.7 4.6 7.8 6.2 7.0 13.1 6.8 5.8 3.6 6.9 3.7 6.1 9.3 12.1 6.0 3.0 11.8 ZNF639 "ANC-2H01, ZASC1" ENSG00000121864 "Zinc finger protein 639" Q9UID6 3 179323031-179338583 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049023, HPA052163" Uncertain Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA049023: AB_2680603, HPA052163: AB_2681747" "unprognostic (5.64e-2)" "unprognostic (6.16e-2)" "unprognostic (8.15e-2)" "unprognostic (1.33e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (7.74e-2)" "unprognostic (1.05e-2)" "unprognostic (2.16e-3)" "unprognostic (4.70e-3)" "unprognostic (4.58e-2)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" 20.8 19.5 16.5 18.0 17.5 59.2 28.0 22.1 19.3 27.6 15.0 26.6 17.4 31.5 25.6 20.9 26.0 19.8 27.4 16.4 16.6 25.1 23.9 21.9 26.6 16.4 16.8 32.7 24.6 38.6 18.2 22.5 15.9 26.3 22.1 40.0 24.5 27.0 27.3 16.9 18.6 31.0 16.8 23.7 20.6 19.1 17.3 26.6 41.4 30.3 24.6 21.5 18.3 18.0 81.3 18.7 35.5 43.9 31.7 38.4 35.2 37.8 56.4 61.0 54.8 31.7 31.3 94.2 56.4 46.6 74.1 30.1 55.2 50.5 76.0 86.7 43.1 96.1 26.8 31.8 55.0 76.1 34.5 31.1 51.9 31.3 72.5 45.7 42.1 61.3 59.4 48.6 48.6 41.2 79.5 33.7 59.9 56.9 43.5 75.4 37.1 112.1 37.8 32.4 65.3 39.9 37.9 41.1 49.2 29.8 104.9 59.4 34.5 41.3 43.7 33.1 98.7 19.7 19.0 174.2 30.3 58.5 28.9 2.5 1.1 1.2 1.6 0.7 1.5 1.8 2.6 2.6 0.9 2.0 2.2 2.2 0.7 2.2 0.5 0.3 2.4 0.8 16.5 17.5 22.1 19.3 16.4 16.6 16.4 16.8 15.9 16.8 17.3 18.0 16.9 19.2 11.7 9.4 24.2 20.9 34.0 7.0 32.5 21.5 21.6 13.2 19.4 10.0 8.8 14.7 54.2 14.7 18.3 8.6 33.2 12.2 29.8 21.6 22.4 19.4 18.7 29.0 8.7 10.0 11.3 21.8 11.2 30.3 10.1 18.5 18.5 17.0 9.9 16.8 10.6 15.6 6.1 13.2 17.2 8.8 24.5 13.8 14.2 4.7 13.5 19.6 13.4 8.5 9.6 11.5 9.4 24.0 27.5 36.1 11.2 22.2 7.2 44.9 26.3 27.1 22.7 29.9 21.3 29.9 17.5 3.4 23.2 19.8 12.2 24.9 ZNF649 FLJ12644 ENSG00000198093 "Zinc finger protein 649" Q9BS31 19 51889235-51905040 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 29.1" "Low region specificity" "Detected in all" HPA026541 Uncertain NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 22: Epithelial cell types - Mixed function" "HPA026541: AB_1859390" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (8.03e-2)" "unprognostic (1.53e-1)" "unprognostic (2.15e-3)" "unprognostic (2.13e-2)" "unprognostic (2.60e-1)" "unprognostic (4.23e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (2.24e-1)" "unprognostic (2.11e-1)" "unprognostic (2.66e-2)" "prognostic favorable (4.60e-5)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.07e-2)" "unprognostic (1.41e-2)" 5.7 4.7 5.6 5.2 6.0 6.5 10.1 9.1 7.8 5.4 1.2 5.6 4.1 8.6 7.0 6.5 7.2 5.6 6.5 5.6 9.2 6.3 4.6 5.6 7.9 7.8 5.2 9.9 6.0 9.5 3.3 8.9 6.1 21.2 6.0 12.8 4.9 7.1 4.0 8.1 4.3 7.6 4.1 6.5 5.5 7.9 6.5 7.9 8.2 6.9 6.4 6.8 3.8 13.8 4.1 0.6 18.3 13.4 7.1 5.7 0.8 7.7 5.4 7.8 7.2 3.5 3.2 3.9 1.8 5.9 5.4 5.6 9.4 7.4 7.3 1.8 22.5 18.4 1.7 4.3 5.5 5.9 8.2 7.1 5.1 9.9 3.3 6.0 4.7 1.0 4.4 0.2 6.6 1.2 16.1 8.2 29.1 0.1 1.7 9.5 10.1 6.6 7.3 15.2 8.2 8.4 9.4 4.8 6.1 10.0 5.9 8.1 3.6 7.0 6.7 2.7 9.5 5.2 0.7 4.9 2.6 1.6 15.3 3.1 4.4 7.7 6.0 4.6 11.6 4.8 7.2 6.7 5.6 9.1 7.4 5.5 1.6 7.7 4.3 4.5 10.1 4.2 5.6 6.0 9.1 7.8 5.6 9.2 7.8 5.2 6.1 4.1 6.5 13.8 5.1 0.0 3.2 0.3 5.9 6.5 10.6 4.2 1.8 8.0 5.4 6.5 5.5 10.0 3.0 3.7 0.0 6.2 4.1 2.5 13.7 5.3 1.2 2.7 6.1 5.6 3.0 6.9 2.0 2.4 7.1 6.1 5.6 3.5 12.0 7.3 5.3 2.9 4.1 15.2 2.2 3.7 0.0 3.5 3.3 1.5 5.3 3.4 5.4 1.9 1.9 6.8 7.2 4.0 6.1 3.5 1.0 9.1 2.4 7.2 1.2 3.8 0.5 6.2 6.6 7.2 5.7 4.4 3.3 4.9 8.1 7.0 3.4 4.1 2.6 8.4 ZNF654 "FLJ10997, FLJ21142" ENSG00000175105 "Zinc finger protein 654" 3 88059255-88144660 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 51.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036172, HPA036173, HPA049262, HPA077939" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 44: Endometrium - Transcription" Microtubules "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364" "unprognostic (2.54e-2)" "unprognostic (2.28e-1)" "unprognostic (6.89e-3)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (5.74e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (2.02e-1)" "unprognostic (5.72e-3)" "prognostic unfavorable (9.97e-6)" "unprognostic (1.29e-2)" "unprognostic (2.92e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (2.50e-2)" 5.0 3.7 2.6 4.1 2.7 8.1 5.5 4.9 3.3 5.1 1.8 4.4 4.5 4.6 4.7 5.6 3.4 4.8 3.4 2.4 3.2 4.8 7.0 4.5 6.1 2.8 3.1 6.4 4.1 4.3 1.2 5.0 3.3 5.5 4.2 11.7 4.6 4.1 3.0 6.5 4.8 4.1 3.2 4.9 4.7 6.0 2.7 7.6 5.9 4.9 5.7 5.1 2.3 3.9 7.2 3.0 5.0 6.9 9.9 8.6 4.6 9.3 8.4 6.1 8.4 4.4 4.3 11.3 6.2 7.4 4.4 4.7 5.3 8.6 11.8 7.0 3.0 7.0 3.9 3.2 7.5 8.0 7.6 8.4 7.4 6.7 7.8 12.1 8.1 6.6 4.9 9.0 13.6 5.3 8.0 6.5 2.7 5.7 4.8 5.7 3.4 5.4 5.4 9.0 3.7 3.3 6.8 5.2 17.0 6.0 7.3 5.7 9.5 13.6 8.7 51.8 6.6 10.1 7.6 7.9 10.8 7.5 8.6 9.7 1.2 1.8 1.7 1.2 2.0 1.1 1.8 2.4 1.5 1.7 2.2 1.5 1.7 4.0 1.0 0.7 1.4 1.0 2.6 2.7 4.9 3.3 2.4 3.2 2.8 3.1 3.3 3.2 2.7 3.9 18.2 9.6 13.1 10.1 12.8 22.4 10.1 7.9 9.1 14.0 17.4 10.2 11.8 5.7 10.8 5.5 12.5 4.8 14.5 11.9 1.9 7.6 1.4 9.4 16.0 12.4 5.3 5.2 11.7 5.3 4.2 11.7 5.1 12.2 15.8 14.5 8.9 14.0 6.3 16.8 11.3 7.1 10.2 12.3 19.5 1.5 7.5 14.8 8.8 7.5 10.9 9.9 9.2 9.0 13.3 8.4 8.2 12.4 9.2 12.0 9.0 6.0 10.7 14.3 6.6 13.9 11.5 12.1 10.4 11.4 18.6 8.2 14.0 9.0 7.8 14.4 ZNF665 "FLJ14345, ZFP160L" ENSG00000197497 "Zinc finger protein 665" Q9H7R5 19 53159213-53193386 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA023437 Uncertain Approved "Nuclear membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" "Nuclear membrane" "HPA023437: AB_2671205" "unprognostic (8.01e-2)" "unprognostic (2.44e-1)" "unprognostic (1.73e-1)" "unprognostic (8.04e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (1.26e-1)" "unprognostic (3.27e-2)" "unprognostic (5.81e-4)" "unprognostic (2.26e-1)" "unprognostic (1.04e-2)" "unprognostic (2.45e-1)" "unprognostic (9.27e-2)" 0.7 0.6 0.6 0.6 0.8 0.8 1.3 2.2 1.0 1.1 0.3 0.7 0.3 1.4 1.3 0.6 1.8 0.8 0.5 0.5 0.7 0.6 0.2 1.0 1.4 0.7 0.8 3.3 0.5 1.5 0.4 0.7 0.7 1.2 0.6 0.9 0.8 0.9 0.3 1.0 0.4 1.0 0.4 1.1 0.6 0.9 0.4 1.5 1.6 0.2 0.6 0.8 0.7 2.0 0.7 0.1 0.6 2.1 0.6 1.1 1.4 1.4 0.9 1.4 2.0 0.2 0.6 1.2 1.2 1.0 1.0 0.2 0.4 0.1 2.4 0.0 0.0 0.0 0.4 0.0 1.3 0.2 0.6 1.2 0.0 1.3 0.0 0.5 0.1 0.0 0.2 0.3 0.0 0.2 3.0 0.9 1.1 0.0 0.3 0.0 0.0 0.4 0.3 3.0 0.3 1.2 0.1 0.2 0.1 1.4 0.9 0.5 0.4 1.0 1.3 0.9 0.6 0.2 2.7 3.0 0.1 0.7 1.3 0.8 0.2 0.5 0.3 0.1 0.4 1.2 0.4 0.9 0.4 2.1 0.8 0.8 0.6 2.0 0.6 0.7 0.3 0.2 0.6 0.8 2.2 1.0 0.5 0.7 0.7 0.8 0.7 0.4 0.4 2.0 3.0 19.2 8.4 4.9 4.9 1.1 2.5 0.4 0.6 6.0 1.7 2.2 0.9 4.3 4.0 5.5 0.0 2.4 1.2 0.5 3.9 1.2 2.2 2.8 2.9 4.2 2.4 2.5 3.2 0.7 2.5 4.9 0.0 3.7 5.1 8.0 1.8 0.3 1.3 11.8 4.0 0.5 0.0 0.8 1.1 1.7 2.1 1.9 1.8 4.7 2.5 6.4 5.2 3.5 4.5 0.6 0.3 3.0 0.4 2.9 0.3 0.8 4.6 4.0 0.0 4.4 2.5 2.7 6.7 0.9 0.6 0.8 3.9 4.9 1.0 2.1 ZNF669 FLJ12606 ENSG00000188295 "Zinc finger protein 669" Q96BR6 1 247099962-247104372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044043 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA044043: AB_10964039" "unprognostic (1.88e-1)" "unprognostic (6.57e-2)" "unprognostic (2.01e-2)" "unprognostic (1.32e-1)" "unprognostic (3.80e-2)" "unprognostic (6.04e-2)" "unprognostic (1.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (5.98e-2)" "unprognostic (1.09e-1)" "prognostic favorable (4.59e-7)" "unprognostic (2.60e-2)" "unprognostic (1.47e-1)" "unprognostic (3.11e-2)" "unprognostic (4.81e-2)" 3.4 1.8 2.0 2.6 1.7 11.7 5.5 4.8 2.2 3.8 1.5 3.7 2.9 4.7 3.2 2.5 4.0 3.0 2.5 1.6 1.7 3.8 2.1 3.4 5.5 1.7 1.5 4.6 4.3 4.3 1.6 2.8 1.9 3.1 3.6 5.1 2.9 3.2 2.0 2.8 2.4 3.7 1.1 4.0 3.3 4.7 2.0 8.8 5.0 3.7 5.6 2.7 1.6 3.3 4.2 2.9 9.4 10.9 5.4 4.8 9.6 6.1 6.2 8.1 8.3 7.1 4.3 5.9 8.9 4.2 5.8 5.3 9.2 7.2 9.0 3.1 2.2 0.4 6.4 5.2 4.3 5.7 6.9 4.5 7.4 6.6 4.8 3.9 4.9 15.1 10.4 4.1 8.6 3.7 14.6 5.7 22.1 8.7 5.9 11.6 9.1 4.3 6.0 12.0 10.1 17.9 7.8 4.1 3.1 10.5 8.0 20.3 5.6 5.7 6.4 5.3 11.4 10.2 20.1 12.0 1.5 2.9 5.8 10.7 2.4 8.9 4.4 1.6 5.8 6.4 5.2 4.2 3.1 5.1 5.9 5.8 5.8 4.3 2.4 4.2 6.2 2.9 2.0 1.7 4.8 2.2 1.6 1.7 1.7 1.5 1.9 1.1 2.0 3.3 10.2 3.2 8.3 1.6 17.5 9.7 6.2 4.8 7.4 27.1 5.1 5.6 1.6 12.8 4.5 1.8 12.5 3.6 11.3 2.3 7.9 5.1 11.5 9.0 7.2 8.3 7.8 8.6 3.0 7.7 4.9 5.4 3.6 11.5 15.2 9.7 8.6 2.5 4.8 16.8 3.3 2.6 2.0 6.0 19.8 7.4 7.2 7.3 12.4 3.7 4.7 9.9 18.6 3.0 2.4 8.1 1.2 3.8 8.1 3.3 2.8 3.6 7.5 31.1 0.0 5.9 6.2 10.4 9.5 5.1 8.5 2.3 10.5 9.7 2.5 4.1 ZNF671 FLJ23506 ENSG00000083814 "Zinc finger protein 671" Q8TAW3 19 57719751-57727624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1" "Low region specificity" "Detected in all" "HPA046099, HPA056043" Uncertain Approved Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA046099: AB_10962484, HPA056043: " "prognostic favorable (2.20e-4)" "unprognostic (4.16e-3)" "unprognostic (6.02e-2)" "unprognostic (5.91e-3)" "unprognostic (8.76e-2)" "unprognostic (3.97e-3)" "unprognostic (6.12e-2)" "unprognostic (5.56e-3)" "unprognostic (8.26e-3)" "unprognostic (2.04e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.14e-1)" "unprognostic (1.92e-3)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (4.22e-1)" 2.9 6.8 6.8 3.7 7.1 4.4 4.3 11.0 7.7 3.4 7.1 6.5 1.8 2.5 5.3 2.0 4.5 2.8 6.8 6.6 7.7 6.0 2.8 4.0 7.9 6.7 7.1 3.3 3.4 9.4 9.7 4.0 6.8 5.8 2.3 8.3 3.8 5.8 7.7 2.2 6.4 2.7 7.3 13.5 2.7 6.4 7.8 13.7 8.3 6.9 8.5 4.8 2.0 7.4 0.1 0.2 2.2 0.0 0.4 0.1 0.0 2.5 1.4 4.8 1.7 0.3 0.4 5.2 0.8 3.6 1.5 0.1 1.9 2.1 5.6 5.7 3.6 0.1 0.8 0.0 4.2 0.0 7.3 6.2 1.5 3.0 1.7 5.6 0.7 5.4 0.8 2.5 4.4 0.1 10.1 0.1 3.2 0.0 5.1 3.9 6.8 3.2 1.8 0.2 0.2 0.0 0.0 0.1 3.5 5.4 1.4 7.3 0.0 0.5 2.6 0.0 1.9 4.5 0.1 2.8 0.5 1.2 1.6 19.4 10.5 19.3 8.0 9.5 21.4 22.7 17.0 14.1 14.9 30.4 24.2 19.7 7.3 20.9 15.1 13.7 18.9 15.0 6.8 7.1 11.0 7.7 6.6 7.7 6.7 7.1 6.8 7.3 7.8 7.4 1.1 0.0 0.6 5.9 5.2 0.6 0.7 0.9 0.0 5.8 1.3 1.0 5.4 4.3 1.2 3.7 0.0 2.3 2.0 0.0 1.9 3.7 0.2 0.8 0.4 1.7 0.0 3.4 3.4 0.0 1.1 0.7 0.0 0.7 2.5 2.9 1.1 1.2 3.8 6.7 4.1 0.2 6.1 2.7 0.8 0.7 0.0 2.3 1.8 2.8 1.9 8.4 6.2 4.0 2.8 0.3 0.1 0.4 3.8 0.5 0.9 1.6 0.9 7.8 0.0 0.2 1.6 7.0 5.0 0.4 0.4 0.8 4.1 0.6 0.5 0.1 ZNF675 "TBZF, TIZ" ENSG00000197372 "Zinc finger protein 675" Q8TD23 19 23525631-23687220 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 65.0;Late spermatids: 108.1;Spermatocytes: 36.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 58.0" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (3.75e-2)" "unprognostic (6.67e-2)" "unprognostic (3.73e-2)" "unprognostic (2.03e-3)" "unprognostic (4.62e-2)" "unprognostic (1.68e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (8.50e-4)" "unprognostic (9.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.16e-2)" "unprognostic (4.54e-1)" "unprognostic (3.57e-3)" "unprognostic (9.55e-2)" "unprognostic (2.60e-2)" "unprognostic (2.11e-2)" 6.9 4.9 5.4 5.7 4.7 11.0 8.0 8.2 8.1 6.8 2.3 7.6 5.8 4.5 11.0 5.6 5.8 4.8 3.0 5.4 3.1 4.7 6.1 5.7 11.7 3.1 2.2 5.8 6.6 6.9 2.0 5.6 3.7 5.0 11.6 7.3 5.8 4.3 3.0 8.6 5.2 3.7 0.8 8.4 8.3 12.6 4.2 9.8 8.0 3.4 11.3 5.1 4.9 7.1 6.7 7.8 15.1 14.7 4.6 4.8 12.8 7.1 10.4 17.8 23.2 4.8 5.4 14.7 17.1 5.1 9.0 8.9 15.2 8.7 17.7 58.0 10.1 11.0 12.1 4.6 1.8 10.6 8.3 7.2 7.4 8.9 17.2 5.9 6.5 17.4 12.8 21.1 13.7 8.0 28.6 13.7 17.5 4.6 10.0 21.4 9.1 18.6 16.7 20.9 8.3 10.6 23.1 0.8 6.1 17.3 9.7 12.2 7.3 8.7 3.9 10.9 15.4 4.7 10.7 24.7 0.6 13.1 4.1 2.8 4.5 9.0 6.6 5.6 6.6 9.8 8.2 7.8 4.9 11.0 10.9 9.6 2.5 8.2 3.7 6.4 9.5 4.0 5.4 4.7 8.2 8.1 5.4 3.1 3.1 2.2 3.7 0.8 4.2 7.1 6.6 19.2 7.3 2.9 15.2 1.5 2.9 3.8 2.8 8.4 4.7 6.5 5.0 1.5 4.5 1.8 0.0 3.5 18.0 6.2 3.9 4.9 65.0 4.7 8.9 6.1 3.5 4.6 9.8 3.4 5.0 6.1 4.1 6.3 9.5 8.7 2.9 0.9 5.4 1.7 10.4 4.1 10.2 3.8 2.4 108.1 5.0 7.4 0.0 10.3 11.0 6.0 12.3 14.1 10.5 4.3 6.4 3.8 4.4 2.0 2.2 2.9 6.1 3.3 6.6 5.1 5.4 36.1 16.0 7.2 2.7 4.4 14.9 8.8 3.5 4.8 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol Yes No "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoli, Mitochondria, Cytosol" "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 2.5 3.1 2.2 3.0 3.3 3.4 3.7 3.6 2.8 3.6 1.1 2.9 2.3 3.8 2.4 2.1 3.1 3.1 1.9 2.3 4.3 2.6 2.2 3.2 4.4 3.1 2.8 4.0 3.3 2.3 1.5 4.2 2.8 4.0 4.1 5.7 2.7 2.4 1.5 1.4 2.1 2.4 2.3 3.6 3.3 3.9 3.4 4.4 5.4 2.7 4.0 2.1 2.3 5.6 2.5 4.0 13.6 15.5 1.6 3.7 8.3 3.3 3.2 4.8 4.9 3.3 2.9 9.7 8.3 1.5 2.5 4.6 8.3 2.2 7.6 4.2 15.8 4.5 2.9 2.0 3.0 8.0 12.0 3.3 3.8 2.8 6.0 3.5 4.5 10.9 12.4 15.1 5.2 2.0 11.3 2.8 12.1 3.6 6.3 8.4 8.9 3.9 3.4 7.7 5.8 11.2 4.8 5.6 2.3 6.6 7.9 9.2 3.3 5.9 5.5 5.2 6.6 4.8 11.8 10.5 2.3 1.4 6.2 5.4 0.6 0.8 1.3 0.1 1.6 3.7 1.3 0.8 1.2 2.6 1.2 1.7 0.1 1.4 0.4 1.8 1.7 0.8 2.2 3.3 3.6 2.8 2.3 4.3 3.1 2.8 2.8 2.3 3.4 5.6 10.9 3.2 7.3 21.2 7.8 2.3 4.0 2.9 2.2 12.2 5.5 2.9 4.2 4.3 4.5 3.7 4.2 2.1 8.2 6.8 1.9 4.0 0.9 4.6 6.0 6.5 9.6 10.3 11.7 5.2 2.4 6.5 7.1 4.8 3.8 9.4 5.3 3.0 1.8 1.7 17.2 4.8 4.1 3.1 3.7 0.6 7.5 3.3 0.0 17.8 3.3 4.7 5.2 38.2 44.7 3.3 7.3 2.6 5.8 5.4 1.3 1.4 5.5 7.3 0.0 12.3 4.9 7.6 10.5 3.1 0.6 1.4 5.8 4.2 3.8 3.8 ZNF681 FLJ31526 ENSG00000196172 "Zinc finger protein 681" Q96N22 19 23739195-23758891 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 13.2;Spermatogonia: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 16.2;RPMI-8226: 10.7" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (1.48e-1)" "unprognostic (4.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (6.22e-2)" "unprognostic (1.01e-1)" "unprognostic (2.45e-3)" "unprognostic (8.55e-2)" "unprognostic (1.61e-2)" "unprognostic (5.24e-2)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (7.98e-2)" "unprognostic (2.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.55e-2)" 0.6 1.3 0.7 0.9 0.7 0.7 2.0 2.2 1.0 1.4 0.0 1.6 1.0 1.1 1.6 1.9 1.3 0.7 0.5 0.8 0.9 0.7 0.2 0.9 2.8 0.7 0.8 2.0 1.9 0.8 0.3 1.0 0.8 1.1 1.9 0.9 0.6 0.7 0.1 2.2 0.6 0.8 0.4 1.8 1.0 2.5 0.8 3.9 1.8 0.2 2.2 1.6 1.0 0.7 0.8 0.0 5.0 9.7 0.3 0.0 2.7 0.6 0.1 1.5 1.6 1.4 2.6 1.3 4.5 0.9 2.2 2.4 4.6 0.2 2.5 16.2 1.7 2.5 0.0 0.0 0.7 0.0 0.6 1.1 0.9 0.6 0.6 0.3 0.0 3.5 7.0 0.0 2.6 2.2 8.8 2.2 7.2 0.1 2.2 6.8 3.5 10.7 1.3 4.9 0.4 5.1 0.0 0.0 0.8 6.9 5.3 0.4 0.0 1.0 0.1 3.1 3.6 0.0 9.7 7.9 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 1.6 1.2 1.8 1.5 0.6 2.1 3.6 3.2 0.2 0.9 0.2 0.9 2.0 0.8 0.7 0.7 2.2 1.0 0.8 0.9 0.7 0.8 0.8 0.4 0.8 0.7 2.9 3.2 0.0 3.3 5.8 1.1 1.2 0.2 1.8 3.4 4.0 4.6 1.1 2.8 3.4 1.8 0.0 3.6 3.8 3.9 1.9 1.9 9.7 1.9 3.6 2.6 2.4 2.5 5.9 2.3 4.2 2.5 1.5 2.8 0.0 9.1 1.4 0.0 2.4 1.7 7.4 2.5 0.0 2.6 0.8 5.2 0.6 1.3 1.8 2.8 1.1 2.7 11.3 12.1 5.4 1.2 1.9 3.0 0.6 1.1 0.4 1.8 5.4 1.2 0.0 1.9 2.1 13.2 16.7 3.3 1.3 3.7 3.8 4.9 2.2 1.1 ZNF699 "FLJ38144, hang" ENSG00000196110 "Zinc finger protein 699" Q32M78 19 9291140-9309838 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cells: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 12.4;hTERT-HME1: 12.3;U-138 MG: 14.1" HPA058287 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 63: NK-cells & T-cells - Immune response" "HPA058287: AB_2683669" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (1.26e-2)" "unprognostic (2.07e-1)" "unprognostic (1.62e-3)" "unprognostic (2.83e-3)" "unprognostic (2.75e-1)" "unprognostic (5.93e-2)" "unprognostic (3.16e-1)" "unprognostic (6.58e-2)" "unprognostic (1.20e-1)" "unprognostic (8.37e-2)" "unprognostic (2.10e-5)" "unprognostic (1.02e-1)" "unprognostic (2.23e-1)" "unprognostic (6.69e-2)" "unprognostic (3.07e-1)" 1.5 1.4 1.2 1.7 1.1 2.1 2.2 2.6 1.2 2.2 1.1 1.2 1.5 2.7 2.0 1.4 1.7 1.6 1.4 1.3 1.4 1.6 1.0 1.9 2.5 1.2 1.1 3.7 1.2 3.0 0.8 1.4 1.1 1.9 1.4 3.3 1.2 1.7 0.7 1.7 1.1 1.9 0.9 2.2 1.5 0.9 1.6 2.6 2.3 1.4 2.4 1.3 0.9 1.5 2.0 0.8 3.0 3.2 1.9 2.5 1.5 2.5 3.2 6.3 6.5 0.8 0.7 1.6 1.3 3.4 2.0 1.0 2.0 7.8 12.4 2.0 0.8 2.0 1.3 0.5 2.1 0.5 2.4 3.3 2.1 6.7 12.3 3.2 1.5 3.7 1.2 3.6 8.8 0.6 2.6 2.7 0.9 0.1 2.2 1.2 8.2 0.4 1.1 3.1 1.5 1.4 6.1 0.3 2.7 1.9 1.0 1.2 1.5 14.1 11.2 1.8 6.5 1.1 0.3 2.6 1.4 1.5 3.3 0.7 0.3 1.9 1.0 0.5 0.8 1.0 0.9 0.8 0.6 0.7 1.3 0.8 0.8 0.6 0.8 0.3 0.5 0.5 1.2 1.1 2.6 1.2 1.3 1.4 1.2 1.1 1.1 0.9 1.6 1.5 5.0 3.2 0.5 2.0 8.3 2.0 6.2 2.3 6.8 8.3 2.2 3.3 1.6 1.5 6.4 1.8 8.4 0.6 13.6 1.2 0.0 1.0 0.1 1.1 5.0 3.4 1.2 1.3 4.4 1.0 1.2 3.9 2.6 2.8 1.3 3.4 3.9 0.7 1.2 5.0 4.3 0.2 8.2 1.9 2.9 0.4 2.1 4.1 3.6 5.6 3.7 5.1 15.5 6.0 3.8 1.6 1.5 4.1 6.1 3.2 2.4 0.8 0.4 13.5 0.0 3.8 4.7 3.7 2.3 3.2 2.4 1.0 12.2 1.9 0.7 4.1 ZNF701 FLJ10891 ENSG00000167562 "Zinc finger protein 701" Q9NV72 19 52555457-52587174 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 28.6" HPA005532 Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Centriolar satellite" "HPA005532: AB_1080746" "unprognostic (1.21e-1)" "unprognostic (4.98e-3)" "unprognostic (5.58e-2)" "unprognostic (3.40e-1)" "unprognostic (7.74e-2)" "unprognostic (1.13e-2)" "unprognostic (8.86e-2)" "unprognostic (4.67e-2)" "unprognostic (5.46e-4)" "unprognostic (3.75e-1)" "unprognostic (2.86e-1)" "unprognostic (1.16e-2)" "unprognostic (8.17e-3)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (2.79e-1)" "prognostic favorable (4.89e-5)" 5.1 4.1 3.9 6.4 5.6 10.1 7.9 6.7 4.5 5.7 7.4 5.6 5.0 5.7 7.2 4.3 6.2 5.0 5.7 4.8 4.2 6.3 2.7 5.7 8.0 5.3 4.4 6.2 4.7 6.2 4.4 7.6 6.0 6.5 6.7 6.3 5.8 4.7 5.7 7.3 6.4 4.7 3.2 7.3 6.4 6.1 4.9 9.3 9.4 5.7 7.1 5.5 5.7 8.3 2.3 0.3 5.0 8.9 5.5 6.5 9.2 5.9 5.8 7.8 8.1 4.6 5.5 11.0 3.3 4.6 7.6 3.5 2.3 6.3 8.3 0.4 6.6 3.0 9.3 1.1 5.6 0.4 14.1 6.8 5.0 6.0 10.1 4.0 7.4 5.8 15.0 1.4 7.2 1.8 11.3 5.2 4.8 2.9 8.0 11.8 6.6 4.6 6.2 28.6 4.9 5.4 3.9 10.1 3.1 10.1 12.9 6.2 7.3 6.2 3.1 3.0 10.7 1.1 7.1 14.4 0.2 12.4 10.1 21.6 9.0 18.1 9.3 9.8 7.9 9.2 7.3 8.2 6.7 9.0 8.5 9.1 23.0 14.2 7.7 6.6 9.1 7.0 3.9 5.6 6.7 4.5 4.8 4.2 5.3 4.4 6.0 3.2 4.9 8.3 7.2 0.0 6.1 4.6 11.1 2.2 6.7 6.0 0.6 5.4 6.3 7.6 4.8 4.3 7.7 14.7 14.6 13.5 13.8 8.9 3.9 6.8 2.3 9.2 7.8 7.3 2.4 5.2 2.1 3.9 9.7 5.5 5.6 9.7 2.5 13.6 6.4 0.6 5.3 3.3 2.4 6.2 8.2 5.5 8.2 1.2 6.2 6.8 3.6 3.7 9.9 3.8 15.5 3.5 5.9 5.5 8.8 3.8 3.0 8.2 13.1 3.7 9.7 6.0 0.0 3.7 7.0 3.8 10.8 3.0 3.7 23.5 9.9 7.2 3.8 11.7 ZNF714 ENSG00000160352 "Zinc finger protein 714" 19 21082159-21125270 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 17.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Granulosa cells: 49.8;Oligodendrocyte precursor cells: 40.2;Theca cells: 40.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 49.5" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (2.72e-1)" "unprognostic (3.04e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (5.47e-4)" "unprognostic (4.75e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (1.02e-1)" "unprognostic (2.20e-2)" "prognostic favorable (4.27e-5)" "unprognostic (1.21e-1)" "unprognostic (6.88e-3)" "unprognostic (6.32e-2)" "unprognostic (3.15e-2)" "unprognostic (2.73e-1)" "unprognostic (5.40e-3)" "unprognostic (7.86e-2)" 1.5 4.4 2.9 3.2 4.6 6.9 3.3 7.4 3.4 2.1 0.0 2.1 2.6 3.1 3.4 5.3 2.6 1.6 1.4 3.0 2.9 1.7 0.6 2.1 4.9 2.6 2.8 17.3 3.8 1.6 1.2 2.9 3.2 2.4 3.7 3.2 2.1 1.6 2.9 6.7 3.3 1.7 2.0 2.4 2.8 3.9 3.5 5.7 14.4 1.8 4.3 1.6 2.2 3.4 18.3 3.5 26.9 12.5 1.3 3.8 21.2 10.2 6.0 21.8 20.3 8.2 14.1 7.6 14.8 5.5 7.9 4.6 0.1 8.9 32.4 6.1 18.6 1.3 12.9 8.2 2.1 10.3 8.2 2.2 1.6 15.0 6.1 5.5 7.3 39.3 20.0 9.4 13.0 4.3 49.5 7.0 25.8 3.9 5.8 17.1 1.8 7.3 5.9 10.7 23.6 13.9 16.1 0.2 4.8 20.8 0.5 1.0 3.4 9.7 0.3 8.9 6.7 7.6 22.6 1.4 0.4 2.9 3.4 5.4 2.0 4.9 2.3 2.4 2.3 1.9 2.4 3.3 3.1 2.9 4.4 3.9 1.4 2.7 1.8 7.8 3.6 1.3 2.9 4.6 7.4 3.4 3.0 2.9 2.6 2.8 3.2 2.0 3.5 3.4 3.9 44.8 9.1 27.4 8.0 4.1 4.3 4.6 13.1 22.3 4.6 5.5 4.9 5.7 6.3 5.5 16.7 7.7 7.3 6.6 1.9 4.2 1.6 4.7 8.7 4.9 6.7 9.7 28.8 3.8 13.6 7.4 6.6 7.0 1.3 49.8 5.3 0.1 4.9 16.8 37.0 3.3 4.1 6.0 8.2 1.5 5.3 5.2 3.6 13.1 2.6 6.2 6.2 40.2 19.6 3.3 2.2 3.8 11.5 6.3 4.1 1.1 3.0 14.5 6.6 4.9 6.9 36.3 15.6 7.5 4.0 4.7 6.7 40.0 5.5 7.7 ZNF718 FLJ90036 ENSG00000250312 "Zinc finger protein 718" Q3SXZ3 4 124501-202303 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 37.5;Excitatory neurons: 40.1;Inhibitory neurons: 58.2;Microglial cells: 47.8;Oligodendrocyte precursor cells: 62.8;Oligodendrocytes: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 19.3" NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (1.96e-1)" "unprognostic (1.38e-1)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (3.62e-2)" "unprognostic (6.59e-3)" "unprognostic (1.01e-2)" "unprognostic (2.41e-2)" "unprognostic (2.60e-1)" "unprognostic (8.97e-2)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "prognostic favorable (7.67e-6)" "unprognostic (1.39e-1)" "unprognostic (6.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.92e-1)" 1.9 3.0 1.8 2.2 1.8 3.0 2.6 3.4 2.5 3.3 0.5 2.5 1.7 2.2 2.1 1.8 2.9 2.0 1.9 1.3 2.3 2.5 1.4 2.0 3.8 2.0 2.5 3.5 2.5 2.7 2.0 2.8 2.4 3.0 2.2 2.7 2.2 2.2 0.9 3.0 1.9 1.9 1.5 2.9 1.9 2.0 2.4 4.6 4.7 1.8 3.4 2.0 2.3 2.7 0.0 0.9 5.4 0.0 3.3 6.2 1.3 6.9 0.9 4.3 3.3 5.9 7.7 8.5 4.0 2.5 7.6 2.0 4.4 3.2 5.8 0.0 1.6 0.0 1.5 0.0 4.1 0.1 0.1 3.2 2.8 4.3 0.6 3.9 2.9 2.4 4.1 0.1 7.6 4.4 0.8 5.3 6.6 0.0 2.4 19.3 2.1 4.7 3.5 2.1 7.3 1.7 3.5 1.2 4.2 4.3 12.5 1.6 2.1 3.2 4.0 4.1 5.1 0.0 0.0 13.3 0.0 0.0 4.0 2.6 1.3 5.7 2.2 1.8 2.1 2.0 1.9 1.4 2.4 2.2 2.2 2.1 1.6 5.4 1.1 2.4 1.6 1.2 1.8 1.8 3.4 2.5 1.3 2.3 2.0 2.5 2.4 1.5 2.4 2.7 4.0 3.2 3.6 37.5 6.5 2.0 2.2 1.4 4.6 8.4 3.5 3.0 2.4 0.0 5.1 0.0 2.1 1.9 7.6 1.2 0.0 3.1 0.3 1.0 3.7 3.4 1.2 9.7 40.1 1.4 1.4 3.6 4.1 1.6 5.7 6.6 6.1 0.9 1.4 8.4 58.2 0.7 0.0 1.6 1.9 0.7 3.7 2.9 3.6 47.8 1.7 2.6 15.5 62.8 85.0 1.6 0.1 4.5 4.6 0.9 0.5 1.4 2.6 5.1 0.0 4.4 3.8 2.4 4.1 3.0 0.9 1.4 5.5 4.0 0.8 1.4 ZNF720 ENSG00000197302 "Zinc finger protein 720" Q7Z2F6 16 31713229-31794869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA041570 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "Nucleoplasm, Plasma membrane" "HPA041570: AB_10795126" "unprognostic (5.52e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" "unprognostic (2.58e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-3)" "unprognostic (8.72e-2)" "unprognostic (5.94e-2)" "unprognostic (1.54e-1)" "unprognostic (8.91e-3)" "unprognostic (5.47e-3)" "unprognostic (3.70e-2)" "unprognostic (9.62e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-2)" 6.0 6.9 5.9 6.8 5.7 6.5 7.2 10.8 6.4 5.1 5.9 7.3 4.1 6.2 9.4 7.8 7.0 5.9 4.6 5.7 6.3 8.7 6.7 6.1 11.0 6.8 7.3 4.4 7.2 7.2 7.3 9.2 7.7 7.9 7.9 6.1 5.8 7.0 6.3 10.0 5.3 6.1 6.6 8.2 8.3 8.2 6.5 7.4 7.7 4.4 10.8 6.2 5.7 6.3 15.1 10.5 12.6 10.7 10.9 16.5 12.4 15.9 10.1 7.6 10.1 7.9 15.8 7.3 27.2 5.3 11.2 10.2 12.7 6.2 11.3 32.7 6.6 4.1 5.7 21.8 16.4 8.8 21.6 11.1 16.7 5.3 7.3 15.1 14.3 17.4 13.8 9.4 8.3 24.5 8.9 11.6 12.5 10.4 8.2 17.0 5.7 11.5 8.5 9.4 5.6 8.6 15.9 6.8 15.4 19.9 13.5 17.3 9.5 5.5 4.3 11.1 4.9 15.5 18.3 21.0 4.9 13.3 8.8 21.2 6.7 33.7 18.6 7.6 14.3 19.9 13.0 17.2 7.4 20.3 12.2 15.1 8.8 20.2 8.5 12.9 18.1 6.8 5.9 5.7 10.8 6.4 5.7 6.3 6.8 7.3 7.7 6.6 6.5 6.3 19.4 16.0 21.0 25.8 19.8 9.1 16.9 23.4 6.8 25.6 15.0 18.4 12.2 5.7 19.4 5.5 6.2 35.4 24.5 10.3 23.5 16.9 7.3 20.6 19.2 21.5 17.4 9.9 32.0 13.5 12.3 16.4 15.3 20.1 21.5 25.8 15.7 10.6 16.8 23.5 28.7 13.5 22.4 9.5 14.5 4.1 13.4 13.0 10.6 24.4 14.5 18.1 40.2 40.2 31.0 19.0 10.8 18.4 13.9 28.4 7.2 15.7 19.5 9.8 32.9 21.3 15.3 28.2 19.3 9.4 11.5 71.0 20.9 25.7 10.6 24.3 ZNF721 KIAA1982 ENSG00000182903 "Zinc finger protein 721" Q8TF20 4 425815-499156 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA065313 Approved "Centriolar satellite,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Cytosol "Centriolar satellite" "HPA065313: AB_2685464" "unprognostic (2.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" "unprognostic (1.57e-1)" "unprognostic (6.91e-2)" "unprognostic (7.66e-2)" "unprognostic (1.51e-2)" "unprognostic (3.26e-2)" "unprognostic (3.48e-2)" "unprognostic (1.96e-2)" "unprognostic (3.43e-2)" "unprognostic (1.25e-1)" "unprognostic (5.12e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-3)" "prognostic favorable (2.76e-4)" 12.5 10.9 8.3 14.4 9.2 18.0 18.8 18.9 12.7 12.1 4.4 10.9 10.5 12.9 14.2 10.4 14.7 10.0 8.2 9.2 8.7 11.8 12.8 12.6 22.6 5.0 5.2 15.3 15.1 15.5 11.2 10.0 6.1 11.5 12.0 19.9 11.1 10.0 10.5 18.5 11.4 10.3 4.6 14.9 12.9 14.2 7.1 19.1 16.8 16.1 22.0 10.9 11.9 12.5 17.2 10.4 20.2 25.0 14.5 19.9 12.7 15.2 13.1 16.4 14.5 15.4 17.1 28.8 16.3 14.9 23.6 11.3 20.9 19.0 22.0 10.4 24.4 51.0 10.7 10.4 14.2 21.5 2.4 17.5 16.3 18.0 27.3 25.6 17.1 40.4 29.9 19.7 23.0 16.4 35.3 32.4 32.1 11.3 22.1 28.6 30.1 16.4 17.9 22.8 29.6 18.9 20.2 11.6 19.3 17.3 21.2 22.4 22.0 14.5 5.3 11.5 27.3 22.7 22.2 68.7 11.1 5.2 13.9 8.0 8.3 12.9 12.1 8.7 12.2 16.6 13.3 12.0 8.4 15.9 20.8 16.5 11.4 13.5 8.2 10.3 16.7 7.3 8.3 9.2 18.9 12.7 9.2 8.7 5.0 5.2 6.1 4.6 7.1 12.5 44.4 25.6 31.9 29.7 44.9 21.0 26.4 18.6 25.6 38.0 25.0 27.3 16.7 25.8 24.8 18.4 31.3 16.9 33.0 10.9 15.6 12.9 34.5 29.6 31.9 30.7 12.7 33.2 37.6 14.9 10.6 26.0 29.0 29.0 26.0 32.0 28.5 17.6 10.9 23.5 30.1 16.4 4.1 18.8 19.1 12.3 19.6 18.8 12.4 11.2 14.8 24.7 46.4 24.6 32.7 13.8 11.3 12.0 23.4 27.8 12.4 14.5 24.9 35.1 19.7 30.5 20.1 35.2 34.3 23.1 23.2 17.4 40.9 29.5 15.8 31.0 ZNF726 ZNF92P3 ENSG00000213967 "Zinc finger protein 726" A6NNF4 19 23914876-23945159 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.2;NK-cell: 3.1" "Group enriched" "Detected in many" 4 "granulocytes: 8.2;NK-cells: 3.1" "Cell line enhanced" "Detected in many" "MOLT-4: 29.6" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 12: Non-specific - Cell cycle regulation" "unprognostic (5.40e-2)" "unprognostic (2.27e-1)" "unprognostic (4.41e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.80e-1)" "unprognostic (2.91e-2)" "unprognostic (8.26e-4)" "unprognostic (5.65e-4)" "unprognostic (2.14e-2)" "unprognostic (9.87e-3)" "unprognostic (2.90e-2)" "unprognostic (4.25e-2)" "unprognostic (1.64e-1)" "unprognostic (4.97e-2)" "unprognostic (3.20e-3)" 1.2 1.3 2.5 1.8 1.8 5.8 4.2 3.8 2.3 2.9 0.9 1.9 1.2 2.2 5.1 2.4 1.7 2.1 0.7 2.0 2.6 2.8 2.2 1.6 4.2 1.9 2.2 1.4 0.7 2.1 0.6 3.4 2.2 2.5 3.9 3.2 1.3 2.0 1.6 4.8 1.3 1.0 1.6 2.5 3.0 2.9 3.4 6.1 2.2 1.0 3.4 1.7 2.8 2.5 1.1 1.9 16.3 9.0 1.1 1.1 0.8 4.0 1.4 8.7 8.3 1.4 5.3 0.1 7.5 1.7 6.3 1.2 15.2 0.2 11.8 11.3 8.0 6.6 1.5 0.4 0.6 0.1 3.8 1.2 0.9 5.2 0.3 1.0 0.0 9.5 5.2 0.1 3.3 5.6 29.6 19.8 9.8 0.1 8.4 21.6 12.1 4.8 3.0 6.6 5.4 9.1 0.0 0.1 4.1 7.9 10.5 1.3 1.1 3.1 2.3 13.5 8.5 0.1 9.2 13.1 0.1 2.4 4.5 8.2 0.4 0.2 0.4 0.5 0.2 0.7 1.0 1.0 0.4 1.0 1.0 1.2 0.8 3.1 0.3 1.1 1.2 0.6 2.5 1.8 3.8 2.3 2.0 2.6 1.9 2.2 2.2 1.6 3.4 2.5 0.6 3.2 0.0 2.9 2.4 0.9 1.6 0.2 0.6 3.8 2.4 1.3 4.5 1.5 1.1 3.7 0.0 7.2 2.9 1.5 1.9 1.4 0.1 1.8 2.4 2.2 0.0 9.0 1.0 0.2 6.7 1.8 0.0 2.6 3.8 5.3 1.4 2.0 2.2 5.0 2.4 0.7 2.0 1.9 2.0 0.3 0.3 1.2 0.0 0.0 0.8 0.6 3.1 5.0 2.9 0.6 0.3 1.9 1.4 0.9 0.1 0.5 2.5 1.2 0.0 1.7 1.7 2.3 6.0 2.0 1.7 4.1 2.4 1.8 0.5 1.5 ZNF737 ZNF102 ENSG00000237440 "Zinc finger protein 737" O75373 19 20535825-20565809 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 27.0;Inhibitory neurons: 25.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 26.4;RT4: 27.3" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "unprognostic (3.86e-2)" "unprognostic (1.61e-1)" "unprognostic (8.63e-2)" "unprognostic (3.42e-1)" "unprognostic (3.14e-2)" "unprognostic (1.23e-3)" "unprognostic (1.61e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-2)" "unprognostic (1.51e-2)" "unprognostic (2.62e-2)" "unprognostic (1.06e-1)" "unprognostic (1.33e-3)" "unprognostic (8.49e-2)" "unprognostic (8.28e-2)" "unprognostic (3.43e-2)" "unprognostic (1.47e-3)" 5.1 10.9 6.1 6.6 15.4 4.4 14.0 10.3 7.8 11.0 0.0 6.6 4.1 8.2 11.4 4.2 10.2 6.5 4.6 7.1 8.2 9.8 1.5 7.1 17.5 2.4 3.3 29.8 13.0 12.8 4.8 5.1 2.7 10.9 8.7 9.7 4.8 11.9 1.7 12.7 5.6 5.9 2.9 11.5 9.9 4.2 5.9 20.3 37.9 2.3 14.7 11.6 3.6 11.6 0.1 0.9 4.7 11.5 6.6 10.9 4.7 4.2 2.8 5.6 6.9 2.1 4.0 7.3 7.1 4.5 3.8 2.1 0.6 0.7 6.9 0.5 2.9 0.3 0.9 3.1 2.6 0.5 0.3 5.4 2.3 2.3 0.6 4.4 3.7 7.6 0.5 0.9 5.2 1.7 26.4 4.2 6.0 0.0 0.3 14.2 7.1 1.5 7.2 27.3 10.0 8.4 0.2 1.2 1.5 11.7 5.2 3.0 1.6 0.3 0.2 4.8 3.1 1.8 9.8 7.4 0.2 0.1 2.0 3.9 0.3 4.5 4.5 0.7 3.9 7.9 5.8 6.7 0.8 9.0 6.4 5.0 5.4 2.2 0.7 2.1 5.2 1.7 6.1 15.4 10.3 7.8 7.1 8.2 2.4 3.3 2.7 2.9 5.9 11.6 4.5 0.0 2.0 15.7 10.2 0.3 0.6 0.1 2.8 7.1 3.1 2.9 1.8 0.0 3.3 1.8 0.0 1.3 4.8 0.2 9.8 2.2 2.2 5.6 4.5 2.5 0.0 5.7 27.0 1.7 0.7 4.3 3.1 4.7 1.3 11.4 2.2 0.2 0.3 16.8 25.3 1.1 0.0 0.6 0.6 1.7 4.1 1.0 0.0 14.0 0.9 3.9 5.2 32.2 34.4 1.2 2.6 1.9 3.7 0.7 0.7 1.6 0.9 2.5 0.0 3.1 3.4 6.3 8.9 2.1 0.3 1.4 5.7 9.7 0.7 0.6 ZNF749 FLJ16360 ENSG00000186230 "Zinc finger protein 749" O43361 19 57435325-57447101 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 27.9;Excitatory neurons: 24.2;Inhibitory neurons: 21.1;Melanocytes: 23.2;Oligodendrocyte precursor cells: 18.1;Squamous epithelial cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 24.0" "HPA042082, HPA042091, HPA056001" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear membrane" "HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005" "unprognostic (2.54e-1)" "unprognostic (1.55e-1)" "unprognostic (6.67e-2)" "unprognostic (9.92e-2)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.87e-1)" "unprognostic (8.23e-2)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (9.27e-3)" "unprognostic (2.76e-2)" "unprognostic (3.05e-5)" "unprognostic (1.35e-1)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-1)" 1.3 1.2 1.6 1.8 1.4 1.4 1.7 3.6 1.5 1.1 1.0 1.0 1.5 1.3 0.9 1.4 1.6 0.9 1.0 1.6 1.2 1.1 1.6 1.0 1.8 0.8 1.1 1.7 1.1 1.5 1.1 1.3 1.1 1.2 0.9 4.0 1.5 0.9 1.3 2.2 1.2 1.1 0.3 1.6 1.2 1.3 1.2 1.9 1.3 0.4 1.6 1.3 1.3 1.7 2.8 6.2 5.5 5.9 1.3 1.3 2.3 1.6 1.1 2.6 4.6 2.5 2.0 5.4 1.5 1.6 1.9 2.1 4.9 4.2 3.8 2.3 24.0 4.6 6.5 3.0 1.9 5.6 3.0 1.9 4.6 3.1 7.7 2.5 1.3 5.6 4.7 6.4 2.0 1.3 6.6 2.4 5.6 1.8 8.8 6.9 7.8 4.2 1.4 6.5 5.7 4.7 3.2 2.0 1.5 4.2 2.9 1.8 1.5 5.0 3.7 1.7 4.8 5.0 6.8 5.8 2.8 2.4 3.2 0.2 0.4 0.1 0.6 0.9 0.9 0.9 1.1 0.8 1.1 0.8 1.2 0.8 0.2 0.6 0.4 0.5 0.8 0.8 1.6 1.4 3.6 1.5 1.6 1.2 0.8 1.1 1.1 0.3 1.2 1.7 1.1 3.2 1.1 7.2 6.7 2.4 1.3 2.9 27.9 1.2 4.0 2.9 0.5 7.2 3.2 0.0 0.0 0.9 2.3 0.4 3.9 1.1 1.0 7.1 1.4 2.3 3.0 8.8 24.2 0.4 0.6 2.5 10.7 3.5 0.0 1.2 1.1 4.0 0.8 3.3 21.1 1.7 2.0 0.8 1.6 0.1 0.6 1.9 23.2 5.6 0.7 0.2 0.0 18.1 10.6 0.8 0.3 0.0 11.6 0.9 3.8 8.1 3.4 0.8 6.6 1.8 2.0 1.2 1.8 35.9 3.1 0.8 4.3 0.3 1.1 1.1 ZNF765 ENSG00000196417 "Zinc finger protein 765" Q7L2R6 19 53389793-53430413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 27.8;Granulosa cells: 36.9;Leydig cells: 37.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "prognostic unfavorable (9.11e-4)" "unprognostic (4.56e-2)" "unprognostic (1.66e-1)" "unprognostic (7.05e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (1.17e-4)" "unprognostic (7.38e-2)" "unprognostic (6.76e-3)" "unprognostic (5.78e-2)" "unprognostic (1.75e-1)" "unprognostic (6.84e-2)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.31e-1)" "unprognostic (1.16e-1)" "unprognostic (2.89e-2)" 2.7 3.8 1.8 2.6 2.9 4.2 3.6 2.6 2.3 2.9 2.8 3.4 3.1 2.6 2.9 2.6 2.8 2.4 1.9 1.9 2.7 2.8 2.0 3.1 3.9 2.7 2.3 8.7 4.6 8.8 2.0 4.7 2.7 4.2 3.8 2.1 2.8 1.8 1.8 4.2 2.8 2.2 1.8 3.4 2.9 3.5 2.4 4.4 3.2 1.6 3.8 2.7 2.9 4.4 6.0 5.4 2.9 8.8 3.4 3.1 8.6 3.9 5.5 3.1 4.3 4.3 3.8 12.0 4.2 4.1 4.3 4.8 7.9 4.2 6.6 5.4 10.9 12.9 5.6 3.6 3.8 0.7 7.7 6.0 6.8 5.3 3.6 3.8 3.7 6.5 9.2 9.0 8.3 3.7 9.7 4.2 5.3 7.5 5.7 6.5 11.0 7.9 4.2 22.5 4.6 4.2 10.8 5.7 2.6 8.2 4.7 6.5 7.8 7.6 4.5 3.2 5.2 6.1 13.5 13.5 2.4 1.0 6.0 3.6 2.5 5.4 3.6 3.3 5.1 5.0 3.7 4.4 3.3 4.0 3.9 3.8 2.5 4.0 2.3 2.0 3.2 2.8 1.8 2.9 2.6 2.3 1.9 2.7 2.7 2.3 2.7 1.8 2.4 4.4 9.1 0.0 3.1 0.7 5.9 2.2 7.1 2.1 5.7 7.2 4.8 3.7 4.4 10.0 1.6 1.8 0.0 9.2 5.7 6.5 1.9 4.5 3.2 4.7 5.0 7.4 7.3 6.3 0.8 2.8 27.8 7.1 4.1 5.8 5.7 36.9 22.9 3.1 5.2 8.4 2.2 6.4 0.0 4.8 1.6 1.4 37.3 4.3 1.8 4.7 5.6 5.0 4.1 2.5 5.6 3.4 4.8 17.0 4.7 11.8 4.4 3.4 1.7 2.6 13.1 8.9 4.7 6.4 11.3 4.1 3.4 23.0 4.8 15.2 7.1 9.3 ZNF766 ENSG00000196214 "Zinc finger protein 766" Q5HY98 19 52269587-52296046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 83.6;Late spermatids: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044882, HPA063496" Uncertain Supported Centrosome NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Centrosome "HPA044882: AB_10965173, HPA063496: AB_2685024" "unprognostic (1.47e-1)" "unprognostic (1.04e-2)" "unprognostic (4.15e-1)" "unprognostic (1.20e-1)" "unprognostic (9.45e-2)" "unprognostic (9.28e-3)" "unprognostic (6.85e-3)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (6.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.26e-2)" "unprognostic (2.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.75e-1)" "unprognostic (3.85e-3)" 7.6 5.8 5.1 8.5 5.3 16.2 12.5 7.2 5.4 9.5 5.7 9.2 6.2 9.7 7.4 7.2 9.6 6.4 7.0 4.7 6.2 7.9 5.5 8.7 12.6 6.4 5.8 14.6 5.6 9.3 6.1 6.4 6.1 9.4 8.3 5.6 8.3 7.2 6.9 8.7 7.0 6.8 4.4 11.2 8.4 23.8 5.2 14.1 14.0 7.2 11.3 8.1 6.3 7.8 11.8 18.8 13.8 16.0 13.5 19.4 10.2 11.2 11.0 7.2 14.2 5.0 9.2 19.4 10.4 11.9 11.1 11.5 13.0 11.1 12.7 15.1 17.6 20.2 11.0 5.7 7.9 22.7 13.3 15.3 15.8 8.3 19.5 14.0 11.3 25.4 13.7 10.7 12.7 8.0 29.9 9.5 15.6 16.9 20.8 20.7 23.8 17.3 9.2 34.2 17.0 14.1 17.3 13.4 9.7 20.9 15.9 14.2 13.8 6.7 9.5 5.7 11.9 18.6 56.9 29.4 6.4 11.6 13.2 51.4 14.8 30.1 26.1 21.3 36.3 32.7 27.8 29.8 15.1 29.2 43.7 34.6 15.4 31.7 22.9 10.6 32.3 20.9 5.1 5.3 7.2 5.4 4.7 6.2 6.4 5.8 6.1 4.4 5.2 7.8 12.0 22.4 8.7 3.9 17.7 5.5 17.0 13.1 5.2 15.1 8.6 12.2 20.2 14.3 12.7 14.7 4.2 13.3 11.4 4.4 15.6 18.7 83.6 8.9 16.1 12.8 9.1 17.9 8.4 10.3 10.7 12.6 4.1 9.3 10.1 21.1 11.7 5.9 6.5 15.2 10.0 10.5 18.3 8.2 6.4 53.2 11.5 7.6 3.6 7.5 16.5 11.2 21.6 8.5 11.7 11.3 11.2 10.5 5.8 19.2 4.7 8.9 9.7 10.5 0.0 15.7 10.6 13.7 30.8 4.5 7.7 11.9 15.7 12.7 7.5 18.2 ZNF773 "MGC4728, ZNF419B" ENSG00000152439 "Zinc finger protein 773" Q6PK81 19 57499915-57518404 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003152 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716" "unprognostic (6.53e-2)" "unprognostic (3.79e-3)" "unprognostic (2.09e-1)" "unprognostic (1.29e-1)" "unprognostic (6.06e-2)" "unprognostic (2.07e-1)" "unprognostic (3.21e-2)" "unprognostic (5.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (9.50e-4)" "unprognostic (2.97e-2)" "unprognostic (3.56e-4)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (1.14e-1)" "unprognostic (3.71e-3)" 4.0 4.4 4.6 3.1 4.1 6.6 6.0 6.7 5.1 2.9 3.2 3.6 4.5 3.3 5.6 2.8 4.3 2.8 3.3 4.2 4.8 4.1 2.4 3.8 4.8 4.0 4.1 6.0 2.4 6.9 4.4 4.5 3.5 4.8 3.6 5.1 3.8 3.8 4.5 5.2 3.5 3.8 2.5 5.7 3.6 4.4 3.9 5.3 6.1 3.2 5.5 3.2 2.7 5.0 2.3 4.3 7.0 9.7 4.9 6.4 0.4 7.1 10.0 6.1 24.8 4.3 3.6 4.5 3.7 4.3 4.6 1.8 3.6 7.6 9.0 0.2 22.8 8.0 0.6 2.7 8.9 5.9 6.2 14.0 9.9 4.5 15.8 7.8 4.4 8.2 0.3 0.8 7.8 0.6 11.3 4.3 7.7 1.2 12.8 6.4 11.6 6.9 4.3 8.7 7.4 9.4 1.3 3.2 6.9 6.6 5.4 10.7 3.7 9.5 4.3 2.5 7.5 10.9 12.7 7.3 3.8 5.7 8.3 30.4 6.4 10.7 10.6 5.0 17.7 15.3 13.2 11.7 8.8 19.2 21.4 17.2 2.8 13.0 4.4 9.3 10.1 7.9 4.6 4.1 6.7 5.1 4.2 4.8 4.0 4.1 3.5 2.5 3.9 5.0 3.2 0.0 2.6 2.9 6.6 1.0 2.7 1.8 1.8 5.2 2.0 2.0 1.3 2.8 3.9 0.0 6.2 3.0 2.3 0.0 3.9 2.4 0.6 1.3 1.7 3.4 0.0 2.1 6.2 0.7 0.9 2.0 1.5 1.0 1.3 3.9 3.6 0.9 0.9 6.7 5.1 0.9 4.1 1.6 1.2 0.3 1.2 1.5 1.8 0.0 1.7 4.2 3.1 3.5 3.6 1.1 1.7 3.8 2.1 2.3 1.0 0.8 0.8 7.5 13.1 2.3 2.6 4.5 7.7 2.0 0.6 2.9 5.3 4.8 0.9 2.3 ZNF776 FLJ38288 ENSG00000152443 "Zinc finger protein 776" Q68DI1 19 57746815-57758148 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA046653, HPA068553" Uncertain Approved Nucleoplasm,Cytosol No No "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA046653: AB_10961126, HPA068553: AB_2686002" "unprognostic (6.73e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (3.99e-2)" "unprognostic (3.26e-1)" "unprognostic (6.35e-2)" "unprognostic (2.73e-2)" "unprognostic (1.62e-1)" "unprognostic (2.69e-2)" "unprognostic (2.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (7.45e-3)" "unprognostic (1.71e-3)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (6.86e-2)" 4.4 6.5 4.5 5.2 5.5 17.2 9.1 10.6 6.3 6.6 5.4 6.4 6.4 5.0 21.6 5.0 7.0 4.0 7.2 5.4 4.9 7.7 6.8 6.3 8.3 4.4 3.8 8.3 4.7 10.8 8.3 7.7 4.7 8.5 6.7 20.7 7.8 7.7 9.1 6.4 5.9 4.2 3.7 8.2 7.6 6.6 4.4 12.6 9.3 10.3 8.2 5.5 5.3 8.2 6.2 5.3 16.7 11.2 2.6 8.2 7.2 5.0 8.3 8.7 5.6 3.2 6.8 7.2 4.4 4.6 4.6 4.1 8.8 8.7 13.8 6.5 32.1 9.8 12.6 3.7 6.2 5.5 7.5 9.5 7.1 5.8 6.2 9.2 6.7 11.6 6.6 5.0 11.2 2.9 18.2 4.9 9.7 2.8 11.0 11.6 12.7 8.3 6.4 20.0 18.7 13.7 9.3 7.7 5.5 9.0 7.9 7.7 6.2 9.2 4.9 0.8 7.6 13.8 16.8 12.1 5.5 5.1 7.7 6.6 1.8 8.9 1.1 1.3 2.7 2.4 1.9 2.4 1.7 3.7 2.8 2.2 4.6 5.6 1.7 1.9 1.8 1.6 4.5 5.5 10.6 6.3 5.4 4.9 4.4 3.8 4.7 3.7 4.4 8.2 3.3 3.2 4.1 7.2 7.1 2.7 4.1 3.9 1.8 8.7 7.7 5.3 12.3 11.5 3.2 9.2 2.1 3.1 2.5 3.9 5.9 3.3 1.4 8.3 3.7 6.5 8.4 8.6 7.1 1.3 2.3 2.8 4.1 6.9 3.8 6.9 10.4 8.1 3.5 11.8 7.7 4.1 6.1 6.0 1.8 0.6 1.2 3.6 0.0 6.5 3.1 12.0 5.2 8.0 9.1 2.5 2.1 4.9 3.9 4.1 3.9 2.8 6.0 7.5 0.0 2.6 3.9 2.9 4.8 3.1 1.7 2.9 3.3 2.9 3.2 5.5 ZNF791 FLJ90396 ENSG00000173875 "Zinc finger protein 791" Q3KP31 19 12610918-12633840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021537 Uncertain Approved Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA021537: AB_2670741" "unprognostic (1.95e-1)" "unprognostic (4.88e-3)" "unprognostic (1.73e-2)" "unprognostic (7.58e-2)" "unprognostic (2.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.86e-2)" "prognostic favorable (9.07e-4)" "unprognostic (1.88e-2)" "unprognostic (1.59e-2)" "unprognostic (3.38e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" "prognostic favorable (1.39e-5)" 8.3 5.9 4.9 7.4 5.7 13.3 9.3 11.6 6.1 8.6 6.7 7.2 5.7 8.2 7.6 6.9 7.8 5.1 6.3 4.7 6.4 6.3 6.7 8.6 8.6 6.0 6.2 10.2 7.2 9.6 7.3 6.5 5.8 7.2 6.4 13.6 7.3 6.7 6.9 8.6 7.8 5.7 4.8 7.8 6.7 2.7 5.4 5.2 12.1 8.2 10.1 8.2 8.1 8.3 7.2 4.0 7.6 7.7 8.6 11.3 6.4 9.7 10.1 5.8 8.3 5.0 4.5 1.6 9.1 9.8 3.8 6.7 7.1 8.7 10.6 4.8 7.7 7.6 10.0 6.9 6.9 9.7 6.7 9.9 9.6 8.5 11.4 10.4 7.3 4.4 8.6 11.2 7.2 10.9 6.2 3.5 8.2 4.3 11.9 4.4 13.0 6.2 5.9 14.3 8.5 10.3 7.9 6.6 8.5 8.9 6.5 8.1 7.5 13.2 5.3 11.8 7.3 15.6 22.8 5.0 8.9 6.8 8.3 9.9 2.6 4.7 5.5 1.9 5.5 6.2 4.8 5.6 2.4 8.6 5.4 6.6 4.6 9.2 3.5 8.3 4.2 2.2 4.9 5.7 11.6 6.1 4.7 6.4 6.0 6.2 5.8 4.8 5.4 8.3 34.2 12.8 28.2 4.9 56.1 29.2 31.2 18.1 35.9 75.5 28.3 25.7 21.8 27.1 22.6 18.4 98.0 30.5 56.7 29.0 19.6 23.8 5.5 35.6 29.3 41.2 37.1 16.8 9.1 17.6 19.4 31.6 15.8 34.2 9.5 58.7 48.9 26.5 14.0 35.3 9.4 26.3 16.2 21.8 33.5 3.9 39.1 24.9 14.2 1.0 19.8 36.2 49.4 3.0 10.9 26.3 15.4 39.1 69.5 37.6 33.0 13.3 27.9 98.0 39.5 34.8 34.6 13.4 12.7 22.1 27.7 39.1 41.5 33.2 24.1 36.8 ZNF808 ENSG00000198482 "Zinc finger protein 808" Q8N4W9 19 52527652-52564464 "Predicted intracellular proteins, Transcription factors" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 13.1" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (4.11e-2)" "unprognostic (8.36e-2)" "unprognostic (1.93e-2)" "unprognostic (8.78e-2)" "unprognostic (2.44e-1)" "unprognostic (2.04e-2)" "unprognostic (2.83e-2)" "unprognostic (2.05e-2)" "unprognostic (2.80e-3)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (1.54e-1)" "unprognostic (7.14e-3)" "unprognostic (7.19e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (7.82e-4)" "prognostic favorable (3.88e-4)" 1.6 1.1 1.4 2.3 3.2 6.6 2.2 2.9 1.5 2.9 7.6 2.9 2.4 2.8 3.2 1.5 3.1 2.2 3.1 2.0 1.8 3.4 1.5 2.8 2.8 2.0 3.0 3.9 1.2 4.3 0.9 2.9 2.7 2.5 3.7 4.0 2.1 2.3 3.1 2.2 2.4 2.3 0.4 4.2 3.1 3.6 1.4 3.7 5.2 6.1 2.2 2.4 1.6 2.7 2.3 0.2 1.7 5.0 2.9 5.3 4.5 2.3 2.8 2.4 4.8 4.6 2.5 4.3 1.8 3.0 4.1 1.8 4.2 2.9 4.1 1.1 3.9 5.1 6.0 0.2 1.2 0.2 6.1 3.1 1.0 3.2 2.6 4.1 3.2 5.3 2.9 0.0 2.1 1.4 5.4 1.9 2.3 3.0 1.2 1.6 3.4 2.2 1.0 13.1 1.9 2.3 5.9 2.9 2.0 5.7 3.7 2.4 2.9 2.2 2.2 2.2 2.8 0.7 11.6 9.1 0.0 1.3 3.5 12.6 4.6 10.0 5.4 4.0 6.4 7.1 4.6 5.3 3.4 5.9 5.4 5.1 10.9 7.3 3.3 4.8 3.8 2.1 1.4 3.2 2.9 1.5 2.0 1.8 2.0 3.0 2.7 0.4 1.4 2.7 7.9 6.4 6.5 19.6 8.4 1.9 5.5 2.7 8.0 8.4 3.0 3.0 19.8 4.3 7.6 0.0 6.2 6.4 11.6 9.8 7.9 2.9 3.8 14.2 6.6 7.5 4.2 4.2 13.1 1.5 5.4 5.1 11.7 7.9 2.5 6.4 4.2 2.5 3.5 8.4 13.5 6.7 8.2 6.6 3.9 1.8 1.2 6.0 3.6 12.2 6.0 3.6 21.6 15.6 16.9 2.0 6.8 2.6 7.0 5.2 8.0 3.8 8.3 11.4 0.0 5.8 6.7 5.3 8.2 6.7 2.7 3.6 9.1 3.9 5.0 6.5 ZNF845 ENSG00000213799 "Zinc finger protein 845" Q96IR2 19 53333749-53356906 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (4.85e-3)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (5.78e-2)" "unprognostic (1.07e-3)" "unprognostic (9.79e-2)" "unprognostic (3.12e-3)" "unprognostic (1.05e-1)" "unprognostic (7.52e-2)" "unprognostic (2.46e-2)" "prognostic favorable (3.98e-4)" "unprognostic (3.13e-1)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (1.65e-1)" 2.6 1.7 1.0 2.7 1.5 5.0 4.1 2.1 1.4 2.9 1.3 2.9 2.5 2.2 2.4 2.5 2.9 2.0 2.1 1.0 1.4 2.5 1.5 2.9 4.3 1.4 1.3 4.2 2.0 3.6 0.9 3.0 1.3 2.9 3.1 1.3 2.1 2.4 0.6 3.1 2.6 2.0 1.0 3.6 3.6 2.3 1.3 4.2 3.7 2.0 3.8 2.7 2.3 2.0 4.7 5.6 3.3 5.1 4.5 4.6 9.0 3.8 5.4 4.1 6.0 4.4 3.5 7.8 3.3 4.1 5.0 5.2 6.1 6.0 6.5 2.3 9.5 9.1 3.6 3.7 4.6 0.0 6.2 4.6 5.9 4.6 6.4 3.6 5.1 6.2 6.6 0.0 5.8 4.8 10.1 3.3 6.1 7.4 5.8 6.9 9.2 5.5 3.0 15.2 4.9 3.0 12.0 6.0 2.9 7.7 4.4 6.2 4.8 6.8 4.4 3.5 4.5 5.4 8.1 12.7 1.3 5.1 6.7 1.3 1.6 2.3 2.2 2.3 3.3 3.3 2.5 3.4 1.8 2.0 3.3 3.1 1.3 2.3 1.4 1.3 3.8 1.9 1.0 1.5 2.1 1.4 1.0 1.4 1.4 1.3 1.3 1.0 1.3 2.0 3.6 0.0 6.1 1.6 3.5 0.4 1.7 1.0 3.4 1.4 3.0 2.8 3.1 2.8 3.8 1.8 4.2 2.7 6.5 4.5 1.9 2.8 0.4 2.1 2.4 2.8 0.0 3.6 1.0 3.6 1.9 3.5 1.5 2.8 1.3 5.7 4.2 1.2 2.4 3.3 1.3 2.7 0.0 3.8 1.7 0.1 2.1 2.6 3.6 4.7 3.4 1.4 2.1 1.0 3.6 2.5 2.1 1.2 2.3 1.9 3.1 2.2 3.5 0.6 0.0 2.0 2.8 0.9 2.8 1.3 1.8 7.7 3.0 2.4 2.0 1.8 ZNF852 ENSG00000178917 "Zinc finger protein 852" Q6ZMS4 3 44494847-44510636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 9.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA048312, HPA071850" Uncertain Approved Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "HPA048312: AB_2680352, HPA071850: AB_2686458" "unprognostic (2.64e-1)" "unprognostic (2.62e-1)" "unprognostic (5.93e-3)" "unprognostic (1.73e-1)" "unprognostic (2.29e-2)" "unprognostic (1.30e-3)" "unprognostic (3.47e-2)" "unprognostic (2.55e-2)" "unprognostic (5.11e-2)" "unprognostic (1.43e-1)" "unprognostic (3.80e-2)" "unprognostic (1.03e-1)" "unprognostic (6.62e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (8.05e-2)" "unprognostic (1.11e-2)" 1.3 1.4 0.7 2.5 0.6 1.6 2.1 3.4 0.9 2.0 3.6 1.9 1.7 2.2 1.7 0.9 1.6 1.3 0.5 0.8 1.1 1.7 1.7 1.8 2.5 0.9 0.7 2.5 2.1 2.9 0.8 2.3 1.1 2.6 3.1 0.9 3.7 2.1 0.5 2.5 2.0 1.9 0.3 2.7 3.0 1.3 1.2 2.9 1.7 0.9 3.2 1.1 0.8 0.7 1.0 1.4 3.9 6.6 0.8 2.3 2.4 1.0 1.3 2.1 3.1 2.1 1.1 3.2 0.7 0.8 0.9 0.8 4.3 1.1 2.8 2.8 1.5 3.1 6.5 1.9 1.2 3.3 5.7 0.8 1.9 2.7 1.1 2.2 1.7 3.3 3.7 1.4 2.5 0.2 3.0 3.8 2.4 1.2 0.8 1.5 4.3 1.9 1.6 3.2 3.0 2.5 2.2 0.9 0.7 6.6 2.2 3.5 2.8 2.6 2.5 1.4 1.0 2.4 1.9 1.9 1.1 2.6 1.7 0.0 0.4 0.7 0.2 0.5 0.3 1.1 0.5 0.3 0.2 0.9 0.5 0.7 0.6 0.4 0.2 1.4 0.2 0.1 0.7 0.6 3.4 0.9 0.8 1.1 0.9 0.7 1.1 0.3 1.2 0.7 2.0 0.0 5.4 5.9 2.3 3.3 0.8 0.9 1.2 2.1 1.5 1.5 1.8 2.8 1.4 0.0 2.1 0.8 5.1 0.8 3.9 1.9 0.3 2.6 1.6 2.0 0.0 3.2 5.7 1.4 0.9 1.4 1.1 1.5 1.3 1.8 2.2 1.4 0.7 1.7 6.8 0.9 2.0 0.3 1.0 0.4 0.6 1.4 1.8 1.9 1.4 2.8 3.1 9.0 9.2 1.5 0.1 1.2 6.8 1.1 1.0 1.0 4.2 1.6 0.0 2.4 1.6 2.0 1.6 0.5 1.8 0.3 2.3 1.6 0.8 0.9 ZNF878 ENSG00000257446 "Zinc finger protein 878" C9JN71 19 12043805-12052961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.0;Cytotrophoblasts: 1.2;Spermatogonia: 1.2;Syncytiotrophoblasts: 1.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2" HPA052735 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm Nucleoli "HPA052735: AB_2681932" "unprognostic (3.27e-2)" "unprognostic (1.76e-1)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (1.56e-2)" "unprognostic (3.00e-4)" "unprognostic (1.42e-1)" "unprognostic (7.43e-3)" "unprognostic (2.80e-1)" "unprognostic (6.67e-2)" "unprognostic (8.75e-2)" "unprognostic (3.02e-1)" "unprognostic (7.65e-3)" "unprognostic (6.82e-2)" "unprognostic (4.04e-1)" "unprognostic (3.62e-2)" 0.3 0.3 0.1 0.2 0.0 1.3 0.2 0.7 0.4 0.4 0.1 0.3 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.1 1.1 0.2 0.4 0.2 0.2 0.2 0.5 0.5 0.1 0.2 0.7 0.2 0.3 0.2 0.4 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.3 0.3 1.0 0.3 0.2 0.3 0.1 0.1 0.3 0.2 0.0 1.5 0.0 0.8 3.2 0.0 0.0 2.0 0.5 0.2 0.6 0.8 1.3 0.2 0.7 0.7 0.2 0.9 0.4 0.3 0.5 0.5 0.0 0.5 0.9 0.0 1.7 0.0 0.6 1.6 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 1.6 0.9 1.8 0.0 0.2 1.2 1.6 0.0 1.1 1.2 0.8 0.1 0.0 0.0 0.1 1.7 1.7 2.1 0.0 0.9 0.7 0.7 0.9 0.6 2.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.0 0.8 0.0 0.0 0.0 0.0 1.2 0.3 0.1 0.0 0.3 0.1 0.2 0.2 0.4 0.0 0.0 0.2 0.2 0.9 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.3 0.4 1.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 ZNF880 ENSG00000221923 "Zinc finger protein 880" Q6PDB4 19 52369917-52385795 "Predicted intracellular proteins, Transcription factors" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 38.9" HPA077316 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "HPA077316: AB_2686833" "unprognostic (2.66e-3)" "unprognostic (2.19e-2)" "unprognostic (2.55e-1)" "unprognostic (3.99e-2)" "unprognostic (7.72e-2)" "unprognostic (1.54e-2)" "unprognostic (7.61e-2)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (2.52e-1)" "prognostic favorable (4.33e-8)" "unprognostic (4.14e-2)" "unprognostic (4.99e-1)" "unprognostic (1.77e-1)" "unprognostic (5.60e-3)" 12.5 11.0 8.6 10.9 10.4 17.7 13.5 23.7 10.6 11.9 7.0 11.6 5.7 13.1 11.2 6.3 12.1 10.7 17.5 8.7 9.2 15.1 3.6 11.2 14.7 11.2 11.2 18.4 7.2 5.3 10.4 10.0 12.0 17.1 8.8 16.0 10.8 13.0 7.1 11.2 10.0 11.9 9.4 14.4 9.5 9.9 11.4 15.3 18.1 7.9 14.3 13.5 8.8 12.7 0.3 1.6 19.1 16.0 10.8 29.1 21.9 13.5 13.9 9.2 17.7 0.4 9.1 0.3 4.8 22.2 19.1 3.2 0.1 12.5 14.5 0.3 24.2 0.6 1.0 0.0 12.7 0.5 16.7 23.1 15.6 16.7 0.0 1.1 14.7 1.7 1.7 0.7 18.4 1.3 2.0 1.2 27.6 0.0 3.3 1.4 38.9 1.4 25.8 20.8 14.9 18.8 0.1 4.0 5.9 35.2 0.7 4.3 11.8 0.6 0.4 4.2 12.7 0.8 8.0 0.6 0.4 0.4 26.8 80.3 12.9 31.9 25.1 12.9 32.4 50.3 31.8 27.2 20.9 53.4 37.9 33.0 5.2 26.2 15.2 41.2 37.2 17.5 8.6 10.4 23.7 10.6 8.7 9.2 11.2 11.2 12.0 9.4 11.4 12.7 13.3 12.8 3.9 4.2 15.2 5.9 22.6 22.6 10.8 15.9 7.2 9.7 13.1 4.3 20.4 20.2 12.5 9.9 12.4 2.2 29.4 18.8 12.8 19.2 10.6 10.8 0.0 5.9 3.5 14.8 14.8 11.9 5.6 13.5 10.1 6.0 9.3 1.5 7.0 23.5 4.2 6.2 18.3 4.9 9.8 5.3 13.7 8.2 8.8 1.9 13.9 12.1 32.0 4.5 5.8 20.8 7.9 6.4 2.8 23.3 2.3 8.4 11.3 16.7 19.7 12.3 14.0 4.6 10.1 4.3 7.1 14.4 13.5 5.2 4.0 23.5 ZNF90 HTF9 ENSG00000213988 "Zinc finger protein 90" Q03938 19 20077994-20127076 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 217.1;Langerhans cells: 329.2;Smooth muscle cells: 451.1;Suprabasal keratinocytes: 280.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 10.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 9.5;NB-4: 7.9;NTERA-2: 17.0;SuSa: 10.5;U-2197: 7.0" HPA003227 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Golgi apparatus" "HPA003227: AB_1859471" "unprognostic (4.52e-2)" "unprognostic (2.64e-3)" "unprognostic (3.93e-1)" "unprognostic (2.45e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-2)" "unprognostic (7.34e-3)" "unprognostic (4.95e-1)" "unprognostic (4.44e-3)" "unprognostic (2.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-4)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (9.10e-2)" "unprognostic (2.60e-2)" 0.3 0.2 0.1 0.6 0.3 0.6 0.5 1.0 0.2 0.8 0.2 0.5 0.2 0.9 0.6 0.4 0.8 0.3 0.3 0.1 0.2 0.5 0.1 0.7 1.2 0.3 0.2 1.5 0.9 1.8 0.3 1.2 0.3 0.6 0.7 0.0 0.3 1.4 0.2 1.1 0.6 0.6 0.1 0.5 0.8 0.6 0.3 0.8 1.9 0.0 0.8 1.0 0.7 0.4 0.0 0.0 3.7 9.5 0.0 0.0 0.0 0.9 0.3 3.3 4.0 3.2 2.3 1.3 1.7 0.6 2.5 1.1 0.0 0.5 5.7 0.0 0.9 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 3.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.8 7.9 17.0 0.0 0.0 0.0 3.1 0.4 2.3 3.3 0.0 3.9 0.0 1.4 0.2 10.5 1.8 0.0 0.0 1.0 0.0 7.0 3.7 0.0 1.5 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.2 0.1 0.2 0.3 0.2 0.3 0.1 0.3 0.4 2.2 6.4 8.4 1.0 31.7 217.1 112.5 32.7 2.8 0.6 7.8 6.6 1.9 50.1 16.7 7.3 2.1 87.5 25.1 4.8 17.6 2.3 8.2 1.9 4.9 28.8 8.5 26.7 0.5 2.0 99.1 27.6 1.5 4.5 1.3 9.3 54.3 57.1 47.8 0.0 0.7 16.9 14.2 107.1 329.2 24.2 60.9 14.9 124.5 5.6 34.6 2.2 44.3 1.5 2.9 1.2 12.3 34.6 1.8 87.8 8.4 14.0 8.6 2.5 19.7 45.2 451.1 8.6 16.7 1.9 280.3 81.5 40.1 16.0 19.0 66.4 ZNF92 "HPF12, TF12" ENSG00000146757 "Zinc finger protein 92" Q03936 7 65373799-65401136 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003173 Approved Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "unprognostic (8.53e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (5.48e-3)" "unprognostic (1.30e-2)" "unprognostic (3.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.40e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-3)" 2.7 4.5 2.9 5.5 3.5 16.5 10.4 5.8 4.9 5.1 1.4 4.1 4.0 3.5 4.5 5.5 3.3 4.0 2.9 2.8 3.4 3.5 3.2 3.2 10.9 3.6 3.5 5.5 3.6 4.9 2.0 3.7 3.8 3.6 4.5 3.0 2.7 3.3 2.7 3.1 4.5 2.4 4.2 6.7 5.1 5.2 3.5 10.2 6.0 4.2 9.6 3.8 2.4 4.9 7.6 5.0 21.7 21.6 5.4 6.6 10.4 6.1 4.6 6.6 9.6 9.3 10.9 29.3 11.6 3.4 10.0 7.3 17.2 4.2 10.7 11.1 11.4 13.1 2.7 9.3 2.0 16.2 12.1 5.6 3.6 6.1 4.7 8.9 8.3 15.4 17.3 11.7 9.7 2.2 23.7 17.6 29.3 7.9 6.9 21.3 12.8 9.9 7.3 15.1 18.5 14.0 9.4 14.6 7.0 20.7 10.3 21.5 6.1 7.7 6.9 4.6 8.8 7.4 6.9 41.8 5.1 12.6 6.9 4.7 1.3 3.5 2.1 1.8 4.4 8.5 3.2 3.2 1.9 7.1 3.8 4.1 1.1 7.7 2.5 1.9 5.0 1.7 2.9 3.5 5.8 4.9 2.8 3.4 3.6 3.5 3.8 4.2 3.5 4.9 13.9 9.6 1.1 3.9 44.9 5.6 7.2 3.1 8.6 8.2 15.9 11.6 5.2 5.7 6.2 5.5 0.0 6.5 35.4 4.6 11.7 7.9 1.3 5.8 11.2 9.3 7.2 13.5 7.7 4.7 5.4 9.6 6.6 11.9 11.4 17.0 9.3 2.2 4.5 5.0 11.1 8.2 6.1 6.3 3.8 2.2 7.2 11.7 5.4 3.7 10.8 11.8 14.4 12.1 12.3 6.4 7.4 6.4 17.6 6.7 2.4 5.0 2.1 5.0 0.0 11.1 10.2 25.1 24.8 5.1 3.8 4.9 23.2 16.4 6.2 7.1 ZNF93 "FLJ12488, HPF34, TF34, ZNF505" ENSG00000184635 "Zinc finger protein 93" P35789 19 19900913-19963464 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 35.2" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.49e-1)" "unprognostic (2.28e-2)" "unprognostic (9.05e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-2)" "unprognostic (8.25e-2)" "unprognostic (4.88e-3)" "unprognostic (1.66e-1)" "unprognostic (6.80e-5)" "prognostic favorable (9.31e-6)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (3.18e-6)" "unprognostic (7.35e-2)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (6.06e-2)" 1.7 1.1 1.3 3.6 2.4 3.2 3.4 4.0 2.2 3.3 0.5 2.1 1.1 4.6 3.0 1.4 2.0 3.2 1.3 1.1 1.2 2.2 1.1 1.9 5.1 1.1 0.9 4.5 3.1 1.9 1.1 3.1 1.0 3.0 2.8 3.4 2.0 2.2 1.8 4.1 1.6 4.0 0.6 3.1 2.4 4.0 1.5 6.2 7.1 1.5 5.0 3.3 1.4 2.4 0.1 0.0 19.1 21.8 1.9 1.7 18.3 7.6 4.2 15.9 19.3 4.6 4.0 5.6 6.4 4.4 13.3 0.7 0.0 0.4 19.8 0.2 1.0 0.1 0.7 0.4 1.4 0.1 0.3 2.8 1.5 14.6 1.4 2.9 0.5 0.2 3.7 0.7 15.5 2.1 24.1 11.7 35.2 0.0 4.4 21.5 19.0 8.0 4.5 12.7 10.8 7.9 0.4 1.9 3.5 21.5 6.4 13.5 0.4 15.6 0.7 15.8 11.0 2.7 11.6 13.9 0.3 3.0 5.4 3.9 2.5 7.2 1.1 3.0 1.5 4.0 2.1 1.8 2.5 6.0 2.9 1.6 5.3 4.0 3.1 2.2 4.0 1.4 1.3 2.4 4.0 2.2 1.1 1.2 1.1 0.9 1.0 0.6 1.5 2.4 3.0 3.2 2.0 2.6 5.1 1.0 5.2 1.0 0.0 1.5 3.5 4.6 3.3 2.8 2.7 1.8 2.1 5.0 1.8 1.1 7.9 5.7 3.4 6.5 3.8 3.1 0.0 2.1 2.2 6.2 14.7 3.6 2.6 9.2 7.0 15.2 1.4 0.1 8.4 3.3 3.7 2.0 4.1 3.7 2.2 1.5 1.2 5.2 1.8 1.9 5.4 2.4 2.1 7.1 4.1 5.2 0.8 3.0 5.8 2.6 0.5 1.7 3.5 2.9 0.0 1.1 5.7 9.6 10.5 2.5 2.7 5.1 2.8 3.1 2.0 3.9 ZRANB2 "ZIS, ZIS1, ZIS2, ZNF265" ENSG00000132485 "Zinc finger RANBP2-type containing 2" O95218 1 71063291-71081289 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053960, HPA061949, HPA063298" Supported Enhanced Nucleoplasm NA Yes 13000 "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979" "unprognostic (2.10e-1)" "unprognostic (7.54e-2)" "unprognostic (4.15e-3)" "unprognostic (8.11e-2)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (4.25e-3)" "unprognostic (1.24e-2)" "unprognostic (7.79e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (1.57e-8)" "unprognostic (3.96e-2)" "unprognostic (8.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-3)" 41.0 39.4 29.7 45.3 31.1 60.0 52.6 36.9 47.0 45.0 36.8 40.8 35.5 70.7 67.6 29.3 45.4 29.6 42.7 30.7 29.1 35.3 30.2 40.4 62.5 32.0 27.7 56.7 33.8 33.2 64.5 36.3 31.6 44.2 42.9 62.1 39.5 38.0 58.9 43.4 37.9 50.1 29.3 42.6 35.6 50.4 30.3 47.6 48.5 38.9 49.3 37.9 35.2 38.8 86.8 31.1 122.3 73.0 46.5 79.8 71.0 103.2 55.6 89.2 113.2 58.7 55.5 177.6 89.0 64.2 82.7 53.5 111.1 63.9 133.4 127.5 79.9 154.5 127.3 50.0 70.8 171.5 62.7 61.7 80.3 86.1 73.5 98.1 76.3 90.3 165.1 93.6 69.6 29.3 145.0 58.4 128.7 52.9 59.6 159.8 92.3 108.4 60.5 72.6 93.8 58.3 88.7 58.8 91.4 63.7 74.7 76.8 102.5 65.9 62.1 51.9 103.8 75.7 100.6 193.8 96.4 160.3 94.6 99.1 33.4 32.1 44.5 32.3 51.2 68.8 47.5 44.0 26.8 63.1 61.2 48.7 30.7 48.2 33.8 73.4 49.6 31.2 29.7 31.1 36.9 47.0 30.7 29.1 32.0 27.7 31.6 29.3 30.3 38.8 86.9 99.3 154.5 83.6 109.8 50.6 94.4 66.1 59.7 166.5 61.4 66.5 99.9 50.1 68.4 49.7 129.3 55.1 136.9 85.8 49.0 60.2 190.3 79.9 123.5 63.5 73.0 87.1 135.3 68.2 50.4 92.6 62.7 85.7 87.4 132.8 50.7 41.8 45.4 213.7 114.7 64.5 54.9 34.5 39.7 46.2 185.4 55.7 48.0 73.1 74.8 116.6 139.0 90.5 131.9 69.2 76.5 115.5 127.5 54.8 41.2 41.1 76.5 202.2 118.3 88.1 99.2 218.7 113.0 55.3 46.5 63.5 89.6 96.4 55.1 68.5 ZSCAN12 "dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96" ENSG00000158691 "Zinc finger and SCAN domain containing 12" O43309 6 28378955-28399734 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006637, HPA007018" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA006637: AB_1080646, HPA007018: " "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (8.35e-4)" "unprognostic (1.51e-2)" "unprognostic (9.99e-2)" "unprognostic (1.00e-3)" "unprognostic (4.73e-2)" "unprognostic (9.96e-2)" "unprognostic (1.91e-2)" "unprognostic (2.35e-1)" "unprognostic (4.44e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (8.71e-2)" 2.4 2.3 1.8 2.6 2.0 2.2 5.6 3.6 2.5 3.6 1.6 2.9 2.5 4.3 3.6 1.8 3.0 2.3 2.4 1.8 2.2 2.9 1.6 2.9 4.7 1.7 2.1 5.5 3.2 4.0 2.0 3.6 1.6 4.3 2.9 6.8 3.1 3.7 0.9 1.8 2.7 3.6 1.6 3.9 2.9 4.1 2.2 5.1 5.1 1.7 4.1 3.1 2.9 2.0 5.5 1.8 8.1 0.1 4.1 3.2 5.7 3.7 5.1 5.5 7.6 1.2 2.0 5.3 6.8 2.6 2.8 2.4 0.0 4.6 5.6 0.0 6.6 7.6 5.6 3.8 3.8 2.7 1.8 4.2 4.3 5.5 9.9 6.0 1.5 0.0 11.4 1.1 3.5 0.6 0.0 6.1 5.1 0.5 0.9 9.2 7.3 1.4 4.1 3.5 9.8 10.0 1.9 4.3 6.4 8.0 1.7 6.7 1.5 2.2 4.6 1.7 3.0 3.1 3.4 1.0 1.9 0.7 3.4 2.4 0.7 1.5 1.5 0.4 1.4 1.8 1.1 1.8 1.0 2.7 1.8 1.6 0.2 1.8 0.8 0.9 0.9 0.8 1.8 2.0 3.6 2.5 1.8 2.2 1.7 2.1 1.6 1.6 2.2 2.0 2.1 6.4 5.1 4.6 4.0 0.4 1.1 0.9 0.6 6.1 2.6 2.5 3.2 1.5 6.5 0.0 4.2 1.5 3.6 0.3 1.9 1.7 31.8 0.6 2.4 1.9 1.2 2.1 6.9 2.6 1.0 2.7 1.5 0.9 1.3 5.5 3.3 1.0 1.0 6.7 7.0 1.2 0.0 1.3 1.1 9.7 1.8 1.1 1.8 1.0 1.8 4.9 2.1 10.1 6.2 1.3 0.3 3.4 2.4 1.5 1.5 1.2 0.6 6.0 6.6 1.7 2.4 12.6 3.9 1.2 0.3 0.5 1.5 4.2 2.1 0.7 ZSCAN25 "FLJ32468, ZNF498" ENSG00000197037 "Zinc finger and SCAN domain containing 25" Q6NSZ9 7 99616946-99632408 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 34.6;Excitatory neurons: 48.1;Inhibitory neurons: 44.9;Microglial cells: 32.8;Oligodendrocyte precursor cells: 47.7;Oligodendrocytes: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055127, HPA057173" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoli fibrillar center" Nucleoplasm "HPA055127: AB_2682706, HPA057173: AB_2683360" "unprognostic (2.21e-3)" "unprognostic (3.96e-2)" "unprognostic (4.45e-1)" "unprognostic (3.92e-2)" "unprognostic (5.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (1.57e-3)" "unprognostic (3.97e-2)" "unprognostic (8.44e-2)" "unprognostic (3.82e-3)" "unprognostic (9.98e-2)" "unprognostic (1.10e-2)" "unprognostic (5.21e-2)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (7.19e-3)" 4.2 4.0 2.8 4.8 2.7 6.4 5.0 3.3 3.1 4.9 3.1 4.4 3.3 5.1 2.3 4.7 5.1 3.3 3.0 2.6 2.5 3.9 3.3 3.8 6.0 2.8 2.3 7.7 4.5 5.7 3.1 4.1 2.5 4.7 3.6 2.7 4.5 5.4 4.5 6.1 4.1 4.8 2.2 5.1 3.9 5.3 2.8 9.5 4.6 3.9 5.3 4.3 4.3 3.1 7.6 3.5 10.0 11.5 4.3 3.3 9.8 8.2 6.9 9.3 9.6 9.3 6.1 10.6 9.3 6.9 8.5 9.7 11.0 9.5 11.5 6.1 9.4 7.1 5.8 8.1 7.4 16.6 6.3 5.2 11.7 7.4 7.7 3.7 6.0 11.7 20.4 8.3 6.6 8.4 24.0 23.4 18.4 4.2 8.3 10.0 10.3 11.4 4.0 10.3 6.8 16.8 10.8 16.2 11.7 11.8 4.5 11.2 4.3 14.4 11.6 8.3 14.0 7.4 12.8 18.2 7.8 10.2 21.6 3.5 2.4 3.2 4.3 2.6 5.3 1.9 3.0 4.2 1.9 1.6 5.0 5.1 2.9 2.8 2.4 1.6 4.7 3.3 2.8 2.7 3.3 3.1 2.6 2.5 2.8 2.3 2.5 2.2 2.8 3.1 3.9 0.0 6.2 34.6 4.6 3.4 1.8 2.6 2.8 4.9 4.0 4.4 4.2 2.8 1.5 1.8 8.4 4.3 5.1 5.2 1.9 2.9 5.2 2.3 4.6 3.9 2.4 5.5 48.1 2.8 3.4 3.3 3.6 3.5 5.1 4.5 4.2 3.6 3.6 5.0 44.9 4.4 6.1 6.0 1.4 2.7 3.7 2.0 1.8 32.8 3.9 2.3 4.1 47.7 44.4 2.1 3.1 6.0 5.5 3.0 3.7 2.4 2.5 4.7 6.6 4.0 3.9 10.0 7.6 4.0 2.3 1.9 6.2 4.7 3.7 1.7 ZSWIM3 "C20orf164, dJ337O18.7, PPP1R174" ENSG00000132801 "Zinc finger SWIM-type containing 3" Q96MP5 20 45857614-45879122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 7.6;Inhibitory neurons: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055692, HPA060508" Uncertain Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Vesicles "Nucleoli fibrillar center, Cytosol" "HPA055692: AB_2682887, HPA060508: AB_2684297" "prognostic unfavorable (9.32e-5)" "unprognostic (8.53e-2)" "unprognostic (3.55e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (4.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.77e-3)" "unprognostic (4.49e-2)" "unprognostic (2.20e-1)" "unprognostic (1.36e-2)" "unprognostic (2.72e-3)" "unprognostic (9.28e-2)" "unprognostic (4.74e-2)" "unprognostic (5.55e-2)" "unprognostic (1.76e-1)" "unprognostic (4.69e-2)" "unprognostic (4.13e-2)" 1.3 2.9 2.3 2.0 2.2 0.7 1.8 2.8 2.5 1.8 1.4 2.3 2.4 1.9 2.8 1.8 2.1 1.5 2.0 2.1 2.3 1.8 2.3 1.9 3.4 2.0 2.1 2.7 1.5 2.2 1.9 1.7 2.1 1.9 2.3 3.3 1.8 1.6 1.4 2.2 2.4 1.7 2.0 3.2 1.8 3.2 2.2 3.5 1.9 2.4 3.9 1.6 1.4 2.1 1.7 1.4 4.1 2.4 4.9 3.5 2.4 2.6 3.1 4.7 4.6 5.9 2.6 5.3 8.8 2.2 2.3 2.8 5.9 2.8 3.5 3.3 2.5 5.1 2.6 3.8 5.9 2.9 6.7 3.2 3.1 3.6 2.2 5.0 4.1 4.6 4.8 2.5 3.6 8.5 4.0 5.8 1.6 3.9 5.6 3.9 3.8 4.0 1.3 1.0 5.4 2.7 4.2 4.8 3.3 3.1 2.3 7.6 4.1 4.7 1.5 1.8 1.6 5.4 3.0 3.4 4.0 3.4 1.5 1.0 1.1 1.6 1.3 1.5 2.8 2.1 1.5 2.0 1.9 1.8 1.4 1.9 0.8 1.7 4.8 1.1 2.4 1.1 2.3 2.2 2.8 2.5 2.1 2.3 2.0 2.1 2.1 2.0 2.2 2.1 1.6 3.2 1.1 4.6 4.1 0.4 0.3 0.7 0.6 4.4 1.1 1.0 1.3 0.0 0.5 1.8 0.0 1.3 1.4 2.8 0.0 1.2 0.5 0.6 1.2 1.8 2.4 0.8 7.6 1.4 0.6 1.4 1.5 1.0 0.0 5.2 2.2 0.8 1.0 0.0 9.2 1.1 0.0 1.3 1.4 0.7 0.3 1.1 0.0 6.5 0.6 2.8 0.0 7.1 7.0 0.6 0.3 1.2 2.6 0.2 2.0 1.2 0.5 4.3 0.0 1.3 1.2 2.4 4.3 1.3 0.3 0.8 3.1 4.7 0.9 0.4